molecule,cas,best_match_url,results,query_url,query_type,Highest Development Event Status and Year,Highest Development Event Source ID,Highest Development Event Source URL,Earliest Approved Event Status and Year,Earliest Approved Event Source ID,Earliest Approved Event Source URL,conditions,phases
"1,2 PROPANEDIOL DIACETATE",623-84-7,https://drugs.ncats.io/drug/5Z492UNF9O,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""623%2084%207"")",ONLY CAS,Possibly Marketed Outside US 1996,ANDA040166,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c0ec47b7-c13a-4fa0-91fe-d7a03c70aec9,Possibly Marketed Outside US 1996,ANDA040166,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c0ec47b7-c13a-4fa0-91fe-d7a03c70aec9,Bacillus cereus infection,Basic research
1 HEXADECANOL,36653-82-4,https://drugs.ncats.io/drug/936JST6JCN,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""36653%2082%204"")",ONLY CAS,US Previously Marketed 1990,EXOSURF NEONATAL by GLAXOSMITHKLINE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020044,Possibly Marketed Outside US 1984,"NU-DERM SUNFADER  Skin Lightener with Sunscreen (SPF 15) PABA FREE by OMP, INC.",https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c67b0629-5529-412d-99ee-186df4ecad5a,"Dry, itchy skin; Respiratory distress syndrome, neonatal",Approved; Approved
1 OCTADECANOL,112-92-5,https://drugs.ncats.io/drug/2KR89I4H1Y,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""112%2092%205"")",ONLY CAS,US Previously Marketed ,"21 CFR 310.545(a)(18)(i)(B) skin protectant:w/ sales less than $25,000 stearyl alcohol",https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec310-545.xml,Possibly Marketed Outside US 1970,Ala Quin by Crown Laboratories,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d2ae30c6-ad64-47ed-b371-778eaebeeddf,SUNBURN,Approved
2 OXOGLUTARIC ACID,328-50-7,https://drugs.ncats.io/drug/8ID597Z82X,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""328%2050%207"")",ONLY CAS,Possibly Marketed Outside US ,ALPHA-KETOGLUTARATE,http://naturaldatabase.therapeuticresearch.com/nd/PrintVersion.aspx?id=144&AspxAutoDetectCookieSupport=1 | http://www.webmd.com/vitamins-supplements/ingredientmono-144-alpha-ketoglutarate.aspx?activeingredientid=144&activeingredientname=alpha-ketoglutarate,,,,Osteoporosis; Gastrointestinal microbiota imbalance; Short bowel syndrome; Burn; Kidney failure,Not Provided; Not Provided; Not Provided; Approved; Approved
2 PROPANOL,67-63-0,https://drugs.ncats.io/drug/ND2M416302,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""67%2063%200"")",ONLY CAS,US Approved OTC ,21 CFR 344.12 otic:ear drying aid isopropyl alcohol,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec344-12.xml,US Previously Marketed 1921,Rubbing Alcohol,https://books.google.com/books?id=1n4gAQAAMAAJ&newbks=1&newbks_redir=0&dq=alcohol%20rubbing%20usp&pg=PA85#v=onepage&q=alcohol%20rubbing%20usp&f=false,,
4 AMINOBUTYRIC ACID,56-12-2,https://drugs.ncats.io/drug/2ACZ6IPC6I,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""56%2012%202"")",ONLY CAS,Possibly Marketed Outside US ,Theracodeine-300 by Physician Therapeutics Llc,https://www.drugbank.ca/drugs/DB02530,Possibly Marketed Outside US 2009,21 CFR 352,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1725b5af-fe03-4372-beaf-d6fd9088a1f1,Type 1 diabetes mellitus; Stress; Vascular diseases of the brain; Atherosclerosis of cerebral arteries; Chronic cerebrovascular insufficiency; Partial Seizures,Phase II; Phase I; Approved; Approved; Approved; Not Provided
7 OXO-DEHYDROEPIANDROSTERONE,566-19-8,https://drugs.ncats.io/drug/2334LJD2E9,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""566%2019%208"")",ONLY CAS,Possibly Marketed Outside US 2015,21 CFR 348,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6c5854bb-b51a-4583-9148-6f76c59ff24c,Possibly Marketed Outside US 2015,21 CFR 348,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6c5854bb-b51a-4583-9148-6f76c59ff24c,,
8 QUINOLINOL,148-24-3,https://drugs.ncats.io/drug/5UTX5635HP,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""148%2024%203"")",ONLY CAS,US Previously Marketed ,21 CFR 310.545(a)(18)(ii) skin protectant:astringent oxyquinoline sulfate,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec310-545.xml,Possibly Marketed Outside US 1964,UDDER BALM by H. W. Naylor Company Inc.,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2907f343-4457-bf36-2e0b-aa074e63a4bd,Unknown,
ABACAVIR,136470-78-5,https://drugs.ncats.io/drug/WR2TIP26VS,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""136470%2078%205"")",ONLY CAS,US Approved Rx 2017,ANDA204990,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204990,US Previously Marketed 1998,ZIAGEN by VIIV HLTHCARE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020977,HIV-1 infection,Approved
ABALOPARATIDE,247062-33-5,https://drugs.ncats.io/drug/AVK0I6HY2U,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""247062%2033%205"")",ONLY CAS,US Approved Rx 2017,NDA208743,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208743,US Approved Rx 2017,NDA208743,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208743,Osteoporosis,Approved
ABARELIX,183552-38-7,https://drugs.ncats.io/drug/W486SJ5824,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""183552%2038%207"")",ONLY CAS,US Previously Marketed 2003,PLENAXIS by SPECIALITY EUROPEAN,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021320,US Previously Marketed 2003,PLENAXIS by SPECIALITY EUROPEAN,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021320,Advanced prostate cancer,Approved
ABATACEPT,332348-12-6,https://drugs.ncats.io/drug/7D0YB67S97,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""332348%2012%206"")",ONLY CAS,US Approved Rx 2005,BLA125118,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125118,US Approved Rx 2005,BLA125118,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125118,,
ABCIXIMAB,143653-53-6,https://drugs.ncats.io/drug/X85G7936GV,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""143653%2053%206"")",ONLY CAS,US Approved Rx 1994,BLA103575,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103575,Possibly Marketed Outside US 1993,BLA103575,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=033d4c3b-4630-4256-b8f7-9ed5f15de9a3,,
ABEMACICLIB,1231929-97-7,https://drugs.ncats.io/drug/60UAB198HK,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1231929%2097%207"")",ONLY CAS,US Approved Rx 2017,NDA208716,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208716,US Approved Rx 2017,NDA208716,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208716,Breast cancer; Melanoma; Glioblastoma; Non-small cell lung cancer; HER2-negative advanced breast cancer,Phase III; Phase II; Phase II; Phase III; Approved
ABIRATERONE ACETATE,154229-18-2,https://drugs.ncats.io/drug/EM5OCB9YJ6,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""154229%2018%202"")",ONLY CAS,US Approved Rx 2023,NDA216793,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216793,US Approved Rx 2011,NDA202379,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202379,Metastatic castration-resistant prostate cancer,Approved
ACALABRUTINIB,1420477-60-6,https://drugs.ncats.io/drug/I42748ELQW,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1420477%2060%206"")",ONLY CAS,US Approved Rx 2022,NDA216387,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216387,US Approved Rx 2017,NDA210259,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210259,Chronic lymphocytic leukemia; Rheumatoid arthritis; Glioblastoma multiforme; Mantle cell lymphoma; Head and neck squamous cell carcinoma; mantle cell lymphoma,Phase III; Phase II; Phase II; Phase II; Phase II; Approved
ACAMPROSATE,77337-76-9,https://drugs.ncats.io/drug/N4K14YGM3J,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""77337%2076%209"")",ONLY CAS,US Approved Rx 2013,ANDA202229,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202229,US Previously Marketed 2004,CAMPRAL by FOREST LABS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021431,Alcohol addiction,Approved
ACARBOSE,56180-94-0,https://drugs.ncats.io/drug/T58MSI464G,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""56180%2094%200"")",ONLY CAS,US Approved Rx 2009,ANDA078441,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=078441,US Previously Marketed 1995,PRECOSE by BAYER HLTHCARE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020482,Type 2 diabetes mellitus,Approved
ACEBUTOLOL,37517-30-9,https://drugs.ncats.io/drug/67P356D8GH,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""37517%2030%209"")",ONLY CAS,US Approved Rx 1995,ANDA074007,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=074007,US Previously Marketed 1984,SECTRAL by PROMIUS PHARMA,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018917,Ventricular arrhythmia; Hypertension,Approved; Approved
ACEMANNAN,110042-95-0,https://drugs.ncats.io/drug/UZ29E6L2X8,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""110042%2095%200"")",ONLY CAS,Possibly Marketed Outside US 2014,21 CFR 347,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=122273ec-d670-4606-baf8-c9fe3fddebed,Possibly Marketed Outside US 2014,21 CFR 347,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=122273ec-d670-4606-baf8-c9fe3fddebed,,
ACEPROMAZINE,61-00-7,https://drugs.ncats.io/drug/54EJ303F0R,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""61%2000%207"")",ONLY CAS,Possibly Marketed Outside US ,Canada:ACEPROMAZINE MALEATE,https://tripod.nih.gov/npc/#Download,Possibly Marketed Outside US 2011,NADA015030,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=11ee8981-46eb-4791-8e40-727c991341fe,Agitation (veterinary); Schizophrenia,Approved; Not Provided
ACESULFAME,33665-90-6,https://drugs.ncats.io/drug/MA3UYZ6K1H,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""33665%2090%206"")",ONLY CAS,Possibly Marketed Outside US 2012,21 CFR 334,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=62cbf4ea-5ae5-4f4d-b054-6fe4635a93fe,Possibly Marketed Outside US 2002,NDA022410,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=16695a4c-9e32-4a4d-8aa9-e10fd2412a46,Obesity,Approved
ACETAZOLAMIDE,59-66-5,https://drugs.ncats.io/drug/O3FX965V0I,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""59%2066%205"")",ONLY CAS,US Approved Rx 2023,ANDA211151,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211151,US Previously Marketed 1953,DIAMOX by TEVA BRANDED PHARM,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=008943,Open-angle glaucoma; Acute mountain sickness,Approved; Approved
ACETIC ACID,64-19-7,https://drugs.ncats.io/drug/Q40Q9N063P,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""64%2019%207"")",ONLY CAS,US Approved Rx 1978,ANDA085998,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=085998,US Previously Marketed 1921,Sodium Chloride U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,Otitis externa; Cyanide poisoning,Approved; Approved
ACETOHEXAMIDE,968-81-0,https://drugs.ncats.io/drug/QGC8W08I6I,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""968%2081%200"")",ONLY CAS,US Previously Marketed 1986,ACETOHEXAMIDE by USL PHARMA,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=070754,US Previously Marketed 1964,DYMELOR by LILLY,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=013378,Type 2 diabetes mellitus,Approved
ACETOHYDROXAMIC ACID,546-88-3,https://drugs.ncats.io/drug/4RZ82L2GY5,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""546%2088%203"")",ONLY CAS,US Approved Rx 1983,NDA018749,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018749,US Approved Rx 1983,NDA018749,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018749,chronic urea-splitting urinary infection,Approved
ACETONE,67-64-1,https://drugs.ncats.io/drug/1364PS73AF,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""67%2064%201"")",ONLY CAS,US Previously Marketed 1921,Acetone U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,US Previously Marketed 1921,Acetone U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,,
ACETYL-L-CARNITINE,3040-38-8,https://drugs.ncats.io/drug/6DH1W9VH8Q,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""3040%2038%208"")",ONLY CAS,US Approved Rx 1985,NDA018948,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018948,US Approved Rx 1985,NDA018948,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018948,Systemic primary carnitine deficiency; Ulcerative colitis; Peripheral arterial occlusive disorders; Congestive heart failure,Approved; Phase III; Approved; Phase III
ACETYLCHOLINE,51-84-3,https://drugs.ncats.io/drug/N9YNS0M02X,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""51%2084%203"")",ONLY CAS,US Approved Rx 1993,NDA020213,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020213,US Previously Marketed 1966,MIOCHOL by NOVARTIS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016211,Mydriasis,Approved
ACETYLCYSTEINE,616-91-1,https://drugs.ncats.io/drug/WYQ7N0BPYC,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""616%2091%201"")",ONLY CAS,US Approved Rx 2012,ANDA203853,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203853,US Previously Marketed 1963,MUCOMYST by APOTHECON,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=013601,Cystic fibrosis; Hepatic injury,Approved; Approved
ACETYLSALICYLIC ACID,50-78-2,https://drugs.ncats.io/drug/R16CO5Y76E,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""50%2078%202"")",ONLY CAS,US Approved OTC ,21 CFR 343.13(b) internal analgesic:rheumatologic aspirin (buffered),https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec343-13.xml,US Previously Marketed 1899,"Aspirin by Friedr. Bayer & Co., Elberfeld, Germany",https://catalog.hathitrust.org/Record/100782317,Headache; Pain; Stroke; Myocardial infarction,Approved; Approved; Approved; Approved
ACETYLSULFAFURAZOLE,80-74-0,https://drugs.ncats.io/drug/WBT5QH3KED,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""80%2074%200"")",ONLY CAS,US Previously Marketed 1949,Gantrisin by Hoffmann-La Roche,DeHaen 1940-1975 NMEs,US Previously Marketed 1948,GANTRISIN by ROCHE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=006525,Acute otitis media,Approved
ACHILLEA MILLEFOLIUM,977000-16-0,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""977000%2016%200"")",ONLY CAS,,,,,,,,
ACICLOVIR,59277-89-3,https://drugs.ncats.io/drug/X4HES1O11F,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""59277%2089%203"")",ONLY CAS,US Approved Rx 2019,ANDA210774,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210774,US Approved Rx 1982,NDA018604,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018604,Cold sores; Genital herpes; Herpes zoster infections; Herpes simplex infection; Herpes zoster infections,Approved; Approved; Approved; Approved; Approved
ACITRETIN,55079-83-9,https://drugs.ncats.io/drug/LCH760E9T7,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""55079%2083%209"")",ONLY CAS,US Approved Rx 2013,ANDA202897,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202897,US Previously Marketed 1996,SORIATANE by STIEFEL LABS INC,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019821,Psoriasis,Approved
ACLIDINIUM BROMIDE,320345-99-1,https://drugs.ncats.io/drug/UQW7UF9N91,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""320345%2099%201"")",ONLY CAS,US Approved Rx 2019,NDA210595,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210595,US Approved Rx 2012,NDA202450,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202450,Bronchospasm associated with chronic obstructive pulmonary disease,Approved
ACRIVASTINE,87848-99-5,https://drugs.ncats.io/drug/A20F9XAI7W,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""87848%2099%205"")",ONLY CAS,US Previously Marketed 1994,SEMPREX-D by AUXILIUM PHARMS LLC,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019806,US Previously Marketed 1994,SEMPREX-D by AUXILIUM PHARMS LLC,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019806,Seasonal allergic rhinitis,Approved
ADALIMUMAB,331731-18-1,https://drugs.ncats.io/drug/FYS6T7F842,7,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""331731%2018%201"")%20AND%20(root_names_name:""%5EADALIMUMAB$"")",EXACT NAME,US Approved Rx 2002,BLA125057,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125057,Possibly Marketed Outside US 2002,BLA125057,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=608d4f0d-b19f-46d3-749a-7159aa5f933d,,
ADAPALENE,106685-40-9,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""106685%2040%209"")",ONLY CAS,,,,,,,,
ADEFOVIR DIPIVOXIL,142340-99-6,https://drugs.ncats.io/drug/U6Q8Z01514,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""142340%2099%206"")",ONLY CAS,US Approved Rx 2013,ANDA202051,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202051,US Previously Marketed 2002,HEPSERA by GILEAD,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021449,Chronic hepatitis B,Approved
ADEMETIONINE,29908-03-0,https://drugs.ncats.io/drug/7LP2MPO46S,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""29908%2003%200"")",ONLY CAS,Possibly Marketed Outside US ,WHO-ATC:A16AA02,https://ginas.ncats.nih.gov/ginas/app/substance/7LP2MPO46S,,,,"Non-alcoholic fatty liver disease; Liver disease, alcoholic; Depression; Osteoarthritis; Fibromyalgia",Phase III; Phase III; Approved; Approved; Approved
ADENOSINE,58-61-7,https://drugs.ncats.io/drug/K72T3FS567,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""58%2061%207"")",ONLY CAS,US Approved Rx 2005,ANDA077133,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=077133,US Previously Marketed 1976,VIRA-A by PARKEDALE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050486,Keratoconjunctivitis; Epithelial keratitis; Herpes simplex infection; Paroxysmal supraventricular tachycardia,Approved; Approved; Phase III; Approved
ADENOSINE TRIPHOSPHATE,56-65-5,https://drugs.ncats.io/drug/8L70Q75FXE,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""56%2065%205"")",ONLY CAS,Possibly Marketed Outside US ,Japan:Adenosine 5'-Triphosphate Disodium,https://tripod.nih.gov/npc/#Download,Possibly Marketed Outside US 2009,21 CFR 352,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1725b5af-fe03-4372-beaf-d6fd9088a1f1,,
ADIPIODONE,606-17-7,https://drugs.ncats.io/drug/TKQ858A3VW,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""606%2017%207"")",ONLY CAS,US Previously Marketed 1958,SINOGRAFIN by BRACCO,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=011324,US Previously Marketed 1954,CHOLOGRAFIN MEGLUMINE by BRACCO,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=009321,Hepatobiliary disease,Approved
AFATINIB,850140-72-6,https://drugs.ncats.io/drug/41UD74L59M,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""850140%2072%206"")",ONLY CAS,US Approved Rx 2013,NDA201292,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201292,US Approved Rx 2013,NDA201292,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201292,Non-small cell lung cancer,Approved
AFLIBERCEPT,862111-32-8,https://drugs.ncats.io/drug/15C2VL427D,2,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""862111%2032%208"")%20AND%20(root_names_name:""%5EAFLIBERCEPT$"")",EXACT NAME,US Approved Rx 2012,BLA125418,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125418,US Approved Rx 2011,BLA125387,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125387,,
AGALSIDASE BETA,104138-64-9,https://drugs.ncats.io/drug/RZD65TSM9U,2,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""104138%2064%209"")%20AND%20(root_names_name:""%5EAGALSIDASE%20BETA$"")",EXACT NAME,US Approved Rx 2003,BLA103979,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103979,US Approved Rx 2003,BLA103979,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103979,,
ALANINE,56-41-7,https://drugs.ncats.io/drug/OF5P57N2ZX,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""56%2041%207"")",ONLY CAS,US Previously Marketed ,21 CFR 310.532(a) benign prostatic hypertrophy alanine,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec310-532.xml,Possibly Marketed Outside US 1971,NDA016822,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6ea7ec73-403e-4303-8862-6380e2f1fda6,Fructose intolerance; Muscle atrophy; Low birth weight; Burns,Natural Metabolite; Natural Metabolite; Natural Metabolite; Approved
ALATROFLOXACIN,146961-76-4,https://drugs.ncats.io/drug/7QVV6I50DT,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""146961%2076%204"")",ONLY CAS,US Previously Marketed 1997,TROVAN PRESERVATIVE FREE by PFIZER,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020760,US Previously Marketed 1997,TROVAN PRESERVATIVE FREE by PFIZER,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020760,Complicated skin and skin structure infections; Pneumonia; Intra-abdominal infections; Complicated intra-abdominal infections; Skin infections; Pneumonia; Gynecologic infections; Nosocomial pneumonia,Approved; Approved; Approved; Withdrawn; Withdrawn; Withdrawn; Withdrawn; Withdrawn
ALBENDAZOLE,54965-21-8,https://drugs.ncats.io/drug/F4216019LN,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""54965%2021%208"")",ONLY CAS,US Approved Rx 2019,ANDA208094,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208094,Possibly Marketed Outside US 1989,NADA110048,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=94cf5818-f27d-4374-87ad-54a2d9ce6ef1,Neurocysticercosis; Hydatid disease,Approved; Approved
ALBIGLUTIDE,782500-75-8,https://drugs.ncats.io/drug/5E7U48495E,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""782500%2075%208"")",ONLY CAS,US Previously Marketed 2014,TANZEUM by GLAXOSMITHKLINE LLC,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125431,US Previously Marketed 2014,TANZEUM by GLAXOSMITHKLINE LLC,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125431,,
ALBUMIN,33069-62-4,https://drugs.ncats.io/drug/P88XT4IS4D,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""33069%2062%204"")",ONLY CAS,US Approved Rx 2018,ANDA205720,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205720,US Previously Marketed 1992,TAXOL by HQ SPCLT PHARMA,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020262,Advanced carcinoma of the ovary; Non-small cell lung cancer; Breast cancer,Approved; Approved; Approved
ALBUTREPENONACOG ALFA,1357448-54-4,https://drugs.ncats.io/drug/A57KX1VL5P,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1357448%2054%204"")",ONLY CAS,Possibly Marketed Outside US ,EU/1/16/1095/004,https://www.drugbank.ca/drugs/DB13884,Possibly Marketed Outside US 2016,BLA125582,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f74301bf-95e2-44ab-a8b6-98aa07b04683,,
ALCAFTADINE,147084-10-4,https://drugs.ncats.io/drug/7Z8O94ECSX,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""147084%2010%204"")",ONLY CAS,US Approved Rx 2024,ANDA209706,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209706,US Approved Rx 2010,NDA022134,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022134,Itching associated with allergic conjunctivitis,Approved
ALCLOMETASONE,67452-97-5,https://drugs.ncats.io/drug/136H45TB7B,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""67452%2097%205"")",ONLY CAS,US Approved Rx 2005,ANDA076973,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=076973,US Previously Marketed 1982,ACLOVATE by FOUGERA PHARMS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018707,Corticosteroid-responsive dermatoses,Approved
ALDESLEUKIN,110942-02-4,https://drugs.ncats.io/drug/M89N0Q7EQR,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""110942%2002%204"")",ONLY CAS,US Approved Rx 1992,BLA103293,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103293,US Approved Rx 1992,BLA103293,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103293,,
ALDIOXA,5579-81-7,https://drugs.ncats.io/drug/8T66I31YNK,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""5579%2081%207"")",ONLY CAS,US Approved OTC ,21 CFR 346.20(a) anorectal:keratolytic alcloxa,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec346-20.xml,US Previously Marketed 1961,ALLANTOMIDE ALLANTOIN by NATIONAL DRUG,https://www.govinfo.gov/content/pkg/FR-1972-02-12/pdf/FR-1972-02-12.pdf,Chaffing; Functional dyspepsia; Gastritis; Duodenal ulcer; Gastric ulcer,Not Provided; Preclinical; Approved; Approved; Approved
ALECTINIB,1256580-46-7,https://drugs.ncats.io/drug/LIJ4CT1Z3Y,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1256580%2046%207"")",ONLY CAS,US Approved Rx 2015,NDA208434,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208434,US Approved Rx 2015,NDA208434,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208434,"Anaplastic lymphoma kinase (ALK)-positive, metastatic non-small cell lung cancer",Approved
ALEFACEPT,222535-22-0,https://drugs.ncats.io/drug/ELK3V90G6C,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""222535%2022%200"")",ONLY CAS,US Previously Marketed 2003,Amevive,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125036,US Previously Marketed 2003,Amevive,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125036,,
ALEMTUZUMAB,216503-57-0,https://drugs.ncats.io/drug/3A189DH42V,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""216503%2057%200"")",ONLY CAS,US Approved Rx 2001,BLA103948,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103948,US Approved Rx 2001,BLA103948,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103948,,
ALENDRONIC ACID,66376-36-1,https://drugs.ncats.io/drug/X1J18R4W8P,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""66376%2036%201"")",ONLY CAS,US Approved Rx 2009,ANDA090258,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=090258,US Approved Rx 1995,NDA020560,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020560,Glucocorticoid-induced osteoporosis; Osteoporosis; Paget's disease,Approved; Approved; Approved
ALFENTANIL,71195-58-9,https://drugs.ncats.io/drug/1N74HM2BS7,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""71195%2058%209"")",ONLY CAS,US Approved Rx 1986,NDA019353,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019353,US Approved Rx 1986,NDA019353,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019353,Pain,Approved
ALFUZOSIN,81403-80-7,https://drugs.ncats.io/drug/90347YTW5F,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""81403%2080%207"")",ONLY CAS,US Approved Rx 2012,ANDA079060,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=079060,US Approved Rx 2003,NDA021287,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021287,Benign prostatic hyperplasia,Approved
ALGINIC ACID,9005-32-7,https://drugs.ncats.io/drug/8C3Z4148WZ,3,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""9005%2032%207"")%20AND%20(root_names_name:""%5EALGINIC%20ACID$"")",EXACT NAME,US Previously Marketed ,21 CFR 310.545(a)(20) weight control alginic acid,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec310-545.xml,Possibly Marketed Outside US 2002,NDA013217,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5e1ec092-4748-47c6-9b72-1b826da0ce02,,
ALGLUCERASE,143003-46-7,https://drugs.ncats.io/drug/27T56C7KK0,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""143003%2046%207"")",ONLY CAS,US Previously Marketed 1991,Ceredase by Genzyme,OB NME Appendix 1950-1993,US Previously Marketed 1991,Ceredase by Genzyme,OB NME Appendix 1950-1993,,
ALGLUCOSIDASE ALFA,420784-05-0,https://drugs.ncats.io/drug/DTI67O9503,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""420784%2005%200"")",ONLY CAS,US Approved Rx 2010,BLA125291,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125291,US Approved Rx 2006,BLA125141,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125141,,
ALIROCUMAB,1245916-14-6,https://drugs.ncats.io/drug/PP0SHH6V16,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1245916%2014%206"")",ONLY CAS,US Approved Rx 2015,BLA125559,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125559,US Approved Rx 2015,BLA125559,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125559,,
ALISKIREN,173334-57-1,https://drugs.ncats.io/drug/502FWN4Q32,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""173334%2057%201"")",ONLY CAS,US Approved Rx 2019,ANDA206665,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206665,US Approved Rx 2007,NDA021985,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021985,Hypertension,Approved
ALITRETINOIN,5300-03-8,https://drugs.ncats.io/drug/1UA8E65KDZ,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""5300%2003%208"")",ONLY CAS,US Approved Rx 2019,ANDA211644,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211644,US Previously Marketed 1971,RETIN-A by VALEANT INTL,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016921,severe recalcitrant nodular acne; Acne vulgaris; Acute promyelocytic leukemia; AIDS-related Kaposi’s sarcoma,Approved; Approved; Approved; Approved
ALKYL SULFONATES,55-98-1,https://drugs.ncats.io/drug/G1LN9045DK,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""55%2098%201"")",ONLY CAS,US Approved Rx 1999,NDA020954,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020954,US Previously Marketed 1954,Myleran by Burroughs Wellcome,OB NME Appendix 1950-1985,Chronic myeloid leukemia,Approved
ALLANTOIN,97-59-6,https://drugs.ncats.io/drug/344S277G0Z,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""97%2059%206"")",ONLY CAS,US Approved OTC ,21 CFR 346.20(a) anorectal:keratolytic alcloxa,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec346-20.xml,US Previously Marketed 1961,ALLANTOMIDE ALLANTOIN by NATIONAL DRUG,https://www.govinfo.gov/content/pkg/FR-1972-02-12/pdf/FR-1972-02-12.pdf,Chaffing; Functional dyspepsia; Gastritis; Duodenal ulcer; Gastric ulcer,Not Provided; Preclinical; Approved; Approved; Approved
ALLOPURINOL,315-30-0,https://drugs.ncats.io/drug/63CZ7GJN5I,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""315%2030%200"")",ONLY CAS,US Approved Rx 2007,ANDA078253,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=078253,US Approved Rx 1966,NDA016084,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016084,Lymphoma; Gout; Leukemia,Approved; Approved; Approved
ALLYL ISOTHIOCYANATE,57-06-7,https://drugs.ncats.io/drug/BN34FX42G3,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""57%2006%207"")",ONLY CAS,US Previously Marketed ,21 CFR 310.545(a)(6)(ii)(A) cough/cold:nasal decongestant allyl isothiocyanate,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec310-545.xml,,,,,
ALMOTRIPTAN,154323-57-6,https://drugs.ncats.io/drug/1O4XL5SN61,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""154323%2057%206"")",ONLY CAS,US Approved Rx 2015,ANDA205171,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205171,US Previously Marketed 2001,AXERT by JANSSEN PHARMS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021001,Migraine,Approved
ALOE BARBADENSIS,1415-73-2,https://drugs.ncats.io/drug/648RW354S9,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1415%2073%202"")",ONLY CAS,,,,,,,Non-small cell lung cancer; Myocardial ischemia-reperfusion injury; Ventricular arrhythmia,Preclinical; Preclinical; Preclinical
ALOGLIPTIN,850649-61-5,https://drugs.ncats.io/drug/JHC049LO86,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""850649%2061%205"")",ONLY CAS,US Approved Rx 2013,NDA203414,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203414,US Approved Rx 2013,NDA203414,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203414,Type 2 diabetes mellitus,Approved
ALOSETRON,122852-42-0,https://drugs.ncats.io/drug/13Z9HTH115,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""122852%2042%200"")",ONLY CAS,US Approved Rx 2019,ANDA209180,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209180,US Approved Rx 2000,NDA021107,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021107,Irritable bowel syndrome,Approved
ALPHA-GALACTOSIDASE,7493-95-0,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""7493%2095%200"")",ONLY CAS,,,,,,,,
ALPHA AMYLASE,9005-82-7,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""9005%2082%207"")",ONLY CAS,,,,,,,,
ALPHA CAROTENE,7488-99-5,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""7488%2099%205"")",ONLY CAS,,,,,,,,
ALPRAZOLAM,28981-97-7,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""28981%2097%207"")",ONLY CAS,,,,,,,,
ALPROSTADIL,745-65-3,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""745%2065%203"")",ONLY CAS,,,,,,,,
ALTEPLASE,105857-23-6,https://drugs.ncats.io/drug/1RXS4UE564,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""105857%2023%206"")",ONLY CAS,US Approved Rx 1987,BLA103172,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103172,US Approved Rx 1987,BLA103172,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103172,,
ALTRETAMINE,645-05-6,https://drugs.ncats.io/drug/Q8BIH59O7H,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""645%2005%206"")",ONLY CAS,US Previously Marketed 1990,HEXALEN by EISAI INC,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019926,US Previously Marketed 1990,HEXALEN by EISAI INC,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019926,"Ovarian cancer, persistent or recurrent",Approved
ALUMINIUM,7429-90-5,https://drugs.ncats.io/drug/CPD4NFA903,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""7429%2090%205"")",ONLY CAS,US Previously Marketed 1921,Solution of Aluminum Acetico-Tartrate N.F.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,US Previously Marketed 1921,Solution of Aluminum Acetico-Tartrate N.F.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,,
ALUMINIUM AND MAGNESIUM,110070-78-5,https://drugs.ncats.io/drug/A585MN1H2L,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""110070%2078%205"")",ONLY CAS,Possibly Marketed Outside US ,Canada:SODIUM BENTONITE,https://tripod.nih.gov/npc/#Download,Possibly Marketed Outside US 1946,M006,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=90f80e35-095d-88f9-8ea3-0fd54f1e916c,"Allergy due to ivy, oak and sumac",Approved
ALVIMOPAN,156053-89-3,https://drugs.ncats.io/drug/Q153V49P3Z,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""156053%2089%203"")",ONLY CAS,US Approved Rx 2023,ANDA216843,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216843,US Previously Marketed 2008,ENTEREG by CUBIST PHARMS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021775,Postoperative ileus,Approved
AMANTADINE,768-94-5,https://drugs.ncats.io/drug/BF4C9Z1J53,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""768%2094%205"")",ONLY CAS,US Approved Rx 2018,NDA209410,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209410,US Previously Marketed 1966,SYMMETREL by ENDO PHARMS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016020,Influenza A virus infection; Parkinson's disease,Approved; Approved
AMBENONIUM,7648-98-8,https://drugs.ncats.io/drug/L16PUN799N,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""7648%2098%208"")",ONLY CAS,US Previously Marketed 1956,MYTELASE by SANOFI AVENTIS US,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=010155,US Previously Marketed 1956,MYTELASE by SANOFI AVENTIS US,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=010155,Myasthenia gravis,Approved
AMBRISENTAN,177036-94-1,https://drugs.ncats.io/drug/HW6NV07QEC,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""177036%2094%201"")",ONLY CAS,US Approved Rx 2022,ANDA210701,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210701,US Approved Rx 2007,NDA022081,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022081,Pulmonary arterial hypertension,Approved
AMCINONIDE,51022-69-6,https://drugs.ncats.io/drug/423W026MA9,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""51022%2069%206"")",ONLY CAS,US Approved Rx 2003,ANDA076065,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=076065,US Previously Marketed 1979,CYCLOCORT by ASTELLAS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018116,Corticosteroid-responsive dermatoses,Approved
AMFEPRAMONE,90-84-6,https://drugs.ncats.io/drug/Q94YYU22B8,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""90%2084%206"")",ONLY CAS,US Approved Rx 2011,ANDA091680,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=091680,US Previously Marketed 1959,TEPANIL by 3M,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=011673,Unknown; Exogenous obesity; Unknown,Approved
AMFETAMINE,300-62-9,https://drugs.ncats.io/drug/CK833KGX7E,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""300%2062%209"")",ONLY CAS,US Approved Rx 2003,ANDA040480,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=040480,US Previously Marketed 1931,Benzedrine Inhaler,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2377281/,Attention deficit hyperactivity disorder,Approved
AMIFOSTINE,20537-88-6,https://drugs.ncats.io/drug/ILA426L95O,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""20537%2088%206"")",ONLY CAS,US Approved Rx 1995,NDA020221,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020221,US Approved Rx 1995,NDA020221,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020221,Ovarian cancer; Head and neck cancer,Approved; Approved
AMIKACIN,37517-28-5,https://drugs.ncats.io/drug/84319SGC3C,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""37517%2028%205"")",ONLY CAS,US Approved Rx 1993,ANDA064045,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=064045,US Previously Marketed 1976,AMIKIN by APOTHECON,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050495,Cystic fibrosis; Sepsis; Urinary tract infections; Meningitis; Pneumonia,Phase III; Approved; Approved; Approved; Phase III
AMILORIDE,2609-46-3,https://drugs.ncats.io/drug/7DZO8EB0Z3,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""2609%2046%203"")",ONLY CAS,US Approved Rx 2009,ANDA079133,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=079133,US Previously Marketed 1981,MODURETIC 5-50 by MERCK,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018201,Hypertension; Heart failure,Approved; Approved
AMINOACIDS,2097132-02-8,https://drugs.ncats.io/drug/71RR81V666,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""2097132%2002%208"")",ONLY CAS,Clinical ,INN:iodine (¹³¹I) apamistamab [INN],https://ginas.ncats.nih.gov/ginas/app/substance/71RR81V666,,,,,
AMINOACRIDINE,90-45-9,https://drugs.ncats.io/drug/78OY3Z0P7Z,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""90%2045%209"")",ONLY CAS,US Previously Marketed 1934,Aminacrine,https://books.google.com/books?id=jglFsz5EJR8C&lpg=PA381&ots=DG2kaw3Z_a&dq=AMINACRINE%20first%20marketed&pg=PA381#v=onepage&q=AMINACRINE%20first%20marketed&f=false,US Previously Marketed 1934,Aminacrine,https://books.google.com/books?id=jglFsz5EJR8C&lpg=PA381&ots=DG2kaw3Z_a&dq=AMINACRINE%20first%20marketed&pg=PA381#v=onepage&q=AMINACRINE%20first%20marketed&f=false,Adult T-cell leukemia/lymphoma; Vaginal trichomoniasis; Mycoses,Basic research; Phase I; Approved
AMINOCAPROIC ACID,60-32-2,https://drugs.ncats.io/drug/U6F3787206,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""60%2032%202"")",ONLY CAS,US Approved Rx 2021,ANDA213825,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213825,US Previously Marketed 1964,AMICAR by EPIC PHARMA LLC,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=015229,Bleeding,Approved
AMINOGLUTETHIMIDE,125-84-8,https://drugs.ncats.io/drug/0O54ZQ14I9,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""125%2084%208"")",ONLY CAS,US Previously Marketed 1960,Elipten by Ciba,DeHaen 1940-1975 NMEs,US Previously Marketed 1960,Elipten by Ciba,DeHaen 1940-1975 NMEs,Cushing’s disease,Approved
AMINOLEVULINIC ACID,106-60-5,https://drugs.ncats.io/drug/88755TAZ87,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""106%2060%205"")",ONLY CAS,US Approved Rx 2017,NDA208630,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208630,Possibly Marketed Outside US 1995,ANDA077614,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0bfea06d-7abe-407a-80a4-d15d373569f7,Condylomata acuminata; Malignant glioma; Actinic keratosis,Approved; Approved; Approved
AMINOPHYLLINE,317-34-0,https://drugs.ncats.io/drug/27Y3KJK423,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""317%2034%200"")",ONLY CAS,US Approved Rx 1983,ANDA087943,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=087943,US Previously Marketed 1921,Theophylline U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,Airway obstruction,Approved
AMINOPYRIDINE,504-29-0,https://drugs.ncats.io/drug/WSX981HEWU,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""504%2029%200"")",ONLY CAS,,,,,,,,
AMINOSALICYLIC ACID,65-49-6,https://drugs.ncats.io/drug/5B2658E0N2,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""65%2049%206"")",ONLY CAS,US Approved Rx 1994,ANDA074346,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=074346,US Previously Marketed 1948,Pamisyl by Parke-Davis,DeHaen 1940-1975 NMEs,Tuberculosis; Crohn's disease; Ulcerative colitis,Approved; Phase II; Phase II
AMIODARONE,1951-25-3,https://drugs.ncats.io/drug/N3RQ532IUT,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1951%2025%203"")",ONLY CAS,US Approved Rx 2008,ANDA077234,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=077234,US Previously Marketed 1985,CORDARONE by WYETH PHARMS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018972,Ventricular tachycardia; Recurring ventricular fibrillation,Approved; Approved
AMITRIPTYLINE,50-48-6,https://drugs.ncats.io/drug/1806D8D52K,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""50%2048%206"")",ONLY CAS,US Approved Rx 1987,ANDA089400,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=089400,US Previously Marketed 1961,ELAVIL by ASTRAZENECA,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=012703,Depressive disorder,Approved
AMLEXANOX,68302-57-8,https://drugs.ncats.io/drug/BRL1C2459K,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""68302%2057%208"")",ONLY CAS,US Previously Marketed 2004,AMLEXANOX by ULURU,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021727,US Previously Marketed 1996,APHTHASOL by ULURU,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020511,Aphthous ulcers,Approved
AMLODIPINE,88150-42-9,https://drugs.ncats.io/drug/1J444QC288,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""88150%2042%209"")",ONLY CAS,US Approved Rx 2015,ANDA202829,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202829,Possibly Marketed Outside US 1987,NDA019787,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d233a645-805b-45be-ae20-534367bc15ff,Coronary artery disease; Hypertension; Chagas disease,Approved; Approved; Preclinical
AMMONIA,7664-41-7,https://drugs.ncats.io/drug/5138Q19F1X,3,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""7664%2041%207"")%20AND%20(root_names_name:""%5EAMMONIA$"")",EXACT NAME,US Approved Rx 1984,ANDA088366,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=088366,US Previously Marketed 1921,Ammonium Chloride U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,Metabolic alkalosis,Approved
AMMONIUM,14798-03-9,https://drugs.ncats.io/drug/54S68520I4,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""14798%2003%209"")",ONLY CAS,US Approved Rx 1984,ANDA088366,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=088366,US Previously Marketed 1921,Ammonium Chloride U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,Metabolic alkalosis,Approved
AMOBARBITAL,57-43-2,https://drugs.ncats.io/drug/GWH6IJ239E,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""57%2043%202"")",ONLY CAS,US Previously Marketed 1923,amobarbital,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2424120/,US Previously Marketed 1923,amobarbital,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2424120/,Anxiety; Insomnia,Approved; Approved
AMOXAPINE,14028-44-5,https://drugs.ncats.io/drug/R63VQ857OT,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""14028%2044%205"")",ONLY CAS,US Approved Rx 1992,ANDA072691,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=072691,US Previously Marketed 1980,ASENDIN by LEDERLE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018021,Neurotic or reactive depressive disorders; Psychotic depressions,Approved; Approved
AMOXICILLIN,26787-78-0,https://drugs.ncats.io/drug/9EM05410Q9,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""26787%2078%200"")",ONLY CAS,US Approved Rx 2005,ANDA065191,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=065191,US Previously Marketed 1973,AMOXIL by GLAXOSMITHKLINE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050459,"Infections of the ear, nose, and throat; Skin and skin structure infections; Gonorrhea, acute uncomplicated; Helicobacter pylori infection and duodenal ulcer disease; Infections of the genitourinary tract",Approved; Approved; Approved; Approved; Approved
AMPHETAMINE,300-62-9,https://drugs.ncats.io/drug/CK833KGX7E,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""300%2062%209"")",ONLY CAS,US Approved Rx 2003,ANDA040480,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=040480,US Previously Marketed 1931,Benzedrine Inhaler,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2377281/,Attention deficit hyperactivity disorder,Approved
AMPHOTERICIN B,"1397-89-3
30652-87-0",N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1397%2089%203
30652%2087%200"")",ONLY CAS,,,,,,,,
AMPICILLIN,69-53-4,https://drugs.ncats.io/drug/7C782967RD,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""69%2053%204"")",ONLY CAS,US Approved Rx 1993,ANDA062797,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=062797,US Previously Marketed 1963,POLYCILLIN by BRISTOL,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050310,Bacterial Infections,Approved
AMPRENAVIR,161814-49-9,https://drugs.ncats.io/drug/5S0W860XNR,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""161814%2049%209"")",ONLY CAS,US Approved Rx 2016,ANDA204060,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204060,US Previously Marketed 1999,AGENERASE by GLAXOSMITHKLINE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021039,HIV-1 infection,Approved
AMRINONE,60719-84-8,https://drugs.ncats.io/drug/JUT23379TN,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""60719%2084%208"")",ONLY CAS,US Approved Rx 2000,ANDA075513,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=075513,US Previously Marketed 1984,INOCOR by SANOFI AVENTIS US,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018700,Congestive heart failure,Approved
AMYL NITRITE,463-04-7,https://drugs.ncats.io/drug/H2HUX79FYK,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""463%2004%207"")",ONLY CAS,US Previously Marketed 1880,Amyl Nitrite U.S.P.,https://books.google.com/books?id=WO5NAAAAMAAJ&newbks=1&newbks_redir=0&dq=united%20states%20pharmacopeia%201880&pg=PA14#v=onepage&q=amyl%20nitrite&f=false,US Previously Marketed 1880,Amyl Nitrite U.S.P.,https://books.google.com/books?id=WO5NAAAAMAAJ&newbks=1&newbks_redir=0&dq=united%20states%20pharmacopeia%201880&pg=PA14#v=onepage&q=amyl%20nitrite&f=false,,
ANAESTHETIC ETHER,60-29-7,https://drugs.ncats.io/drug/0F5N573A2Y,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""60%2029%207"")",ONLY CAS,US Previously Marketed 1921,Ether U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,US Previously Marketed 1846,ether,https://catalog.hathitrust.org/Record/100782317,,
ANAGRELIDE,68475-42-3,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""68475%2042%203"")",ONLY CAS,,,,,,,,
ANAKINRA,143090-92-0,https://drugs.ncats.io/drug/9013DUQ28K,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""143090%2092%200"")%20AND%20(root_names_name:""%5EANAKINRA"")",APPROXIMATE NAME,US Approved Rx 2001,BLA103950,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103950,US Approved Rx 2001,BLA103950,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103950,,
ANASTROZOLE,120511-73-1,https://drugs.ncats.io/drug/2Z07MYW1AZ,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""120511%2073%201"")",ONLY CAS,US Approved Rx 2010,ANDA090568,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=090568,US Approved Rx 1995,NDA020541,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020541,Breast cancer,Approved
ANDEXANET ALFA,1262449-58-0,https://drugs.ncats.io/drug/BI009E452R,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1262449%2058%200"")",ONLY CAS,Possibly Marketed Outside US ,WHO-ATC:V03AB38,https://ginas.ncats.nih.gov/ginas/app/substance/BI009E452R,Possibly Marketed Outside US 2018,BLA125586,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ae7f0c50-ff2d-49e5-8e10-4efa861556e6,,
ANGELICA ARCHANGELICA,482-27-9,https://drugs.ncats.io/drug/20GCF755G6,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""482%2027%209"")",ONLY CAS,,,,,,,Skin cancer,Basic research
ANGIOTENSIN 2 (HUMAN),138402-11-6,https://drugs.ncats.io/drug/J0E2756Z7N,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""138402%2011%206"")",ONLY CAS,US Approved Rx 2012,ANDA077369,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=077369,US Approved Rx 1997,NDA020758,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020758,Hypertension; Diabetic nephropathy,Approved; Approved
ANIDULAFUNGIN,166663-25-8,https://drugs.ncats.io/drug/9HLM53094I,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""166663%2025%208"")",ONLY CAS,US Approved Rx 2006,NDA021632,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021632,US Approved Rx 2006,NDA021632,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021632,Esophageal candidiasis; Candidemia,Approved; Approved
ANISINDIONE,117-37-3,https://drugs.ncats.io/drug/S747T1ERAJ,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""117%2037%203"")",ONLY CAS,US Previously Marketed 1957,MIRADON by SCHERING,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=010909,US Previously Marketed 1957,MIRADON by SCHERING,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=010909,Pulmonary embolism; Coronary occlusion; Atrial fibrillation with embolization; Venous thrombosis,Approved; Approved; Approved; Approved
ANTACIDS,471-34-1,https://drugs.ncats.io/drug/H0G9379FGK,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""471%2034%201"")",ONLY CAS,US Approved OTC ,21 CFR 331.11(i)(2) antacid:calcium-containing calcium (mono or dibasic salt),https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec331-11.xml,US Previously Marketed 1921,Precipitated Calcium Phosphate N.F.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,Unknown; Hypocalcemia; Chronic obstructive pulmonary disease; Cystic fibrosis; Unknown; Hypocalcemia,Not Provided; Phase I; Phase I; Approved
ANTAZOLINE,91-75-8,https://drugs.ncats.io/drug/DHA8014SS1,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""91%2075%208"")",ONLY CAS,US Previously Marketed 1990,VASOCON-A by NOVARTIS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018746,US Previously Marketed 1948,Antistine Phosphate by Ciba,DeHaen 1940-1975 NMEs,Allergic conjunctivitis,Approved
ANTHEMIS NOBILIS,84649-86-5,https://drugs.ncats.io/drug/3d398778,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""84649%2086%205"")",ONLY CAS,,,,,,,,
ANTI-ACNE SOAP,69-72-7,https://drugs.ncats.io/drug/O414PZ4LPZ,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""69%2072%207"")",ONLY CAS,US Approved OTC ,21 CFR 358.110(b) wart remover:collodoin-like vehicle salicylic acid,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec358-110.xml,US Previously Marketed 1860,sodium salicylate,https://catalog.hathitrust.org/Record/100782317,Psoriasis; Ichthyosis vulgaris; Keratosis palmaris; Bruises; Arthritis; Strains and sprains; Simple backache,Approved; Approved; Approved; Approved; Approved; Approved; Approved
ANTI-PSORIASIS,69-72-7,https://drugs.ncats.io/drug/O414PZ4LPZ,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""69%2072%207"")",ONLY CAS,US Approved OTC ,21 CFR 358.110(b) wart remover:collodoin-like vehicle salicylic acid,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec358-110.xml,US Previously Marketed 1860,sodium salicylate,https://catalog.hathitrust.org/Record/100782317,Psoriasis; Ichthyosis vulgaris; Keratosis palmaris; Bruises; Arthritis; Strains and sprains; Simple backache,Approved; Approved; Approved; Approved; Approved; Approved; Approved
ANTIFUNGAL,"10043-35-3
11113-50-1",N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""10043%2035%203
11113%2050%201"")",ONLY CAS,,,,,,,,
ANTIHISTAMINES,58-73-1,https://drugs.ncats.io/drug/8GTS82S83M,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""58%2073%201"")",ONLY CAS,US Approved OTC ,21 CFR 336.10(c) antiemetic diphenhydramine hydrochloride,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec336-10.xml,US Previously Marketed 1946,BENADRYL by MCNEIL CONS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=005845,Occasional sleeplessness; Seasonal allergic rhinitis,Approved; Approved
ANTIMONY,7440-36-0,https://drugs.ncats.io/drug/9IT35J3UV3,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""7440%2036%200"")",ONLY CAS,US Previously Marketed 1921,Wine of Antimony N.F.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,US Previously Marketed 1921,Wine of Antimony N.F.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,,
ANTITHROMBIN III,9000-94-6,https://drugs.ncats.io/drug/T0LTO7L82X,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""9000%2094%206"")",ONLY CAS,Possibly Marketed Outside US ,Thrombate III by Grifols Therapeutics Llc [Canada],https://www.drugbank.ca/drugs/DB11598,Possibly Marketed Outside US 1991,BLA103196,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b2a9f856-3ef7-8da4-920c-f738e4f1f7d7,,
APALUTAMIDE,956104-40-8,https://drugs.ncats.io/drug/4T36H88UA7,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""956104%2040%208"")",ONLY CAS,US Approved Rx 2018,NDA210951,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210951,US Approved Rx 2018,NDA210951,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210951,Prostate cancer,Approved
APIXABAN,503612-47-3,https://drugs.ncats.io/drug/3Z9Y7UWC1J,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""503612%2047%203"")",ONLY CAS,US Approved Rx 2019,ANDA210171,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210171,US Approved Rx 2012,NDA202155,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202155,Embolism and thrombosis; Stroke,Approved; Approved
APOMORPHINE,58-00-4,https://drugs.ncats.io/drug/N21FAR7B4S,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""58%2000%204"")",ONLY CAS,US Approved Rx 2022,ANDA212025,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212025,US Previously Marketed 1880,apomorphia,https://catalog.hathitrust.org/Record/100782317,Parkinson's disease,Approved
APPLE VINEGAR,69-72-7,https://drugs.ncats.io/drug/O414PZ4LPZ,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""69%2072%207"")",ONLY CAS,US Approved OTC ,21 CFR 358.110(b) wart remover:collodoin-like vehicle salicylic acid,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec358-110.xml,US Previously Marketed 1860,sodium salicylate,https://catalog.hathitrust.org/Record/100782317,Psoriasis; Ichthyosis vulgaris; Keratosis palmaris; Bruises; Arthritis; Strains and sprains; Simple backache,Approved; Approved; Approved; Approved; Approved; Approved; Approved
APRACLONIDINE,66711-21-5,https://drugs.ncats.io/drug/843CEN85DI,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""66711%2021%205"")",ONLY CAS,US Approved Rx 1987,NDA019779,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019779,US Approved Rx 1987,NDA019779,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019779,Ocular hypertension,Approved
APREMILAST,608141-41-9,https://drugs.ncats.io/drug/UP7QBP99PN,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""608141%2041%209"")",ONLY CAS,US Approved Rx 2024,ANDA211734,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211734,US Approved Rx 2014,NDA205437,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205437,"Psoriasis; Arthritis, psoriatic",Approved; Approved
APREPITANT,170729-80-3,https://drugs.ncats.io/drug/1NF15YR6UY,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""170729%2080%203"")",ONLY CAS,US Approved Rx 2008,NDA022023,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022023,US Approved Rx 2003,NDA021549,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021549,Postoperative nausea and vomiting; Chemotherapy induced nausea and vomiting; Chemotherapy induced nausea and vomiting; Postoperative nausea and vomiting,Approved; Approved; Approved; Approved
APROTININ,9087-70-1,https://drugs.ncats.io/drug/04XPW8C0FL,3,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""9087%2070%201"")%20AND%20(root_names_name:""%5EAPROTININ$"")",EXACT NAME,US Previously Marketed 1993,TRASYLOL by BAYER HLTHCARE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020304,US Previously Marketed 1993,TRASYLOL by BAYER HLTHCARE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020304,,
ARABINOGALACTAN,9036-66-2,https://drugs.ncats.io/drug/SL4SX1O487,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""9036%2066%202"")",ONLY CAS,Possibly Marketed Outside US 2013,21 CFR 352,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a9dfa6b8-4b1a-4233-91f0-ad7423b2e04f,Possibly Marketed Outside US 2009,21 CFR 352,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=44318cdb-aa87-0b09-e054-00144ff8d46c,,
ARALIA RACEMOSA,89957-50-6,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""89957%2050%206"")",ONLY CAS,,,,,,,,
ARANEUS DIADEMATUS,91745-67-4,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""91745%2067%204"")",ONLY CAS,,,,,,,,
ARDEPARIN SODIUM,9041-08-1,https://drugs.ncats.io/drug/N3927D01PB,13,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""9041%2008%201"")%20AND%20(root_names_name:""%5EARDEPARIN%20SODIUM$"")",EXACT NAME,US Previously Marketed 1997,NORMIFLO by PHARMACIA AND UPJOHN,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020227,US Previously Marketed 1997,NORMIFLO by PHARMACIA AND UPJOHN,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020227,,
ARFORMOTEROL,67346-49-0,https://drugs.ncats.io/drug/F91H02EBWT,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""67346%2049%200"")",ONLY CAS,US Approved Rx 2021,ANDA200293,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=200293,US Approved Rx 2006,NDA021912,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021912,Chronic obstructive pulmonary disease,Approved
ARGATROBAN,74863-84-6,https://drugs.ncats.io/drug/OCY3U280Y3,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""74863%2084%206"")",ONLY CAS,US Approved Rx 2021,NDA212035,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212035,US Previously Marketed 2000,ARGATROBAN by SANDOZ,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020883,Heparin-induced thrombocytopenia; Thrombosis,Approved; Approved
ARGININE,74-79-3,https://drugs.ncats.io/drug/94ZLA3W45F,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""74%2079%203"")",ONLY CAS,US Approved Rx 1973,NDA016931,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016931,US Previously Marketed 1957,Argivine by Gray,DeHaen 1940-1975 NMEs,Gigantism; Acromegaly; Pituitary dwarfism; Panhypopituitarism; Type 2 diabetes mellitus; Hypertension; Preeclampsia,Approved; Approved; Approved; Approved; Phase III; Phase III; Phase III
ARIPIPRAZOLE,129722-12-9,https://drugs.ncats.io/drug/82VFR53I78,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""129722%2012%209"")",ONLY CAS,US Approved Rx 2016,ANDA206383,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206383,US Approved Rx 2002,NDA021436,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021436,Major depressive disorder; Autism; Bipolar I disorder; Schizophrenia; Tourette's syndrome; Agitation associated with schizophrenia or bipolar mania,Approved; Approved; Approved; Approved; Approved; Approved
ARIPIPRAZOLE LAUROXIL,1259305-29-7,https://drugs.ncats.io/drug/B786J7A343,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1259305%2029%207"")",ONLY CAS,US Approved Rx 2016,ANDA206383,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206383,US Approved Rx 2002,NDA021436,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021436,Major depressive disorder; Autism; Bipolar I disorder; Schizophrenia; Tourette's syndrome; Agitation associated with schizophrenia or bipolar mania,Approved; Approved; Approved; Approved; Approved; Approved
ARMODAFINIL,112111-43-0,https://drugs.ncats.io/drug/V63XWA605I,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""112111%2043%200"")",ONLY CAS,US Approved Rx 2012,ANDA200043,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=200043,US Approved Rx 1998,NDA020717,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020717,Obstructive sleep apnea; Narcolepsy; Sleep disorder,Approved; Approved; Approved
ARSENIC,7440-38-2,https://drugs.ncats.io/drug/N712M78A8G,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""7440%2038%202"")",ONLY CAS,US Previously Marketed 1921,"Stronger Pills of Iron, Quinine, Strychnine, and Arsenic N.F.",https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,US Previously Marketed 1921,"Stronger Pills of Iron, Quinine, Strychnine, and Arsenic N.F.",https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,,
ARTEMETHER,71963-77-4,https://drugs.ncats.io/drug/C7D6T3H22J,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""71963%2077%204"")",ONLY CAS,US Approved Rx 2009,NDA022268,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022268,US Approved Rx 2009,NDA022268,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022268,Plasmodium falciparum malaria; Cervical cancer; Plasmodium falciparum malaria; Malaria,Approved; Not Provided; Approved; Approved
ARTEMISIA ABSINTHIUM,1362-42-1,https://drugs.ncats.io/drug/OE5992O64P,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1362%2042%201"")",ONLY CAS,,,,,,,Acute lung injury,Preclinical
ARTICAINE,23964-58-1,https://drugs.ncats.io/drug/D3SQ406G9X,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""23964%2058%201"")",ONLY CAS,US Approved Rx 2006,NDA022010,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022010,US Approved Rx 2000,NDA020971,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020971,Pain,Approved
ARTIFICIAL SWEETENERS,7681-49-4,https://drugs.ncats.io/drug/8ZYQ1474W7,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""7681%2049%204"")",ONLY CAS,US Approved OTC ,21 CFR 355.10(c)(1)(ii) anticaries:dentifrices stannous fluoride,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec355-10.xml,US Previously Marketed 1921,Calcium Oxide U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,Dental caries; Unknown,Approved
ASCOPHYLLUM NODOSUM,84775-78-0,https://drugs.ncats.io/drug/c9e81cc9,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""84775%2078%200"")",ONLY CAS,,,,,,,,
ASCORBIC ACID,50-81-7,https://drugs.ncats.io/drug/PQ6CK8PD0R,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""50%2081%207"")",ONLY CAS,US Approved Rx 2018,NDA209381,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209381,US Previously Marketed 1947,BEROCCA PN by ROCHE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=006071,Scurvy; Vitamin C deficiency,Approved; Approved
ASENAPINE,65576-45-6,https://drugs.ncats.io/drug/JKZ19V908O,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""65576%2045%206"")",ONLY CAS,US Approved Rx 2009,NDA022117,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22117,US Approved Rx 2009,NDA022117,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22117,Bipolar I disorder (manic or mixed episodes); Schizophrenia,Approved; Approved
ASFOTASE ALFA,854107-55-4,https://drugs.ncats.io/drug/5G7AKV2MKP,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""854107%2055%204"")",ONLY CAS,US Approved Rx 2021,NDA213498,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213498,US Approved Rx 2021,NDA213498,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213498,,
ASPARAGINASE,9015-68-3,https://drugs.ncats.io/drug/G4FQ3CKY5R,2,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""9015%2068%203"")%20AND%20(root_names_name:""%5EASPARAGINASE$"")",EXACT NAME,US Approved Rx 1978,BLA101063,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=101063,US Approved Rx 1978,BLA101063,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=101063,,
ASPARTAME,22839-47-0,https://drugs.ncats.io/drug/Z0H242BBR1,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""22839%2047%200"")",ONLY CAS,Possibly Marketed Outside US ,CFR:21 CFR 201.21,https://ginas.ncats.nih.gov/ginas/app/substance/Z0H242BBR1,Possibly Marketed Outside US 2001,21 CFR 334,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d7655c03-8a47-4349-940c-f51c876ebeef,Osteoarthritis; Sickle cell anemia; sweetener,Preclinical; Not Provided; Approved
ASPARTIC ACID,56-84-8,https://drugs.ncats.io/drug/30KYC7MIAI,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""56%2084%208"")",ONLY CAS,US Previously Marketed 1961,Spartase by Wyeth,DeHaen 1940-1975 NMEs,US Previously Marketed 1921,potassium aspartate,https://catalog.hathitrust.org/Record/100163146,Opiate abstinence syndrome; Neonatal jaundice; Unknown,Natural Metabolite; Natural Metabolite
ASTAXANTHIN,472-61-7,https://drugs.ncats.io/drug/8XPW32PR7I,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""472%2061%207"")",ONLY CAS,Possibly Marketed Outside US ,Astaxanthin by Josun International Limited,https://www.drugbank.ca/drugs/DB06543,Possibly Marketed Outside US 2010,21 CFR 352,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5996f9b2-18c1-4c8f-a0ab-eca180db61ad,Aging; Genitourinary cancer; Neurological disorders,Not Provided; Basic research; Basic research
ASTEMIZOLE,68844-77-9,https://drugs.ncats.io/drug/7HU6337315,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""68844%2077%209"")",ONLY CAS,US Previously Marketed 1988,Hismanal by Janssen,OB NME Appendix 1950-1993,US Previously Marketed 1988,Hismanal by Janssen,OB NME Appendix 1950-1993,Seasonal allergic rhinitis; Chronic idiopathic urticaria,Withdrawn; Withdrawn
ASTRAGALUS,486-66-8,https://drugs.ncats.io/drug/6287WC5J2L,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""486%2066%208"")",ONLY CAS,Clinical 2011,NCT01556737: Not Applicable Interventional Completed Postmenopause,https://clinicaltrials.gov/ct2/show/NCT01556737,,,,Unknown,
ATAZANAVIR,198904-31-3,https://drugs.ncats.io/drug/QZU4H47A3S,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""198904%2031%203"")",ONLY CAS,US Approved Rx 2020,ANDA209717,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209717,US Approved Rx 2003,NDA021567,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021567,HIV-1 infection,Approved
ATENOLOL,29122-68-7,https://drugs.ncats.io/drug/50VV3VW0TI,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""29122%2068%207"")",ONLY CAS,US Approved Rx 2005,ANDA076900,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=076900,US Approved Rx 1981,NDA018240,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018240,Hypertension; Angina pectoris; Acute myocardial infarction,Approved; Approved; Approved
ATEZOLIZUMAB,1380723-44-3,https://drugs.ncats.io/drug/52CMI0WC3Y,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1380723%2044%203"")",ONLY CAS,US Approved Rx 2016,BLA761034,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761034,US Approved Rx 2016,BLA761034,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761034,,
ATOMOXETINE,83015-26-3,https://drugs.ncats.io/drug/ASW034S0B8,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""83015%2026%203"")",ONLY CAS,US Approved Rx 2002,NDA021411,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021411,US Approved Rx 2002,NDA021411,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021411,Attention deficit hyperactivity disorder,Approved
ATORVASTATIN,134523-00-5,https://drugs.ncats.io/drug/A0JWA85V8F,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""134523%2000%205"")",ONLY CAS,US Approved Rx 2023,ANDA214344,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214344,US Approved Rx 1996,NDA020702,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020702,Cardiovascular diseases; Hyperlipidemia,Approved; Approved
ATOVAQUONE,94015-53-9,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""94015%2053%209"")",ONLY CAS,,,,,,,,
ATRACURIUM BESILATE,64228-81-5,https://drugs.ncats.io/drug/40AX66P76P,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""64228%2081%205"")",ONLY CAS,US Approved Rx 1997,ANDA074900,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=074900,US Previously Marketed 1983,TRACRIUM PRESERVATIVE FREE by HOSPIRA,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018831,Skeletal muscle relaxation,Approved
ATROPA BELLADONNA,8007-93-0,https://drugs.ncats.io/drug/2ec3b2a1,2,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""8007%2093%200"")%20AND%20(root_names_name:""%5EATROPA%20BELLADONNA"")",APPROXIMATE NAME,,,,,,,,
ATROPINE,51-55-8,https://drugs.ncats.io/drug/7C0697DR9I,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""51%2055%208"")",ONLY CAS,US Approved Rx 2001,NDA021146,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021146,US Previously Marketed 1921,Atropine U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,Bradyasystolic cardiac arrest; Muscarinic mushroom poisoning; Increased salivary flow; Vagus nerve activation; Organophosphorus poisoning,Approved; Approved; Approved; Approved; Approved
ATTAPULGITE,12174-11-7,https://drugs.ncats.io/drug/U6V729APAM,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""12174%2011%207"")",ONLY CAS,US Previously Marketed 1962,QUINTESS-N ATTAPULGITE by LILLY,https://cdn.loc.gov/service/ll/fedreg/fr035/fr035128/fr035128.pdf,US Previously Marketed 1962,QUINTESS-N ATTAPULGITE by LILLY,https://cdn.loc.gov/service/ll/fedreg/fr035/fr035128/fr035128.pdf,,
AURANOFIN,34031-32-8,https://drugs.ncats.io/drug/3H04W2810V,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""34031%2032%208"")",ONLY CAS,US Approved Rx 1985,NDA018689,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018689,Possibly Marketed Outside US 1985,NDA018689,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=05c34ddf-a0f7-4267-83f5-d02be3defc37,Rheumatoid arthritis,Approved
AURANTIIN,10236-47-2,https://drugs.ncats.io/drug/N7TD9J649B,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""10236%2047%202"")",ONLY CAS,Clinical 2011,NCT01423019: Not Applicable Interventional Completed Weight Loss,https://clinicaltrials.gov/ct2/show/NCT01423019,,,,Liver cancer; Parkinson's disease,Basic research; Basic research
AUROTHIOGLUCOSE,12192-57-3,https://drugs.ncats.io/drug/2P2V9Q0E78,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""12192%2057%203"")",ONLY CAS,US Previously Marketed 1949,Solganal by Schering,DeHaen 1940-1975 NMEs,US Previously Marketed 1949,Solganal by Schering,DeHaen 1940-1975 NMEs,Rheumatoid arthritis,Approved
AUROTHIOMALIC ACID,33796-26-8,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""33796%2026%208"")",ONLY CAS,,,,,,,,
AVANAFIL,330784-47-9,https://drugs.ncats.io/drug/DR5S136IVO,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""330784%2047%209"")",ONLY CAS,US Approved Rx 2012,NDA202276,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202276,US Approved Rx 2012,NDA202276,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202276,Erectile dysfunction,Approved
AVATROMBOPAG,570406-98-3,https://drugs.ncats.io/drug/3H8GSZ4SQL,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""570406%2098%203"")",ONLY CAS,US Approved Rx 2018,NDA210238,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210238,US Approved Rx 2018,NDA210238,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210238,Chronic liver disease-associated thrombocytopenia,Approved
AVELUMAB,1537032-82-8,https://drugs.ncats.io/drug/KXG2PJ551I,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1537032%2082%208"")",ONLY CAS,US Approved Rx 2017,BLA761078,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761078,US Approved Rx 2017,BLA761078,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761078,,
AVIBACTAM,1192500-31-4,https://drugs.ncats.io/drug/7352665165,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1192500%2031%204"")",ONLY CAS,,,,,,,,
AVOBENZONE,70356-09-1,https://drugs.ncats.io/drug/G63QQF2NOX,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""70356%2009%201"")",ONLY CAS,US Approved Rx 2008,NDA022009,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022009,US Previously Marketed 1988,Photoplex by Herbert,OB NME Appendix 1950-1993,Sunburn,Approved
AXITINIB,319460-85-0,https://drugs.ncats.io/drug/C9LVQ0YUXG,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""319460%2085%200"")",ONLY CAS,US Approved Rx 2012,NDA202324,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202324,US Approved Rx 2012,NDA202324,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202324,Renal cell carcinoma,Approved
AZACITIDINE,320-67-2,https://drugs.ncats.io/drug/M801H13NRU,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""320%2067%202"")",ONLY CAS,US Approved Rx 2020,NDA214120,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214120,US Approved Rx 2004,NDA050794,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050794,Myelodysplastic syndromes,Approved
AZADIRACHTA INDICA,25990-37-8,https://drugs.ncats.io/drug/N993G4LGD6,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""25990%2037%208"")",ONLY CAS,,,,,,,,
AZATADINE,3964-81-6,https://drugs.ncats.io/drug/94Z39NID6C,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""3964%2081%206"")",ONLY CAS,US Previously Marketed 1977,OPTIMINE by SCHERING,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017601,US Previously Marketed 1977,OPTIMINE by SCHERING,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017601,Rashes; Hives; Itching; Sneezing,Approved; Approved; Approved; Approved
AZATHIOPRINE,446-86-6,https://drugs.ncats.io/drug/MRK240IY2L,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""446%2086%206"")",ONLY CAS,US Approved Rx 1996,ANDA074069,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=074069,US Approved Rx 1968,NDA016324,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016324,Rheumatoid arthritis,Approved
AZELAIC ACID,123-99-9,https://drugs.ncats.io/drug/F2VW3D43YT,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""123%2099%209"")",ONLY CAS,US Approved Rx 2002,NDA021470,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021470,US Approved Rx 1995,NDA020428,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020428,Rosacea,Approved
AZELASTINE,58581-89-8,https://drugs.ncats.io/drug/ZQI909440X,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""58581%2089%208"")",ONLY CAS,US Approved Rx 2017,ANDA204660,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204660,US Previously Marketed 1996,ASTELIN by MYLAN SPCLT VIATRIS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020114,Seasonal allergic rhinitis; Perennial allergic rhinitis,Approved; Approved
AZILSARTAN MEDOXOMIL,863031-21-4,https://drugs.ncats.io/drug/LL0G25K7I2,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""863031%2021%204"")",ONLY CAS,US Approved Rx 2011,NDA202331,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202331,US Approved Rx 2011,NDA202331,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202331,Hypertension; Hypertension,Approved; Phase III
AZITHROMYCIN,83905-01-5,https://drugs.ncats.io/drug/J2KLZ20U1M,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""83905%2001%205"")",ONLY CAS,US Approved Rx 2018,ANDA208249,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208249,US Previously Marketed 1991,ZITHROMAX by PFIZER,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050670,Acute bacterial exacerbation of chronic bronchitis; Acute bacterial sinusitis; Acute otitis media; Skin structure infections; Urethritis; Community-acquired pneumonia,Approved; Approved; Approved; Approved; Approved; Approved
AZTREONAM,78110-38-0,https://drugs.ncats.io/drug/G2B4VE5GH8,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""78110%2038%200"")",ONLY CAS,US Approved Rx 2010,NDA050814,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050814,US Approved Rx 1986,NDA050580,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050580,Sepsis; Skin and skin structure infections; Gynecologic infections; Respiratory symptoms in cystic fibrosis (CF) patients with Pseudomonas aeruginosa; Intra-abdominal infections; Lower respiratory tract infections; Urinary tract infections,Approved; Approved; Approved; Approved; Approved; Approved; Approved
B>-SITOSTEROL,83-46-5,https://drugs.ncats.io/drug/S347WMO6M4,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""83%2046%205"")",ONLY CAS,US Previously Marketed 1956,Cytellin by Lilly,DeHaen 1940-1975 NMEs,US Previously Marketed 1956,Cytellin by Lilly,DeHaen 1940-1975 NMEs,Benign prostatic hyperplasia; Breast cancer; Sitosterolemia; Cystic fibrosis; Cervical cancer,Natural Metabolite; Natural Metabolite; Natural Metabolite; Natural Metabolite; Natural Metabolite
BABY LOTION,64-17-5,https://drugs.ncats.io/drug/3K9958V90M,3,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""64%2017%205"")",ONLY CAS,US Approved Rx 2001,NDA021074,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021074,US Previously Marketed 0652,alcohol,https://en.wikipedia.org/wiki/Alcohol_(drug),Bacterial infections,Approved
BABY SHAMPOOS,7704-34-9,https://drugs.ncats.io/drug/70FD1KFU70,4,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""7704%2034%209"")",ONLY CAS,US Approved OTC ,21 CFR 358.710(a)(7) dandruff:dandruff sulfur,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec358-710.xml,US Previously Marketed 1921,Washed Sulphur U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,Scalp itching and flaking,Approved
BACILLUS COAGULANS,68038-65-3,https://drugs.ncats.io/drug/ISK1LOY57E,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""68038%2065%203"")",ONLY CAS,Possibly Marketed Outside US 2019,Provad by TMIG Inc,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=302af4c2-78e2-4082-9b09-25ac2790762f,Possibly Marketed Outside US 2015,"BIOVITA by ILDONG PHARMACEUTICAL CO., LTD.",https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1414abaf-1158-4d8b-8906-59dc85f17e1c,,
BACITRACIN,1405-87-4,https://drugs.ncats.io/drug/58H6RWO52I,2,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1405%2087%204"")%20AND%20(root_names_name:""%5EBACITRACIN$"")",EXACT NAME,US Approved OTC ,21 CFR 333.110(a) first aid antibiotic:ointment bacitracin,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec333-110.xml,US Previously Marketed 1921,Zinc U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,Skin diseases; Infection; Superficial infections of the external eye and its adnexa caused by susceptible bacteria,Approved; Approved; Approved
BACLOFEN,1134-47-0,https://drugs.ncats.io/drug/H789N3FKE8,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1134%2047%200"")",ONLY CAS,US Approved Rx 2007,ANDA077088,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=077088,US Previously Marketed 1977,LIORESAL by NOVARTIS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017851,Spasticity,Approved
BALOXAVIR MARBOXIL,1985606-14-1,https://drugs.ncats.io/drug/505CXM6OHG,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1985606%2014%201"")",ONLY CAS,US Approved Rx 2018,NDA210854,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210854,US Approved Rx 2018,NDA210854,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210854,Influenza,Phase II
BALSALAZIDE,80573-04-2,https://drugs.ncats.io/drug/P80AL8J7ZP,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""80573%2004%202"")",ONLY CAS,US Approved Rx 2000,NDA020610,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020610,US Approved Rx 2000,NDA020610,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020610,Ulcerative colitis,Approved
BARBITAL,57-44-3,https://drugs.ncats.io/drug/5WZ53ENE2P,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""57%2044%203"")",ONLY CAS,US Previously Marketed 1903,"Veronal by Friedr. Bayer 8: Co., Elberfeld, Germany, and E. Merck, Darmstadt, Germany.",https://catalog.hathitrust.org/Record/100782317,US Previously Marketed 1903,"Veronal by Friedr. Bayer 8: Co., Elberfeld, Germany, and E. Merck, Darmstadt, Germany.",https://catalog.hathitrust.org/Record/100782317,Insomnia,Approved
BARICITINIB,1187594-09-7,https://drugs.ncats.io/drug/ISP4442I3Y,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1187594%2009%207"")",ONLY CAS,US Approved Rx 2018,NDA207924,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207924,US Approved Rx 2018,NDA207924,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207924,Rheumatoid arthritis,Approved
BARIUM,7440-39-3,https://drugs.ncats.io/drug/24GP945V5T,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""7440%2039%203"")",ONLY CAS,Possibly Marketed Outside US 2010,21 CFR 352,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=da19d3ec-3547-48c0-a08a-5b4e35d1db1d,Possibly Marketed Outside US 2010,21 CFR 352,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=da19d3ec-3547-48c0-a08a-5b4e35d1db1d,,
BASILIXIMAB,179045-86-4,https://drugs.ncats.io/drug/9927MT646M,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""179045%2086%204"")",ONLY CAS,US Approved Rx 1998,BLA103764,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103764,US Approved Rx 1998,BLA103764,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103764,,
BAZEDOXIFENE,198481-32-2,https://drugs.ncats.io/drug/Q16TT9C5BK,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""198481%2032%202"")",ONLY CAS,US Approved Rx 2013,NDA022247,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022247,US Approved Rx 2013,NDA022247,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022247,Postmenopausal osteoporosis; Hot flashes,Approved; Approved
BECAPLERMIN,165101-51-9,https://drugs.ncats.io/drug/1B56C968OA,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""165101%2051%209"")",ONLY CAS,US Approved Rx 1997,BLA103691,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103691,US Approved Rx 1997,BLA103691,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103691,,
BECLOMETASONE,4419-39-0,https://drugs.ncats.io/drug/KGZ1SLC28Z,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""4419%2039%200"")",ONLY CAS,US Previously Marketed 1987,VANCENASE AQ by SCHERING,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019589,US Previously Marketed 1987,VANCENASE AQ by SCHERING,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019589,Asthma,Approved
BEDAQUILINE,843663-66-1,https://drugs.ncats.io/drug/78846I289Y,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""843663%2066%201"")",ONLY CAS,US Approved Rx 2012,NDA204384,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204384,US Approved Rx 2012,NDA204384,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204384,"Tuberculosis, multidrug-resistant",Approved
BELATACEPT,706808-37-9,https://drugs.ncats.io/drug/E3B2GI648A,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""706808%2037%209"")",ONLY CAS,US Approved Rx 2011,BLA125288,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125288,US Approved Rx 2011,BLA125288,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125288,,
BELIMUMAB,356547-88-1,https://drugs.ncats.io/drug/73B0K5S26A,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""356547%2088%201"")",ONLY CAS,US Approved Rx 2017,BLA761043,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761043,US Approved Rx 2011,BLA125370,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125370,,
BELINOSTAT,866323-14-0,https://drugs.ncats.io/drug/F4H96P17NZ,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""866323%2014%200"")",ONLY CAS,US Approved Rx 2014,NDA206256,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206256,US Approved Rx 2014,NDA206256,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206256,"Lymphoma, T-cell, peripheral",Approved
BENAZEPRIL,86541-75-5,https://drugs.ncats.io/drug/UDM7Q7QWP8,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""86541%2075%205"")",ONLY CAS,US Approved Rx 2004,ANDA076118,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=076118,Possibly Marketed Outside US 1991,NDA019851,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2abb091b-a53e-46b0-9b84-e5ee8f2bdd8e,Hypertension,Approved
BENDAMUSTINE,16506-27-7,https://drugs.ncats.io/drug/9266D9P3PQ,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""16506%2027%207"")",ONLY CAS,US Approved Rx 2015,NDA208194,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208194,US Approved Rx 2008,NDA022303,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022303,Non-Hodgkin's lymphoma; Chronic lymphocytic leukemia,Phase III; Approved
BENDROFLUMETHIAZIDE,73-48-3,https://drugs.ncats.io/drug/5Q52X6ICJI,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""73%2048%203"")",ONLY CAS,US Previously Marketed 1983,CORZIDE by KING PHARMS LLC,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018647,US Previously Marketed 1959,NATURETIN-2.5 by APOTHECON,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=012164,Hypertension,Approved
BENRALIZUMAB,1044511-01-4,https://drugs.ncats.io/drug/71492GE1FX,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1044511%2001%204"")",ONLY CAS,US Approved Rx 2017,BLA761070,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761070,US Approved Rx 2017,BLA761070,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761070,,
BENTOQUATAM,1340-69-8,https://drugs.ncats.io/drug/7F465U79Q1,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1340%2069%208"")",ONLY CAS,US Approved Rx 1996,NDA020532,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020532,US Approved Rx 1996,NDA020532,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020532,,
BENZALKONIUM CHLORIDE,100-51-6,https://drugs.ncats.io/drug/LKG8494WBH,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""100%2051%206"")",ONLY CAS,US Approved OTC ,21 CFR 346.10(b) anorectal:local anesthetic benzyl alcohol,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec346-10.xml,US Previously Marketed 1921,Benzyl Alcohol,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,Head lice infestation,Approved
BENZATROPINE,86-13-5,https://drugs.ncats.io/drug/1NHL2J4X8K,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""86%2013%205"")",ONLY CAS,US Approved Rx 1989,ANDA072266,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=072266,US Previously Marketed 1954,COGENTIN by MERCK,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=009193,Parkinsonism; Extrapyramidal disorders,Approved; Approved
BENZETHONIUM CHLORIDE,121-54-0,https://drugs.ncats.io/drug/PH41D05744,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""121%2054%200"")",ONLY CAS,US Previously Marketed 1942,Phemerol Chloride by Parke-Davis,DeHaen 1940-1975 NMEs,US Previously Marketed 1942,Phemerol Chloride by Parke-Davis,DeHaen 1940-1975 NMEs,Head and neck cancer; Methicillin-resistant Staphylococcus aureus; Skin infections; Bacterial Infections,Preclinical; Basic research; Basic research; Approved
BENZOCAINE,94-09-7,https://drugs.ncats.io/drug/U3RSY48JW5,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""94%2009%207"")",ONLY CAS,US Approved OTC ,21 CFR 346.10(a) anorectal:local anesthetic benzocaine,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec346-10.xml,US Previously Marketed 1895,Americaine,https://catalog.hathitrust.org/Record/100782317,Otitis media; Burn; Canker sores; Sore mouth; Sore throat; Hemorrhoids,Approved; Approved; Approved; Approved; Approved; Approved
BENZOIC ACID,65-85-0,https://drugs.ncats.io/drug/8SKN0B0MIM,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""65%2085%200"")",ONLY CAS,US Approved Rx 2016,ANDA207096,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207096,US Previously Marketed 1921,Benzoic Acid U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,Unknown; Tinea capitis; Hyperammonemia; Tinea pedis,Approved; Approved; Approved
BENZONATATE,104-31-4,https://drugs.ncats.io/drug/5P4DHS6ENR,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""104%2031%204"")",ONLY CAS,US Approved Rx 2019,ANDA211518,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211518,US Approved Rx 1958,NDA011210,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=011210,Cough,Approved
BENZOPHENONE,119-61-9,https://drugs.ncats.io/drug/701M4TTV9O,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""119%2061%209"")",ONLY CAS,Possibly Marketed Outside US ,part352,https://www.drugbank.ca/drugs/DB01878,Possibly Marketed Outside US 2009,21 CFR 333D,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7d15560f-d8d1-4dfe-8eca-b16bb529ad87,Skin pigmentation,Approved
BENZOXIQUINE,86-75-9,https://drugs.ncats.io/drug/GRE0P19C3Z,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""86%2075%209"")",ONLY CAS,US Previously Marketed ,21 CFR 310.545(a)(18)(ii) skin protectant:astringent oxyquinoline sulfate,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec310-545.xml,Possibly Marketed Outside US 1964,UDDER BALM by H. W. Naylor Company Inc.,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2907f343-4457-bf36-2e0b-aa074e63a4bd,Unknown,
BENZOYL PEROXIDE,94-36-0,https://drugs.ncats.io/drug/W9WZN9A0GM,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""94%2036%200"")",ONLY CAS,US Approved OTC ,21 CFR 333.310(a) acne benzoyl peroxide,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec333-310.xml,US Approved Rx 1984,NDA050557,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050557,Acne vulgaris,Approved
BENZPHETAMINE,156-08-1,https://drugs.ncats.io/drug/0M3S43XK27,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""156%2008%201"")",ONLY CAS,US Approved Rx 2010,ANDA090968,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=090968,US Previously Marketed 1960,DIDREX by PFIZER,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=012427,Exogenous obesity,Approved
BENZYL ALCOHOL,100-51-6,https://drugs.ncats.io/drug/LKG8494WBH,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""100%2051%206"")",ONLY CAS,US Approved OTC ,21 CFR 346.10(b) anorectal:local anesthetic benzyl alcohol,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec346-10.xml,US Previously Marketed 1921,Benzyl Alcohol,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,Head lice infestation,Approved
BENZYL BENZOATE,120-51-4,https://drugs.ncats.io/drug/N863NB338G,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""120%2051%204"")",ONLY CAS,US Previously Marketed 1976,BENZYL BENZOATE by LANNETT,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=084535,US Previously Marketed 1921,Benzyl benzoate by Merck,https://books.google.com/books?id=3VM5AQAAMAAJ&newbks=1&newbks_redir=0&dq=benzyl%20benzoate%20van%20dyk&pg=PA61#v=onepage&q=benzyl%20benzoate%20van%20dyk&f=false,Scabies caused by the Sarcoptes scabiei mite.; Pediculosis caused by Pediculus capitis (head louse) and Phthirus pubis (pubic or crab louse); Sunburn,Withdrawn; Withdrawn; Approved
BEPOTASTINE,125602-71-3,https://drugs.ncats.io/drug/HYD2U48IAS,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""125602%2071%203"")",ONLY CAS,US Approved Rx 2023,ANDA214588,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214588,US Approved Rx 2009,NDA022288,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022288,Allergic conjunctivitis; Allergic rhinitis,Approved; Approved
BEPRIDIL,64706-54-3,https://drugs.ncats.io/drug/755BO701MA,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""64706%2054%203"")",ONLY CAS,US Previously Marketed 1990,BEPADIN by MEDPOINTE PHARM HLC,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019001,US Previously Marketed 1990,BEPADIN by MEDPOINTE PHARM HLC,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019001,Chronic stable angina; Tachyarrhythmia; Atrial fibrillation; Hypertension,Approved; Approved; Approved; Approved
BERACTANT,108778-82-1,https://drugs.ncats.io/drug/S866O45PIG,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""108778%2082%201"")",ONLY CAS,US Approved Rx 1991,BLA020032,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020032,US Approved Rx 1991,BLA020032,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020032,,
BERBERIS VULGARIS,84649-92-3,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""84649%2092%203"")",ONLY CAS,,,,,,,,
BESIFLOXACIN,141388-76-3,https://drugs.ncats.io/drug/BFE2NBZ7NX,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""141388%2076%203"")",ONLY CAS,US Approved Rx 2009,NDA022308,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022308,US Approved Rx 2009,NDA022308,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022308,Bacterial conjunctivitis,Approved
BETACAROTENE,7235-40-7,https://drugs.ncats.io/drug/01YAE03M7J,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""7235%2040%207"")",ONLY CAS,US Previously Marketed 1975,SOLATENE by ROCHE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017589,Possibly Marketed Outside US 1964,UDDER BALM by H. W. Naylor Company Inc.,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2907f343-4457-bf36-2e0b-aa074e63a4bd,"Macular degeneration; Neuroblastoma; Head and neck cancer; Retinitis pigmentosa; Psoriasis; Chronic pancreatitis; Cardiovascular diseases; Maternal mortality, fetal loss, or infant mortality; Erythropoietic protoporphyria",Phase III; Basic research; Phase III; Phase III; Phase III; Phase III; Phase II; Phase III; Approved
BETAHISTINE,5638-76-6,https://drugs.ncats.io/drug/X32KK4201D,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""5638%2076%206"")",ONLY CAS,US Previously Marketed 1966,Serc by Unimed More,DeHaen 1940-1975 NMEs,US Previously Marketed 1966,Serc by Unimed More,DeHaen 1940-1975 NMEs,Meniere's disease,Approved
BETAINE,107-43-7,https://drugs.ncats.io/drug/3SCV180C9W,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""107%2043%207"")",ONLY CAS,US Approved Rx 2021,ANDA214864,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214864,US Previously Marketed 1880,Betain,https://books.google.com/books?id=hg5KAAAAMAAJ&newbks=1&newbks_redir=0&dq=betaine%20cooley&pg=PA316#v=onepage&q=betaine&f=false,Homocystinuria,Approved
BETAMETHASONE,378-44-9,https://drugs.ncats.io/drug/9842X06Q6M,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""378%2044%209"")",ONLY CAS,US Approved Rx 2020,NDA213422,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213422,US Previously Marketed 1961,CELESTONE by SCHERING,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=012657,Congenital adrenal hyperplasia; Lymphomas; Asthma; Allergic rhinitis; Ulcerative colitis; Acute exacerbations of multiple sclerosis,Approved; Approved; Approved; Approved; Approved; Approved
BETAXOLOL,63659-18-7,https://drugs.ncats.io/drug/O0ZR1R6RZ2,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""63659%2018%207"")",ONLY CAS,US Approved Rx 2009,ANDA078694,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=078694,US Approved Rx 1985,NDA019270,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019270,Open-angle glaucoma; Ocular hypertension; Hypertension,Approved; Approved; Approved
BETHANECHOL,674-38-4,https://drugs.ncats.io/drug/004F72P8F4,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""674%2038%204"")",ONLY CAS,US Approved Rx 1978,ANDA086263,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=086263,US Previously Marketed 1948,URECHOLINE by ODYSSEY PHARMS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=006536,Urinary retention,Approved
BETRIXABAN,330942-05-7,https://drugs.ncats.io/drug/74RWP7W0J9,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""330942%2005%207"")",ONLY CAS,US Previously Marketed 2017,BEVYXXA by PORTOLA PHARMS INC,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208383,US Previously Marketed 2017,BEVYXXA by PORTOLA PHARMS INC,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208383,Venous thromboembolism; venous thromboembolism,Phase III; Approved
BEVACIZUMAB,216974-75-3,https://drugs.ncats.io/drug/2S9ZZM9Q9V,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""216974%2075%203"")",ONLY CAS,US Approved Rx 2019,BLA761099,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761099,US Approved Rx 2004,BLA125085,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125085,,
BEXAROTENE,153559-49-0,https://drugs.ncats.io/drug/A61RXM4375,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""153559%2049%200"")",ONLY CAS,US Approved Rx 2018,ANDA209861,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209861,US Approved Rx 1999,NDA021055,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021055,,
BEZLOTOXUMAB,1246264-45-8,https://drugs.ncats.io/drug/4H5YMK1H2E,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1246264%2045%208"")",ONLY CAS,US Approved Rx 2016,BLA761046,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761046,US Approved Rx 2016,BLA761046,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761046,,
BICALUTAMIDE,90357-06-5,https://drugs.ncats.io/drug/A0Z3NAU9DP,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""90357%2006%205"")",ONLY CAS,US Approved Rx 2015,ANDA091011,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=091011,US Approved Rx 1995,NDA020498,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020498,Stage D2 metastatic carcinoma of the prostate,Approved
BICTEGRAVIR,1611493-60-7,https://drugs.ncats.io/drug/8GB79LOJ07,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1611493%2060%207"")",ONLY CAS,US Approved Rx 2018,NDA210251,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210251,US Approved Rx 2018,NDA210251,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210251,HIV-1 infection,Approved
BIMATOPROST,155206-00-1,https://drugs.ncats.io/drug/QXS94885MZ,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""155206%2000%201"")",ONLY CAS,US Approved Rx 2015,ANDA203991,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203991,US Previously Marketed 2001,LUMIGAN by ABBVIE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021275,Ocular hypertension; Open-angle glaucoma,Approved; Approved
BINIMETINIB,606143-89-9,https://drugs.ncats.io/drug/181R97MR71,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""606143%2089%209"")",ONLY CAS,US Approved Rx 2018,NDA210498,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210498,US Approved Rx 2018,NDA210498,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210498,BRAF V600E-mutant metastatic colorectal cancer; Metastatic or unresectable cutaneous melanoma,Phase III; Approved
BIOFLAVONOIDS,153-18-4,https://drugs.ncats.io/drug/5G06TVY3R7,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""153%2018%204"")",ONLY CAS,US Previously Marketed 1921,rutin,https://catalog.hathitrust.org/Record/100163146,US Previously Marketed 1921,rutin,https://catalog.hathitrust.org/Record/100163146,Osteoarthritis; Open-angle glaucoma; Postmastectomy lymphoedema of the arm,Approved; Phase II; Approved
BIOTIN,58-85-5,https://drugs.ncats.io/drug/6SO6U10H04,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""58%2085%205"")",ONLY CAS,US Approved Rx 2000,NDA021163,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021163,US Previously Marketed 1947,BEROCCA PN by ROCHE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=006071,Vitamin deficiency; Biotin deficiency,Approved; Approved
BIPERIDEN,514-65-8,https://drugs.ncats.io/drug/0FRP6G56LD,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""514%2065%208"")",ONLY CAS,US Previously Marketed 1959,AKINETON by ABBVIE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=012003,US Previously Marketed 1959,AKINETON by ABBVIE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=012003,Idiopathic Parkinson's disease; Postencephalitic parkinsonism; Arteriosclerotic parkinsonism,Approved; Approved; Approved
BISACODYL,603-50-9,https://drugs.ncats.io/drug/10X0709Y6I,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""603%2050%209"")",ONLY CAS,US Previously Marketed 1958,Dulcolax by Geigy,DeHaen 1940-1975 NMEs,US Previously Marketed 1958,Dulcolax by Geigy,DeHaen 1940-1975 NMEs,Constipation,Withdrawn
BISMUTH,7440-69-9,https://drugs.ncats.io/drug/U015TT5I8H,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""7440%2069%209"")",ONLY CAS,US Previously Marketed 1921,Bismuth Magma U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,US Previously Marketed 1921,Bismuth Magma U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,,
BISOPROLOL,66722-44-9,https://drugs.ncats.io/drug/Y41JS2NL6U,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""66722%2044%209"")",ONLY CAS,US Approved Rx 2024,ANDA217617,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217617,US Previously Marketed 1992,ZEBETA by TEVA WOMENS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019982,Hypertension,Approved
BITOLTEROL,30392-40-6,https://drugs.ncats.io/drug/9KY0QXD6LI,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""30392%2040%206"")",ONLY CAS,US Previously Marketed 1992,TORNALATE by SANOFI AVENTIS US,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019548,US Previously Marketed 1984,TORNALATE by SANOFI AVENTIS US,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018770,Asthma; Chronic obstructive pulmonary disease,Approved; Approved
BIVALIRUDIN,128270-60-0,https://drugs.ncats.io/drug/TN9BEX005G,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""128270%2060%200"")",ONLY CAS,US Approved Rx 2019,NDA211215,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211215,US Approved Rx 2000,NDA020873,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020873,unstable angina,Approved
BLEOMYCIN,11056-06-7,https://drugs.ncats.io/drug/40S1VHN69B,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""11056%2006%207"")",ONLY CAS,US Approved Rx 2001,ANDA065042,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=065042,US Previously Marketed 1973,BLENOXANE by BRISTOL MYERS SQUIBB,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050443,"Squamous cell carcinoma, cervix; Malignant pleural effusion; Squamous cell carcinoma, vulva; Non-Hodgkin's lymphoma; Squamous cell carcinoma, penis; Embryonal cell, choriocarcinoma; Head and neck squamous cell carcinoma; Hodgkin's lymphoma; Teratocarcinoma; Hodgkin's lymphoma; Non-Hodgkin's lymphoma; Malignant pleural effusion; Testicular cancer; Squamous cell carcinoma",Approved; Approved; Approved; Approved; Approved; Approved; Approved; Approved; Approved; Approved; Approved; Approved; Approved; Approved
BLINATUMOMAB,853426-35-4,https://drugs.ncats.io/drug/4FR53SIF3A,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""853426%2035%204"")",ONLY CAS,US Approved Rx 2014,BLA125557,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125557,US Approved Rx 2014,BLA125557,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125557,,
BOCEPREVIR,394730-60-0,https://drugs.ncats.io/drug/89BT58KELH,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""394730%2060%200"")",ONLY CAS,US Previously Marketed 2011,VICTRELIS by MERCK SHARP DOHME,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202258,US Previously Marketed 2011,VICTRELIS by MERCK SHARP DOHME,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202258,Chronic hepatitis C,Approved
BORIC ACID,"10043-35-3
11113-50-1",N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""10043%2035%203
11113%2050%201"")",ONLY CAS,,,,,,,,
BORTEZOMIB,179324-69-7,https://drugs.ncats.io/drug/69G8BD63PP,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""179324%2069%207"")",ONLY CAS,US Approved Rx 2022,ANDA209659,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209659,US Approved Rx 2003,NDA021602,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021602,Multiple myeloma; Mantle cell lymphoma,Approved; Approved
BOSENTAN,147536-97-8,https://drugs.ncats.io/drug/XUL93R30K2,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""147536%2097%208"")",ONLY CAS,US Approved Rx 2019,ANDA207110,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207110,US Approved Rx 2001,NDA021290,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021290,Pulmonary arterial hypertension,Approved
BOSUTINIB,380843-75-4,https://drugs.ncats.io/drug/5018V4AEZ0,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""380843%2075%204"")",ONLY CAS,US Approved Rx 2023,NDA217729,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217729,US Approved Rx 2012,NDA203341,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203341,"Leukemia, myelogenous, chronic, BCR-ABL positive",Approved
BRASSICA NAPUS,173740-48-2,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""173740%2048%202"")",ONLY CAS,,,,,,,,
BRENTUXIMAB VEDOTIN,914088-09-8,https://drugs.ncats.io/drug/7XL5ISS668,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""914088%2009%208"")",ONLY CAS,US Approved Rx 2011,BLA125399,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125399,US Approved Rx 2011,BLA125399,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125399,,
BRETYLIUM,59-41-6,https://drugs.ncats.io/drug/RZR75EQ2KJ,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""59%2041%206"")",ONLY CAS,US Previously Marketed 2018,BRETYLIUM TOSYLATE by BRECKENRIDGE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204386,US Previously Marketed 1978,BRETYLOL by HOSPIRA,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017954,Ventricular fibrillation; Ventricular arrhythmia,Approved; Approved
BREXPIPRAZOLE,913611-97-9,https://drugs.ncats.io/drug/2J3YBM1K8C,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""913611%2097%209"")",ONLY CAS,US Approved Rx 2023,ANDA213782,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213782,US Approved Rx 2015,NDA205422,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205422,Major depressive disorder; Schizophrenia,Approved; Approved
BRIGATINIB,1197953-54-0,https://drugs.ncats.io/drug/HYW8DB273J,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1197953%2054%200"")",ONLY CAS,US Approved Rx 2017,NDA208772,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208772,US Approved Rx 2017,NDA208772,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208772,ALK-positive advanced non-small cell lung cancer; ALK-positive metastatic non-small cell lung cancer,Phase III; Approved
BRILLIANT GREEN,633-03-4,https://drugs.ncats.io/drug/G0L543D370,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""633%2003%204"")",ONLY CAS,Possibly Marketed Outside US ,part333E,https://www.drugbank.ca/drugs/DB11279,Possibly Marketed Outside US 1960,Pad Kote by Happy Jack Inc,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=120d77fd-eb27-4418-9b49-6f60ecee001b,Bacterial infections; Umbilical cord area infection in newborn,Approved; Approved
BRIMONIDINE,59803-98-4,https://drugs.ncats.io/drug/E6GNX3HHTE,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""59803%2098%204"")",ONLY CAS,US Approved Rx 2022,ANDA091087,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=091087,US Previously Marketed 1996,ALPHAGAN by ALLERGAN,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020613,Open-angle glaucoma; Ocular hypertension; Persistent (nontransient) facial erythema of rosacea,Approved; Approved; Approved
BRINZOLAMIDE,138890-62-7,https://drugs.ncats.io/drug/9451Z89515,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""138890%2062%207"")",ONLY CAS,US Approved Rx 2020,ANDA209406,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209406,US Approved Rx 1998,NDA020816,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020816,Ocular hypertension; Open-angle glaucoma,Approved; Approved
BRIVARACETAM,357336-20-0,https://drugs.ncats.io/drug/U863JGG2IA,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""357336%2020%200"")",ONLY CAS,US Approved Rx 2016,NDA205836,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205836,US Approved Rx 2016,NDA205836,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205836,Epilepsy,Approved
BRODALUMAB,1174395-19-7,https://drugs.ncats.io/drug/6ZA31Y954Z,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1174395%2019%207"")",ONLY CAS,US Approved Rx 2017,BLA761032,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761032,US Approved Rx 2017,BLA761032,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761032,,
BROMAZINE,118-23-0,https://drugs.ncats.io/drug/T032BI7727,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""118%2023%200"")",ONLY CAS,US Previously Marketed 1953,Ambodryl HCl by Parke-Davis,DeHaen 1940-1975 NMEs,US Previously Marketed 1951,Ambodryl by Parke Davis,OB NME Appendix 1950-1985,Allergy,Approved
BROMFENAC,91714-94-2,https://drugs.ncats.io/drug/864P0921DW,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""91714%2094%202"")",ONLY CAS,US Approved Rx 2024,ANDA211239,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211239,US Previously Marketed 1997,Duract,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20535,Postoperative inflammation; Ocular pain,Approved; Approved
BROMINE,7726-95-6,https://drugs.ncats.io/drug/SBV4XY874G,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""7726%2095%206"")",ONLY CAS,US Previously Marketed 1921,Bromine N.F.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,US Previously Marketed 1921,Bromine N.F.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,,
BROMOCRIPTINE,25614-03-3,https://drugs.ncats.io/drug/3A64E3G5ZO,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""25614%2003%203"")",ONLY CAS,US Approved Rx 2008,ANDA078899,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=078899,US Approved Rx 1978,NDA017962,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017962,Parkinson's disease; Acromegaly; Type 2 diabetes mellitus; Hyperprolactinemia-associated dysfunctions,Approved; Approved; Approved; Approved
BROMPHENIRAMINE,86-22-6,https://drugs.ncats.io/drug/H57G17P2FN,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""86%2022%206"")",ONLY CAS,US Approved OTC ,21 CFR 341.12(a) cough/cold:antihistamine brompheniramine maleate,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec341-12.xml,US Previously Marketed 1956,Dimetane by Robins,OB NME Appendix 1950-1985,Rhinitis; Nasal congestion and inflammations; Common cold,Phase III; Phase III; Approved
BRONOPOL,52-51-7,https://drugs.ncats.io/drug/6PU1E16C9W,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""52%2051%207"")",ONLY CAS,US Approved Allergenic Extract 1994,BLA103738,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2f082b68-dc74-418a-9e6f-b3c285b41d44,US Approved Allergenic Extract 1994,BLA103738,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2f082b68-dc74-418a-9e6f-b3c285b41d44,Unknown,
BUDESONIDE,51333-22-3,https://drugs.ncats.io/drug/Q3OKS62Q6X,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""51333%2022%203"")",ONLY CAS,US Approved Rx 2014,NDA205613,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205613,US Previously Marketed 1994,RHINOCORT by ASTRAZENECA,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020233,Distal ulcerative colitis; Asthma; Crohn's disease; Perennial allergic rhinitis,Approved; Approved; Approved; Approved
BUMETANIDE,28395-03-1,https://drugs.ncats.io/drug/0Y2S3XUQ5H,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""28395%2003%201"")",ONLY CAS,US Approved Rx 2008,ANDA079196,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=079196,US Previously Marketed 1983,BUMEX by VALIDUS PHARMS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018226,Edema,Approved
BUPIVACAINE,38396-39-3,https://drugs.ncats.io/drug/Y8335394RO,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""38396%2039%203"")",ONLY CAS,US Approved Rx 1988,ANDA071168,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=071168,US Approved Rx 1972,NDA016964,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016964,Pain,Approved
BUPRENORPHINE,52485-79-7,https://drugs.ncats.io/drug/40D3SCR4GZ,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""52485%2079%207"")",ONLY CAS,US Approved Rx 2013,ANDA091422,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=091422,US Previously Marketed 1981,BUPRENEX by INDIVIOR,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018401,Rheumatoid arthritis; Opioid dependence; Osteoarthritis; Lower back pain; Chronic pain,Phase IV; Approved; Phase IV; Phase IV; Approved
BUPROPION,34911-55-2,https://drugs.ncats.io/drug/01ZG3TPX31,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""34911%2055%202"")",ONLY CAS,US Approved Rx 2011,NDA022497,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022497,US Previously Marketed 1985,WELLBUTRIN by GLAXOSMITHKLINE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018644,Major depressive disorder; Nicotine dependence,Approved; Approved
BUROSUMAB,1610833-03-8,https://drugs.ncats.io/drug/G9WJT6RD29,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1610833%2003%208"")",ONLY CAS,US Approved Rx 2018,BLA761068,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761068,US Approved Rx 2018,BLA761068,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761068,,
BUSPIRONE,36505-84-7,https://drugs.ncats.io/drug/TK65WKS8HL,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""36505%2084%207"")",ONLY CAS,US Approved Rx 2015,ANDA202087,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202087,US Previously Marketed 1986,BUSPAR by BRISTOL MYERS SQUIBB,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018731,Anxiety,Approved
BUSULFAN,55-98-1,https://drugs.ncats.io/drug/G1LN9045DK,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""55%2098%201"")",ONLY CAS,US Approved Rx 1999,NDA020954,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020954,US Previously Marketed 1954,Myleran by Burroughs Wellcome,OB NME Appendix 1950-1985,Chronic myeloid leukemia,Approved
BUTALAMINE,22131-35-7,https://drugs.ncats.io/drug/140T9JTG43,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""22131%2035%207"")",ONLY CAS,Possibly Marketed Outside US ,WHO-ATC:C04AX23,https://ginas.ncats.nih.gov/ginas/app/substance/140T9JTG43,,,,,
BUTALBITAL,77-26-9,https://drugs.ncats.io/drug/KHS0AZ4JVK,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""77%2026%209"")",ONLY CAS,US Approved Rx 1987,ANDA089175,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=089175,US Previously Marketed 1929,Sandoptal by Sandoz,https://books.google.com/books?id=i9BQAAAAYAAJ&q=SANDOPTAL&dq=SANDOPTAL&hl=en&newbks=1&newbks_redir=0&sa=X&ved=2ahUKEwj_i7-Hg_TmAhVDU98KHX8dCOAQ6AEwAHoECAYQAg,Tension or muscle contraction headache,Approved
BUTENAFINE,101828-21-1,https://drugs.ncats.io/drug/91Y494NL0X,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""101828%2021%201"")",ONLY CAS,US Approved Rx 2017,ANDA205181,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205181,Possibly Marketed Outside US 1993,NDA021307,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0eadac26-4619-4227-9dda-28e739d77a87,Tinea versicolor; Tinea,Approved; Approved
BUTOCONAZOLE,64872-76-0,https://drugs.ncats.io/drug/0Q771797PH,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""64872%2076%200"")",ONLY CAS,US Approved Rx 2012,ANDA200923,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=200923,US Previously Marketed 1985,FEMSTAT by ROCHE PALO,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019215,Vulvovaginal candidiasis,Approved
BUTORPHANOL,42408-82-2,https://drugs.ncats.io/drug/QV897JC36D,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""42408%2082%202"")",ONLY CAS,US Approved Rx 2001,ANDA075759,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=075759,US Previously Marketed 1978,STADOL PRESERVATIVE FREE by APOTHECON,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017857,Pain,Approved
BUTYLATED HYDROXYANISOLE,25013-16-5,https://drugs.ncats.io/drug/REK4960K2U,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""25013%2016%205"")",ONLY CAS,Possibly Marketed Outside US 1941,Morphine Sulfate by Padagis US LLC,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=649d731b-962a-45df-b043-7e0781e8a530,Possibly Marketed Outside US 1941,Morphine Sulfate by Padagis US LLC,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=649d731b-962a-45df-b043-7e0781e8a530,,
BUTYLCAINE,94-25-7,https://drugs.ncats.io/drug/EFW857872Q,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""94%2025%207"")",ONLY CAS,Possibly Marketed Outside US ,"One Touch Advanced Topical Anesthetic Bubble Gum by Hager Worldwide, Inc.",https://www.drugbank.ca/drugs/DB11148,Possibly Marketed Outside US 1958,"Cetacaine Anesthetic by Cetylite Industries, Inc.",https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=af1773c5-5d5b-4278-b551-30ad2df6d5b5,Topical anesthetic,Basic research
BUTYLPARABEN,94-26-8,https://drugs.ncats.io/drug/3QPI1U3FV8,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""94%2026%208"")",ONLY CAS,Possibly Marketed Outside US ,Canada:BUTYLPARABEN,https://tripod.nih.gov/npc/#Download,Possibly Marketed Outside US 1984,"NU-DERM SUNFADER  Skin Lightener with Sunscreen (SPF 15) PABA FREE by OMP, INC.",https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c67b0629-5529-412d-99ee-186df4ecad5a,Depression; Unknown,Approved
C1 INHIBITOR (HUMAN),80295-38-1,https://drugs.ncats.io/drug/5QS67N4551,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""80295%2038%201"")",ONLY CAS,Possibly Marketed Outside US ,WHO-ATC:B06AC04,https://ginas.ncats.nih.gov/ginas/app/substance/5QS67N4551,Possibly Marketed Outside US 2014,BLA125495,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b81613ee-506e-47eb-91a7-708dfc958ea3,,
CABAZITAXEL,183133-96-2,https://drugs.ncats.io/drug/51F690397J,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""183133%2096%202"")",ONLY CAS,US Approved Rx 2021,NDA207949,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207949,US Approved Rx 2010,NDA201023,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201023,Hormone-refractory metastatic prostate cancer,Approved
CABERGOLINE,81409-90-7,https://drugs.ncats.io/drug/LL60K9J05T,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""81409%2090%207"")",ONLY CAS,US Approved Rx 2007,ANDA077750,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=077750,US Previously Marketed 1996,DOSTINEX by PFIZER,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020664,"Hyperprolactinemic disorders, idiopathic; Hyperprolactinemic disorders, due to pituitary adenomas",Approved; Approved
CABOZANTINIB,849217-68-1,https://drugs.ncats.io/drug/1C39JW444G,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""849217%2068%201"")",ONLY CAS,US Approved Rx 2022,ANDA215942,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215942,US Approved Rx 2012,NDA203756,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203756,"Medullary thyroid cancer; Medullary thyroid cancer, metastatic; Renal cell carcinoma",Approved; Approved; Approved
CADEXOMER IODINE,94820-09-4,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""94820%2009%204"")",ONLY CAS,,,,,,,,
CADE OIL,8013-10-3,https://drugs.ncats.io/drug/1Q84T0P2G3,2,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""8013%2010%203"")%20AND%20(root_names_name:""%5ECADE%20OIL$"")",EXACT NAME,US Approved OTC ,"21 CFR 346.16(b) anorectal:analgesic, anesthetic, antipruritic juniper tar",https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec346-16.xml,US Previously Marketed 1921,Oil of Cade U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,,
CAFFEINE,58-08-2,https://drugs.ncats.io/drug/3G6A5W338E,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""58%2008%202"")",ONLY CAS,US Approved OTC ,21 CFR 340.10 stimulant caffeine,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec340-10.xml,US Previously Marketed 1921,Citrated Caffeine U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,Migraine; Atopic dermatitis; Apnea of prematurity; Drowsiness,Approved; Not Provided; Approved; Approved
CALAMINE,8011-96-9,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""8011%2096%209"")",ONLY CAS,,,,,,,,
CALCIFEDIOL,19356-17-3,https://drugs.ncats.io/drug/T0WXW8F54E,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""19356%2017%203"")",ONLY CAS,US Approved Rx 2016,NDA208010,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208010,US Previously Marketed 1980,CALDEROL by ORGANON USA INC,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018312,"Secondary hyperparathyroidism in adults with stage 3 or 4 chronic kidney disease; Hypocalcemia, chronic; Hypophosphatemia; Osteodystrophy",Approved; Approved; Approved; Approved
CALCIPOTRIOL,112965-21-6,https://drugs.ncats.io/drug/143NQ3779B,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""112965%2021%206"")",ONLY CAS,US Approved Rx 2020,NDA213422,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213422,US Previously Marketed 1993,DOVONEX by LEO PHARMA AS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020273,Plaque psoriasis; Unknown; Colon cancer; Lung cancer; Breast cancer,Approved; Preclinical; Preclinical; Preclinical
CALCITONIN (SALMON),9007-12-9,https://drugs.ncats.io/drug/DF35I47HCM,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""9007%2012%209"")",ONLY CAS,Possibly Marketed Outside US 2020,NCT04445857: Phase 4 Interventional Completed Analgesia,https://clinicaltrials.gov/ct2/show/NCT04445857,,,,,
CALCITRIOL,32222-06-3,https://drugs.ncats.io/drug/FXC9231JVH,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""32222%2006%203"")",ONLY CAS,US Approved Rx 2008,ANDA078066,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=078066,US Approved Rx 1978,NDA018044,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018044,Mild to moderate plaque psoriasis; Hypocalcemia; Secondary hyperparathyroidism; Unknown,Approved; Approved; Approved
CALCIUM,7440-70-2,https://drugs.ncats.io/drug/SY7Q814VUP,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""7440%2070%202"")",ONLY CAS,US Approved OTC ,21 CFR 331.11(i)(2) antacid:calcium-containing calcium (mono or dibasic salt),https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec331-11.xml,US Previously Marketed 1921,Precipitated Calcium Phosphate N.F.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,Unknown; Hypocalcemia; Chronic obstructive pulmonary disease; Cystic fibrosis; Unknown; Hypocalcemia,Not Provided; Phase I; Phase I; Approved
CALCIUM FOLINATE,1492-18-8,https://drugs.ncats.io/drug/RPR1R4C0P4,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1492%2018%208"")",ONLY CAS,US Approved Rx 2023,ANDA216590,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216590,US Previously Marketed 1952,Leucovorin by Lederle,OB NME Appendix 1950-1985,Megaloblastic anemia; Advanced colorectal cancer; Osteosarcoma,Approved; Approved; Approved
CALCIUM LEVOFOLINATE,80433-71-2,https://drugs.ncats.io/drug/778XL6VBS8,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""80433%2071%202"")",ONLY CAS,US Approved Rx 2019,ANDA211003,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211003,Possibly Marketed Outside US 1952,NDA211226,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=344f65ac-9f04-49d7-b7c3-4ba19bd7b429,Methotrexate toxicity; Metastatic colorectal cancer,Approved; Approved
CALCIUM MEFOLINATE,26560-38-3,https://drugs.ncats.io/drug/9I291HQ60G,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""26560%2038%203"")",ONLY CAS,Possibly Marketed Outside US ,vitaMedMD One Rx by vitaMedMD,https://www.drugbank.ca/drugs/DB04789,Possibly Marketed Outside US 2012,vitaMedMD One Rx by vitaMedMD,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c321dba6-eae6-42fa-8ff9-bdfa6ffabcd9,Methylenetetrahydrofolate reductase deficiency,Not Provided
CALFACTANT,183325-78-2,https://drugs.ncats.io/drug/Q4K217VGA9,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""183325%2078%202"")",ONLY CAS,US Approved Rx 1998,BLA020521,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020521,US Approved Rx 1998,BLA020521,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020521,,
CAMPESTEROL,474-62-4,https://drugs.ncats.io/drug/5L5O665639,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""474%2062%204"")",ONLY CAS,Possibly Marketed Outside US 2012,21 CFR 352,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bae69545-3b5a-4994-a357-7f93c474340f,Possibly Marketed Outside US 2012,21 CFR 352,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bae69545-3b5a-4994-a357-7f93c474340f,,
CAMPHOR,76-22-2,https://drugs.ncats.io/drug/5TJD82A1ET,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""76%2022%202"")",ONLY CAS,US Approved OTC ,"21 CFR 346.16(a) anorectal:analgesic, anesthetic, antipruritic camphor",https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec346-16.xml,US Previously Marketed 1921,Camphor U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,Cough; Muscle pain; Pain,Approved; Approved; Approved
CANAGLIFLOZIN,842133-18-0,https://drugs.ncats.io/drug/6S49DGR869,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""842133%2018%200"")",ONLY CAS,US Approved Rx 2014,NDA204353,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204353,US Approved Rx 2013,NDA204042,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204042,Type 2 diabetes mellitus,Approved
CANAKINUMAB,914613-48-2,https://drugs.ncats.io/drug/37CQ2C7X93,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""914613%2048%202"")",ONLY CAS,US Approved Rx 2009,BLA125319,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125319,US Approved Rx 2009,BLA125319,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125319,,
CANDESARTAN CILEXETIL,145040-37-5,https://drugs.ncats.io/drug/R85M2X0D68,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""145040%2037%205"")",ONLY CAS,US Approved Rx 2016,ANDA203813,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203813,US Approved Rx 1998,NDA020838,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020838,Heart failure; Hypertension,Approved; Approved
CANGRELOR,163706-06-7,https://drugs.ncats.io/drug/6AQ1Y404U7,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""163706%2006%207"")",ONLY CAS,US Approved Rx 2015,NDA204958,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204958,US Approved Rx 2015,NDA204958,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204958,Myocardial infarction; Blood clotting; Degenerative brain disease,Approved; Approved; Basic research
CANNABIDIOL,13956-29-1,https://drugs.ncats.io/drug/19GBJ60SN5,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""13956%2029%201"")",ONLY CAS,US Approved Rx 2018,NDA210365,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210365,Possibly Marketed Outside US 2018,M012,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a698502d-c1c5-41ca-8142-74338b834c8b,Tuberous sclerosis complex; Dravet syndrome; Lennox-Gastaut syndrome; Pain; Multiple sclerosis,Phase III; Phase III; Phase III; Approved; Approved
CANTHARIDES,56-25-7,https://drugs.ncats.io/drug/IGL471WQ8P,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""56%2025%207"")",ONLY CAS,US Approved Rx 2023,NDA212905,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212905,US Previously Marketed 2019,cantharidin,https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-216/subpart-B/section-216.23,Warts,Approved
CANTHARIDIN,56-25-7,https://drugs.ncats.io/drug/IGL471WQ8P,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""56%2025%207"")",ONLY CAS,US Approved Rx 2023,NDA212905,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212905,US Previously Marketed 2019,cantharidin,https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-216/subpart-B/section-216.23,Warts,Approved
CAPECITABINE,154361-50-9,https://drugs.ncats.io/drug/6804DJ8Z9U,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""154361%2050%209"")",ONLY CAS,US Approved Rx 2018,ANDA210604,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210604,US Approved Rx 1998,NDA020896,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020896,Breast cancer; Colorectal cancer,Approved; Approved
CAPLACIZUMAB,915810-67-2,https://drugs.ncats.io/drug/2R27AB6766,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""915810%2067%202"")",ONLY CAS,US Approved Rx 2019,BLA761112,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761112,US Approved Rx 2019,BLA761112,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761112,,
CAPREOMYCIN,11003-38-6,https://drugs.ncats.io/drug/232HYX66HC,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""11003%2038%206"")",ONLY CAS,US Previously Marketed 2017,CAPREOMYCIN SULFATE by MYLAN LABS LTD,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202634,US Previously Marketed 1971,CAPASTAT SULFATE by EPIC PHARMA LLC,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050095,Pulmonary infections,Approved
CAPSAICIN,404-86-4,https://drugs.ncats.io/drug/S07O44R1ZM,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""404%2086%204"")",ONLY CAS,US Approved Rx 2009,NDA022395,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022395,Possibly Marketed Outside US 1988,21 CFR 348,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fbec6898-5417-dbce-e053-6294a90af139,Neuropathic pain associated with postherpetic neuralgia,Approved
CAPSICUM,84625-29-6,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""84625%2029%206"")",ONLY CAS,,,,,,,,
CAPSICUM OLEORESIN,8023-77-6,https://drugs.ncats.io/drug/UW86K581WY,3,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""8023%2077%206"")%20AND%20(root_names_name:""%5ECAPSICUM%20OLEORESIN$"")",EXACT NAME,Possibly Marketed Outside US ,part348,https://www.drugbank.ca/drugs/DB11131,Possibly Marketed Outside US 1988,21 CFR 348,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2d8f4048-14cb-7484-e054-00144ff88e88,,
CAPTOPRIL,62571-86-2,https://drugs.ncats.io/drug/9G64RSX1XD,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""62571%2086%202"")",ONLY CAS,US Approved Rx 2019,ANDA212809,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212809,US Previously Marketed 1981,CAPOTEN by STRIDES PHARMA,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018343,Hypertension; Hypertension; Heart Failure; Left Ventricular Dysfunction; Diabetic Nephropathy,Preclinical; Approved; Approved; Approved; Approved
CARAMIPHEN,77-22-5,https://drugs.ncats.io/drug/97J7NP0XJY,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""77%2022%205"")",ONLY CAS,US Previously Marketed 1949,Panparnit HCl by Geigy,DeHaen 1940-1975 NMEs,US Previously Marketed 1949,Panparnit HCl by Geigy,DeHaen 1940-1975 NMEs,Cough; Parkinson's disease,Approved; Approved
CARBACHOL,51-83-2,https://drugs.ncats.io/drug/8Y164V895Y,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""51%2083%202"")",ONLY CAS,US Approved Rx 1972,NDA016968,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016968,US Approved Rx 1972,NDA016968,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016968,Elevated intraocular pressure,Approved
CARBAMAZEPINE,298-46-4,https://drugs.ncats.io/drug/33CM23913M,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""298%2046%204"")",ONLY CAS,US Approved Rx 2005,ANDA077272,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=077272,US Approved Rx 1968,NDA016608,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016608,Epilepsy; Trigeminal neuralgia,Approved; Approved
CARBENICILLIN,4697-36-3,https://drugs.ncats.io/drug/G42ZU72N5G,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""4697%2036%203"")",ONLY CAS,US Previously Marketed 1970,Pyopen by Beecham,DeHaen 1940-1975 NMEs,US Previously Marketed 1970,Pyopen by Beecham,DeHaen 1940-1975 NMEs,Urinary tract infections; Acute and chronic infections of the upper and lower urinary tract; Prostatitis,Approved; Approved; Approved
CARBIDOPA,28860-95-9,https://drugs.ncats.io/drug/KR87B45RGH,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""28860%2095%209"")",ONLY CAS,US Approved Rx 2023,ANDA217961,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217961,US Approved Rx 1975,NDA017555,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017555,Idiopathic Parkinson's disease,Approved
CARBINOXAMINE,486-16-8,https://drugs.ncats.io/drug/982A7M02H5,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""486%2016%208"")",ONLY CAS,US Approved Rx 2003,ANDA040458,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=040458,US Previously Marketed 1953,CLISTIN by ORTHO MCNEIL PHARM,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=008915,Perennial allergic rhinitis; Vasomotor rhinitis; Allergic conjunctivitis; Angioedema; Urticaria; Anaphylaxis; Seasonal allergic rhinitis,Approved; Approved; Approved; Approved; Approved; Approved; Approved
CARBITOL,111-90-0,https://drugs.ncats.io/drug/A1A1I8X02B,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""111%2090%200"")",ONLY CAS,Possibly Marketed Outside US 2004,21 CFR 348,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ff24f080-33ca-4c97-9739-625bb58a39fe,Possibly Marketed Outside US 1955,NDA021794,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8dbe1a41-6d9d-414f-aa9c-09bd95857e2a,,
CARBOCISTEINE,638-23-3,https://drugs.ncats.io/drug/740J2QX53R,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""638%2023%203"")",ONLY CAS,Possibly Marketed Outside US ,UK NHS:Carbocisteine,https://tripod.nih.gov/npc/#Download,Possibly Marketed Outside US 2008,21 CFR 333D,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=de384124-cdb9-4d6b-ae4d-351214182c58,Chronic obstructive pulmonary disease,Approved
CARBOHYDRATES,2280-44-6,https://drugs.ncats.io/drug/5SL0G7R0OK,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""2280%2044%206"")",ONLY CAS,US Approved Rx 1986,NDA019445,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019445,US Previously Marketed 1921,dextrose,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,Hypoglycemia; Caloric intake deficit,Basic research; Approved
CARBOMER,79-10-7,https://drugs.ncats.io/drug/J94PBK7X8S,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""79%2010%207"")",ONLY CAS,Possibly Marketed Outside US 2010,21 CFR 333D,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=03227fa6-2e64-4879-b90d-5fd355072d98,Possibly Marketed Outside US 2000,M017,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=941de921-c1f5-4293-973e-d3b786c78511,,
CARBONIC ACID,463-79-6,https://drugs.ncats.io/drug/67507691,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""463%2079%206"")",ONLY CAS,,,,,,,,
CARBOPROST,35700-23-3,https://drugs.ncats.io/drug/7B5032XT6O,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""35700%2023%203"")",ONLY CAS,US Approved Rx 2022,ANDA215337,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215337,US Approved Rx 1979,NDA017989,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017989,Postpartum hemorrhage due to uterine atony; Aborting pregnancy,Approved; Approved
CARFILZOMIB,868540-17-4,https://drugs.ncats.io/drug/72X6E3J5AR,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""868540%2017%204"")",ONLY CAS,US Approved Rx 2012,NDA202714,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202714,US Approved Rx 2012,NDA202714,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202714,Multiple myeloma,Approved
CARGLUMIC ACID,1188-38-1,https://drugs.ncats.io/drug/5L0HB4V1EW,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1188%2038%201"")",ONLY CAS,US Approved Rx 2010,NDA022562,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022562,US Approved Rx 2010,NDA022562,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022562,Acute hyperammonemia; Chronic hyperammonemia,Approved; Approved
CARICA PAPAYA,108333-82-0,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""108333%2082%200"")",ONLY CAS,,,,,,,,
CARINDACILLIN,35531-88-5,https://drugs.ncats.io/drug/5V278481KE,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""35531%2088%205"")",ONLY CAS,US Previously Marketed 1970,Pyopen by Beecham,DeHaen 1940-1975 NMEs,US Previously Marketed 1970,Pyopen by Beecham,DeHaen 1940-1975 NMEs,Urinary tract infections; Acute and chronic infections of the upper and lower urinary tract; Prostatitis,Approved; Approved; Approved
CARIPRAZINE,839712-12-8,https://drugs.ncats.io/drug/F6RJL8B278,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""839712%2012%208"")",ONLY CAS,US Approved Rx 2015,NDA204370,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204370,US Approved Rx 2015,NDA204370,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204370,Bipolar I disorder; Schizophrenia,Approved; Approved
CARISOPRODOL,78-44-4,https://drugs.ncats.io/drug/21925K482H,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""78%2044%204"")",ONLY CAS,US Approved Rx 1989,ANDA081025,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=081025,US Approved Rx 1959,NDA011792,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=011792,Painful musculoskeletal conditions,Approved
CARMELLOSE,9000-11-7,https://drugs.ncats.io/drug/05JZI7B19X,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""9000%2011%207"")",ONLY CAS,US Approved OTC ,21 CFR 349.12(a)(1) ophthalmic:demulcents carboxymethylcellulose sodium,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec349-12.xml,US Previously Marketed 1949,Carmethose by Ciba,DeHaen 1940-1975 NMEs,,
CARMUSTINE,154-93-8,https://drugs.ncats.io/drug/U68WG3173Y,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""154%2093%208"")",ONLY CAS,US Approved Rx 2019,ANDA209278,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209278,US Approved Rx 1977,NDA017422,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017422,Glioblastoma; Ependymoma; Astrocytoma; Multiple myeloma; Hodgkin's lymphoma; Non-Hodgkin's lymphoma; Medulloblastoma,Approved; Approved; Approved; Approved; Approved; Approved; Approved
CARNAUBA WAX,8015-86-9,https://drugs.ncats.io/drug/R12CBM0EIZ,2,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""8015%2086%209"")%20AND%20(root_names_name:""%5ECARNAUBA%20WAX$"")",EXACT NAME,Possibly Marketed Outside US ,Japan:Carnauba Wax,https://tripod.nih.gov/npc/#Download,Possibly Marketed Outside US 2001,Walgreens Urinary Pain Relief by Walgreens Co,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=54b7e667-bb24-49a6-940d-226b2990d91b,,
CARNOSINE,305-84-0,https://drugs.ncats.io/drug/8HO6PVN24W,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""305%2084%200"")",ONLY CAS,Possibly Marketed Outside US ,"Remedient by Levins Pharmaceuticals, LLC",https://www.drugbank.ca/drugs/DB11695,Possibly Marketed Outside US 2006,21 CFR 352,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f8832036-fe7a-43a4-849a-26e254ebd95b,Parkinson's disease; Acute lung injury; Hepatocellular carcinoma,Preclinical; Preclinical; Preclinical
CAROTEN,5300-03-8,https://drugs.ncats.io/drug/1UA8E65KDZ,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""5300%2003%208"")",ONLY CAS,US Approved Rx 2019,ANDA211644,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211644,US Previously Marketed 1971,RETIN-A by VALEANT INTL,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016921,severe recalcitrant nodular acne; Acne vulgaris; Acute promyelocytic leukemia; AIDS-related Kaposi’s sarcoma,Approved; Approved; Approved; Approved
CAROTENOIDS (UNSPECIFIED),11103-57-4,https://drugs.ncats.io/drug/81G40H8B0T,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""11103%2057%204"")",ONLY CAS,US Approved Rx 2001,NDA021265,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021265,US Previously Marketed 1947,BEROCCA PN by ROCHE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=006071,Vitamin A deficiency; Maternal morbidity; Maternal mortality; Measles; Vitamin A deficiency; Skin aging; Skin photodamage,Phase III; Phase III; Phase III; Approved; Approved; Phase IV; Phase II
CARTEOLOL,51781-06-7,https://drugs.ncats.io/drug/8NF31401XG,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""51781%2006%207"")",ONLY CAS,,,,,,,Chronic open-angle glaucoma; Intraocular hypertension,Approved; Approved
CARVEDILOL,72956-09-3,https://drugs.ncats.io/drug/0K47UL67F2,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""72956%2009%203"")",ONLY CAS,US Approved Rx 2007,ANDA077316,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=077316,US Approved Rx 1995,NDA020297,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020297,Heart failure; Myocardial infarction; Hypertension,Approved; Approved; Approved
CASANTHRANOL,8024-48-4,https://drugs.ncats.io/drug/3SJ3U7J6V2,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""8024%2048%204"")",ONLY CAS,US Previously Marketed 1956,Peri-Colace by Mead Johnson,OB NME Appendix 1950-1993,US Previously Marketed 1956,Peri-Colace by Mead Johnson,OB NME Appendix 1950-1993,,
CASEIN,9000-71-9,https://drugs.ncats.io/drug/48268V50D5,2,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""9000%2071%209"")%20AND%20(root_names_name:""%5ECASEIN$"")",EXACT NAME,US Approved Allergenic Extract 1941,BLA103888,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2235beb8-cf43-4f3c-8e02-598b54283f04,US Approved Allergenic Extract 1941,BLA103888,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2235beb8-cf43-4f3c-8e02-598b54283f04,,
CASPOFUNGIN,162808-62-0,https://drugs.ncats.io/drug/F0XDI6ZL63,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""162808%2062%200"")",ONLY CAS,US Approved Rx 2016,NDA206110,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206110,US Approved Rx 2001,NDA021227,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021227,Intra-abdominal abscesses; Esophageal candidiasis; Peritonitis; Candidemia; Invasive aspergillosis,Approved; Approved; Approved; Approved; Approved
CATRIDECACOG,606138-08-3,https://drugs.ncats.io/drug/NU23Q531G1,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""606138%2008%203"")",ONLY CAS,Possibly Marketed Outside US ,EU/1/12/775/001,https://www.drugbank.ca/drugs/DB09310,Possibly Marketed Outside US 2013,BLA125398,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8664978e-1814-4930-aca5-97a24455f6df,,
CEFACLOR,53994-73-3,https://drugs.ncats.io/drug/3Z6FS3IK0K,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""53994%2073%203"")",ONLY CAS,US Approved Rx 2002,ANDA065058,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=065058,US Previously Marketed 1979,CEFACLOR by CEPH INTL,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=062205,Pharyngitis; Lower respiratory tract infections; Otitis media; Skin and skin structure infections; Urinary tract infections; Tonsillitis,Approved; Approved; Approved; Approved; Approved; Approved
CEFADROXIL,50370-12-2,https://drugs.ncats.io/drug/Q525PA8JJB,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""50370%2012%202"")",ONLY CAS,US Approved Rx 2007,ANDA065352,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=065352,US Previously Marketed 1978,Duracef by Mead Johnson,OB NME Appendix 1950-1985,Bacterial infections,Approved
CEFALEXIN,15686-71-2,https://drugs.ncats.io/drug/5SFF1W6677,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""15686%2071%202"")",ONLY CAS,US Approved Rx 2005,ANDA065253,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=065253,US Previously Marketed 1971,KEFLEX by PRAGMA,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050405,Bacterial Infections,Approved
CEFAMANDOLE,34444-01-4,https://drugs.ncats.io/drug/5CKP8C2LLI,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""34444%2001%204"")",ONLY CAS,US Previously Marketed 1978,MANDOL by LILLY,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050504,US Previously Marketed 1978,MANDOL by LILLY,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050504,Sepsis; Peritonitis; Lower respiratory infections; Urinary tract infections,Approved; Approved; Approved; Approved
CEFAPIRIN,21593-23-7,https://drugs.ncats.io/drug/89B59H32VN,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""21593%2023%207"")",ONLY CAS,US Previously Marketed 1987,CEPHAPIRIN SODIUM by HIKMA,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=062720,US Previously Marketed 1974,CEFADYL by APOTHECON,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=061769,Bacterial infections,Approved
CEFAZOLIN,25953-19-9,https://drugs.ncats.io/drug/IHS69L0Y4T,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""25953%2019%209"")",ONLY CAS,US Approved Rx 1988,ANDA062831,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=062831,US Previously Marketed 1973,ANCEF by GLAXOSMITHKLINE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050461,Genital Infections; Urinary tract infections; Respiratory tract infections; Sepsis,Approved; Approved; Approved; Approved
CEFDINIR,91832-40-5,https://drugs.ncats.io/drug/CI0FAO63WC,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""91832%2040%205"")",ONLY CAS,US Approved Rx 2007,ANDA065473,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=065473,US Previously Marketed 1997,OMNICEF by ABBVIE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050749,Acute maxillary sinusitis; Uncomplicated skin and skin-structure infections; Tonsillitis; Pharyngitis; Acute exacerbations of chronic bronchitis; Community-acquired pneumonia,Approved; Approved; Approved; Approved; Approved; Approved
CEFDITOREN PIVOXIL,117467-28-4,https://drugs.ncats.io/drug/78THA212DH,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""117467%2028%204"")",ONLY CAS,US Previously Marketed 2001,SPECTRACEF by VANSEN PHARMA,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021222,US Previously Marketed 2001,SPECTRACEF by VANSEN PHARMA,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021222,Pharyngitis; Community-acquired pneumonia; Tonsillitis; Uncomplicated skin and skin-structure infections; Acute bacterial exacerbation of chronic bronchitis,Approved; Approved; Approved; Approved; Approved
CEFEPIME,88040-23-7,https://drugs.ncats.io/drug/807PW4VQE3,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""88040%2023%207"")",ONLY CAS,US Approved Rx 2020,ANDA212721,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212721,US Previously Marketed 1996,MAXIPIME by HOSPIRA INC,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050679,Pneumonia; Complicated intra-abdominal infections; Urinary tract infections; Febrile neutropenia; Uncomplicated skin and skin-structure infections,Approved; Approved; Approved; Approved; Approved
CEFIXIME,79350-37-1,https://drugs.ncats.io/drug/XZ7BG04GJX,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""79350%2037%201"")",ONLY CAS,US Approved Rx 2013,NDA202091,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202091,Possibly Marketed Outside US 1986,ANDA065355,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d0fd45bd-7d52-4fa6-a5f7-f46d5651ffa2,Otitis media; Pharyngitis; Gonorrhea; Chronic bronchitis; Urinary tract infections,Approved; Approved; Approved; Approved; Approved
CEFMETAZOLE,56796-20-4,https://drugs.ncats.io/drug/3J962UJT8H,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""56796%2020%204"")",ONLY CAS,US Previously Marketed 1989,ZEFAZONE by PHARMACIA AND UPJOHN,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050637,US Previously Marketed 1989,ZEFAZONE by PHARMACIA AND UPJOHN,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050637,Intra-abdominal infections; Respiratory tract infections; Urinary tract infections; Gynecologic infections; Skin and soft tissue infections,Approved; Approved; Approved; Approved; Approved
CEFONICID,61270-58-4,https://drugs.ncats.io/drug/6532B86WFG,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""61270%2058%204"")",ONLY CAS,US Previously Marketed 1984,MONOCID by GLAXOSMITHKLINE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050579,US Previously Marketed 1984,MONOCID by GLAXOSMITHKLINE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050579,Bacterial infections,Approved
CEFOPERAZONE,62893-19-0,https://drugs.ncats.io/drug/7U75I1278D,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""62893%2019%200"")",ONLY CAS,US Previously Marketed 1982,CEFOBID by PFIZER,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050551,US Previously Marketed 1982,CEFOBID by PFIZER,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050551,Sepsis; Urinary tract infections; Peritonitis and other intra-abdominal infections; Skin and skin structure infections; Pelvic inflammatory disease; Respiratory tract infections,Approved; Approved; Approved; Approved; Approved; Approved
CEFOTAXIME,63527-52-6,https://drugs.ncats.io/drug/N2GI8B1GK7,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""63527%2052%206"")",ONLY CAS,US Previously Marketed 2010,CEFOTAXIME SODIUM by CEPHAZONE PHARMA,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=065348,US Previously Marketed 1981,CLAFORAN by STERIMAX,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050547,Lower respiratory tract infections; Urinary tract infections; Uncomplicated gonorrhea; Intra-abdominal infections; Central nervous system infections; Bone and joint infections; Skin and skin structure infections; Gynecologic infections; Sepsis,Approved; Approved; Approved; Approved; Approved; Approved; Approved; Approved; Approved
CEFOTETAN,69712-56-7,https://drugs.ncats.io/drug/48SPP0PA9Q,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""69712%2056%207"")",ONLY CAS,US Approved Rx 2007,ANDA065374,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=065374,US Previously Marketed 1985,CEFOTAN by PAI HOLDINGS PHARM,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050588,Urinary tract infections; Intra-abdominal infections; Skin and skin structure infections; Bone and joint infections; Lower respiratory tract infections; Gynecologic infections,Approved; Approved; Approved; Approved; Approved; Approved
CEFOXITIN,35607-66-0,https://drugs.ncats.io/drug/6OEV9DX57Y,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""35607%2066%200"")",ONLY CAS,US Approved Rx 2009,ANDA065414,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=065414,US Previously Marketed 1978,MEFOXIN by MYLAN INSTITUTIONAL,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050517,Lower respiratory tract infections; Peritonitis; Urinary tract infections,Approved; Approved; Approved
CEFPODOXIME PROXETIL,87239-81-4,https://drugs.ncats.io/drug/2TB00A1Z7N,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""87239%2081%204"")",ONLY CAS,US Approved Rx 2007,ANDA065388,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=065388,US Previously Marketed 1992,BANAN by SANKYO,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050687,"Acute bacterial exacerbation of chronic bronchitis; Acute, uncomplicated urethral and cervical gonorrhea; Acute maxillary sinusitis; Uncomplicated skin and skin-structure infections; Cystitis; Acute, uncomplicated ano-rectal infections in women; Community-acquired pneumonia; Tonsillitis; Pharyngitis; Acute otitis media",Approved; Approved; Approved; Approved; Approved; Approved; Approved; Approved; Approved; Approved
CEFPROZIL,92676-86-3,https://drugs.ncats.io/drug/S1SDI2FJIY,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""92676%2086%203"")",ONLY CAS,Possibly Marketed Outside US ,Apo-cefprozil by Apotex Corporation [Canada],https://www.drugbank.ca/drugs/DB01150,,,,Unknown,
CEFRADINE,38821-53-3,https://drugs.ncats.io/drug/9YA6SX5S4D,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""38821%2053%203"")",ONLY CAS,US Previously Marketed 1977,VELOSEF by APOTHECON,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=061976,US Previously Marketed 1974,ANSPOR by GLAXOSMITHKLINE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=061859,Respiratory tract infections; Skin and skin structure infections; Urinary tract infections; Otitis media,Approved; Approved; Approved; Approved
CEFTAROLINE FOSAMIL,229016-73-3,https://drugs.ncats.io/drug/7P6FQA5D21,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""229016%2073%203"")",ONLY CAS,US Approved Rx 2010,NDA200327,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=200327,US Approved Rx 2010,NDA200327,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=200327,Acute bacterial skin and skin structure infection; Community-acquired bacterial pneumonia,Approved; Approved
CEFTAZIDIME,72558-82-8,https://drugs.ncats.io/drug/DZR1ENT301,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""72558%2082%208"")",ONLY CAS,US Approved Rx 1986,ANDA062662,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=062662,US Previously Marketed 1985,FORTAZ by PAI HOLDINGS PHARM,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050578,Urinary tract infections; Skin and skin structure infections; Lower respiratory tract infections; Cystic fibrosis,Approved; Approved; Approved; Phase IV
CEFTIBUTEN,97519-39-6,https://drugs.ncats.io/drug/IW71N46B4Y,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""97519%2039%206"")",ONLY CAS,US Previously Marketed 1995,Cedax,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50685,US Previously Marketed 1995,Cedax,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=50685,Acute bacterial otitis media; Acute bacterial exacerbation of chronic bronchitis; Pharyngitis; Tonsillitis,Approved; Approved; Approved; Approved
CEFTIZOXIME,68401-81-0,https://drugs.ncats.io/drug/C43C467DPE,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""68401%2081%200"")",ONLY CAS,US Previously Marketed 1983,CEFIZOX by ASTELLAS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050560,US Previously Marketed 1983,CEFIZOX by ASTELLAS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050560,Meningitis caused by Haemophilus influenzae; Urinary tract infections; Lower respiratory tract infections; Gonorrhea; Pelvic inflammatory disease,Approved; Approved; Approved; Approved; Approved
CEFTOLOZANE,689293-68-3,https://drugs.ncats.io/drug/37A4IES95Q,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""689293%2068%203"")",ONLY CAS,US Approved Rx 2014,NDA206829,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206829,US Approved Rx 2014,NDA206829,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206829,Pyelonephritis; Intra-abdominal infections,Approved; Approved
CEFTRIAXONE,73384-59-5,https://drugs.ncats.io/drug/75J73V1629,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""73384%2059%205"")",ONLY CAS,US Approved Rx 2016,ANDA203702,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203702,US Previously Marketed 1984,ROCEPHIN by HOFFMANN LA ROCHE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050585,Acute bacterial otitis media; Lower respiratory tract infections; Urinary tract infections; Skin and skin structure infections; Pelvic inflammatory disease; Uncomplicated gonorrhea; Sepsis; Intra-abdominal infections; Bone and joint infections; Meningitis,Approved; Approved; Approved; Approved; Approved; Approved; Approved; Approved; Approved; Approved
CEFUROXIME,55268-75-2,https://drugs.ncats.io/drug/O1R9FJ93ED,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""55268%2075%202"")",ONLY CAS,US Approved Rx 2010,ANDA065496,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=065496,US Previously Marketed 1983,ZINACEF by PAI HOLDINGS PHARM,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050558,Bacterial infections,Approved
CEFUROXIME AXETIL,64544-07-6,https://drugs.ncats.io/drug/Z49QDT0J8Z,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""64544%2007%206"")",ONLY CAS,US Approved Rx 2010,ANDA065496,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=065496,US Previously Marketed 1983,ZINACEF by PAI HOLDINGS PHARM,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050558,Bacterial infections,Approved
CELECOXIB,169590-42-5,https://drugs.ncats.io/drug/JCX84Q7J1L,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""169590%2042%205"")",ONLY CAS,US Approved Rx 2020,ANDA207872,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207872,Possibly Marketed Outside US 1998,NDA020998,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fe09528e-a072-4bc8-84eb-e79ed06cd553,Juvenile rheumatoid arthritis; Ankylosing spondylitis; Acute pain; Osteoarthritis; Rheumatoid arthritis; Primary dysmenorrhea,Approved; Approved; Approved; Approved; Approved; Approved
CELLULASE,9012-54-8,https://drugs.ncats.io/drug/7Q170212NX,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""9012%2054%208"")",ONLY CAS,,,,,,,,
CELLULOSE,9004-34-6,https://drugs.ncats.io/drug/d4796cd1,16,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""9004%2034%206"")%20AND%20(root_names_name:""%5ECELLULOSE$"")",EXACT NAME,,,,,,,,
CEMIPLIMAB,1801342-60-8,https://drugs.ncats.io/drug/6QVL057INT,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1801342%2060%208"")",ONLY CAS,US Approved Rx 2018,BLA761097,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761097,US Approved Rx 2018,BLA761097,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761097,,
CERAMIDE,5466-77-3,https://drugs.ncats.io/drug/4Y5P7MUD51,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""5466%2077%203"")",ONLY CAS,US Previously Marketed 1992,SHADE UVAGUARD by BAYER HEALTHCARE LLC,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020045,Possibly Marketed Outside US 1984,"NU-DERM SUNFADER  Skin Lightener with Sunscreen (SPF 15) PABA FREE by OMP, INC.",https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f439d77f-ec5b-4534-a005-08f2e7af8d0c,Sunburns,Approved
CERITINIB,1032900-25-6,https://drugs.ncats.io/drug/K418KG2GET,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1032900%2025%206"")",ONLY CAS,US Approved Rx 2019,NDA211225,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211225,US Previously Marketed 2014,ZYKADIA by NOVARTIS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205755,Non-small cell lung cancer,Approved
CERIUM,7440-45-1,https://drugs.ncats.io/drug/30K4522N6T,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""7440%2045%201"")",ONLY CAS,Clinical 2001,NCT00745108: Phase 3 Interventional Completed Postmenopausal Women,https://clinicaltrials.gov/ct2/show/NCT00745108,,,,,
CERIVASTATIN,145599-86-6,https://drugs.ncats.io/drug/AM91H2KS67,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""145599%2086%206"")",ONLY CAS,US Previously Marketed 1997,BAYCOL by BAYER PHARMS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020740,US Previously Marketed 1997,BAYCOL by BAYER PHARMS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020740,Hypercholesterolemia; Mixed dyslipidemia (Fredrickson types IIa and IIb),Withdrawn; Withdrawn
CERLIPONASE ALFA,151662-36-1,https://drugs.ncats.io/drug/X8R2D92QP1,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""151662%2036%201"")",ONLY CAS,US Approved Rx 2017,BLA761052,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761052,US Approved Rx 2017,BLA761052,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761052,,
CERTOLIZUMAB PEGOL,428863-50-7,https://drugs.ncats.io/drug/UMD07X179E,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""428863%2050%207"")",ONLY CAS,US Approved Rx 2008,BLA125160,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125160,Possibly Marketed Outside US 2008,BLA125160,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b4c2c9dc-a0bb-4d64-a667-a67ebe88392d,,
CETALKONIUM,10328-34-4,https://drugs.ncats.io/drug/FHG725432Z,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""10328%2034%204"")",ONLY CAS,US Previously Marketed ,21 CFR 310.545(a)(18)(vi)(A) skin protectant:poison ivy/oak/sumac cetalkonium chloride,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec310-545.xml,Possibly Marketed Outside US 1983,NDA214965,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c795cd2f-89da-78e3-e053-2a95a90a9422,Mouth ulcers; Cold sores; Dry eye syndrome,Approved; Approved; Approved
CETIRIZINE,83881-51-0,https://drugs.ncats.io/drug/YO7261ME24,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""83881%2051%200"")",ONLY CAS,US Approved Rx 2018,ANDA210719,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210719,Possibly Marketed Outside US 1988,ANDA077170,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=20932906-e5bf-4858-ac54-2e5b96c20b37,Allergic rhinitis; Perennial allergic rhinitis; Seasonal allergic rhinitis,Approved; Approved; Approved
CETRIMIDE,8044-71-1,https://drugs.ncats.io/drug/24QSH2NL8N,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""8044%2071%201"")",ONLY CAS,Possibly Marketed Outside US ,Cetrimide Cream 0.5% by Canadian Custom Packaging Company [Canada],https://www.drugbank.ca/drugs/DB01718,Possibly Marketed Outside US 1999,21 CFR 358H,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=afa58a8f-5cbf-408e-9900-668ad9355349,Seborrheic dermatitis; Skin infections,Approved; Approved
CETRORELIX,120287-85-6,https://drugs.ncats.io/drug/OON1HFZ4BA,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""120287%2085%206"")",ONLY CAS,US Approved Rx 2000,NDA021197,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021197,US Approved Rx 2000,NDA021197,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021197,Female infertility,Approved
CETUXIMAB,205923-56-4,https://drugs.ncats.io/drug/PQX0D8J21J,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""205923%2056%204"")",ONLY CAS,US Approved Rx 2004,BLA125084,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125084,US Approved Rx 2004,BLA125084,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125084,,
CETYLPYRIDINIUM,7773-52-6,https://drugs.ncats.io/drug/CUB7JI0JV3,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""7773%2052%206"")",ONLY CAS,US Previously Marketed 1941,Ceepryn by Merrell,DeHaen 1940-1975 NMEs,US Previously Marketed 1941,Ceepryn by Merrell,DeHaen 1940-1975 NMEs,Gingivitis; Dental plaque,Approved; Approved
CEVIMELINE,107233-08-9,https://drugs.ncats.io/drug/K9V0CDQ56E,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""107233%2008%209"")",ONLY CAS,US Approved Rx 2023,ANDA215056,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215056,US Approved Rx 2000,NDA020989,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020989,Sjogren's syndrome,Approved
CHARCOAL,16291-96-6,https://drugs.ncats.io/drug/bb1e7d07,3,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""16291%2096%206"")%20AND%20(root_names_name:""%5ECHARCOAL$"")",EXACT NAME,,,,,,,,
CHLORAL HYDRATE,302-17-0,https://drugs.ncats.io/drug/418M5916WG,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""302%2017%200"")",ONLY CAS,US Previously Marketed 1963,Beta-Chlor by Mead Johnson,DeHaen 1940-1975 NMEs,US Previously Marketed 1963,Beta-Chlor by Mead Johnson,DeHaen 1940-1975 NMEs,Insomnia,Approved
CHLORAMBUCIL,305-03-3,https://drugs.ncats.io/drug/18D0SL7309,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""305%2003%203"")",ONLY CAS,US Approved Rx 1957,NDA010669,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=010669,US Approved Rx 1957,NDA010669,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=010669,Giant follicular lymphoma; Chronic lymphocytic leukemia; Lymphosarcoma; Hodgkin's lymphoma,Approved; Approved; Approved; Approved
CHLORAMPHENICOL,56-75-7,https://drugs.ncats.io/drug/66974FR9Q1,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""56%2075%207"")",ONLY CAS,US Approved Rx 1982,ANDA062365,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=062365,US Previously Marketed 1950,Chloromycetin by Warner-Lambert,OB NME Appendix 1950-1993,Eye infections,Approved
CHLORCYCLIZINE,82-93-9,https://drugs.ncats.io/drug/M26C4IP44P,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""82%2093%209"")",ONLY CAS,US Approved OTC ,21 CFR 341.12(b) cough/cold:antihistamine chlorcyclizine hydrochloride,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec341-12.xml,US Previously Marketed 1949,Perazil by Burroughs Wellcome,DeHaen 1940-1975 NMEs,Allergic rhinitis,Approved
CHLORDIAZEPOXIDE,58-25-3,https://drugs.ncats.io/drug/6RZ6XEZ3CR,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""58%2025%203"")",ONLY CAS,US Approved Rx 2022,ANDA215835,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215835,US Previously Marketed 1960,LIBRIUM by VALEANT PHARM INTL,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=012249,Major depressive disorder; Anxiety; Withdrawal symptoms of acute alcoholism,Phase III; Approved; Approved
CHLORHEXIDINE,55-56-1,https://drugs.ncats.io/drug/R4KO0DY52L,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""55%2056%201"")",ONLY CAS,US Approved Rx 1976,NDA017768,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017768,US Previously Marketed 1959,Hibitane by Ayerst,DeHaen 1940-1975 NMEs,Gingivitis,Approved
CHLORINE,7782-50-5,https://drugs.ncats.io/drug/4R7X1O2820,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""7782%2050%205"")",ONLY CAS,US Previously Marketed 1921,Compound Solution of Chlorine N.F.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,US Previously Marketed 1921,Compound Solution of Chlorine N.F.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,,
CHLORMETHINE,51-75-2,https://drugs.ncats.io/drug/50D9XSG0VR,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""51%2075%202"")",ONLY CAS,US Approved Rx 2013,NDA202317,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202317,US Previously Marketed 1949,MUSTARGEN by RECORDATI RARE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=006695,Lymphosarcoma; Chronic lymphocytic leukemia; Mycosis fungoides; Chronic myelocytic leukemia; Hodgkin's disease (Stages III and IV),Approved; Approved; Approved; Approved; Approved
CHLOROBUTANOL,57-15-8,https://drugs.ncats.io/drug/HM4YQM8WRC,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""57%2015%208"")",ONLY CAS,US Previously Marketed 1961,OTOMIDE CHLOROBUTANOL by WHITE,https://www.govinfo.gov/content/pkg/FR-1972-02-12/pdf/FR-1972-02-12.pdf,US Previously Marketed 1911,Chloretone by Parke-Davis,https://catalog.hathitrust.org/Record/100782317,Pain,Not Provided
CHLOROETHANE,75-00-3,https://drugs.ncats.io/drug/46U771ERWK,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""75%2000%203"")",ONLY CAS,US Previously Marketed 1921,Ethyl Chloride U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,US Previously Marketed 1921,Ethyl Chloride U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,,
CHLOROFORM,67-66-3,https://drugs.ncats.io/drug/7V31YC746X,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""67%2066%203"")",ONLY CAS,US Previously Marketed 1847,chloroform,https://catalog.hathitrust.org/Record/100782317,US Previously Marketed 1847,chloroform,https://catalog.hathitrust.org/Record/100782317,,
CHLOROPHYLL,1406-65-1,https://drugs.ncats.io/drug/00WNZ48OR9,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1406%2065%201"")",ONLY CAS,US Previously Marketed 1945,Chloresium by Rystan,DeHaen 1940-1975 NMEs,US Previously Marketed 1945,Chloresium by Rystan,DeHaen 1940-1975 NMEs,Cancer,Approved
CHLOROPROCAINE,133-16-4,https://drugs.ncats.io/drug/5YVB0POT2H,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""133%2016%204"")",ONLY CAS,US Approved Rx 1998,ANDA040273,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=040273,US Approved Rx 1955,NDA009435,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=009435,Pain,Approved
CHLOROQUINE,54-05-7,https://drugs.ncats.io/drug/886U3H6UFF,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""54%2005%207"")",ONLY CAS,US Approved Rx 2021,ANDA214756,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214756,US Previously Marketed 1943,Aralen by Winthrop,DeHaen 1940-1975 NMEs,Extraintestinal amebiasis; HIV-1 infection; Acute attacks of malaria,Approved; Phase II; Approved
CHLOROTHIAZIDE,58-94-6,https://drugs.ncats.io/drug/77W477J15H,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""58%2094%206"")",ONLY CAS,US Approved Rx 2011,ANDA091546,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=091546,US Previously Marketed 1958,DIUPRES-250 by MERCK,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=011635,Congestive heart failure; Nephrotic syndrome,Approved; Approved
CHLOROTHYMOL,89-68-9,https://drugs.ncats.io/drug/LJ25TI0CVT,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""89%2068%209"")",ONLY CAS,US Previously Marketed ,21 CFR 310.545(a)(22)(ii) antifungal:diaper rash chlorothymol,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec310-545.xml,Possibly Marketed Outside US 1950,21 CFR 347,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=24682288-1be4-42af-e054-00144ff88e88,Otitis externa; Nasal congestion and colds,Approved; Approved
CHLOROXINE,773-76-2,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""773%2076%202"")",ONLY CAS,,,,,,,,
CHLOROXYLENOL,88-04-0,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""88%2004%200"")",ONLY CAS,,,,,,,,
CHLORPHENAMINE,113-92-8,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""113%2092%208"")",ONLY CAS,,,,,,,,
CHLORPHENESIN,104-29-0,https://drugs.ncats.io/drug/I670DAL4SZ,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""104%2029%200"")%20AND%20(root_names_name:""%5ECHLORPHENESIN"")",APPROXIMATE NAME,Possibly Marketed Outside US ,part333A,https://www.drugbank.ca/drugs/DB00856,Possibly Marketed Outside US 2013,21 CFR 352,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9e104ad0-088a-47ee-a037-3c9fa3af797c,Sunburns,Approved
CHLORPROMAZINE,34468-21-8,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""34468%2021%208"")",ONLY CAS,,,,,,,,
CHLORPROPAMIDE,94-20-2,https://drugs.ncats.io/drug/WTM2C3IL2X,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""94%2020%202"")",ONLY CAS,US Previously Marketed 1984,CHLORPROPAMIDE by ANI PHARMS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=088919,US Previously Marketed 1958,DIABINESE by PFIZER,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=011641,Type 2 diabetes mellitus,Approved
CHLORTALIDONE,77-36-1,https://drugs.ncats.io/drug/Q0MQD1073Q,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""77%2036%201"")",ONLY CAS,US Approved Rx 1984,NDA018760,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018760,US Previously Marketed 1960,HYGROTON by SANOFI AVENTIS US,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=012283,Hypertension; Edema,Approved; Approved
CHLORZOXAZONE,95-25-0,https://drugs.ncats.io/drug/H0DE420U8G,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""95%2025%200"")",ONLY CAS,US Approved Rx 2010,ANDA040861,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=040861,US Previously Marketed 1958,PARAFON FORTE DSC by JANSSEN R AND D,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=011529,Muscle spasm,Approved
CHOLESTEROL,57-88-5,https://drugs.ncats.io/drug/97C5T2UQ7J,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""57%2088%205"")",ONLY CAS,US Previously Marketed ,21 CFR 310.531(a) boil treatment cholesterol,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec310-531.xml,Possibly Marketed Outside US 1992,21 CFR 352,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4ba50cf4-b3d3-4b87-80da-483a006f694e,Fatigue; Hypercholesterolemia; Gallbladder health,Not Provided; Natural Metabolite; Not Provided
CHOLINE,62-49-7,https://drugs.ncats.io/drug/N91BDP6H0X,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""62%2049%207"")",ONLY CAS,US Previously Marketed ,21 CFR 310.545(a)(20) weight control choline,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec310-545.xml,Possibly Marketed Outside US 2001,Vitamin B Complex 150 by Covetrus North America,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a7e15f37-7d33-40e8-b578-46e7549df257,Postoperative pain; anxiety disorder; Autism; Fatty liver disease,Phase IV; Approved; Phase IV; Phase IV
CHOLINE FENOFIBRATE,856676-23-8,https://drugs.ncats.io/drug/4BMH7IZT98,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""856676%2023%208"")",ONLY CAS,US Approved Rx 2015,ANDA200920,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=200920,US Approved Rx 2008,NDA022224,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022224,hypertriglyceridemia,Approved
CHOLINE THEOPHYLLINATE,58-55-9,https://drugs.ncats.io/drug/0I55128JYK,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""58%2055%209"")",ONLY CAS,US Approved Rx 1983,ANDA087943,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=087943,US Previously Marketed 1921,Theophylline U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,Airway obstruction,Approved
CHONDROITINSULFURIC ACID,24967-94-0,https://drugs.ncats.io/drug/fd6596d5,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""24967%2094%200"")",ONLY CAS,,,,,,,,
CHONDRUS CRISPUS,9000-07-1,https://drugs.ncats.io/drug/5C69YCD2YJ,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""9000%2007%201"")",ONLY CAS,US Previously Marketed ,21 CFR 310.545(a)(20) weight control carrageenan,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec310-545.xml,Possibly Marketed Outside US 1984,Liquid Polibar Plus by E-Z-EM Canada Inc,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5b78c1b9-3013-4add-b439-663c419054b3,,
CHORIOGONADOTROPIN ALFA,177073-44-8,https://drugs.ncats.io/drug/6413W06WR3,2,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""177073%2044%208"")%20AND%20(root_names_name:""%5ECHORIOGONADOTROPIN%20ALFA$"")",EXACT NAME,US Approved Rx 2000,BLA021149,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021149,Possibly Marketed Outside US 1976,BLA017692,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3e26b843-9c7a-4517-a1b6-9362aab0b86c,,
CHORIONIC GONADOTROPHIN,9002-61-3,https://drugs.ncats.io/drug/20ED16GHEB,2,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""9002%2061%203"")%20AND%20(root_names_name:""%5ECHORIONIC%20GONADOTROPHIN$"")",EXACT NAME,US Approved Rx 1974,BLA017016,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017016,US Previously Marketed 1940,RIOGON by OJF,*!,,
CHROMIUM,7440-47-3,https://drugs.ncats.io/drug/0R0008Q3JB,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""7440%2047%203"")",ONLY CAS,Possibly Marketed Outside US ,Formula Hh by Inno Vite Incorporated [Canada],https://www.drugbank.ca/drugs/DB11136,Possibly Marketed Outside US 1996,"Strovite Forte Caplet by Everett Laboratories, Inc.",https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=add96910-9404-48aa-bb3c-945e321a11ab,,
CHRYSIN,480-40-0,https://drugs.ncats.io/drug/3CN01F5ZJ5,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""480%2040%200"")",ONLY CAS,Possibly Marketed Outside US 2011,21 CFR 333D,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=33fb5893-ea63-49a3-bb02-6b98c747c4fe,Possibly Marketed Outside US 2011,21 CFR 333D,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=33fb5893-ea63-49a3-bb02-6b98c747c4fe,Neurological disorders; Inflammation,Basic research; Basic research
CICLESONIDE,126544-47-6,https://drugs.ncats.io/drug/S59502J185,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""126544%2047%206"")",ONLY CAS,US Approved Rx 2006,NDA022004,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022004,US Approved Rx 2006,NDA022004,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022004,Asthma; Seasonal allergic rhinitis; Perennial allergic rhinitis,Approved; Approved; Approved
CICLOPIROX,29342-05-0,https://drugs.ncats.io/drug/19W019ZDRJ,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""29342%2005%200"")",ONLY CAS,US Approved Rx 2005,ANDA077092,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=077092,US Previously Marketed 1982,Loprox by Hoechst Roussel,OB NME Appendix 1950-1985,Onychomycosis of fingernails and toenails due to Trichophyton rubrum; Seborrheic dermatitis,Approved; Approved
CICLOSPORIN,59865-13-3,https://drugs.ncats.io/drug/83HN0GTJ6D,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""59865%2013%203"")",ONLY CAS,US Approved Rx 2022,ANDA216046,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216046,US Approved Rx 1983,NDA050574,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050574,"Psoriasis; Organ rejection in kidney, liver, and heart allogeneic transplants; Keratoconjunctivitis sicca; Rheumatoid arthritis",Approved; Approved; Approved; Approved
CIDOFOVIR,113852-37-2,https://drugs.ncats.io/drug/768M1V522C,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""113852%2037%202"")",ONLY CAS,US Approved Rx 2021,NDA214460,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214460,US Previously Marketed 1996,VISTIDE by GILEAD SCIENCES INC,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020638,Cytomegalovirus retinitis,Approved
CILASTATIN,82009-34-5,https://drugs.ncats.io/drug/141A6AMN38,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""82009%2034%205"")",ONLY CAS,US Approved Rx 2019,NDA212819,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212819,US Approved Rx 1985,NDA050587,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050587,Bacterial Infections,Approved
CILOSTAZOL,73963-72-1,https://drugs.ncats.io/drug/N7Z035406B,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""73963%2072%201"")",ONLY CAS,US Approved Rx 2004,ANDA077028,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=077028,US Previously Marketed 1999,PLETAL by OTSUKA,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020863,Intermittent claudication,Approved
CIMETIDINE,51481-61-9,https://drugs.ncats.io/drug/80061L1WGD,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""51481%2061%209"")",ONLY CAS,US Approved Rx 1997,ANDA074553,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=074553,US Previously Marketed 1977,TAGAMET by GLAXOSMITHKLINE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017920,Stomach Ulcer; Gastroesophageal reflux disease,Approved; Approved
CINACALCET,226256-56-0,https://drugs.ncats.io/drug/UAZ6V7728S,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""226256%2056%200"")",ONLY CAS,US Approved Rx 2020,ANDA211892,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211892,US Approved Rx 2004,NDA021688,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021688,Hypercalcemia in patients with parathyroid carcinoma; Secondary hyperparathyroidism in patients with chronic kidney disease on dialysis,Approved; Approved
CINCHOCAINE,85-79-0,https://drugs.ncats.io/drug/L6JW2TJG99,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""85%2079%200"")",ONLY CAS,US Approved OTC ,21 CFR 346.10(d) anorectal:local anesthetic dibucaine hydrochloride,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec346-10.xml,US Previously Marketed 1930,"Dibucaine; Nupercaine by Society of Chemical Industry in Basle, Basle, Switzerland (Ciba Company, Inc., New York, distributor).",https://archive.org/details/newnonofficialre39coun,Pain,Approved
CINEOLE,470-82-6,https://drugs.ncats.io/drug/RV6J6604TK,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""470%2082%206"")",ONLY CAS,US Previously Marketed 1921,Eucalyptol U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,US Previously Marketed 1921,Eucalyptol U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,Rhinosinusitis; Cough,Not Provided; Phase III
CINNAMEDRINE,90-86-8,https://drugs.ncats.io/drug/Y1245J8012,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""90%2086%208"")",ONLY CAS,Possibly Marketed Outside US ,https://www.fda.gov/Drugs/DevelopmentApprovalProcess/DevelopmentResources/Over-the-CounterOTCDrugs/StatusofOTCRulemakings/ucm071887.htm menstrual/diuretic:muscle relaxant cinnamedrine hydrochloride,https://www.fda.gov/Drugs/DevelopmentApprovalProcess/DevelopmentResources/Over-the-CounterOTCDrugs/StatusofOTCRulemakings/ucm071887.htm,,,,Dysmenorrhea,Not Provided
CINOXACIN,28657-80-9,https://drugs.ncats.io/drug/LMK22VUH23,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""28657%2080%209"")",ONLY CAS,US Previously Marketed 1992,CINOXACIN by TEVA,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=073005,US Previously Marketed 1980,CINOBAC by LILLY,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018067,Urinary tract infections,Not Provided
CINOXATE,104-28-9,https://drugs.ncats.io/drug/5437O7N5BH,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""104%2028%209"")",ONLY CAS,US Previously Marketed 1961,Sundare Clear by Texas Pharmacal,OB NME Appendix 1950-1985,US Previously Marketed 1961,Sundare Clear by Texas Pharmacal,OB NME Appendix 1950-1985,Unknown,
CIPROFLOXACIN,85721-33-1,https://drugs.ncats.io/drug/5E8K9I0O4U,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""85721%2033%201"")",ONLY CAS,US Approved Rx 2004,ANDA076558,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=076558,US Approved Rx 1987,NDA019537,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019537,Infectious diarrhea; Urinary tract infections; Lower respiratory tract infections,Approved; Approved; Approved
CISAPRIDE,81098-60-4,https://drugs.ncats.io/drug/UVL329170W,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""81098%2060%204"")",ONLY CAS,US Previously Marketed 1993,PROPULSID by JANSSEN PHARMS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020210,US Previously Marketed 1993,PROPULSID by JANSSEN PHARMS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020210,Gastroesophageal reflux disease; Megacolon; Constipation,Withdrawn; Not Provided; Not Provided
CISATRACURIUM BESILATE,96946-42-8,https://drugs.ncats.io/drug/80YS8O1MBS,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""96946%2042%208"")",ONLY CAS,US Approved Rx 2018,ANDA203238,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203238,US Approved Rx 1995,NDA020551,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020551,Skeletal muscle relaxation,Approved
CISPLATIN,15663-27-1,https://drugs.ncats.io/drug/Q20Q21Q62J,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""15663%2027%201"")",ONLY CAS,US Approved Rx 1978,NDA018057,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018057,US Approved Rx 1978,NDA018057,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018057,Unknown; Advanced bladder cancer; Metastatic ovarian tumors; Metastatic testicular tumors; Non-small cell lung cancer; Unknown,Approved; Approved; Approved; Phase IV
CITALOPRAM,59729-33-8,https://drugs.ncats.io/drug/0DHU5B8D6V,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""59729%2033%208"")",ONLY CAS,US Approved Rx 2006,ANDA077289,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=077289,US Approved Rx 1998,NDA020822,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020822,Depression; Depression,Approved; Approved
CITICOLINE,987-78-0,https://drugs.ncats.io/drug/536BQ2JVC7,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""987%2078%200"")",ONLY CAS,Possibly Marketed Outside US ,Japan:Citicoline,https://tripod.nih.gov/npc/#Download,Possibly Marketed Outside US 2023,Nerve Mushroom gummies by XIAN CHIANG COMPANY LIMITED,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=07a81afd-b86f-87af-e063-6294a90a65f9,Acute ischemic stroke; Alcohol addiction; Bipolar disorder; Cocaine addiction; Traumatic brain injury,Approved; Phase IV; Phase IV; Phase IV; Approved
CITRIC ACID,77-92-9,https://drugs.ncats.io/drug/XF417D3PSL,2,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""77%2092%209"")%20AND%20(root_names_name:""%5ECITRIC%20ACID"")",APPROXIMATE NAME,US Approved OTC ,"21 CFR 331.11(e) antacid:citrate-containing citrate (containing active ingredients: citrate ion, as citric acid or salt)",https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec331-11.xml,US Previously Marketed 1921,Potassium Citrate U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,Renal tubular acidosis; Nephrolithiasis,Approved; Approved
CITRONELLA OIL,8000-29-1,https://drugs.ncats.io/drug/QYO8Q067D0,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""8000%2029%201"")",ONLY CAS,Possibly Marketed Outside US 2024,M017,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=94fa1774-73ef-4b30-8069-617750dedc0c,Possibly Marketed Outside US 1966,21 CFR 348,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=91bf3641-e83d-49e9-9b53-ce7c37452811,,
CITRULLINE,372-75-8,https://drugs.ncats.io/drug/29VT07BGDA,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""372%2075%208"")",ONLY CAS,Possibly Marketed Outside US ,Lipovite by Perdido Key Health And Wellness Inc,https://www.drugbank.ca/drugs/DB00155,Possibly Marketed Outside US 2012,SPAI-SONSPROLAC-VIT by SPAI-SONS PHARMACEUTICAL INTERNATIONAL COSMETICS,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4c294bea-5a61-4756-af3c-17ed30f2c0d8,,
CITRUS DECUMANA,90045-43-5,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""90045%2043%205"")",ONLY CAS,,,,,,,,
CLADRIBINE,4291-63-8,https://drugs.ncats.io/drug/47M74X9YT5,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""4291%2063%208"")",ONLY CAS,US Approved Rx 2019,NDA022561,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022561,US Previously Marketed 1993,LEUSTATIN by JANSSEN PHARMS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020229,Hairy cell leukemia,Approved
CLARITHROMYCIN,81103-11-9,https://drugs.ncats.io/drug/H1250JIK0A,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""81103%2011%209"")",ONLY CAS,US Approved Rx 1993,NDA050697,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050697,US Previously Marketed 1991,BIAXIN by ABBVIE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050662,Community-acquired pneumonia; Uncomplicated skin and skin-structure infections; Disseminated mycobacterial infections; Bacterial pharyngitis; Bacterial tonsillitis; Acute bacterial maxillary sinusitis; Acute bacterial exacerbation of chronic bronchitis; Helicobacter pylori infection; Acute bacterial otitis media,Approved; Approved; Approved; Approved; Approved; Approved; Approved; Approved; Approved
CLAVULANIC ACID,58001-44-8,https://drugs.ncats.io/drug/23521W1S24,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""58001%2044%208"")",ONLY CAS,US Approved Rx 2023,ANDA209351,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209351,US Previously Marketed 1984,AUGMENTIN '250' by US ANTIBIOTICS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050564,Lower respiratory tract infections; Sinusitis; Skin and skin structure infections; Urinary tract infections; Otitis media,Approved; Approved; Approved; Approved; Approved
CLAY,12141-46-7,https://drugs.ncats.io/drug/T1FAD4SS2M,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""12141%2046%207"")",ONLY CAS,US Previously Marketed 1921,sodium aluminosilicate,https://catalog.hathitrust.org/Record/100163146,US Previously Marketed 1921,sodium aluminosilicate,https://catalog.hathitrust.org/Record/100163146,Hypertension,Approved
CLEMASTINE,15686-51-8,https://drugs.ncats.io/drug/95QN29S1ID,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""15686%2051%208"")",ONLY CAS,US Approved Rx 1994,ANDA073399,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=073399,US Previously Marketed 1977,TAVIST by NOVARTIS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017661,Allergic rhinitis; Urticaria,Approved; Approved
CLEVIDIPINE,167221-71-8,https://drugs.ncats.io/drug/19O2GP3B7Q,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""167221%2071%208"")",ONLY CAS,US Approved Rx 2008,NDA022156,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022156,US Approved Rx 2008,NDA022156,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022156,Hypertension,Approved
CLIDINIUM,7020-55-5,https://drugs.ncats.io/drug/BO76JF850N,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""7020%2055%205"")",ONLY CAS,US Approved Rx 2022,ANDA215453,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215453,US Previously Marketed 1956,QUARZAN by ROCHE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=010355,Acute enterocolitis; Irritable bowel syndrome; Intestinal spasm; Peptic ulcer,Approved; Approved; Approved; Approved
CLINDAMYCIN,18323-44-9,https://drugs.ncats.io/drug/3U02EL437C,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""18323%2044%209"")",ONLY CAS,US Approved Rx 2012,ANDA090979,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=090979,US Approved Rx 1970,NDA050162,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050162,Serious skin infections; Infections of the female pelvis; Serious respiratory tract infections; Intra-abdominal infections; Infections of the genital tract; Serious soft tissue infections; Sepsis; Acne vulgaris; Lower respiratory tract infections; Gynecological infections; Skin and skin structure infections; Sepsis; Bone and joint infections; Intra-abdominal infections,Approved; Approved; Approved; Approved; Approved; Approved; Approved; Approved; Approved; Approved; Approved; Approved; Approved; Approved
CLIOQUINOL,130-26-7,https://drugs.ncats.io/drug/7BHQ856EJ5,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""130%2026%207"")",ONLY CAS,US Approved OTC ,21 CFR 333.210(a) antifungal clioquinol,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec333-210.xml,US Previously Marketed 1961,NYSTAFORM by BAYER PHARMS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050235,Pruritus Ani; Eczema; Dermatitis,Approved; Approved; Approved
CLOBAZAM,22316-47-8,https://drugs.ncats.io/drug/2MRO291B4U,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""22316%2047%208"")",ONLY CAS,US Approved Rx 2018,ANDA211449,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211449,US Approved Rx 2011,NDA202067,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202067,Lennox-Gastaut syndrome,Approved
CLOBETASOL,25122-41-2,https://drugs.ncats.io/drug/ADN79D536H,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""25122%2041%202"")",ONLY CAS,US Approved Rx 2017,ANDA210199,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210199,US Previously Marketed 1985,TEMOVATE by FOUGERA PHARMS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019323,Inflammatory and pruritic dermatoses,Approved
CLOCORTOLONE,4828-27-7,https://drugs.ncats.io/drug/N8ZUB7XE0H,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""4828%2027%207"")",ONLY CAS,US Approved Rx 1977,NDA017765,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017765,US Approved Rx 1977,NDA017765,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017765,Dermatoses,Approved
CLOFARABINE,123318-82-1,https://drugs.ncats.io/drug/762RDY0Y2H,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""123318%2082%201"")",ONLY CAS,US Approved Rx 2017,ANDA205375,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205375,US Approved Rx 2004,NDA021673,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021673,Relapsed or refractory acute lymphoblastic leukemia,Approved
CLOFAZIMINE,2030-63-9,https://drugs.ncats.io/drug/D959AE5USF,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""2030%2063%209"")",ONLY CAS,US Previously Marketed 1986,LAMPRENE by NOVARTIS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019500,US Previously Marketed 1986,LAMPRENE by NOVARTIS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019500,Lepromatous leprosy,Approved
CLOFEDANOL,791-35-5,https://drugs.ncats.io/drug/42C50P12AP,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""791%2035%205"")",ONLY CAS,US Approved OTC ,21 CFR 341.14(a)(1) cough/cold:antitussive chlophedianol hydrochloride,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec341-14.xml,US Previously Marketed 1960,Ulo by Riker,OB NME Appendix 1950-1985,Cough,Approved
CLOFIBRATE,637-07-0,https://drugs.ncats.io/drug/HPN91K7FU3,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""637%2007%200"")",ONLY CAS,US Previously Marketed 1967,ATROMID-S by WYETH AYERST,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016099,US Previously Marketed 1967,ATROMID-S by WYETH AYERST,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016099,Multiple myeloma; Hyperlipoproteinemia,Basic research; Approved
CLOMIFENE,15690-55-8,https://drugs.ncats.io/drug/3JU1DU3652,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""15690%2055%208"")",ONLY CAS,US Approved Rx 1999,ANDA075528,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=075528,US Previously Marketed 1967,CLOMID by SANOFI AVENTIS US,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016131,Ovulatory dysfunction,Approved
CLOMIPRAMINE,303-49-1,https://drugs.ncats.io/drug/NUV44L116D,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""303%2049%201"")",ONLY CAS,US Approved Rx 2020,ANDA213221,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213221,US Approved Rx 1989,NDA019906,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019906,Obsessive-compulsive disorder,Approved
CLONAZEPAM,1622-61-3,https://drugs.ncats.io/drug/5PE9FDE8GB,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1622%2061%203"")",ONLY CAS,US Approved Rx 2019,ANDA211033,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211033,Possibly Marketed Outside US 1975,NDA017533,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bda569c3-106c-41c1-913c-6f6e8e60bfd4,Seizure disorders; Panic disorder,Approved; Approved
CLONIDINE,4205-90-7,https://drugs.ncats.io/drug/MN3L5RMN02,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""4205%2090%207"")",ONLY CAS,US Approved Rx 1986,ANDA070974,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=070974,US Previously Marketed 1974,COMBIPRES by BOEHRINGER INGELHEIM,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017503,Attention deficit hyperactivity disorder; Opioid withdrawal; Hypertension,Approved; Phase IV; Approved
CLOPIDOGREL,113665-84-2,https://drugs.ncats.io/drug/A74586SNO7,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""113665%2084%202"")",ONLY CAS,US Approved Rx 2014,ANDA204165,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204165,US Approved Rx 1997,NDA020839,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020839,Atherosclerosis; Acute coronary syndrome; Myocardial infarction; Peripheral arterial disease,Approved; Approved; Approved; Approved
CLORAZEPIC ACID,23887-31-2,https://drugs.ncats.io/drug/D51WO0G0L4,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""23887%2031%202"")",ONLY CAS,US Approved Rx 2022,ANDA213730,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213730,US Approved Rx 1972,NDA017105,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017105,Anxiety; Partial seizures,Approved; Approved
CLOTRIMAZOLE,23593-75-1,https://drugs.ncats.io/drug/G07GZ97H65,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""23593%2075%201"")",ONLY CAS,US Approved OTC ,21 CFR 333.210(g) antifungal clotrimazole,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec333-210.xml,US Previously Marketed 1975,LOTRIMIN by SCHERING PLOUGH,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017619,Tinea corporis; Vaginal yeast infections; Tinea cruris; Tinea pedis,Approved; Approved; Approved; Approved
CLOXACILLIN,61-72-3,https://drugs.ncats.io/drug/O6X5QGC2VB,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""61%2072%203"")",ONLY CAS,US Previously Marketed 1989,CLOXACILLIN SODIUM by TEVA,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=062978,US Previously Marketed 1965,TEGOPEN by APOTHECON,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050192,Bacterial otitis; Septicaemia; Septic arthritis; Urinary tract infections; Infective endocarditis; Respiratory tract infections; Bacterial osteomyelitis; Meningitis; Skin and soft tissue infections,Approved; Approved; Approved; Approved; Approved; Approved; Approved; Approved; Approved
CLOXIQUINE,130-16-5,https://drugs.ncats.io/drug/BPF36H1G6S,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""130%2016%205"")",ONLY CAS,US Previously Marketed ,21 CFR 310.545(a)(1) acne chlorhydroxyquinoline (cloxyquin),https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec310-545.xml,,,,Tuberculosis; Migraine; Cryptosporidium parvum infection,Basic research; Basic research; Basic research
CLOZAPINE,5786-21-0,https://drugs.ncats.io/drug/J60AR2IKIC,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""5786%2021%200"")",ONLY CAS,US Approved Rx 1989,NDA019758,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019758,US Approved Rx 1989,NDA019758,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019758,Treatment-resistant schizophrenia,Approved
COAL TAR,8007-45-2,https://drugs.ncats.io/drug/R533ESO2EC,3,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""8007%2045%202"")%20AND%20(root_names_name:""%5ECOAL%20TAR$"")",EXACT NAME,US Approved OTC ,21 CFR 358.710(b)(1) dandruff:seborrheic dermatitis coal tar,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec358-710.xml,US Previously Marketed 1921,Coal Tar N.F.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,,
COBALT,7440-48-4,https://drugs.ncats.io/drug/3G0H8C9362,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""7440%2048%204"")",ONLY CAS,US Previously Marketed ,21 CFR 310.502(a) certain drugs cobalt,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec310-502.xml,,,,,
COBAMAMIDE,13870-90-1,https://drugs.ncats.io/drug/F0R1QK73KB,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""13870%2090%201"")",ONLY CAS,Possibly Marketed Outside US ,"BumP DHA by Centurion Labs, LLC",https://www.drugbank.ca/drugs/DB11191,Possibly Marketed Outside US 2011,EnLyte by Jaymac Pharma,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e83b2dd3-a9a0-40bc-ade4-6cd4db433b06,,
COBICISTAT,1004316-88-4,https://drugs.ncats.io/drug/LW2E03M5PG,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1004316%2088%204"")",ONLY CAS,US Approved Rx 2015,NDA205395,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205395,US Approved Rx 2012,NDA203100,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203100,HIV-1 infection,Approved
COBIMETINIB,934660-93-2,https://drugs.ncats.io/drug/ER29L26N1X,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""934660%2093%202"")",ONLY CAS,US Approved Rx 2015,NDA206192,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206192,US Approved Rx 2015,NDA206192,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206192,Unresectable or metastatic melanoma with a BRAF V600E or V600K mutation,Approved
COCAINE,50-36-2,https://drugs.ncats.io/drug/I5Y540LHVR,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""50%2036%202"")",ONLY CAS,US Approved Rx 2017,NDA209963,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209963,US Previously Marketed 1860,Cocaine,https://catalog.hathitrust.org/Record/100782317,Cocaine-related disorders; Procedures and surgeries on or through accessible mucous membranes of the nasal cavities,Phase IV; Approved
COCARBOXYLASE,154-87-0,https://drugs.ncats.io/drug/XMK8K8EVIU,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""154%2087%200"")",ONLY CAS,Possibly Marketed Outside US ,"EnBrace HR by Jaymac Pharmaceuticals, Llc",https://www.drugbank.ca/drugs/DB01987,Possibly Marketed Outside US 2011,EnBrace HR by Jaymac Pharma,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6f14fa40-97ab-4ec5-b66b-793d6d1abac9,Vitamin deficiency; Vitamin deficiency,Phase I; Approved
COCCULUS,124-87-8,https://drugs.ncats.io/drug/ZLT174DL7U,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""124%2087%208"")",ONLY CAS,US Previously Marketed ,21 CFR 310.545(a)(25)(i) pediculicide picrotoxin,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec310-545.xml,,,,,
CODEINE,76-57-3,https://drugs.ncats.io/drug/UX6OWY2V7J,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""76%2057%203"")",ONLY CAS,US Approved OTC ,21 CFR 341.14(a)(2)(ii) cough/cold:antitussive codeine phosphate,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec341-14.xml,US Previously Marketed 1921,Codeine Sulphate U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,Pain,Approved
COD LIVER OIL,8001-69-2,https://drugs.ncats.io/drug/BBL281NWFG,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""8001%2069%202"")",ONLY CAS,US Approved OTC ,21 CFR 346.14(b)(2) anorectal:protectant cod liver oil (in combination only),https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec346-14.xml,US Previously Marketed 1921,Cod Liver Oil U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,,
COLCHICINE,64-86-8,https://drugs.ncats.io/drug/SML2Y3J35T,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""64%2086%208"")",ONLY CAS,US Approved Rx 2016,ANDA204711,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204711,US Previously Marketed 1921,Colchicine U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,Gout; Familial mediterranean fever,Approved; Approved
COLECALCIFEROL,67-97-0,https://drugs.ncats.io/drug/1C6V77QF41,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""67%2097%200"")",ONLY CAS,US Approved Rx 2000,NDA021163,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021163,US Previously Marketed 1921,vitamin D,https://catalog.hathitrust.org/Record/100163146,Vitamin D deficiency,Approved
COLESEVELAM,182815-43-6,https://drugs.ncats.io/drug/1XU104G55N,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""182815%2043%206"")",ONLY CAS,US Approved Rx 2023,ANDA212886,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212886,US Previously Marketed 2000,WELCHOL by COSETTE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021141,Type 2 diabetes mellitus; Familial hypercholesterolemia; Primary hyperlipidemia,Approved; Approved; Approved
COLESTIPOL,50925-79-6,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""50925%2079%206"")",ONLY CAS,,,,,,,,
COLEUS FORSKOHLII,66575-29-9,https://drugs.ncats.io/drug/1F7A44V6OU,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""66575%2029%209"")",ONLY CAS,Clinical ,INN:colforsin [INN],https://ginas.ncats.nih.gov/ginas/app/substance/1F7A44V6OU,,,,,
COLFOSCERIL PALMITATE,63-89-8,https://drugs.ncats.io/drug/319X2NFW0A,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""63%2089%208"")",ONLY CAS,US Previously Marketed 1990,EXOSURF NEONATAL by GLAXOSMITHKLINE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020044,US Previously Marketed 1990,EXOSURF NEONATAL by GLAXOSMITHKLINE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020044,respiratory distress syndrome,Approved
COLISTIN,1066-17-7,https://drugs.ncats.io/drug/Z67X93HJG1,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1066%2017%207"")",ONLY CAS,US Approved Rx 1962,NDA050356,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050356,US Previously Marketed 1962,COLY-MYCIN S by PARKE DAVIS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050355,Infections of mastoidectomy and fenestration cavities; Superficial bacterial infections of the external auditory canal,Approved; Approved
COLLAGEN,9007-34-5,https://drugs.ncats.io/drug/8JC99XGU4W,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""9007%2034%205"")",ONLY CAS,Possibly Marketed Outside US ,Ramosu Collagen Ampoule 200 by RaMoSu,https://www.drugbank.ca/drugs/DB14246,Possibly Marketed Outside US 1973,NDA022070,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b6b45969-a64a-4ce3-b3b6-157d2568a301,,
COLLAGENASE,9001-12-1,https://drugs.ncats.io/drug/9X7O8V25IT,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""9001%2012%201"")",ONLY CAS,US Approved Rx 1965,BLA101995,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=101995,US Approved Rx 1965,BLA101995,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=101995,,
COLLAGENASE CLOSTRIDIUM HISTOLYTICUM,9001-12-1,https://drugs.ncats.io/drug/9X7O8V25IT,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""9001%2012%201"")",ONLY CAS,US Approved Rx 1965,BLA101995,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=101995,US Approved Rx 1965,BLA101995,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=101995,,
CONESTAT ALFA,80295-38-1,https://drugs.ncats.io/drug/5QS67N4551,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""80295%2038%201"")",ONLY CAS,Possibly Marketed Outside US ,WHO-ATC:B06AC04,https://ginas.ncats.nih.gov/ginas/app/substance/5QS67N4551,Possibly Marketed Outside US 2014,BLA125495,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b81613ee-506e-47eb-91a7-708dfc958ea3,,
CONIVAPTAN,210101-16-9,https://drugs.ncats.io/drug/0NJ98Y462X,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""210101%2016%209"")",ONLY CAS,US Approved Rx 2007,NDA022016,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022016,US Approved Rx 2005,NDA021697,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021697,Hyponatremia; Traumatic brain injury; Liver cirrhosis; Heart failure,Approved; Phase I; Phase II; Phase III
COOLING PAD,69-72-7,https://drugs.ncats.io/drug/O414PZ4LPZ,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""69%2072%207"")",ONLY CAS,US Approved OTC ,21 CFR 358.110(b) wart remover:collodoin-like vehicle salicylic acid,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec358-110.xml,US Previously Marketed 1860,sodium salicylate,https://catalog.hathitrust.org/Record/100782317,Psoriasis; Ichthyosis vulgaris; Keratosis palmaris; Bruises; Arthritis; Strains and sprains; Simple backache,Approved; Approved; Approved; Approved; Approved; Approved; Approved
COPANLISIB,1032568-63-0,https://drugs.ncats.io/drug/WI6V529FZ9,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1032568%2063%200"")",ONLY CAS,US Previously Marketed 2017,ALIQOPA by BAYER HEALTHCARE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209936,US Previously Marketed 2017,ALIQOPA by BAYER HEALTHCARE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209936,Relapsed follicular lymphoma,Approved
COPPER,7440-50-8,https://drugs.ncats.io/drug/789U1901C5,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""7440%2050%208"")",ONLY CAS,US Approved Rx 1984,NDA018680,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018680,US Previously Marketed 1921,copper,https://catalog.hathitrust.org/Record/100163146,Pregnancy prevention,Approved
CORBADRINE,829-74-3,https://drugs.ncats.io/drug/V008L6478D,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""829%2074%203"")",ONLY CAS,US Previously Marketed 1961,NOV PONT W/NEOCOBEFRIN LEVONORDEFRIN by COOKE-WAITE,*!,US Previously Marketed 1952,RAVOCAINE AND NOVOCAIN W/ NEO-COBEFRIN by EASTMAN KODAK,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=008592,Dental care,Approved
CORTICORELIN,86784-80-7,https://drugs.ncats.io/drug/305OE8862Y,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""86784%2080%207"")",ONLY CAS,Possibly Marketed Outside US ,WHO-ATC:V04CD04,https://ginas.ncats.nih.gov/ginas/app/substance/305OE8862Y,,,,,
CORTICOTROPIN,9002-60-2,https://drugs.ncats.io/drug/097da217,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""9002%2060%202"")",ONLY CAS,,,,,,,,
CORTISONE,53-06-5,https://drugs.ncats.io/drug/V27W9254FZ,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""53%2006%205"")",ONLY CAS,US Previously Marketed 1975,CORTISONE ACETATE by EVERYLIFE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=084246,US Previously Marketed 1950,CORTONE by MERCK,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=007110,Primary adrenocortical insufficiency; Severe or incapacitating allergic conditions; Rheumatic diseases,Approved; Approved; Approved
COUGH AND COLD PREPARATIONS,616-91-1,https://drugs.ncats.io/drug/WYQ7N0BPYC,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""616%2091%201"")",ONLY CAS,US Approved Rx 2012,ANDA203853,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203853,US Previously Marketed 1963,MUCOMYST by APOTHECON,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=013601,Cystic fibrosis; Hepatic injury,Approved; Approved
CREATINE,57-00-1,https://drugs.ncats.io/drug/MU72812GK0,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""57%2000%201"")",ONLY CAS,Possibly Marketed Outside US ,"Ginsamin Energy by Biogrand Co., Ltd",https://www.drugbank.ca/drugs/DB00148,Possibly Marketed Outside US 2004,21 CFR 352,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2b67a454-26ba-4049-854c-9335668236cd,,
CREATININE,60-27-5,https://drugs.ncats.io/drug/AYI8EX34EU,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""60%2027%205"")",ONLY CAS,Possibly Marketed Outside US 1996,ANDA040069,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=580b36d2-1400-4096-aff1-cbc1f6d0ad4c,Possibly Marketed Outside US 1996,ANDA040069,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=580b36d2-1400-4096-aff1-cbc1f6d0ad4c,Renal failure; Sunburn,Natural Metabolite; Approved
CREOSOTE,8021-39-4,https://drugs.ncats.io/drug/3JYG22FD73,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""8021%2039%204"")",ONLY CAS,US Previously Marketed 1921,Creosote U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,US Previously Marketed 1921,Creosote U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,,
CRISABOROLE,906673-24-3,https://drugs.ncats.io/drug/Q2R47HGR7P,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""906673%2024%203"")",ONLY CAS,US Approved Rx 2016,NDA207695,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207695,US Approved Rx 2016,NDA207695,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207695,Atopic dermatitis,Approved
CRIZOTINIB,877399-52-5,https://drugs.ncats.io/drug/53AH36668S,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""877399%2052%205"")",ONLY CAS,US Approved Rx 2011,NDA202570,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202570,US Approved Rx 2011,NDA202570,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202570,Metastatic non-small cell lung cancer; Cancer,Approved; Basic research
CROFELEMER,148465-45-6,https://drugs.ncats.io/drug/PY79D6C8RX,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""148465%2045%206"")",ONLY CAS,US Approved Rx 2012,NDA202292,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202292,US Approved Rx 2012,NDA202292,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202292,HIV associated diarrhea,Approved
CROMOGLICIC ACID,16110-51-3,https://drugs.ncats.io/drug/Y0TK0FS77W,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""16110%2051%203"")",ONLY CAS,US Approved Rx 2000,ANDA075271,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=075271,US Previously Marketed 1973,INTAL by SANOFI AVENTIS US,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016990,Asthma; Allergic rhinitis; Allergic conjunctivitis; Mastocytosis; Allergic rhinitis; Vernal keratoconjunctivitis; Bronchial asthma,Approved; Approved; Approved; Approved; Approved; Approved; Approved
CROTAMITON,124236-29-9,https://drugs.ncats.io/drug/2EEH27851Y,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""124236%2029%209"")",ONLY CAS,US Approved Rx 1955,NDA009112,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=009112,US Previously Marketed 1949,EURAX by JOURNEY,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=006927,Unknown; Pruritus; Scabies,Approved; Approved
CRYOFLUORANE,"76-14-2
1320-37-2 (mixed isomers)",N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""76%2014%202
1320%2037%202 (mixed isomers)"")",ONLY CAS,,,,,,,,
CRYPTOXANTHIN,472-70-8,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""472%2070%208"")",ONLY CAS,,,,,,,,
CRYSTAL VIOLET,548-62-9,https://drugs.ncats.io/drug/J4Z741D6O5,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""548%2062%209"")%20AND%20(root_names_name:""%5ECRYSTAL%20VIOLET"")",APPROXIMATE NAME,US Previously Marketed 1977,GENAPAX by KEY PHARMS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=085017,US Previously Marketed 1921,gentian violet,https://catalog.hathitrust.org/Record/100163146,Fungal infection; Bacterial infections,Approved; Approved
CURCUMA LONGA,458-37-7,https://drugs.ncats.io/drug/IT942ZTH98,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""458%2037%207"")",ONLY CAS,Possibly Marketed Outside US ,Kaydia Patch by Strong Current Enterprises Limited,https://www.drugbank.ca/drugs/DB11672,Possibly Marketed Outside US 2009,21 CFR 348,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0fdc9bac-a0c4-4a8f-a36d-1a113b5bfa6d,Asthma; Schizophrenia; Mucositis; Colon cancer; Prostate cancer,Not Provided; Preclinical; Phase II; Phase I; Phase III
CURCUMIN,458-37-7,https://drugs.ncats.io/drug/IT942ZTH98,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""458%2037%207"")",ONLY CAS,Possibly Marketed Outside US ,Kaydia Patch by Strong Current Enterprises Limited,https://www.drugbank.ca/drugs/DB11672,Possibly Marketed Outside US 2009,21 CFR 348,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0fdc9bac-a0c4-4a8f-a36d-1a113b5bfa6d,Asthma; Schizophrenia; Mucositis; Colon cancer; Prostate cancer,Not Provided; Preclinical; Phase II; Phase I; Phase III
CYANOCOBALAMIN,68-19-9,https://drugs.ncats.io/drug/P6YC3EG204,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""68%2019%209"")",ONLY CAS,US Approved Rx 2020,ANDA213874,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213874,US Previously Marketed 1947,BEROCCA PN by ROCHE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=006071,Folic acid deficiency; Malignancy of pancreas or bowel; Fish tapeworm infestation; Addisonian (pernicious) anemia,Approved; Approved; Approved; Approved
CYCLANDELATE,456-59-7,https://drugs.ncats.io/drug/4139O1OAY2,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""456%2059%207"")",ONLY CAS,US Previously Marketed 1958,Cyclospasmol by Ives-Cameron (Ives),OB NME Appendix 1950-1985,US Previously Marketed 1958,Cyclospasmol by Ives-Cameron (Ives),OB NME Appendix 1950-1985,Intermittent claudication; Alzheimer’s disease,Approved; Approved
CYCLIZINE,82-92-8,https://drugs.ncats.io/drug/QRW9FCR9P2,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""82%2092%208"")",ONLY CAS,US Approved OTC ,21 CFR 336.10(a) antiemetic cyclizine hydrochloride,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec336-10.xml,US Previously Marketed 1953,Marezine by Burroughs Wellcome,OB NME Appendix 1950-1985,Motion sickness; Vomiting associated with radiotherapy; Postoperative nausea and vomiting,Approved; Approved; Approved
CYCLOBENZAPRINE,303-53-7,https://drugs.ncats.io/drug/69O5WQQ5TI,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""303%2053%207"")",ONLY CAS,US Approved Rx 2020,ANDA213324,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213324,US Previously Marketed 1977,FLEXERIL by JANSSEN RES AND DEV,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017821,"Acute, painful musculoskeletal conditions",Approved
CYCLOMETHICONE,69430-24-6,https://drugs.ncats.io/drug/NMQ347994Z,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""69430%2024%206"")",ONLY CAS,Possibly Marketed Outside US ,EHP Cleansing by Miguhara,https://www.drugbank.ca/drugs/DB14124,Possibly Marketed Outside US 1983,NDA019555,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fbf56a50-741f-4d86-b995-e6f5fb454df4,,
CYCLOPENTASILOXANE,541-02-6,https://drugs.ncats.io/drug/0THT5PCI0R,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""541%2002%206"")",ONLY CAS,Possibly Marketed Outside US ,Bp by Miguhara,https://www.drugbank.ca/drugs/DB11244,Possibly Marketed Outside US 2005,"Lustra by Taro Pharmaceuticals U.S.A., Inc.",https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c1d01301-70c3-484b-8967-2324afa1781e,Sunburn,Approved
CYCLOPENTOLATE,512-15-2,https://drugs.ncats.io/drug/I76F4SHP7J,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""512%2015%202"")",ONLY CAS,US Approved Rx 1974,ANDA084108,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=084108,US Previously Marketed 1953,Cyclogyl HCl by Schieffelin,DeHaen 1940-1975 NMEs,Eye diseases,Approved
CYCLOPHOSPHAMIDE,50-18-0,https://drugs.ncats.io/drug/6UXW23996M,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""50%2018%200"")",ONLY CAS,US Approved Rx 2023,ANDA211552,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211552,US Previously Marketed 1959,CYTOXAN by BAXTER HLTHCARE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=012142,"Burkitt’s lymphoma; Acute myelogenous and monocytic leukemia; Mycosis fungoides; Hodgkin’s disease mixed-cell type lymphoma; Chronic granulocytic leukemia; Breast cancer; Retinoblastoma; Neuroblastoma; Multiple myeloma; Chronic lymphocytic leukemia; Adenocarcinoma of the ovary; Minimal change nephrotic syndrome; Hodgkin’s disease histiocytic lymphoma; Acute lymphoblastic leukemia; Hodgkin’s disease, lymphocytic lymphoma  (nodular or diffuse)",Approved; Approved; Approved; Approved; Approved; Approved; Approved; Approved; Approved; Approved; Approved; Approved; Approved; Approved; Approved
CYCLOSERINE,68-41-7,https://drugs.ncats.io/drug/95IK5KI84Z,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""68%2041%207"")",ONLY CAS,US Approved Rx 1964,ANDA060593,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=060593,US Previously Marketed 1956,Seromycin by Lilly,DeHaen 1940-1975 NMEs,Tuberculosis,Approved
CYPROHEPTADINE,129-03-3,https://drugs.ncats.io/drug/2YHB6175DO,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""129%2003%203"")",ONLY CAS,US Approved Rx 2006,ANDA040668,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=040668,US Previously Marketed 1961,PERIACTIN by MERCK,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=012649,Cold urticaria; Vasomotor rhinitis; Uncomplicated allergic skin manifestations of angioedema; Perennial allergic rhinitis; Anaphylaxis; Vasomotor rhinitis; Angioedema; Urticaria; Seasonal allergic rhinitis; Allergic conjunctivitis,Approved; Approved; Approved; Approved; Approved; Approved; Approved; Approved; Approved; Approved
CYSTEINE,52-90-4,https://drugs.ncats.io/drug/K848JZ4886,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""52%2090%204"")",ONLY CAS,US Approved Rx 2019,NDA210660,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210660,Possibly Marketed Outside US 1952,NDA008372,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7b48ddec-e815-45f4-9ca0-5c0daaf56f30,Parenteral nutrition,Approved
CYSTINE,56-89-3,https://drugs.ncats.io/drug/48TCX9A1VT,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""56%2089%203"")",ONLY CAS,US Previously Marketed ,21 CFR 310.545(a)(20) weight control cystine,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec310-545.xml,Possibly Marketed Outside US 2008,BLA125265,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f3182470-1965-4e20-dbaf-e3506f893ea5,Colon cancer; Gastric cancer,Not Provided; Not Provided
CYTARABINE,147-94-4,https://drugs.ncats.io/drug/04079A1RDZ,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""147%2094%204"")",ONLY CAS,US Approved Rx 1990,ANDA071868,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=071868,US Previously Marketed 1969,CYTARABINE by TEVA PARENTERAL,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016793,Chronic myelogenous leukemia; Lymphomatous meningitis,Phase III; Approved
D-LACTIC ACID,10326-41-7,https://drugs.ncats.io/drug/3Q6M5SET7W,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""10326%2041%207"")",ONLY CAS,Possibly Marketed Outside US 2016,21 CFR 347,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2cea5bb8-9683-6957-e054-00144ff8d46c,Possibly Marketed Outside US 2016,21 CFR 347,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2cea5bb8-9683-6957-e054-00144ff8d46c,Unknown,
DABIGATRAN ETEXILATE,211915-06-9,https://drugs.ncats.io/drug/2E18WX195X,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""211915%2006%209"")",ONLY CAS,US Approved Rx 2020,ANDA207961,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207961,US Approved Rx 2010,NDA022512,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022512,Unknown; Deep venous thrombosis; Systemic embolism in patients with non-valvular atrial fibrillation; Pulmonary embolism,Approved; Approved; Approved
DABRAFENIB,1195765-45-7,https://drugs.ncats.io/drug/QGP4HA4G1B,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1195765%2045%207"")",ONLY CAS,US Approved Rx 2023,NDA217514,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217514,US Approved Rx 2013,NDA202806,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202806,Melanoma,Approved
DACARBAZINE,4342-03-4,https://drugs.ncats.io/drug/7GR28W0FJI,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""4342%2003%204"")",ONLY CAS,US Approved Rx 1999,ANDA075371,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=075371,US Previously Marketed 1975,DTIC-DOME by BAYER HLTHCARE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017575,Hodgkin's lymphoma; Malignant melanoma,Approved; Approved
DACLATASVIR,1009119-64-5,https://drugs.ncats.io/drug/LI2427F9CI,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1009119%2064%205"")",ONLY CAS,US Previously Marketed 2015,DAKLINZA by BRISTOL-MYERS SQUIBB,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206843,US Previously Marketed 2015,DAKLINZA by BRISTOL-MYERS SQUIBB,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206843,Chronic hepatitis C virus genotype 3 infection,Approved
DACLIZUMAB,152923-56-3,https://drugs.ncats.io/drug/CUJ2MVI71Y,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""152923%2056%203"")",ONLY CAS,US Approved Rx 2016,BLA761029,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761029,US Previously Marketed 1997,Zenapax,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103749,,
DACOMITINIB,1110813-31-4,https://drugs.ncats.io/drug/2XJX250C20,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1110813%2031%204"")",ONLY CAS,US Approved Rx 2018,NDA211288,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211288,US Approved Rx 2018,NDA211288,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211288,Non-small cell lung cancer; Glioblastoma; Esophageal squamous cell carcinoma; Head and neck squamous cell carcinoma,Approved; Phase II; Phase II; Phase II
DACTINOMYCIN,50-76-0,https://drugs.ncats.io/drug/1CC1JFE158,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""50%2076%200"")",ONLY CAS,US Approved Rx 2017,ANDA203385,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203385,US Previously Marketed 1964,Cosmegen by Merck Sharp & Dohme,OB NME Appendix 1950-1993,Locally recurrent and locoregional carcinomas; Locally recurrent and locoregional sarcomas; Wilms' tumor; Gestational trophoblastic neoplasia; Locally recurrent and locoregional adenocarcinomas; Ewing’s sarcoma; Metastatic nonseminomatous testicular cancer; Childhood rhabdomyosarcoma,Approved; Approved; Approved; Approved; Approved; Approved; Approved; Approved
DACTYLIS GLOMERATA,94349-98-1,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""94349%2098%201"")",ONLY CAS,,,,,,,,
DALBAVANCIN,171500-79-1,https://drugs.ncats.io/drug/808UI9MS5K,2,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""171500%2079%201"")%20AND%20(root_names_name:""%5EDALBAVANCIN$"")",EXACT NAME,US Approved Rx 2014,NDA021883,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021883,US Approved Rx 2014,NDA021883,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021883,Acute bacterial skin and skin structure infection,Approved
DALFOPRISTIN,112362-50-2,https://drugs.ncats.io/drug/R9M4FJE48E,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""112362%2050%202"")",ONLY CAS,US Approved Rx 1999,NDA050748,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050748,US Approved Rx 1999,NDA050748,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050748,Complicated skin and skin structure infections caused by Staphylococcus aureus or Streptococcus pyogenes,Approved
DALTEPARIN SODIUM,9005-49-6,https://drugs.ncats.io/drug/S79O08V79F,12,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""9005%2049%206"")",ONLY CAS,US Approved Rx 1994,NDA020287,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020287,US Approved Rx 1994,NDA020287,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020287,,
DAMOCTOCOG ALFA PEGOL,1363853-26-2,https://drugs.ncats.io/drug/BY4TSK952Y,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1363853%2026%202"")",ONLY CAS,Possibly Marketed Outside US ,Jivi by Bayer [Canada],https://www.drugbank.ca/drugs/DB14700,Possibly Marketed Outside US 2018,BLA125661,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f04e5bd5-d7e2-453b-a407-2616d81a695d,,
DANAZOL,17230-88-5,https://drugs.ncats.io/drug/N29QWW3BUO,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""17230%2088%205"")",ONLY CAS,US Approved Rx 2005,ANDA077246,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=077246,US Previously Marketed 1976,DANOCRINE by SANOFI AVENTIS US,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017557,Hereditary angioedema; Endometriosis; Fibrocystic breast disease,Approved; Approved; Approved
DANTROLENE,7261-97-4,https://drugs.ncats.io/drug/F64QU97QCR,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""7261%2097%204"")",ONLY CAS,US Approved Rx 1974,NDA017443,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017443,US Approved Rx 1974,NDA017443,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017443,Malignant hyperthermia; Chronic spasticity,Approved; Approved
DANTRON,117-10-2,https://drugs.ncats.io/drug/Z4XE6IBF3V,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""117%2010%202"")",ONLY CAS,US Previously Marketed ,21 CFR 310.545(a)(12)(iv)(B) laxative:stimulant laxative danthron,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec310-545.xml,,,,Constipation in terminally ill patients,Withdrawn
DAPAGLIFLOZIN,461432-26-8,https://drugs.ncats.io/drug/1ULL0QJ8UC,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""461432%2026%208"")",ONLY CAS,US Approved Rx 2017,NDA209091,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209091,Possibly Marketed Outside US 2008,NDA202293,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=01f90c94-71cb-4a1f-81ff-8004b850529b,Type 2 diabetes mellitus,Approved
DAPIPRAZOLE,72822-12-9,https://drugs.ncats.io/drug/5RNZ8GJO7K,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""72822%2012%209"")",ONLY CAS,US Previously Marketed 2019,DAPIPRAZOLE HYDROCHLORIDE by WOODWARD,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204902,US Previously Marketed 1990,DAPIPRAZOLE HYDROCHLORIDE by FERA PHARMS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019849,Pharmacologically induced mydriasis,Approved
DAPSONE,80-08-0,https://drugs.ncats.io/drug/8W5C518302,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""80%2008%200"")",ONLY CAS,US Approved Rx 2016,NDA207154,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207154,US Previously Marketed 1955,Avlosulfon by Ayerst,OB NME Appendix 1950-1985,Dermatitis herpetiformis; Acne vulgaris; Leprosy,Approved; Approved; Approved
DAPTOMYCIN,103060-53-3,https://drugs.ncats.io/drug/NWQ5N31VKK,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""103060%2053%203"")",ONLY CAS,US Approved Rx 2017,NDA208385,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208385,US Previously Marketed 2003,CUBICIN by CUBIST PHARMS LLC,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021572,Complicated skin and skin structure infections; Staphylococcus aureus bloodstream infections,Approved; Approved
DARATUMUMAB,945721-28-8,https://drugs.ncats.io/drug/4Z63YK6E0E,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""945721%2028%208"")",ONLY CAS,US Approved Rx 2015,BLA761036,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761036,US Approved Rx 2015,BLA761036,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761036,,
DARBEPOETIN ALFA,209810-58-2,https://drugs.ncats.io/drug/15UQ94PT4P,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""209810%2058%202"")",ONLY CAS,US Approved Rx 2001,BLA103951,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103951,US Approved Rx 2001,BLA103951,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103951,,
DARIFENACIN,133099-04-4,https://drugs.ncats.io/drug/APG9819VLM,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""133099%2004%204"")",ONLY CAS,US Approved Rx 2017,ANDA207302,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207302,US Previously Marketed 2004,ENABLEX by ABBVIE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021513,Overactive bladder,Approved
DARUNAVIR,206361-99-1,https://drugs.ncats.io/drug/YO603Y8113,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""206361%2099%201"")",ONLY CAS,US Approved Rx 2023,ANDA215389,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215389,US Approved Rx 2006,NDA021976,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21976,HIV-1 infection,Approved
DASABUVIR,1132935-63-7,https://drugs.ncats.io/drug/DE54EQW8T1,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1132935%2063%207"")",ONLY CAS,US Previously Marketed 2016,VIEKIRA XR by ABBVIE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208624,US Previously Marketed 2014,VIEKIRA PAK (COPACKAGED) by ABBVIE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206619,Chronic hepatitis C,Approved
DASATINIB,302962-49-8,https://drugs.ncats.io/drug/X78UG0A0RN,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""302962%2049%208"")",ONLY CAS,US Approved Rx 2006,NDA021986,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021986,Possibly Marketed Outside US 2006,NDA021986,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4764f37b-c9e6-4ede-bcc2-8a03b7c521df,Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML); Acute lymphoblastic leukemia,Approved; Approved
DAUNORUBICIN,20830-81-3,https://drugs.ncats.io/drug/ZS7284E0ZP,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""20830%2081%203"")",ONLY CAS,US Approved Rx 2019,ANDA208759,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208759,US Previously Marketed 1979,CERUBIDINE by WYETH AYERST,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050484,Neuroblastoma; Acute lymphoblastic leukemia; Acute myeloblastic leukemia,Approved; Approved; Approved
DEANOL,108-01-0,https://drugs.ncats.io/drug/2N6K9DRA24,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""108%2001%200"")",ONLY CAS,US Previously Marketed 1961,DEANER 100MG by RIKER,https://cdn.loc.gov/service/ll/fedreg/fr035/fr035095/fr035095.pdf,US Previously Marketed 1958,Deaner by Riker,DeHaen 1940-1975 NMEs,,
DECANOIC ACID,334-48-5,https://drugs.ncats.io/drug/4G9EDB6V73,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""334%2048%205"")",ONLY CAS,Possibly Marketed Outside US 2010,"OHUI Wrinkle Science wrinkle repair eye by LG Household and Healthcare, Inc.",https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b8e85860-f7ce-4e47-9321-4c916ce7e9da,Possibly Marketed Outside US 1968,NDA204017,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bcaf8db0-1750-425d-b008-255b5e7a9cc6,Seizure; Inherited metabolic diseases,Preclinical; Basic research
DECITABINE,2353-33-5,https://drugs.ncats.io/drug/776B62CQ27,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""2353%2033%205"")",ONLY CAS,US Approved Rx 2013,ANDA203131,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203131,US Previously Marketed 2006,DACOGEN by OTSUKA,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021790,Myelodysplastic syndromes,Approved
DEFERASIROX,201530-41-8,https://drugs.ncats.io/drug/V8G4MOF2V9,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""201530%2041%208"")",ONLY CAS,US Approved Rx 2022,ANDA216229,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216229,US Approved Rx 2005,NDA021882,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021882,Beta-thalassemia; Transfusional hemosiderosis,Approved; Approved
DEFERIPRONE,30652-11-0,https://drugs.ncats.io/drug/2BTY8KH53L,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""30652%2011%200"")",ONLY CAS,US Approved Rx 2020,NDA212269,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212269,US Approved Rx 2011,NDA021825,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021825,Iron overload; Thalassemia syndrome,Approved; Approved
DEFEROXAMINE,70-51-9,https://drugs.ncats.io/drug/J06Y7MXW4D,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""70%2051%209"")",ONLY CAS,US Approved Rx 2017,ANDA207384,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207384,US Approved Rx 1968,NDA016267,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016267,Acute iron intoxication; Chronic iron overload,Approved; Approved
DEFIBROTIDE,83712-60-1,https://drugs.ncats.io/drug/L7CHH2B2J0,2,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""83712%2060%201"")%20AND%20(root_names_name:""%5EDEFIBROTIDE$"")",EXACT NAME,US Approved Rx 2016,NDA208114,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208114,US Approved Rx 2016,NDA208114,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208114,,
DEFLAZACORT,14484-47-0,https://drugs.ncats.io/drug/KR5YZ6AE4B,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""14484%2047%200"")",ONLY CAS,US Approved Rx 2017,NDA208684,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208684,US Approved Rx 2017,NDA208684,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208684,Immune system diseases,Approved
DEGARELIX,214766-78-6,https://drugs.ncats.io/drug/SX0XJI3A11,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""214766%2078%206"")",ONLY CAS,US Approved Rx 2008,NDA022201,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022201,US Approved Rx 2008,NDA022201,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022201,Advanced prostate cancer,Approved
DELAFLOXACIN,189279-58-1,https://drugs.ncats.io/drug/6315412YVF,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""189279%2058%201"")",ONLY CAS,US Approved Rx 2017,NDA208610,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208610,US Approved Rx 2017,NDA208610,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208610,Gonorrhea; Community-acquired bacterial pneumonia; Acute bacterial skin and skin structure infection,Phase III; Phase III; Approved
DELAVIRDINE,136817-59-9,https://drugs.ncats.io/drug/DOL5F9JD3E,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""136817%2059%209"")",ONLY CAS,US Previously Marketed 1997,RESCRIPTOR by VIIV HLTHCARE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020705,US Previously Marketed 1997,RESCRIPTOR by VIIV HLTHCARE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020705,HIV-1 infection,Approved
DEMECARIUM,16505-84-3,https://drugs.ncats.io/drug/ILP8XJ8R5K,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""16505%2084%203"")",ONLY CAS,US Previously Marketed 1959,HUMORSOL by MERCK,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=011860,US Previously Marketed 1959,HUMORSOL by MERCK,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=011860,Accommodative esotropia; Open-angle glaucoma,Approved; Approved
DEMECLOCYCLINE,64-73-3,https://drugs.ncats.io/drug/29O079NTYT,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""64%2073%203"")",ONLY CAS,US Approved Rx 2008,ANDA065389,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=065389,US Previously Marketed 1959,Declomycin by Lederle,DeHaen 1940-1975 NMEs,Bacterial infections,Approved
DENILEUKIN DIFTITOX,173146-27-5,https://drugs.ncats.io/drug/25E79B5CTM,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""173146%2027%205"")",ONLY CAS,US Approved Rx 1999,BLA103767,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103767,US Approved Rx 1999,BLA103767,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103767,,
DENOSUMAB,615258-40-7,https://drugs.ncats.io/drug/4EQZ6YO2HI,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""615258%2040%207"")",ONLY CAS,US Approved Rx 2010,BLA125320,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125320,US Approved Rx 2010,BLA125320,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125320,,
DENTAL FLOSS,7631-97-2,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""7631%2097%202"")",ONLY CAS,,,,,,,,
DEOXYCHOLIC ACID,83-44-3,https://drugs.ncats.io/drug/005990WHZZ,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""83%2044%203"")",ONLY CAS,US Approved Rx 2021,ANDA212296,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212296,US Previously Marketed 1942,Doxychol by Breon,https://books.google.com/books?id=NwRGZTzHKRUC&lpg=PA9322&ots=xiCPzCwR9r&dq=doxychol%20breon&pg=PA9322#v=onepage&q=doxychol%20breon&f=false,Subcutaneous fat disorders; Lipoma,Approved; Phase II
DESERPIDINE,131-01-1,https://drugs.ncats.io/drug/9016E3VB47,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""131%2001%201"")",ONLY CAS,US Previously Marketed 1984,METHYCLOTHIAZIDE AND DESERPIDINE by WATSON LABS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=088452,US Previously Marketed 1957,HARMONYL by ABBVIE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=010796,Hypertension,Approved
DESFLURANE,57041-67-5,https://drugs.ncats.io/drug/CRS35BZ94Q,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""57041%2067%205"")",ONLY CAS,US Approved Rx 1992,NDA020118,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020118,US Approved Rx 1992,NDA020118,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020118,skeletal muscle relaxation,Approved
DESIPRAMINE,50-47-5,https://drugs.ncats.io/drug/TG537D343B,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""50%2047%205"")",ONLY CAS,US Approved Rx 1987,ANDA071602,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=071602,US Approved Rx 1964,NDA014399,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=014399,Depression,Approved
DESIRUDIN,120993-53-5,https://drugs.ncats.io/drug/U0JZ726775,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""120993%2053%205"")",ONLY CAS,US Previously Marketed 2003,IPRIVASK by BAUSCH,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021271,US Previously Marketed 2003,IPRIVASK by BAUSCH,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021271,Deep vein thrombosis,Approved
DESLORATADINE,100643-71-8,https://drugs.ncats.io/drug/FVF865388R,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""100643%2071%208"")",ONLY CAS,US Approved Rx 2011,ANDA078365,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=078365,US Approved Rx 2001,NDA021165,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021165,Seasonal allergic rhinitis; Perennial allergic rhinitis; Chronic idiopathic urticaria,Approved; Approved; Approved
DESMOPRESSIN,16679-58-6,https://drugs.ncats.io/drug/ENR1LLB0FP,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""16679%2058%206"")",ONLY CAS,US Approved Rx 2020,ANDA210223,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210223,US Previously Marketed 1978,DDAVP by FERRING PHARMS INC,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017922,von Willebrand’s disease (Type I); Hemophilia A; Central cranial diabetes insipidus,Withdrawn; Approved; Approved
DESOGESTREL,54024-22-5,https://drugs.ncats.io/drug/81K9V7M3A3,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""54024%2022%205"")",ONLY CAS,US Approved Rx 2013,ANDA202296,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202296,US Previously Marketed 1992,ORTHO-CEPT by JANSSEN PHARMS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020301,Pregnancy,Approved
DESONIDE,638-94-8,https://drugs.ncats.io/drug/J280872D1O,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""638%2094%208"")",ONLY CAS,US Approved Rx 2017,ANDA208836,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208836,US Approved Rx 1972,NDA017010,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017010,Contact dermatitis; Atopic dermatitis; Psoriasis; Seborrheic dermatitis; Eczema,Approved; Approved; Approved; Approved; Approved
DESOXIMETASONE,140218-14-0,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""140218%2014%200"")",ONLY CAS,,,,,,,,
DESVENLAFAXINE,93413-62-8,https://drugs.ncats.io/drug/NG99554ANW,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""93413%2062%208"")",ONLY CAS,US Approved Rx 2018,ANDA210014,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210014,US Approved Rx 2008,NDA021992,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021992,Major depressive disorder,Approved
DEUTETRABENAZINE,1392826-25-3,https://drugs.ncats.io/drug/P341G6W9NB,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1392826%2025%203"")",ONLY CAS,US Approved Rx 2017,NDA209885,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209885,US Approved Rx 2017,NDA209885,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209885,Huntington's disease; Tardive dyskinesia,Approved; Approved
DEXAMETHASONE,50-02-2,https://drugs.ncats.io/drug/7S5I7G3JQL,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""50%2002%202"")",ONLY CAS,US Approved Rx 2020,ANDA210966,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210966,US Previously Marketed 1958,DECADRON by MERCK,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=011664,Cyclitis; Iritis; Herpes zoster keratitis; Allergic conjunctivitis; Acne rosacea; Superficial punctate keratitis; Corneal injury; Bacterial conjunctivitis; Multiple myeloma,Approved; Approved; Approved; Approved; Approved; Approved; Approved; Approved; Approved
DEXAMFETAMINE,51-64-9,https://drugs.ncats.io/drug/TZ47U051FI,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""51%2064%209"")",ONLY CAS,US Approved Rx 1976,NDA017078,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017078,US Previously Marketed 1937,Dexedrine by Smith Kline French,https://web.archive.org/web/20091219120223/http://www.medic8.com/medicines/Dexedrine.html,Attention deficit hyperactivity disorder; Moderate to severe binge eating disorder; Attention deficit hyperactivity disorder,Approved; Approved; Approved
DEXBROMPHENIRAMINE,86-22-6,https://drugs.ncats.io/drug/H57G17P2FN,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""86%2022%206"")",ONLY CAS,US Approved OTC ,21 CFR 341.12(a) cough/cold:antihistamine brompheniramine maleate,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec341-12.xml,US Previously Marketed 1956,Dimetane by Robins,OB NME Appendix 1950-1985,Rhinitis; Nasal congestion and inflammations; Common cold,Phase III; Phase III; Approved
DEXCHLORPHENIRAMINE,25523-97-1,https://drugs.ncats.io/drug/3Q9Q0B929N,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""25523%2097%201"")",ONLY CAS,US Approved OTC ,21 CFR 341.12(e) cough/cold:antihistamine dexchlorpheniramine maleate,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec341-12.xml,US Previously Marketed 1958,Polaramine by Schering,DeHaen 1940-1975 NMEs,Allergy,Approved
DEXLANSOPRAZOLE,138530-94-6,https://drugs.ncats.io/drug/UYE4T5I70X,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""138530%2094%206"")",ONLY CAS,US Approved Rx 2012,ANDA202176,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202176,US Approved Rx 1995,NDA020406,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020406,Active duodenal ulcer; Gastric ulcer; Gastroesophageal reflux disease; Erosive esophagitis; Heartburn; Gastroesophageal reflux disease; Active duodenal ulcer; Gastric ulcer,Approved; Approved; Approved; Approved; Approved; Approved; Approved; Approved
DEXMEDETOMIDINE,113775-47-6,https://drugs.ncats.io/drug/67VB76HONO,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""113775%2047%206"")",ONLY CAS,US Approved Rx 2018,ANDA206798,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206798,US Approved Rx 1999,NDA021038,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021038,Pain,Approved
DEXMETHYLPHENIDATE,40431-64-9,https://drugs.ncats.io/drug/M32RH9MFGP,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""40431%2064%209"")",ONLY CAS,US Approved Rx 2015,ANDA201231,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201231,US Approved Rx 2001,NDA021278,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021278,Attention deficit hyperactivity disorder,Approved
DEXPANTHENOL,81-13-0,https://drugs.ncats.io/drug/1O6C93RI7Z,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""81%2013%200"")",ONLY CAS,US Approved Rx 2000,NDA021163,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021163,US Previously Marketed 1947,BEROCCA PN by ROCHE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=006071,Skin moisturizer; SUNBURN,Basic research; Approved
DEXRAZOXANE,24584-09-6,https://drugs.ncats.io/drug/048L81261F,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""24584%2009%206"")",ONLY CAS,US Approved Rx 2011,ANDA200752,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=200752,US Previously Marketed 1995,Zinecard,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20212,Breast cancer,Approved
DEXTRAN,9004-54-0,https://drugs.ncats.io/drug/7SA290YK68,15,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""9004%2054%200"")%20AND%20(root_names_name:""%5EDEXTRAN"")",APPROXIMATE NAME,US Approved OTC ,21 CFR 349.12(b) ophthalmic:demulcents dextran 70,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec349-12.xml,US Previously Marketed 1953,Dextran 70 6% in 0.9% Sodium Chloride by American McGaw,OB NME Appendix 1950-1985,,
DEXTRANOMER,56087-11-7,https://drugs.ncats.io/drug/30KXI0TVD3,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""56087%2011%207"")",ONLY CAS,Possibly Marketed Outside US ,WHO-ATC:D03AX02,https://ginas.ncats.nih.gov/ginas/app/substance/30KXI0TVD3,,,,,
DEXTRIN,9004-53-9,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""9004%2053%209"")",ONLY CAS,,,,,,,,
DEXTROMETHORPHAN,125-71-3,https://drugs.ncats.io/drug/7355X3ROTS,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""125%2071%203"")",ONLY CAS,US Approved OTC ,21 CFR 341.14(a)(4) cough/cold:antitussive dextromethorphan hydrobromide,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec341-14.xml,US Previously Marketed 1954,Romilar by Hoffmann-La Roche,OB NME Appendix 1950-1985,Cough; Pseudobulbar affect,Approved; Approved
DEXTROPROPOXYPHENE,469-62-5,https://drugs.ncats.io/drug/S2F83W92TK,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""469%2062%205"")",ONLY CAS,US Previously Marketed 1974,PROPOXYPHENE HYDROCHLORIDE AND ACETAMINOPHEN by MYLAN,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=083689,US Previously Marketed 1957,DARVON by XANODYNE PHARM,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=010997,Mild to moderate pain,Approved
DEXTROTHYROXINE,51-49-0,https://drugs.ncats.io/drug/4W9K63FION,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""51%2049%200"")",ONLY CAS,US Previously Marketed 1967,CHOLOXIN by ABBVIE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=012302,US Previously Marketed 1967,CHOLOXIN by ABBVIE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=012302,Hypercholesterolemia,Approved
DIATRIZOIC ACID,117-96-4,https://drugs.ncats.io/drug/5UVC90J1LK,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""117%2096%204"")",ONLY CAS,US Approved Rx 2022,ANDA214201,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214201,US Previously Marketed 1954,HYPAQUE by GE HEALTHCARE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=009561,Urinary system disease; Gastrointestinal disorders,Approved; Approved
DIAZEPAM,439-14-5,https://drugs.ncats.io/drug/Q3JTX2Q7TU,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""439%2014%205"")",ONLY CAS,US Approved Rx 1988,ANDA072079,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=072079,US Approved Rx 1963,NDA013263,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=013263,Muscle spasm; Anxiety; Convulsive disorders; Acute alcohol withdrawal,Approved; Approved; Approved; Approved
DIAZOLIDINYL UREA,78491-02-8,https://drugs.ncats.io/drug/H5RIZ3MPW4,2,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""78491%2002%208"")%20AND%20(root_names_name:""%5EDIAZOLIDINYL%20UREA$"")",EXACT NAME,Possibly Marketed Outside US ,part333E,https://www.drugbank.ca/drugs/DB14173,Possibly Marketed Outside US 2000,ProPet by United Pet Group,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2d02a287-cd7d-481d-bd23-9d48dc8b9214,Pain,Approved
DIAZOXIDE,364-98-7,https://drugs.ncats.io/drug/O5CB12L4FN,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""364%2098%207"")",ONLY CAS,US Approved Rx 2020,ANDA210799,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210799,US Previously Marketed 1973,HYPERSTAT by SCHERING,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016996,Hyperinsulinemia,Approved
DICHLORALPHENAZONE,480-30-8,https://drugs.ncats.io/drug/YYX637R279,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""480%2030%208"")",ONLY CAS,Possibly Marketed Outside US ,WHO-ATC:N05CC04,https://ginas.ncats.nih.gov/ginas/app/substance/YYX637R279,,,,,
DICHLOROACETIC ACID,79-43-6,https://drugs.ncats.io/drug/9LSH52S3LQ,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""79%2043%206"")",ONLY CAS,Possibly Marketed Outside US ,Canada:DICHLORACETIC ACID,https://tripod.nih.gov/npc/#Download,Possibly Marketed Outside US 2011,21 CFR 352,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=045ded38-5d0a-45b3-951f-a58ae3cf5516,Pyruvate dehydrogenase complex deficiency; Cancer; Congenital lactic acidosis,Phase III; Phase II; Phase III
DICHLORODIFLUORO-METHANE,75-71-8,https://drugs.ncats.io/drug/OFM06SG1KO,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""75%2071%208"")",ONLY CAS,Excipient ,"26%w/v INTRAPLEURAL AEROSOL, METERED",https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=D,,,,,
DICLOFENAC,15307-86-5,https://drugs.ncats.io/drug/144O8QL0L1,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""15307%2086%205"")",ONLY CAS,US Approved Rx 2023,ANDA216548,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216548,US Previously Marketed 1988,VOLTAREN by NOVARTIS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019201,Osteoarthritis; Rheumatoid arthritis,Approved; Approved
DICLOFENAMIDE,120-97-8,https://drugs.ncats.io/drug/VVJ6673MHY,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""120%2097%208"")",ONLY CAS,US Approved Rx 2022,ANDA215924,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215924,US Approved Rx 1958,NDA011366,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=011366,Primary hypokalemic periodic paralysis; Primary hyperkalemic periodic paralysis,Approved; Approved
DICLOXACILLIN,3116-76-5,https://drugs.ncats.io/drug/COF19H7WBK,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""3116%2076%205"")",ONLY CAS,US Approved Rx 2022,ANDA216845,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216845,US Previously Marketed 1968,Veracillin by Ayerst,DeHaen 1940-1975 NMEs,Infections caused by penicillinase-producing staphylococci; Pneumonia; Bronchitis,Approved; Approved; Approved
DICOUMAROL,66-76-2,https://drugs.ncats.io/drug/7QID3E7BG7,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""66%2076%202"")",ONLY CAS,US Previously Marketed 1944,DICUMAROL by ABBVIE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=005545,US Previously Marketed 1944,DICUMAROL by ABBVIE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=005545,Blood clotting,Approved
DICYCLOVERINE,77-19-0,https://drugs.ncats.io/drug/4KV4X8IF6V,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""77%2019%200"")",ONLY CAS,US Approved Rx 2021,ANDA214721,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214721,US Previously Marketed 1950,BENTYL by ALLERGAN,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=007409,Irritable bowel syndrome,Approved
DIDANOSINE,69655-05-6,https://drugs.ncats.io/drug/K3GDH6OH08,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""69655%2005%206"")",ONLY CAS,US Previously Marketed 1991,VIDEX by BRISTOL MYERS SQUIBB,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020154,US Previously Marketed 1991,VIDEX by BRISTOL MYERS SQUIBB,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020154,HIV-1 infection,Approved
DIENESTROL,13029-44-2,https://drugs.ncats.io/drug/RRW32X4U1F,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""13029%2044%202"")",ONLY CAS,US Previously Marketed 1947,DIENESTROL by ORTHO MCNEIL PHARM,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=006110,US Previously Marketed 1947,DIENESTROL by ORTHO MCNEIL PHARM,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=006110,Atrophic vaginitis; Kraurosis vulvae,Approved; Approved
DIENOGEST,65928-58-7,https://drugs.ncats.io/drug/46M3EV8HHE,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""65928%2058%207"")",ONLY CAS,US Approved Rx 2017,ANDA202349,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202349,US Approved Rx 2010,NDA022252,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022252,Endometriosis; Pregnancy; Heavy menstrual bleeding,Approved; Approved; Approved
DIETHYLSTILBESTROL,56-53-1,https://drugs.ncats.io/drug/731DCA35BT,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""56%2053%201"")",ONLY CAS,US Previously Marketed 1982,DIETHYLSTILBESTROL by LILLY,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=004040,US Previously Marketed 1941,Diethylstilbestrol by Various Mfrs.,DeHaen 1940-1975 NMEs,Prostate cancer; Prostate cancer; Miscarriage; Atrophic vaginitis; Vulvar dystrophy; Amenorrhea; Female hypogonadism; Postmenopausal osteoporosis; Menopausal syndrome,Approved; Approved; Approved; Approved; Approved; Approved; Approved; Approved; Approved
DIETHYLTOLUAMIDE,134-62-3,https://drugs.ncats.io/drug/FB0C1XZV4Y,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""134%2062%203"")",ONLY CAS,Possibly Marketed Outside US ,part352,https://www.drugbank.ca/drugs/DB11282,Possibly Marketed Outside US 2015,21 CFR 352,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6ccdc093-8af9-4bd8-84b0-f229fccd2f1c,West Nile virus infectious disease; Malaria; Lyme disease,Approved; Approved; Approved
DIFENOXIN,28782-42-5,https://drugs.ncats.io/drug/3ZZ5BJ9F2Q,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""28782%2042%205"")",ONLY CAS,US Approved Rx 1978,NDA017744,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017744,US Approved Rx 1978,NDA017744,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017744,Diarrhea,Approved
DIFLORASONE,2557-49-5,https://drugs.ncats.io/drug/T2DHJ9645W,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""2557%2049%205"")",ONLY CAS,US Approved Rx 2017,ANDA207440,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207440,US Previously Marketed 1977,FLORONE by PFIZER,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017741,Corticosteroid-responsive dermatoses,Approved
DIFLUNISAL,22494-42-4,https://drugs.ncats.io/drug/7C546U4DEN,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""22494%2042%204"")",ONLY CAS,US Approved Rx 1992,ANDA073673,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=073673,US Previously Marketed 1982,DOLOBID by MERCK,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018445,Osteoarthritis; Pain; Rheumatoid arthritis,Approved; Approved; Approved
DIFLUPREDNATE,23674-86-4,https://drugs.ncats.io/drug/S8A06QG2QE,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""23674%2086%204"")",ONLY CAS,US Approved Rx 2021,ANDA211776,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211776,US Approved Rx 2008,NDA022212,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022212,Endogenous anterior uveitis,Approved
DIGITOXIN,71-63-6,https://drugs.ncats.io/drug/E90NZP2L9U,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""71%2063%206"")",ONLY CAS,US Previously Marketed 1978,CRYSTODIGIN by LILLY,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=084100,US Previously Marketed 1954,ACYLANID by NOVARTIS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=009436,Chronic atrial fibrillation; Heart failure,Approved; Approved
DIGOXIN,20830-75-5,https://drugs.ncats.io/drug/73K4184T59,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""20830%2075%205"")",ONLY CAS,US Approved Rx 2004,NDA021648,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021648,US Approved Rx 1954,NDA009330,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=009330,Heart failure; Chronic atrial fibrillation,Approved; Approved
DIHYDROCODEINE,125-28-0,https://drugs.ncats.io/drug/N9I9HDB855,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""125%2028%200"")",ONLY CAS,US Approved Rx 2014,ANDA204785,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204785,US Previously Marketed 1956,Rapacodin by Knoll,DeHaen 1940-1975 NMEs,Pain,Approved
DIHYDROERGOTAMINE,511-12-6,https://drugs.ncats.io/drug/436O5HM03C,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""511%2012%206"")",ONLY CAS,US Approved Rx 2017,ANDA206621,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206621,US Previously Marketed 1946,D.H.E. 45 by BAUSCH,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=005929,Migraine,Approved
DIHYDROERGOTOXINE,11032-41-0,https://drugs.ncats.io/drug/34HPE9Z8IP,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""11032%2041%200"")",ONLY CAS,US Approved Rx 1991,ANDA081113,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=081113,US Previously Marketed 1953,Hydergine by Sandoz,OB NME Appendix 1950-1993,Primary progressive dementia; Alzheimer's dementia; Multi-infarct dementia,Approved; Approved; Approved
DIHYDROTACHYSTEROL,67-96-9,https://drugs.ncats.io/drug/R5LM3H112R,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""67%2096%209"")",ONLY CAS,US Previously Marketed 1940,Hytakerol by Winthrop-Stearns (Winthrop),DeHaen 1940-1975 NMEs,US Previously Marketed 1940,Hytakerol by Winthrop-Stearns (Winthrop),DeHaen 1940-1975 NMEs,Hypocalcemia; Hypoparathyroidism,Approved; Approved
DIHYDROXYACETONE,96-26-4,https://drugs.ncats.io/drug/O10DDW6JOO,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""96%2026%204"")",ONLY CAS,Possibly Marketed Outside US 1999,21 CFR 352,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6c517222-35fe-4d93-8fc9-bd38ccda65fc,Possibly Marketed Outside US 1999,21 CFR 352,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6c517222-35fe-4d93-8fc9-bd38ccda65fc,sunburn,Approved
DIHYDROXYALUMINIUM,7047-84-9,https://drugs.ncats.io/drug/P9BC99461E,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""7047%2084%209"")",ONLY CAS,Possibly Marketed Outside US ,Japan:Aluminum Monostearate,https://tripod.nih.gov/npc/#Download,Possibly Marketed Outside US 1993,NDA020215,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bf9e7e35-7707-42a0-88d6-6292fa52bbfa,Angina pectoris due to coronary artery disease; Unknown,Approved
DIIODOHYDROXYQUINOLINE,83-73-8,https://drugs.ncats.io/drug/63W7IE88K8,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""83%2073%208"")",ONLY CAS,US Previously Marketed 1953,BACULIN by AMFRE GRANT,"Federal Register v.40 (1975), page 12698, retrieved from: https://books.google.ru/books?id=Bs7A91z1w6sC",US Previously Marketed 1953,BACULIN by AMFRE GRANT,"Federal Register v.40 (1975), page 12698, retrieved from: https://books.google.ru/books?id=Bs7A91z1w6sC",Amebiasis,Withdrawn
DILTIAZEM,56209-45-1,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""56209%2045%201"")",ONLY CAS,,,,,,,,
DIMENHYDRINATE,523-87-5,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""523%2087%205"")",ONLY CAS,,,,,,,,
DIMETHYLGLYCINE,1118-68-9,https://drugs.ncats.io/drug/7797M4CPPA,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1118%2068%209"")%20AND%20(root_names_name:""%5EDIMETHYLGLYCINE"")",APPROXIMATE NAME,,,,,,,Unknown,
DIMETHYL FUMARATE,624-49-7,https://drugs.ncats.io/drug/FO2303MNI2,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""624%2049%207"")",ONLY CAS,US Approved Rx 2019,NDA211855,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211855,Possibly Marketed Outside US 1946,NDA006035,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b1552d48-86f5-4184-810a-001e57e96c02,Arthritis; Multiple sclerosis; Ischemic stroke; Cancer; Periapical diseases; Unknown; Relapsing forms of multiple sclerosis; Unknown,Preclinical; Approved; Preclinical; Natural Metabolite; Not Provided; Approved
DIMETHYL SULFONE,67-71-0,https://drugs.ncats.io/drug/9H4PO4Z4FT,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""67%2071%200"")",ONLY CAS,Possibly Marketed Outside US ,Powerfulx Ginseng RecoveryCream by Powerful X,https://www.drugbank.ca/drugs/DB14090,Possibly Marketed Outside US 1988,21 CFR 348,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d5f76bfc-6601-815a-e053-2995a90ac124,Dietary Supplements; Osteoarthritis,Approved; Approved
DIMETHYL SULFOXIDE,67-68-5,https://drugs.ncats.io/drug/YOW8V9698H,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""67%2068%205"")",ONLY CAS,US Approved Rx 1978,NDA017788,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017788,Possibly Marketed Outside US 1972,NADA045512,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4ae0564a-6c03-4848-88d0-621943d94ea1,interstitial cystitis,Approved
DIMETICONE,107-51-7,https://drugs.ncats.io/drug/9G1ZW13R0G,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""107%2051%207"")",ONLY CAS,Possibly Marketed Outside US ,Canada:DIMETHICONE,https://tripod.nih.gov/npc/#Download,Possibly Marketed Outside US 2004,21 CFR 352,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2b67a454-26ba-4049-854c-9335668236cd,Sunburn,Approved
DINOPROSTONE,363-24-6,https://drugs.ncats.io/drug/K7Q1JQR04M,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""363%2024%206"")",ONLY CAS,US Approved Rx 1995,NDA020411,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020411,US Previously Marketed 1977,PROSTIN E2 by PFIZER,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017810,Unknown; Labor complications,Approved
DINUTUXIMAB,1363687-32-4,https://drugs.ncats.io/drug/7SQY4ZUD30,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1363687%2032%204"")",ONLY CAS,US Approved Rx 2015,BLA125516,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125516,US Approved Rx 2015,BLA125516,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125516,,
DIOSMIN,520-27-4,https://drugs.ncats.io/drug/7QM776WJ5N,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""520%2027%204"")",ONLY CAS,Possibly Marketed Outside US ,"Vasculera by Primus Pharmaceuticals, Inc.",https://www.drugbank.ca/drugs/DB08995,Possibly Marketed Outside US 2012,"Vasculera by Primus Pharmaceuticals, Inc.",https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=563d3d34-a547-471e-aecd-f4a4a57cbf1d,Menorrhagia; Venous insufficiency; Hemorrhoids,Phase II; Not Provided; Not Provided
DIOXYBENZONE,131-53-3,https://drugs.ncats.io/drug/B762XZ551X,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""131%2053%203"")",ONLY CAS,US Previously Marketed 1966,Solhar by Person-Covey,OB NME Appendix 1950-1985,US Previously Marketed 1966,Solhar by Person-Covey,OB NME Appendix 1950-1985,Sunburn,Approved
DIPHENHYDRAMINE,58-73-1,https://drugs.ncats.io/drug/8GTS82S83M,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""58%2073%201"")",ONLY CAS,US Approved OTC ,21 CFR 336.10(c) antiemetic diphenhydramine hydrochloride,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec336-10.xml,US Previously Marketed 1946,BENADRYL by MCNEIL CONS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=005845,Occasional sleeplessness; Seasonal allergic rhinitis,Approved; Approved
DIPHENOXYLATE,915-30-0,https://drugs.ncats.io/drug/73312P173G,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""915%2030%200"")",ONLY CAS,US Approved Rx 1960,NDA012462,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=012462,US Approved Rx 1960,NDA012462,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=012462,Acute diarrhea,Approved
DIPHENYLPYRALINE,147-20-6,https://drugs.ncats.io/drug/33361OE3AV,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""147%2020%206"")",ONLY CAS,US Previously Marketed 1961,PYRALINE HCL 2MG by NOPCO,https://www.govinfo.gov/content/pkg/FR-1977-09-02/pdf/FR-1977-09-02.pdf,US Previously Marketed 1953,Diafen by SchenLabs (Riker),OB NME Appendix 1950-1985,Rhinitis; Pruritus; Allergic rhinitis,Approved; Approved; Approved
DIPIVEFRINE,52365-63-6,https://drugs.ncats.io/drug/8Q1PVL543G,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""52365%2063%206"")",ONLY CAS,US Previously Marketed 1995,AKPRO by EPIC PHARMA LLC,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=074382,US Previously Marketed 1980,PROPINE by ALLERGAN,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018239,Chronic open-angle glaucoma,Approved
DIPROPHYLLINE,479-18-5,https://drugs.ncats.io/drug/263T0E9RR9,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""479%2018%205"")",ONLY CAS,US Previously Marketed 1951,NEOTHYLLINE by TEVA,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=007794,US Previously Marketed 1951,NEOTHYLLINE by TEVA,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=007794,Acute bronchial asthma; Chronic bronchitis; Emphysema,Approved; Approved; Approved
DIPROPYLENEGLYCOL,25265-71-8,https://drugs.ncats.io/drug/E107L85C40,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""25265%2071%208"")",ONLY CAS,Possibly Marketed Outside US ,"Abelia green tea energy mask by Terrasun Co., Ltd.",https://www.drugbank.ca/drugs/DB14140,Possibly Marketed Outside US 1958,"Cetacaine Anesthetic by Cetylite Industries, Inc.",https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=af1773c5-5d5b-4278-b551-30ad2df6d5b5,,
DIPYRIDAMOLE,58-32-2,https://drugs.ncats.io/drug/64ALC7F90C,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""58%2032%202"")",ONLY CAS,US Approved Rx 2017,ANDA206753,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206753,US Approved Rx 1961,NDA012836,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=012836,Postoperative thromboembolic complications of cardiac valve replacement,Approved
DIRITHROMYCIN,62013-04-1,https://drugs.ncats.io/drug/1801D76STL,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""62013%2004%201"")",ONLY CAS,US Previously Marketed 1995,DYNABAC by LILLY RES LABS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050678,US Previously Marketed 1995,DYNABAC by LILLY RES LABS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050678,"Uncomplicated skin and skin structure infections due to Staphylococcus aureus (methiciIlin-susceptible strains) or Streptococcus pyogenes.; Chronic bronchitis due to Haemophilus in<U+FB02>uenzae, Moraxella catarrhalis, or Streptococcus pneumoniae",Approved; Approved
DISOPYRAMIDE,3737-09-5,https://drugs.ncats.io/drug/GFO928U8MQ,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""3737%2009%205"")",ONLY CAS,US Approved Rx 1985,ANDA070101,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=070101,US Approved Rx 1977,NDA017447,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017447,Ventricular arrhythmia,Approved
DISPOSABLE MEDICAL DEVICES,67-63-0,https://drugs.ncats.io/drug/ND2M416302,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""67%2063%200"")",ONLY CAS,US Approved OTC ,21 CFR 344.12 otic:ear drying aid isopropyl alcohol,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec344-12.xml,US Previously Marketed 1921,Rubbing Alcohol,https://books.google.com/books?id=1n4gAQAAMAAJ&newbks=1&newbks_redir=0&dq=alcohol%20rubbing%20usp&pg=PA85#v=onepage&q=alcohol%20rubbing%20usp&f=false,,
DISULFIRAM,97-77-8,https://drugs.ncats.io/drug/TR3MLJ1UAI,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""97%2077%208"")",ONLY CAS,US Approved Rx 2013,ANDA091681,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=091681,US Previously Marketed 1951,ANTABUSE by TEVA WOMENS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=007883,Chronic alcoholism,Approved
DITHRANOL,1143-38-0,https://drugs.ncats.io/drug/U8CJK0JH5M,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1143%2038%200"")",ONLY CAS,US Previously Marketed 1929,Anthralin by Abbott,https://books.google.com/books?id=TAhtAAAAMAAJ&q=anthralin+drug&dq=anthralin+drug,US Previously Marketed 1929,Anthralin by Abbott,https://books.google.com/books?id=TAhtAAAAMAAJ&q=anthralin+drug&dq=anthralin+drug,Quiescent or chronic psoriasis,Basic research
DL-LACTIC ACID,50-21-5,https://drugs.ncats.io/drug/3B8D35Y7S4,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""50%2021%205"")",ONLY CAS,US Approved Rx 1971,NDA016679,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016679,US Previously Marketed 1921,Lactic Acid U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,Metabolic acidosis,Approved
DOBUTAMINE,34368-04-2,https://drugs.ncats.io/drug/3S12J47372,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""34368%2004%202"")",ONLY CAS,US Approved Rx 1994,ANDA074277,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=074277,US Previously Marketed 1978,DOBUTREX by LILLY,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017820,Heart diseases,Approved
DOCETAXEL,114977-28-5,https://drugs.ncats.io/drug/699121PHCA,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""114977%2028%205"")",ONLY CAS,US Approved Rx 2017,ANDA207563,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207563,US Approved Rx 1996,NDA020449,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020449,Non-small cell lung cancer; Head and neck squamous cell carcinoma; Breast cancer; Gastric adenocarcinoma; Hormone refractory prostate cancer,Approved; Approved; Approved; Approved; Approved
DOCONEXENT,6217-54-5,https://drugs.ncats.io/drug/ZAD9OKH9JC,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""6217%2054%205"")",ONLY CAS,Possibly Marketed Outside US ,Ultra Omega 3 by Liberty Bioscience LLC,https://www.drugbank.ca/drugs/DB03756,Possibly Marketed Outside US 2007,"DHA by Exeltis USA, Inc",https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a0e273e2-0876-4830-a903-282085be7f32,Alzheimer’s disease; Coronary heart disease; Age-related macular degeneration; Pregnancy,Approved; Approved; Phase III; Phase III
DOCOSAHEXANOIC ACID,6217-54-5,https://drugs.ncats.io/drug/ZAD9OKH9JC,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""6217%2054%205"")",ONLY CAS,Possibly Marketed Outside US ,Ultra Omega 3 by Liberty Bioscience LLC,https://www.drugbank.ca/drugs/DB03756,Possibly Marketed Outside US 2007,"DHA by Exeltis USA, Inc",https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a0e273e2-0876-4830-a903-282085be7f32,Alzheimer’s disease; Coronary heart disease; Age-related macular degeneration; Pregnancy,Approved; Approved; Phase III; Phase III
DOCOSANOL,661-19-8,https://drugs.ncats.io/drug/9G1OE216XY,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""661%2019%208"")",ONLY CAS,US Approved Rx 2022,ANDA212385,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212385,US Approved Rx 2000,NDA020941,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020941,Herpes labialis,Approved
DOCOSAPENTAENOIC ACID,24880-45-3,https://drugs.ncats.io/drug/NS3OZT14QT,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""24880%2045%203"")",ONLY CAS,,,,,,,,
DOCUSATE,10041-19-7,https://drugs.ncats.io/drug/M7P27195AG,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""10041%2019%207"")",ONLY CAS,US Previously Marketed 1956,Peri-Colace by Mead Johnson,OB NME Appendix 1950-1993,US Previously Marketed 1956,Peri-Colace by Mead Johnson,OB NME Appendix 1950-1993,Constipation,Approved
DODECYL SULFOACETIC ACID,1847-58-1,https://drugs.ncats.io/drug/D0Y70F2B9J,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1847%2058%201"")",ONLY CAS,Possibly Marketed Outside US ,Microlax Micro Enema by Mcneil Consumer Healthcare Division Of Johnson & Johnson Inc [Canada],https://www.drugbank.ca/drugs/DB13157,Possibly Marketed Outside US 2002,21 CFR 333A,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3f95cedf-d58b-4301-9c4b-7363c5da656f,Constipation,Approved
DOFETILIDE,115256-11-6,https://drugs.ncats.io/drug/R4Z9X1N2ND,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""115256%2011%206"")",ONLY CAS,US Approved Rx 2018,ANDA208625,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208625,US Approved Rx 1999,NDA020931,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020931,Atrial fibrillation,Approved
DOLASETRON,115956-12-2,https://drugs.ncats.io/drug/82WI2L7Q6E,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""115956%2012%202"")",ONLY CAS,US Approved Rx 1997,NDA020623,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020623,US Previously Marketed 1997,ANZEMET by VALIDUS PHARMS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020624,Nausea and vomiting associated with moderately emetogenic cancer chemotherapy; Fibromyalgia; Postoperative nausea and vomiting,Approved; Phase III; Approved
DOLOMITE,60937-55-5,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""60937%2055%205"")",ONLY CAS,,,,,,,,
DOLUTEGRAVIR,1051375-16-6,https://drugs.ncats.io/drug/DKO1W9H7M1,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1051375%2016%206"")",ONLY CAS,US Approved Rx 2017,NDA210192,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210192,US Approved Rx 2013,NDA204790,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204790,HIV-1 infection,Approved
DOMIPHEN,13900-14-6,https://drugs.ncats.io/drug/4AZL56CU0F,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""13900%2014%206"")",ONLY CAS,US Previously Marketed 1958,Bradosol Bromide by Ciba,DeHaen 1940-1975 NMEs,US Previously Marketed 1958,Bradosol Bromide by Ciba,DeHaen 1940-1975 NMEs,Acute infectious dental diseases; Bacterial Infections,Not Provided; Approved
DOMPERIDONE,57808-66-9,https://drugs.ncats.io/drug/5587267Z69,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""57808%2066%209"")",ONLY CAS,Possibly Marketed Outside US ,Bio-domperidone by Biomed Pharma [Canada],https://www.drugbank.ca/drugs/DB01184,Possibly Marketed Outside US 2009,MIF900001,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bed61e35-01c1-4171-87b9-2b66388673ad,Chronic constipation; Gastroesophageal reflux disease; Emesis; Gastroparesis,Not Provided; Phase IV; Approved; Approved
DONEPEZIL,120014-06-4,https://drugs.ncats.io/drug/8SSC91326P,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""120014%2006%204"")",ONLY CAS,US Approved Rx 2014,ANDA203104,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203104,US Approved Rx 1996,NDA020690,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020690,Alzheimer’s disease,Approved
DOPAMINE,51-61-6,https://drugs.ncats.io/drug/VTD58H1Z2X,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""51%2061%206"")",ONLY CAS,US Approved Rx 2018,ANDA207707,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207707,US Previously Marketed 1974,INTROPIN by HOSPIRA,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017395,Hemodynamic imbalances present in the shock syndrome,Approved
DORAVIRINE,1338225-97-0,https://drugs.ncats.io/drug/913P6LK81M,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1338225%2097%200"")",ONLY CAS,US Approved Rx 2018,NDA210807,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210807,Possibly Marketed Outside US 2018,NDA210806,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6084e889-6092-4d8d-b7d0-18aae29b6817,HIV-1 infection,Approved
DORIPENEM,148016-81-3,https://drugs.ncats.io/drug/BHV525JOBH,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""148016%2081%203"")",ONLY CAS,US Previously Marketed 2007,DORIBAX by SHIONOGI INC,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022106,US Previously Marketed 2007,DORIBAX by SHIONOGI INC,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022106,"Nosocomial pneumonia (NP), including ventilator associated pneumonia (VAP).; Complicated urinary tract infections; Complicated intra-abdominal infections",Withdrawn; Approved; Approved
DORNASE ALFA,143831-71-4,https://drugs.ncats.io/drug/953A26OA1Y,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""143831%2071%204"")",ONLY CAS,US Approved Rx 1993,BLA103532,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103532,US Approved Rx 1993,BLA103532,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103532,,
DORZOLAMIDE,120279-96-1,https://drugs.ncats.io/drug/9JDX055TW1,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""120279%2096%201"")",ONLY CAS,US Approved Rx 2019,ANDA204778,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204778,US Previously Marketed 1994,TRUSOPT by MSD SUB MERCK,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020408,Open-angle glaucoma; Ocular hypertension,Approved; Approved
DOXAPRAM,309-29-5,https://drugs.ncats.io/drug/94F3830Q73,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""309%2029%205"")",ONLY CAS,US Approved Rx 2003,ANDA076266,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=076266,US Approved Rx 1965,NDA014879,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=014879,Drug-induced postanesthesia respiratory depression; Chronic pulmonary disease associated with acute hypercapnia,Approved; Approved
DOXAZOSIN,74191-85-8,https://drugs.ncats.io/drug/NW1291F1W8,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""74191%2085%208"")",ONLY CAS,US Approved Rx 2017,ANDA208719,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208719,US Approved Rx 1990,NDA019668,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019668,Hypertension; Benign prostatic hyperplasia,Approved; Approved
DOXEPIN,1668-19-5,https://drugs.ncats.io/drug/5ASJ6HUZ7D,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1668%2019%205"")",ONLY CAS,US Approved Rx 2023,ANDA217688,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217688,US Previously Marketed 1969,SINEQUAN by PFIZER,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016798,Depression; Psychoneurotic patients with anxiety; Moderate pruritus in adult patients with atopic dermatitis or lichen simplex chronicus,Approved; Approved; Approved
DOXERCALCIFEROL,54573-75-0,https://drugs.ncats.io/drug/3DIZ9LF5Y9,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""54573%2075%200"")",ONLY CAS,US Approved Rx 2000,NDA021027,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021027,US Approved Rx 1999,NDA020862,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020862,Secondary hyperparathyroidism in patients with chronic kidney disease on dialysis,Approved
DOXORUBICIN,23214-92-8,https://drugs.ncats.io/drug/80168379AG,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""23214%2092%208"")",ONLY CAS,US Approved Rx 2022,ANDA212219,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212219,US Previously Marketed 1974,DOXORUBICIN HYDROCHLORIDE by PFIZER,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050467,AIDS-related Kaposi’s sarcoma; Multiple myeloma; Ovarian cancer; Locally advanced or unresectable soft tissue sarcoma; Glioblastoma; Kaposi’s sarcoma; Metastatic non-small cell lung cancer; Pancreatic ductal adenocarcinoma,Approved; Approved; Approved; Phase III; Phase II; Phase II; Phase II; Phase II
DOXYCYCLINE,564-25-0,https://drugs.ncats.io/drug/334895S862,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""564%2025%200"")",ONLY CAS,US Approved Rx 2019,ANDA211343,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211343,US Approved Rx 1967,NDA050007,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050007,Bartonellosis; Periodontitis; Campylobacter fetus infections; Campylobacter fetus infections; Granuloma inguinale; Rocky Mountain spotted fever; Typhus fever; Bartonellosis,Approved; Approved; Approved; Approved; Approved; Approved; Approved; Approved
DOXYLAMINE,469-21-6,https://drugs.ncats.io/drug/95QB77JKPL,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""469%2021%206"")",ONLY CAS,US Approved OTC ,21 CFR 341.12(h) cough/cold:antihistamine doxylamine succinate,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec341-12.xml,US Previously Marketed 1948,DECAPRYN by SANOFI AVENTIS US,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=006412,Insomnia; Allergic rhinitis,Approved; Approved
DRONABINOL,1972-08-3,https://drugs.ncats.io/drug/7J8897W37S,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1972%2008%203"")",ONLY CAS,US Approved Rx 1985,NDA018651,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018651,US Approved Rx 1985,NDA018651,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018651,Anorexia in AIDS; Nausea in cancer chemotherapy; Vomiting in cancer chemotherapy,Approved; Approved; Approved
DRONEDARONE,141626-36-0,https://drugs.ncats.io/drug/JQZ1L091Y2,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""141626%2036%200"")",ONLY CAS,US Approved Rx 2024,ANDA205904,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205904,US Approved Rx 2009,NDA022425,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022425,Atrial fibrillation; Atrial flutter,Approved; Approved
DROPERIDOL,548-73-2,https://drugs.ncats.io/drug/O9U0F09D5X,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""548%2073%202"")",ONLY CAS,US Approved Rx 1988,ANDA072123,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=072123,US Previously Marketed 1968,INNOVAR by EPIC PHARMA LLC,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016049,Nausea and vomiting associated with surgical and diagnostic procedures,Approved
DROSERA ROTUNDIFOLIA,84696-10-6,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""84696%2010%206"")",ONLY CAS,,,,,,,,
DROSPIRENONE,67392-87-4,https://drugs.ncats.io/drug/N295J34A25,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""67392%2087%204"")",ONLY CAS,US Approved Rx 2012,ANDA201663,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201663,US Approved Rx 2001,NDA021098,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021098,Vulvar and vaginal atrophy symptoms due to menopause; Pregnancy; Vasomotor symptoms due to menopause,Approved; Approved; Approved
DROTRECOGIN ALFA (ACTIVATED),98530-76-8,https://drugs.ncats.io/drug/JGH8MYC891,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""98530%2076%208"")",ONLY CAS,US Previously Marketed 2001,Xigris,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125029,US Previously Marketed 2001,Xigris,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125029,,
DROXIDOPA,23651-95-8,https://drugs.ncats.io/drug/J7A92W69L7,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""23651%2095%208"")",ONLY CAS,US Approved Rx 2018,ANDA210839,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210839,US Approved Rx 1950,NDA007513,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=007513,Hypotension; Cardiac arrest; Systemic inflammatory response syndrome; Neurogenic orthostatic hypotension,Approved; Approved; Phase IV; Approved
DULAGLUTIDE,923950-08-7,https://drugs.ncats.io/drug/WTT295HSY5,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""923950%2008%207"")",ONLY CAS,US Approved Rx 2014,BLA125469,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125469,US Approved Rx 2014,BLA125469,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125469,,
DULOXETINE,116539-59-4,https://drugs.ncats.io/drug/O5TNM5N07U,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""116539%2059%204"")",ONLY CAS,US Approved Rx 2018,ANDA211310,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211310,US Approved Rx 2004,NDA021733,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021733,Fibromyalgia; Major depressive disorder; Generalized anxiety disorder,Approved; Approved; Approved
DUPILUMAB,1190264-60-8,https://drugs.ncats.io/drug/420K487FSG,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1190264%2060%208"")",ONLY CAS,US Approved Rx 2017,BLA761055,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761055,US Approved Rx 2017,BLA761055,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761055,,
DURVALUMAB,1428935-60-7,https://drugs.ncats.io/drug/28X28X9OKV,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1428935%2060%207"")",ONLY CAS,US Approved Rx 2017,BLA761069,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761069,US Approved Rx 2017,BLA761069,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761069,,
DUTASTERIDE,164656-23-9,https://drugs.ncats.io/drug/O0J6XJN02I,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""164656%2023%209"")",ONLY CAS,US Approved Rx 2015,ANDA203118,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203118,US Approved Rx 2001,NDA021319,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021319,Benign prostatic hyperplasia,Approved
DUVELISIB,1201438-56-3,https://drugs.ncats.io/drug/610V23S0JI,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1201438%2056%203"")",ONLY CAS,US Approved Rx 2018,NDA211155,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211155,US Approved Rx 2018,NDA211155,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211155,Relapsed or refractory follicular lymphoma; Relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma,Approved; Approved
DYCLONINE,586-60-7,https://drugs.ncats.io/drug/078A24Q30O,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""586%2060%207"")",ONLY CAS,US Approved OTC ,21 CFR 346.10(e) anorectal:local anesthetic dyclonine hydrochloride,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec346-10.xml,US Previously Marketed 1955,DYCLONE by ASTRAZENECA,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=009925,Friedreich ataxia; Cancer; Sore throat; Pain,Not Provided; Basic research; Approved; Approved
ECALLANTIDE,460738-38-9,https://drugs.ncats.io/drug/5Q6TZN2HNM,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""460738%2038%209"")",ONLY CAS,US Approved Rx 2009,BLA125277,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125277,US Approved Rx 2009,BLA125277,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125277,hereditary angioedema,Approved
ECHINACEA ANGUSTIFOLIA,84696-11-7,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""84696%2011%207"")",ONLY CAS,,,,,,,,
ECHINACEA PURPUREA,90028-20-9,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""90028%2020%209"")",ONLY CAS,,,,,,,,
ECONAZOLE,27220-47-9,https://drugs.ncats.io/drug/6Z1Y2V4A7M,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""27220%2047%209"")",ONLY CAS,US Approved Rx 2013,NDA205175,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205175,US Previously Marketed 1982,SPECTAZOLE by ALVOGEN,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018751,Tinea pedis,Approved
ECOTHIOPATE,6736-03-4,https://drugs.ncats.io/drug/0F350BVT6S,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""6736%2003%204"")",ONLY CAS,US Approved Rx 1960,NDA011963,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=011963,Possibly Marketed Outside US 1959,NDA011963,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e4bb53c7-9061-43fc-878f-dc1b19801bfc,Accommodative esotropia; Open-angle glaucoma,Approved; Approved
ECULIZUMAB,219685-50-4,https://drugs.ncats.io/drug/A3ULP0F556,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""219685%2050%204"")",ONLY CAS,US Approved Rx 2007,BLA125166,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125166,US Approved Rx 2007,BLA125166,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125166,,
EDARAVONE,"89-25-8
19735-89-8",N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""89%2025%208
19735%2089%208"")",ONLY CAS,,,,,,,,
EDETIC ACID,60-00-4,https://drugs.ncats.io/drug/9G34HU7RV0,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""60%2000%204"")",ONLY CAS,US Approved Rx 2023,ANDA216435,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216435,US Previously Marketed 1953,CALCIUM DISODIUM VERSENATE by BAUSCH,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=008922,Heavy metal poisoning; Hypercalcemia; Ventricular arrhythmias associated with digitalis toxicity; Lead encephalopathy; Lead poisoning,Approved; Not Provided; Not Provided; Approved; Approved
EDOXABAN,480449-70-5,https://drugs.ncats.io/drug/NDU3J18APO,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""480449%2070%205"")",ONLY CAS,US Approved Rx 2015,NDA206316,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206316,US Approved Rx 2015,NDA206316,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206316,Nonvalvular atrial fibrillation; Pulmonary embolism; Deep vein thrombosis,Approved; Approved; Approved
EDROPHONIUM,312-48-1,https://drugs.ncats.io/drug/70FP3JLY7N,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""312%2048%201"")",ONLY CAS,US Previously Marketed 1985,ENLON by MYLAN INSTITUTIONAL,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=088873,US Previously Marketed 1951,TENSILON by PAI HOLDINGS PHARM,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=007959,Neuromuscular blockade; Myasthenia gravis,Approved; Approved
EFALIZUMAB,214745-43-4,https://drugs.ncats.io/drug/XX2MN88N5D,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""214745%2043%204"")",ONLY CAS,US Previously Marketed 2003,Raptiva,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125075,US Previously Marketed 2003,Raptiva,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125075,,
EFAVIRENZ,154598-52-4,https://drugs.ncats.io/drug/JE6H2O27P8,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""154598%2052%204"")",ONLY CAS,US Approved Rx 2018,NDA208255,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208255,US Previously Marketed 1998,SUSTIVA by BRISTOL MYERS SQUIBB,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020972,HIV-1 infection,Approved
EFINACONAZOLE,164650-44-6,https://drugs.ncats.io/drug/J82SB7FXWB,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""164650%2044%206"")",ONLY CAS,US Approved Rx 2021,ANDA211969,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211969,US Approved Rx 2014,NDA203567,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203567,Onychomycosis,Approved
EFLORNITHINE,70052-12-9,https://drugs.ncats.io/drug/ZQN1G5V6SR,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""70052%2012%209"")",ONLY CAS,US Approved Rx 2023,NDA215500,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215500,US Previously Marketed 1990,ORNIDYL by SANOFI AVENTIS US,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019879,Facial hirsutism,Approved
EFMOROCTOCOG ALFA,1270012-79-7,https://drugs.ncats.io/drug/7PCM518YLR,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1270012%2079%207"")",ONLY CAS,Possibly Marketed Outside US ,Eloctate by Bioverativ Canada Inc [Canada],https://www.drugbank.ca/drugs/DB11607,Possibly Marketed Outside US 2014,BLA125487,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bec39fa0-1524-4e6b-897f-db0ef093085e,,
EFTRENONACOG ALFA,1270012-74-2,https://drugs.ncats.io/drug/02E00T2QDE,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1270012%2074%202"")",ONLY CAS,Possibly Marketed Outside US ,Alprolix by Bioverativ Canada Inc [Canada],https://www.drugbank.ca/drugs/DB11608,Possibly Marketed Outside US 2014,BLA125444,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2fb3fb92-379d-4683-80d6-b06c0a7dc063,,
ELAGOLIX,834153-87-6,https://drugs.ncats.io/drug/5B2546MB5Z,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""834153%2087%206"")",ONLY CAS,US Approved Rx 2020,NDA213388,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213388,US Approved Rx 2018,NDA210450,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210450,Pain associated with endometriosis; Uterine Fibroids,Approved; Phase III
ELAPEGADEMASE,1709806-75-6,https://drugs.ncats.io/drug/9R3D3Y0UHS,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1709806%2075%206"")",ONLY CAS,US Approved Rx 2018,BLA761092,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761092,US Approved Rx 2018,BLA761092,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761092,,
ELASTIN,9007-58-3,https://drugs.ncats.io/drug/VRC4754D50,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""9007%2058%203"")",ONLY CAS,Possibly Marketed Outside US 2016,"Shampoo for dyed and damaged hair with collagen, lanolin, biotin and arginine Horse Force by Zeldis-farma, Ooo",https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=331c14e9-3b2e-1f4a-e054-00144ff88e88,Possibly Marketed Outside US 2016,"Shampoo for dyed and damaged hair with collagen, lanolin, biotin and arginine Horse Force by Zeldis-farma, Ooo",https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=331c14e9-3b2e-1f4a-e054-00144ff88e88,,
ELBASVIR,1370468-36-2,https://drugs.ncats.io/drug/632L571YDK,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1370468%2036%202"")",ONLY CAS,US Approved Rx 2016,NDA208261,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208261,US Approved Rx 2016,NDA208261,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208261,Chronic hepatitis C,Approved
ELECTROLYTE SOLUTIONS,7664-93-9,https://drugs.ncats.io/drug/O40UQP6WCF,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""7664%2093%209"")",ONLY CAS,US Approved Rx 2023,ANDA215469,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215469,US Previously Marketed 1921,Potassium Sulphate N.F.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,Bowel Cleanser,Approved
ELETRIPTAN,143322-58-1,https://drugs.ncats.io/drug/22QOO9B8KI,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""143322%2058%201"")",ONLY CAS,US Approved Rx 2002,NDA021016,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021016,US Approved Rx 2002,NDA021016,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021016,Migraine,Approved
ELETTARIA CARDAMOMUM,977005-95-0,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""977005%2095%200"")",ONLY CAS,,,,,,,,
ELIGLUSTAT,491833-29-5,https://drugs.ncats.io/drug/DR40J4WA67,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""491833%2029%205"")",ONLY CAS,US Approved Rx 2023,ANDA212420,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212420,US Approved Rx 2014,NDA205494,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205494,Gaucher's disease type I,Approved
ELOSULFASE ALFA,9025-60-9,https://drugs.ncats.io/drug/ODJ69JZG85,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""9025%2060%209"")",ONLY CAS,US Approved Rx 2014,BLA125460,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125460,US Approved Rx 2014,BLA125460,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125460,,
ELOTUZUMAB,915296-00-3,https://drugs.ncats.io/drug/1351PE5UGS,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""915296%2000%203"")",ONLY CAS,US Approved Rx 2015,BLA761035,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761035,US Approved Rx 2015,BLA761035,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761035,,
ELTROMBOPAG,496775-61-2,https://drugs.ncats.io/drug/S56D65XJ9G,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""496775%2061%202"")",ONLY CAS,US Approved Rx 2008,NDA022291,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022291,US Approved Rx 2008,NDA022291,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022291,Immune thrombocytopenia; Severe aplastic anemia,Approved; Approved
ELUXADOLINE,864821-90-9,https://drugs.ncats.io/drug/45TPJ4MBQ1,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""864821%2090%209"")",ONLY CAS,US Approved Rx 2021,ANDA213613,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213613,US Approved Rx 2015,NDA206940,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206940,Irritable bowel syndrome with diarrhea,Approved
ELVITEGRAVIR,697761-98-1,https://drugs.ncats.io/drug/4GDQ854U53,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""697761%2098%201"")",ONLY CAS,US Approved Rx 2015,NDA207561,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207561,US Approved Rx 2012,NDA203100,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203100,HIV-1 infection,Approved
EMAPALUMAB,1709815-23-5,https://drugs.ncats.io/drug/3S252O2Z4X,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1709815%2023%205"")",ONLY CAS,US Approved Rx 2018,BLA761107,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761107,US Approved Rx 2018,BLA761107,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761107,,
EMEDASTINE,87233-61-2,https://drugs.ncats.io/drug/9J1H7Y9OJV,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""87233%2061%202"")",ONLY CAS,US Previously Marketed 1997,EMADINE by NOVARTIS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020706,US Previously Marketed 1997,EMADINE by NOVARTIS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020706,Allergic conjunctivitis,Approved
EMICIZUMAB,1610943-06-0,https://drugs.ncats.io/drug/7NL2E3F6K3,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1610943%2006%200"")",ONLY CAS,US Approved Rx 2017,BLA761083,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761083,US Approved Rx 2017,BLA761083,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761083,,
EMOLLIENT,56-81-5,https://drugs.ncats.io/drug/PDC6A3C0OX,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""56%2081%205"")",ONLY CAS,US Approved OTC ,21 CFR 347.10(h) skin protectant glycerin,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec347-10.xml,US Previously Marketed 1921,Glycerin U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,Dry skin or hair,Approved
EMPAGLIFLOZIN,864070-44-0,https://drugs.ncats.io/drug/HDC1R2M35U,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""864070%2044%200"")",ONLY CAS,US Approved Rx 2020,NDA212614,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212614,US Approved Rx 2014,NDA204629,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204629,Type 2 diabetes mellitus,Approved
EMTRICITABINE,143491-57-0,https://drugs.ncats.io/drug/G70B4ETF4S,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""143491%2057%200"")",ONLY CAS,US Approved Rx 2023,ANDA079188,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=079188,US Approved Rx 2003,NDA021500,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021500,HIV-1 infection,Approved
ENALAPRIL,75847-73-3,https://drugs.ncats.io/drug/69PN84IO1A,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""75847%2073%203"")",ONLY CAS,US Approved Rx 2001,ANDA075727,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=075727,US Approved Rx 1985,NDA018998,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018998,Hypertension; Asymptomatic left ventricular dysfunction; Heart failure,Approved; Approved; Approved
ENALAPRILAT,76420-72-9,https://drugs.ncats.io/drug/Q508Q118JM,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""76420%2072%209"")",ONLY CAS,US Approved Rx 2001,ANDA075727,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=075727,US Approved Rx 1985,NDA018998,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018998,Hypertension; Asymptomatic left ventricular dysfunction; Heart failure,Approved; Approved; Approved
ENASIDENIB,1446502-11-9,https://drugs.ncats.io/drug/3T1SS4E7AG,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1446502%2011%209"")",ONLY CAS,US Approved Rx 2017,NDA209606,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209606,US Approved Rx 2017,NDA209606,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209606,Acute myeloid leukemia; acute myeloid leukemia,Phase III; Approved
ENCORAFENIB,1269440-17-6,https://drugs.ncats.io/drug/8L7891MRB6,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1269440%2017%206"")",ONLY CAS,US Approved Rx 2018,NDA210496,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210496,US Approved Rx 2018,NDA210496,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210496,Melanoma; Metastatic colorectal cancer; Relapsed or refractory multiple myeloma,Approved; Phase III; Phase II
ENFLURANE,13838-16-9,https://drugs.ncats.io/drug/91I69L5AY5,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""13838%2016%209"")",ONLY CAS,US Previously Marketed 1987,ENFLURANE by ABBOTT,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=070803,US Previously Marketed 1972,ETHRANE by BAXTER HLTHCARE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017087,Pain,Approved
ENFUVIRTIDE,159519-65-0,https://drugs.ncats.io/drug/19OWO1T3ZE,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""159519%2065%200"")",ONLY CAS,US Approved Rx 2003,NDA021481,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021481,US Approved Rx 2003,NDA021481,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021481,HIV-1 infection,Approved
ENOXACIN,74011-58-8,https://drugs.ncats.io/drug/325OGW249P,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""74011%2058%208"")",ONLY CAS,US Previously Marketed 1991,PENETREX by SANOFI AVENTIS US,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019616,US Previously Marketed 1991,PENETREX by SANOFI AVENTIS US,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019616,"Uncomplicated urethral or cervical gonorrhea due to Neisseria gonorrhoeae.; Complicated urinary tract infections; Uncomplicated urinary tract infections (cystitis) due to Escherichia coli, Staphylococcus epidermidis, or Staphylococcus saprophyticus",Approved; Approved; Approved
ENOXAPARIN SODIUM,679809-58-6,https://drugs.ncats.io/drug/8NZ41MIK1O,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""679809%2058%206"")",ONLY CAS,US Approved Rx 2014,ANDA076726,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=076726,US Approved Rx 1993,NDA020164,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020164,Deep vein thrombosis; Myocardial infarction; Unstable angina,Approved; Approved; Approved
ENOXOLONE,471-53-4,https://drugs.ncats.io/drug/P540XA09DR,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""471%2053%204"")",ONLY CAS,US Previously Marketed 1921,Ammoniated Glycyrrhizin U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,US Previously Marketed 1921,Ammoniated Glycyrrhizin U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,Hepatitis B; Autoimmune hepatitis; Chronic hepatitis C; Chronic hepatitis C; Erythema; Cardiomyopathy; Autoimmune hepatitis; Ovarian cancer; Radiodermatitis; Leukemia; Unknown; Unknown; Inflammation,Not Provided; Phase I; Not Provided; Approved; Phase I; Preclinical; Phase I; Basic research; Basic research; Basic research; Basic research
ENROFLOXACIN,93106-60-6,https://drugs.ncats.io/drug/3DX3XEK1BN,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""93106%2060%206"")",ONLY CAS,Possibly Marketed Outside US ,Canada:ENROFLOXACIN,https://tripod.nih.gov/npc/#Download,Possibly Marketed Outside US 1988,NADA140441,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e6228e80-a92a-4c24-8a0b-10bd0aff53db,Bacterial infections,Approved
ENTACAPONE,130929-57-6,https://drugs.ncats.io/drug/4975G9NM6T,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""130929%2057%206"")",ONLY CAS,US Approved Rx 2017,ANDA207210,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207210,US Approved Rx 1999,NDA020796,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020796,Parkinson's disease,Approved
ENTECAVIR,142217-69-4,https://drugs.ncats.io/drug/NNU2O4609D,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""142217%2069%204"")",ONLY CAS,US Approved Rx 2018,ANDA208721,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208721,US Approved Rx 2005,NDA021798,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021798,Hepatitis B,Approved
ENZALUTAMIDE,915087-33-1,https://drugs.ncats.io/drug/93T0T9GKNU,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""915087%2033%201"")",ONLY CAS,US Approved Rx 2020,NDA213674,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213674,US Approved Rx 2012,NDA203415,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203415,Castrate-resistant prostate cancer,Approved
EPHEDRINE,299-42-3,https://drugs.ncats.io/drug/GN83C131XS,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""299%2042%203"")",ONLY CAS,US Approved OTC ,21 CFR 341.20(b)(3) cough/cold:nasal decongestant ephedrine hydrochloride,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec341-20.xml,US Previously Marketed 1928,Ephetonine by Merck,https://www.google.com/books/edition/American_Journal_of_Pharmacy/NEAfAQAAIAAJ?hl=en&gbpv=1&bsq=ephetonine&dq=ephetonine&printsec=frontcover,Anesthesia-induced hypotension,Approved
EPIGALLOCATECHIN GALLATE,989-51-5,https://drugs.ncats.io/drug/BQM438CTEL,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""989%2051%205"")",ONLY CAS,Possibly Marketed Outside US 2023,21 CFR 341,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=00f8f724-87bc-e3f5-e063-6394a90a2eed,Possibly Marketed Outside US 2012,BabySpaShea Butter Diaper by EXPRO3 LLC,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=15c9f3c4-833a-4211-a0d0-31e754e7fb9f,Multiple sclerosis; Multiple system atrophy; Duchenne muscular dystrophy,Phase III; Phase III; Phase III
EPINASTINE,80012-43-7,https://drugs.ncats.io/drug/Q13WX941EF,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""80012%2043%207"")",ONLY CAS,US Approved Rx 2011,ANDA090870,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=090870,US Previously Marketed 2003,ELESTAT by ALLERGAN,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021565,Allergic conjunctivitis,Approved
EPINEPHRINE,51-43-4,https://drugs.ncats.io/drug/YKH834O4BH,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""51%2043%204"")",ONLY CAS,US Approved OTC ,21 CFR 346.12(c) anorectal:vasoconstrictor epinephrine hydrochloride,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec346-12.xml,US Previously Marketed 1901,Adrenalin by Parke Davis,https://babel.hathitrust.org/cgi/pt?id=mdp.39015064545372&view=1up&seq=65,Miosis; Anaphylaxis,Approved; Approved
EPIRUBICIN,56420-45-2,https://drugs.ncats.io/drug/3Z8479ZZ5X,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""56420%2045%202"")",ONLY CAS,US Approved Rx 2009,ANDA090163,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=090163,US Approved Rx 1999,NDA050778,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050778,Primary breast cancer,Approved
EPLERENONE,107724-20-9,https://drugs.ncats.io/drug/6995V82D0B,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""107724%2020%209"")",ONLY CAS,US Approved Rx 2018,ANDA208283,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208283,US Approved Rx 2002,NDA021437,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021437,Hypertension,Approved
EPOETIN ALFA,11096-26-7,https://drugs.ncats.io/drug/64FS3BFH5W,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""11096%2026%207"")",ONLY CAS,US Approved Rx 2018,BLA125545,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125545,US Approved Rx 1989,BLA103234,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103234,,
EPOETIN ZETA,11096-26-7,https://drugs.ncats.io/drug/64FS3BFH5W,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""11096%2026%207"")",ONLY CAS,US Approved Rx 2018,BLA125545,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125545,US Approved Rx 1989,BLA103234,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103234,,
EPOPROSTENOL,35121-78-9,https://drugs.ncats.io/drug/DCR9Z582X0,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""35121%2078%209"")",ONLY CAS,US Approved Rx 2008,NDA022260,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022260,US Approved Rx 1995,NDA020444,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020444,Primary pulmonary hypertension,Approved
EPROSARTAN,133040-01-4,https://drugs.ncats.io/drug/2KH13Z0S0Y,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""133040%2001%204"")",ONLY CAS,US Previously Marketed 2001,TEVETEN HCT by ABBVIE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021268,US Previously Marketed 1997,TEVETEN by ABBVIE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020738,Hypertension,Approved
EPTIFIBATIDE,188627-80-7,https://drugs.ncats.io/drug/NA8320J834,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""188627%2080%207"")",ONLY CAS,US Approved Rx 2015,ANDA206127,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206127,US Previously Marketed 1998,INTEGRILIN by MSD SUB MERCK,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020718,Acute coronary syndrome,Approved
EQUISETUM ARVENSE,71011-23-9,https://drugs.ncats.io/drug/9bafb98f,2,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""71011%2023%209"")%20AND%20(root_names_name:""%5EEQUISETUM%20ARVENSE"")",APPROXIMATE NAME,,,,,,,,
ERAVACYCLINE,1207283-85-9,https://drugs.ncats.io/drug/07896928ZC,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1207283%2085%209"")",ONLY CAS,US Approved Rx 2018,NDA211109,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211109,US Approved Rx 2018,NDA211109,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211109,Intra-abdominal infections,Approved
ERENUMAB,1582205-90-0,https://drugs.ncats.io/drug/I5I8VB78VT,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1582205%2090%200"")",ONLY CAS,US Approved Rx 2018,BLA761077,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761077,US Approved Rx 2018,BLA761077,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761077,,
ERGOCALCIFEROL,50-14-6,https://drugs.ncats.io/drug/VS041H42XC,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""50%2014%206"")",ONLY CAS,US Approved Rx 1941,NDA003444,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=003444,US Approved Rx 1941,NDA003444,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=003444,Hypoparathyroidism; Familial hypophosphatemia; Refractory rickets,Approved; Approved; Approved
ERGOMETRINE,60-79-7,https://drugs.ncats.io/drug/WH41D8433D,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""60%2079%207"")",ONLY CAS,US Previously Marketed 1959,TACE 25 MG ERGONOVINE by MERRELL,https://www.govinfo.gov/content/pkg/FR-1998-12-17/pdf/98-33453.pdf,US Previously Marketed 1959,TACE 25 MG ERGONOVINE by MERRELL,https://www.govinfo.gov/content/pkg/FR-1998-12-17/pdf/98-33453.pdf,Postpartum haemorrhage; Postabortion haemorrhage,Approved; Approved
ERGOTAMINE,379-79-3,https://drugs.ncats.io/drug/MRU5XH3B48,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""379%2079%203"")",ONLY CAS,US Approved Rx 1983,ANDA086557,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=086557,US Previously Marketed 1948,CAFERGOT by NOVARTIS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=006620,Migraine; Migraine; Migraine,Approved; Approved; Approved
ERIBULIN,253128-41-5,https://drugs.ncats.io/drug/LR24G6354G,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""253128%2041%205"")",ONLY CAS,US Approved Rx 2010,NDA201532,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201532,US Approved Rx 2010,NDA201532,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201532,Breast Cancer,Approved
ERLOTINIB,183321-74-6,https://drugs.ncats.io/drug/J4T82NDH7E,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""183321%2074%206"")",ONLY CAS,US Approved Rx 2014,ANDA091002,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=091002,US Previously Marketed 2004,TARCEVA by OSI PHARMS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021743,"Locally advanced or metastatic non-small cell lung cancer; Locally advanced, unresectable or metastatic pancreatic cancer",Approved; Approved
ERTAPENEM,153832-46-3,https://drugs.ncats.io/drug/G32F6EID2H,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""153832%2046%203"")",ONLY CAS,US Approved Rx 2018,ANDA208790,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208790,US Approved Rx 2001,NDA021337,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021337,"Complicated intra-abdominal infections; Complicated skin and skin structure infections; Community acquired pneumonia; Complicated urinary tract infections including pyelonephritis; Acute pelvic infections including postpartum endomyometritis, septic abortion and post surgical gynecologic infections",Approved; Approved; Approved; Approved; Approved
ERTUGLIFLOZIN,1210344-57-2,https://drugs.ncats.io/drug/6C282481IP,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1210344%2057%202"")",ONLY CAS,US Approved Rx 2017,NDA209806,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209806,US Approved Rx 2017,NDA209806,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209806,Type 2 diabetes mellitus; type 2 diabetes mellitus,Phase III; Approved
ERYTHROMYCIN,643-22-1,https://drugs.ncats.io/drug/LXW024X05M,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""643%2022%201"")",ONLY CAS,US Approved Rx 2020,ANDA212015,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212015,US Previously Marketed 1952,Ilotycin by Lilly,DeHaen 1940-1975 NMEs,Acne; Pneumonia; Bacterial endocarditis; Staphylococcal dermatitis; Listeriosis; Diphtheria; Respiratory tract infections; Skin and skin structure infections; Erythrasma; Diphtheria; Skin and skin structure infections; Respiratory tract infections; Listeriosis; Erythrasma,Approved; Approved; Approved; Approved; Approved; Approved; Approved; Approved; Approved; Approved; Approved; Approved; Approved; Approved
ESCITALOPRAM,128196-01-0,https://drugs.ncats.io/drug/4O4S742ANY,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""128196%2001%200"")",ONLY CAS,US Approved Rx 2002,NDA021323,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021323,US Approved Rx 2002,NDA021323,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021323,Generalized anxiety disorder; Major depressive disorder,Approved; Approved
ESKETAMINE,33643-46-8,https://drugs.ncats.io/drug/50LFG02TXD,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""33643%2046%208"")",ONLY CAS,US Approved Rx 2019,NDA211243,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211243,Possibly Marketed Outside US 1970,NDA211243,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d81a6a79-a74a-44b7-822c-0dfa3036eaed,,
ESLICARBAZEPINE ACETATE,236395-14-5,https://drugs.ncats.io/drug/BEA68ZVB2K,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""236395%2014%205"")",ONLY CAS,US Approved Rx 2023,ANDA211236,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211236,US Approved Rx 2013,NDA022416,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022416,Partial-onset seizures,Approved
ESMOLOL,81147-92-4,https://drugs.ncats.io/drug/MDY902UXSR,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""81147%2092%204"")",ONLY CAS,US Approved Rx 2022,ANDA214172,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214172,US Approved Rx 1986,NDA019386,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019386,Supraventricular tachycardia; Noncompensatory sinus tachycardia,Approved; Approved
ESOMEPRAZOLE,119141-88-7,https://drugs.ncats.io/drug/N3PA6559FT,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""119141%2088%207"")",ONLY CAS,US Approved Rx 2020,ANDA212866,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212866,Possibly Marketed Outside US 1989,ANDA078003,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1f0ba9c8-e5f2-4d65-a0e3-19a6541a03b5,Heartburn,Approved
ESTAZOLAM,29975-16-4,https://drugs.ncats.io/drug/36S3EQV54C,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""29975%2016%204"")",ONLY CAS,US Approved Rx 1997,ANDA074826,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=074826,US Previously Marketed 1990,PROSOM by ABBOTT,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019080,Insomnia,Approved
ESTRADIOL,17916-67-5,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""17916%2067%205"")",ONLY CAS,,,,,,,,
ESTRAMUSTINE,2998-57-4,https://drugs.ncats.io/drug/35LT29625A,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""2998%2057%204"")",ONLY CAS,US Approved Rx 1981,NDA018045,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018045,US Approved Rx 1981,NDA018045,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018045,Carcinoma of the prostate,Approved
ESTRIOL,50-27-1,https://drugs.ncats.io/drug/FB33469R8E,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""50%2027%201"")",ONLY CAS,Possibly Marketed Outside US ,WHO-ATC:G03CA04,https://ginas.ncats.nih.gov/ginas/app/substance/FB33469R8E,Possibly Marketed Outside US 2012,NADA141325,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9b6e29b3-7286-4408-9a44-7d8589d1d958,Urinary tract infections; Atrophic vaginitis; Genital prolapse,Phase IV; Phase III; Phase IV
ESTROGENIC SUBSTANCE,53-16-7,https://drugs.ncats.io/drug/2DI9HA706A,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""53%2016%207"")",ONLY CAS,US Approved Rx 1977,ANDA083220,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=083220,US Previously Marketed 1931,Theelin by Parke Davis,https://en.wikipedia.org/wiki/Estrone_(medication),Endometrial hyperplasia/carcinoma; Menopausal and postmenopausal disorder; Ovarian diseases; Precocious puberty; Amenorrhea; Infertility; Breast cancer; Prostate cancer; Obesity; Endometrial cancer; Benign breast disease; Premenstrual syndrome; Menopausal and postmenopausal disorders,Approved; Approved; Natural Metabolite; Natural Metabolite; Natural Metabolite; Natural Metabolite; Natural Metabolite; Natural Metabolite; Natural Metabolite; Natural Metabolite; Natural Metabolite; Phase III; Approved
ESTROGENIC SUBSTANCES- CONJUGATED,12126-59-9,https://drugs.ncats.io/drug/IU5QR144QX,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""12126%2059%209"")",ONLY CAS,US Approved Rx 2003,NDA021417,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021417,US Approved Rx 1942,NDA004782,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=004782,,
ESTRONE,53-16-7,https://drugs.ncats.io/drug/2DI9HA706A,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""53%2016%207"")",ONLY CAS,US Approved Rx 1977,ANDA083220,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=083220,US Previously Marketed 1931,Theelin by Parke Davis,https://en.wikipedia.org/wiki/Estrone_(medication),Endometrial hyperplasia/carcinoma; Menopausal and postmenopausal disorder; Ovarian diseases; Precocious puberty; Amenorrhea; Infertility; Breast cancer; Prostate cancer; Obesity; Endometrial cancer; Benign breast disease; Premenstrual syndrome; Menopausal and postmenopausal disorders,Approved; Approved; Natural Metabolite; Natural Metabolite; Natural Metabolite; Natural Metabolite; Natural Metabolite; Natural Metabolite; Natural Metabolite; Natural Metabolite; Natural Metabolite; Phase III; Approved
ESZOPICLONE,138729-47-2,https://drugs.ncats.io/drug/UZX80K71OE,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""138729%2047%202"")",ONLY CAS,US Approved Rx 2015,ANDA202929,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202929,US Approved Rx 2004,NDA021476,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021476,Insomnia,Approved
ETACRYNIC ACID,58-54-8,https://drugs.ncats.io/drug/M5DP350VZV,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""58%2054%208"")",ONLY CAS,US Approved Rx 2019,ANDA211232,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211232,US Approved Rx 1967,NDA016093,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016093,Nephrotic syndrome; Congestive heart failure,Approved; Approved
ETANERCEPT,185243-69-0,https://drugs.ncats.io/drug/OP401G7OJC,7,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""185243%2069%200"")%20AND%20(root_names_name:""%5EETANERCEPT$"")",EXACT NAME,US Approved Rx 1998,BLA103795,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103795,US Approved Rx 1998,BLA103795,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103795,,
ETELCALCETIDE,1262780-97-1,https://drugs.ncats.io/drug/60ME133FJB,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1262780%2097%201"")",ONLY CAS,US Approved Rx 2017,NDA208325,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208325,US Approved Rx 2017,NDA208325,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208325,Secondary hyperparathyroidism in adult patients with chronic kidney disease on hemodialysis,Approved
ETEPLIRSEN,1173755-55-9,https://drugs.ncats.io/drug/AIW6036FAS,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1173755%2055%209"")",ONLY CAS,US Approved Rx 2016,NDA206488,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206488,US Approved Rx 2016,NDA206488,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206488,,
ETHAMBUTOL,74-55-5,https://drugs.ncats.io/drug/8G167061QZ,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""74%2055%205"")",ONLY CAS,US Approved Rx 1999,ANDA075095,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=075095,US Approved Rx 1967,NDA016320,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016320,Pulmonary tuberculosis,Approved
ETHANOL,443-48-1,https://drugs.ncats.io/drug/140QMO216E,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""443%2048%201"")",ONLY CAS,US Approved Rx 2016,ANDA208162,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208162,US Previously Marketed 1963,FLAGYL by PFIZER,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=012623,Anaerobic bacterial infections; Trichomoniasis; Acute intestinal amebiasis,Approved; Approved; Approved
ETHANOLAMINE,141-43-5,https://drugs.ncats.io/drug/5KV86114PT,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""141%2043%205"")",ONLY CAS,Possibly Marketed Outside US 2008,NDA022032,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b6c87a6a-253a-4455-9b7d-62f506da592e,Possibly Marketed Outside US 1980,NADA113232,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d14180ed-329c-464a-a9ac-b7bbf3d59536,Myocardial ischemia,Preclinical
ETHCHLORVYNOL,113-18-8,https://drugs.ncats.io/drug/6EIM3851UZ,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""113%2018%208"")",ONLY CAS,US Previously Marketed 1961,PLACIDYL by ABBVIE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=010021,US Previously Marketed 1955,Placidyl by Abbott,OB NME Appendix 1950-1985,Insomnia,Approved
ETHINYLESTRADIOL,57-63-6,https://drugs.ncats.io/drug/423D2T571U,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""57%2063%206"")",ONLY CAS,US Approved Rx 1992,ANDA072693,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=072693,US Previously Marketed 1943,ESTINYL by SCHERING,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=005292,Pregnancy,Approved
ETHIONAMIDE,536-33-4,https://drugs.ncats.io/drug/OAY8ORS3CQ,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""536%2033%204"")",ONLY CAS,US Approved Rx 1965,NDA013026,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=013026,US Approved Rx 1965,NDA013026,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=013026,Tuberculosis,Approved
ETHOSUXIMIDE,77-67-8,https://drugs.ncats.io/drug/5SEH9X1D1D,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""77%2067%208"")",ONLY CAS,US Approved Rx 2012,ANDA200892,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=200892,US Approved Rx 1960,NDA012380,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=012380,Absence epilepsy,Approved
ETHOTOIN,86-35-1,https://drugs.ncats.io/drug/46QG38NC4U,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""86%2035%201"")",ONLY CAS,US Previously Marketed 1957,PEGANONE by RECORDATI RARE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=010841,US Previously Marketed 1957,PEGANONE by RECORDATI RARE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=010841,Epilepsy,Approved
ETHYLENE GLYCOL,107-21-1,https://drugs.ncats.io/drug/FC72KVT52F,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""107%2021%201"")",ONLY CAS,Possibly Marketed Outside US 2020,21 CFR 333A,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ada16013-e7cc-2f13-e053-2995a90ae1e3,Possibly Marketed Outside US 2003,NDA021385,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=821073f7-33f6-464d-baed-f66d97987d6d,,
ETIDOCAINE,36637-18-0,https://drugs.ncats.io/drug/I6CQM0F31V,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""36637%2018%200"")",ONLY CAS,US Previously Marketed 1976,DURANEST by DENTSPLY PHARM,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021384,US Previously Marketed 1976,DURANEST by DENTSPLY PHARM,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021384,Pain,Approved
ETIDRONIC ACID,2809-21-4,https://drugs.ncats.io/drug/M2F465ROXU,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""2809%2021%204"")",ONLY CAS,US Previously Marketed 1987,DIDRONEL by MGI PHARMA INC,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019545,Possibly Marketed Outside US 1965,M006,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=89577417-76a0-cb04-e053-2995a90a5733,Heterotopic ossification; Paget’s disease of bone,Approved; Approved
ETODOLAC,41340-25-4,https://drugs.ncats.io/drug/2M36281008,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""41340%2025%204"")",ONLY CAS,US Approved Rx 2000,ANDA075665,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=075665,US Previously Marketed 1991,LODINE by WYETH PHARMS INC,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018922,Osteoarthritis; Acute pain; Rheumatoid arthritis,Approved; Approved; Approved
ETOMIDATE,33125-97-2,https://drugs.ncats.io/drug/Z22628B598,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""33125%2097%202"")",ONLY CAS,US Approved Rx 2016,ANDA202354,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202354,US Approved Rx 1982,NDA018227,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018227,Pain,Approved
ETONOGESTREL,54048-10-1,https://drugs.ncats.io/drug/304GTH6RNH,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""54048%2010%201"")",ONLY CAS,US Approved Rx 2001,NDA021187,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021187,US Approved Rx 2001,NDA021187,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021187,Pregnancy,Approved
ETOPOSIDE,33419-42-0,https://drugs.ncats.io/drug/6PLQ3CP4P3,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""33419%2042%200"")",ONLY CAS,US Approved Rx 1998,ANDA074983,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=074983,US Previously Marketed 1983,VEPESID by CORDEN PHARMA,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018768,Refractory testicular tumors; Small-cell lung cancer,Approved; Approved
ETOPOSIDE PHOSPHATE,117091-64-2,https://drugs.ncats.io/drug/528XYJ8L1N,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""117091%2064%202"")",ONLY CAS,US Approved Rx 1998,ANDA074983,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=074983,US Previously Marketed 1983,VEPESID by CORDEN PHARMA,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018768,Refractory testicular tumors; Small-cell lung cancer,Approved; Approved
ETRAVIRINE,269055-15-4,https://drugs.ncats.io/drug/0C50HW4FO1,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""269055%2015%204"")",ONLY CAS,US Approved Rx 2022,ANDA215402,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215402,US Approved Rx 2008,NDA022187,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022187,HIV-1 infection,Approved
ETYNODIOL,1231-93-2,https://drugs.ncats.io/drug/9E01C36A9S,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1231%2093%202"")",ONLY CAS,US Approved Rx 2018,ANDA209547,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209547,US Previously Marketed 1966,OVULEN by GD SEARLE LLC,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016029,Pregnancy,Approved
EUGENOL,97-53-0,https://drugs.ncats.io/drug/3T8H1794QW,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""97%2053%200"")",ONLY CAS,US Approved Allergenic Extract 1994,BLA103738,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2f082b68-dc74-418a-9e6f-b3c285b41d44,US Previously Marketed 1921,Eugenol U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,Toothache,Approved
EUPATORIUM PERFOLIATUM,84625-35-4,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""84625%2035%204"")",ONLY CAS,,,,,,,,
EVENING PRIMROSE OIL,308064-97-3,https://drugs.ncats.io/drug/3Q9L08K71N,2,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""308064%2097%203"")%20AND%20(root_names_name:""%5EEVENING%20PRIMROSE%20OIL$"")",EXACT NAME,Possibly Marketed Outside US ,Evening Primrose Oil With Vitamin E by Ashbury Research Corporation [Canada],https://www.drugbank.ca/drugs/DB11358,Possibly Marketed Outside US 2001,21 CFR 352,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6ba437d1-d96f-4235-bebf-611eb09ea11d,,
EVEROLIMUS,159351-69-6,https://drugs.ncats.io/drug/9HW64Q8G6G,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""159351%2069%206"")",ONLY CAS,US Approved Rx 2021,ANDA205426,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205426,US Approved Rx 2009,NDA022334,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022334,"Advanced hormone receptor-positive, HER2­ negative breast cancer; Neuroendocrine tumors; Advanced renal cell carcinoma",Approved; Approved; Approved
EVODIA,1180-71-8,https://drugs.ncats.io/drug/L0F260866S,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1180%2071%208"")",ONLY CAS,,,,,,,Neuroblastoma; HIV-1 infection; Colon cancer,Basic research; Basic research; Basic research
EVOLOCUMAB,1256937-27-5,https://drugs.ncats.io/drug/LKC0U3A8NJ,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1256937%2027%205"")",ONLY CAS,US Approved Rx 2015,BLA125522,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125522,US Approved Rx 2015,BLA125522,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125522,,
EXEMESTANE,107868-30-4,https://drugs.ncats.io/drug/NY22HMQ4BX,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""107868%2030%204"")",ONLY CAS,US Approved Rx 2020,ANDA213547,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213547,US Approved Rx 1999,NDA020753,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020753,Estrogen-receptor positive early breast cancer; Advanced breast cancer in postmenopausal women,Approved; Approved
EXENATIDE,141758-74-9,https://drugs.ncats.io/drug/9P1872D4OL,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""141758%2074%209"")",ONLY CAS,US Approved Rx 2005,NDA021773,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021773,US Approved Rx 2005,NDA021773,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021773,Type 2 diabetes mellitus,Approved
EYE CREAM,58-61-7,https://drugs.ncats.io/drug/K72T3FS567,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""58%2061%207"")",ONLY CAS,US Approved Rx 2005,ANDA077133,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=077133,US Previously Marketed 1976,VIRA-A by PARKEDALE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050486,Keratoconjunctivitis; Epithelial keratitis; Herpes simplex infection; Paroxysmal supraventricular tachycardia,Approved; Approved; Phase III; Approved
EZETIMIBE,163222-33-1,https://drugs.ncats.io/drug/EOR26LQQ24,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""163222%2033%201"")",ONLY CAS,US Approved Rx 2022,ANDA210859,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210859,US Approved Rx 2002,NDA021445,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021445,Homozygous familial sitosterolemia; Homozygous familial hypercholesterolemia; Hyperlipidemia,Approved; Approved; Approved
FACIAL CLEANSER,69-72-7,https://drugs.ncats.io/drug/O414PZ4LPZ,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""69%2072%207"")",ONLY CAS,US Approved OTC ,21 CFR 358.110(b) wart remover:collodoin-like vehicle salicylic acid,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec358-110.xml,US Previously Marketed 1860,sodium salicylate,https://catalog.hathitrust.org/Record/100782317,Psoriasis; Ichthyosis vulgaris; Keratosis palmaris; Bruises; Arthritis; Strains and sprains; Simple backache,Approved; Approved; Approved; Approved; Approved; Approved; Approved
FACTOR VII,56283-52-4,https://drugs.ncats.io/drug/D7DS8XY15Y,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""56283%2052%204"")",ONLY CAS,,,,,,,,
FACTOR VIII,17493-86-6,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""17493%2086%206"")",ONLY CAS,,,,,,,,
FACTOR VIII INHIBITOR BYPASSING FRACTION,78690-39-8,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""78690%2039%208"")",ONLY CAS,,,,,,,,
FACTOR VON WILLEBRAND,109319-16-6,https://drugs.ncats.io/drug/ZE22NE22F1,2,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""109319%2016%206"")",ONLY CAS,Possibly Marketed Outside US ,Humate-P by Csl Behring [Canada],https://www.drugbank.ca/drugs/DB13133,Possibly Marketed Outside US 2009,BLA125251,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a8ef06b8-b041-054e-e58d-fd8a994a8071,,
FACTOR X,64-17-5,https://drugs.ncats.io/drug/3K9958V90M,3,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""64%2017%205"")",ONLY CAS,US Approved Rx 2001,NDA021074,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021074,US Previously Marketed 0652,alcohol,https://en.wikipedia.org/wiki/Alcohol_(drug),Bacterial infections,Approved
FACTOR XIII,97089-56-0,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""97089%2056%200"")",ONLY CAS,,,,,,,,
FAMCICLOVIR,104227-87-4,https://drugs.ncats.io/drug/QIC03ANI02,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""104227%2087%204"")",ONLY CAS,US Approved Rx 1996,NDA020629,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020629,US Previously Marketed 1994,FAMVIR by NOVARTIS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020363,Recurrent herpes labialis,Approved
FAMOTIDINE,76824-35-6,https://drugs.ncats.io/drug/5QZO15J2Z8,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""76824%2035%206"")",ONLY CAS,US Approved Rx 2023,ANDA218181,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218181,US Previously Marketed 1986,PEPCID by BAUSCH,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019462,Duodenal ulcer; Gastric ulcer; Gastroesophageal reflux disease,Approved; Approved; Approved
FAMPRIDINE,504-24-5,https://drugs.ncats.io/drug/BH3B64OKL9,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""504%2024%205"")",ONLY CAS,US Approved Rx 2018,ANDA206863,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206863,US Approved Rx 2010,NDA022250,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022250,Multiple sclerosis,Approved
FAT,57-10-3,https://drugs.ncats.io/drug/2V16EO95H1,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""57%2010%203"")",ONLY CAS,Possibly Marketed Outside US ,"Sha-lem by Shalem Products, Inc.",https://www.drugbank.ca/drugs/DB03796,Possibly Marketed Outside US 1990,21 CFR 358A,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6eef6b11-20c2-4665-a5dd-cce4e790102e,Respiratory distress syndrome in premature infants,Approved
FEBUXOSTAT,144060-53-7,https://drugs.ncats.io/drug/101V0R1N2E,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""144060%2053%207"")",ONLY CAS,US Approved Rx 2021,ANDA212924,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212924,US Approved Rx 2009,NDA021856,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021856,Hyperuricemia in patients with gout,Approved
FELBAMATE,25451-15-4,https://drugs.ncats.io/drug/X72RBB02N8,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""25451%2015%204"")",ONLY CAS,US Approved Rx 2016,ANDA204595,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204595,US Approved Rx 1993,NDA020189,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020189,Epilepsy,Approved
FELODIPINE,72509-76-3,https://drugs.ncats.io/drug/OL961R6O2C,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""72509%2076%203"")",ONLY CAS,US Approved Rx 2018,ANDA210847,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210847,US Previously Marketed 1991,PLENDIL by ASTRAZENECA,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019834,Hypertension,Approved
FENAMISAL,133-11-9,https://drugs.ncats.io/drug/52936SIP7V,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""133%2011%209"")",ONLY CAS,US Previously Marketed 1961,PHENY-PAS-TEBAMIN by PHARM RES ASSOC,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=011695,US Previously Marketed 1959,Pheny-PAS-Tebamin by Purdue Frederick,DeHaen 1940-1975 NMEs,Tuberculosis,Approved
FENBENDAZOLE,43210-67-9,https://drugs.ncats.io/drug/621BVT9M36,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""43210%2067%209"")",ONLY CAS,Possibly Marketed Outside US ,Canada:FENBENDAZOLE,https://tripod.nih.gov/npc/#Download,Possibly Marketed Outside US 1977,NADA128620,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=859d4e30-d70c-4baf-aa62-0d3feff25057,Cancer; Gastrointestinal parasitic disease,Basic research; Approved
FENFLURAMINE,458-24-2,https://drugs.ncats.io/drug/2DS058H2CF,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""458%2024%202"")",ONLY CAS,US Approved Rx 2020,NDA212102,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212102,US Previously Marketed 1973,Pondimin by Robins,OB NME Appendix 1950-1985,Dravet syndrome; Lennox gastaut syndrome; Seizure disorders; Obesity; Epilepsy,Phase III; Phase II; Phase III; Approved; Phase II
FENOFIBRATE,49562-28-9,https://drugs.ncats.io/drug/U202363UOS,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""49562%2028%209"")",ONLY CAS,US Approved Rx 2012,ANDA090715,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=090715,US Previously Marketed 1993,LIPIDIL by ABBVIE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019304,Hypertriglyceridemia; Hypercholesterolemia,Approved; Approved
FENOFIBRIC ACID,42017-89-0,https://drugs.ncats.io/drug/BGF9MN2HU1,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""42017%2089%200"")",ONLY CAS,US Approved Rx 2015,ANDA200920,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=200920,US Approved Rx 2008,NDA022224,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022224,hypertriglyceridemia,Approved
FENOLDOPAM,67227-56-9,https://drugs.ncats.io/drug/INU8H2KAWG,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""67227%2056%209"")",ONLY CAS,US Approved Rx 1997,NDA019922,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019922,US Approved Rx 1997,NDA019922,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019922,Hypertension,Approved
FENOPROFEN,29679-58-1,https://drugs.ncats.io/drug/RA33EAC7KY,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""29679%2058%201"")",ONLY CAS,US Approved Rx 1976,NDA017604,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017604,US Approved Rx 1976,NDA017604,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017604,Rheumatoid arthritis; Pain; Osteoarthritis,Approved; Approved; Approved
FENPROPOREX,16397-28-7,https://drugs.ncats.io/drug/W0194S5FOA,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""16397%2028%207"")",ONLY CAS,Possibly Marketed Outside US ,Lipolin by ICN-Usafarma [Brazil],https://archive.org/details/Pharmaceutical_Manufacturing_Encyclopedia_Vols_12_2nd_Ed,,,,Obesity,Withdrawn
FENTANYL,437-38-7,https://drugs.ncats.io/drug/UF599785JZ,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""437%2038%207"")",ONLY CAS,US Approved Rx 2019,ANDA210762,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210762,US Previously Marketed 1968,INNOVAR by EPIC PHARMA LLC,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016049,Pain,Approved
FERUMOXIDES,119683-68-0,https://drugs.ncats.io/drug/G6N3J05W84,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""119683%2068%200"")",ONLY CAS,US Approved Rx 2009,NDA022180,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022180,Possibly Marketed Outside US 1995,ANDA065520,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e1904c28-8c19-44da-b395-1e4bd08d6122,Acne,Approved
FERUMOXSIL,171544-35-7,https://drugs.ncats.io/drug/6HJV9H13XS,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""171544%2035%207"")",ONLY CAS,US Previously Marketed 1996,GASTROMARK by AMAG PHARMS INC,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020410,US Previously Marketed 1996,GASTROMARK by AMAG PHARMS INC,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020410,,
FERUMOXYTOL,1309-38-2,https://drugs.ncats.io/drug/8bef4e84,2,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1309%2038%202"")%20AND%20(root_names_name:""%5EFERUMOXYTOL$"")",EXACT NAME,,,,,,,,
FESOTERODINE,286930-02-7,https://drugs.ncats.io/drug/621G617227,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""286930%2002%207"")",ONLY CAS,US Approved Rx 2023,ANDA204973,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204973,US Approved Rx 2008,NDA022030,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022030,Overactive bladder; Urinary incontinence; Partial urethral obstruction; Overactive bladder,Approved; Preclinical; Preclinical; Approved
FEXOFENADINE,83799-24-0,https://drugs.ncats.io/drug/E6582LOH6V,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""83799%2024%200"")",ONLY CAS,US Approved Rx 2012,ANDA091567,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=091567,US Previously Marketed 1996,ALLEGRA by CHATTEM SANOFI,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020625,Seasonal allergic rhinitis,Approved
FIBRINOGEN,25878-23-3,https://drugs.ncats.io/drug/82FOM4R7CD,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""25878%2023%203"")",ONLY CAS,,,,,,,,
FIDAXOMICIN,873857-62-6,https://drugs.ncats.io/drug/Z5N076G8YQ,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""873857%2062%206"")",ONLY CAS,US Approved Rx 2024,ANDA208443,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208443,US Approved Rx 2011,NDA201699,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201699,Clostridium difficile-associated diarrhea,Approved
FILGRASTIM,121181-53-1,https://drugs.ncats.io/drug/PVI5M0M1GW,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""121181%2053%201"")",ONLY CAS,US Approved Rx 1991,BLA103353,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103353,US Approved Rx 1991,BLA103353,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103353,,
FINASTERIDE,98319-26-7,https://drugs.ncats.io/drug/57GNO57U7G,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""98319%2026%207"")",ONLY CAS,US Approved Rx 2006,ANDA076511,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=076511,US Approved Rx 1992,NDA020180,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020180,Androgenic alopecia; Benign prostatic hyperplasia,Approved; Approved
FINGOLIMOD,162359-55-9,https://drugs.ncats.io/drug/3QN8BYN5QF,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""162359%2055%209"")",ONLY CAS,US Approved Rx 2022,ANDA208003,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208003,US Approved Rx 2010,NDA022527,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22527,Multiple sclerosis,Approved
FIXATIVES,111-30-8,https://drugs.ncats.io/drug/T3C89M417N,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""111%2030%208"")",ONLY CAS,Possibly Marketed Outside US ,Canada:GLUTARAL,https://tripod.nih.gov/npc/#Download,Possibly Marketed Outside US 1985,Paraguard by Seachem Laboratories Inc.,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=984f46c0-6651-46c6-b5f2-e86b557953c7,Unknown,
FLAVIN-ADENINE DINUCLEOTIDE,146-14-5,https://drugs.ncats.io/drug/ZC44YTI8KK,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""146%2014%205"")",ONLY CAS,Possibly Marketed Outside US ,"BumP DHA by Centurion Labs, LLC",https://www.drugbank.ca/drugs/DB03147,Possibly Marketed Outside US 2011,EnBrace HR by Jaymac Pharma,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6f14fa40-97ab-4ec5-b66b-793d6d1abac9,Vitamin B2 deficiency; Stomatitis; Conjunctivitis,Approved; Approved; Approved
FLAVIN MONONUCLEOTIDE,146-17-8,https://drugs.ncats.io/drug/7N464URE7E,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""146%2017%208"")",ONLY CAS,US Approved Rx 2016,NDA203324,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203324,US Previously Marketed 1947,BEROCCA PN by ROCHE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=006071,Vitamin deficiency; Cerebral infarction; Atherosclerosis,Approved; Approved; Approved
FLAVOCOXID,1206488-21-2,https://drugs.ncats.io/drug/KDQ7F67CVT,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1206488%2021%202"")",ONLY CAS,,,,,,,,
FLAVOXATE,15301-69-6,https://drugs.ncats.io/drug/3E74Y80MEY,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""15301%2069%206"")",ONLY CAS,US Approved Rx 2004,ANDA076831,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=076831,US Previously Marketed 1970,URISPAS by ORTHO MCNEIL JANSSEN,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016769,Urethritis; Prostatitis; Cystitis,Approved; Approved; Approved
FLECAINIDE,54143-55-4,https://drugs.ncats.io/drug/K94FTS1806,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""54143%2055%204"")",ONLY CAS,US Approved Rx 2020,ANDA210683,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210683,US Previously Marketed 1985,TAMBOCOR by ALVOGEN,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018830,Documented ventricular arrhythmias; Paroxysmal atrial fibrillation,Approved; Approved
FLIBANSERIN,167933-07-5,https://drugs.ncats.io/drug/37JK4STR6Z,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""167933%2007%205"")",ONLY CAS,US Approved Rx 2015,NDA022526,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022526,US Approved Rx 2015,NDA022526,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022526,Hypoactive sexual desire disorder,Approved
FLORBETAPIR (18F),956103-76-7,https://drugs.ncats.io/drug/6W15Z5R0RU,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""956103%2076%207"")",ONLY CAS,US Approved Rx 2012,NDA202008,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202008,US Approved Rx 2012,NDA202008,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202008,Alzheimer’s disease,Approved
FLOXURIDINE,50-91-9,https://drugs.ncats.io/drug/039LU44I5M,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""50%2091%209"")",ONLY CAS,US Approved Rx 2001,ANDA075837,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=075837,US Previously Marketed 1970,FUDR by HOSPIRA,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016929,Gastrointestinal adenocarcinoma metastatic to the liver,Approved
FLUCONAZOLE,86386-73-4,https://drugs.ncats.io/drug/8VZV102JFY,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""86386%2073%204"")",ONLY CAS,US Approved Rx 2012,ANDA078698,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=078698,US Previously Marketed 1990,DIFLUCAN IN SODIUM CHLORIDE 0.9% by PFIZER,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019950,Cryptococcal meningitis; Vaginal candidiasis,Approved; Approved
FLUCYTOSINE,2022-85-7,https://drugs.ncats.io/drug/D83282DT06,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""2022%2085%207"")",ONLY CAS,US Approved Rx 2017,ANDA204652,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204652,US Approved Rx 1971,NDA017001,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017001,Systemic candidiasis; Cryptococcal meningitis; Cryptococcus pulmonary infections; Candida urinary system infections; Candida endocarditis,Approved; Approved; Approved; Approved; Approved
FLUDARABINE,21679-14-1,https://drugs.ncats.io/drug/P2K93U8740,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""21679%2014%201"")",ONLY CAS,US Approved Rx 2007,ANDA078393,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=078393,US Previously Marketed 1991,FLUDARA by GENZYME CORP,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020038,Chronic lymphocytic leukemia,Approved
FLUDROCORTISONE,127-31-1,https://drugs.ncats.io/drug/U0476M545B,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""127%2031%201"")",ONLY CAS,US Approved Rx 2022,ANDA215279,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215279,US Previously Marketed 1955,FLORINEF by CASPER PHARMA LLC,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=010060,Addison's disease; Salt-losing adrenogenital syndrome,Approved; Approved
FLUDROXYCORTIDE,1524-88-5,https://drugs.ncats.io/drug/8EUL29XUQT,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1524%2088%205"")",ONLY CAS,US Approved Rx 2016,ANDA207133,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207133,US Previously Marketed 1961,Cordran by Lilly,https://books.google.com/books?id=ZiiU-iiF1K8C&newbks=1&newbks_redir=0&dq=hydroxyphenamate&pg=PA367#v=onepage&q=hydroxyphenamate&f=false,Inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses,Approved
FLUMAZENIL,78755-81-4,https://drugs.ncats.io/drug/40P7XK9392,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""78755%2081%204"")",ONLY CAS,US Approved Rx 2004,ANDA076787,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=076787,US Previously Marketed 1991,ROMAZICON by HOFFMANN LA ROCHE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020073,Benzodiazepine overdose,Approved
FLUNISOLIDE,3385-03-3,https://drugs.ncats.io/drug/78M02AA8KF,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""3385%2003%203"")",ONLY CAS,US Approved Rx 2002,ANDA074805,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=074805,US Previously Marketed 1981,NASALIDE by IVAX RES,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018148,Perennial or seasonal allergic rhinitis,Approved
FLUOCINOLONE ACETONIDE,67-73-2,https://drugs.ncats.io/drug/0CD5FD6S2M,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""67%2073%202"")",ONLY CAS,US Approved Rx 1994,ANDA040041,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=040041,US Approved Rx 1961,NDA012787,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=012787,Chronic non-infectious uveitis affecting the posterior segment of the eye; Corticosteroid-responsive dermatoses,Approved; Approved
FLUOCINONIDE,356-12-7,https://drugs.ncats.io/drug/2W4A77YPAN,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""356%2012%207"")",ONLY CAS,US Approved Rx 2020,ANDA208989,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208989,US Previously Marketed 1971,LIDEX by ALVOGEN,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016909,Corticosteroid-responsive dermatoses,Approved
FLUORESCEIN,2321-07-5,https://drugs.ncats.io/drug/TPY09G7XIR,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""2321%2007%205"")",ONLY CAS,US Approved Rx 2023,ANDA215709,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215709,Possibly Marketed Outside US 1958,NDA208742,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7514e6b8-c33f-4fbf-8810-ef520e1eb4bd,Fluorescein angiography or angioscopy of the retina vasculature; Fluorescein angiography or angioscopy of the iris vasculature,Approved; Approved
FLUORINE,7782-41-4,https://drugs.ncats.io/drug/284SYP0193,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""7782%2041%204"")",ONLY CAS,Clinical 2021,NCT04705428: Not Applicable Interventional Completed White Spot Lesion,https://clinicaltrials.gov/ct2/show/NCT04705428,,,,,
FLUOROMETHOLONE,426-13-1,https://drugs.ncats.io/drug/SV0CSG527L,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""426%2013%201"")",ONLY CAS,US Approved Rx 1972,NDA016851,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016851,US Previously Marketed 1959,Oxylone Cream by Upjohn,OB NME Appendix 1950-1993,"Inflammation of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe",Approved
FLUOROURACIL,51-21-8,https://drugs.ncats.io/drug/U3P01618RT,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""51%2021%208"")",ONLY CAS,US Approved Rx 1998,ANDA040278,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=040278,US Previously Marketed 1962,FLUOROURACIL by SPECTRUM PHARMS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=012209,Prostate cancer; Lung cancer; Breast cancer; Head and neck cancer; Digestive system neoplasms; Breast adenocarcinoma; Gastric adenocarcinoma; Adenocarcinoma of the colon,Approved; Approved; Approved; Approved; Approved; Approved; Approved; Approved
FLUOXETINE,54910-89-3,https://drugs.ncats.io/drug/01K63SUP8D,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""54910%2089%203"")",ONLY CAS,US Approved Rx 2001,ANDA075049,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=075049,US Approved Rx 1987,NDA018936,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018936,Obsessive-compulsive disorder; Panic disorder; Bulimia nervosa; Major depressive disorder,Approved; Approved; Approved; Approved
FLUOXYMESTERONE,76-43-7,https://drugs.ncats.io/drug/9JU12S4YFY,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""76%2043%207"")",ONLY CAS,US Previously Marketed 1983,FLUOXYMESTERONE by WATSON LABS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=088309,US Previously Marketed 1956,HALOTESTIN by PHARMACIA AND UPJOHN,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=010611,Male hypogonadism; Delayed male puberty; Inoperable metastatic female breast cancer,Approved; Approved; Approved
FLUPHENAZINE,69-23-8,https://drugs.ncats.io/drug/S79426A41Z,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""69%2023%208"")",ONLY CAS,US Approved Rx 2023,ANDA217410,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217410,US Previously Marketed 1959,PROLIXIN by APOTHECON,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=012145,Schizophrenia,Approved
FLURAZEPAM,17617-23-1,https://drugs.ncats.io/drug/IHP475989U,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""17617%2023%201"")",ONLY CAS,US Approved Rx 1989,ANDA072368,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=072368,US Previously Marketed 1970,DALMANE by VALEANT PHARM INTL,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016721,Insomnia,Approved
FLURBIPROFEN,5104-49-4,https://drugs.ncats.io/drug/5GRO578KLP,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""5104%2049%204"")",ONLY CAS,US Approved Rx 1995,ANDA074447,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=074447,US Previously Marketed 1986,OCUFEN by ALLERGAN,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019404,Osteoarthritis; Rheumatoid arthritis; Osteoarthritis,Approved; Approved; Approved
FLUTAMIDE,13311-84-7,https://drugs.ncats.io/drug/76W6J0943E,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""13311%2084%207"")",ONLY CAS,US Approved Rx 2001,ANDA075298,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=075298,US Previously Marketed 1989,EULEXIN by SCHERING,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018554,Metastatic carcinoma of the prostate,Approved
FLUTICASONE,90566-53-3,https://drugs.ncats.io/drug/CUT2W21N7U,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""90566%2053%203"")",ONLY CAS,Possibly Marketed Outside US ,WHO-ATC:D07AC17,https://ginas.ncats.nih.gov/ginas/app/substance/CUT2W21N7U,,,,,
FLUTICASONE FUROATE,397864-44-7,https://drugs.ncats.io/drug/JS86977WNV,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""397864%2044%207"")",ONLY CAS,US Approved Rx 2007,NDA022051,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022051,US Approved Rx 2007,NDA022051,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022051,Asthma; Chronic obstructive pulmonary disease; Perennial or seasonal allergic rhinitis,Approved; Approved; Approved
FLUVASTATIN,93957-54-1,https://drugs.ncats.io/drug/4L066368AS,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""93957%2054%201"")",ONLY CAS,US Approved Rx 2012,ANDA078407,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=078407,US Previously Marketed 1993,LESCOL by NOVARTIS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020261,Hypercholesterolemia; Atherosclerosis; Dyslipidemia,Approved; Approved; Approved
FLUVOXAMINE,54739-18-3,https://drugs.ncats.io/drug/O4L1XPO44W,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""54739%2018%203"")",ONLY CAS,US Approved Rx 2013,ANDA091476,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=091476,US Previously Marketed 1994,LUVOX by SOLVAY,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020243,Obsessive-compulsive disorder,Approved
FOLIC ACID,59-30-3,https://drugs.ncats.io/drug/935E97BOY8,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""59%2030%203"")",ONLY CAS,US Approved Rx 2005,ANDA040625,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=040625,US Previously Marketed 1946,FOLVRON by LEDERLE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=006012,Megaloblastic anemia,Approved
FOLLICLE-STIMULATING HORMONE,9002-68-0,https://drugs.ncats.io/drug/8FYM5179QJ,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""9002%2068%200"")",ONLY CAS,Possibly Marketed Outside US ,Menopur by Ferring Pharmaceuticals [Canada],https://www.drugbank.ca/drugs/DB00032,Possibly Marketed Outside US 2016,NADA141431,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=88a149f0-8a44-48d1-a5df-35b1fd1559a1,,
FOLLITROPIN ALFA,56832-30-5,https://drugs.ncats.io/drug/9ML606PR4C,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""56832%2030%205"")",ONLY CAS,,,,,,,,
FOLLITROPIN BETA,146479-72-3,https://drugs.ncats.io/drug/W9BB98U6HP,3,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""146479%2072%203"")",ONLY CAS,US Approved Rx 2002,BLA021484,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021484,US Previously Marketed 1986,METRODIN by SERONO,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019415,,
FOMEPIZOLE,7554-65-6,https://drugs.ncats.io/drug/83LCM6L2BY,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""7554%2065%206"")",ONLY CAS,US Approved Rx 2023,ANDA216791,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216791,US Previously Marketed 1997,ANTIZOL by PAR PHARM INC,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020696,Ethylene glycol Poisoning,Approved
FONDAPARINUX SODIUM,114870-03-0,https://drugs.ncats.io/drug/X0Q6N9USOZ,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""114870%2003%200"")",ONLY CAS,US Approved Rx 2018,ANDA208615,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208615,US Approved Rx 2001,NDA021345,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021345,Deep Vein Thrombosis,Approved
FORMALDEHYDE,50-00-0,https://drugs.ncats.io/drug/1HG84L3525,2,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""50%2000%200"")%20AND%20(root_names_name:""%5EFORMALDEHYDE$"")",EXACT NAME,US Previously Marketed 1921,Solution of Formaldehyde U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,US Previously Marketed 1921,Solution of Formaldehyde U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,Warts,Approved
FORMIC ACID,68-12-2,https://drugs.ncats.io/drug/8696NH0Y2X,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""68%2012%202"")",ONLY CAS,Possibly Marketed Outside US 2015,NCT02683863: Phase 4 Interventional Completed Multiple Sclerosis,https://clinicaltrials.gov/ct2/show/NCT02683863,,,,,
FORMOTEROL,73573-87-2,https://drugs.ncats.io/drug/5ZZ84GCW8B,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""73573%2087%202"")",ONLY CAS,US Approved Rx 2022,ANDA211699,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211699,US Previously Marketed 2001,FORADIL by NOVARTIS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020831,Asthma; Chronic obstructive pulmonary disease,Approved; Approved
FOSAMPRENAVIR,226700-79-4,https://drugs.ncats.io/drug/WOU1621EEG,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""226700%2079%204"")",ONLY CAS,US Approved Rx 2016,ANDA204060,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204060,US Previously Marketed 1999,AGENERASE by GLAXOSMITHKLINE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021039,HIV-1 infection,Approved
FOSAPREPITANT,172673-20-0,https://drugs.ncats.io/drug/6L8OF9XRDC,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""172673%2020%200"")",ONLY CAS,US Approved Rx 2008,NDA022023,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022023,US Approved Rx 2003,NDA021549,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021549,Postoperative nausea and vomiting; Chemotherapy induced nausea and vomiting; Chemotherapy induced nausea and vomiting; Postoperative nausea and vomiting,Approved; Approved; Approved; Approved
FOSCARNET SODIUM,34156-56-4,https://drugs.ncats.io/drug/964YS0OOG1,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""34156%2056%204"")",ONLY CAS,US Approved Rx 2021,ANDA212483,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212483,US Approved Rx 1991,NDA020068,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020068,Cytomegalovirus retinitis,Approved
FOSFESTROL,522-40-7,https://drugs.ncats.io/drug/A0E0NMA80F,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""522%2040%207"")",ONLY CAS,US Previously Marketed 1982,DIETHYLSTILBESTROL by LILLY,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=004040,US Previously Marketed 1941,Diethylstilbestrol by Various Mfrs.,DeHaen 1940-1975 NMEs,Prostate cancer; Prostate cancer; Miscarriage; Atrophic vaginitis; Vulvar dystrophy; Amenorrhea; Female hypogonadism; Postmenopausal osteoporosis; Menopausal syndrome,Approved; Approved; Approved; Approved; Approved; Approved; Approved; Approved; Approved
FOSFOMYCIN TROMETAMOL,77-86-1,https://drugs.ncats.io/drug/023C2WHX2V,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""77%2086%201"")",ONLY CAS,US Previously Marketed 1965,THAM-E by HOSPIRA,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=013025,US Previously Marketed 1965,THAM-E by HOSPIRA,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=013025,Metabolic acidosis,Approved
FOSINOPRIL,98048-97-6,https://drugs.ncats.io/drug/R43D2573WO,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""98048%2097%206"")",ONLY CAS,US Approved Rx 2009,ANDA079245,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=079245,US Previously Marketed 1991,MONOPRIL by BRISTOL MYERS SQUIBB,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019915,Hypertension,Approved
FOSPHENYTOIN,93390-81-9,https://drugs.ncats.io/drug/B4SF212641,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""93390%2081%209"")",ONLY CAS,US Approved Rx 2006,ANDA040684,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=040684,US Previously Marketed 1938,Dilantin by Parke-Davis,http://triggered.edina.clockss.org/ServeContent?rft_id=info:doi/10.1124/mi.9.5.1,Seizures; Status epilepticus,Approved; Approved
FOSPROPOFOL,258516-89-1,https://drugs.ncats.io/drug/LZ257RZP7K,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""258516%2089%201"")",ONLY CAS,US Approved Rx 2018,ANDA205067,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205067,US Approved Rx 1989,NDA019627,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019627,Pain,Approved
FOSTAMATINIB,901119-35-5,https://drugs.ncats.io/drug/SQ8A3S5101,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""901119%2035%205"")",ONLY CAS,US Approved Rx 2018,NDA209299,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209299,US Approved Rx 2018,NDA209299,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209299,Rheumatoid arthritis; Immune thrombocytopenia; Autoimmune hemolytic anemia; IgA nephropathy; Ovarian cancer,Phase III; Approved; Phase II; Phase II; Phase I
FREMANEZUMAB,1655501-53-3,https://drugs.ncats.io/drug/PF8K38CG54,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1655501%2053%203"")",ONLY CAS,US Approved Rx 2018,BLA761089,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761089,US Approved Rx 2018,BLA761089,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761089,,
FROVATRIPTAN,158747-02-5,https://drugs.ncats.io/drug/H82Q2D5WA7,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""158747%2002%205"")",ONLY CAS,US Approved Rx 2022,ANDA213891,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213891,US Approved Rx 2001,NDA021006,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021006,Migraine without aura; Migraine with aura,Approved; Approved
FRUCTOSE,6347-01-9,https://drugs.ncats.io/drug/6YSS42VSEV,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""6347%2001%209"")",ONLY CAS,US Previously Marketed 1953,Levugen by Mead Johnson,DeHaen 1940-1975 NMEs,US Previously Marketed 1921,fructose,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,Pain,Approved
FUCOXANTHIN,3351-86-8,https://drugs.ncats.io/drug/06O0TC0VSM,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""3351%2086%208"")",ONLY CAS,Clinical 2019,"NCT03613740: Phase 2 Interventional Active, not recruiting Metabolic Syndrome",https://clinicaltrials.gov/ct2/show/NCT03613740,,,,Cancer; Non-alcoholic fatty liver disease; Alzheimer’s disease,Preclinical; Not Provided; Preclinical
FUCUS VESICULOSUS,977001-75-4,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""977001%2075%204"")",ONLY CAS,,,,,,,,
FULVESTRANT,129453-61-8,https://drugs.ncats.io/drug/22X328QOC4,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""129453%2061%208"")",ONLY CAS,US Approved Rx 2019,ANDA205935,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205935,US Approved Rx 2002,NDA021344,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021344,Hormone receptor positive metastatic breast cancer,Approved
FUMARIC ACID,110-17-8,https://drugs.ncats.io/drug/88XHZ13131,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""110%2017%208"")",ONLY CAS,US Approved Rx 2019,NDA211855,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211855,Possibly Marketed Outside US 1946,NDA006035,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b1552d48-86f5-4184-810a-001e57e96c02,Arthritis; Multiple sclerosis; Ischemic stroke; Cancer; Periapical diseases; Unknown; Relapsing forms of multiple sclerosis; Unknown,Preclinical; Approved; Preclinical; Natural Metabolite; Not Provided; Approved
FURAZOLIDONE,67-45-8,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""67%2045%208"")",ONLY CAS,,,,,,,,
FUROSEMIDE,54-31-9,https://drugs.ncats.io/drug/7LXU5N7ZO5,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""54%2031%209"")",ONLY CAS,US Approved Rx 2014,ANDA203428,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203428,US Approved Rx 1966,NDA016273,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016273,Hypertension; Edema,Approved; Approved
GABAPENTIN,60142-96-3,https://drugs.ncats.io/drug/6CW7F3G59X,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""60142%2096%203"")",ONLY CAS,US Approved Rx 2007,ANDA078428,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=078428,US Approved Rx 1993,NDA020235,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020235,Restless legs syndrome; Postherpetic neuralgia,Approved; Approved
GABAPENTIN ENACARBIL,478296-72-9,https://drugs.ncats.io/drug/75OCL1SPBQ,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""478296%2072%209"")",ONLY CAS,US Approved Rx 2007,ANDA078428,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=078428,US Approved Rx 1993,NDA020235,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020235,Restless legs syndrome; Postherpetic neuralgia,Approved; Approved
GADOBENIC ACID,113662-23-0,https://drugs.ncats.io/drug/15G12L5X8K,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""113662%2023%200"")",ONLY CAS,US Approved Rx 2013,NDA204781,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204781,US Previously Marketed 1988,MAGNEVIST by BAYER HLTHCARE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019596,"Central nervous system diseases; Breast cancer; Renal artery obstruction; Disruption of the blood brain barrier and abnormal vascularity in brain, spine and associated tissues",Approved; Approved; Approved; Approved
GADOBUTROL,770691-21-9,https://drugs.ncats.io/drug/1BJ477IO2L,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""770691%2021%209"")",ONLY CAS,US Approved Rx 2013,NDA204781,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204781,US Previously Marketed 1988,MAGNEVIST by BAYER HLTHCARE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019596,"Central nervous system diseases; Breast cancer; Renal artery obstruction; Disruption of the blood brain barrier and abnormal vascularity in brain, spine and associated tissues",Approved; Approved; Approved; Approved
GADODIAMIDE,131410-48-5,https://drugs.ncats.io/drug/84F6U3J2R6,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""131410%2048%205"")",ONLY CAS,US Approved Rx 2007,NDA022066,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022066,US Approved Rx 1993,NDA020123,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020123,Contrast agent for MRI,Approved
GADOFOSVESET,201688-00-8,https://drugs.ncats.io/drug/E65RW73PHS,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""201688%2000%208"")",ONLY CAS,US Approved Rx 2013,NDA204781,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204781,US Previously Marketed 1988,MAGNEVIST by BAYER HLTHCARE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019596,"Central nervous system diseases; Breast cancer; Renal artery obstruction; Disruption of the blood brain barrier and abnormal vascularity in brain, spine and associated tissues",Approved; Approved; Approved; Approved
GADOPENTETIC ACID,80529-93-7,https://drugs.ncats.io/drug/K2I13DR72L,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""80529%2093%207"")",ONLY CAS,US Approved Rx 2013,NDA204781,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204781,US Previously Marketed 1988,MAGNEVIST by BAYER HLTHCARE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019596,"Central nervous system diseases; Breast cancer; Renal artery obstruction; Disruption of the blood brain barrier and abnormal vascularity in brain, spine and associated tissues",Approved; Approved; Approved; Approved
GADOTERIC ACID,72573-82-1,https://drugs.ncats.io/drug/QVF9Y6955W,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""72573%2082%201"")",ONLY CAS,US Approved Rx 2013,NDA204781,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204781,US Previously Marketed 1988,MAGNEVIST by BAYER HLTHCARE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019596,"Central nervous system diseases; Breast cancer; Renal artery obstruction; Disruption of the blood brain barrier and abnormal vascularity in brain, spine and associated tissues",Approved; Approved; Approved; Approved
GADOTERIDOL,120066-54-8,https://drugs.ncats.io/drug/0199MV609F,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""120066%2054%208"")",ONLY CAS,US Approved Rx 2003,NDA021489,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021489,US Approved Rx 1992,NDA020131,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020131,"Lesions with abnormal vascularity in the brain (intracranial lesions), spine and associated tissues",Approved
GADOVERSETAMIDE,131069-91-5,https://drugs.ncats.io/drug/RLM74T3Z9D,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""131069%2091%205"")",ONLY CAS,US Approved Rx 2013,NDA204781,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204781,US Previously Marketed 1988,MAGNEVIST by BAYER HLTHCARE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019596,"Central nervous system diseases; Breast cancer; Renal artery obstruction; Disruption of the blood brain barrier and abnormal vascularity in brain, spine and associated tissues",Approved; Approved; Approved; Approved
GADOXETIC ACID,135326-11-3,https://drugs.ncats.io/drug/3QJA87N40S,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""135326%2011%203"")",ONLY CAS,US Approved Rx 2013,NDA204781,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204781,US Previously Marketed 1988,MAGNEVIST by BAYER HLTHCARE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019596,"Central nervous system diseases; Breast cancer; Renal artery obstruction; Disruption of the blood brain barrier and abnormal vascularity in brain, spine and associated tissues",Approved; Approved; Approved; Approved
GALACTOSE,10257-28-0,https://drugs.ncats.io/drug/X2RN3Q8DNE,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""10257%2028%200"")",ONLY CAS,Possibly Marketed Outside US ,WHO-ATC:V04CE01,https://ginas.ncats.nih.gov/ginas/app/substance/X2RN3Q8DNE,Possibly Marketed Outside US 1995,ANDA074077,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ff6b4568-1383-46b6-a1c6-385fc31fb210,,
GALANTAMINE,357-70-0,https://drugs.ncats.io/drug/0D3Q044KCA,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""357%2070%200"")",ONLY CAS,US Approved Rx 2008,ANDA079028,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=079028,US Previously Marketed 2001,RAZADYNE by JANSSEN PHARMS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021224,Alzheimer’s disease,Approved
GALCANEZUMAB,1578199-75-3,https://drugs.ncats.io/drug/55KHL3P693,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1578199%2075%203"")",ONLY CAS,US Approved Rx 2018,BLA761063,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761063,US Approved Rx 2018,BLA761063,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761063,,
GALLIUM,7440-55-3,https://drugs.ncats.io/drug/CH46OC8YV4,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""7440%2055%203"")",ONLY CAS,Possibly Marketed Outside US 2012,NCT01534182: Phase 4 Interventional Completed Relapsing Remitting Multiple Sclerosis,https://clinicaltrials.gov/ct2/show/NCT01534182,,,,,
GALSULFASE,552858-79-4,https://drugs.ncats.io/drug/59UA429E5G,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""552858%2079%204"")",ONLY CAS,US Approved Rx 2005,BLA125117,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125117,US Approved Rx 2005,BLA125117,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125117,,
GAMOLENIC ACID,506-26-3,https://drugs.ncats.io/drug/78YC2MAX4O,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""506%2026%203"")",ONLY CAS,Possibly Marketed Outside US ,Canada:GAMMA-LINOLENIC ACID,https://tripod.nih.gov/npc/#Download,Possibly Marketed Outside US 2017,21 CFR 333A,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4e2726f7-f199-1c0d-e054-00144ff8d46c,Atopic dermatitis; Mastalgia,Approved; Approved
GANCICLOVIR,82410-32-0,https://drugs.ncats.io/drug/P9G3CKZ4P5,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""82410%2032%200"")",ONLY CAS,US Approved Rx 2003,ANDA076222,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=076222,US Previously Marketed 1989,CYTOVENE by CHEPLAPHARM,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019661,"Unknown; Cytomegalovirus retinitis; Cytomegalovirus infectious disease in kidney, heart, and kidney-pancreas transplantation; Cytomegalovirus retinitis; Acute herpetic keratitis",Approved; Approved; Approved; Approved
GANIRELIX,124904-93-4,https://drugs.ncats.io/drug/IX503L9WN0,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""124904%2093%204"")",ONLY CAS,US Approved Rx 2018,ANDA204246,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204246,US Approved Rx 1999,NDA021057,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021057,Prevent premature ovulation,Approved
GARCINIA CAMBOGIA,77-92-9,https://drugs.ncats.io/drug/XF417D3PSL,2,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""77%2092%209"")",ONLY CAS,US Approved OTC ,"21 CFR 331.11(e) antacid:citrate-containing citrate (containing active ingredients: citrate ion, as citric acid or salt)",https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec331-11.xml,US Previously Marketed 1921,Potassium Citrate U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,Renal tubular acidosis; Nephrolithiasis,Approved; Approved
GARCINIA MANGOSTANA,107390-08-9,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""107390%2008%209"")",ONLY CAS,,,,,,,,
GARDENIA,3380-34-5,https://drugs.ncats.io/drug/4NM5039Y5X,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""3380%2034%205"")",ONLY CAS,US Previously Marketed 1997,COLGATE TOTAL by COLGATE PALMOLIVE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020231,US Previously Marketed 1969,P-300 Antibacterial by Colgate-Palmolive,OB NME Appendix 1950-1993,Bacterial infections,Approved
GATIFLOXACIN,112811-59-3,https://drugs.ncats.io/drug/81485Y3A9A,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""112811%2059%203"")",ONLY CAS,US Approved Rx 2016,ANDA204227,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204227,US Previously Marketed 1999,Tequin,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21061,Bacterial conjunctivitis,Approved
GAULTHERIA PROCUMBENS,977092-74-2,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""977092%2074%202"")",ONLY CAS,,,,,,,,
GEFITINIB,184475-35-2,https://drugs.ncats.io/drug/S65743JHBS,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""184475%2035%202"")",ONLY CAS,US Approved Rx 2022,ANDA209532,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209532,US Previously Marketed 2003,IRESSA by ASTRAZENECA,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021399,Non-small cell lung cancer,Approved
GELATIN,9000-70-8,https://drugs.ncats.io/drug/2G86QN327L,9,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""9000%2070%208"")%20AND%20(root_names_name:""%5EGELATIN$"")",EXACT NAME,US Approved OTC ,21 CFR 349.12(c) ophthalmic:demulcents gelatin,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec349-12.xml,US Previously Marketed 1921,Gelatin U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,,
GELSEMIUM SEMPERVIRENS,84650-08-8,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""84650%2008%208"")",ONLY CAS,,,,,,,,
GEMCITABINE,95058-81-4,https://drugs.ncats.io/drug/B76N6SBZ8R,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""95058%2081%204"")",ONLY CAS,US Approved Rx 2011,NDA200795,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=200795,US Previously Marketed 1996,GEMZAR by LILLY,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020509,Advanced ovarian cancer; Metastatic breast cancer; Pancreatic cancer; Non-small cell lung cancer,Approved; Approved; Approved; Approved
GEMFIBROZIL,25812-30-0,https://drugs.ncats.io/drug/Q8X02027X3,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""25812%2030%200"")",ONLY CAS,US Approved Rx 2010,ANDA079072,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=079072,US Approved Rx 1981,NDA018422,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018422,Hyperlipidemia; Coronary heart disease,Approved; Approved
GEMIFLOXACIN,175463-14-6,https://drugs.ncats.io/drug/OKR68Y0E4T,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""175463%2014%206"")",ONLY CAS,US Previously Marketed 2003,FACTIVE by LG CHEM LTD,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021158,US Previously Marketed 2003,FACTIVE by LG CHEM LTD,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021158,Community-acquired pneumonia; Chronic bronchitis,Approved; Approved
GEMTUZUMAB OZOGAMICIN,220578-59-6,https://drugs.ncats.io/drug/8GZG754X6M,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""220578%2059%206"")",ONLY CAS,US Approved Rx 2017,BLA761060,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761060,US Previously Marketed 2000,Mylotarg,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21174,,
GENERAL NUTRIENTS,2280-44-6,https://drugs.ncats.io/drug/5SL0G7R0OK,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""2280%2044%206"")",ONLY CAS,US Approved Rx 1986,NDA019445,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019445,US Previously Marketed 1921,dextrose,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,Hypoglycemia; Caloric intake deficit,Basic research; Approved
GENISTEIN,446-72-0,https://drugs.ncats.io/drug/DH2M523P0H,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""446%2072%200"")",ONLY CAS,Possibly Marketed Outside US ,"Fosteum by Primus Pharmaceuticals, Inc.",https://www.drugbank.ca/drugs/DB01645,Possibly Marketed Outside US 2007,"Fosteum by Primus Pharmaceuticals, Inc.",https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=899ea7ce-0996-4635-9545-1e07091cf400,,
GENTAMICIN,1403-66-3,https://drugs.ncats.io/drug/T6Z9V48IKG,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1403%2066%203"")",ONLY CAS,US Approved Rx 1984,ANDA062533,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=062533,US Previously Marketed 1966,Garamycio by Schering,DeHaen 1940-1975 NMEs,Infection caused by Staphylococcus species; Escherichia coli infections; Infection caused by Proteus species; Infection caused by Klebsiella-Enterobacter-Serratia species; Pseudomonas aeruginosa infection; Infection caused by Citrobacter species; Infections caused by Staphylococcus species; Escherichia coli infections; Infection caused by Citrobacter species,Approved; Approved; Approved; Approved; Approved; Approved; Approved; Approved; Approved
GERANIUM MACULATUM,84650-10-2,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""84650%2010%202"")",ONLY CAS,,,,,,,,
GERANIUM ROBERTIANUM,84650-11-3,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""84650%2011%203"")",ONLY CAS,,,,,,,,
GILTERITINIB,1254053-43-4,https://drugs.ncats.io/drug/66D92MGC8M,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1254053%2043%204"")",ONLY CAS,US Approved Rx 2018,NDA211349,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211349,US Approved Rx 2018,NDA211349,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211349,Acute myeloid leukemia,Approved
GINKGO BILOBA,90045-36-6,https://drugs.ncats.io/drug/19FUJ2C58T,2,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""90045%2036%206"")%20AND%20(root_names_name:""%5EGINKGO%20BILOBA$"")",EXACT NAME,Possibly Marketed Outside US ,"Ginsamin Power by Biogrand Co., Ltd",https://www.drugbank.ca/drugs/DB01381,Possibly Marketed Outside US 1999,M012,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=31ff48fc-9603-413c-ab7c-2598b3e08f9c,,
GLASDEGIB,1095173-27-5,https://drugs.ncats.io/drug/K673DMO5H9,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1095173%2027%205"")",ONLY CAS,US Approved Rx 2018,NDA210656,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210656,US Approved Rx 2018,NDA210656,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210656,Myelodysplastic syndromes; Solid tumors; Acute myeloid leukemia,Phase II; Phase I; Approved
GLATIRAMER ACETATE,147245-92-9,https://drugs.ncats.io/drug/5M691HL4BO,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""147245%2092%209"")",ONLY CAS,US Approved Rx 2017,ANDA091646,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=091646,US Approved Rx 1996,NDA020622,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020622,,
GLECAPREVIR,1365970-03-1,https://drugs.ncats.io/drug/K6BUU8J72P,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1365970%2003%201"")",ONLY CAS,US Approved Rx 2021,NDA215110,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215110,US Approved Rx 2017,NDA209394,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209394,Chronic hepatitis C,Approved
GLIBENCLAMIDE,10238-21-8,https://drugs.ncats.io/drug/SX6K58TVWC,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""10238%2021%208"")",ONLY CAS,US Approved Rx 1984,NDA017532,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017532,US Approved Rx 1984,NDA017532,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017532,Type 2 diabetes mellitus,Approved
GLICLAZIDE,21187-98-4,https://drugs.ncats.io/drug/G4PX8C4HKV,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""21187%2098%204"")",ONLY CAS,Possibly Marketed Outside US ,Diamicron Mr by Servier [Canada],https://www.drugbank.ca/drugs/DB01120,,,,Type 2 diabetes mellitus,Approved
GLIMEPIRIDE,93479-97-1,https://drugs.ncats.io/drug/6KY687524K,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""93479%2097%201"")",ONLY CAS,US Approved Rx 2006,NDA021925,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021925,US Approved Rx 1995,NDA020496,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020496,Type 2 diabetes mellitus,Approved
GLIPIZIDE,29094-61-9,https://drugs.ncats.io/drug/X7WDT95N5C,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""29094%2061%209"")",ONLY CAS,US Approved Rx 2018,ANDA203499,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203499,US Previously Marketed 1984,GLUCOTROL by PFIZER,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017783,Type 2 diabetes mellitus,Approved
GLUCAGON,9007-92-5,https://drugs.ncats.io/drug/76LA80IG2G,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""9007%2092%205"")",ONLY CAS,US Approved Rx 2020,ANDA208086,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208086,US Previously Marketed 1960,GLUCAGON by LILLY,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=012122,Hypoglycemia,Approved
GLUCANASE,72626-61-0,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""72626%2061%200"")",ONLY CAS,,,,,,,,
GLUCARPIDASE,9074-87-7,https://drugs.ncats.io/drug/2GFP9BJD79,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""9074%2087%207"")",ONLY CAS,US Approved OTC ,21 CFR 347.10(t) skin protectant zinc carbonate,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec347-10.xml,US Previously Marketed 1921,Precipitated Zinc Carbonate U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,Caries; Ulcerative colitis; Breast cancer; Acute myeloid leukemia; Unknown; Unknown; Poison Ivy dermatitis; Diaper dermatitis; Dysgeusia; Mucositis; Gastrointestinal disorders; Renal insufficiency; Unknown; Unknown; Zinc deficiency,Basic research; Approved; Basic research; Basic research; Approved; Approved; Phase III; Phase III; Approved; Approved; Preclinical
GLUCOMANNAN,76081-94-2,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""76081%2094%202"")",ONLY CAS,,,,,,,,
GLUCONIC ACID,19222-41-4,https://drugs.ncats.io/drug/QHP99G979J,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""19222%2041%204"")",ONLY CAS,US Approved Rx 1979,NDA017378,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017378,US Approved Rx 1975,NDA017586,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017586,Unknown; Iron deficiency anemia,Approved
GLUCOSAMINE,90-77-7,https://drugs.ncats.io/drug/N08U5BOQ1K,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""90%2077%207"")",ONLY CAS,Possibly Marketed Outside US ,"Glucosamine Sulfate, Chondroitin Sulfate, Ibuprofen by Contract Pharmacal Corp.",https://www.drugbank.ca/drugs/DB01296,Possibly Marketed Outside US 1988,21 CFR 348,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d5f76bfc-6601-815a-e053-2995a90ac124,Oral lichen planus; Low back pain; Osteoarthritis of knee,Phase IV; Phase IV; Phase IV
GLUCOSE,2280-44-6,https://drugs.ncats.io/drug/5SL0G7R0OK,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""2280%2044%206"")",ONLY CAS,US Approved Rx 1986,NDA019445,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019445,US Previously Marketed 1921,dextrose,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,Hypoglycemia; Caloric intake deficit,Basic research; Approved
GLUCOSE- BLOOD TESTS,64-77-7,https://drugs.ncats.io/drug/982XCM1FOI,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""64%2077%207"")",ONLY CAS,US Previously Marketed 1985,TOLBUTAMIDE by PUREPAC PHARM,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=088950,US Previously Marketed 1957,ORINASE by PHARMACIA AND UPJOHN,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=010670,Type 2 diabetes mellitus,Approved
GLUCOSE OXIDASE,492-61-5,https://drugs.ncats.io/drug/J4R00M814D,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""492%2061%205"")",ONLY CAS,Possibly Marketed Outside US 2019,M020,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8d420e4b-c778-3ed4-e053-2995a90a59a9,Possibly Marketed Outside US 2013,21 CFR 358H,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ab084d44-dfb8-4cde-bfa1-17d72cce686e,,
GLUCUROLACTONE,32449-92-6,https://drugs.ncats.io/drug/XE4Y3016M9,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""32449%2092%206"")",ONLY CAS,US Previously Marketed 1950,Glucurone by Commercial Solvents,DeHaen 1940-1975 NMEs,US Previously Marketed 1950,Glucurone by Commercial Solvents,DeHaen 1940-1975 NMEs,Unknown,
GLUTAMIC ACID,56-86-0,https://drugs.ncats.io/drug/3KX376GY7L,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""56%2086%200"")",ONLY CAS,US Previously Marketed 1961,GLUTAVENE by TILDEN YATES,https://www.govinfo.gov/content/pkg/FR-1973-12-05/pdf/FR-1973-12-05.pdf,US Previously Marketed 1939,FLANITHIN 325MG by TABLE ROCK,https://www.govinfo.gov/content/pkg/FR-1969-09-12/pdf/FR-1969-09-12.pdf,Delayed gastric emptying; Postoperative heart failure; Nerve damage,Not Provided; Phase III; Phase III
GLUTAMINE,56-85-9,https://drugs.ncats.io/drug/0RH81L854J,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""56%2085%209"")",ONLY CAS,US Approved Rx 2017,NDA208587,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208587,US Previously Marketed 2004,NUTRESTORE by EMMAUS MEDCL,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021667,Short bowel syndrome,Approved
GLUTARAL,111-30-8,https://drugs.ncats.io/drug/T3C89M417N,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""111%2030%208"")",ONLY CAS,Possibly Marketed Outside US ,Canada:GLUTARAL,https://tripod.nih.gov/npc/#Download,Possibly Marketed Outside US 1985,Paraguard by Seachem Laboratories Inc.,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=984f46c0-6651-46c6-b5f2-e86b557953c7,Unknown,
GLUTATHIONE,70-18-8,https://drugs.ncats.io/drug/GAN16C9B8O,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""70%2018%208"")",ONLY CAS,Possibly Marketed Outside US ,"Tobakient by Levins Pharmaceuticals, LLC",https://www.drugbank.ca/drugs/DB00143,Possibly Marketed Outside US 2003,BLA125063,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=80fa03d2-cd4c-4155-9b57-1396c4fa42da,Breast cancer; Back pain from urinating; Free radical toxicit; Parkinson's disease; Cystic fibrosis,Phase II; Not Provided; Not Provided; Phase II; Phase III
GLYCEROL,56-81-5,https://drugs.ncats.io/drug/PDC6A3C0OX,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""56%2081%205"")",ONLY CAS,US Approved OTC ,21 CFR 347.10(h) skin protectant glycerin,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec347-10.xml,US Previously Marketed 1921,Glycerin U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,Dry skin or hair,Approved
GLYCEROL PHENYLBUTYRATE,611168-24-2,https://drugs.ncats.io/drug/ZH6F1VCV7B,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""611168%2024%202"")",ONLY CAS,US Approved Rx 2022,ANDA216462,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216462,US Approved Rx 1996,NDA020573,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020573,Late-onset disease; Urea cycle disorders,Approved; Approved
GLYCEROPHOSPHORIC ACID,57-03-4,https://drugs.ncats.io/drug/9NTI6P3O4X,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""57%2003%204"")",ONLY CAS,US Approved Rx 2014,NDA200656,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=200656,US Previously Marketed 1921,Sodium Glycerophosphate U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,Essential fatty acid deficiency or negative nitrogen balance,Approved
GLYCERYL MONOSTEARATE,123-94-4,https://drugs.ncats.io/drug/258491E1RZ,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""123%2094%204"")",ONLY CAS,US Previously Marketed ,"21 CFR 310.545(a)(18)(i)(B) skin protectant:w/ sales less than $25,000 glyceryl stearate",https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec310-545.xml,Possibly Marketed Outside US 1971,ANDA090256,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9ff7fa78-0fca-976f-e053-2995a90a4641,Dry Skin,Approved
GLYCINE,56-40-6,https://drugs.ncats.io/drug/TE7660XO1C,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""56%2040%206"")",ONLY CAS,US Approved OTC ,21 CFR 331.11(f) antacid glycine (aminoacetic acid),https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec331-11.xml,US Previously Marketed 1921,Glycocoll,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,Cystic fibrosis; Brain tumor malignancy; Schizophrenia; Malnutrition,Phase II; Natural Metabolite; Phase III; Approved
GLYCINE MAX,56-40-6,https://drugs.ncats.io/drug/TE7660XO1C,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""56%2040%206"")",ONLY CAS,US Approved OTC ,21 CFR 331.11(f) antacid glycine (aminoacetic acid),https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec331-11.xml,US Previously Marketed 1921,Glycocoll,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,Cystic fibrosis; Brain tumor malignancy; Schizophrenia; Malnutrition,Phase II; Natural Metabolite; Phase III; Approved
GLYCOLIC ACID,79-14-1,https://drugs.ncats.io/drug/0WT12SX38S,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""79%2014%201"")",ONLY CAS,US Previously Marketed 2022,glycolic acid,https://www.federalregister.gov/documents/2022/01/27/2022-01558/list-of-bulk-drug-substances-for-which-there-is-a-clinical-need-under-section-503b-of-the-federal,Possibly Marketed Outside US 1947,NDA006188,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b0c23a2c-b250-4c0d-9b2a-c1483faa2ca0,Acne,Not Provided
GLYCOPYRRONIUM,13283-82-4,https://drugs.ncats.io/drug/A14FB57V1D,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""13283%2082%204"")",ONLY CAS,US Approved Rx 2022,ANDA212467,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212467,Possibly Marketed Outside US 1961,NDA012827,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bd65ee5e-2000-423c-b0a6-72eb213455c4,Peptic ulcer; Chronic obstructive pulmonary disease,Approved; Approved
GLYCYRRHIZA GLABRA,5634-39-9,https://drugs.ncats.io/drug/34ON63CCO3,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""5634%2039%209"")",ONLY CAS,,,,,,,,
GLYCYRRHIZIC ACID,1405-86-3,https://drugs.ncats.io/drug/6FO62043WK,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1405%2086%203"")",ONLY CAS,US Previously Marketed 1921,Ammoniated Glycyrrhizin U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,US Previously Marketed 1921,Ammoniated Glycyrrhizin U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,Hepatitis B; Autoimmune hepatitis; Chronic hepatitis C; Chronic hepatitis C; Erythema; Cardiomyopathy; Autoimmune hepatitis; Ovarian cancer; Radiodermatitis; Leukemia; Unknown; Unknown; Inflammation,Not Provided; Phase I; Not Provided; Approved; Phase I; Preclinical; Phase I; Basic research; Basic research; Basic research; Basic research
GOLD,7440-57-5,https://drugs.ncats.io/drug/79Y1949PYO,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""7440%2057%205"")",ONLY CAS,Possibly Marketed Outside US ,Canada:AURUM MURIATICUM,https://tripod.nih.gov/npc/#Download,Possibly Marketed Outside US 2002,NDA207202,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e8787c3f-5e41-42d1-8091-44b56346620f,,
GOLIMUMAB,476181-74-5,https://drugs.ncats.io/drug/91X1KLU43E,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""476181%2074%205"")",ONLY CAS,US Approved Rx 2009,BLA125289,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125289,US Approved Rx 2009,BLA125289,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125289,,
GONADORELIN,9034-40-6,https://drugs.ncats.io/drug/9O7312W37G,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""9034%2040%206"")",ONLY CAS,US Previously Marketed 1982,FACTREL by HIKMA,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018123,Possibly Marketed Outside US 1978,NADA098379,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cddeff5b-ba19-4d92-8f91-8a6238f89c98,Hypogonadism; Amenorrhea,Approved; Approved
GOSERELIN,65807-02-5,https://drugs.ncats.io/drug/0F65R8P09N,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""65807%2002%205"")",ONLY CAS,US Approved Rx 1996,NDA020578,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020578,US Approved Rx 1989,NDA019726,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019726,Advanced carcinoma of the prostate; Locally confined carcinoma of the prostate,Approved; Approved
GRAMICIDIN,1405-97-6,https://drugs.ncats.io/drug/5IE62321P4,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1405%2097%206"")",ONLY CAS,US Approved Rx 1968,ANDA060582,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=060582,US Previously Marketed 1949,Gramoderm by Schering,DeHaen 1940-1975 NMEs,,
GRANISETRON,109889-09-0,https://drugs.ncats.io/drug/WZG3J2MCOL,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""109889%2009%200"")",ONLY CAS,US Approved Rx 2009,ANDA078531,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=078531,US Previously Marketed 1993,KYTRIL by ROCHE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020239,Nausea and vomiting associated with emetogenic chemotherapy,Approved
GRAPHITE,7782-42-5,https://drugs.ncats.io/drug/4QQN74LH4O,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""7782%2042%205"")",ONLY CAS,Possibly Marketed Outside US ,Canada:GRAPHITE,https://tripod.nih.gov/npc/#Download,Possibly Marketed Outside US 2023,Herpes Relief Cream by Ehy Holdings LLC,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f209ee77-d290-1203-e053-2a95a90adb8c,,
GRAZOPREVIR,1350514-68-9,https://drugs.ncats.io/drug/8YE81R1X1J,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1350514%2068%209"")",ONLY CAS,US Approved Rx 2016,NDA208261,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208261,US Approved Rx 2016,NDA208261,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208261,Hepatitis C,Approved
GREPAFLOXACIN,119914-60-2,https://drugs.ncats.io/drug/L1M1U2HC31,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""119914%2060%202"")",ONLY CAS,US Previously Marketed 1997,RAXAR by OTSUKA,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020695,US Previously Marketed 1997,RAXAR by OTSUKA,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020695,"Community-acquired pneumonia caused by Haemophilus influenzae, Streptococcus pneumoniae, Moraxella catarrhalis, or Mycoplasma pneumonia; Acute bacterial exacerbations of chronic bronchitis caused by Haemophilus influenzae, Streptococcus pneumoniae, or Moraxella catarrhalis; Uncomplicated gonorrhea (urethral In males and endocervical and rectal in females) caused by Neissen'a gononrhoeae",Withdrawn; Withdrawn; Withdrawn
GRISEOFULVIN,126-07-8,https://drugs.ncats.io/drug/32HRV3E3D5,3,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""126%2007%208"")%20AND%20(root_names_name:""%5EGRISEOFULVIN$"")",EXACT NAME,US Approved Rx 2005,ANDA065200,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=065200,US Previously Marketed 1959,Grisactin by Ayerst,DeHaen 1940-1975 NMEs,Dermatophyte infection,Approved
GUAIACOL,90-05-1,https://drugs.ncats.io/drug/6JKA7MAH9C,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""90%2005%201"")",ONLY CAS,US Previously Marketed 1892,Guaiacol,https://books.google.com/books?id=T41MAQAAMAAJ&newbks=1&newbks_redir=0&dq=Guaiacol&pg=PA381#v=onepage&q=Guaiacol&f=false,US Previously Marketed 1892,Guaiacol,https://books.google.com/books?id=T41MAQAAMAAJ&newbks=1&newbks_redir=0&dq=Guaiacol&pg=PA381#v=onepage&q=Guaiacol&f=false,Cough,Approved
GUAIFENESIN,93-14-1,https://drugs.ncats.io/drug/495W7451VQ,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""93%2014%201"")",ONLY CAS,US Approved OTC ,21 CFR 341.18 cough/cold:expectorant guaifenesin,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec341-18.xml,US Previously Marketed 1961,BRONKODYL GLYCERYL GUAIACOLATE by PRL,https://cdn.loc.gov/service/ll/fedreg/fr037/fr037145/fr037145.pdf,Common cold; Cough,Approved; Approved
GUANABENZ,60329-03-5,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""60329%2003%205"")",ONLY CAS,,,,,,,,
GUANADREL,40580-59-4,https://drugs.ncats.io/drug/765C9332T4,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""40580%2059%204"")",ONLY CAS,US Previously Marketed 1982,HYLOREL by PHARMACIA AND UPJOHN,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018104,US Previously Marketed 1982,HYLOREL by PHARMACIA AND UPJOHN,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018104,Hypertension,Approved
GUANETHIDINE,55-65-2,https://drugs.ncats.io/drug/ZTI6C33Q2Q,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""55%2065%202"")",ONLY CAS,US Previously Marketed 1985,GUANETHIDINE MONOSULFATE by WATSON LABS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=086114,US Previously Marketed 1960,lsmelin Sulfate by Ciba,DeHaen 1940-1975 NMEs,Hypertension,Approved
GUANFACINE,29110-47-2,https://drugs.ncats.io/drug/30OMY4G3MK,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""29110%2047%202"")",ONLY CAS,US Approved Rx 1997,ANDA074796,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=074796,US Previously Marketed 1986,TENEX by PROMIUS PHARMA,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019032,Attention deficit hyperactivity disorder; Hypertension,Approved; Approved
GUANIDINE,113-00-8,https://drugs.ncats.io/drug/JU58VJ6Y3B,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""113%2000%208"")",ONLY CAS,US Previously Marketed 1939,GUANIDINE HYDROCHLORIDE by MERCK SHARP DOHME,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=001546,US Previously Marketed 1939,GUANIDINE HYDROCHLORIDE by MERCK SHARP DOHME,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=001546,Eaton-Lambert syndrome,Approved
GUAR GUM,9000-30-0,https://drugs.ncats.io/drug/E89I1637KE,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""9000%2030%200"")",ONLY CAS,US Previously Marketed ,21 CFR 310.545(a)(12)(i) laxative:bulk laxative guar gum,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec310-545.xml,Possibly Marketed Outside US 1974,ANDA080767,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=77bb4ef4-c10e-4acc-8225-651d003f4561,,
GUSELKUMAB,1350289-85-8,https://drugs.ncats.io/drug/089658A12D,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1350289%2085%208"")",ONLY CAS,US Approved Rx 2017,BLA761061,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761061,US Approved Rx 2017,BLA761061,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761061,,
HAIR CONDITIONER,69-72-7,https://drugs.ncats.io/drug/O414PZ4LPZ,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""69%2072%207"")",ONLY CAS,US Approved OTC ,21 CFR 358.110(b) wart remover:collodoin-like vehicle salicylic acid,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec358-110.xml,US Previously Marketed 1860,sodium salicylate,https://catalog.hathitrust.org/Record/100782317,Psoriasis; Ichthyosis vulgaris; Keratosis palmaris; Bruises; Arthritis; Strains and sprains; Simple backache,Approved; Approved; Approved; Approved; Approved; Approved; Approved
HALAZEPAM,23092-17-3,https://drugs.ncats.io/drug/320YC168LF,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""23092%2017%203"")",ONLY CAS,US Previously Marketed 1981,PAXIPAM by SCHERING,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017736,US Previously Marketed 1981,PAXIPAM by SCHERING,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017736,Seizures; Anxiety,Preclinical; Approved
HALCINONIDE,3093-35-4,https://drugs.ncats.io/drug/SI86V6QNEG,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""3093%2035%204"")",ONLY CAS,US Approved Rx 1974,NDA017556,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017556,US Approved Rx 1974,NDA017556,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017556,Inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses,Approved
HALOPERIDOL,52-86-8,https://drugs.ncats.io/drug/J6292F8L3D,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""52%2086%208"")",ONLY CAS,US Approved Rx 1987,ANDA071131,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=071131,US Previously Marketed 1967,HALDOL by ORTHO MCNEIL,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=015922,Schizophrenia; Tourette's syndrome,Approved; Approved
HALOTHANE,151-67-7,https://drugs.ncats.io/drug/UQT9G45D1P,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""151%2067%207"")",ONLY CAS,US Previously Marketed 1975,HALOTHANE by HOSPIRA,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=083254,US Previously Marketed 1958,FLUOTHANE by WYETH AYERST,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=011338,Pain,Approved
HELODERMA HORRIDUM,141758-74-9,https://drugs.ncats.io/drug/9P1872D4OL,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""141758%2074%209"")",ONLY CAS,US Approved Rx 2005,NDA021773,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021773,US Approved Rx 2005,NDA021773,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021773,Type 2 diabetes mellitus,Approved
HEMICELLULASE,9025-56-3,https://drugs.ncats.io/drug/S2MZZ5DR1O,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""9025%2056%203"")",ONLY CAS,Possibly Marketed Outside US ,Canada:HEMICELLULASE,https://tripod.nih.gov/npc/#Download,Possibly Marketed Outside US 2019,"Stozyme by Chunwoo Pharmaceutical Co., Ltd.",https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=96932453-80c2-4a44-e053-2a95a90a7bb6,,
HEPARIN,9005-49-6,https://drugs.ncats.io/drug/T2410KM04A,12,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""9005%2049%206"")%20AND%20(root_names_name:""%5EHEPARIN$"")",EXACT NAME,US Approved Rx 2020,ANDA212060,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212060,US Previously Marketed 1939,LIQUAEMIN SODIUM by ORGANON USA INC,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=000552,venous thrombosis; peripheral arterial embolism; pulmonary embolism,Approved; Approved; Approved
HERBAL,69-72-7,https://drugs.ncats.io/drug/O414PZ4LPZ,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""69%2072%207"")",ONLY CAS,US Approved OTC ,21 CFR 358.110(b) wart remover:collodoin-like vehicle salicylic acid,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec358-110.xml,US Previously Marketed 1860,sodium salicylate,https://catalog.hathitrust.org/Record/100782317,Psoriasis; Ichthyosis vulgaris; Keratosis palmaris; Bruises; Arthritis; Strains and sprains; Simple backache,Approved; Approved; Approved; Approved; Approved; Approved; Approved
HESPERIDIN,520-26-3,https://drugs.ncats.io/drug/E750O06Y6O,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""520%2026%203"")",ONLY CAS,US Previously Marketed 1961,CVP WITH VITAMIN K BIOFLAVONOID by USV,https://patents.google.com/patent/US2888381,US Previously Marketed 1921,bioflavonoid,https://catalog.hathitrust.org/Record/100163146,"Metabolic syndrome; Obesity; Osteoporosis, osteopenia; Allergies; Skin Care",Phase II; Phase II; Phase III; Approved; Approved
HEXACHLOROPHENE,70-30-4,https://drugs.ncats.io/drug/IWW5FV6NK2,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""70%2030%204"")",ONLY CAS,US Approved Rx 1978,NDA017433,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017433,US Previously Marketed 1948,Hexachlorophene by Various Mfrs.,DeHaen 1940-1975 NMEs,Skin infections,Approved
HEXAMIDINE,3811-75-4,https://drugs.ncats.io/drug/3483C2H13H,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""3811%2075%204"")",ONLY CAS,Possibly Marketed Outside US ,WHO-ATC:R02AA18,https://ginas.ncats.nih.gov/ginas/app/substance/3483C2H13H,Possibly Marketed Outside US 2017,M006,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d39ee6a2-5d65-4198-82d9-deb83471f312,,
HEXYLRESORCINOL,136-77-6,https://drugs.ncats.io/drug/R9QTB5E82N,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""136%2077%206"")",ONLY CAS,US Previously Marketed 1926,hexylresorcinol by Leonard,https://jamanetwork.com/journals/jama/article-abstract/239930,US Previously Marketed 1926,hexylresorcinol by Leonard,https://jamanetwork.com/journals/jama/article-abstract/239930,Respiratory tract infections; Sore throat; Hyperpigmentation,Preclinical; Approved; Preclinical
HIBISCUS,64-17-5,https://drugs.ncats.io/drug/3K9958V90M,3,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""64%2017%205"")",ONLY CAS,US Approved Rx 2001,NDA021074,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021074,US Previously Marketed 0652,alcohol,https://en.wikipedia.org/wiki/Alcohol_(drug),Bacterial infections,Approved
HISTAMINE,51-45-6,https://drugs.ncats.io/drug/820484N8I3,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""51%2045%206"")",ONLY CAS,US Approved Allergenic Extract 1995,BLA103891,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5c20f3f4-65f8-4cdb-bdd1-5774da1c551b,US Previously Marketed 1939,HISTAMINE PHOSPHATE by LILLY,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=000734,Multiple sclerosis; Gastric acid secretory; Allergenic skin,Basic research; Approved; Not Provided
HISTIDINE,71-00-1,https://drugs.ncats.io/drug/4QD397987E,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""71%2000%201"")",ONLY CAS,US Previously Marketed ,21 CFR 310.545(a)(20) weight control histidine,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec310-545.xml,Possibly Marketed Outside US 1971,NDA016822,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6ea7ec73-403e-4303-8862-6380e2f1fda6,Histidyl-tRNA synthetase deficiency; Rheumatoid arthritis; Cholera; Menkes disease; Burn,Phase I; Not Provided; Not Provided; Phase III; Approved
HISTOPLASMIN,9008-05-3,https://drugs.ncats.io/drug/aef54421,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""9008%2005%203"")",ONLY CAS,,,,,,,,
HISTRELIN,76712-82-8,https://drugs.ncats.io/drug/H50H3S3W74,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""76712%2082%208"")",ONLY CAS,US Approved Rx 2007,NDA022058,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022058,US Previously Marketed 1991,SUPPRELIN by SHIRE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019836,Advanced prostate cancer,Approved
HOMATROPINE,87-00-3,https://drugs.ncats.io/drug/8QS6WCL55Z,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""87%2000%203"")",ONLY CAS,US Previously Marketed 1961,NUCODAN HOMATROPINE TEREPHTHALATE by ENDO,"Federal Register v. 40 (1975), page 17868, retrieved from: https://books.google.ru/books?id=UGhzt0-ApCwC",US Previously Marketed 1921,Homatropine Hydrobromide U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,Cough,Approved
HOMOSALATE,118-56-9,https://drugs.ncats.io/drug/V06SV4M95S,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""118%2056%209"")",ONLY CAS,Possibly Marketed Outside US ,part352,https://www.drugbank.ca/drugs/DB11064,Possibly Marketed Outside US 2004,21 CFR 352,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=aae30d5c-186a-4d63-b4d7-09e4edc10f05,Skin sun damage,Phase III
HONEY,8028-66-8,https://drugs.ncats.io/drug/Y9H1V576FH,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""8028%2066%208"")",ONLY CAS,US Previously Marketed 1921,Honey U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,US Previously Marketed 1921,Honey U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,,
HUMAN ALPHA1 PROTEINASE INHIBITOR,9041-92-3,https://drugs.ncats.io/drug/F43I396OIS,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""9041%2092%203"")",ONLY CAS,Possibly Marketed Outside US ,Zemaira by Csl Behring [Canada],https://www.drugbank.ca/drugs/DB00058,Possibly Marketed Outside US 1987,BLA103174,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2b620e6b-6a24-0957-1288-ae529c4cc3a2,,
HUMULUS LUPULUS,6754-58-1,https://drugs.ncats.io/drug/T4467YT1NT,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""6754%2058%201"")",ONLY CAS,Clinical 2019,"NCT03735420: Phase 1 Interventional Active, not recruiting Healthy",https://clinicaltrials.gov/ct2/show/NCT03735420,,,,Cancer; Metabolic syndrome; Alzheimer’s disease,Phase I; Phase I; Basic research
HUPERZINE A,102518-79-6,https://drugs.ncats.io/drug/0111871I23,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""102518%2079%206"")",ONLY CAS,Possibly Marketed Outside US 2019,NCT02931136: Phase 4 Interventional Not yet recruiting Mild Cognitive Impairment,https://clinicaltrials.gov/ct2/show/NCT02931136,,,,Alzheimer’s disease; Schizophrenia; Age-related memory impairment,Phase III; Phase IV; Approved
HYALURONIC ACID,9004-61-9,https://drugs.ncats.io/drug/S270N0TRQY,2,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""9004%2061%209"")%20AND%20(root_names_name:""%5EHYALURONIC%20ACID$"")",EXACT NAME,Possibly Marketed Outside US ,"Elcosys by DS TECH CO., LTD",https://www.drugbank.ca/drugs/DB08818,Possibly Marketed Outside US 2002,ANDA076559,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a75e2bb2-f89a-53f4-e053-2a95a90a93c7,Pain in osteoarthritis,Approved
HYALURONIDASE,9001-54-1,https://drugs.ncats.io/drug/8KOG53Z5EM,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""9001%2054%201"")",ONLY CAS,US Approved Rx 2004,BLA021665,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021665,US Previously Marketed 1949,Alidase by Searle,DeHaen 1940-1975 NMEs,,
HYDANTOIN,461-72-3,https://drugs.ncats.io/drug/I6208298TA,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""461%2072%203"")",ONLY CAS,Possibly Marketed Outside US 2015,21 CFR 333E,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=733b5ee5-76e2-4945-8d87-13e4e760f1d0,Possibly Marketed Outside US 2009,"WOUND and INFECTION MEDICATION by WESTWOOD LABORATORIES, INC.",https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=246acf39-6d01-4a6e-9efb-4e6c9ffab2cb,,
HYDRALAZINE,86-54-4,https://drugs.ncats.io/drug/26NAK24LS8,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""86%2054%204"")",ONLY CAS,US Approved Rx 2001,ANDA040388,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=040388,US Previously Marketed 1953,APRESOLINE by NOVARTIS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=008303,Hypertension,Approved
HYDROCHLORIC ACID,7647-01-0,https://drugs.ncats.io/drug/QTT17582CB,2,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""7647%2001%200"")%20AND%20(root_names_name:""%5EHYDROCHLORIC%20ACID$"")",EXACT NAME,US Previously Marketed 1921,Hydrochloric Acid U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,US Previously Marketed 1921,Hydrochloric Acid U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,Surgical Blood Losses,Approved
HYDROCHLOROTHIAZIDE,58-93-5,https://drugs.ncats.io/drug/0J48LPH2TH,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""58%2093%205"")",ONLY CAS,US Approved Rx 2013,ANDA201682,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201682,US Previously Marketed 1959,ORETIC by ABBVIE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=011971,Hypertension,Approved
HYDROCODONE,125-29-1,https://drugs.ncats.io/drug/6YKS4Y3WQ7,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""125%2029%201"")",ONLY CAS,US Approved Rx 2006,ANDA040655,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=040655,US Previously Marketed 1943,HYCODAN by GENUS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=005213,Pain; Acute pain,Approved; Approved
HYDROCORTISONE,50-23-7,https://drugs.ncats.io/drug/WI4X0X7BPJ,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""50%2023%207"")",ONLY CAS,US Approved Rx 1998,ANDA075043,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=075043,US Previously Marketed 1951,HYDROCORTONE by MERCK,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=008228,Congenital adrenal hyperplasia; Rheumatoid arthritis; Bronchial asthma; Leukemia,Approved; Approved; Approved; Approved
HYDROCORTISONE BUTEPRATE,72590-77-3,https://drugs.ncats.io/drug/O6550D6K3A,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""72590%2077%203"")",ONLY CAS,US Approved Rx 1998,ANDA075043,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=075043,US Previously Marketed 1951,HYDROCORTONE by MERCK,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=008228,Congenital adrenal hyperplasia; Rheumatoid arthritis; Bronchial asthma; Leukemia,Approved; Approved; Approved; Approved
HYDROFLUMETHIAZIDE,135-09-1,https://drugs.ncats.io/drug/501CFL162R,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""135%2009%201"")",ONLY CAS,US Previously Marketed 1985,HYDROFLUMETHIAZIDE by PAR PHARM,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=088850,US Previously Marketed 1959,SALURON by SHIRE LLC,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=011949,Hypertension; Edema,Approved; Approved
HYDROGEN PEROXIDE,7722-84-1,https://drugs.ncats.io/drug/BBX060AN9V,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""7722%2084%201"")",ONLY CAS,US Approved OTC ,21 CFR 344.1 otic:earwax removal aid carbamide peroxide 6.5% (in anhydrous glycerin),https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec344-10.xml,US Previously Marketed 1921,Hydrogen Peroxide ,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,Gingivitis; Skin infections; Seborrheic keratoses,Approved; Approved; Approved
HYDROMORPHONE,466-99-9,https://drugs.ncats.io/drug/Q812464R06,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""466%2099%209"")",ONLY CAS,US Approved Rx 2010,ANDA078261,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=078261,Possibly Marketed Outside US 1972,Hydromorphone Hydrochloride by Hikma Pharmaceuticals USA Inc.,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b325028e-0722-4c8c-9fdb-ab6fb0dc460c,Pain,Approved
HYDROQUINONE,123-31-9,https://drugs.ncats.io/drug/XV74C1N1AE,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""123%2031%209"")",ONLY CAS,US Approved Rx 2002,NDA021112,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021112,Possibly Marketed Outside US 1984,"NU-DERM SUNFADER  Skin Lightener with Sunscreen (SPF 15) PABA FREE by OMP, INC.",https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c67b0629-5529-412d-99ee-186df4ecad5a,Melasma of the face,Approved
HYDROXOCOBALAMIN,13422-51-0,https://drugs.ncats.io/drug/Q40X8H422O,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""13422%2051%200"")",ONLY CAS,US Approved Rx 1978,ANDA085998,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=085998,US Previously Marketed 1921,Sodium Chloride U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,Otitis externa; Cyanide poisoning,Approved; Approved
HYDROXYAMPHETAMINE,103-86-6,https://drugs.ncats.io/drug/FQR280JW2N,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""103%2086%206"")",ONLY CAS,US Previously Marketed 1961,VASOCORT HYDROXYAMPHETAMINE HYDROBROMIDE by SKF,https://cdn.loc.gov/service/ll/fedreg/fr036/fr036110/fr036110.pdf,US Previously Marketed 1935,Paredrine,https://trademarks.justia.com/713/72/paredrine-71372217.html,Eye diseases,Approved
HYDROXYCARBAMIDE,127-07-1,https://drugs.ncats.io/drug/X6Q56QN5QC,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""127%2007%201"")",ONLY CAS,US Approved Rx 1998,ANDA075143,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=075143,US Approved Rx 1967,NDA016295,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016295,Sickle cell anemia,Approved
HYDROXYCHLOROQUINE,118-42-3,https://drugs.ncats.io/drug/4QWG6N8QKH,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""118%2042%203"")",ONLY CAS,US Approved Rx 1998,ANDA040274,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=040274,US Approved Rx 1955,NDA009768,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=009768,Rheumatoid arthritis; Malaria; Systemic lupus erythematosus,Approved; Approved; Approved
HYDROXYLYSINE,1190-94-9,https://drugs.ncats.io/drug/2GQB349IUB,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1190%2094%209"")",ONLY CAS,Possibly Marketed Outside US 2012,SPAI-SONSPROLAC-VIT by SPAI-SONS PHARMACEUTICAL INTERNATIONAL COSMETICS,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4c294bea-5a61-4756-af3c-17ed30f2c0d8,Possibly Marketed Outside US 2012,SPAI-SONSPROLAC-VIT by SPAI-SONS PHARMACEUTICAL INTERNATIONAL COSMETICS,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4c294bea-5a61-4756-af3c-17ed30f2c0d8,,
HYDROXYPROGESTERONE,68-96-2,https://drugs.ncats.io/drug/21807M87J2,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""68%2096%202"")",ONLY CAS,Possibly Marketed Outside US ,WHO-ATC:G03DA03,https://ginas.ncats.nih.gov/ginas/app/substance/21807M87J2,,,,Recurrent miscarriage; Female infertility; Hypertrichosis; Premature labour,Approved; Approved; Approved; Approved
HYDROXYPROLINE,618-28-0,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""618%2028%200"")",ONLY CAS,,,,,,,,
HYDROXYTOLUIC ACID,83-40-9,https://drugs.ncats.io/drug/ZH3HEY032H,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""83%2040%209"")",ONLY CAS,Clinical ,INN:hydroxytoluic acid,https://tripod.nih.gov/npc/#Download,,,,Inflammation; Diabetes mellitus,Preclinical; Not Provided
HYDROXYZINE,68-88-2,https://drugs.ncats.io/drug/30S50YM8OG,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""68%2088%202"")",ONLY CAS,US Approved Rx 2008,ANDA040804,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=040804,US Previously Marketed 1956,ATARAX by ROERIG,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=010485,Anxiety; Pruritus,Approved; Approved
HYOSCYAMINE,101-31-5,https://drugs.ncats.io/drug/PX44XO846X,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""101%2031%205"")",ONLY CAS,US Previously Marketed 1961,RABELLON HYOSCYAMINE HYDROBROMIDE by MSD,https://www.govinfo.gov/content/pkg/FR-1970-11-07/pdf/FR-1970-11-07.pdf,US Previously Marketed 1921,Hyoscyamine Hydrobromide U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,,
HYPERICUM PERFORATUM,548-04-9,https://drugs.ncats.io/drug/7V2F1075HD,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""548%2004%209"")",ONLY CAS,Possibly Marketed Outside US ,"Unknown by Brockmann, H. et al.",https://link.springer.com/article/10.1007%2FBF01495453,,,,Depression; Cutaneous T-cell lymphoma; HIV-1 infection,Approved; Phase III; Phase I
HYPOCHLOROUS ACID,7790-92-3,https://drugs.ncats.io/drug/712K4CDC10,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""7790%2092%203"")",ONLY CAS,US Previously Marketed 1955,Kasdenol by Kasdenol,OB NME Appendix 1950-1993,US Previously Marketed 1921,Chlorinated Lime U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,,
IBALIZUMAB,680188-33-4,https://drugs.ncats.io/drug/LT369U66CE,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""680188%2033%204"")",ONLY CAS,US Approved Rx 2018,BLA761065,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761065,US Approved Rx 2018,BLA761065,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761065,,
IBANDRONIC ACID,114084-78-5,https://drugs.ncats.io/drug/UMD7G2653W,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""114084%2078%205"")",ONLY CAS,US Approved Rx 2016,ANDA206058,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206058,US Previously Marketed 2003,BONIVA by HOFFMANN LA ROCHE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021455,Postmenopausal osteoporosis; Bone cancer; Osteoporosis,Approved; Approved; Approved
IBRITUMOMAB TIUXETAN,206181-63-7,https://drugs.ncats.io/drug/4Q52C550XK,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""206181%2063%207"")",ONLY CAS,US Approved Rx 2002,BLA125019,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125019,US Approved Rx 2002,BLA125019,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125019,,
IBRUTINIB,936563-96-1,https://drugs.ncats.io/drug/1X70OSD4VX,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""936563%2096%201"")",ONLY CAS,US Approved Rx 2022,NDA217003,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217003,US Approved Rx 2013,NDA205552,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205552,Waldenström's macroglobulinemia; Mantle cell lymphoma; Chronic lymphocytic leukemia,Approved; Approved; Approved
IBUPROFEN,15687-27-1,https://drugs.ncats.io/drug/WK2XYI10QM,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""15687%2027%201"")",ONLY CAS,US Approved Rx 1987,ANDA072096,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=072096,US Previously Marketed 1974,MOTRIN by MCNEIL CONSUMER,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017463,Headache; Common cold; Backache; Toothache; Muscular aches,Approved; Approved; Approved; Approved; Approved
IBUTILIDE,122647-31-8,https://drugs.ncats.io/drug/2436VX1U9B,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""122647%2031%208"")",ONLY CAS,US Approved Rx 2010,ANDA090643,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=090643,US Approved Rx 1995,NDA020491,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020491,Atrial fibrillation,Approved
ICATIBANT,130308-48-4,https://drugs.ncats.io/drug/7PG89G35Q7,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""130308%2048%204"")",ONLY CAS,US Approved Rx 2020,ANDA211501,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211501,US Approved Rx 2011,NDA022150,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022150,Hereditary angioedema,Approved
ICOSAPENT,10417-94-4,https://drugs.ncats.io/drug/AAN7QOV9EA,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""10417%2094%204"")",ONLY CAS,US Approved Rx 2023,ANDA217844,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217844,Possibly Marketed Outside US 2008,DHA by Mission Pharmacal Company,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=40480393-700d-4afd-8309-704ac8689e85,Hypertriglyceridemia; Major depressive disorder; Alzheimer’s disease,Approved; Phase III; Phase III
IDARUBICIN,58957-92-9,https://drugs.ncats.io/drug/ZRP63D75JW,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""58957%2092%209"")",ONLY CAS,US Approved Rx 2007,ANDA065288,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=065288,US Previously Marketed 1990,IDAMYCIN by PFIZER,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050661,Acute myeloid leukemia,Approved
IDARUCIZUMAB,1362509-93-0,https://drugs.ncats.io/drug/97RWB5S1U6,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1362509%2093%200"")",ONLY CAS,US Approved Rx 2015,BLA761025,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761025,US Approved Rx 2015,BLA761025,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761025,,
IDEBENONE,58186-27-9,https://drugs.ncats.io/drug/HB6PN45W4J,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""58186%2027%209"")",ONLY CAS,Possibly Marketed Outside US ,EU/1/15/1020/001,https://www.drugbank.ca/drugs/DB09081,Possibly Marketed Outside US 2011,21 CFR 352,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=22729742-a481-40a3-9cba-7bedf054faca,Alzheimer’s disease; Leber’s hereditary optic neuropathy; Duchenne muscular dystrophy; Friedreich ataxia,Approved; Approved; Phase III; Approved
IDELALISIB,870281-82-6,https://drugs.ncats.io/drug/YG57I8T5M0,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""870281%2082%206"")",ONLY CAS,US Approved Rx 2014,NDA206545,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206545,US Approved Rx 2014,NDA206545,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206545,Small lymphocytic lymphoma; Follicular B-cell non-Hodgkin lymphoma (FL); Chronic lymphocytic leukemia,Approved; Approved; Approved
IDOXURIDINE,54-42-2,https://drugs.ncats.io/drug/LGP81V5245,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""54%2042%202"")",ONLY CAS,US Previously Marketed 1963,HERPLEX by ALLERGAN,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=013935,US Previously Marketed 1963,HERPLEX by ALLERGAN,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=013935,Herpes simplex keratitis,Approved
IDURSULFASE,50936-59-9,https://drugs.ncats.io/drug/5W8JGG2651,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""50936%2059%209"")",ONLY CAS,US Approved Rx 2006,BLA125151,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125151,US Approved Rx 2006,BLA125151,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125151,,
IFOSFAMIDE,3778-73-2,https://drugs.ncats.io/drug/UM20QQM95Y,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""3778%2073%202"")",ONLY CAS,US Approved Rx 2011,ANDA076619,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=076619,US Previously Marketed 1987,IFEX by BAXTER HLTHCARE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019763,Germ cell testicular cancer,Approved
ILEX AQUIFOLIUM,90045-83-3,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""90045%2083%203"")",ONLY CAS,,,,,,,,
ILOPERIDONE,133454-47-4,https://drugs.ncats.io/drug/VPO7KJ050N,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""133454%2047%204"")",ONLY CAS,US Approved Rx 2009,NDA022192,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022192,US Approved Rx 2009,NDA022192,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022192,Schizophrenia,Approved
ILOPROST,78919-13-8,https://drugs.ncats.io/drug/JED5K35YGL,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""78919%2013%208"")",ONLY CAS,US Approved Rx 2024,NDA217933,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217933,US Approved Rx 2004,NDA021779,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021779,Pulmonary arterial hypertension,Approved
IMATINIB,152459-95-5,https://drugs.ncats.io/drug/BKJ8M8G5HI,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""152459%2095%205"")",ONLY CAS,US Approved Rx 2015,ANDA078340,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=078340,US Previously Marketed 2001,GLEEVEC by NOVARTIS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021335,Myelodysplastic/myeloproliferative diseases associated with PDGFR; Hypereosinophilic syndrome; Philadelphia chromosome positive chronic myeloid leukemia; Philadelphia chromosome positive acute lymphoblastic leukemia; Aggressive systemic mastocytosis (D816V c-Kit mutation status negative/c-Kit mutational status unknown),Approved; Approved; Approved; Approved; Approved
IMIGLUCERASE,143003-46-7,https://drugs.ncats.io/drug/27T56C7KK0,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""143003%2046%207"")",ONLY CAS,US Previously Marketed 1991,Ceredase by Genzyme,OB NME Appendix 1950-1993,US Previously Marketed 1991,Ceredase by Genzyme,OB NME Appendix 1950-1993,,
IMIPENEM,64221-86-9,https://drugs.ncats.io/drug/Q20IM7HE75,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""64221%2086%209"")",ONLY CAS,US Approved Rx 2011,ANDA090577,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=090577,US Approved Rx 1985,NDA050587,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050587,Bacterial infections; Escherichia coli infections; Staphylococcal infections; Endocarditis; Urinary tract infections; Lower respiratory tract infections,Approved; Approved; Approved; Approved; Approved; Approved
IMIPRAMINE,50-49-7,https://drugs.ncats.io/drug/OGG85SX4E4,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""50%2049%207"")",ONLY CAS,US Approved Rx 2008,ANDA040751,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=040751,US Previously Marketed 1959,TOFRANIL by NOVARTIS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=011838,Depression,Approved
IMIQUIMOD,99011-02-6,https://drugs.ncats.io/drug/P1QW714R7M,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""99011%2002%206"")",ONLY CAS,US Approved Rx 2010,NDA022483,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022483,US Previously Marketed 1997,ALDARA by BAUSCH,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020723,Actinic keratosis; External genital and perianal warts/condyloma acuminata; Primary superficial basal cell carcinoma,Approved; Approved; Approved
IMMUNOGLOBULIN ANTI-CYTOMEGALOVIRUS,138660-96-5,https://drugs.ncats.io/drug/HV6MT68KKF,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""138660%2096%205"")",ONLY CAS,Clinical ,INN:sevirumab [INN],https://ginas.ncats.nih.gov/ginas/app/substance/HV6MT68KKF,,,,,
IMMUNOGLOBULIN ANTI-HEPATITIS B SURFACE ANTIGEN,569658-80-6,https://drugs.ncats.io/drug/5Q374M1S1P,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""569658%2080%206"")",ONLY CAS,Clinical ,INN:exbivirumab [INN],https://ginas.ncats.nih.gov/ginas/app/substance/5Q374M1S1P,,,,,
IMMUNOGLOBULIN ANTI-RABIES,2618667-99-3,https://drugs.ncats.io/drug/K3CR9VL7SE,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""2618667%2099%203"")",ONLY CAS,Clinical ,INN:silevimig [INN],https://ginas.ncats.nih.gov/ginas/app/substance/K3CR9VL7SE,,,,,
INDACATEROL,312753-06-3,https://drugs.ncats.io/drug/8OR09251MQ,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""312753%2006%203"")",ONLY CAS,US Previously Marketed 2015,UTIBRON by NOVARTIS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207930,US Previously Marketed 2011,ARCAPTA NEOHALER by NOVARTIS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022383,"Airflow obstruction in patients with chronic obstructive pulmonary disease (COPD); Airflow obstruction in patients with chronic obstructive pulmonary disease (COPD),",Approved; Approved
INDAPAMIDE,26807-65-8,https://drugs.ncats.io/drug/F089I0511L,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""26807%2065%208"")",ONLY CAS,US Approved Rx 1996,ANDA074722,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=074722,US Previously Marketed 1983,LOZOL by SANOFI AVENTIS US,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018538,Congestive heart failure; Hypertension,Approved; Approved
INDIGO CARMINE,860-22-0,https://drugs.ncats.io/drug/D3741U8K7L,2,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""860%2022%200"")%20AND%20(root_names_name:""%5EINDIGO%20CARMINE$"")",EXACT NAME,US Approved Rx 2022,NDA216264,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216264,Possibly Marketed Outside US 1975,NDA017555,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0caee228-12c7-437c-9ea6-06b4e51722e1,Bladder conditions,Approved
INDINAVIR,150378-17-9,https://drugs.ncats.io/drug/9MG78X43ZT,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""150378%2017%209"")",ONLY CAS,US Previously Marketed 1996,CRIXIVAN by MERCK SHARP DOHME,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020685,US Previously Marketed 1996,CRIXIVAN by MERCK SHARP DOHME,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020685,HIV infection,Approved
INDOCYANINE GREEN,3599-32-4,https://drugs.ncats.io/drug/IX6J1063HV,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""3599%2032%204"")",ONLY CAS,US Approved Rx 2007,ANDA040811,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=040811,US Previously Marketed 1959,IC-GREEN by RENEW PHARMS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=011525,Age-related macular degeneration; Surgery,Approved; Approved
INDOLE-3 CARBINOL,700-06-1,https://drugs.ncats.io/drug/C11E72455F,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""700%2006%201"")",ONLY CAS,Clinical 2018,NCT03687073: Phase 1 Interventional Completed Smoking,https://clinicaltrials.gov/ct2/show/NCT03687073,,,,Breast cancer; Cancer; Obesity,Phase III; Phase I; Phase II
INDOMETACIN,53-86-1,https://drugs.ncats.io/drug/XXE1CET956,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""53%2086%201"")",ONLY CAS,US Approved Rx 2009,ANDA079175,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=079175,US Previously Marketed 1965,INDOCIN by ZYLA LIFE SCIENCES,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016059,Osteoarthritis; Ankylosing spondylitis; Arthritis; Rheumatoid arthritis,Approved; Approved; Approved; Approved
INFLIXIMAB,170277-31-3,https://drugs.ncats.io/drug/B72HH48FLU,2,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""170277%2031%203"")%20AND%20(root_names_name:""%5EINFLIXIMAB$"")",EXACT NAME,US Approved Rx 2019,BLA761086,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761086,US Approved Rx 1998,BLA103772,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103772,,
INGENOL MEBUTATE,75567-37-2,https://drugs.ncats.io/drug/7686S50JAH,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""75567%2037%202"")",ONLY CAS,US Previously Marketed 2019,INGENOL MEBUTATE by PADAGIS ISRAEL,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209018,US Previously Marketed 2012,PICATO by LEO LABS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202833,Actinic keratosis; Unknown,Approved
INOSITOL,551-72-4,https://drugs.ncats.io/drug/63GQX5QW03,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""551%2072%204"")",ONLY CAS,,,,,,,,
INOSITOL NICOTINATE,6556-11-2,https://drugs.ncats.io/drug/A99MK953KZ,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""6556%2011%202"")",ONLY CAS,US Approved Rx 2014,ANDA090892,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=090892,US Previously Marketed 1937,"Niacin by Merck & Co, Inc.",https://archive.org/details/in.ernet.dli.2015.145864,Hyperlipidemia; Atherosclerotic disease; Myocardial infarction,Approved; Approved; Approved
INOTUZUMAB OZOGAMICIN,635715-01-4,https://drugs.ncats.io/drug/P93RUU11P7,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""635715%2001%204"")",ONLY CAS,US Approved Rx 2017,BLA761040,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761040,US Approved Rx 2017,BLA761040,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761040,,
INSULIN ASPART,116094-23-6,https://drugs.ncats.io/drug/D933668QVX,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""116094%2023%206"")",ONLY CAS,US Approved Rx 2000,BLA020986,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020986,US Approved Rx 2000,BLA020986,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020986,diabetes mellitus,Approved
INSULIN DEGLUDEC,844439-96-9,https://drugs.ncats.io/drug/54Q18076QB,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""844439%2096%209"")",ONLY CAS,US Approved Rx 2016,BLA208583,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208583,US Previously Marketed 2015,RYZODEG 70/30 by NOVO,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203313,,
INSULIN DETEMIR,169148-63-4,https://drugs.ncats.io/drug/4FT78T86XV,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""169148%2063%204"")",ONLY CAS,US Approved Rx 2005,BLA021878,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021878,US Approved Rx 2005,BLA021878,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021878,diabetes mellitus,Approved
INSULIN GLARGINE,160337-95-1,https://drugs.ncats.io/drug/2ZM8CX04RZ,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""160337%2095%201"")",ONLY CAS,US Approved Rx 2015,BLA205692,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205692,US Approved Rx 2000,BLA021081,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021081,type 1 diabetes mellitus; type 2 diabetes mellitus,Approved; Approved
INSULIN GLULISINE,207748-29-6,https://drugs.ncats.io/drug/7XIY785AZD,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""207748%2029%206"")",ONLY CAS,US Approved Rx 2004,BLA021629,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021629,US Approved Rx 2004,BLA021629,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021629,,
INSULIN HUMAN BASE,122320-73-4,https://drugs.ncats.io/drug/05V02F2KDG,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""122320%2073%204"")",ONLY CAS,US Previously Marketed 2007,ROSIGLITAZONE by WATSON LABS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=078023,US Previously Marketed 1999,AVANDIA by WOODWARD,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021071,Type 2 diabetes mellitus,Approved
INSULIN HUMAN ISOPHANE,8049-62-5,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""8049%2062%205"")",ONLY CAS,,,,,,,,
INSULIN HUMAN ZINC SUSPENSION (COMPOUND),8049-62-5,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""8049%2062%205"")",ONLY CAS,,,,,,,,
INSULIN HUMAN ZINC SUSPENSION (CRYSTALLINE),8049-62-5,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""8049%2062%205"")",ONLY CAS,,,,,,,,
INSULIN LISPRO,133107-64-9,https://drugs.ncats.io/drug/GFX7QIS1II,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""133107%2064%209"")",ONLY CAS,US Approved Rx 1996,BLA020563,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020563,US Approved Rx 1996,BLA020563,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020563,diabetes mellitus,Approved
INSULIN LISPRO PROTAMINE,133107-64-9,https://drugs.ncats.io/drug/GFX7QIS1II,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""133107%2064%209"")",ONLY CAS,US Approved Rx 1996,BLA020563,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020563,US Approved Rx 1996,BLA020563,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020563,diabetes mellitus,Approved
INSULIN PORCINE ISOPHANE,8049-62-5,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""8049%2062%205"")",ONLY CAS,,,,,,,,
INSULIN PORCINE ZINC SUSPENSION (COMPOUND),8049-62-5,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""8049%2062%205"")",ONLY CAS,,,,,,,,
INTERFERON ALFA-2A,76543-88-9,https://drugs.ncats.io/drug/47RRR83SK7,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""76543%2088%209"")",ONLY CAS,Possibly Marketed Outside US ,UK NHS:Interferon alfa-2a,https://tripod.nih.gov/npc/#Download,,,,,
INTERFERON ALFA-2B,98530-12-2,https://drugs.ncats.io/drug/43K1W2T1M6,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""98530%2012%202"")",ONLY CAS,US Approved Rx 1986,BLA103132,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103132,US Approved Rx 1986,BLA103132,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103132,,
INTERFERON ALFACON-1,118390-30-0,https://drugs.ncats.io/drug/56588OP40D,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""118390%2030%200"")",ONLY CAS,US Previously Marketed 1997,Infergen,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103663,US Previously Marketed 1997,Infergen,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103663,,
INTERFERON BETA-1A,145258-61-3,https://drugs.ncats.io/drug/XRO4566Q4R,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""145258%2061%203"")",ONLY CAS,US Approved Rx 1996,BLA103628,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103628,US Approved Rx 1996,BLA103628,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103628,,
INTERFERON BETA-1B,145155-23-3,https://drugs.ncats.io/drug/TTD90R31WZ,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""145155%2023%203"")",ONLY CAS,US Approved Rx 1993,BLA103471,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103471,US Approved Rx 1993,BLA103471,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103471,,
INTRINSIC FACTOR,9008-12-2,https://drugs.ncats.io/drug/70BT6OQT2Q,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""9008%2012%202"")",ONLY CAS,US Previously Marketed 1953,Bifacton by Organon,DeHaen 1940-1975 NMEs,US Previously Marketed 1953,Bifacton by Organon,DeHaen 1940-1975 NMEs,,
INULIN,9005-80-5,https://drugs.ncats.io/drug/JOS53KRJ01,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""9005%2080%205"")",ONLY CAS,US Previously Marketed 1940,INULIN AND SODIUM CHLORIDE by ISO TEX,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=002282,US Previously Marketed 1940,INULIN AND SODIUM CHLORIDE by ISO TEX,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=002282,kidney disease,Approved
IODINATED POPPYSEED OIL,8002-46-8,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""8002%2046%208"")",ONLY CAS,,,,,,,,
IODINE,7553-56-2,https://drugs.ncats.io/drug/9679TC07X4,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""7553%2056%202"")",ONLY CAS,US Approved OTC ,21 CFR 333.210(d) antifungal povidone-iodine,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec333-210.xml,US Previously Marketed 1921,Iodine U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,antiseptic,Approved
IODIXANOL,92339-11-2,https://drugs.ncats.io/drug/HW8W27HTXX,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""92339%2011%202"")",ONLY CAS,US Approved Rx 1997,NDA020808,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020808,US Approved Rx 1996,NDA020351,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020351,Cardiovascular diseases,Approved
IODOFORM,75-47-8,https://drugs.ncats.io/drug/KXI2J76489,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""75%2047%208"")",ONLY CAS,US Previously Marketed 1921,Iodoform U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,US Previously Marketed 1921,Iodoform U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,Root canal filling; Irritated ears,Not Provided; Not Provided
IOHEXOL,66108-95-0,https://drugs.ncats.io/drug/4419T9MX03,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""66108%2095%200"")",ONLY CAS,US Approved Rx 1995,NDA020608,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020608,US Approved Rx 1985,NDA018956,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018956,,
IOPAMIDOL,60166-93-0,https://drugs.ncats.io/drug/JR13W81H44,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""60166%2093%200"")",ONLY CAS,US Approved Rx 1985,NDA018735,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018735,US Approved Rx 1985,NDA018735,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018735,Urinary system disease; Cardiovascular diseases; Glioma,Approved; Approved; Approved
IOPANOIC ACID,96-83-3,https://drugs.ncats.io/drug/FE9794P71J,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""96%2083%203"")",ONLY CAS,US Previously Marketed 1951,TELEPAQUE by GE HEALTHCARE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=008032,US Previously Marketed 1951,TELEPAQUE by GE HEALTHCARE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=008032,Cholelithiasis; Gallbladder disease,Approved; Approved
IOPODIC ACID,5587-89-3,https://drugs.ncats.io/drug/F604ZKI910,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""5587%2089%203"")",ONLY CAS,US Previously Marketed 1962,ORAGRAFIN SODIUM by BRACCO,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=012967,US Previously Marketed 1962,ORAGRAFIN SODIUM by BRACCO,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=012967,Hyperthyroidism; Graves' hyperthyroidism,Approved; Approved
IOPROMIDE,73334-07-3,https://drugs.ncats.io/drug/712BAC33MZ,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""73334%2007%203"")",ONLY CAS,US Approved Rx 1995,NDA020220,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020220,US Approved Rx 1995,NDA020220,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020220,Cancer; Cardiovascular diseases; Urinary system disease,Approved; Approved; Approved
IOTALAMIC ACID,2276-90-6,https://drugs.ncats.io/drug/16CHD79MIX,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""2276%2090%206"")",ONLY CAS,US Approved Rx 1962,NDA013295,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=013295,US Approved Rx 1962,NDA013295,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=013295,Kidney failure,Approved
IOVERSOL,87771-40-2,https://drugs.ncats.io/drug/N3RIB7X24K,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""87771%2040%202"")",ONLY CAS,US Approved Rx 1988,NDA019710,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019710,US Approved Rx 1988,NDA019710,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019710,Urinary system disease; Cardiovascular diseases; Glioma,Approved; Approved; Approved
IOXAGLIC ACID,59017-64-0,https://drugs.ncats.io/drug/Z40X7EI2AF,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""59017%2064%200"")",ONLY CAS,US Previously Marketed 1985,HEXABRIX by GUERBET,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018905,US Previously Marketed 1985,HEXABRIX by GUERBET,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018905,Vascular cerebral disorders; Joint disorder; Coronary artery disease; Urinary tract disorders; Vein disease; Kidney failure; Brain disease; Coronary artery disease,Approved; Approved; Approved; Approved; Approved; Approved; Approved; Approved
IOXILAN,107793-72-6,https://drugs.ncats.io/drug/A4YJ7J11TG,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""107793%2072%206"")",ONLY CAS,US Previously Marketed 1995,OXILAN-300 by GUERBET,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020316,US Previously Marketed 1995,OXILAN-300 by GUERBET,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020316,Contrast agent,Approved
IPILIMUMAB,477202-00-9,https://drugs.ncats.io/drug/6T8C155666,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""477202%2000%209"")",ONLY CAS,US Approved Rx 2011,BLA125377,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125377,US Approved Rx 2011,BLA125377,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125377,,
IPRATROPIUM BROMIDE,22254-24-6,https://drugs.ncats.io/drug/VJV4X1P2Z1,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""22254%2024%206"")",ONLY CAS,US Approved Rx 2003,ANDA076025,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=076025,US Previously Marketed 1986,ATROVENT by BOEHRINGER INGELHEIM,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019085,Chronic obstructive pulmonary disease,Approved
IRBESARTAN,138402-11-6,https://drugs.ncats.io/drug/J0E2756Z7N,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""138402%2011%206"")",ONLY CAS,US Approved Rx 2012,ANDA077369,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=077369,US Approved Rx 1997,NDA020758,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020758,Hypertension; Diabetic nephropathy,Approved; Approved
IRINOTECAN,97682-44-5,https://drugs.ncats.io/drug/7673326042,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""97682%2044%205"")",ONLY CAS,,,,,,,,
IRON DEXTRAN,9004-66-4,https://drugs.ncats.io/drug/95HR524N2M,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""9004%2066%204"")",ONLY CAS,US Approved OTC ,21 CFR 347.10(c) skin protectant calamine,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec347-10.xml,US Previously Marketed 1921,Saccharated Ferric Oxide N.F.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,Iron deficiency anemia; Radioactive cesium and/or radioactive or non-radioactive thallium internal contamination; Pain; Unknown; Chronic kidney disease; Unknown; Unknown; Unknown; Dental diseases; Parenteral Nutrition; Iron deficiency,Approved; Approved; Approved; Approved; Basic research; Approved; Approved
IRON FERRIC,7705-08-0,https://drugs.ncats.io/drug/U38V3ZVV3V,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""7705%2008%200"")",ONLY CAS,US Approved OTC ,21 CFR 347.10(c) skin protectant calamine,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec347-10.xml,US Previously Marketed 1921,Saccharated Ferric Oxide N.F.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,Iron deficiency anemia; Radioactive cesium and/or radioactive or non-radioactive thallium internal contamination; Pain; Unknown; Chronic kidney disease; Unknown; Unknown; Unknown; Dental diseases; Parenteral Nutrition; Iron deficiency,Approved; Approved; Approved; Approved; Basic research; Approved; Approved
IRON FERROUS,50-81-7,https://drugs.ncats.io/drug/PQ6CK8PD0R,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""50%2081%207"")",ONLY CAS,US Approved Rx 2018,NDA209381,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209381,US Previously Marketed 1947,BEROCCA PN by ROCHE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=006071,Scurvy; Vitamin C deficiency,Approved; Approved
IRON METAL,7439-89-6,https://drugs.ncats.io/drug/E1UOL152H7,4,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""7439%2089%206"")",ONLY CAS,US Previously Marketed 1961,PRELU-VITE IRON by GEIGY,https://www.govinfo.gov/content/pkg/FR-1970-08-08/pdf/FR-1970-08-08.pdf,US Previously Marketed 1921,Iron U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,,
ISAVUCONAZOLE,241479-67-4,https://drugs.ncats.io/drug/60UTO373KE,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""241479%2067%204"")",ONLY CAS,US Approved Rx 2015,NDA207500,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207500,US Approved Rx 2015,NDA207500,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207500,Invasive aspergillosis; Invasive mucormycosis,Approved; Approved
ISAVUCONAZONIUM,742049-41-8,https://drugs.ncats.io/drug/VH2L779W8Q,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""742049%2041%208"")",ONLY CAS,US Approved Rx 2015,NDA207500,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207500,US Approved Rx 2015,NDA207500,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207500,Invasive aspergillosis; Invasive mucormycosis,Approved; Approved
ISOCARBOXAZID,59-63-2,https://drugs.ncats.io/drug/34237V843T,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""59%2063%202"")",ONLY CAS,US Approved Rx 1959,NDA011961,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=011961,US Approved Rx 1959,NDA011961,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=011961,Depression,Approved
ISOETARINE,530-08-5,https://drugs.ncats.io/drug/YV0SN3276Q,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""530%2008%205"")",ONLY CAS,US Previously Marketed 1983,ISOETHARINE HYDROCHLORIDE by ROXANE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=088275,US Previously Marketed 1961,Bronkosol by Sterling,OB NME Appendix 1950-1993,Chronic bronchitis; Emphysema,Approved; Approved
ISOFLURANE,26675-46-7,https://drugs.ncats.io/drug/CYS9AKD70P,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""26675%2046%207"")",ONLY CAS,US Approved Rx 1999,ANDA075225,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=075225,US Approved Rx 1979,NDA017624,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017624,Pain,Approved
ISOHEXADECANE,1560-93-6,https://drugs.ncats.io/drug/04R9AW5KWV,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1560%2093%206"")",ONLY CAS,,,,,,,,
ISOLEUCINE,443-79-8,https://drugs.ncats.io/drug/5HX0BYT4E3,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""443%2079%208"")",ONLY CAS,US Previously Marketed ,21 CFR 310.545(a)(20) weight control isoleucine,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec310-545.xml,Possibly Marketed Outside US 1971,NDA016822,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=aa89dad1-bf4f-4f7e-ad1b-2431bdf36a2d,Acute infectious diarrhoea; Hyperglycemia; Liver cirrhosis; Burns,Phase II; Not Provided; Phase IV; Approved
ISOMETHEPTENE,503-01-5,https://drugs.ncats.io/drug/Y7L24THH6T,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""503%2001%205"")",ONLY CAS,,,,,,,Migraine; Headache; Neuralgia,Approved; Approved; Approved
ISONIAZID,54-85-3,https://drugs.ncats.io/drug/V83O1VOZ8L,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""54%2085%203"")",ONLY CAS,US Approved Rx 2014,ANDA202610,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202610,US Previously Marketed 1952,NYDRAZID by SANDOZ,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=008662,Tuberculosis,Approved
ISOPRENALINE,7683-59-2,https://drugs.ncats.io/drug/L628TT009W,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""7683%2059%202"")",ONLY CAS,US Approved Rx 2021,ANDA211864,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211864,US Previously Marketed 1948,ISUPREL by SANOFI AVENTIS US,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=006328,Bronchospasm occurring during anesthesia; Cardiac arrest; Heart block; Adams-stokes syndrome,Approved; Approved; Approved; Approved
ISOPROPYL MYRISTATE,110-27-0,https://drugs.ncats.io/drug/0RE8K4LNJS,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""110%2027%200"")",ONLY CAS,Possibly Marketed Outside US ,Resultz by Aralez Pharmaceuticals Canada Inc [Canada],https://www.drugbank.ca/drugs/DB13966,Possibly Marketed Outside US 2000,Excel by United Pet Group,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=447024cb-5965-4f1e-9e8d-d12d9ba3fca0,Unknown,
ISOPROPYL PALMITATE,142-91-6,https://drugs.ncats.io/drug/8CRQ2TH63M,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""142%2091%206"")",ONLY CAS,US Previously Marketed ,"21 CFR 310.545(a)(18)(vi)(B) skin protectant:poison ivy/oak/sumac w/ sales less than $25,000 isopropyl palmitate",https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec310-545.xml,Possibly Marketed Outside US 1996,Hydrocortisone Acetate Pramoxine Hcl by Bryant Ranch Prepack,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=79fae74b-bef2-4e13-a2e9-da68747951eb,Unknown,
ISOSORBIDE,652-67-5,https://drugs.ncats.io/drug/WXR179L51S,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""652%2067%205"")",ONLY CAS,US Previously Marketed 1974,ISMOTIC by ALCON,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017063,US Previously Marketed 1974,ISMOTIC by ALCON,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017063,Ocular hypertension; Glaucoma,Approved; Approved
ISOSORBIDE DINITRATE,87-33-2,https://drugs.ncats.io/drug/IA7306519N,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""87%2033%202"")",ONLY CAS,,,,,,,,
ISOSORBIDE MONONITRATE,16051-77-7,https://drugs.ncats.io/drug/LX1OH63030,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""16051%2077%207"")",ONLY CAS,US Approved Rx 2018,ANDA207141,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207141,US Previously Marketed 1921,Spirit of Glyceryl Trinitrate U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,Angina pectoris; Coronary heart disease; Pulmonary hypertension; Angina pectoris; Hypertensive crises; Heart failure; Angina pectoris; Hypertension; Angina; Heart failure; Myocardial infarction; Angina pectoris; Angina pectoris,Approved; Basic research; Approved; Approved; Approved; Approved; Approved; Approved; Approved; Approved; Approved; Approved; Approved
ISOTRETINOIN,4759-48-2,https://drugs.ncats.io/drug/EH28UP18IF,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""4759%2048%202"")",ONLY CAS,US Approved Rx 2019,ANDA211644,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211644,US Previously Marketed 1971,RETIN-A by VALEANT INTL,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016921,severe recalcitrant nodular acne; Acne vulgaris; Acute promyelocytic leukemia; AIDS-related Kaposi’s sarcoma,Approved; Approved; Approved; Approved
ISOXSUPRINE,395-28-8,https://drugs.ncats.io/drug/R15UI3245N,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""395%2028%208"")",ONLY CAS,US Previously Marketed 1959,Vasodilan by Mead Johnson,OB NME Appendix 1950-1993,US Previously Marketed 1959,Vasodilan by Mead Johnson,OB NME Appendix 1950-1993,Arteriosclerosis obliterans; Thromboangitis obliterans; Raynaud's disease,Approved; Approved; Approved
ISRADIPINE,75695-93-1,https://drugs.ncats.io/drug/YO1UK1S598,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""75695%2093%201"")",ONLY CAS,US Approved Rx 2006,ANDA077169,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=077169,US Previously Marketed 1990,DYNACIRC by SMITHKLINE BEECHAM,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019546,Hypertension,Approved
ITRACONAZOLE,84625-61-6,https://drugs.ncats.io/drug/304NUG5GF4,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""84625%2061%206"")",ONLY CAS,US Approved Rx 2015,ANDA205573,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205573,US Approved Rx 1992,NDA020083,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020083,"Blastomycosis, pulmonary and extrapulmonary; Onychomycosis; Aspergillosis, pulmonary and extrapulmonary; Histoplasmosis",Phase III; Approved; Approved; Approved
IVABRADINE,155974-00-8,https://drugs.ncats.io/drug/3H48L0LPZQ,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""155974%2000%208"")",ONLY CAS,US Approved Rx 2023,ANDA213442,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213442,US Approved Rx 2015,NDA206143,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206143,Chronic heart failure,Approved
IVACAFTOR,873054-44-5,https://drugs.ncats.io/drug/1Y740ILL1Z,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""873054%2044%205"")",ONLY CAS,US Approved Rx 2018,NDA210491,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210491,US Approved Rx 2012,NDA203188,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203188,Cystic fibrosis,Approved
IVERMECTIN,70288-86-7,https://drugs.ncats.io/drug/8883YP2R6D,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""70288%2086%207"")",ONLY CAS,US Approved Rx 2019,ANDA210019,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210019,Possibly Marketed Outside US 1984,NADA128409,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5d8e1598-f824-415e-927c-dbe70e735f80,Onchocerciasis; Strongyloidiasis of the intestinal tract,Approved; Approved
IVOSIDENIB,1448347-49-6,https://drugs.ncats.io/drug/Q2PCN8MAM6,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1448347%2049%206"")",ONLY CAS,US Approved Rx 2018,NDA211192,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211192,US Approved Rx 2018,NDA211192,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211192,Relapsed or refractory acute myeloid leukemia; Cholangiocarcinoma,Approved; Phase III
IXABEPILONE,219989-84-1,https://drugs.ncats.io/drug/K27005NP0A,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""219989%2084%201"")",ONLY CAS,US Approved Rx 2007,NDA022065,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022065,US Approved Rx 2007,NDA022065,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022065,Breast cancer,Approved
IXAZOMIB,1072833-77-2,https://drugs.ncats.io/drug/71050168A2,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1072833%2077%202"")",ONLY CAS,US Approved Rx 2015,NDA208462,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208462,US Approved Rx 2015,NDA208462,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208462,Multiple myeloma; Bladder cancer; Multiple myeloma; Glioblastoma,Approved; Phase II; Approved; Phase I
IXEKIZUMAB,1143503-69-8,https://drugs.ncats.io/drug/BTY153760O,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1143503%2069%208"")",ONLY CAS,US Approved Rx 2016,BLA125521,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125521,US Approved Rx 2016,BLA125521,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125521,,
JOJOBA OIL,61789-91-1,https://drugs.ncats.io/drug/724GKU717M,2,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""61789%2091%201"")%20AND%20(root_names_name:""%5EJOJOBA%20OIL$"")",EXACT NAME,US Previously Marketed ,21 CFR 310.527(a) hair loss prevention jojoba oil,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec310-527.xml,Possibly Marketed Outside US 2007,21 CFR 333,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d645ab34-1a96-48d1-b9d2-e2dd9e614f78,,
KANAMYCIN,59-01-8,https://drugs.ncats.io/drug/EQK9Q303C5,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""59%2001%208"")",ONLY CAS,US Previously Marketed 2002,KANAMYCIN SULFATE by FRESENIUS KABI USA,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=065111,US Previously Marketed 1958,Kantrex by Bristol,DeHaen 1940-1975 NMEs,Unknown,
KAOLIN,1332-58-7,https://drugs.ncats.io/drug/24H4NWX5CO,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1332%2058%207"")",ONLY CAS,US Approved OTC ,21 CFR 335.10(b) antidiarrheal kaolin,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec335-10.xml,US Previously Marketed 1921,Kaolin N.F.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,Diaper rash; Ulcerative colitis; Radiation- and chemotherapy-induced mucositis; Diarrhea; Cholera,Approved; Approved; Approved; Approved; Approved
KEROSENE,8008-20-6,https://drugs.ncats.io/drug/1C89KKC04E,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""8008%2020%206"")",ONLY CAS,,,,,,,,
KETAMINE,6740-88-1,https://drugs.ncats.io/drug/690G0D6V8H,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""6740%2088%201"")",ONLY CAS,US Approved Rx 1996,ANDA074549,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=074549,US Approved Rx 1970,NDA016812,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016812,Pain,Approved
KETOCONAZOLE,65277-42-1,https://drugs.ncats.io/drug/R9400W927I,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""65277%2042%201"")",ONLY CAS,US Approved Rx 2000,ANDA075581,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=075581,US Previously Marketed 1981,NIZORAL by JANSSEN PHARMS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018533,Tinea corporis; Tinea pedis; Cutaneous candidiasis; Blastomycosis; Coccidioidomycosis; Cushing’s disease; Type 2 diabetes mellitus,Approved; Approved; Approved; Approved; Approved; Phase III; Phase II
KETOPROFEN,22071-15-4,https://drugs.ncats.io/drug/90Y4QC304K,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""22071%2015%204"")",ONLY CAS,US Approved Rx 1993,ANDA074014,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=074014,US Previously Marketed 1986,ORUDIS by WYETH AYERST,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018754,"Rheumatoid arthritis; Pain; Osteoarthritis; Primary dysmenorrhea; Migraine; Pain, postoperative; Musculoskeletal pain",Approved; Approved; Approved; Approved; Approved; Approved; Approved
KETOROLAC,74103-06-3,https://drugs.ncats.io/drug/YZI5105V0L,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""74103%2006%203"")",ONLY CAS,US Approved Rx 2009,ANDA077308,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=077308,US Previously Marketed 1989,TORADOL by ROCHE PALO,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019698,Ocular pain,Approved
KETOTIFEN,34580-13-7,https://drugs.ncats.io/drug/X49220T18G,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""34580%2013%207"")",ONLY CAS,US Approved Rx 2008,ANDA077200,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=077200,US Previously Marketed 1999,ZADITOR by ALCON PHARMA,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021066,Allergic conjunctivitis,Approved
KOJIC ACID,501-30-4,https://drugs.ncats.io/drug/6K23F1TT52,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""501%2030%204"")",ONLY CAS,Possibly Marketed Outside US 2024,505G(a)(3),https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=10c878ed-c1d6-5948-e063-6294a90a5bac,Possibly Marketed Outside US 2002,21 CFR 358,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c24a9fd8-1fb5-4643-92df-b268479a35e5,Hyperpigmentation,Preclinical
L-METHIONINE,63-68-3,https://drugs.ncats.io/drug/AE28F7PNPL,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""63%2068%203"")",ONLY CAS,US Previously Marketed 1945,Methionine by Various Mfrs.,DeHaen 1940-1975 NMEs,US Previously Marketed 1945,Methionine by Various Mfrs.,DeHaen 1940-1975 NMEs,AIDS vacuolar myelopathy; Skin irritation in incontinent adults and diaper rash in infants; Alkaline urine,Phase III; Not Provided; Approved
LABETALOL,36894-69-6,https://drugs.ncats.io/drug/R5H8897N95,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""36894%2069%206"")",ONLY CAS,US Approved Rx 2018,ANDA209603,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209603,Possibly Marketed Outside US 1984,NDA018716,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a4195473-51a9-40f1-8678-1478ebca2d84,Hypertension,Approved
LACOSAMIDE,175481-36-4,https://drugs.ncats.io/drug/563KS2PQY5,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""175481%2036%204"")",ONLY CAS,US Approved Rx 2023,ANDA215379,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215379,US Approved Rx 2008,NDA022254,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022254,Partial-onset seizures; Diabetic neuropathy,Approved; Phase III
LACTOBACILLUS ACIDOPHILUS,68333-16-4,https://drugs.ncats.io/drug/1PRR1V42V5,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""68333%2016%204"")",ONLY CAS,US Previously Marketed 1921,Lactobacillus acidophilus,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,US Previously Marketed 1921,Lactobacillus acidophilus,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,,
LACTOBACILLUS CASEI,68333-14-2,https://drugs.ncats.io/drug/SA940P2U00,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""68333%2014%202"")",ONLY CAS,Possibly Marketed Outside US ,Canada:LACTOBACILLUS CASEI,https://tripod.nih.gov/npc/#Download,Possibly Marketed Outside US 2013,Fusion Plus by U.S. Pharmaceutical Corporation,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1c692970-41fc-47a9-a0ff-67b9d41ab217,,
LACTOFERRIN,446-72-0,https://drugs.ncats.io/drug/DH2M523P0H,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""446%2072%200"")",ONLY CAS,Possibly Marketed Outside US ,"Fosteum by Primus Pharmaceuticals, Inc.",https://www.drugbank.ca/drugs/DB01645,Possibly Marketed Outside US 2007,"Fosteum by Primus Pharmaceuticals, Inc.",https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=899ea7ce-0996-4635-9545-1e07091cf400,Metabolic syndrome; Colorectal cancer; Cystic fibrosis,Phase III; Phase II; Phase II
LACTOSE,63-42-3,https://drugs.ncats.io/drug/3SY5LH9PMK,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""63%2042%203"")",ONLY CAS,US Previously Marketed 1921,Sugar of Milk U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,US Previously Marketed 1921,Sugar of Milk U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,Unknown,
LACTUCA VIROSA,85117-07-3,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""85117%2007%203"")",ONLY CAS,,,,,,,,
LACTULOSE,4618-18-2,https://drugs.ncats.io/drug/9U7D5QH5AE,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""4618%2018%202"")",ONLY CAS,US Approved Rx 2003,ANDA076645,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=076645,Possibly Marketed Outside US 1966,ANDA074623,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0f19e4ed-c90a-4330-a7fa-bf911aa98f09,Chronic constipation; Portal-systemic encephalopathy,Approved; Approved
LAGERSTROEMIA SPECIOSA,4547-24-4,https://drugs.ncats.io/drug/AMX2I57A98,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""4547%2024%204"")",ONLY CAS,,,,,,,Type 2 diabetes mellitus,Basic research
LAMIVUDINE,134678-17-4,https://drugs.ncats.io/drug/2T8Q726O95,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""134678%2017%204"")",ONLY CAS,US Approved Rx 1998,NDA021004,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021004,US Approved Rx 1995,NDA020564,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020564,HIV-1 infection; Chronic hepatitis B; Unknown,Approved; Approved
LAMOTRIGINE,84057-84-1,https://drugs.ncats.io/drug/U3H27498KS,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""84057%2084%201"")",ONLY CAS,US Approved Rx 2015,ANDA204158,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204158,US Approved Rx 1994,NDA020241,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020241,Epilepsy; Bipolar disorder,Approved; Approved
LANADELUMAB,1426055-14-2,https://drugs.ncats.io/drug/2372V1TKXK,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1426055%2014%202"")",ONLY CAS,Possibly Marketed Outside US ,Takhzyro by Shire Pharma Canada Ulc [Canada],https://www.drugbank.ca/drugs/DB14597,Possibly Marketed Outside US 2018,BLA761090,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=15f99d8c-efe7-4f7d-aa20-0d0f1e30c6e8,,
LANREOTIDE,108736-35-2,https://drugs.ncats.io/drug/0G3DE8943Y,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""108736%2035%202"")",ONLY CAS,US Approved Rx 2007,NDA022074,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022074,US Approved Rx 2007,NDA022074,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022074,Acromegaly,Approved
LANSOPRAZOLE,103577-45-3,https://drugs.ncats.io/drug/0K5C5T2QPG,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""103577%2045%203"")",ONLY CAS,US Approved Rx 2012,ANDA202176,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202176,US Approved Rx 1995,NDA020406,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020406,Active duodenal ulcer; Gastric ulcer; Gastroesophageal reflux disease; Erosive esophagitis; Heartburn; Gastroesophageal reflux disease; Active duodenal ulcer; Gastric ulcer,Approved; Approved; Approved; Approved; Approved; Approved; Approved; Approved
LANTHANUM,7439-91-0,https://drugs.ncats.io/drug/6I3K30563S,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""7439%2091%200"")",ONLY CAS,Possibly Marketed Outside US 2010,"Lancell Slimming by MICELLBio Co., Ltd",https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ef3b1b6a-9976-4cc2-bdcf-c56e6798a988,Possibly Marketed Outside US 2010,"Lancell Slimming by MICELLBio Co., Ltd",https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ef3b1b6a-9976-4cc2-bdcf-c56e6798a988,,
LAPATINIB,231277-92-2,https://drugs.ncats.io/drug/0VUA21238F,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""231277%2092%202"")",ONLY CAS,US Approved Rx 2007,NDA022059,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022059,US Approved Rx 2007,NDA022059,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022059,Breast cancer,Approved
LARONIDASE,210589-09-6,https://drugs.ncats.io/drug/WP58SVM6R4,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""210589%2009%206"")",ONLY CAS,US Approved Rx 2003,BLA125058,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125058,US Approved Rx 2003,BLA125058,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125058,,
LAROTRECTINIB,1223403-58-4,https://drugs.ncats.io/drug/PF9462I9HX,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1223403%2058%204"")",ONLY CAS,US Approved Rx 2018,NDA210861,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210861,US Approved Rx 2018,NDA210861,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210861,Non-Hodgkin's lymphoma; Solid tumors; Central nervous system neoplasms,Phase II; Approved; Phase II
LATANOPROST,130209-82-4,https://drugs.ncats.io/drug/6Z5B6HVF6O,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""130209%2082%204"")",ONLY CAS,US Approved Rx 2022,NDA216472,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216472,Possibly Marketed Outside US 1995,NDA020597,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0f4881ec-2984-4853-bc25-5b14c3b79da7,Ocular hypertension; Open-angle glaucoma; Open-angle glaucoma; Ocular hypertension; Open-angle glaucoma; Ocular hypertension,Approved; Approved; Approved; Approved; Approved; Approved
LATANOPROSTENE BUNOD,860005-21-6,https://drugs.ncats.io/drug/I6393O0922,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""860005%2021%206"")",ONLY CAS,US Approved Rx 2022,NDA216472,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216472,Possibly Marketed Outside US 1995,NDA020597,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0f4881ec-2984-4853-bc25-5b14c3b79da7,Ocular hypertension; Open-angle glaucoma; Open-angle glaucoma; Ocular hypertension; Open-angle glaucoma; Ocular hypertension,Approved; Approved; Approved; Approved; Approved; Approved
LAURIC ACID,143-07-7,https://drugs.ncats.io/drug/1160N9NU9U,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""143%2007%207"")",ONLY CAS,Possibly Marketed Outside US ,"Vitafol Plus by Everett Laboratories, Inc.",https://www.drugbank.ca/drugs/DB03017,Possibly Marketed Outside US 2010,21 CFR 333A,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7cf1bfa5-65fb-4aac-8454-11d3e008ec1e,Acne vulgaris; SUNBURN,Preclinical; Approved
LAUROAMPHOACETATE,156028-14-7,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""156028%2014%207"")",ONLY CAS,,,,,,,,
LAURYLSULFONIC ACID,1510-16-3,https://drugs.ncats.io/drug/YGB5540EYF,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1510%2016%203"")",ONLY CAS,,,,,,,,
LAURYLSULFURIC ACID,151-21-3,https://drugs.ncats.io/drug/368GB5141J,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""151%2021%203"")",ONLY CAS,Possibly Marketed Outside US ,part356,https://www.drugbank.ca/drugs/DB00815,Possibly Marketed Outside US 1952,NDA007936,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6a621a9c-7380-4a9f-ac54-75b48fe8518e,Acne; Human papilloma virus; HIV-1 infection; Herpes simplex virus type 2 infection,Approved; Preclinical; Preclinical; Preclinical
LECITHIN,8002-43-5,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""8002%2043%205"")",ONLY CAS,,,,,,,,
LEDIPASVIR,1256388-51-8,https://drugs.ncats.io/drug/013TE6E4WV,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1256388%2051%208"")",ONLY CAS,US Approved Rx 2014,NDA205834,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205834,US Approved Rx 2014,NDA205834,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205834,Chronic hepatitis C,Approved
LEFLUNOMIDE,75706-12-6,https://drugs.ncats.io/drug/G162GK9U4W,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""75706%2012%206"")",ONLY CAS,US Approved Rx 2020,ANDA209677,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209677,US Approved Rx 1998,NDA020905,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020905,Multiple sclerosis; Active rheumatoid arthritis,Approved; Approved
LENALIDOMIDE,191732-72-6,https://drugs.ncats.io/drug/F0P408N6V4,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""191732%2072%206"")",ONLY CAS,US Approved Rx 2021,ANDA201452,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201452,US Approved Rx 2005,NDA021880,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021880,Multiple myeloma; Mantle cell lymphoma; Myelodysplastic syndromes,Approved; Approved; Approved
LENVATINIB,417716-92-8,https://drugs.ncats.io/drug/EE083865G2,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""417716%2092%208"")",ONLY CAS,US Approved Rx 2022,NDA213092,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213092,US Approved Rx 2015,NDA206947,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206947,Renal cell cancer; Differentiated thyroid cancer,Approved; Approved
LEPIDIUM MEYENII,5327-45-7,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""5327%2045%207"")",ONLY CAS,,,,,,,,
LEPIRUDIN,138068-37-8,https://drugs.ncats.io/drug/Y43GF64R34,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""138068%2037%208"")",ONLY CAS,US Previously Marketed 1998,Refludan,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20807,US Previously Marketed 1998,Refludan,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20807,heparin-associated thrombocytopenia,Approved
LESINURAD,878672-00-5,https://drugs.ncats.io/drug/09ERP08I3W,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""878672%2000%205"")",ONLY CAS,US Previously Marketed 2015,ZURAMPIC by IRONWOOD PHARMS INC,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207988,US Previously Marketed 2015,ZURAMPIC by IRONWOOD PHARMS INC,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207988,Hyperuricemia,Approved
LETERMOVIR,917389-32-3,https://drugs.ncats.io/drug/1H09Y5WO1F,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""917389%2032%203"")",ONLY CAS,US Approved Rx 2017,NDA209940,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209940,US Approved Rx 2017,NDA209940,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209940,Cytomegalovirus infection; cytomegalovirus infection,Phase III; Approved
LETROZOLE,112809-51-5,https://drugs.ncats.io/drug/7LKK855W8I,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""112809%2051%205"")",ONLY CAS,US Approved Rx 2011,ANDA090289,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=090289,US Approved Rx 1997,NDA020726,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020726,Breast cancer,Approved
LEUCINE,61-90-5,https://drugs.ncats.io/drug/GMW67QNF9C,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""61%2090%205"")",ONLY CAS,US Previously Marketed ,21 CFR 310.545(a)(20) weight control leucine,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec310-545.xml,Possibly Marketed Outside US 1971,NDA016822,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=aa89dad1-bf4f-4f7e-ad1b-2431bdf36a2d,Diamond-Blackfan anemia; Pure red cell aplasia; Non-alcoholic fatty liver disease; Burns,Phase II; Phase II; Phase II; Approved
LEUPRORELIN,53714-56-0,https://drugs.ncats.io/drug/EFY6W0M8TG,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""53714%2056%200"")",ONLY CAS,US Approved Rx 2021,ANDA213829,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213829,US Previously Marketed 1985,LUPRON by ABBVIE ENDOCRINE INC,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019010,Prostate cancer; Endometriosis; Uterine leiomyomata,Approved; Approved; Approved
LEVACETYLMETHADOL,1477-40-3,https://drugs.ncats.io/drug/R3B637Y991,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1477%2040%203"")",ONLY CAS,Possibly Marketed Outside US ,WHO-ATC:N07BC03,https://ginas.ncats.nih.gov/ginas/app/substance/R3B637Y991,,,,Opioid dependence,Approved
LEVAMISOLE,14769-73-4,https://drugs.ncats.io/drug/2880D3468G,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""14769%2073%204"")",ONLY CAS,US Previously Marketed 1990,ERGAMISOL by JANSSEN PHARMA,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020035,US Previously Marketed 1990,ERGAMISOL by JANSSEN PHARMA,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020035,Dukes' Stage C colon cancer; Ascariasis; Steroid-sensitive idiopathic nephrotic syndrome,Approved; Not Provided; Not Provided
LEVETIRACETAM,102767-28-2,https://drugs.ncats.io/drug/44YRR34555,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""102767%2028%202"")",ONLY CAS,US Approved Rx 2022,ANDA214815,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214815,US Approved Rx 1999,NDA021035,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021035,Partial onset seizures; Juvenile myoclonic epilepsy; Idiopathic generalized epilepsy,Approved; Approved; Approved
LEVMETAMFETAMINE,33817-09-3,https://drugs.ncats.io/drug/Y24T9BT2Q2,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""33817%2009%203"")",ONLY CAS,US Approved OTC ,21 CFR 341.20(b)(1) cough/cold:nasal decongestant levmetamfetamine,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec341-20.xml,Possibly Marketed Outside US 2014,21 CFR 341,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=904b7e21-cce5-4b96-afc1-b36f532f98ac,,
LEVOBUNOLOL,47141-42-4,https://drugs.ncats.io/drug/G6317AOI7K,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""47141%2042%204"")",ONLY CAS,US Approved Rx 1994,ANDA074326,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=074326,US Approved Rx 1985,NDA019219,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019219,Chronic open-angle glaucoma; Ocular hypertension,Approved; Approved
LEVOBUPIVACAINE,27262-47-1,https://drugs.ncats.io/drug/A5H73K9U3W,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""27262%2047%201"")",ONLY CAS,US Previously Marketed 1999,CHIROCAINE by PURDUE PHARMA LP,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020997,US Previously Marketed 1999,CHIROCAINE by PURDUE PHARMA LP,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020997,Pain,Approved
LEVOCABASTINE,79449-98-2,https://drugs.ncats.io/drug/COU3RRH769,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""79449%2098%202"")",ONLY CAS,US Previously Marketed 1993,LIVOSTIN by NOVARTIS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020219,US Previously Marketed 1993,LIVOSTIN by NOVARTIS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020219,Seasonal allergic conjunctivitis,Approved
LEVOCARNITINE,541-15-1,https://drugs.ncats.io/drug/0G389FZZ9M,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""541%2015%201"")",ONLY CAS,US Approved Rx 1985,NDA018948,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018948,US Approved Rx 1985,NDA018948,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018948,Systemic primary carnitine deficiency; Ulcerative colitis; Peripheral arterial occlusive disorders; Congestive heart failure,Approved; Phase III; Approved; Phase III
LEVOCETIRIZINE,130018-77-8,https://drugs.ncats.io/drug/6U5EA9RT2O,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""130018%2077%208"")",ONLY CAS,US Approved Rx 2013,ANDA090362,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=090362,Possibly Marketed Outside US 1995,NDA022064,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=371ca86d-7ffd-4f20-b6c6-af0a9ff7362f,Perennial allergic rhinitis; Chronic idiopathic urticaria; Seasonal allergic rhinitis; Dermatitis; Allergic rhinitis; Chronic Idiopathic Urticaria,Approved; Approved; Approved; Phase III; Approved; Approved
LEVODOPA,60-18-4,https://drugs.ncats.io/drug/42HK56048U,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""60%2018%204"")",ONLY CAS,US Previously Marketed 1961,TPN by INTL MINERALS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=008378,US Previously Marketed 1961,TPN by INTL MINERALS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=008378,Negative nitrogen balance,Approved
LEVOFLOXACIN,100986-85-4,https://drugs.ncats.io/drug/RIX4E89Y14,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""100986%2085%204"")",ONLY CAS,US Approved Rx 2011,ANDA090787,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=090787,US Previously Marketed 1996,LEVAQUIN by JANSSEN PHARMS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020635,Complicated Skin and Skin Structure Infections; Plague; Chronic bacterial prostatitis; Chronic bronchitis; Urinary tract infections; Pneumonia,Approved; Approved; Approved; Approved; Approved; Approved
LEVOMEFOLIC ACID,31690-09-2,https://drugs.ncats.io/drug/8S95DH25XC,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""31690%2009%202"")",ONLY CAS,Possibly Marketed Outside US ,Yasmin Plus by Bayer [Canada],https://www.drugbank.ca/drugs/DB11256,Possibly Marketed Outside US 2010,"Zatean-Pn DHA by Trigen Laboratories, LLC",https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f6ee5344-98ea-45a5-85be-712ef43a809e,Pregnancy,Approved
LEVOMENOL,23089-26-1,https://drugs.ncats.io/drug/24WE03BX2T,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""23089%2026%201"")",ONLY CAS,Possibly Marketed Outside US ,"PurpleU BAOBAB FACE by Recipe Co., Ltd.",https://www.drugbank.ca/drugs/DB13153,Possibly Marketed Outside US 2009,21 CFR 333D,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=51f03428-f25a-4d6f-affb-71c41effd67b,sunburn; Alzheimer’s disease; Inflammatory pain; Pancreatic cancer,Approved; Basic research; Not Provided; Basic research
LEVOMENTHOL,89-78-1,https://drugs.ncats.io/drug/YS08XHA860,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""89%2078%201"")",ONLY CAS,US Approved OTC ,"21 CFR 346.16(c) anorectal:analgesic, anesthetic, antipruritic menthol",https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec346-16.xml,US Previously Marketed 1921,Menthol U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,Itching; Mild pain; Rhinitis; Gastrointestinal endoscopy; Common cold; Pain; Sore throat; Arthritis; Simple backache,Approved; Approved; Approved; Phase III; Approved; Not Provided; Approved; Approved; Approved
LEVOMILNACIPRAN,96847-54-0,https://drugs.ncats.io/drug/UGM0326TXX,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""96847%2054%200"")",ONLY CAS,US Approved Rx 2023,ANDA210771,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210771,Possibly Marketed Outside US 2009,ANDA210790,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bcbc5d92-e022-4a0d-ab4d-2b0d7aa68c58,Ischemic stroke; Major depressive disorder,Phase III; Approved
LEVONORGESTREL,797-63-7,https://drugs.ncats.io/drug/5W7SIA7YZW,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""797%2063%207"")",ONLY CAS,US Approved Rx 2015,ANDA201088,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201088,US Previously Marketed 1968,OVRAL-28 by WYETH PHARMS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016806,Heavy menstrual bleeding; Fertilization; Pregnancy; Pregnancy,Approved; Approved; Approved; Approved
LEVORPHANOL,297-90-5,https://drugs.ncats.io/drug/V7R79HN3XD,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""297%2090%205"")",ONLY CAS,US Previously Marketed 1953,Dromoran by Hoffmann-La Roche,DeHaen 1940-1975 NMEs,US Previously Marketed 1953,Dromoran by Hoffmann-La Roche,DeHaen 1940-1975 NMEs,Unknown,
LEVOSALBUTAMOL,34391-04-3,https://drugs.ncats.io/drug/EDN2NBH5SS,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""34391%2004%203"")",ONLY CAS,US Approved Rx 2013,ANDA078171,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=078171,US Approved Rx 1999,NDA020837,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020837,Asthma; Chronic obstructive pulmonary disease,Approved; Approved
LEVOTHYROXINE SODIUM,51-48-9,https://drugs.ncats.io/drug/Q51BO43MG4,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""51%2048%209"")",ONLY CAS,US Approved Rx 2016,ANDA206163,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206163,US Previously Marketed 1953,Synthroid Sodium by Travenol,DeHaen 1940-1975 NMEs,Euthyroid goiters; Hypothyroidism,Approved; Approved
LIDOCAINE,137-58-6,https://drugs.ncats.io/drug/98PI200987,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""137%2058%206"")",ONLY CAS,US Approved OTC ,21 CFR 346.10(f) anorectal:local anesthetic lidocaine,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec346-10.xml,US Previously Marketed 1948,XYLOCAINE DENTAL by DENTSPLY PHARM,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021380,Ventricular arrhythmia; Pain,Approved; Approved
LIFITEGRAST,1025967-78-5,https://drugs.ncats.io/drug/038E5L962W,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1025967%2078%205"")",ONLY CAS,US Approved Rx 2023,ANDA215063,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215063,US Approved Rx 2016,NDA208073,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208073,Dry eye syndrome; Allergic conjunctivitis,Approved; Phase II
LIMONENE,138-86-3,https://drugs.ncats.io/drug/9MC3I34447,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""138%2086%203"")",ONLY CAS,Possibly Marketed Outside US 2016,Younique Royalty Hydrating Day Cream SPF 20 by Younique LLC,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4443398b-4073-448e-e054-00144ff8d46c,Possibly Marketed Outside US 1982,NDA018613,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2024030e-b00d-4fcc-b51d-45dc86933749,Unknown,
LINACLOTIDE,851199-59-2,https://drugs.ncats.io/drug/N0TXR0XR5X,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""851199%2059%202"")",ONLY CAS,US Approved Rx 2012,NDA202811,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202811,US Approved Rx 2012,NDA202811,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202811,Irritable bowel syndrome; Constipation,Approved; Approved
LINAGLIPTIN,668270-12-0,https://drugs.ncats.io/drug/3X29ZEJ4R2,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""668270%2012%200"")",ONLY CAS,US Approved Rx 2016,NDA208026,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208026,US Approved Rx 2011,NDA201280,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201280,Type 2 diabetes mellitus,Approved
LINALOOL,78-70-6,https://drugs.ncats.io/drug/D81QY6I88E,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""78%2070%206"")",ONLY CAS,Possibly Marketed Outside US 2011,21 CFR 333D,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=56f966a1-4317-412f-b5b8-bb7f1d6e0279,Possibly Marketed Outside US 1990,M032,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=eb1d6e9e-e7fd-478e-80c0-3a3f529682d7,Flea infestations,Not Provided
LINCOMYCIN,154-21-2,https://drugs.ncats.io/drug/BOD072YW0F,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""154%2021%202"")",ONLY CAS,US Approved Rx 1964,NDA050317,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050317,US Approved Rx 1964,NDA050317,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050317,Streptococcal infections; Pneumococcal infections; Staphylococcal infections,Approved; Approved; Approved
LINDANE,58-89-9,https://drugs.ncats.io/drug/59NEE7PCAB,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""58%2089%209"")",ONLY CAS,US Previously Marketed 1982,SCABENE by STIEFEL,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=086769,US Previously Marketed 1951,Kwell by Reed & Carnrick,OB NME Appendix 1950-1993,Scabies; Lice infestation,Approved; Approved
LINEZOLID,165800-03-3,https://drugs.ncats.io/drug/ISQ9I6J12J,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""165800%2003%203"")",ONLY CAS,US Approved Rx 2017,ANDA205154,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205154,US Approved Rx 2000,NDA021131,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021131,Vancomycin-resistant Enterococcus faecium infections; Community-acquired pneumonia; Skin infections; Nosocomial pneumonia,Approved; Approved; Approved; Approved
LINOLEIC ACID,60-33-3,https://drugs.ncats.io/drug/9KJL21T0QJ,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""60%2033%203"")",ONLY CAS,US Previously Marketed 1961,LENIC WITH NIACIN LINOLEIC ACID by CROOKES-BARNES,https://www.govinfo.gov/content/pkg/FR-1973-05-30/pdf/FR-1973-05-30.pdf,US Previously Marketed 1921,linoleic acid,https://catalog.hathitrust.org/Record/100163146,Unknown; Multiple sclerosis; Parenteral Nutrition,Phase I; Approved
LINOLENIC ACID,463-40-1,https://drugs.ncats.io/drug/0RBV727H71,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""463%2040%201"")",ONLY CAS,Possibly Marketed Outside US ,Canada:LINOLENIC ACID,https://tripod.nih.gov/npc/#Download,Possibly Marketed Outside US 1985,"Keradan by Medimetriks Pharmaceuticals, Inc.",https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4d5c5b14-9e4f-4d43-a336-e4ae71d34e42,Parenteral Nutrition,Approved
LIOTHYRONINE,15785-49-6,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""15785%2049%206"")",ONLY CAS,,,,,,,,
LIPASE,96829-58-2,https://drugs.ncats.io/drug/95M8R751W8,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""96829%2058%202"")",ONLY CAS,US Approved Rx 2007,NDA021887,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021887,US Approved Rx 1999,NDA020766,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020766,Obesity,Approved
LIPIDS,7664-41-7,https://drugs.ncats.io/drug/5138Q19F1X,3,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""7664%2041%207"")",ONLY CAS,US Approved Rx 1984,ANDA088366,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=088366,US Previously Marketed 1921,Ammonium Chloride U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,Metabolic alkalosis,Approved
LIRAGLUTIDE,204656-20-2,https://drugs.ncats.io/drug/839I73S42A,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""204656%2020%202"")",ONLY CAS,US Approved Rx 2014,NDA206321,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206321,US Approved Rx 2010,NDA022341,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022341,type 2 diabetes mellitus,Approved
LISDEXAMFETAMINE,608137-32-2,https://drugs.ncats.io/drug/H645GUL8KJ,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""608137%2032%202"")",ONLY CAS,US Approved Rx 1976,NDA017078,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017078,US Previously Marketed 1937,Dexedrine by Smith Kline French,https://web.archive.org/web/20091219120223/http://www.medic8.com/medicines/Dexedrine.html,Attention deficit hyperactivity disorder; Moderate to severe binge eating disorder; Attention deficit hyperactivity disorder,Approved; Approved; Approved
LISINOPRIL,76547-98-3,https://drugs.ncats.io/drug/7Q3P4BS2FD,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""76547%2098%203"")",ONLY CAS,US Approved Rx 2006,ANDA077622,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=077622,US Previously Marketed 1987,PRINIVIL by MERCK,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019558,Heart failure; Acute myocardial infarction; Hypertension,Approved; Approved; Approved
LISSAMINE GREEN,11096-63-2,https://drugs.ncats.io/drug/9B7E8Y9D0X,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""11096%2063%202"")",ONLY CAS,Possibly Marketed Outside US 2021,21 CFR 333A,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bb80ef22-bcd2-9276-e053-2995a90a6557,Possibly Marketed Outside US 2021,21 CFR 333A,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bb80ef22-bcd2-9276-e053-2995a90a6557,Eye diseases,Approved
LITHIUM,7439-93-2,https://drugs.ncats.io/drug/9FN79X2M3F,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""7439%2093%202"")",ONLY CAS,US Approved Rx 1986,ANDA070755,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=070755,US Previously Marketed 1921,Lithium Salicylate N.F.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,"Bipolar disorder, manic episodes",Approved
LITHIUM MAGNESIUM SODIUM,12173-47-6,https://drugs.ncats.io/drug/08X4KI73EZ,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""12173%2047%206"")",ONLY CAS,Possibly Marketed Outside US 2001,21 CFR 348,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=74310788-9022-4fb1-8c9e-187721f80afe,Possibly Marketed Outside US 2000,21 CFR 350,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e0e3b39e-3d90-4c5f-9c03-497b6f2a9cdf,,
LIXISENATIDE,320367-13-3,https://drugs.ncats.io/drug/74O62BB01U,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""320367%2013%203"")",ONLY CAS,US Approved Rx 2016,BLA208471,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208471,US Approved Rx 2016,BLA208471,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208471,Type 2 diabetes mellitus,Approved
LOBARIA PULMONARIA,90063-60-8,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""90063%2060%208"")",ONLY CAS,,,,,,,,
LOBELIA INFLATA,84696-23-1,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""84696%2023%201"")",ONLY CAS,,,,,,,,
LODOXAMIDE,53882-12-5,https://drugs.ncats.io/drug/SPU695OD73,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""53882%2012%205"")",ONLY CAS,US Approved Rx 1993,NDA020191,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020191,US Approved Rx 1993,NDA020191,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020191,Vernal keratitis; Vernal conjunctivitis; Vernal keratoconjunctivitis,Approved; Approved; Approved
LOFEXIDINE,31036-80-3,https://drugs.ncats.io/drug/UI82K0T627,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""31036%2080%203"")",ONLY CAS,US Approved Rx 2018,NDA209229,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209229,US Approved Rx 2018,NDA209229,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209229,Opioid-Related Disorders,Approved
LOLIUM PERENNE,90063-63-1,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""90063%2063%201"")",ONLY CAS,,,,,,,,
LOMEFLOXACIN,98079-51-7,https://drugs.ncats.io/drug/L6BR2WJD8V,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""98079%2051%207"")",ONLY CAS,US Previously Marketed 1992,MAXAQUIN by PHARMACIA,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020013,US Previously Marketed 1992,MAXAQUIN by PHARMACIA,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020013,Uncomplicated urinary tract infections; Chronic bronchitis; Bacterial conjunctivitis,Approved; Approved; Approved
LOMITAPIDE,182431-12-5,https://drugs.ncats.io/drug/82KUB0583F,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""182431%2012%205"")",ONLY CAS,US Approved Rx 2012,NDA203858,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203858,US Approved Rx 2012,NDA203858,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203858,Homozygous familial hypercholesterolemia,Approved
LOMUSTINE,13010-47-4,https://drugs.ncats.io/drug/7BRF0Z81KG,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""13010%2047%204"")",ONLY CAS,US Approved Rx 1976,NDA017588,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017588,US Approved Rx 1976,NDA017588,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017588,Hodgkin's lymphoma; Brain cancer,Approved; Approved
LONICERA,906-33-2,https://drugs.ncats.io/drug/O4601UER1Z,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""906%2033%202"")",ONLY CAS,,,,,,,Unknown; Breast cancer; Constipation; Inflammation,Basic research; Natural Metabolite; Natural Metabolite
LONOCTOCOG ALFA,1388129-63-2,https://drugs.ncats.io/drug/VQ723R7O8R,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1388129%2063%202"")",ONLY CAS,Possibly Marketed Outside US ,Afstyla by Csl Behring [Canada],https://www.drugbank.ca/drugs/DB13998,Possibly Marketed Outside US 2016,BLA125591,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=51f19873-a63f-4229-9477-5da4ecf31cde,,
LOPERAMIDE,53179-11-6,https://drugs.ncats.io/drug/6X9OC3H4II,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""53179%2011%206"")",ONLY CAS,US Approved Rx 2021,ANDA215579,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215579,US Previously Marketed 1976,IMODIUM by J AND J CONSUMER INC,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017690,Diarrhea,Approved
LOPINAVIR,192725-17-0,https://drugs.ncats.io/drug/2494G1JF75,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""192725%2017%200"")",ONLY CAS,US Approved Rx 2021,ANDA091677,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=091677,US Previously Marketed 2000,KALETRA by ABBVIE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021226,HIV infection; HPV positive with high grade squamous intraepithelial lesions,Approved; Phase II
LORACARBEF,76470-66-1,https://drugs.ncats.io/drug/W72I5ZT78Z,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""76470%2066%201"")",ONLY CAS,US Previously Marketed 1991,LORABID by KING PHARMS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050668,US Previously Marketed 1991,LORABID by KING PHARMS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050668,Bacterial infections,Approved
LORATADINE,79794-75-5,https://drugs.ncats.io/drug/7AJO3BO7QN,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""79794%2075%205"")",ONLY CAS,US Approved Rx 2019,ANDA210033,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210033,US Approved Rx 1993,NDA019658,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019658,Upper respiratory allergies,Approved
LORAZEPAM,846-49-1,https://drugs.ncats.io/drug/O26FZP769L,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""846%2049%201"")",ONLY CAS,US Approved Rx 1980,NDA018140,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018140,US Approved Rx 1977,NDA017794,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017794,Anxiety,Approved
LORCASERIN,616202-92-7,https://drugs.ncats.io/drug/637E494O0Z,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""616202%2092%207"")",ONLY CAS,US Previously Marketed 2019,LORCASERIN HYDROCHLORIDE by ZYDUS PHARMS USA INC,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209464,US Previously Marketed 2012,BELVIQ,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22529,Obesity,Approved
LORLATINIB,1454846-35-5,https://drugs.ncats.io/drug/OSP71S83EU,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1454846%2035%205"")",ONLY CAS,US Approved Rx 2018,NDA210868,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210868,US Approved Rx 2018,NDA210868,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210868,"Neuroblastoma; Anaplastic Large Cell Lymphoma, ALK-Positive; Non-small cell lung cancer",Phase I; Phase II; Approved
LOSARTAN,114798-26-4,https://drugs.ncats.io/drug/JMS50MPO89,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""114798%2026%204"")",ONLY CAS,US Approved Rx 2012,ANDA091541,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=091541,US Approved Rx 1995,NDA020387,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020387,Hypertension; Stroke; Heart failure; Diabetic nephropathy,Phase IV; Phase IV; Approved; Approved
LOTEPREDNOL,129260-79-3,https://drugs.ncats.io/drug/Z8CBU6KR16,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""129260%2079%203"")",ONLY CAS,Possibly Marketed Outside US ,WHO-ATC:S01BA14,https://ginas.ncats.nih.gov/ginas/app/substance/Z8CBU6KR16,,,,Allergic conjunctivitis; Acne rosacea; Herpes zoster keratitis,Approved; Approved; Approved
LOVASTATIN,75330-75-5,https://drugs.ncats.io/drug/9LHU78OQFD,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""75330%2075%205"")",ONLY CAS,US Approved Rx 2001,ANDA075551,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=075551,US Previously Marketed 1987,MEVACOR by MERCK,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019643,Hyperlipidemia; Coronary heart disease; Prostate cancer; Atherosclerotic cardiovascular disease; Hypercholesterolemia,Approved; Approved; Phase II; Approved; Approved
LOXAPINE,1977-10-2,https://drugs.ncats.io/drug/LER583670J,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1977%2010%202"")",ONLY CAS,US Approved Rx 1988,ANDA072206,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=072206,US Previously Marketed 1975,LOXITANE by TEVA BRANDED PHARM,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017525,Schizophrenia; Schizophrenia; Bipolar I disorder,Approved; Approved; Approved
LUBIPROSTONE,333963-40-9,https://drugs.ncats.io/drug/7662KG2R6K,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""333963%2040%209"")",ONLY CAS,US Approved Rx 2022,ANDA209920,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209920,US Approved Rx 2006,NDA021908,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021908,Constipation,Approved
LUCINACTANT,825600-90-6,https://drugs.ncats.io/drug/5BSH2G9BH8,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""825600%2090%206"")",ONLY CAS,US Previously Marketed 2012,SURFAXIN by LEES PHARM HK,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021746,US Previously Marketed 2012,SURFAXIN by LEES PHARM HK,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021746,,
LULICONAZOLE,187164-19-8,https://drugs.ncats.io/drug/RE91AN4S8G,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""187164%2019%208"")",ONLY CAS,US Approved Rx 2013,NDA204153,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204153,US Approved Rx 2013,NDA204153,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204153,Tinea cruris; Onychomycosis; Tinea corporis; Tinea pedis,Approved; Phase II; Approved; Approved
LUMACAFTOR,936727-05-8,https://drugs.ncats.io/drug/EGP8L81APK,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""936727%2005%208"")",ONLY CAS,US Approved Rx 2018,NDA211358,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211358,US Approved Rx 2015,NDA206038,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206038,Cystic fibrosis (CF) in patients homozygous for the F508del mutation in the CFTR gene,Approved
LUMEFANTRINE,82186-77-4,https://drugs.ncats.io/drug/F38R0JR742,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""82186%2077%204"")",ONLY CAS,US Approved Rx 2009,NDA022268,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022268,US Approved Rx 2009,NDA022268,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022268,Malaria,Approved
LURASIDONE,367514-87-2,https://drugs.ncats.io/drug/22IC88528T,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""367514%2087%202"")",ONLY CAS,US Approved Rx 2019,ANDA208049,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208049,US Approved Rx 2010,NDA200603,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=200603,Autism; Bipolar depression; Schizophrenia; Major depressive disorder,Phase III; Approved; Approved; Phase III
LUSUTROMBOPAG,1110766-97-6,https://drugs.ncats.io/drug/6LL5JFU42F,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1110766%2097%206"")",ONLY CAS,US Approved Rx 2018,NDA210923,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210923,US Approved Rx 2018,NDA210923,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210923,Chronic liver disease,Approved
LUTEINISING HORMONE,9034-40-6,https://drugs.ncats.io/drug/9O7312W37G,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""9034%2040%206"")",ONLY CAS,US Previously Marketed 1982,FACTREL by HIKMA,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018123,Possibly Marketed Outside US 1978,NADA098379,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cddeff5b-ba19-4d92-8f91-8a6238f89c98,Hypogonadism; Amenorrhea,Approved; Approved
LYCIUM,56973-41-2,https://drugs.ncats.io/drug/9YU877VU8K,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""56973%2041%202"")",ONLY CAS,,,,,,,,
LYCOPENE,502-65-8,https://drugs.ncats.io/drug/SB0N2N0WV6,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""502%2065%208"")",ONLY CAS,Possibly Marketed Outside US ,"Corvita by Trigen Laboratories, LLC",https://www.drugbank.ca/drugs/DB11231,Possibly Marketed Outside US 2007,"Corvite Free by Vertical Pharmaceuticals, LLC",https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=61f55a42-a2c3-4aa7-9935-69ada425b211,Prostate cancer; Atherosclerosis; Coronary heart disease,Phase III; Phase III; Phase III
LYCOPODIUM,8023-70-9,https://drugs.ncats.io/drug/C88X29Y479,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""8023%2070%209"")",ONLY CAS,US Previously Marketed 1921,Lycopodium U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,US Previously Marketed 1921,Lycopodium U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,,
LYSINE,56-87-1,https://drugs.ncats.io/drug/K3Z4F929H6,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""56%2087%201"")",ONLY CAS,US Previously Marketed ,21 CFR 310.545(a)(20) weight control lysine hydrochloride,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec310-545.xml,Possibly Marketed Outside US 1971,NDA016822,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6ea7ec73-403e-4303-8862-6380e2f1fda6,Osteoporosis; Angina pectoris; Herpes simplex infection; Heroin dependence; Anxiety; Patent ductus arteriosus,Natural Metabolite; Natural Metabolite; Natural Metabolite; Natural Metabolite; Natural Metabolite; Approved
LYSOZYME,9066-59-5,https://drugs.ncats.io/drug/4YRW73H69V,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""9066%2059%205"")",ONLY CAS,Possibly Marketed Outside US ,Japan:Lysozyme Hydrochloride,https://tripod.nih.gov/npc/#Download,Possibly Marketed Outside US 2012,21 CFR 346,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b607f6a7-f2e2-4af8-8ae5-9d66f1b1fb06,,
M-CRESOL,108-39-4,https://drugs.ncats.io/drug/GGO4Y809LO,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""108%2039%204"")",ONLY CAS,US Previously Marketed ,21 CFR 310.545(a)(22)(iv) antifungal:scalp or nails m-cresol,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec310-545.xml,Possibly Marketed Outside US 1982,BLA018780,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b519bd83-038c-4ec5-a231-a51ec5cc291f,,
M-CRESYL ACETATE,122-46-3,https://drugs.ncats.io/drug/73UDH1DF0R,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""122%2046%203"")",ONLY CAS,,,,,,,,
MACIMORELIN,381231-18-1,https://drugs.ncats.io/drug/8680B21W73,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""381231%2018%201"")",ONLY CAS,US Previously Marketed 2017,MACRILEN by NOVO,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205598,US Previously Marketed 2017,MACRILEN by NOVO,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205598,Growth hormone deficiency,Approved
MACITENTAN,441798-33-0,https://drugs.ncats.io/drug/Z9K9Y9WMVL,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""441798%2033%200"")",ONLY CAS,US Approved Rx 2013,NDA204410,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204410,US Approved Rx 2013,NDA204410,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204410,Pulmonary arterial hypertension,Approved
MAFENIDE,138-39-6,https://drugs.ncats.io/drug/58447S8P4L,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""138%2039%206"")",ONLY CAS,US Approved Rx 1969,NDA016763,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016763,US Previously Marketed 1948,Sulfamylon by Winthrop,DeHaen 1940-1975 NMEs,Burn,Approved
MAGALDRATE,74978-16-8,https://drugs.ncats.io/drug/6V88E24N5T,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""74978%2016%208"")",ONLY CAS,US Approved OTC ,21 CFR 331.11(g)(2) antacid:magnesium-containing magaldrate,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec331-11.xml,US Previously Marketed 1960,Riopan by Ayerst,DeHaen 1940-1975 NMEs,Heartburn; Pain in the upper abdomen; Heartburn; indigestion; Nausea,Approved; Approved; Approved; Approved
MAGNESIUM,7439-95-4,https://drugs.ncats.io/drug/I38ZP9992A,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""7439%2095%204"")",ONLY CAS,US Approved OTC ,21 CFR 331.11(g)(7) antacid:magnesium-containing magnesium oxide,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec331-11.xml,US Previously Marketed 1921,Magnesium Carbonate U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,Bone disease; Bacterial infections; Bronchial spasm; Unknown; Magnesium deficiency; Convulsions; Eclampsia; Unknown; Eclampsia; Preeclampsia; Preparation for colonoscopy; Atrial fibrillation; Unknown; Magnesium deficiency; Unknown; Unknown; Oxaluria; Constipation; Magnesium deficiency; Stroke; Magnesium deficiency; Fibromyalgia; Unknown; Magnesium deficiency; Unknown; Unknown,Basic research; Preclinical; Preclinical; Not Provided; Not Provided; Not Provided; Approved; Approved; Approved; Phase III; Approved; Approved; Approved; Approved; Phase III; Approved; Phase II; Approved
MAGNOLIA,64-17-5,https://drugs.ncats.io/drug/3K9958V90M,3,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""64%2017%205"")",ONLY CAS,US Approved Rx 2001,NDA021074,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021074,US Previously Marketed 0652,alcohol,https://en.wikipedia.org/wiki/Alcohol_(drug),Bacterial infections,Approved
MALATHION,121-75-5,https://drugs.ncats.io/drug/U5N7SU872W,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""121%2075%205"")",ONLY CAS,US Approved Rx 2012,ANDA091559,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=091559,US Previously Marketed 1982,OVIDE by TARO,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018613,Pediculosis; Scabies,Approved; Approved
MALIC ACID,6915-15-7,https://drugs.ncats.io/drug/817L1N4CKP,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""6915%2015%207"")",ONLY CAS,Possibly Marketed Outside US ,Canada:MALIC ACID,https://tripod.nih.gov/npc/#Download,Possibly Marketed Outside US 1942,21 CFR 356,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=989f8509-cd28-48e7-9aa1-baddfbcac95a,Skin injuries; Cisplatin-induced toxicity; Cardiac arrhythmia,Approved; Preclinical; Preclinical
MALONIC ACID,141-82-2,https://drugs.ncats.io/drug/9KX7ZMG0MK,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""141%2082%202"")",ONLY CAS,US Previously Marketed 1940,KOAGAMIN PARENTERAL MALONIC ACID by CHATHAM,https://archive.org/details/arizonamedicinej202unse/page/n77?q=koagamin,US Previously Marketed 1940,KOAGAMIN PARENTERAL MALONIC ACID by CHATHAM,https://archive.org/details/arizonamedicinej202unse/page/n77?q=koagamin,,
MALTODEXTRIN,9050-36-6,https://drugs.ncats.io/drug/7CVR7L4A2D,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""9050%2036%206"")",ONLY CAS,US Previously Marketed ,21 CFR 310.545(a)(20) weight control maltodextrin,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec310-545.xml,Possibly Marketed Outside US 1984,NeuroBion by BENARD INDUSTRIES INC,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a55617fa-abea-468d-a5b2-022868fe4b2a,,
MANGAFODIPIR,155319-91-8,https://drugs.ncats.io/drug/N02W67RKJS,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""155319%2091%208"")",ONLY CAS,US Previously Marketed 1997,TESLASCAN by IC TARGETS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020652,US Previously Marketed 1997,TESLASCAN by IC TARGETS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020652,Cancer; Myocardial Infarction; Colon cancer; Hepatocellular carcinoma,Withdrawn; Phase II; Phase II; Approved
MANGANESE,7439-96-5,https://drugs.ncats.io/drug/42Z2K6ZL8P,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""7439%2096%205"")",ONLY CAS,US Previously Marketed 1921,Solution of Peptonate of Iron and Manganese N.F.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,US Previously Marketed 1921,Solution of Peptonate of Iron and Manganese N.F.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,,
MANNITOL,69-65-8,https://drugs.ncats.io/drug/3OWL53L36A,6,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""69%2065%208"")%20AND%20(root_names_name:""%5EMANNITOL$"")",EXACT NAME,US Approved Rx 2020,NDA202049,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202049,Possibly Marketed Outside US 1955,Levsin by Alaven Pharmaceutical LLC,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=32388e18-08de-455c-aad4-9c2264435f0f,Constipation; End-Stage Renal Disease; Cystic fibrosis; Asthma; Acute renal failure; Elevated intraocular pressure; Cerebral edema,Basic research; Approved; Approved; Approved; Approved; Approved; Approved
MAPROTILINE,10262-69-8,https://drugs.ncats.io/drug/2U1W68TROF,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""10262%2069%208"")",ONLY CAS,US Previously Marketed 1988,MAPROTILINE HYDROCHLORIDE by AM THERAP,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=072131,US Previously Marketed 1980,LUDIOMIL by NOVARTIS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017543,Major depressive disorder; Dysthymic disorder,Approved; Approved
MARAVIROC,376348-65-1,https://drugs.ncats.io/drug/MD6P741W8A,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""376348%2065%201"")",ONLY CAS,US Approved Rx 2007,NDA022128,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022128,US Approved Rx 2007,NDA022128,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022128,CCR5-tropic HIV-1 infection,Approved
MATRICARIA CHAMOMILLA,977001-96-9,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""977001%2096%209"")",ONLY CAS,,,,,,,,
MAZINDOL,22232-71-9,https://drugs.ncats.io/drug/C56709M5NH,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""22232%2071%209"")",ONLY CAS,US Previously Marketed 1980,MAZANOR by WYETH AYERST,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017980,US Previously Marketed 1973,SANOREX by NOVARTIS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017247,Obesity; Duchenne muscular dystrophy,Approved; Approved
MEBENDAZOLE,31431-39-7,https://drugs.ncats.io/drug/81G6I5V05I,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""31431%2039%207"")",ONLY CAS,US Approved Rx 1995,ANDA073580,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=073580,US Previously Marketed 1974,VERMOX by JANSSEN PHARMS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017481,Necator americanus infection; Enterobius vermicularis (pinworm) infection; Ascaris lumbricoides infection; Trichuriasis infection,Approved; Approved; Approved; Approved
MECAMYLAMINE,60-40-2,https://drugs.ncats.io/drug/6EE945D3OK,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""60%2040%202"")",ONLY CAS,US Approved Rx 2013,ANDA204054,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204054,US Previously Marketed 1956,INVERSINE by TARGACEPT,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=010251,Hypertension; Alcohol addiction,Approved; Phase III
MECASERMIN,67763-96-6,https://drugs.ncats.io/drug/7GR9I2683O,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""67763%2096%206"")",ONLY CAS,US Approved Rx 2005,BLA021839,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021839,US Approved Rx 2005,BLA021839,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021839,,
MECASERMIN RINFABATE,478166-15-3,https://drugs.ncats.io/drug/NZ8M50KKRG,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""478166%2015%203"")",ONLY CAS,US Previously Marketed 2005,IPLEX by INSMED,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021884,US Previously Marketed 2005,IPLEX by INSMED,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021884,,
MECLOFENAMIC ACID,644-62-2,https://drugs.ncats.io/drug/48I5LU4ZWD,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""644%2062%202"")",ONLY CAS,US Approved Rx 1986,ANDA071081,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=071081,US Previously Marketed 1980,MECLOMEN by PARKE DAVIS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018006,Idiopathic heavy menstrual blood loss; Juvenile arthritis; Primary dysmenorrhea; Rheumatoid arthritis; Osteoarthritis,Approved; Approved; Approved; Approved; Approved
MECLOZINE,569-65-3,https://drugs.ncats.io/drug/3L5TQ84570,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""569%2065%203"")",ONLY CAS,US Approved OTC ,21 CFR 336.10(d) antiemetic meclizine hydrochloride,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec336-10.xml,US Previously Marketed 1954,Bonine by Pfizer,OB NME Appendix 1950-1985,Vertigo; Motion sickness,Approved; Approved
MECOBALAMIN,13422-55-4,https://drugs.ncats.io/drug/BR1SN1JS2W,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""13422%2055%204"")",ONLY CAS,Possibly Marketed Outside US ,"Vita-Rx Diabetic Vitamin by Pure Source, Llc",https://www.drugbank.ca/drugs/DB03614,Possibly Marketed Outside US 2013,"healthy mamaBE WELL ROUNDED BE WELL ROUNDED by MATERNAL SCIENCE, LLC",https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b0addefd-148c-423b-bcff-332c255a2d90,Peripheral neuropathy; Diabetic peripheral neuropathy; Vitamin B12 deficiency; Alzheimer's dementia,Phase IV; Phase IV; Not Provided; Approved
MEDICATED DRESSINGS,3380-34-5,https://drugs.ncats.io/drug/4NM5039Y5X,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""3380%2034%205"")",ONLY CAS,US Previously Marketed 1997,COLGATE TOTAL by COLGATE PALMOLIVE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020231,US Previously Marketed 1969,P-300 Antibacterial by Colgate-Palmolive,OB NME Appendix 1950-1993,,
MEDICATED SHAMPOOS,10182-92-0,https://drugs.ncats.io/drug/Y3IR7RCT6J,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""10182%2092%200"")",ONLY CAS,Possibly Marketed Outside US ,"CLEARASIL DAILY CLEAR   REVIVING TONER by Shelton, R. S.; Campen, M. G. Van; Tilford, C. H.; Lang, H. C.; Nisonger, L.; Bandelin, F. J.; Rubenkoenig, H. L.",https://pubs.acs.org/doi/abs/10.1021/ja01209a012,,,,acne,Approved
MEDROXYPROGESTERONE,520-85-4,https://drugs.ncats.io/drug/HSU1C9YRES,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""520%2085%204"")",ONLY CAS,US Approved Rx 2022,ANDA212844,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212844,Possibly Marketed Outside US 1959,NDA011839,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2627eb11-06bf-4a45-9172-094468e3ca07,Secondary amenorrhea; Abnormal uterine bleeding; Endometrial cancer,Approved; Approved; Approved
MEDRYSONE,2668-66-8,https://drugs.ncats.io/drug/D2UFC189XF,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""2668%2066%208"")",ONLY CAS,US Previously Marketed 1969,HMS by ALLERGAN,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016624,US Previously Marketed 1969,HMS by ALLERGAN,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016624,Vernal conjunctivitis; Episcleritis; Allergic conjunctivitis,Approved; Approved; Approved
MEFENAMIC ACID,61-68-7,https://drugs.ncats.io/drug/367589PJ2C,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""61%2068%207"")",ONLY CAS,US Approved Rx 2010,ANDA090562,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=090562,US Approved Rx 1967,NDA015034,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=015034,Pain; Primary dysmenorrhea,Approved; Approved
MEFLOQUINE,51742-87-1,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""51742%2087%201"")",ONLY CAS,,,,,,,,
MEGESTROL,3562-63-8,https://drugs.ncats.io/drug/EA6LD1M70M,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""3562%2063%208"")",ONLY CAS,US Approved Rx 1988,ANDA072422,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=072422,US Previously Marketed 1971,MEGACE by BRISTOL MYERS SQUIBB,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016979,Anorexia; Cachexia,Approved; Approved
MEGLUMINE AMIDOTRIZOATE,131-49-7,https://drugs.ncats.io/drug/3X9MR4N98U,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""131%2049%207"")",ONLY CAS,US Approved Rx 2022,ANDA214201,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214201,US Previously Marketed 1954,HYPAQUE by GE HEALTHCARE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=009561,Urinary system disease; Gastrointestinal disorders,Approved; Approved
MELATONIN,73-31-4,https://drugs.ncats.io/drug/JL5DK93RCL,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""73%2031%204"")",ONLY CAS,US Previously Marketed 1961,TRIPLE HORMONE MELATONIN by TAYLOR DRUG,https://books.google.com/books?id=5HC9y4UuGLwC&newbks=1&newbks_redir=0&dq=triple%20hormone%208-808&pg=PA3147#v=onepage&q=triple%20hormone%208-808&f=false,US Previously Marketed 1921,melatonin,https://catalog.hathitrust.org/Record/100163146,Jet lag syndrome; Insomnia,Not Provided; Phase III
MELISSA OFFICINALIS,8014-71-9,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""8014%2071%209"")",ONLY CAS,,,,,,,,
MELOXICAM,71125-38-7,https://drugs.ncats.io/drug/VG2QF83CGL,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""71125%2038%207"")",ONLY CAS,US Approved Rx 2021,NDA211988,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211988,US Previously Marketed 2000,MOBIC by BOEHRINGER INGELHEIM,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020938,Juvenile rheumatoid arthritis; Rheumatoid arthritis; Osteoarthritis,Approved; Approved; Approved
MELPHALAN,148-82-3,https://drugs.ncats.io/drug/Q41OR9510P,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""148%2082%203"")",ONLY CAS,US Approved Rx 2020,ANDA209197,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209197,US Previously Marketed 1964,ALKERAN by APOTEX,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=014691,Epithelial carcinoma of the ovary; Multiple myeloma,Approved; Approved
MEMANTINE,19982-08-2,https://drugs.ncats.io/drug/W8O17SJF3T,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""19982%2008%202"")",ONLY CAS,US Approved Rx 2020,ANDA210319,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210319,US Approved Rx 2003,NDA021487,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021487,Moderate to severe dementia of the Alzheimer’s type,Approved
MENADIONE,58-27-5,https://drugs.ncats.io/drug/723JX6CXY5,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""58%2027%205"")",ONLY CAS,US Previously Marketed 1940,Kayquinone by Abbott,DeHaen 1940-1975 NMEs,US Previously Marketed 1940,Kayquinone by Abbott,DeHaen 1940-1975 NMEs,Vitamin K deficiency; Severe hypoprothrombinaemia; Allergic rhinitis,Approved; Approved; Approved
MENAQUINONE-7,2124-57-4,https://drugs.ncats.io/drug/8427BML8NY,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""2124%2057%204"")",ONLY CAS,Possibly Marketed Outside US 2018,algeaSAN pro by sanPharma GmbH,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bc1e5766-fdf1-475b-8e4b-f10d73f93533,Possibly Marketed Outside US 2018,algeaSAN pro by sanPharma GmbH,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bc1e5766-fdf1-475b-8e4b-f10d73f93533,,
MENTHA PIPERITA,84082-70-2,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""84082%2070%202"")",ONLY CAS,,,,,,,,
MENTHOL,89-78-1,https://drugs.ncats.io/drug/YS08XHA860,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""89%2078%201"")",ONLY CAS,US Approved OTC ,"21 CFR 346.16(c) anorectal:analgesic, anesthetic, antipruritic menthol",https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec346-16.xml,US Previously Marketed 1921,Menthol U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,Itching; Mild pain; Rhinitis; Gastrointestinal endoscopy; Common cold; Pain; Sore throat; Arthritis; Simple backache,Approved; Approved; Approved; Phase III; Approved; Not Provided; Approved; Approved; Approved
MEPACRINE,83-89-6,https://drugs.ncats.io/drug/H0C805XYDE,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""83%2089%206"")",ONLY CAS,US Previously Marketed 1938,Plasmoquine E,https://books.google.com/books?id=jglFsz5EJR8C&lpg=PA381&ots=DG2kaw3Z_a&dq=AMINACRINE%20first%20marketed&pg=PA381#v=onepage&q=AMINACRINE%20first%20marketed&f=false,US Previously Marketed 1938,Plasmoquine E,https://books.google.com/books?id=jglFsz5EJR8C&lpg=PA381&ots=DG2kaw3Z_a&dq=AMINACRINE%20first%20marketed&pg=PA381#v=onepage&q=AMINACRINE%20first%20marketed&f=false,Ascites due to various cancers; Giardiasis; Cestodiasis; Malaria,Withdrawn; Withdrawn; Withdrawn; Withdrawn
MEPENZOLATE,25990-43-6,https://drugs.ncats.io/drug/ONW3LB39P7,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""25990%2043%206"")",ONLY CAS,US Previously Marketed 1956,CANTIL by SANOFI AVENTIS US,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=010679,US Previously Marketed 1956,CANTIL by SANOFI AVENTIS US,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=010679,Peptic ulcer,Approved
MEPHENESIN,59-47-2,https://drugs.ncats.io/drug/7B8PIR2954,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""59%2047%202"")",ONLY CAS,US Previously Marketed 1961,TOLSEROL by SQUIBB,https://www.govinfo.gov/content/pkg/FR-1970-06-25/pdf/FR-1970-06-25.pdf,US Previously Marketed 1948,Tolserol by Squibb,DeHaen 1940-1975 NMEs,Painful muscular contractions,Approved
MEPHENTERMINE,100-92-5,https://drugs.ncats.io/drug/TEZ91L71V4,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""100%2092%205"")",ONLY CAS,US Previously Marketed 1947,Wyamine Sulfate by Wyeth,DeHaen 1940-1975 NMEs,US Previously Marketed 1947,Wyamine Sulfate by Wyeth,DeHaen 1940-1975 NMEs,Hypotension,Approved
MEPHENYTOIN,50-12-4,https://drugs.ncats.io/drug/R420KW629U,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""50%2012%204"")",ONLY CAS,US Previously Marketed 1946,MESANTOIN by NOVARTIS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=006008,US Previously Marketed 1946,MESANTOIN by NOVARTIS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=006008,Epilepsy,Approved
MEPIVACAINE,96-88-8,https://drugs.ncats.io/drug/B6E06QE59J,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""96%2088%208"")",ONLY CAS,US Approved Rx 1960,NDA012250,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=012250,US Approved Rx 1960,NDA012250,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=012250,Pain,Approved
MEPOLIZUMAB,196078-29-2,https://drugs.ncats.io/drug/90Z2UF0E52,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""196078%2029%202"")",ONLY CAS,US Approved Rx 2015,BLA125526,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125526,US Approved Rx 2015,BLA125526,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125526,,
MEPROBAMATE,57-53-4,https://drugs.ncats.io/drug/9I7LNY769Q,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""57%2053%204"")",ONLY CAS,US Approved Rx 2009,ANDA090122,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=090122,US Previously Marketed 1955,EQUANIL by WYETH AYERST,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=010028,Anxiety,Approved
MEPYRAMINE,91-84-9,https://drugs.ncats.io/drug/HPE317O9TL,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""91%2084%209"")",ONLY CAS,US Approved OTC ,21 CFR 341.12(k) cough/cold:antihistamine pyrilamine maleate,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec341-12.xml,US Previously Marketed 1948,Neo-Antergan by Merck,DeHaen 1940-1975 NMEs,Premenstrual syndrome; Allergic rhinitis; Upper respiratory allergies,Approved; Approved; Approved
MEQUINOL,150-76-5,https://drugs.ncats.io/drug/6HT8U7K3AM,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""150%2076%205"")",ONLY CAS,US Previously Marketed 1999,SOLAGE by ALMIRALL,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020922,US Previously Marketed 1999,SOLAGE by ALMIRALL,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020922,Solar lentigines,Approved
MERBROMIN,129-16-8,https://drugs.ncats.io/drug/M0T18YH28D,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""129%2016%208"")",ONLY CAS,US Previously Marketed 1924,Mercurochrome by HYNSON WESTCOTT & DUNNING,https://trademarks.justia.com/712/05/metaphen-71205188.html,US Previously Marketed 1924,Mercurochrome by HYNSON WESTCOTT & DUNNING,https://trademarks.justia.com/712/05/metaphen-71205188.html,Otomycosis; Burn,Preclinical; Approved
MERCAPTAMINE,60-23-1,https://drugs.ncats.io/drug/5UX2SD1KE2,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""60%2023%201"")",ONLY CAS,US Approved Rx 2020,NDA213491,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213491,US Approved Rx 1994,NDA020392,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020392,Nephropathic cystinosis,Approved
MERCAPTOPURINE,50-44-2,https://drugs.ncats.io/drug/PKK6MUZ20G,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""50%2044%202"")",ONLY CAS,US Approved Rx 2004,ANDA040528,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=040528,US Previously Marketed 1953,PURINETHOL by STASON PHARMS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=009053,Acute lymphoblastic leukemia,Approved
MERCUROUS OXIDE,15829-53-5,https://drugs.ncats.io/drug/0I308SWC92,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""15829%2053%205"")",ONLY CAS,US Approved OTC ,21 CFR 358.710(a)(7) dandruff:dandruff sulfur,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec358-710.xml,US Previously Marketed 1921,Washed Sulphur U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,Scalp itching and flaking,Approved
MERCURY MERCURIC,62-38-4,https://drugs.ncats.io/drug/OSX88361UX,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""62%2038%204"")",ONLY CAS,US Previously Marketed 1921,phenylmercuric  acetate,https://catalog.hathitrust.org/Record/100163146,US Previously Marketed 1921,phenylmercuric  acetate,https://catalog.hathitrust.org/Record/100163146,Ocular fungal infections; Gonorrhea; Pregnancy; Unknown,Basic research; Phase I; Approved
MERCURY MERCUROUS,10112-91-1,https://drugs.ncats.io/drug/J2D46N657D,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""10112%2091%201"")",ONLY CAS,US Approved OTC ,21 CFR 358.710(a)(7) dandruff:dandruff sulfur,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec358-710.xml,US Previously Marketed 1921,Washed Sulphur U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,Scalp itching and flaking,Approved
MEROPENEM,96036-03-2,https://drugs.ncats.io/drug/YOP6PX0BAO,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""96036%2003%202"")",ONLY CAS,US Approved Rx 2016,ANDA205883,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205883,US Approved Rx 1996,NDA050706,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050706,Skin structure infections; Intra-abdominal infections; Bacterial meningitis,Approved; Approved; Approved
MESALAZINE,89-57-6,https://drugs.ncats.io/drug/4Q81I59GXC,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""89%2057%206"")",ONLY CAS,US Approved Rx 2019,ANDA207271,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207271,US Approved Rx 1987,NDA019618,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019618,Ulcerative colitis,Approved
MESNA,19767-45-4,https://drugs.ncats.io/drug/NR7O1405Q9,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""19767%2045%204"")",ONLY CAS,US Approved Rx 2010,ANDA090913,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=090913,US Previously Marketed 1987,IFEX/MESNEX KIT by BAXTER HLTHCARE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019763,Ifosfamide-induced hemorrhagic cystitis,Approved
MESORIDAZINE,5588-33-0,https://drugs.ncats.io/drug/5XE4NWM740,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""5588%2033%200"")",ONLY CAS,US Previously Marketed 1970,SERENTIL by NOVARTIS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016775,US Previously Marketed 1970,SERENTIL by NOVARTIS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016775,Schizophrenia; Psychosis,Approved; Approved
MESTRANOL,72-33-3,https://drugs.ncats.io/drug/B2V233XGE7,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""72%2033%203"")",ONLY CAS,US Previously Marketed 1964,NORINYL 1+50 21-DAY by ACTAVIS LABS UT INC,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=013625,US Previously Marketed 1957,Enovid by Searle,DeHaen 1940-1975 NMEs,Menstrual cycle disorder; Pregnancy,Approved; Approved
MESUXIMIDE,77-41-8,https://drugs.ncats.io/drug/0G76K8X6C0,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""77%2041%208"")",ONLY CAS,US Approved Rx 1957,NDA010596,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=010596,US Approved Rx 1957,NDA010596,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=010596,Epilepsy,Approved
METADOXINE,74536-44-0,https://drugs.ncats.io/drug/EJQ7M98H5J,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""74536%2044%200"")",ONLY CAS,Possibly Marketed Outside US 2010,NCT02161653: Phase 4 Interventional Completed Severe Alcoholic Hepatitis,https://clinicaltrials.gov/ct2/show/NCT02161653,,,,Fragile X syndrome; Alcoholic hepatitis; Attention deficit hyperactivity disorder,Phase II; Approved; Phase III
METARAMINOL,54-49-9,https://drugs.ncats.io/drug/818U2PZ2EH,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""54%2049%209"")",ONLY CAS,US Approved Rx 2021,ANDA211304,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211304,US Previously Marketed 1954,ARAMINE by MERCK,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=009509,Acute hypotensive state; Hemorrhage; Shock; Priapism,Approved; Approved; Approved; Not Provided
METAXALONE,1665-48-1,https://drugs.ncats.io/drug/1NMA9J598Y,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1665%2048%201"")",ONLY CAS,US Approved Rx 2015,ANDA040486,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=040486,US Previously Marketed 1962,SKELAXIN by KING PHARMS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=013217,Painful musculoskeletal conditions,Approved
METFORMIN,657-24-9,https://drugs.ncats.io/drug/9100L32L2N,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""657%2024%209"")",ONLY CAS,US Approved Rx 2006,ANDA077880,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=077880,US Previously Marketed 1995,GLUCOPHAGE by EMD SERONO INC,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020357,Type 2 diabetes mellitus; Cancer,Approved; Phase III
METHACHOLINE,55-92-5,https://drugs.ncats.io/drug/03V657ZD3V,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""55%2092%205"")",ONLY CAS,US Approved Rx 1986,NDA019193,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019193,US Approved Rx 1986,NDA019193,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019193,Asthma,Approved
METHADONE,76-99-3,https://drugs.ncats.io/drug/UC6VBE7V1Z,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""76%2099%203"")",ONLY CAS,US Approved Rx 2015,ANDA203502,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203502,US Approved Rx 1947,NDA021624,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021624,Detoxification & maintenance treatment of opioid addiction; Pain,Approved; Approved
METHAMPHETAMINE,537-46-2,https://drugs.ncats.io/drug/44RAL3456C,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""537%2046%202"")",ONLY CAS,US Approved Rx 2010,ANDA091189,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=091189,US Approved Rx 1943,NDA005378,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=005378,Attention deficit hyperactivity disorder; Exogenous obesity; Unknown,Approved; Approved
METHAPYRILENE,91-80-5,https://drugs.ncats.io/drug/A01LX40298,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""91%2080%205"")",ONLY CAS,US Previously Marketed 1961,SEMIKON HCL by BEECHAM LABS,https://www.govinfo.gov/content/pkg/FR-1973-03-19/pdf/FR-1973-03-19.pdf,US Previously Marketed 1947,Thenylene HCl by Abbott,DeHaen 1940-1975 NMEs,Unknown,
METHAZOLAMIDE,100-97-0,https://drugs.ncats.io/drug/J50OIX95QV,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""100%2097%200"")",ONLY CAS,US Approved Rx 1967,NDA016151,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016151,US Previously Marketed 1894,Urotropine,https://books.google.com/books?id=MacRAAAAYAAJ&newbks=1&newbks_redir=0&dq=urotropine&pg=RA1-PA426#v=onepage&q=urotropine&f=false,Urinary tract infections,Approved
METHENAMINE,100-97-0,https://drugs.ncats.io/drug/J50OIX95QV,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""100%2097%200"")",ONLY CAS,US Approved Rx 1967,NDA016151,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016151,US Previously Marketed 1894,Urotropine,https://books.google.com/books?id=MacRAAAAYAAJ&newbks=1&newbks_redir=0&dq=urotropine&pg=RA1-PA426#v=onepage&q=urotropine&f=false,Urinary tract infections,Approved
METHIONINE,63-68-3,https://drugs.ncats.io/drug/AE28F7PNPL,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""63%2068%203"")",ONLY CAS,US Previously Marketed 1945,Methionine by Various Mfrs.,DeHaen 1940-1975 NMEs,US Previously Marketed 1945,Methionine by Various Mfrs.,DeHaen 1940-1975 NMEs,AIDS vacuolar myelopathy; Skin irritation in incontinent adults and diaper rash in infants; Alkaline urine,Phase III; Not Provided; Approved
METHOCARBAMOL,532-03-6,https://drugs.ncats.io/drug/125OD7737X,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""532%2003%206"")",ONLY CAS,US Approved Rx 2016,ANDA206128,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206128,US Previously Marketed 1957,ROBAXIN by AUXILIUM PHARMS LLC,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=011011,Muscle spasm,Approved
METHOHEXITAL,151-83-7,https://drugs.ncats.io/drug/E5B8ND5IPE,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""151%2083%207"")",ONLY CAS,US Approved Rx 1960,NDA011559,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=011559,US Approved Rx 1960,NDA011559,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=011559,Pain,Approved
METHOTREXATE,59-05-2,https://drugs.ncats.io/drug/YL5FZ2Y5U1,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""59%2005%202"")",ONLY CAS,US Approved Rx 2020,ANDA210454,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210454,US Previously Marketed 1953,METHOTREXATE SODIUM by STRIDES PHARMA,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=008085,Gestational choriocarcinoma; Breast cancer; Lung cancer; Rheumatoid arthritis,Approved; Approved; Approved; Approved
METHOXAMINE,390-28-3,https://drugs.ncats.io/drug/HUQ1KC1YLI,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""390%2028%203"")",ONLY CAS,US Previously Marketed 1949,Vasoxyl by Burroughs Wellcome,DeHaen 1940-1975 NMEs,US Previously Marketed 1949,Vasoxyl by Burroughs Wellcome,DeHaen 1940-1975 NMEs,Fecal incontinence,Approved
METHOXSALEN,298-81-7,https://drugs.ncats.io/drug/U4VJ29L7BQ,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""298%2081%207"")",ONLY CAS,US Approved Rx 1986,NDA019600,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019600,US Previously Marketed 1954,8-MOP by VALEANT PHARM INTL,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=009048,"Idiopathic vitiligo; Cutaneous T-cell lymphoma; Severe, recalcitrant, disabling psoriasis",Approved; Approved; Approved
METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA,677324-53-7,https://drugs.ncats.io/drug/LR3UXN0193,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""677324%2053%207"")",ONLY CAS,US Approved Rx 2007,BLA125164,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125164,US Approved Rx 2007,BLA125164,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125164,,
METHYCLOTHIAZIDE,135-07-9,https://drugs.ncats.io/drug/L3H46UAC61,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""135%2007%209"")",ONLY CAS,US Previously Marketed 1986,METHYCLOTHIAZIDE by PAR PHARM,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=089136,US Previously Marketed 1960,ENDURON by ABBVIE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=012524,Hypertension,Approved
METHYLANTHRANILATE,134-20-3,https://drugs.ncats.io/drug/981I0C1E5W,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""134%2020%203"")",ONLY CAS,Possibly Marketed Outside US 2024,M020,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=51d5862a-8f2c-40c6-a749-5ad6f9420143,Possibly Marketed Outside US 2012,21 CFR 333A,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0dade250-cbaf-47f5-9c31-1b9aa0447cfe,,
METHYLBENZETHONIUM,72013-76-4,https://drugs.ncats.io/drug/NJX1653L36,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""72013%2076%204"")",ONLY CAS,Possibly Marketed Outside US ,"Leshcutan by Bensonab, R.A.|Slobodyab, L.B.|Lillickab, L.|Maffiaab, A.|Sullivan, N.",https://www.sciencedirect.com/science/article/pii/S0022347649801983,,,,Bacterial infections; Leishmaniasis,Approved; Approved
METHYLCELLULOSE,9004-67-5,https://drugs.ncats.io/drug/Z944H5SN0H,8,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""9004%2067%205"")%20AND%20(root_names_name:""%5EMETHYLCELLULOSE$"")",EXACT NAME,US Approved OTC ,21 CFR 349.12(a)(4) ophthalmic:demulcents methylcellulose,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec349-12.xml,Possibly Marketed Outside US 1959,ANDA040124,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5000bfb2-d2da-45cb-acd7-86a4e8ea3b0d,,
METHYLDOPA,555-30-6,https://drugs.ncats.io/drug/M4R0H12F6M,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""555%2030%206"")",ONLY CAS,US Approved Rx 1985,ANDA070075,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=070075,US Previously Marketed 1962,ALDOMET by MERCK,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=013400,Type 1 diabetes in DQ8 positive patients with residual beta cell function; Hypertension; Preeclampsia; Hypertension,Approved; Approved; Phase IV; Approved
METHYLDOPATE,6014-30-8,https://drugs.ncats.io/drug/2579Z4P04J,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""6014%2030%208"")",ONLY CAS,US Approved Rx 1985,ANDA070075,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=070075,US Previously Marketed 1962,ALDOMET by MERCK,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=013400,Type 1 diabetes in DQ8 positive patients with residual beta cell function; Hypertension; Preeclampsia; Hypertension,Approved; Approved; Phase IV; Approved
METHYLENE BLUE,61-73-4,https://drugs.ncats.io/drug/8NAP7826UB,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""61%2073%204"")",ONLY CAS,US Approved Rx 2016,NDA204630,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204630,US Previously Marketed 1921,Methylthionine Chloride U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,Cancer; Ifosfamide-induced encelophaty; Methemoglobinemia; Dermatologic infections; Septic shock; Alzheimer’s disease,Approved; Approved; Approved; Approved; Phase III; Phase II
METHYLERGOMETRINE,113-42-8,https://drugs.ncats.io/drug/W53L6FE61V,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""113%2042%208"")",ONLY CAS,US Approved Rx 2021,ANDA211919,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211919,US Approved Rx 1946,NDA006035,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=006035,Hemorrhage of the uterus following delivery of the placenta,Approved
METHYLFOLATE,70114-87-3,https://drugs.ncats.io/drug/N3K9WO9CMA,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""70114%2087%203"")",ONLY CAS,,,,,,,,
METHYLNALTREXONE BROMIDE,73232-52-7,https://drugs.ncats.io/drug/RFO6IL3D3M,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""73232%2052%207"")",ONLY CAS,US Approved Rx 2016,NDA208271,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208271,US Approved Rx 2008,NDA021964,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021964,Opioid-induced constipation,Approved
METHYLPARABEN,99-76-3,https://drugs.ncats.io/drug/A2I8C7HI9T,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""99%2076%203"")",ONLY CAS,US Previously Marketed ,21 CFR 310.545(a)(22)(ii) antifungal:diaper rash methylparaben,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec310-545.xml,Possibly Marketed Outside US 1974,E-Z-Paste by E-Z-EM Canada Inc,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=704132ea-4986-0b2c-2dd4-de89c0282a15,Unknown; Psychotic Disorders,Approved
METHYLPHENIDATE,113-45-1,https://drugs.ncats.io/drug/207ZZ9QZ49,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""113%2045%201"")",ONLY CAS,US Approved Rx 2018,ANDA210139,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210139,US Approved Rx 1955,NDA010187,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=010187,Attention deficit hyperactivity disorder; Narcolepsy,Approved; Approved
METHYLPHENOBARBITAL,115-38-8,https://drugs.ncats.io/drug/5NC67NU76B,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""115%2038%208"")",ONLY CAS,US Previously Marketed 1961,MONOMEB TABLETS METHYLPHENOBARBITAL by WINTHROP,https://books.google.ru/books?id=szDnBwAAQBAJ&pg=PA73&lpg=PA73&dq=MONOMEB+WINTHROP&source=bl&ots=CvuwHrt5J7&sig=ehypR0G6oGIXd_61JjvD5ZLRJ0U&hl=ru&sa=X&ved=2ahUKEwi17a2517rfAhVGCywKHfM5CnIQ6AEwB3oECAkQAQ#v=onepage&q=MONOMEB%20WINTHROP&f=falsehttps://www.sciencedirect.com/science/article/pii/S0095956116336866 ,US Previously Marketed 1921,methylphenobarbital,https://catalog.hathitrust.org/Record/100163146,Anxiety; Epilepsy,Approved; Approved
METHYLPREDNISOLONE,83-43-2,https://drugs.ncats.io/drug/X4W7ZR7023,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""83%2043%202"")",ONLY CAS,US Approved Rx 2004,ANDA040612,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=040612,US Approved Rx 1957,NDA011153,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=011153,Congenital adrenal hyperplasia; Rheumatoid arthritis; Contact dermatitis,Approved; Approved; Approved
METHYLTESTOSTERONE,58-18-4,https://drugs.ncats.io/drug/V9EFU16ZIF,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""58%2018%204"")",ONLY CAS,US Approved Rx 2015,ANDA204851,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204851,US Previously Marketed 1938,Oreton-M by Schering,https://archive.org/details/in.ernet.dli.2015.145864,Primary hypogonadism; Delayed puberty,Approved; Approved
METHYLTHIONINIUM,7060-82-4,https://drugs.ncats.io/drug/ZMZ79891ZH,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""7060%2082%204"")",ONLY CAS,US Approved Rx 2016,NDA204630,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204630,US Previously Marketed 1921,Methylthionine Chloride U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,Cancer; Ifosfamide-induced encelophaty; Methemoglobinemia; Dermatologic infections; Septic shock; Alzheimer’s disease,Approved; Approved; Approved; Approved; Phase III; Phase II
METHYL ETHER,115-10-6,https://drugs.ncats.io/drug/AM13FS69BX,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""115%2010%206"")",ONLY CAS,Possibly Marketed Outside US ,UK NHS:Methoxymethane,https://tripod.nih.gov/npc/#Download,Possibly Marketed Outside US 1993,21 CFR 352,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=07e93376-9bfa-44ca-acb8-258d6822b1c6,Warts,Approved
METHYSERGIDE,361-37-5,https://drugs.ncats.io/drug/XZA9HY6Z98,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""361%2037%205"")",ONLY CAS,US Previously Marketed 1962,SANSERT by NOVARTIS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=012516,US Previously Marketed 1962,SANSERT by NOVARTIS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=012516,Vascular headaches,Approved
METIPRANOLOL,22664-55-7,https://drugs.ncats.io/drug/X39AL81KEB,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""22664%2055%207"")",ONLY CAS,US Previously Marketed 1989,OPTIPRANOLOL by BAUSCH AND LOMB,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019907,US Previously Marketed 1989,OPTIPRANOLOL by BAUSCH AND LOMB,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019907,Ocular hypertension; Open-angle glaucoma,Approved; Approved
METIROSINE,672-87-7,https://drugs.ncats.io/drug/DOQ0J0TPF7,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""672%2087%207"")",ONLY CAS,US Approved Rx 1979,NDA017871,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017871,US Approved Rx 1979,NDA017871,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017871,Pheochromocytoma,Approved
METOCLOPRAMIDE,364-62-5,https://drugs.ncats.io/drug/L4YEB44I46,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""364%2062%205"")",ONLY CAS,US Approved Rx 2020,NDA209388,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209388,US Previously Marketed 1979,REGLAN by HIKMA,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017862,Gastroesophageal reflux disease; Diabetic gastroparesis,Approved; Approved
METOLAZONE,17560-51-9,https://drugs.ncats.io/drug/TZ7V40X7VX,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""17560%2051%209"")",ONLY CAS,US Approved Rx 2021,ANDA213827,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213827,US Previously Marketed 1973,ZAROXOLYN by I3 PHARMS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017386,Congestive heart failure; Hypertension,Approved; Approved
METOPROLOL,51384-51-1,https://drugs.ncats.io/drug/GEB06NHM23,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""51384%2051%201"")",ONLY CAS,US Approved Rx 2007,ANDA077739,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=077739,US Approved Rx 1978,NDA017963,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017963,Myocardial infarction; Angina pectoris; Hypertension,Approved; Approved; Approved
METRELEPTIN,186018-45-1,https://drugs.ncats.io/drug/TL60C27RLH,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""186018%2045%201"")",ONLY CAS,US Approved Rx 2014,BLA125390,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125390,US Approved Rx 2014,BLA125390,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125390,,
METRONIDAZOLE,443-48-1,https://drugs.ncats.io/drug/140QMO216E,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""443%2048%201"")",ONLY CAS,US Approved Rx 2016,ANDA208162,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208162,US Previously Marketed 1963,FLAGYL by PFIZER,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=012623,Anaerobic bacterial infections; Trichomoniasis; Acute intestinal amebiasis,Approved; Approved; Approved
METYRAPONE,54-36-4,https://drugs.ncats.io/drug/ZS9KD92H6V,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""54%2036%204"")",ONLY CAS,US Approved Rx 1961,NDA012911,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=012911,US Approved Rx 1961,NDA012911,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=012911,Secondary adrenocortical insufficiency,Approved
MEXILETINE,31828-71-4,https://drugs.ncats.io/drug/1U511HHV4Z,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""31828%2071%204"")",ONLY CAS,US Approved Rx 1996,ANDA074450,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=074450,US Previously Marketed 1985,MEXITIL by BOEHRINGER INGELHEIM,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018873,Muscle cramps in amyotrophic lateral sclerosis; Life-threatening arrhythmias; Chronic pain from amputation,Approved; Approved; Phase II
MEZLOCILLIN,51481-65-3,https://drugs.ncats.io/drug/OH2O403D1G,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""51481%2065%203"")",ONLY CAS,US Previously Marketed 1987,MEZLIN by BAYER PHARMS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=062697,US Previously Marketed 1981,MEZLIN by BAYER PHARMS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050549,Bacterial infections,Approved
MIBEFRADIL,116644-53-2,https://drugs.ncats.io/drug/27B90X776A,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""116644%2053%202"")",ONLY CAS,US Previously Marketed 1997,Posicor,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20689,US Previously Marketed 1997,Posicor,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20689,"Stable angina, chronic; Glioblastoma multiforme; Hypertension",Withdrawn; Phase I; Withdrawn
MICAFUNGIN,235114-32-6,https://drugs.ncats.io/drug/R10H71BSWG,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""235114%2032%206"")",ONLY CAS,US Approved Rx 2021,NDA212156,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212156,US Approved Rx 2005,NDA021506,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021506,Esophageal candidiasis; Candida infections in patients undergoing hematopoietic stem cell transplantation,Approved; Approved
MICONAZOLE,22916-47-8,https://drugs.ncats.io/drug/7NNO0D7S5M,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""22916%2047%208"")",ONLY CAS,US Approved OTC ,21 CFR 333.210(c) antifungal miconazole nitrate,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec333-210.xml,US Previously Marketed 1974,MONISTAT-DERM by INSIGHT PHARMS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017494,Oropharyngeal candidiasis; Vulvovaginal candidiasis; Multiple sclerosis,Approved; Approved; Preclinical
MIDAZOLAM,59467-70-8,https://drugs.ncats.io/drug/R60L0SM5BC,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""59467%2070%208"")",ONLY CAS,US Approved Rx 2000,ANDA075421,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=075421,US Previously Marketed 1985,VERSED by HLR,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018654,Pain; Epilepsy; Anxiety,Approved; Approved; Approved
MIDODRINE,42794-76-3,https://drugs.ncats.io/drug/6YE7PBM15H,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""42794%2076%203"")",ONLY CAS,US Approved Rx 2019,ANDA212543,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212543,US Previously Marketed 1996,PROAMATINE by TAKEDA PHARMS USA,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019815,Orthostatic hypotension,Approved
MIDOSTAURIN,120685-11-2,https://drugs.ncats.io/drug/ID912S5VON,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""120685%2011%202"")",ONLY CAS,US Approved Rx 2017,NDA207997,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207997,US Approved Rx 2017,NDA207997,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207997,Myelodysplastic syndromes; Aggressive systemic mastocytosis; Acute myeloid leukemia,Phase III; Phase II; Approved
MIFEPRISTONE,84371-65-3,https://drugs.ncats.io/drug/320T6RNW1F,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""84371%2065%203"")",ONLY CAS,US Approved Rx 2019,ANDA091178,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=091178,US Approved Rx 2000,NDA020687,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020687,Intrauterine pregnancy through 70 days gestation,Approved
MIGLITOL,72432-03-2,https://drugs.ncats.io/drug/0V5436JAQW,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""72432%2003%202"")",ONLY CAS,US Approved Rx 2015,ANDA203965,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203965,US Approved Rx 1996,NDA020682,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020682,Type 2 diabetes mellitus,Approved
MIGLUSTAT,72599-27-0,https://drugs.ncats.io/drug/ADN3S497AZ,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""72599%2027%200"")",ONLY CAS,US Approved Rx 2003,NDA021348,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021348,US Approved Rx 2003,NDA021348,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021348,"Niemann-Pick disease, type C; Gaucher disease",Approved; Approved
MILK SERUM PROTEIN,64-17-5,https://drugs.ncats.io/drug/3K9958V90M,3,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""64%2017%205"")",ONLY CAS,US Approved Rx 2001,NDA021074,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021074,US Previously Marketed 0652,alcohol,https://en.wikipedia.org/wiki/Alcohol_(drug),Bacterial infections,Approved
MILNACIPRAN,96847-55-1,https://drugs.ncats.io/drug/ES1O38J3C4,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""96847%2055%201"")",ONLY CAS,US Approved Rx 2009,NDA022256,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022256,US Approved Rx 2009,NDA022256,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022256,Fibromyalgia; Unknown,Approved
MILRINONE,78415-72-2,https://drugs.ncats.io/drug/JU9YAX04C7,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""78415%2072%202"")",ONLY CAS,US Approved Rx 2005,ANDA077151,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=077151,US Previously Marketed 1987,PRIMACOR by SANOFI AVENTIS US,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019436,Acute decompensated heart failure,Approved
MILTEFOSINE,58066-85-6,https://drugs.ncats.io/drug/53EY29W7EC,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""58066%2085%206"")",ONLY CAS,US Approved Rx 2014,NDA204684,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204684,US Approved Rx 2014,NDA204684,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204684,"Leishmaniasis, visceral; Mucosal leishmaniasis; Cutaneous leishmaniasis",Approved; Approved; Approved
MINOCYCLINE,10118-90-8,https://drugs.ncats.io/drug/FYY3R43WGO,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""10118%2090%208"")",ONLY CAS,US Approved Rx 2016,ANDA204453,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204453,US Previously Marketed 1971,MINOCIN by TRIAX PHARMS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050315,Rocky Mountain spotted fever; Meningitis; Brucellosis; Amebiasis; Respiratory tract infections; Skin and skin structure infections,Approved; Approved; Approved; Approved; Approved; Approved
MINOXIDIL,38304-91-5,https://drugs.ncats.io/drug/5965120SH1,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""38304%2091%205"")",ONLY CAS,US Approved Rx 1999,ANDA075357,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=075357,US Previously Marketed 1979,LONITEN by PFIZER,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018154,Hypertension; Alopecia,Approved; Approved
MIPOMERSEN,1000120-98-8,https://drugs.ncats.io/drug/9GJ8S4GU0M,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1000120%2098%208"")",ONLY CAS,US Previously Marketed 2013,KYNAMRO by KASTLE THERAPS LLC,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203568,US Previously Marketed 2013,KYNAMRO by KASTLE THERAPS LLC,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203568,,
MIRABEGRON,223673-61-8,https://drugs.ncats.io/drug/MVR3JL3B2V,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""223673%2061%208"")",ONLY CAS,US Approved Rx 2021,NDA213801,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213801,US Approved Rx 2012,NDA202611,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202611,Overactive bladder,Approved
MIRTAZAPINE,85650-52-8,https://drugs.ncats.io/drug/A051Q2099Q,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""85650%2052%208"")",ONLY CAS,US Approved Rx 2004,ANDA076921,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=076921,US Approved Rx 1996,NDA020415,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020415,Major depressive disorder,Approved
MISOPROSTOL,59122-46-2,https://drugs.ncats.io/drug/0E43V0BB57,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""59122%2046%202"")",ONLY CAS,US Approved Rx 2012,ANDA201089,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201089,Possibly Marketed Outside US 1986,NDA019268,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4ab12da7-5731-4e06-bf1c-bc3f2e711f12,Gastric ulcer,Approved
MITOMYCIN,50-07-7,https://drugs.ncats.io/drug/50SG953SK6,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""50%2007%207"")",ONLY CAS,US Approved Rx 1995,ANDA064117,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=064117,US Previously Marketed 1974,MUTAMYCIN by BRISTOL,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050450,Disseminated adenocarcinoma of the stomach; Adenocarcinoma of pancreas; Glaucoma surgery,Approved; Approved; Approved
MITOTANE,53-19-0,https://drugs.ncats.io/drug/78E4J5IB5J,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""53%2019%200"")",ONLY CAS,US Approved Rx 1970,NDA016885,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016885,US Approved Rx 1970,NDA016885,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016885,Adrenal cortical carcinoma,Approved
MITOXANTRONE,65271-80-9,https://drugs.ncats.io/drug/BZ114NVM5P,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""65271%2080%209"")",ONLY CAS,US Approved Rx 2006,ANDA077356,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=077356,US Previously Marketed 1987,NOVANTRONE by EMD SERONO,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019297,Secondary progressive multiple sclerosis; Acute non-lymphocytic leukemia; Hormone-refractory prostate cancer,Approved; Approved; Approved
MIVACURIUM CHLORIDE,106861-44-3,https://drugs.ncats.io/drug/600ZG213C3,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""106861%2044%203"")",ONLY CAS,US Approved Rx 2021,ANDA209708,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209708,US Previously Marketed 1992,MIVACRON by ABBVIE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020098,Muscle relaxation,Approved
MODAFINIL,68693-11-8,https://drugs.ncats.io/drug/R3UK8X3U3D,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""68693%2011%208"")",ONLY CAS,US Approved Rx 2012,ANDA200043,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=200043,US Approved Rx 1998,NDA020717,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020717,Obstructive sleep apnea; Narcolepsy; Sleep disorder,Approved; Approved; Approved
MOEXIPRIL,103775-10-6,https://drugs.ncats.io/drug/WT87C52TJZ,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""103775%2010%206"")",ONLY CAS,US Approved Rx 2010,ANDA090416,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=090416,US Previously Marketed 1995,UNIVASC by UCB INC,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020312,Hypertension; Hypertension,Natural Metabolite; Approved
MOGAMULIZUMAB,1159266-37-1,https://drugs.ncats.io/drug/YI437801BE,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1159266%2037%201"")",ONLY CAS,US Approved Rx 2018,BLA761051,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761051,US Approved Rx 2018,BLA761051,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761051,,
MOLINDONE,7416-34-4,https://drugs.ncats.io/drug/RT3Y3QMF8N,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""7416%2034%204"")",ONLY CAS,US Approved Rx 2015,ANDA090453,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=090453,US Previously Marketed 1974,MOBAN by CHARTWELL RX,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017111,Schizophrenia,Approved
MOLYBDENUM,7439-98-7,https://drugs.ncats.io/drug/81AH48963U,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""7439%2098%207"")",ONLY CAS,Possibly Marketed Outside US ,Pro Hers Vanilla by CROWN GENERAL AGENCY INC,https://www.drugbank.ca/drugs/DB11137,Possibly Marketed Outside US 1996,"Strovite Forte Caplet by Everett Laboratories, Inc.",https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=add96910-9404-48aa-bb3c-945e321a11ab,,
MOMETASONE,105102-22-5,https://drugs.ncats.io/drug/8HR4QJ6DW8,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""105102%2022%205"")",ONLY CAS,US Approved Rx 2017,ANDA207989,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207989,US Previously Marketed 1987,ELOCON by ORGANON,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019543,Dermatoses; Asthma,Approved; Approved
MONOBENZONE,103-16-2,https://drugs.ncats.io/drug/9L2KA76MG5,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""103%2016%202"")",ONLY CAS,US Previously Marketed 1952,BENOQUIN by VALEANT PHARM INTL,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=008173,US Previously Marketed 1952,BENOQUIN by VALEANT PHARM INTL,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=008173,Depigmentation; Melanoma,Approved; Preclinical
MONOCHLOROACETIC ACID,79-11-8,https://drugs.ncats.io/drug/5GD84Y125G,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""79%2011%208"")",ONLY CAS,Possibly Marketed Outside US 2012,21 CFR 333A,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=861ae219-9a28-78a0-e053-2991aa0ad056,Possibly Marketed Outside US 2012,21 CFR 333A,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=861ae219-9a28-78a0-e053-2991aa0ad056,,
MONOETHANOLAMINE OLEATE,2272-11-9,https://drugs.ncats.io/drug/U4RY8MRX7C,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""2272%2011%209"")",ONLY CAS,US Approved Rx 1988,NDA019357,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019357,US Approved Rx 1988,NDA019357,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019357,Idiopathic achalasia; Esophageal varices,Not Provided; Approved
MONOFLUOROPHOSPHORIC ACID,13537-32-1,https://drugs.ncats.io/drug/IW87A7KU3R,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""13537%2032%201"")",ONLY CAS,US Approved OTC ,21 CFR 355.10(b)(1) anticaries:dentifrices sodium monolfuorophosphate (gel or paste),https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec355-10.xml,US Previously Marketed 1953,NDK Fluoride Dentrifice by NOK,OB NME Appendix 1950-1993,Anticavity,Approved
MONTELUKAST,158966-92-8,https://drugs.ncats.io/drug/MHM278SD3E,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""158966%2092%208"")",ONLY CAS,US Approved Rx 2015,ANDA204290,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204290,US Approved Rx 1998,NDA020830,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020830,Asthma; Exercise-induced bronchoconstriction; Seasonal allergic rhinitis; Perennial allergic rhinitis,Approved; Approved; Approved; Approved
MORACIZINE,31883-05-3,https://drugs.ncats.io/drug/2GT1D0TMX1,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""31883%2005%203"")",ONLY CAS,US Previously Marketed 1990,ETHMOZINE by SHIRE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019753,US Previously Marketed 1990,ETHMOZINE by SHIRE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019753,Ventricular arrhythmia,Approved
MOROCTOCOG ALFA,284036-24-4,https://drugs.ncats.io/drug/113E3Z3CJJ,2,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""284036%2024%204"")%20AND%20(root_names_name:""%5EMOROCTOCOG%20ALFA$"")",EXACT NAME,Possibly Marketed Outside US ,EU/1/99/103/008,https://www.drugbank.ca/drugs/DB13999,Possibly Marketed Outside US 2008,BLA125264,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=52e97c7f-8240-4cd6-afd2-c452ab2f6e32,,
MORPHINE,57-27-2,https://drugs.ncats.io/drug/76I7G6D29C,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""57%2027%202"")",ONLY CAS,US Approved Rx 2011,ANDA202348,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202348,US Previously Marketed 1827,morphine,https://catalog.hathitrust.org/Record/100782317,Pain severe,Approved
MOXETUMOMAB PASUDOTOX,1020748-57-5,https://drugs.ncats.io/drug/2NDX4B6N8F,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1020748%2057%205"")",ONLY CAS,US Approved Rx 2018,BLA761104,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761104,US Approved Rx 2018,BLA761104,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761104,,
MOXIFLOXACIN,151096-09-2,https://drugs.ncats.io/drug/U188XYD42P,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""151096%2009%202"")",ONLY CAS,US Approved Rx 2017,ANDA208682,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208682,US Previously Marketed 1999,AVELOX by BAYER HLTHCARE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021085,Plague; Community acquired pneumonia; Acute bacterial sinusitis,Approved; Approved; Approved
MUPIROCIN,12650-69-0,https://drugs.ncats.io/drug/D0GX863OA5,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""12650%2069%200"")",ONLY CAS,US Approved Rx 2022,ANDA214811,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214811,US Previously Marketed 1987,BACTROBAN by GLAXOSMITHKLINE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050591,Secondarily infected traumatic skin lesions,Approved
MYCOPHENOLATE MOFETIL,128794-94-5,https://drugs.ncats.io/drug/9242ECW6R0,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""128794%2094%205"")",ONLY CAS,US Approved Rx 2009,ANDA065520,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=065520,US Approved Rx 1995,NDA050722,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050722,Organ transplant rejection,Approved
MYCOPHENOLIC ACID,24280-93-1,https://drugs.ncats.io/drug/HU9DX48N0T,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""24280%2093%201"")",ONLY CAS,US Approved Rx 2009,ANDA065520,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=065520,US Approved Rx 1995,NDA050722,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050722,Organ transplant rejection,Approved
MYRICA CERIFERA,529-44-2,https://drugs.ncats.io/drug/76XC01FTOJ,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""529%2044%202"")",ONLY CAS,Possibly Marketed Outside US 2013,21 CFR 352,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b1990f21-e9c9-4600-ac11-db0f7d4237fd,Possibly Marketed Outside US 2013,21 CFR 352,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b1990f21-e9c9-4600-ac11-db0f7d4237fd,Cancer; Diabetes mellitus,Basic research; Basic research
N-ACETYLGLUCOSAMINE,7512-17-6,https://drugs.ncats.io/drug/V956696549,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""7512%2017%206"")",ONLY CAS,US Previously Marketed 2019,N-acetyl-D-glucosamine,https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-216/subpart-B/section-216.23,Possibly Marketed Outside US 2005,21 CFR 352,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=af05f2b7-bd7f-42a0-8042-92a0e07f0c36,Inflammatory bowel disease; Multiple sclerosis; Osteoarthritis,Not Provided; Preclinical; Preclinical
N-ACETYLTYROSINE,2901-77-1,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""2901%2077%201"")",ONLY CAS,,,,,,,,
N-LAUROYLSARCOSINE,97-78-9,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""97%2078%209"")",ONLY CAS,,,,,,,,
N6 FURFURYLADENINE,525-79-1,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""525%2079%201"")",ONLY CAS,,,,,,,,
NABILONE,51022-71-0,https://drugs.ncats.io/drug/2N4O9L084N,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""51022%2071%200"")%20AND%20(root_names_name:""%5ENABILONE"")",APPROXIMATE NAME,US Approved Rx 1985,NDA018677,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018677,US Approved Rx 1985,NDA018677,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018677,Nausea and vomiting,Approved
NABUMETONE,42924-53-8,https://drugs.ncats.io/drug/LW0TIW155Z,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""42924%2053%208"")",ONLY CAS,US Approved Rx 2008,ANDA078671,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=078671,US Previously Marketed 1991,RELAFEN by SMITHKLINE BEECHAM,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019583,Rheumatoid arthritis; Osteoarthritis,Approved; Approved
NADIDE,53-84-9,https://drugs.ncats.io/drug/0U46U6E8UK,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""53%2084%209"")",ONLY CAS,Possibly Marketed Outside US ,"Bonogen hair care shampoo by Bonogen Co., Ltd",https://www.drugbank.ca/drugs/DB14128,Possibly Marketed Outside US 2010,"Bonogenhair care shampoo by Bonogen Co., Ltd",https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fb0c4f47-299c-4305-9a24-720d3917f89e,Chronic fatigue syndrome; Parkinson's disease,Approved; Phase I
NADOLOL,220045-89-6,https://drugs.ncats.io/drug/FEN504330V,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""220045%2089%206"")",ONLY CAS,US Approved Rx 1993,ANDA074172,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=074172,US Approved Rx 1979,NDA018063,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018063,Angina pectoris; Hypertension,Approved; Approved
NAFARELIN,76932-56-4,https://drugs.ncats.io/drug/1X0094V6JV,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""76932%2056%204"")",ONLY CAS,US Approved Rx 1990,NDA019886,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019886,US Approved Rx 1990,NDA019886,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019886,Central precocious puberty; Endometriosis,Approved; Approved
NAFCILLIN,147-52-4,https://drugs.ncats.io/drug/4CNZ27M7RV,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""147%2052%204"")",ONLY CAS,US Approved Rx 2012,ANDA090580,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=090580,US Previously Marketed 1964,Unipen by Wyeth,DeHaen 1940-1975 NMEs,Stafillococcal infection,Approved
NAFTIFINE,65472-88-0,https://drugs.ncats.io/drug/4FB1TON47A,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""65472%2088%200"")",ONLY CAS,US Approved Rx 1988,NDA019599,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019599,US Approved Rx 1988,NDA019599,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019599,Tinea pedis; Tinea corporis,Approved; Approved
NALBUPHINE,20594-83-6,https://drugs.ncats.io/drug/L2T84IQI2K,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""20594%2083%206"")",ONLY CAS,US Approved Rx 1989,ANDA070915,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=070915,US Previously Marketed 1964,Negram by Winthrop Sterling,OB NME Appendix 1950-1985,Pruritus; Pain,Phase III; Approved
NALDEMEDINE,916072-89-4,https://drugs.ncats.io/drug/03KSI6WLXH,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""916072%2089%204"")",ONLY CAS,US Approved Rx 2017,NDA208854,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208854,US Approved Rx 2017,NDA208854,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208854,Opioid-induced constipation; opioid-induced constipation,Approved; Approved
NALIDIXIC ACID,389-08-2,https://drugs.ncats.io/drug/3B91HWA56M,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""389%2008%202"")",ONLY CAS,US Previously Marketed 1986,NALIDIXIC ACID by SUN PHARM INDUSTRIES,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=070272,US Previously Marketed 1964,NEGGRAM by SANOFI AVENTIS US,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=014214,Urinary tract infections,Approved
NALMEFENE,55096-26-9,https://drugs.ncats.io/drug/TOV02TDP9I,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""55096%2026%209"")",ONLY CAS,US Approved Rx 2022,ANDA212955,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212955,US Previously Marketed 1995,REVEX by HIKMA,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020459,Alcoholism,Approved
NALOXEGOL,854601-70-0,https://drugs.ncats.io/drug/44T7335BKE,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""854601%2070%200"")",ONLY CAS,US Approved Rx 2014,NDA204760,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204760,US Approved Rx 2014,NDA204760,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204760,Opioid-induced constipation,Approved
NALOXONE,465-65-6,https://drugs.ncats.io/drug/36B82AMQ7N,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""465%2065%206"")",ONLY CAS,US Approved Rx 2017,ANDA207634,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207634,US Previously Marketed 1971,NARCAN by ADAPT,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016636,Opioid dependence; Constipation; Respiratory depression,Approved; Approved; Approved
NALTREXONE,16590-41-3,https://drugs.ncats.io/drug/5S6W795CQM,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""16590%2041%203"")",ONLY CAS,US Approved Rx 2014,NDA200063,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=200063,US Previously Marketed 1984,REVIA by TEVA WOMENS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018932,Alcohol addiction; Opioid dependence,Approved; Approved
NANDROLONE,434-22-0,https://drugs.ncats.io/drug/6PG9VR430D,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""434%2022%200"")",ONLY CAS,US Previously Marketed 1983,NANDROLONE PHENPROPIONATE by WATSON LABS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=086386,US Previously Marketed 1959,DURABOLIN by ORGANON USA INC,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=011891,Anemia of renal insufficiency,Approved
NAPHAZOLINE,835-31-4,https://drugs.ncats.io/drug/H231GF11BV,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""835%2031%204"")",ONLY CAS,US Approved OTC ,21 CFR 349.18(b) ophthalmic:vasoconstrictor naphazoline hydrochloride,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec349-18.xml,US Previously Marketed 1942,Privine HCl by Ciba,DeHaen 1940-1975 NMEs,,
NAPROXEN,22204-53-1,https://drugs.ncats.io/drug/57Y76R9ATQ,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""22204%2053%201"")",ONLY CAS,US Approved Rx 2018,ANDA090872,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=090872,US Approved Rx 1976,NDA017581,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017581,Ankylosing spondylitis; Rheumatoid arthritis; Osteoarthritis; Tendonitis; Bursitis,Approved; Approved; Approved; Approved; Approved
NARATRIPTAN,121679-13-8,https://drugs.ncats.io/drug/QX3KXL1ZA2,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""121679%2013%208"")",ONLY CAS,US Approved Rx 2011,ANDA091552,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=091552,US Previously Marketed 1998,AMERGE by GLAXOSMITHKLINE LLC,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020763,Migraine,Approved
NASAL DECONGESTANTS,50-02-2,https://drugs.ncats.io/drug/7S5I7G3JQL,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""50%2002%202"")",ONLY CAS,US Approved Rx 2020,ANDA210966,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210966,US Previously Marketed 1958,DECADRON by MERCK,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=011664,Cyclitis; Iritis; Herpes zoster keratitis; Allergic conjunctivitis; Acne rosacea; Superficial punctate keratitis; Corneal injury; Bacterial conjunctivitis; Multiple myeloma,Approved; Approved; Approved; Approved; Approved; Approved; Approved; Approved; Approved
NASTURTIUM OFFICINALE,84775-70-2,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""84775%2070%202"")",ONLY CAS,,,,,,,,
NATALIZUMAB,189261-10-7,https://drugs.ncats.io/drug/3JB47N2Q2P,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""189261%2010%207"")",ONLY CAS,US Approved Rx 2004,BLA125104,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125104,US Approved Rx 2004,BLA125104,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125104,,
NATAMYCIN,7681-93-8,https://drugs.ncats.io/drug/8O0C852CPO,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""7681%2093%208"")",ONLY CAS,US Approved Rx 1978,NDA050514,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050514,US Approved Rx 1978,NDA050514,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050514,Fusarium solani keratitis; Conjunctivitis; Fungal blepharitis,Approved; Approved; Approved
NATEGLINIDE,105816-04-4,https://drugs.ncats.io/drug/41X3PWK4O2,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""105816%2004%204"")",ONLY CAS,US Approved Rx 2018,ANDA205544,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205544,Possibly Marketed Outside US 2000,NDA021204,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5cbda9bc-3c0d-4d75-a37a-994844680c8c,Type 2 diabetes mellitus,Approved
NEBIVOLOL,99200-09-6,https://drugs.ncats.io/drug/030Y90569U,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""99200%2009%206"")",ONLY CAS,US Approved Rx 2024,ANDA209741,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209741,US Approved Rx 2007,NDA021742,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021742,Hypertension; Hypertension,Approved; Approved
NECITUMUMAB,906805-06-9,https://drugs.ncats.io/drug/2BT4C47RUI,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""906805%2006%209"")",ONLY CAS,US Approved Rx 2015,BLA125547,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125547,US Approved Rx 2015,BLA125547,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125547,,
NEDOCROMIL,69049-73-6,https://drugs.ncats.io/drug/0B535E0BN0,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""69049%2073%206"")",ONLY CAS,US Previously Marketed 1992,TILADE by KING PHARMS LLC,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019660,US Previously Marketed 1992,TILADE by KING PHARMS LLC,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019660,Asthma; Itching associated with allergic conjunctivitis,Approved; Approved
NEFAZODONE,83366-66-9,https://drugs.ncats.io/drug/59H4FCV1TF,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""83366%2066%209"")",ONLY CAS,US Approved Rx 2003,ANDA076037,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=076037,US Previously Marketed 1994,SERZONE by BRISTOL MYERS SQUIBB,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020152,Depression,Approved
NELARABINE,121032-29-9,https://drugs.ncats.io/drug/60158CV180,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""121032%2029%209"")",ONLY CAS,US Approved Rx 2022,ANDA216934,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216934,US Approved Rx 2005,NDA021877,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021877,T-cell acute lymphoblastic leukemia,Approved
NELFINAVIR,159989-64-7,https://drugs.ncats.io/drug/HO3OGH5D7I,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""159989%2064%207"")",ONLY CAS,US Approved Rx 2003,NDA021503,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021503,US Previously Marketed 1997,VIRACEPT by AGOURON PHARMS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020778,HIV infection,Approved
NEOMYCIN,1404-04-2,https://drugs.ncats.io/drug/I16QD7X297,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1404%2004%202"")",ONLY CAS,US Approved OTC ,21 CFR 333.110(d) first aid antibiotic:ointment neomycin sulfate,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec333-110.xml,US Previously Marketed 1951,Mycifradin by Upjohn,DeHaen 1940-1975 NMEs,Bacterial Infection; Hepatic coma,Approved; Approved
NEOSTIGMINE,59-99-4,https://drugs.ncats.io/drug/3982TWQ96G,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""59%2099%204"")",ONLY CAS,US Approved Rx 2019,ANDA212512,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212512,US Previously Marketed 1931,PROSTIGMIN by Valeant,https://trademarks.justia.com/713/22/prostigmin-71322016.html,Myasthenia gravis,Approved
NEPAFENAC,78281-72-8,https://drugs.ncats.io/drug/0J9L7J6V8C,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""78281%2072%208"")",ONLY CAS,US Approved Rx 2005,NDA021862,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021862,US Approved Rx 2005,NDA021862,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021862,Cataract; Pain,Approved; Approved
NERATINIB,698387-09-6,https://drugs.ncats.io/drug/JJH94R3PWB,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""698387%2009%206"")",ONLY CAS,US Approved Rx 2017,NDA208051,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208051,US Approved Rx 2017,NDA208051,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208051,Breast cancer; Colorectal cancer; Non-small cell lung cancer; HER2-overexpressed/amplified breast cancer,Phase III; Phase II; Phase II; Approved
NESIRITIDE,124584-08-3,https://drugs.ncats.io/drug/P7WI8UL647,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""124584%2008%203"")",ONLY CAS,US Previously Marketed 2001,NATRECOR by SCIOS LLC,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020920,Possibly Marketed Outside US 2001,NDA020920,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=44c45bfe-461f-4398-8f20-ea771b2403ee,acutely decompensated heart failure,Approved
NETARSUDIL,1254032-66-0,https://drugs.ncats.io/drug/W6I5QDT7QI,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1254032%2066%200"")",ONLY CAS,US Approved Rx 2019,NDA208259,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208259,US Approved Rx 2017,NDA208254,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208254,Ocular hypertension; Open-angle glaucoma,Approved; Approved
NETUPITANT,290297-26-6,https://drugs.ncats.io/drug/7732P08TIR,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""290297%2026%206"")",ONLY CAS,US Approved Rx 2018,NDA210493,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210493,US Approved Rx 2014,NDA205718,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205718,Nausea and vomiting; Acute and delayed nausea and vomiting,Approved; Approved
NEVIRAPINE,129618-40-2,https://drugs.ncats.io/drug/99DK7FVK1H,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""129618%2040%202"")",ONLY CAS,US Approved Rx 2012,ANDA078584,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=078584,US Previously Marketed 1996,VIRAMUNE by BOEHRINGER INGELHEIM,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020636,HIV-1 infection,Approved
NICARDIPINE,55985-32-5,https://drugs.ncats.io/drug/CZ5312222S,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""55985%2032%205"")",ONLY CAS,US Approved Rx 2023,ANDA216420,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216420,US Previously Marketed 1988,CARDENE by CHIESI,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019488,Hypertension; Chronic stable angina,Approved; Approved
NICKEL,7440-02-0,https://drugs.ncats.io/drug/7OV03QG267,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""7440%2002%200"")",ONLY CAS,Possibly Marketed Outside US ,Canada:NICKEL CHLORIDE,https://tripod.nih.gov/npc/#Download,,,,,
NICOTINAMIDE,98-92-0,https://drugs.ncats.io/drug/25X51I8RD4,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""98%2092%200"")",ONLY CAS,US Approved Rx 2001,NDA021265,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021265,US Previously Marketed 1947,BEROCCA PN by ROCHE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=006071,Pellagra; Arteriosclerotic syndromes; Ophthalmology,Approved; Not Provided; Not Provided
NICOTINE,"54-11-5
22083-74-5",N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""54%2011%205
22083%2074%205"")",ONLY CAS,,,,,,,,
NICOTINIC ACID,59-67-6,https://drugs.ncats.io/drug/2679MF687A,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""59%2067%206"")",ONLY CAS,US Approved Rx 2014,ANDA090892,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=090892,US Previously Marketed 1937,"Niacin by Merck & Co, Inc.",https://archive.org/details/in.ernet.dli.2015.145864,Hyperlipidemia; Atherosclerotic disease; Myocardial infarction,Approved; Approved; Approved
NIFEDIPINE,21829-25-4,https://drugs.ncats.io/drug/I9ZF7L6G2L,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""21829%2025%204"")",ONLY CAS,US Approved Rx 1989,NDA019684,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019684,US Approved Rx 1981,NDA018482,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018482,Chronic stable angina; Vasospastic angina,Approved; Approved
NILOTINIB,641571-10-0,https://drugs.ncats.io/drug/F41401512X,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""641571%2010%200"")",ONLY CAS,US Approved Rx 2007,NDA022068,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22068,US Approved Rx 2007,NDA022068,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22068,Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML),Approved
NILUTAMIDE,63612-50-0,https://drugs.ncats.io/drug/51G6I8B902,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""63612%2050%200"")",ONLY CAS,US Approved Rx 2016,ANDA207631,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207631,US Approved Rx 1996,NDA020169,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020169,Metastatic prostate cancer,Approved
NIMODIPINE,66085-59-4,https://drugs.ncats.io/drug/57WA9QZ5WH,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""66085%2059%204"")",ONLY CAS,US Approved Rx 2013,NDA203340,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203340,US Previously Marketed 1988,NIMOTOP by BAYER PHARMS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018869,Subarachnoid hemorrhage; Subarachnoid hemorrhage; Subarachnoid hemorrhage,Approved; Approved; Approved
NINTEDANIB,656247-17-5,https://drugs.ncats.io/drug/G6HRD2P839,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""656247%2017%205"")",ONLY CAS,US Approved Rx 2014,NDA205832,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205832,US Approved Rx 2014,NDA205832,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205832,Idiopathic pulmonary fibrosis,Approved
NIRAPARIB,1038915-60-4,https://drugs.ncats.io/drug/HMC2H89N35,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1038915%2060%204"")",ONLY CAS,Possibly Marketed Outside US ,Zejula by Glaxosmithkline Inc [Canada],https://www.drugbank.ca/drugs/DB11793,Possibly Marketed Outside US 2017,NDA208447,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c15c7b7e-4b7f-4489-bbbc-884caeee0669,Fallopian tube cancer; Ovarian cancer; Breast cancer; Peritoneal cancer; epithelial ovarian cancer,Phase III; Phase III; Phase III; Phase III; Approved
NISOLDIPINE,63675-72-9,https://drugs.ncats.io/drug/4I8HAB65SZ,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""63675%2072%209"")",ONLY CAS,US Approved Rx 2011,ANDA091001,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=091001,US Approved Rx 1995,NDA020356,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020356,Hypertension,Approved
NITAZOXANIDE,55981-09-4,https://drugs.ncats.io/drug/SOA12P041N,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""55981%2009%204"")",ONLY CAS,US Approved Rx 2002,NDA021498,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021498,US Approved Rx 2002,NDA021498,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021498,Diarrhea caused by Giardia lamblia or Cryptosporidium parvum; Rotavirus gastroenteritis; Tuberculosis; Trichomoniasis; Hepatitis B,Approved; Basic research; Basic research; Basic research; Basic research
NITRIC ACID,7697-37-2,https://drugs.ncats.io/drug/411VRN1TV4,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""7697%2037%202"")",ONLY CAS,US Previously Marketed 1961,VERA-TENSIL R-S POTASSIUM NITRATE by RICHLYN,https://cdn.loc.gov/service/ll/fedreg/fr037/fr037248/fr037248.pdf,US Previously Marketed 1921,Nitric Acid U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,Dental Caries,Not Provided
NITROFURAL,59-87-0,https://drugs.ncats.io/drug/X8XI70B5Z6,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""59%2087%200"")",ONLY CAS,US Previously Marketed 1982,ACTIN-N by SHERWOOD MEDCL,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017343,US Previously Marketed 1945,FURACIN by SHIRE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=005795,Infected burns; Skin infections due to skin grafts,Approved; Approved
NITROFURANTOIN,67-20-9,https://drugs.ncats.io/drug/927AH8112L,2,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""67%2020%209"")%20AND%20(root_names_name:""%5ENITROFURANTOIN$"")",EXACT NAME,US Approved Rx 2017,ANDA205005,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205005,US Approved Rx 1953,NDA009175,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=009175,Urinary tract infections,Approved
NITROGLYCERIN,55-63-0,https://drugs.ncats.io/drug/G59M7S0WS3,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""55%2063%200"")",ONLY CAS,US Approved Rx 2018,ANDA207141,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207141,US Previously Marketed 1921,Spirit of Glyceryl Trinitrate U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,,
NITROPRUSSIDE,15078-28-1,https://drugs.ncats.io/drug/169D1260KM,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""15078%2028%201"")",ONLY CAS,,,,,,,,
NITROUS ACID,7782-77-6,https://drugs.ncats.io/drug/T2I5UM75DN,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""7782%2077%206"")",ONLY CAS,US Approved Rx 2012,NDA203922,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203922,US Previously Marketed 1921,Sodium Nitrite U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,Cyanide poisoning,Approved
NITROUS OXIDE,10024-97-2,https://drugs.ncats.io/drug/K50XQU1029,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""10024%2097%202"")",ONLY CAS,US Approved Rx 2013,NDA206014,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206014,US Previously Marketed 1844,nitrous oxide,https://catalog.hathitrust.org/Record/100782317,Pain,Approved
NIVOLUMAB,946414-94-4,https://drugs.ncats.io/drug/31YO63LBSN,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""946414%2094%204"")",ONLY CAS,US Approved Rx 2015,BLA125527,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125527,US Approved Rx 2014,BLA125554,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125554,,
NIZATIDINE,76963-41-2,https://drugs.ncats.io/drug/P41PML4GHR,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""76963%2041%202"")",ONLY CAS,US Approved Rx 2002,ANDA076178,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=076178,US Previously Marketed 1988,AXID by SMITHKLINE BEECHAM,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019508,Gastroesophageal reflux disease; Gastric ulcer; Duodenal ulcer,Approved; Approved; Approved
NONACOG BETA PEGOL,1175512-71-6,https://drugs.ncats.io/drug/27Y83O992Q,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1175512%2071%206"")",ONLY CAS,Possibly Marketed Outside US ,Rebinyn by Novo Nordisk [Canada],https://www.drugbank.ca/drugs/DB13933,,,,,
NONOXINOL 9,9016-45-9,https://drugs.ncats.io/drug/283U2KY9DD,2,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""9016%2045%209"")",ONLY CAS,,,,,,,,
NON MEDICATED EYE DROPS,1314-13-2,https://drugs.ncats.io/drug/SOI2LOH54Z,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1314%2013%202"")",ONLY CAS,US Approved OTC ,21 CFR 347.10(t) skin protectant zinc carbonate,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec347-10.xml,US Previously Marketed 1921,Precipitated Zinc Carbonate U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,Caries; Ulcerative colitis; Breast cancer; Acute myeloid leukemia; Unknown; Unknown; Poison Ivy dermatitis; Diaper dermatitis; Dysgeusia; Mucositis; Gastrointestinal disorders; Renal insufficiency; Unknown; Unknown; Zinc deficiency,Basic research; Approved; Basic research; Basic research; Approved; Approved; Phase III; Phase III; Approved; Approved; Preclinical
NORACYMETHADOL,1477-39-0,https://drugs.ncats.io/drug/KU5U13XY7J,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1477%2039%200"")",ONLY CAS,Clinical ,INN:noracymethadol,https://tripod.nih.gov/npc/#Download,,,,,
NORELGESTROMIN,53016-31-2,https://drugs.ncats.io/drug/R0TAY3X631,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""53016%2031%202"")",ONLY CAS,US Approved Rx 2014,ANDA200910,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=200910,US Previously Marketed 2001,ORTHO EVRA by JANSSEN PHARMS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021180,Pregnancy; Pregnancy,Approved; Approved
NOREPINEPHRINE,51-41-2,https://drugs.ncats.io/drug/X4W3ENH1CV,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""51%2041%202"")",ONLY CAS,US Approved Rx 2018,ANDA210839,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210839,US Approved Rx 1950,NDA007513,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=007513,Hypotension; Cardiac arrest; Systemic inflammatory response syndrome; Neurogenic orthostatic hypotension,Approved; Approved; Phase IV; Approved
NORETHISTERONE,68-22-4,https://drugs.ncats.io/drug/T18F433X4S,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""68%2022%204"")",ONLY CAS,US Approved Rx 2014,ANDA202996,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202996,US Previously Marketed 1957,Norlutin by Parke-Davis,OB NME Appendix 1950-1985,Endometriosis; Abnormal uterine bleeding; Pregnancy; Secondary amenorrhea,Approved; Approved; Approved; Approved
NORFLOXACIN,70458-96-7,https://drugs.ncats.io/drug/N0F8P22L1P,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""70458%2096%207"")",ONLY CAS,US Previously Marketed 1991,CHIBROXIN by MERCK,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019757,US Previously Marketed 1986,NOROXIN by MERCK,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019384,Urinary tract infections; Conjunctivitis; Prostatitis; Gonorrhea,Approved; Approved; Approved; Approved
NORFLURANE,811-97-2,https://drugs.ncats.io/drug/DH9E53K1Y8,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""811%2097%202"")",ONLY CAS,Possibly Marketed Outside US 2020,21 CFR 333D,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=adc4ed21-dfa8-4dad-8e03-e5f07fca03bc,Possibly Marketed Outside US 1981,NDA021457,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=133fb50a-68d3-4d1b-a47a-67d07cc48da5,,
NORGESTERONE,13563-60-5,https://drugs.ncats.io/drug/YFS274763Y,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""13563%2060%205"")",ONLY CAS,Clinical ,INN:norgesterone,https://tripod.nih.gov/npc/#Download,,,,,
NORGESTIMATE,107382-52-5,https://drugs.ncats.io/drug/NKX8DN6TY9,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""107382%2052%205"")",ONLY CAS,,,,,,,,
NORGESTREL,797-63-7,https://drugs.ncats.io/drug/5W7SIA7YZW,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""797%2063%207"")",ONLY CAS,US Approved Rx 2015,ANDA201088,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201088,US Previously Marketed 1968,OVRAL-28 by WYETH PHARMS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016806,Heavy menstrual bleeding; Fertilization; Pregnancy; Pregnancy,Approved; Approved; Approved; Approved
NORTRIPTYLINE,72-69-5,https://drugs.ncats.io/drug/BL03SY4LXB,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""72%2069%205"")",ONLY CAS,US Approved Rx 1977,NDA018013,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018013,US Previously Marketed 1964,AVENTYL by RANBAXY,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=014685,Depression; Plaque psoriasis; Gastroesophageal reflux disease,Approved; Phase II; Phase III
NOVOBIOCIN,303-81-1,https://drugs.ncats.io/drug/17EC19951N,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""303%2081%201"")",ONLY CAS,US Previously Marketed 1956,Sodium Albamycin by Upjohn,DeHaen 1940-1975 NMEs,US Previously Marketed 1956,Sodium Albamycin by Upjohn,DeHaen 1940-1975 NMEs,Breast cancer; Psoriasis; Non-small cell lung cancer; Bovine subclinical mastitis caused by Staphylococcus aureus and Streptococcus agalactiae; Staphylococcal Infections,Phase I; Not Provided; Phase II; Approved; Approved
NUSINERSEN,1258984-36-9,https://drugs.ncats.io/drug/5Z9SP3X666,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1258984%2036%209"")",ONLY CAS,US Approved Rx 2016,NDA209531,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209531,US Approved Rx 2016,NDA209531,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209531,,
NYSTATIN,1400-61-9,https://drugs.ncats.io/drug/BDF1O1C72E,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1400%2061%209"")",ONLY CAS,US Approved Rx 1988,ANDA062838,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=062838,US Previously Marketed 1954,Mycostatin by Squibb,DeHaen 1940-1975 NMEs,,
O-PHTHALALDEHYDE,643-79-8,https://drugs.ncats.io/drug/4P8QP9768A,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""643%2079%208"")",ONLY CAS,Possibly Marketed Outside US ,Canada:ORTHO-PHTHALALDEHYDE,https://tripod.nih.gov/npc/#Download,Possibly Marketed Outside US 2022,Safe OPA by Valley Inc.,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=89393417-c8a3-46bf-ad89-db7b8c360c85,Metabolic disease; Kidney disease,Approved; Approved
OBETICHOLIC ACID,459789-99-2,https://drugs.ncats.io/drug/0462Z4S4OZ,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""459789%2099%202"")",ONLY CAS,US Approved Rx 2016,NDA207999,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207999,US Approved Rx 2016,NDA207999,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207999,Primary biliary cholangitis,Approved
OBINUTUZUMAB,949142-50-1,https://drugs.ncats.io/drug/O43472U9X8,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""949142%2050%201"")",ONLY CAS,US Approved Rx 2013,BLA125486,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125486,US Approved Rx 2013,BLA125486,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125486,,
OCRELIZUMAB,637334-45-3,https://drugs.ncats.io/drug/A10SJL62JY,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""637334%2045%203"")",ONLY CAS,US Approved Rx 2017,BLA761053,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761053,US Approved Rx 2017,BLA761053,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761053,,
OCRIPLASMIN,1048016-09-6,https://drugs.ncats.io/drug/7V6HE3DM5A,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1048016%2009%206"")",ONLY CAS,US Approved Rx 2012,BLA125422,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125422,US Approved Rx 2012,BLA125422,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125422,,
OCTACOSANOL,557-61-9,https://drugs.ncats.io/drug/81I2215OVK,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""557%2061%209"")",ONLY CAS,Possibly Marketed Outside US ,"Ginsamin Power by Biogrand Co., Ltd",https://www.drugbank.ca/drugs/DB11220,Possibly Marketed Outside US 2010,"Ginsamin Power by Biogrand Co., Ltd",https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=79fdfc31-a9fb-4b79-95d9-a792f982bd14,Myocardial ischemia; Atherosclerosis; Parkinsonism,Basic research; Basic research; Basic research
OCTANOIC ACID,124-07-2,https://drugs.ncats.io/drug/OBL58JN025,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""124%2007%202"")",ONLY CAS,US Previously Marketed 1945,Sodium Caprylate by Pennwalt,DeHaen 1940-1975 NMEs,Possibly Marketed Outside US 1942,BLA101138,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=face90dc-a227-3ec2-1645-f74eb9dac68c,Essential tremor,Phase II
OCTINOXATE,5466-77-3,https://drugs.ncats.io/drug/4Y5P7MUD51,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""5466%2077%203"")",ONLY CAS,US Previously Marketed 1992,SHADE UVAGUARD by BAYER HEALTHCARE LLC,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020045,Possibly Marketed Outside US 1984,"NU-DERM SUNFADER  Skin Lightener with Sunscreen (SPF 15) PABA FREE by OMP, INC.",https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f439d77f-ec5b-4534-a005-08f2e7af8d0c,Sunburns,Approved
OCTOCOG ALFA,17493-86-6,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""17493%2086%206"")",ONLY CAS,,,,,,,,
OCTOCRILENE,6197-30-4,https://drugs.ncats.io/drug/5A68WGF6WM,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""6197%2030%204"")",ONLY CAS,US Approved Rx 2006,NDA021501,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021501,Possibly Marketed Outside US 2004,21 CFR 352,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2b67a454-26ba-4049-854c-9335668236cd,Sunburns,Approved
OCTOXINOL,2315-67-5,https://drugs.ncats.io/drug/20CAX7IO75,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""2315%2067%205"")",ONLY CAS,Possibly Marketed Outside US ,Canada:POLYETHYLENE GLYCOL P-ISOOCTYLPHENYL ETHER,https://tripod.nih.gov/npc/#Download,Possibly Marketed Outside US 2011,21 CFR 333D,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=48782ccf-c030-4478-b9b4-f6868845febd,Unknown,
OCTOXYNOL,2315-67-5,https://drugs.ncats.io/drug/20CAX7IO75,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""2315%2067%205"")",ONLY CAS,Possibly Marketed Outside US ,Canada:POLYETHYLENE GLYCOL P-ISOOCTYLPHENYL ETHER,https://tripod.nih.gov/npc/#Download,Possibly Marketed Outside US 2011,21 CFR 333D,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=48782ccf-c030-4478-b9b4-f6868845febd,Unknown,
OCTREOTIDE,83150-76-9,https://drugs.ncats.io/drug/RWM8CCW8GP,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""83150%2076%209"")",ONLY CAS,US Approved Rx 2005,ANDA075959,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=075959,US Approved Rx 1988,NDA019667,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019667,Vasoactive intestinal peptide tumors (VIPomas); Acromegaly; Carcinoid tumors,Approved; Approved; Approved
OCTYL SALICYLATE,6969-49-9,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""6969%2049%209"")",ONLY CAS,,,,,,,,
OFATUMUMAB,679818-59-8,https://drugs.ncats.io/drug/M95KG522R0,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""679818%2059%208"")",ONLY CAS,US Approved Rx 2009,BLA125326,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125326,US Approved Rx 2009,BLA125326,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125326,,
OFLOXACIN,82419-36-1,https://drugs.ncats.io/drug/A4P49JAZ9H,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""82419%2036%201"")",ONLY CAS,US Approved Rx 2022,ANDA216130,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216130,US Previously Marketed 1990,FLOXIN by JANSSEN PHARMS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019735,Otitis due to bacterial infections; Bacterial conjunctivitis; Bacterial infections; Corneal ulcer due to bacterial infections,Approved; Approved; Approved; Approved
OFTASCEINE,1461-15-0,https://drugs.ncats.io/drug/V0YM2B16TS,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1461%2015%200"")",ONLY CAS,Discontinued ,SoftGlo by Hub Pharmaceuticals,https://www.drugbank.ca/drugs/DB11184,,,,Multidrug resistance,Not Provided
OLANZAPINE,132539-06-1,https://drugs.ncats.io/drug/N7U69T4SZR,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""132539%2006%201"")",ONLY CAS,US Approved Rx 2012,ANDA202050,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202050,US Approved Rx 1996,NDA020592,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020592,Bipolar I disorder; Schizophrenia,Approved; Approved
OLAPARIB,763113-22-0,https://drugs.ncats.io/drug/WOH1JD9AR8,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""763113%2022%200"")",ONLY CAS,US Approved Rx 2017,NDA208558,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208558,US Previously Marketed 2014,LYNPARZA by ASTRAZENECA,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206162,Ovarian cancer,Approved
OLARATUMAB,1024603-93-7,https://drugs.ncats.io/drug/TT6HN20MVF,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1024603%2093%207"")",ONLY CAS,US Approved Rx 2016,BLA761038,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761038,US Approved Rx 2016,BLA761038,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761038,,
OLEA EUROPEA,8001-25-0,https://drugs.ncats.io/drug/6UYK2W1W1E,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""8001%2025%200"")",ONLY CAS,US Approved Rx 2013,NDA204508,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204508,US Previously Marketed 1921,Olive Oil U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,,
OLEIC ACID,112-80-1,https://drugs.ncats.io/drug/2UMI9U37CP,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""112%2080%201"")",ONLY CAS,US Previously Marketed 1921,Oleic Acid U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,US Previously Marketed 1921,Oleic Acid U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,Obesity; Colorectal cancer; Type 2 diabetes mellitus; Atherosclerosis; Unknown,Phase I; Phase II; Phase I; Phase I
OLEYL ALCOHOL,143-28-2,https://drugs.ncats.io/drug/172F2WN8DV,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""143%2028%202"")",ONLY CAS,Possibly Marketed Outside US 2018,NADA141481,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5ff9fdb7-554f-4f91-8cfc-6d05094384c6,Possibly Marketed Outside US 1996,NDA020538,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e6f2e7ed-41a9-4a53-ac80-0cb1fa2edcbf,,
OLMESARTAN MEDOXOMIL,144689-63-4,https://drugs.ncats.io/drug/6M97XTV3HD,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""144689%2063%204"")",ONLY CAS,US Approved Rx 2010,NDA200175,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=200175,US Approved Rx 2002,NDA021286,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021286,Hypertension,Approved
OLODATEROL,868049-49-4,https://drugs.ncats.io/drug/VD2YSN1AFD,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""868049%2049%204"")",ONLY CAS,US Approved Rx 2014,NDA203108,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203108,US Approved Rx 2014,NDA203108,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203108,Chronic obstructive pulmonary disease,Approved
OLOPATADINE,113806-05-6,https://drugs.ncats.io/drug/D27V6190PM,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""113806%2005%206"")",ONLY CAS,US Approved Rx 2015,ANDA206306,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206306,US Approved Rx 1996,NDA020688,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020688,Allergic conjunctivitis; Seasonal allergic rhinitis,Approved; Approved
OLSALAZINE,6054-98-4,https://drugs.ncats.io/drug/Y7JEW0XG7I,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""6054%2098%204"")",ONLY CAS,US Approved Rx 1990,NDA019715,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019715,US Approved Rx 1990,NDA019715,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019715,Ulcerative colitis; Ankylosing spondylitis,Approved; Phase II
OMACETAXINE MEPESUCCINATE,26833-87-4,https://drugs.ncats.io/drug/6FG8041S5B,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""26833%2087%204"")",ONLY CAS,US Approved Rx 2012,NDA203585,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203585,US Approved Rx 2012,NDA203585,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203585,"Unknown; Chronic myeloid leukemia, accelerated phase; Chronic myeloid leukemia, chronic phase",Approved; Approved
OMADACYCLINE,389139-89-3,https://drugs.ncats.io/drug/090IP5RV8F,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""389139%2089%203"")",ONLY CAS,US Approved Rx 2018,NDA209817,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209817,US Approved Rx 2018,NDA209817,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209817,Acute bacterial skin and skin structure infections; Community-acquired bacterial pneumonia; Acute Pyelonephritis; Cystitis,Approved; Approved; Phase II; Phase II
OMALIZUMAB,242138-07-4,https://drugs.ncats.io/drug/2P471X1Z11,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""242138%2007%204"")",ONLY CAS,US Approved Rx 2003,BLA103976,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103976,US Approved Rx 2003,BLA103976,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103976,,
OMBITASVIR,1258226-87-7,https://drugs.ncats.io/drug/2302768XJ8,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1258226%2087%207"")",ONLY CAS,US Previously Marketed 2015,TECHNIVIE by ABBVIE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207931,US Previously Marketed 2015,TECHNIVIE by ABBVIE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207931,Genotype 1 chronic hepatitis C virus (HCV) infection; Genotype 4 chronic hepatitis C virus (HCV) infection without cirrhosis,Approved; Approved
OMEGA-3 ACID ETHYL ESTERS,84494-70-2,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""84494%2070%202"")",ONLY CAS,,,,,,,,
OMEPRAZOLE,73590-58-6,https://drugs.ncats.io/drug/KG60484QX9,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""73590%2058%206"")",ONLY CAS,US Approved Rx 2018,ANDA203290,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203290,US Previously Marketed 1989,PRILOSEC by ASTRAZENECA,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019810,Duodenal ulcer; Gastric ulcer; Gastroesophageal reflux disease; Pathological hypersecretory conditions,Approved; Approved; Approved; Approved
ONDANSETRON,99614-02-5,https://drugs.ncats.io/drug/4AF302ESOS,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""99614%2002%205"")",ONLY CAS,US Approved Rx 2007,ANDA078776,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=078776,US Previously Marketed 1991,ZOFRAN by SANDOZ,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020007,Postoperative nausea and vomiting; Nausea; Vomiting,Approved; Approved; Approved
OPIUM,8008-60-4,https://drugs.ncats.io/drug/37M3MZ001L,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""8008%2060%204"")",ONLY CAS,US Previously Marketed 1921,Opium U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,US Previously Marketed 1921,Opium U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,,
OPRELVEKIN,137598-97-1,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""137598%2097%201"")",ONLY CAS,,,,,,,,
ORCIPRENALINE,586-06-1,https://drugs.ncats.io/drug/53QOG569E0,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""586%2006%201"")%20AND%20(root_names_name:""%5EORCIPRENALINE"")",APPROXIMATE NAME,US Approved Rx 1992,ANDA073632,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=073632,US Previously Marketed 1973,ALUPENT by BOEHRINGER INGELHEIM,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016402,Bronchial asthma,Approved
ORITAVANCIN,171099-57-3,https://drugs.ncats.io/drug/PUG62FRZ2E,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""171099%2057%203"")",ONLY CAS,US Approved Rx 2021,NDA214155,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214155,US Approved Rx 2014,NDA206334,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206334,Acute bacterial skin and skin structure infection,Approved
ORLISTAT,96829-58-2,https://drugs.ncats.io/drug/95M8R751W8,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""96829%2058%202"")",ONLY CAS,US Approved Rx 2007,NDA021887,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021887,US Approved Rx 1999,NDA020766,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020766,Obesity,Approved
ORNIDAZOLE,16773-42-5,https://drugs.ncats.io/drug/62XCK0G93T,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""16773%2042%205"")",ONLY CAS,Possibly Marketed Outside US ,WHO-ATC:G01AF06,https://ginas.ncats.nih.gov/ginas/app/substance/62XCK0G93T,,,,Crohn's disease; Anaerobic bacterial infections; Giardiasis,Phase II; Approved; Approved
ORPHENADRINE,83-98-7,https://drugs.ncats.io/drug/AL805O9OG9,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""83%2098%207"")",ONLY CAS,US Approved Rx 2003,ANDA040463,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=040463,US Previously Marketed 1957,DISIPAL by 3M,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=010653,Quinine-resistant leg cramps; Musculoskeletal pain,Approved; Approved
OSELTAMIVIR,196618-13-0,https://drugs.ncats.io/drug/20O93L6F9H,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""196618%2013%200"")",ONLY CAS,US Approved Rx 2021,ANDA215208,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215208,US Approved Rx 1999,NDA021087,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021087,Influenza virus infections,Approved
OSIMERTINIB,1421373-65-0,https://drugs.ncats.io/drug/3C06JJ0Z2O,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1421373%2065%200"")",ONLY CAS,US Approved Rx 2015,NDA208065,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208065,US Approved Rx 2015,NDA208065,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208065,Metastatic EGFR T790M mutation positive non-small cell lung cancer,Approved
OSPEMIFENE,128607-22-7,https://drugs.ncats.io/drug/B0P231ILBK,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""128607%2022%207"")",ONLY CAS,US Approved Rx 2024,ANDA215574,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215574,US Approved Rx 2013,NDA203505,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203505,Dyspareunia,Approved
OTHERS,7664-41-7,https://drugs.ncats.io/drug/5138Q19F1X,3,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""7664%2041%207"")",ONLY CAS,US Approved Rx 1984,ANDA088366,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=088366,US Previously Marketed 1921,Ammonium Chloride U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,Metabolic alkalosis,Approved
OTHER BLOOD TESTS,50-70-4,https://drugs.ncats.io/drug/506T60A25R,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""50%2070%204"")",ONLY CAS,US Approved Rx 2020,NDA202049,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202049,Possibly Marketed Outside US 1955,Levsin by Alaven Pharmaceutical LLC,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=32388e18-08de-455c-aad4-9c2264435f0f,Constipation; End-Stage Renal Disease; Cystic fibrosis; Asthma; Acute renal failure; Elevated intraocular pressure; Cerebral edema,Basic research; Approved; Approved; Approved; Approved; Approved; Approved
OTHER CLEANSING AGENTS,69-72-7,https://drugs.ncats.io/drug/O414PZ4LPZ,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""69%2072%207"")",ONLY CAS,US Approved OTC ,21 CFR 358.110(b) wart remover:collodoin-like vehicle salicylic acid,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec358-110.xml,US Previously Marketed 1860,sodium salicylate,https://catalog.hathitrust.org/Record/100782317,Psoriasis; Ichthyosis vulgaris; Keratosis palmaris; Bruises; Arthritis; Strains and sprains; Simple backache,Approved; Approved; Approved; Approved; Approved; Approved; Approved
OTHER CONTACT LENS SOLUTIONS,50-37-3,https://drugs.ncats.io/drug/8NA5SWF92O,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""50%2037%203"")",ONLY CAS,Clinical ,INN:lysergide,https://tripod.nih.gov/npc/#Download,,,,Anxiety,Phase II
OTHER FOOT PREPARATIONS,23593-75-1,https://drugs.ncats.io/drug/G07GZ97H65,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""23593%2075%201"")",ONLY CAS,US Approved OTC ,21 CFR 333.210(g) antifungal clotrimazole,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec333-210.xml,US Previously Marketed 1975,LOTRIMIN by SCHERING PLOUGH,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017619,Tinea corporis; Vaginal yeast infections; Tinea cruris; Tinea pedis,Approved; Approved; Approved; Approved
OTHER ORAL HYGIENE PREPARATIONS,7722-84-1,https://drugs.ncats.io/drug/BBX060AN9V,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""7722%2084%201"")",ONLY CAS,US Approved OTC ,21 CFR 344.1 otic:earwax removal aid carbamide peroxide 6.5% (in anhydrous glycerin),https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec344-10.xml,US Previously Marketed 1921,Hydrogen Peroxide ,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,Gingivitis; Skin infections; Seborrheic keratoses,Approved; Approved; Approved
OTHER TESTS,64-77-7,https://drugs.ncats.io/drug/982XCM1FOI,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""64%2077%207"")",ONLY CAS,US Previously Marketed 1985,TOLBUTAMIDE by PUREPAC PHARM,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=088950,US Previously Marketed 1957,ORINASE by PHARMACIA AND UPJOHN,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=010670,Type 2 diabetes mellitus,Approved
OUABAIN,630-60-4,https://drugs.ncats.io/drug/5ACL011P69,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""630%2060%204"")",ONLY CAS,Possibly Marketed Outside US ,WHO-ATC:C01AC01,https://ginas.ncats.nih.gov/ginas/app/substance/5ACL011P69,,,,Atrial fibrillation; Atrial flutter; Cardiac arrhythmia; Unknown,Approved; Approved; Approved
OVALBUMIN,9006-59-1,https://drugs.ncats.io/drug/B05Y6V2CZS,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""9006%2059%201"")",ONLY CAS,Possibly Marketed Outside US 2013,NCT01981083: Phase 4 Interventional Unknown status Protein-Energy Malnutrition,https://clinicaltrials.gov/ct2/show/NCT01981083,,,,,
OVULATION TEST,15690-57-0,https://drugs.ncats.io/drug/R6D2UI4FLS,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""15690%2057%200"")",ONLY CAS,Clinical ,INN:enclomifene [INN],https://ginas.ncats.nih.gov/ginas/app/substance/R6D2UI4FLS,,,,Secondary hypogonadism,Phase III
OXACILLIN,66-79-5,https://drugs.ncats.io/drug/UH95VD7V76,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""66%2079%205"")",ONLY CAS,US Approved Rx 2017,ANDA207147,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207147,US Previously Marketed 1962,PROSTAPHLIN by APOTHECON,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050118,Infections caused by penicillinase-producing staphylococci,Approved
OXALIC ACID,144-62-7,https://drugs.ncats.io/drug/9E7R5L6H31,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""144%2062%207"")",ONLY CAS,US Previously Marketed 1922,Oxalic acid,https://books.google.com/books?id=slZKAAAAMAAJ&newbks=1&newbks_redir=0&dq=%22oxalic%20acid%22%20therapeutic&pg=PA804#v=onepage&q=%22oxalic%20acid%22%20therapeutic&f=false,US Previously Marketed 1922,Oxalic acid,https://books.google.com/books?id=slZKAAAAMAAJ&newbks=1&newbks_redir=0&dq=%22oxalic%20acid%22%20therapeutic&pg=PA804#v=onepage&q=%22oxalic%20acid%22%20therapeutic&f=false,,
OXANDROLONE,53-39-4,https://drugs.ncats.io/drug/7H6TM3CT4L,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""53%2039%204"")",ONLY CAS,US Previously Marketed 2007,OXANDROLONE by UPSHER SMITH LABS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=078033,US Previously Marketed 1964,Anavar by Searle,OB NME Appendix 1950-1985,Protein catabolism; Osteoporosis,Approved; Approved
OXAPROZIN,21256-18-8,https://drugs.ncats.io/drug/MHJ80W9LRB,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""21256%2018%208"")",ONLY CAS,US Approved Rx 2001,ANDA075855,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=075855,US Approved Rx 1992,NDA018841,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018841,Rheumatoid arthritis; Osteoarthritis; Juvenile rheumatoid arthritis,Approved; Approved; Approved
OXAZEPAM,604-75-1,https://drugs.ncats.io/drug/6GOW6DWN2A,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""604%2075%201"")",ONLY CAS,US Approved Rx 1988,ANDA071814,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=071814,US Previously Marketed 1965,SERAX by ALPHARMA US PHARMS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=015539,Acohol withdrawal; Anxiety,Approved; Approved
OXCARBAZEPINE,28721-07-5,https://drugs.ncats.io/drug/VZI5B1W380,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""28721%2007%205"")",ONLY CAS,US Approved Rx 2000,NDA021014,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021014,US Approved Rx 2000,NDA021014,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021014,Bipolar disorder; Partial seizures,Phase III; Approved
OXEDRINE,94-07-5,https://drugs.ncats.io/drug/PEG5DP7434,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""94%2007%205"")",ONLY CAS,US Previously Marketed 1931,Sympatol,https://en.wikipedia.org/wiki/Synephrine,US Previously Marketed 1931,Sympatol,https://en.wikipedia.org/wiki/Synephrine,Obesity,Approved
OXICONAZOLE,64211-45-6,https://drugs.ncats.io/drug/C668Q9I33J,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""64211%2045%206"")",ONLY CAS,US Approved Rx 2016,ANDA205076,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205076,US Approved Rx 1988,NDA019828,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019828,Tinea corporis; Tinea cruris; Tinea pedis; Tinea (pityriasis) versicolor,Approved; Approved; Approved; Approved
OXIDISED CELLULOSE,9032-53-5,https://drugs.ncats.io/drug/44AIH82TSC,2,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""9032%2053%205"")%20AND%20(root_names_name:""%5EOXIDISED%20CELLULOSE"")",APPROXIMATE NAME,US Previously Marketed 1946,Hemo-Pak by Johnson & Johnson,DeHaen 1940-1975 NMEs,US Previously Marketed 1946,Hemo-Pak by Johnson & Johnson,DeHaen 1940-1975 NMEs,,
OXIGLUTATIONE,27025-41-8,https://drugs.ncats.io/drug/ULW86O013H,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""27025%2041%208"")",ONLY CAS,US Approved Rx 1981,NDA018469,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018469,US Approved Rx 1981,NDA018469,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018469,Dry eye syndrome,Approved
OXITRIPTAN,4350-09-8,https://drugs.ncats.io/drug/C1LJO185Q9,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""4350%2009%208"")",ONLY CAS,Possibly Marketed Outside US ,WHO-ATC:N06AX01,https://ginas.ncats.nih.gov/ginas/app/substance/C1LJO185Q9,,,,Migraine; Post-anoxic myoclonus; Major depressive disorder,Approved; Approved; Approved
OXYBENZONE,131-57-7,https://drugs.ncats.io/drug/95OOS7VE0Y,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""131%2057%207"")",ONLY CAS,US Previously Marketed 1992,SHADE UVAGUARD by BAYER HEALTHCARE LLC,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020045,US Previously Marketed 1966,Solhar by Person-Covey,OB NME Appendix 1950-1985,Sunburns,Approved
OXYBUPROCAINE,99-43-4,https://drugs.ncats.io/drug/AXQ0JYM303,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""99%2043%204"")",ONLY CAS,,,,,,,Pain,Approved
OXYBUTYNIN,5633-20-5,https://drugs.ncats.io/drug/K9P6MC7092,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""5633%2020%205"")",ONLY CAS,US Approved Rx 2020,ANDA214415,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214415,US Previously Marketed 1975,DITROPAN by JANSSEN PHARMS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017577,Overactive bladder,Approved
OXYCHLOROSENE,8031-14-9,https://drugs.ncats.io/drug/3214M86B2N,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""8031%2014%209"")",ONLY CAS,US Previously Marketed 1955,Kasdenol by Kasdenol,OB NME Appendix 1950-1993,US Previously Marketed 1921,Chlorinated Lime U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,,
OXYCODONE,76-42-6,https://drugs.ncats.io/drug/CD35PMG570,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""76%2042%206"")",ONLY CAS,US Approved Rx 2017,ANDA207418,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207418,US Approved Rx 1950,NDA007337,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=007337,Osteoarthritis; Opioid-related disorders; Acute and chronic pain,Phase III; Phase II; Approved
OXYMETAZOLINE,1491-59-4,https://drugs.ncats.io/drug/8VLN5B44ZY,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1491%2059%204"")",ONLY CAS,US Approved OTC ,21 CFR 341.20(b)(7) cough/cold:nasal decongestant oxymetazoline hydrochloride,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec341-20.xml,US Previously Marketed 1964,Afrin by Schering,OB NME Appendix 1950-1985,Nasal congestion; Eye irritations,Approved; Approved
OXYMETHOLONE,434-07-1,https://drugs.ncats.io/drug/L76T0ZCA8K,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""434%2007%201"")",ONLY CAS,US Previously Marketed 1960,Adroyd by Parke-Davis,DeHaen 1940-1975 NMEs,US Previously Marketed 1960,Adroyd by Parke-Davis,DeHaen 1940-1975 NMEs,Anemia,Approved
OXYMORPHONE,76-41-5,https://drugs.ncats.io/drug/9VXA968E0C,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""76%2041%205"")",ONLY CAS,US Approved Rx 2014,ANDA201187,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201187,US Previously Marketed 1959,OPANA by ENDO PHARMS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=011707,Pain; Anxiety,Approved; Approved
OXYTETRACYCLINE,79-57-2,https://drugs.ncats.io/drug/SLF0D9077S,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""79%2057%202"")",ONLY CAS,US Approved OTC ,21 CFR 333.120 first aid antibiotic:ointment oxytetracycline hydrochloride (combination only),https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec333-120.xml,US Previously Marketed 1950,Terramycin HCl by Pfizer,DeHaen 1940-1975 NMEs,Superficial ocular infections,Approved
OXYTOCIN,50-56-6,https://drugs.ncats.io/drug/1JQS135EYN,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""50%2056%206"")",ONLY CAS,US Approved Rx 2018,ANDA091676,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=091676,US Previously Marketed 1928,Pitocin,https://books.google.com/books?id=AymgAAAAMAAJ&lpg=PA514&ots=Sv2C9092O9&dq=pitocin%201928&pg=PA514#v=onepage&q=pitocin%201928&f=false,Uterine hemorrhage; Labor,Approved; Approved
P-AMINOBENZOIC ACID,150-13-0,https://drugs.ncats.io/drug/TL2TJE8QTX,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""150%2013%200"")",ONLY CAS,US Previously Marketed 1961,PABIRIN AC AMINOBENZOIC ACID by DORSEY,https://cdn.loc.gov/service/ll/fedreg/fr035/fr035061/fr035061.pdf,Possibly Marketed Outside US 1943,NDA005378,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f03a68d5-ed00-8a2d-af68-28be909ea85f,Rheumatoid arthritis; Eczema dermatitis; Dermatoses; Atopic dermatitis,Not Provided; Not Provided; Not Provided; Not Provided
P-ANISIC ACID,100-09-4,https://drugs.ncats.io/drug/4SB6Y7DMM3,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""100%2009%204"")",ONLY CAS,Possibly Marketed Outside US 2016,M016,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a29fb680-cfc8-4a7b-9970-563fa0e2bed6,Possibly Marketed Outside US 1996,21 CFR 352,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=14c78e8a-eb3e-496b-9cb0-7f8b47b3fb2a,Acne; Fungal infection,Approved; Basic research
P-HYDROXYBENZOIC ACID,99-96-7,https://drugs.ncats.io/drug/JG8Z55Y12H,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""99%2096%207"")",ONLY CAS,Possibly Marketed Outside US 2015,21 CFR 352,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c16e8c37-6773-4fc9-9ea8-bda005742988,Possibly Marketed Outside US 2015,21 CFR 352,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c16e8c37-6773-4fc9-9ea8-bda005742988,,
P-PENTYLOXYPHENOL,18979-53-8,https://drugs.ncats.io/drug/UHM852UB1I,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""18979%2053%208"")",ONLY CAS,,,,,,,,
P-PHENOLSULFONIC ACID,98-67-9,https://drugs.ncats.io/drug/L74LRO149A,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""98%2067%209"")",ONLY CAS,Possibly Marketed Outside US ,DEBACTEROL Canker Sore Pain Relief by Epien Medical Inc,https://www.drugbank.ca/drugs/DB14739,Possibly Marketed Outside US 1996,DEBACTEROL Canker Sore Pain Relief by EPIEN Medical Inc,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=15d22ca4-503e-2751-e054-00144ff8d46c,Unknown; Unknown; Aphthous ulcers,Approved
PACLITAXEL,33069-62-4,https://drugs.ncats.io/drug/P88XT4IS4D,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""33069%2062%204"")",ONLY CAS,US Approved Rx 2018,ANDA205720,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205720,US Previously Marketed 1992,TAXOL by HQ SPCLT PHARMA,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020262,Advanced carcinoma of the ovary; Non-small cell lung cancer; Breast cancer,Approved; Approved; Approved
PADIMATE O,21245-02-3,https://drugs.ncats.io/drug/Z11006CMUZ,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""21245%2002%203"")",ONLY CAS,US Previously Marketed 1988,Photoplex by Herbert,OB NME Appendix 1950-1993,Possibly Marketed Outside US 1964,21 CFR 358A,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c0cc6cd4-8dea-4615-b763-2733f1582a66,Photosensitivity disorders,Approved
PALBOCICLIB,571190-30-2,https://drugs.ncats.io/drug/G9ZF61LE7G,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""571190%2030%202"")",ONLY CAS,US Approved Rx 2015,NDA207103,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207103,US Approved Rx 2015,NDA207103,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207103,"Estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer",Approved
PALIFERMIN,162394-19-6,https://drugs.ncats.io/drug/QMS40680K6,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""162394%2019%206"")",ONLY CAS,US Approved Rx 2004,BLA125103,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125103,US Approved Rx 2004,BLA125103,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125103,,
PALIPERIDONE,144598-75-4,https://drugs.ncats.io/drug/838F01T721,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""144598%2075%204"")",ONLY CAS,US Approved Rx 2015,ANDA203802,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203802,US Approved Rx 2006,NDA021999,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021999,Schizophrenia,Approved
PALIPERIDONE PALMITATE,199739-10-1,https://drugs.ncats.io/drug/R8P8USM8FR,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""199739%2010%201"")",ONLY CAS,US Approved Rx 2015,ANDA203802,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203802,US Approved Rx 2006,NDA021999,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021999,Schizophrenia,Approved
PALIVIZUMAB,188039-54-5,https://drugs.ncats.io/drug/DQ448MW7KS,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""188039%2054%205"")",ONLY CAS,US Approved Rx 1998,BLA103770,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103770,US Approved Rx 1998,BLA103770,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103770,,
PALMARIA PALMATA,977007-74-1,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""977007%2074%201"")",ONLY CAS,,,,,,,,
PALMITIC ACID,57-10-3,https://drugs.ncats.io/drug/2V16EO95H1,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""57%2010%203"")",ONLY CAS,Possibly Marketed Outside US ,"Sha-lem by Shalem Products, Inc.",https://www.drugbank.ca/drugs/DB03796,Possibly Marketed Outside US 1990,21 CFR 358A,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6eef6b11-20c2-4665-a5dd-cce4e790102e,Respiratory distress syndrome in premature infants,Approved
PALONOSETRON,135729-61-2,https://drugs.ncats.io/drug/5D06587D6R,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""135729%2061%202"")",ONLY CAS,US Approved Rx 2018,ANDA205648,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205648,US Previously Marketed 2003,ALOXI by HELSINN HLTHCARE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021372,Postoperative nausea and vomiting; Chemotherapy induced nausea and vomiting,Approved; Approved
PAMABROM,606-04-2,https://drugs.ncats.io/drug/UA8U0KJM72,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""606%2004%202"")",ONLY CAS,US Previously Marketed 1961,NEO BROMTH PAMABROM by BRAYTEN,https://cdn.loc.gov/service/ll/fedreg/fr037/fr037132/fr037132.pdf,US Previously Marketed 1952,Pamabrom by Brayten,DeHaen 1940-1975 NMEs,Menstrual relief,Not Provided
PAMIDRONIC ACID,40391-99-9,https://drugs.ncats.io/drug/OYY3447OMC,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""40391%2099%209"")",ONLY CAS,US Approved Rx 2002,ANDA075841,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=075841,US Previously Marketed 1991,AREDIA by NOVARTIS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020036,,
PANAX GINSENG,41753-43-9,https://drugs.ncats.io/drug/7413S0WMH6,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""41753%2043%209"")",ONLY CAS,Possibly Marketed Outside US ,Unknown,https://clinicaltrials.gov/ct2/show/NCT02413099,,,,Ischemic heart disease; Vascular dementia; Male infertility; Erectile dysfunction,Basic research; Phase II; Phase IV; Phase IV
PANCREAS,9025-24-5,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""9025%2024%205"")",ONLY CAS,,,,,,,,
PANCRELIPASE,53608-75-6,https://drugs.ncats.io/drug/FQ3DRG0N5K,3,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""53608%2075%206"")%20AND%20(root_names_name:""%5EPANCRELIPASE$"")",EXACT NAME,US Approved Rx 2009,BLA022210,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022210,US Previously Marketed 1921,Pancreatin U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,,
PANCURONIUM,16974-53-1,https://drugs.ncats.io/drug/J76UF062FS,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""16974%2053%201"")",ONLY CAS,US Approved Rx 1990,ANDA072760,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=072760,US Previously Marketed 1972,PAVULON by ORGANON USA INC,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017015,Pain,Approved
PANITUMUMAB,339177-26-3,https://drugs.ncats.io/drug/6A901E312A,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""339177%2026%203"")",ONLY CAS,US Approved Rx 2006,BLA125147,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125147,US Approved Rx 2006,BLA125147,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125147,,
PANOBINOSTAT,404950-80-7,https://drugs.ncats.io/drug/9647FM7Y3Z,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""404950%2080%207"")",ONLY CAS,US Previously Marketed 2015,FARYDAK by SECURA,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205353,US Previously Marketed 2015,FARYDAK by SECURA,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205353,Multiple myeloma,Approved
PANTETHINE,16816-67-4,https://drugs.ncats.io/drug/7K81IL792L,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""16816%2067%204"")",ONLY CAS,Possibly Marketed Outside US ,Japan:Pantethine,https://tripod.nih.gov/npc/#Download,Possibly Marketed Outside US 2000,21 CFR 352,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=422d83f6-011b-4a4c-9a7b-50288536938f,Cardiovascular diseases,Approved
PANTHENOL,16485-10-2,https://drugs.ncats.io/drug/WV9CM0O67Z,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""16485%2010%202"")",ONLY CAS,US Approved Rx 2000,NDA021163,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021163,US Previously Marketed 1947,BEROCCA PN by ROCHE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=006071,Skin moisturizer; SUNBURN,Basic research; Approved
PANTOPRAZOLE,102625-70-7,https://drugs.ncats.io/drug/D8TST4O562,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""102625%2070%207"")",ONLY CAS,US Approved Rx 2014,ANDA202052,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202052,US Approved Rx 2000,NDA020987,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020987,Erosive esophagitis associated with gastroesophageal reflux disease; Zollinger-Ellison syndrome,Approved; Approved
PANTOTHENIC ACID,79-83-4,https://drugs.ncats.io/drug/19F5HK2737,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""79%2083%204"")",ONLY CAS,US Previously Marketed 1993,VITAPED by HOSPIRA,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020176,US Previously Marketed 1937,Calcium pentothate,https://books.google.com/books?newbks=1&newbks_redir=0&id=LlpLAAAAMAAJ&dq=dispensatory+pantothenate&focus=searchwithinvolume&q=pantothenate,Acne; Systemic lupus erythematosus; Osteoarthrosis; Rheumatoid arthritis; Pernicious anemia,Not Provided; Not Provided; Not Provided; Not Provided; Approved
PAPAIN,9001-73-4,https://drugs.ncats.io/drug/A236A06Y32,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""9001%2073%204"")",ONLY CAS,US Previously Marketed 1921,Caroid,https://books.google.com/books?id=-Uk2AQAAMAAJ&newbks=1&newbks_redir=0&dq=papain%20first%20marketed&pg=RA1-PA446#v=onepage&q=papain%20first%20marketed&f=false,US Previously Marketed 1921,Caroid,https://books.google.com/books?id=-Uk2AQAAMAAJ&newbks=1&newbks_redir=0&dq=papain%20first%20marketed&pg=RA1-PA446#v=onepage&q=papain%20first%20marketed&f=false,,
PAPAVERINE,58-74-2,https://drugs.ncats.io/drug/DAA13NKG2Q,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""58%2074%202"")",ONLY CAS,Possibly Marketed Outside US ,"Papaverine Hydrochloride by AMERICAN REGENT, INC.",https://www.drugbank.ca/drugs/DB01113,Possibly Marketed Outside US 1995,"Papaverine Hydrochloride by American Regent, Inc.",https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9e5e2ce4-7a57-4c61-a826-64c8d11d038e,Spasm of smooth muscle,Approved
PARACETAMOL,103-90-2,https://drugs.ncats.io/drug/362O9ITL9D,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""103%2090%202"")",ONLY CAS,US Approved Rx 2018,ANDA210644,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210644,US Previously Marketed 1950,Trigesic by Squibb,DeHaen 1940-1975 NMEs,Common cold; Backache; Headache; Arthritis; Fever,Approved; Approved; Approved; Approved; Approved
PARAFFIN OIL,7440-23-5,https://drugs.ncats.io/drug/9NEZ333N27,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""7440%2023%205"")",ONLY CAS,US Previously Marketed 1921,Sodium Indigotindisulphonate U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,US Previously Marketed 1921,Sodium Indigotindisulphonate U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,,
PARATHYROID HORMONE,9002-64-6,https://drugs.ncats.io/drug/N19A0T0E5J,2,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""9002%2064%206"")%20AND%20(root_names_name:""%5EPARATHYROID%20HORMONE$"")",EXACT NAME,US Approved Rx 2015,BLA125511,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125511,US Approved Rx 2015,BLA125511,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125511,Hypoparathyroidism; Postmenopausal osteoporosis,Approved; Approved
PARICALCITOL,131918-61-1,https://drugs.ncats.io/drug/6702D36OG5,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""131918%2061%201"")",ONLY CAS,US Approved Rx 2017,ANDA203897,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203897,US Approved Rx 1998,NDA020819,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020819,Secondary hyperparathyroidism associated with chronic kidney disease,Approved
PARITAPREVIR,1216941-48-8,https://drugs.ncats.io/drug/OU2YM37K86,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1216941%2048%208"")",ONLY CAS,US Previously Marketed 2016,VIEKIRA XR by ABBVIE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208624,US Previously Marketed 2014,VIEKIRA PAK (COPACKAGED) by ABBVIE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206619,Chronic hepatitis C virus (genotype 4) infection,Approved
PAROMOMYCIN,7542-37-2,https://drugs.ncats.io/drug/61JJC8N5ZK,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""7542%2037%202"")",ONLY CAS,US Approved Rx 2007,ANDA065173,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=065173,US Previously Marketed 1960,Humatin by Parke-Davis,DeHaen 1940-1975 NMEs,Hepatic coma; Intestinal amebiasis,Approved; Approved
PAROXETINE,61869-08-7,https://drugs.ncats.io/drug/41VRH5220H,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""61869%2008%207"")",ONLY CAS,US Approved Rx 2005,ANDA076618,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=076618,US Previously Marketed 1992,Paxil by SmithKline,OB NME Appendix 1950-1993,Generalized anxiety disorder; Social anxiety disorder; Post-traumatic stress disorder; Major depressive disorder; Obsessive-compulsive disorder; Panic disorder,Approved; Approved; Approved; Approved; Approved; Approved
PASIREOTIDE,396091-73-9,https://drugs.ncats.io/drug/98H1T17066,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""396091%2073%209"")",ONLY CAS,US Approved Rx 2012,NDA200677,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=200677,US Approved Rx 2012,NDA200677,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=200677,Cushing’s disease,Approved
PATIROMER CALCIUM,1208912-84-8,https://drugs.ncats.io/drug/7T97I3787N,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1208912%2084%208"")",ONLY CAS,US Approved Rx 2015,NDA205739,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205739,US Approved Rx 2015,NDA205739,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205739,,
PATISIRAN,1420706-45-1,https://drugs.ncats.io/drug/50FKX8CB2Y,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1420706%2045%201"")",ONLY CAS,US Approved Rx 2018,NDA210922,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210922,US Approved Rx 2018,NDA210922,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210922,,
PAZOPANIB,444731-52-6,https://drugs.ncats.io/drug/7RN5DR86CK,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""444731%2052%206"")",ONLY CAS,US Approved Rx 2023,ANDA217713,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217713,US Approved Rx 2009,NDA022465,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022465,Soft tissue sarcoma; Renal cell carcinoma,Approved; Approved
PECTIN,9000-69-5,https://drugs.ncats.io/drug/89NA02M4RX,3,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""9000%2069%205"")%20AND%20(root_names_name:""%5EPECTIN$"")",EXACT NAME,US Previously Marketed 1961,CREMOSUXIDINE PECTIN by MSD,https://www.govinfo.gov/content/pkg/FR-1972-12-27/pdf/FR-1972-12-27.pdf,US Previously Marketed 1921,pectin,https://catalog.hathitrust.org/Record/100163146,,
PEGADEMASE,130167-68-9,https://drugs.ncats.io/drug/HW3H7D91F6,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""130167%2068%209"")",ONLY CAS,US Previously Marketed 1990,ADAGEN by LEADIANT BIOSCI INC,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019818,US Previously Marketed 1990,ADAGEN by LEADIANT BIOSCI INC,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019818,,
PEGAPTANIB,222716-86-1,https://drugs.ncats.io/drug/3HP012Q0FH,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""222716%2086%201"")",ONLY CAS,US Previously Marketed 2004,MACUGEN by BAUSCH AND LOMB INC,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021756,US Previously Marketed 2004,MACUGEN by BAUSCH AND LOMB INC,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021756,Age-related macular degeneration,Approved
PEGASPARGASE,130167-69-0,https://drugs.ncats.io/drug/7D96IR0PPM,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""130167%2069%200"")",ONLY CAS,US Approved Rx 1994,BLA103411,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103411,US Approved Rx 1994,BLA103411,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103411,,
PEGFILGRASTIM,208265-92-3,https://drugs.ncats.io/drug/3A58010674,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""208265%2092%203"")",ONLY CAS,US Approved Rx 2019,BLA761045,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761045,US Approved Rx 2002,BLA125031,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125031,,
PEGINTERFERON ALFA-2B,215647-85-1,https://drugs.ncats.io/drug/G8RGG88B68,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""215647%2085%201"")",ONLY CAS,US Approved Rx 2001,BLA103949,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103949,US Approved Rx 2001,BLA103949,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103949,,
PEGINTERFERON BETA-1A,1211327-92-2,https://drugs.ncats.io/drug/I8309403R0,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1211327%2092%202"")",ONLY CAS,US Approved Rx 2014,BLA125499,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125499,US Approved Rx 2014,BLA125499,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125499,,
PEGLOTICASE,885051-90-1,https://drugs.ncats.io/drug/R581OT55EA,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""885051%2090%201"")",ONLY CAS,US Approved Rx 2010,BLA125293,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125293,US Approved Rx 2010,BLA125293,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125293,,
PEGVALIASE,1585984-95-7,https://drugs.ncats.io/drug/N6UAH27EUV,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1585984%2095%207"")",ONLY CAS,US Approved Rx 2018,BLA761079,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761079,US Approved Rx 2018,BLA761079,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761079,,
PEGVISOMANT,218620-50-9,https://drugs.ncats.io/drug/N824AOU5XV,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""218620%2050%209"")",ONLY CAS,US Approved Rx 2003,BLA021106,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021106,US Approved Rx 2003,BLA021106,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021106,,
PEMBROLIZUMAB,1374853-91-4,https://drugs.ncats.io/drug/DPT0O3T46P,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1374853%2091%204"")",ONLY CAS,US Approved Rx 2014,BLA125514,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125514,US Approved Rx 2014,BLA125514,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125514,,
PEMETREXED,137281-23-3,https://drugs.ncats.io/drug/04Q9AIZ7NO,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""137281%2023%203"")",ONLY CAS,US Approved Rx 2022,ANDA090384,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=090384,US Approved Rx 2004,NDA021677,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021677,Nonsquamous non-small cell lung cancer; Malignant pleural mesothelioma,Approved; Approved
PEMIROLAST,69372-19-6,https://drugs.ncats.io/drug/2C09NV773M,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""69372%2019%206"")",ONLY CAS,US Previously Marketed 1999,ALAMAST by SANTEN,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021079,US Previously Marketed 1999,ALAMAST by SANTEN,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021079,Bronchial asthma; Allergic rhinitis,Approved; Approved
PEMOLINE,2152-34-3,https://drugs.ncats.io/drug/7GAQ2332NK,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""2152%2034%203"")",ONLY CAS,US Previously Marketed 1975,CYLERT by ABBOTT,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016832,US Previously Marketed 1975,CYLERT by ABBOTT,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016832,Attention deficit hyperactivity disorder,Approved
PENBUTOLOL,38363-40-5,https://drugs.ncats.io/drug/78W62V43DY,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""38363%2040%205"")",ONLY CAS,US Previously Marketed 1987,LEVATOL by AUXILIUM PHARMS LLC,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018976,US Previously Marketed 1987,LEVATOL by AUXILIUM PHARMS LLC,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018976,Hypertension,Approved
PENCICLOVIR,39809-25-1,https://drugs.ncats.io/drug/359HUE8FJC,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""39809%2025%201"")",ONLY CAS,US Approved Rx 1996,NDA020629,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020629,US Previously Marketed 1994,FAMVIR by NOVARTIS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020363,Recurrent herpes labialis,Approved
PENICILLAMINE,771431-20-0,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""771431%2020%200"")",ONLY CAS,,,,,,,,
PENICILLIN G,61-33-6,https://drugs.ncats.io/drug/Q42T66VG0C,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""61%2033%206"")",ONLY CAS,US Approved Rx 1953,NDA050138,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050138,US Previously Marketed 1943,Penicillin G Sodium by Various Mfrs.,DeHaen 1940-1975 NMEs,Actinomycosis; Sepsis; Anthrax; Botulism; Diphtheria,Approved; Approved; Approved; Approved; Approved
PENICILLIN V,87-08-1,https://drugs.ncats.io/drug/Z61I075U2W,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""87%2008%201"")",ONLY CAS,US Approved Rx 1968,ANDA060456,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=060456,US Previously Marketed 1955,V-Cillin by Lilly,DeHaen 1940-1975 NMEs,Pneumococcal infections; Staphylococcal infections; Streptococcal infections,Approved; Approved; Approved
PENTAFLUOROPROPANE,460-73-1,https://drugs.ncats.io/drug/TA9UOF49CY,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""460%2073%201"")",ONLY CAS,Possibly Marketed Outside US 2014,21 CFR 352,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=aec3924f-3da2-486a-bd4e-59ded15c12b0,Possibly Marketed Outside US 2014,21 CFR 352,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=aec3924f-3da2-486a-bd4e-59ded15c12b0,,
PENTAMIDINE,100-33-4,https://drugs.ncats.io/drug/673LC5J4LQ,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""100%2033%204"")",ONLY CAS,US Approved Rx 1984,NDA019264,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019264,US Approved Rx 1984,NDA019264,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019264,"Pneumocystis jiroveci pneumonia (PJP) in high-risk, HIV-infected patients",Approved
PENTAZOCINE,359-83-1,https://drugs.ncats.io/drug/RP4A60D26L,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""359%2083%201"")",ONLY CAS,US Approved Rx 2001,ANDA075735,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=075735,US Previously Marketed 1967,TALWIN by HOSPIRA,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016194,Pain,Approved
PENTETIC ACID,67-43-6,https://drugs.ncats.io/drug/7A314HQM0I,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""67%2043%206"")",ONLY CAS,US Previously Marketed 2004,PENTETATE ZINC TRISODIUM by HAMELN PHARMA PLUS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021751,Possibly Marketed Outside US 1965,M006,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=89577417-76a0-cb04-e053-2995a90a5733,"Internal contamination with plutonium, americium, or curium; Acne; Contamination with plutonium, americium, or curium",Approved; Approved; Withdrawn
PENTETRAZOLE,54-95-5,https://drugs.ncats.io/drug/WM5Z385K7T,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""54%2095%205"")",ONLY CAS,US Previously Marketed 1950,PARA HYCODAN PENTYLENETETRAZOL by ENDO,"Federal Register v.37 (1972), page 2852, retrieved from: https://books.google.ru/books?id=VNfjJrqyk_8C",US Previously Marketed 1929,Metrazol by Knoll,https://books.google.com/books?id=2QJtAAAAMAAJ&q=metrazol&dq=metrazol&hl=en&newbks=1&newbks_redir=0&sa=X&ved=2ahUKEwiTueXIhv_mAhVOpFkKHSgHAgUQ6AEwAHoECAAQAg,Narcolepsy without cataplexy; Idiopathic hypersomnia,Phase II; Phase II
PENTOBARBITAL,76-74-4,https://drugs.ncats.io/drug/I4744080IR,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""76%2074%204"")",ONLY CAS,US Approved Rx 1973,ANDA083246,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=083246,US Previously Marketed 1921,calcium pentobarbital,https://catalog.hathitrust.org/Record/100163146,Insomnia; Convulsive episodes; Anxiety,Approved; Approved; Approved
PENTOSAN POLYSULFATE SODIUM,37319-17-8,https://drugs.ncats.io/drug/914032762Y,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""37319%2017%208"")",ONLY CAS,US Approved Rx 1996,NDA020193,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020193,US Approved Rx 1996,NDA020193,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020193,Interstitial cystitis,Approved
PENTOSTATIN,53910-25-1,https://drugs.ncats.io/drug/395575MZO7,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""53910%2025%201"")",ONLY CAS,US Approved Rx 1991,NDA020122,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020122,US Approved Rx 1991,NDA020122,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020122,Hairy cell leukemia,Approved
PENTOXIFYLLINE,6493-05-6,https://drugs.ncats.io/drug/SD6QCT3TSU,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""6493%2005%206"")",ONLY CAS,US Approved Rx 1999,ANDA075191,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=075191,US Previously Marketed 1984,TRENTAL by VALIDUS PHARMS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018631,Intermittent claudication,Approved
PENTOXYVERINE,77-23-6,https://drugs.ncats.io/drug/32C726X12W,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""77%2023%206"")",ONLY CAS,US Previously Marketed 1955,Toclase by Pfizer,DeHaen 1940-1975 NMEs,US Previously Marketed 1955,Toclase by Pfizer,DeHaen 1940-1975 NMEs,Cough,Phase I
PEPSIN,608-73-1,https://drugs.ncats.io/drug/5477B350EK,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""608%2073%201"")",ONLY CAS,,,,,,,,
PEPTONE,73049-73-7,https://drugs.ncats.io/drug/0K9R94573C,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""73049%2073%207"")",ONLY CAS,Possibly Marketed Outside US 2022,ANDA204469,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2467e332-e95b-4291-9473-b3594c348fbc,Possibly Marketed Outside US 1995,21 CFR 333E,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=311663b8-0652-4b56-86ef-92e3caa81558,,
PERAMIVIR,330600-85-6,https://drugs.ncats.io/drug/9ZS94HQO3B,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""330600%2085%206"")",ONLY CAS,US Approved Rx 2014,NDA206426,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206426,US Approved Rx 2014,NDA206426,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206426,Influenza virus infections,Approved
PERAMPANEL,380917-97-5,https://drugs.ncats.io/drug/H821664NPK,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""380917%2097%205"")",ONLY CAS,US Approved Rx 2016,NDA208277,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208277,US Approved Rx 2012,NDA202834,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202834,Epilepsy,Approved
PERBORIC ACID,14034-78-7,https://drugs.ncats.io/drug/HC4C3M1FO2,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""14034%2078%207"")",ONLY CAS,US Previously Marketed 1921,Sodium Perborate U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,US Previously Marketed 1921,Sodium Perborate U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,,
PERFLUTREN,76-19-7,https://drugs.ncats.io/drug/CK0N3WH0SR,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""76%2019%207"")",ONLY CAS,US Approved Rx 2001,NDA021064,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021064,Possibly Marketed Outside US 1997,NDA020899,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=46bcf276-d423-408a-a410-f11383406a94,Heart Diseases,Approved
PERGOLIDE,66104-22-1,https://drugs.ncats.io/drug/24MJ822NZ9,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""66104%2022%201"")",ONLY CAS,US Previously Marketed 1988,PERMAX by VALEANT PHARM INTL,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019385,US Previously Marketed 1988,PERMAX by VALEANT PHARM INTL,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019385,Parkinson's disease; Pituitary Pars Intermedia Dysfunction (Equine Cushing’s Disease) in horses,Withdrawn; Approved
PERINDOPRIL,82834-16-0,https://drugs.ncats.io/drug/Y5GMK36KGY,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""82834%2016%200"")",ONLY CAS,US Approved Rx 2009,ANDA079070,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=079070,US Previously Marketed 1993,ACEON by SYMPLMED PHARMS LLC,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020184,Parkinson's disease; Stable coronary artery disease; Hypertension; Unknown; Unknown; Unknown,Not Provided; Approved; Approved
PERMETHRIN,52645-53-1,https://drugs.ncats.io/drug/509F88P9SZ,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""52645%2053%201"")",ONLY CAS,US Approved Rx 1989,NDA019855,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019855,US Previously Marketed 1986,NIX by GLAXOSMITHKLINE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019435,Head lice infestation; Scabies; Pediculosis; Scabies,Approved; Approved; Approved; Approved
PEROXIDASE,726169-73-9,https://drugs.ncats.io/drug/A6GWB8T96J,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""726169%2073%209"")",ONLY CAS,Clinical ,INN:mocetinostat [INN],https://ginas.ncats.nih.gov/ginas/app/substance/A6GWB8T96J,,,,Chronic lymphocytic leukemia; Myelodysplastic syndromes; Non-small cell lung cancer,Phase II; Phase II; Phase II
PERPHENAZINE,58-39-9,https://drugs.ncats.io/drug/FTA7XXY4EZ,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""58%2039%209"")",ONLY CAS,US Approved Rx 2022,ANDA210163,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210163,US Previously Marketed 1957,TRILAFON by SCHERING,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=010775,Depression; Anxiety; Nausea; Schizophrenia; Vomiting,Approved; Approved; Approved; Approved; Approved
PERTUZUMAB,380610-27-5,https://drugs.ncats.io/drug/K16AIQ8CTM,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""380610%2027%205"")",ONLY CAS,US Approved Rx 2020,BLA761170,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761170,US Approved Rx 2012,BLA125409,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125409,,
PERU BALSAM,8007-00-9,https://drugs.ncats.io/drug/8P5F881OCY,2,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""8007%2000%209"")%20AND%20(root_names_name:""%5EPERU%20BALSAM$"")",EXACT NAME,US Approved Allergenic Extract 1994,BLA103738,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2f082b68-dc74-418a-9e6f-b3c285b41d44,US Previously Marketed 1921,Balsam of Peru U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,,
PETHIDINE,57-42-1,https://drugs.ncats.io/drug/9E338QE28F,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""57%2042%201"")",ONLY CAS,US Approved Rx 1942,NDA021171,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021171,US Previously Marketed 1942,DEMEROL by VALIDUS PHARMS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=005010,Pain,Approved
PHENAZONE,60-80-0,https://drugs.ncats.io/drug/T3CHA1B51H,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""60%2080%200"")",ONLY CAS,US Previously Marketed 1885,Antipyrine,https://books.google.com/books?id=Cb6BOkj9fK4C&lpg=PA126&ots=NPafI1BddW&dq=phenazone%20%20discovery&pg=PA126#v=onepage&q=phenazone%20%20discovery&f=false,US Previously Marketed 1885,Antipyrine,https://books.google.com/books?id=Cb6BOkj9fK4C&lpg=PA126&ots=NPafI1BddW&dq=phenazone%20%20discovery&pg=PA126#v=onepage&q=phenazone%20%20discovery&f=false,Otitis media; Asthma; Pain,Approved; Phase II; Not Provided
PHENAZOPYRIDINE,94-78-0,https://drugs.ncats.io/drug/K2J09EMJ52,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""94%2078%200"")",ONLY CAS,US Previously Marketed 2001,SULFAMETHOXAZOLE AND TRIMETHOPRIM AND PHENAZOPYRIDINE HYDROCHLORIDE by ABLE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021105,US Previously Marketed 1928,Pyridium,https://www.ncbi.nlm.nih.gov/pubmed/982458,Urinary tract infections; Urinary tract infections,Approved; Approved
PHENDIMETRAZINE,634-03-7,https://drugs.ncats.io/drug/AB2794W8KV,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""634%2003%207"")",ONLY CAS,US Approved Rx 2010,ANDA091042,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=091042,US Previously Marketed 1961,Plegine by Ayerst,OB NME Appendix 1950-1985,Exogenous obesity,Approved
PHENELZINE,51-71-8,https://drugs.ncats.io/drug/O408N561GF,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""51%2071%208"")",ONLY CAS,US Approved Rx 1961,NDA011909,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=011909,US Approved Rx 1961,NDA011909,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=011909,Depression,Approved
PHENETHYLAMINE,64-04-0,https://drugs.ncats.io/drug/327C7L2BXQ,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""64%2004%200"")",ONLY CAS,,,,,,,Depression,Natural Metabolite
PHENINDAMINE,82-88-2,https://drugs.ncats.io/drug/772BQ8KSST,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""82%2088%202"")",ONLY CAS,US Approved OTC ,21 CFR 341.12(i) cough/cold:antihistamine phenindamine tartrate,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec341-12.xml,US Previously Marketed 1947,Thephorin by Hoffmann-La Roche,DeHaen 1940-1975 NMEs,Allergy,Approved
PHENIRAMINE,86-21-5,https://drugs.ncats.io/drug/134FM9ZZ6M,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""86%2021%205"")",ONLY CAS,US Approved OTC ,21 CFR 341.12(j) cough/cold:antihistamine pheniramine maleate,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec341-12.xml,US Previously Marketed 1948,Trimeton by Schering,DeHaen 1940-1975 NMEs,Allergic conditions; Neurodermatitis; Eye diseases; Meniere's disease; Motion sickness,Approved; Approved; Approved; Approved; Approved
PHENOBARBITAL,50-06-6,https://drugs.ncats.io/drug/YQE403BP4D,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""50%2006%206"")",ONLY CAS,US Approved Rx 2022,NDA215910,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215910,US Previously Marketed 1912,Luminal,https://archive.org/details/newnonofficialre39coun,Anxiety; Insomnia; Tonic-clonic seizures; Febrile seizures; Epilepsy; Hyperbilirubinemia; Cholestasis; Status epilepticus,Approved; Approved; Approved; Approved; Approved; Approved; Approved; Approved
PHENOL,108-95-2,https://drugs.ncats.io/drug/339NCG44TV,2,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""108%2095%202"")%20AND%20(root_names_name:""%5EPHENOL$"")",EXACT NAME,US Approved Allergenic Extract 1941,BLA103888,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d756bf9e-2e57-48a4-897a-ec1d96472dec,US Previously Marketed 1921,Phenol U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,Unknown; Sore throat; Onychocryptosis,Approved; Approved
PHENOLPHTHALEIN,"77-09-8
5768-87-6",N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""77%2009%208
5768%2087%206"")",ONLY CAS,,,,,,,,
PHENOXYBENZAMINE,59-96-1,https://drugs.ncats.io/drug/0TTZ664R7Z,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""59%2096%201"")",ONLY CAS,US Approved Rx 2017,ANDA204522,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204522,US Approved Rx 1953,NDA008708,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=008708,Pheochromocytoma,Approved
PHENTERMINE,122-09-8,https://drugs.ncats.io/drug/C045TQL4WP,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""122%2009%208"")",ONLY CAS,US Approved Rx 2008,ANDA040876,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=040876,US Previously Marketed 1959,IONAMIN by UCB INC,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=011613,Obesity,Approved
PHENTOLAMINE,50-60-2,https://drugs.ncats.io/drug/Z468598HBV,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""50%2060%202"")",ONLY CAS,US Approved Rx 2017,ANDA207686,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207686,US Previously Marketed 1952,Regitine HCl by Ciba,OB NME Appendix 1950-1985,Pheochromocytoma; Dental pain,Approved; Approved
PHENYLALANINE,63-91-2,https://drugs.ncats.io/drug/47E5O17Y3R,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""63%2091%202"")",ONLY CAS,US Previously Marketed ,21 CFR 310.545(a)(20) weight control phenylalanine,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec310-545.xml,Possibly Marketed Outside US 1971,NDA016822,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=aa89dad1-bf4f-4f7e-ad1b-2431bdf36a2d,Pain; Depression; Burns,Not Provided; Not Provided; Approved
PHENYLBUTYRATE,1821-12-1,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1821%2012%201"")",ONLY CAS,,,,,,,,
PHENYLEPHRINE,59-42-7,https://drugs.ncats.io/drug/1WS297W6MV,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""59%2042%207"")",ONLY CAS,US Approved OTC ,21 CFR 349.18(c) ophthalmic:vasoconstrictor phenylephrine hydrochloride (0.08 to 0.2%),https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec349-18.xml,US Previously Marketed 1934,Neosynephrine,https://books.google.com/books?id=kcVEAQAAMAAJ&newbks=1&newbks_redir=0&dq=phenylephrine%201934&pg=PA760#v=onepage&q=phenylephrine%201934&f=false,Hypotension; Eye diseases,Approved; Approved
PHENYLETHYLACETIC ACID,33987-92-7,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""33987%2092%207"")",ONLY CAS,,,,,,,,
PHENYLPROPANOLAMINE,37577-28-9,https://drugs.ncats.io/drug/7875H6443P,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""37577%2028%209"")",ONLY CAS,US Previously Marketed 1985,COLD CAPSULE IV by GRAHAM DM,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018793,US Previously Marketed 1941,Propadrine by Merck Sharp & Dohme,DeHaen 1940-1975 NMEs,Otitis; Sinusitis; Nasal congestion; Obesity; Nasal congestion,Not Provided; Not Provided; Withdrawn; Withdrawn; Withdrawn
PHENYLTOLOXAMINE,92-12-6,https://drugs.ncats.io/drug/K65LB6598J,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""92%2012%206"")",ONLY CAS,US Previously Marketed 1961,HISTIONEX 50 by STRASENBURGH,https://cdn.loc.gov/service/ll/fedreg/fr047/fr047020/fr047020.pdf,US Previously Marketed 1952,Bristamin by Bristol,DeHaen 1940-1975 NMEs,Fever; Premenstrual and menstrual cramps; Headache; Minor aches; Allergy,Not Provided; Not Provided; Not Provided; Not Provided; Approved
PHENYTOIN,57-41-0,https://drugs.ncats.io/drug/6158TKW0C5,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""57%2041%200"")",ONLY CAS,US Approved Rx 2006,ANDA040684,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=040684,US Previously Marketed 1938,Dilantin by Parke-Davis,http://triggered.edina.clockss.org/ServeContent?rft_id=info:doi/10.1124/mi.9.5.1,Seizures; Status epilepticus,Approved; Approved
PHOENIX DACTYLIFERA,89531-62-4,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""89531%2062%204"")",ONLY CAS,,,,,,,,
PHOSPHATIDYLETHANOLAMINE,1334474-30-4,https://drugs.ncats.io/drug/7CMB6B4449,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1334474%2030%204"")",ONLY CAS,,,,,,,,
PHOSPHATIDYL SERINE,1446756-47-3,https://drugs.ncats.io/drug/394XK0IH40,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1446756%2047%203"")",ONLY CAS,Possibly Marketed Outside US ,EnLyte by Jaymac Pharmaceuticals Llc,https://www.drugbank.ca/drugs/DB00144,Possibly Marketed Outside US 2011,EnBrace HR by Jaymac Pharma,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6f14fa40-97ab-4ec5-b66b-793d6d1abac9,,
PHOSPHOLIPIDS,92128-87-5,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""92128%2087%205"")",ONLY CAS,,,,,,,,
PHOSPHORIC ACID,7664-38-2,https://drugs.ncats.io/drug/E4GA8884NN,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""7664%2038%202"")",ONLY CAS,US Approved Rx 2011,ANDA079247,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=079247,US Previously Marketed 1921,Ammonium Phosphate N.F.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,Hypophosphatemia; Hyperphosphatemia; Sore muscles & joints; Fatigue; Nausea; Lose body protein; Occasional sleeplessness; Hypophosphatemia,Natural Metabolite; Natural Metabolite; Not Provided; Not Provided; Not Provided; Approved; Not Provided; Approved
PHOSPHORUS,7723-14-0 (red,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""7723%2014%200 (red"")",ONLY CAS,,,,,,,,
PHYSOSTIGMINE,57-47-6,https://drugs.ncats.io/drug/9U1VM840SP,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""57%2047%206"")",ONLY CAS,US Previously Marketed 1921,Physostigmine Salicylate U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,US Previously Marketed 1921,Physostigmine Salicylate U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,Glaucoma,Approved
PHYTIC ACID,83-86-3,https://drugs.ncats.io/drug/7IGF0S7R8I,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""83%2086%203"")",ONLY CAS,US Previously Marketed 1962,Reneal by Squibb,DeHaen 1940-1975 NMEs,US Previously Marketed 1962,Reneal by Squibb,DeHaen 1940-1975 NMEs,Cancer; Bipolar disorder; Aortic valve calcification; Skin Care; Iron deficiency anemia; Manic depression; Bipolar disorder,Preclinical; Phase I; Phase III; Approved; Not Provided; Phase I; Phase I
PHYTOLACCA,336622-97-0,https://drugs.ncats.io/drug/3M9T3AX86F,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""336622%2097%200"")",ONLY CAS,,,,,,,,
PHYTOMENADIONE,79083-00-4,https://drugs.ncats.io/drug/MLF3D1712D,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""79083%2000%204"")",ONLY CAS,US Approved Rx 1983,ANDA087954,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=087954,US Previously Marketed 1940,Synkamin by Parke-Davis,DeHaen 1940-1975 NMEs,Hypoprothrombinemia; Hemorrhagic disease of newborn; Vitamin K deficiency; Hypoprothrombinemia,Approved; Approved; Approved; Approved
PHYTOSPHINGOSINE,554-62-1,https://drugs.ncats.io/drug/GIN46U9Q2Q,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""554%2062%201"")",ONLY CAS,Possibly Marketed Outside US ,"P1P AC Repair Ampoule by Phytos Co., Ltd.",https://www.drugbank.ca/drugs/DB14119,Possibly Marketed Outside US 2002,M020,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4bfbfac7-6738-4996-a152-95dfbd759154,Metabolic syndrome; Acne vulgaris; Hyperpigmentation; Skin Care,Phase II; Phase II; Basic research; Approved
PIBRENTASVIR,1353900-92-1,https://drugs.ncats.io/drug/2WU922TK3L,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1353900%2092%201"")",ONLY CAS,US Approved Rx 2017,NDA209394,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209394,US Approved Rx 2017,NDA209394,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209394,Chronic hepatitis C,Approved
PICOLINIC ACID,98-98-6,https://drugs.ncats.io/drug/QZV2W997JQ,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""98%2098%206"")",ONLY CAS,,,,,,,Binge eating disorder; Type 2 diabetes mellitus,Phase II; Phase I
PICOSULFURIC ACID,10040-34-3,https://drugs.ncats.io/drug/95D580798S,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""10040%2034%203"")",ONLY CAS,US Approved Rx 2017,NDA209589,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209589,US Previously Marketed 2012,PREPOPIK by FERRING PHARMS INC,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202535,cleansing of the colon; Unknown,Approved
PIDOLIC ACID,98-79-3,https://drugs.ncats.io/drug/SZB83O1W42,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""98%2079%203"")",ONLY CAS,Possibly Marketed Outside US ,part333D,https://www.drugbank.ca/drugs/DB03088,Possibly Marketed Outside US 2002,21 CFR 333D,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=190e3e37-ad29-4e94-840a-fa982fcdaab4,Dry skin; Acne; Halitosis; Seborrhea,Approved; Approved; Phase I; Approved
PILOCARPINE,92-13-7,https://drugs.ncats.io/drug/01MI4Q9DI3,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""92%2013%207"")",ONLY CAS,US Approved Rx 2019,ANDA210384,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210384,US Previously Marketed 1921,Pilocarpine Hydrochloride U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,Sjogren's syndrome; Head and neck cancer; Acute angle-closure glaucoma; Ocular hypertension; Open-angle glaucoma,Approved; Approved; Approved; Approved; Approved
PIMAVANSERIN,706779-91-1,https://drugs.ncats.io/drug/JZ963P0DIK,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""706779%2091%201"")",ONLY CAS,US Approved Rx 2024,ANDA214493,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214493,US Approved Rx 2016,NDA207318,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207318,Parkinson's disease,Approved
PIMECROLIMUS,137071-32-0,https://drugs.ncats.io/drug/7KYV510875,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""137071%2032%200"")",ONLY CAS,US Approved Rx 2018,ANDA209345,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209345,Possibly Marketed Outside US 2001,NDA021302,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e4027e5a-0f9b-4070-b196-f60172f45c4c,Atopic dermatitis,Approved
PIMOBENDAN,74150-27-9,https://drugs.ncats.io/drug/34AP3BBP9T,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""74150%2027%209"")",ONLY CAS,Possibly Marketed Outside US ,Pimobendan by CBSCHEM LIMITED,https://www.drugbank.ca/drugs/DB11450,Possibly Marketed Outside US 2007,NADA141273,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5441e5b2-cdc0-477a-bd9a-ec5f8d912281,Heart failure,Approved
PIMOZIDE,2062-78-4,https://drugs.ncats.io/drug/1HIZ4DL86F,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""2062%2078%204"")",ONLY CAS,US Approved Rx 2015,ANDA204521,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204521,US Previously Marketed 1984,ORAP by TEVA,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017473,Tourette's syndrome,Approved
PINDOLOL,13523-86-9,https://drugs.ncats.io/drug/BJ4HF6IU1D,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""13523%2086%209"")",ONLY CAS,US Approved Rx 1992,ANDA074019,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=074019,US Previously Marketed 1982,VISKEN by NOVARTIS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018285,Hypertension; Hypertension,Approved; Approved
PINUS STROBUS,90082-77-2,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""90082%2077%202"")",ONLY CAS,,,,,,,,
PIOGLITAZONE,111025-46-8,https://drugs.ncats.io/drug/X4OV71U42S,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""111025%2046%208"")",ONLY CAS,US Approved Rx 2005,NDA021842,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021842,US Approved Rx 1999,NDA021073,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021073,X-linked adrenoleukodystrophy; Friedreich ataxia; Type 2 diabetes mellitus,Approved; Phase III; Approved
PIPECURONIUM BROMIDE,52212-02-9,https://drugs.ncats.io/drug/R6ZTY81RE1,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""52212%2002%209"")",ONLY CAS,US Previously Marketed 1990,ARDUAN by ORGANON USA INC,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019638,US Previously Marketed 1990,ARDUAN by ORGANON USA INC,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019638,Pain,Approved
PIPERACILLIN,61477-96-1,https://drugs.ncats.io/drug/9I628532GX,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""61477%2096%201"")",ONLY CAS,US Approved Rx 2017,ANDA207848,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207848,US Previously Marketed 1981,PIPRACIL by WYETH PHARMS INC,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050545,Intra-abdominal infections; Skin and skin structure infections; Female pelvic infections; Community-acquired pneumonia; Nosocomial pneumonia,Approved; Approved; Approved; Approved; Approved
PIPERAZINE ESTRONE SULFATE,7280-37-7,https://drugs.ncats.io/drug/SVI38UY019,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""7280%2037%207"")",ONLY CAS,US Approved Rx 1977,ANDA083220,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=083220,US Previously Marketed 1931,Theelin by Parke Davis,https://en.wikipedia.org/wiki/Estrone_(medication),Endometrial hyperplasia/carcinoma; Menopausal and postmenopausal disorder; Ovarian diseases; Precocious puberty; Amenorrhea; Infertility; Breast cancer; Prostate cancer; Obesity; Endometrial cancer; Benign breast disease; Premenstrual syndrome; Menopausal and postmenopausal disorders,Approved; Approved; Natural Metabolite; Natural Metabolite; Natural Metabolite; Natural Metabolite; Natural Metabolite; Natural Metabolite; Natural Metabolite; Natural Metabolite; Natural Metabolite; Phase III; Approved
PIPERONYL BUTOXIDE,51-03-6,https://drugs.ncats.io/drug/LWK91TU9AH,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""51%2003%206"")",ONLY CAS,US Approved OTC ,21 CFR 358.610 pediculicide piperonyl butoxide,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec358-610.xml,US Previously Marketed 2000,RID MOUSSE by BAYER HEALTHCARE LLC,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021043,Pediculosis,Approved
PIPER METHYSTICUM,9000-38-8,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""9000%2038%208"")",ONLY CAS,,,,,,,,
PIRACETAM,7491-74-9,https://drugs.ncats.io/drug/ZH516LNZ10,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""7491%2074%209"")",ONLY CAS,Possibly Marketed Outside US ,UK NHS:Piracetam,https://tripod.nih.gov/npc/#Download,,,,Myoclonus of cortical origin; Vaso-occlusive crises in sickle cell anemia; Cognitive disorders,Approved; Approved; Approved
PIRBUTEROL,38677-81-5,https://drugs.ncats.io/drug/OG645J8RVW,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""38677%2081%205"")",ONLY CAS,US Previously Marketed 1986,MAXAIR by BAUSCH,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019009,US Previously Marketed 1986,MAXAIR by BAUSCH,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019009,Asthma,Approved
PIRFENIDONE,53179-13-8,https://drugs.ncats.io/drug/D7NLD2JX7U,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""53179%2013%208"")",ONLY CAS,US Approved Rx 2017,NDA208780,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208780,US Approved Rx 2014,NDA022535,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022535,Idiopathic pulmonary fibrosis,Approved
PIROCTONE,50650-76-5,https://drugs.ncats.io/drug/R49EFA73Q7,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""50650%2076%205"")",ONLY CAS,Possibly Marketed Outside US 2001,21 CFR 352,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=51f0e5c5-e2be-4be6-bf09-4b8da2758664,Possibly Marketed Outside US 2001,21 CFR 352,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=51f0e5c5-e2be-4be6-bf09-4b8da2758664,Myeloma; Dandruff,Preclinical; Not Provided
PIROXICAM,36322-90-4,https://drugs.ncats.io/drug/13T4O6VMAM,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""36322%2090%204"")",ONLY CAS,US Approved Rx 2016,ANDA207938,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207938,US Approved Rx 1982,NDA018147,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018147,Rheumatoid arthritis; Osteoarthritis,Approved; Approved
PITAVASTATIN,147511-69-1,https://drugs.ncats.io/drug/M5681Q5F9P,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""147511%2069%201"")",ONLY CAS,US Approved Rx 2023,ANDA206047,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206047,US Approved Rx 2009,NDA022363,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022363,Primary hyperlipidemia; Mixed dyslipidemia,Approved; Approved
PLANTAGO MAJOR,84929-43-1,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""84929%2043%201"")",ONLY CAS,,,,,,,,
PLASMIN,62354-43-2,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""62354%2043%202"")",ONLY CAS,,,,,,,,
PLAZOMICIN,1154757-24-0,https://drugs.ncats.io/drug/LYO9XZ250J,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1154757%2024%200"")",ONLY CAS,US Approved Rx 2018,NDA210303,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210303,US Approved Rx 2018,NDA210303,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210303,"Urinary tract infections, complicated",Approved
PLECANATIDE,467426-54-6,https://drugs.ncats.io/drug/7IK8Z952OK,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""467426%2054%206"")",ONLY CAS,US Approved Rx 2017,NDA208745,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208745,US Approved Rx 2017,NDA208745,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208745,Chronic idiopathic constipation,Approved
PLERIXAFOR,110078-46-1,https://drugs.ncats.io/drug/S915P5499N,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""110078%2046%201"")",ONLY CAS,US Approved Rx 2023,ANDA211901,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211901,US Approved Rx 2008,NDA022311,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022311,Multiple myeloma; Non-Hodgkin's lymphoma,Approved; Approved
PLICAMYCIN,18378-89-7,https://drugs.ncats.io/drug/NIJ123W41V,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""18378%2089%207"")",ONLY CAS,US Previously Marketed 1970,MITHRACIN by PFIZER,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050109,US Previously Marketed 1970,MITHRACIN by PFIZER,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050109,Hypercalcemia or hypercalciuria; Testicular cancer,Approved; Approved
PODOFILOX,518-28-5,https://drugs.ncats.io/drug/L36H50F353,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""518%2028%205"")",ONLY CAS,US Approved Rx 2002,ANDA075600,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=075600,US Approved Rx 1990,NDA019795,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019795,External genital warts (Condyloma acuminatum),Approved
PODOPHYLLIN,9000-55-9,https://drugs.ncats.io/drug/16902YVY2B,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""9000%2055%209"")",ONLY CAS,US Previously Marketed ,21 CFR 310.545(a)(12)(iv)(A) laxative:stimulant laxative podophyllum resin (podophyllin),https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec310-545.xml,Possibly Marketed Outside US 1990,Podocon 25 by Bryant Ranch Prepack,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a13345b7-c42b-4459-b0ff-03cf91e46b7d,Condylomata acuminata,Approved
POLICOSANOL,71-23-8,https://drugs.ncats.io/drug/96F264O9SV,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""71%2023%208"")",ONLY CAS,Possibly Marketed Outside US ,part333E,https://www.drugbank.ca/drugs/DB03175,Possibly Marketed Outside US 2006,21 CFR 333E,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4ec12f4d-6cb7-4154-8cf3-02d4bb8a6d9c,,
POLIDOCANOL,3055-99-0,https://drugs.ncats.io/drug/0AWH8BFG9A,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""3055%2099%200"")",ONLY CAS,US Approved Rx 2013,NDA205098,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205098,US Approved Rx 2010,NDA021201,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021201,Unknown; Incompetent saphenous veins; Visible varicosity of the great saphenous vein system; Reticular veins; Spider veins,Approved; Approved; Approved; Approved
POLIGLUSAM,9012-76-4,https://drugs.ncats.io/drug/82LKS4QV2Y,6,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""9012%2076%204"")%20AND%20(root_names_name:""%5EPOLIGLUSAM$"")",EXACT NAME,Possibly Marketed Outside US ,"U-max Beauty by VS Shinbi Co., Ltd.",https://www.drugbank.ca/drugs/DB11234,Possibly Marketed Outside US 2012,"U-max Beauty by VS Shinbi Co., Ltd.",https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0c14e666-7734-4228-9004-403ce2156cb4,,
POLLEN,56-81-5,https://drugs.ncats.io/drug/PDC6A3C0OX,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""56%2081%205"")",ONLY CAS,US Approved OTC ,21 CFR 347.10(h) skin protectant glycerin,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec347-10.xml,US Previously Marketed 1921,Glycerin U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,Dry skin or hair,Approved
POLOXALKOL,53637-25-5,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""53637%2025%205"")",ONLY CAS,,,,,,,,
POLOXAMER,53637-25-5,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""53637%2025%205"")",ONLY CAS,,,,,,,,
POLOXAMER 407,691397-13-4,https://drugs.ncats.io/drug/TUF2IVW3M2,39,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""691397%2013%204"")%20AND%20(root_names_name:""%5EPOLOXAMER%20407$"")",EXACT NAME,Possibly Marketed Outside US ,"Natural Care by K&J.C Co., Ltd",https://www.drugbank.ca/drugs/DB11252,Possibly Marketed Outside US 1947,NDA017116,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=808a9d0b-720b-4034-a862-5122ff514608,,
POLYAMINOPROPYL BIGUANIDE,133029-32-0,https://drugs.ncats.io/drug/DT9D8Z79ET,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""133029%2032%200"")",ONLY CAS,Possibly Marketed Outside US ,part333A,https://www.drugbank.ca/drugs/DB15677,Possibly Marketed Outside US 2010,21 CFR 352,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5996f9b2-18c1-4c8f-a0ab-eca180db61ad,,
POLYCARBOPHIL,9003-97-8,https://drugs.ncats.io/drug/W25LM17A4W,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""9003%2097%208"")",ONLY CAS,US Previously Marketed 1960,Sorboquel by White (Schering),DeHaen 1940-1975 NMEs,US Previously Marketed 1960,Sorboquel by White (Schering),DeHaen 1940-1975 NMEs,,
POLYDEXTROSE,68424-04-4,https://drugs.ncats.io/drug/VH2XOU12IE,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""68424%2004%204"")",ONLY CAS,Possibly Marketed Outside US 1970,"O-Cal FA multivitamin by Pharmics, Inc.",https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3b24458b-6d48-4cc6-8233-81f173277cb8,Possibly Marketed Outside US 1960,ANDA040424,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=48115c9e-c82f-438d-b178-dce1b73687db,,
POLYETHYLENE,9002-88-4,https://drugs.ncats.io/drug/UG00KM4WR7,4,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""9002%2088%204"")%20AND%20(root_names_name:""%5EPOLYETHYLENE$"")",EXACT NAME,Possibly Marketed Outside US 2003,21 CFR 333D,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f149e3da-2e72-4965-8364-264860ebfca4,Possibly Marketed Outside US 1982,ANDA062124,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=01777cce-37ea-499c-ab13-82041a37ccfc,,
POLYMYXIN B,1404-26-8,https://drugs.ncats.io/drug/J2VZ07J96K,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1404%2026%208"")",ONLY CAS,US Approved OTC ,21 CFR 333.120 first aid antibiotic:ointment polymyxin b sulfate (combination only),https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec333-120.xml,US Previously Marketed 1951,Aerosporin by Burroughs Wellcome,DeHaen 1940-1975 NMEs,"Acute Infections due to Pseudomonas aeruginosa; Sepsis; Meningeal infections due to H influenzae; Urinary tract infections, E.coli",Approved; Approved; Approved; Approved
POLYQUAD,75345-27-6,https://drugs.ncats.io/drug/6716Z5YR3G,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""75345%2027%206"")",ONLY CAS,Possibly Marketed Outside US ,Canada:POLYQUATERNIUM-1,https://tripod.nih.gov/npc/#Download,Possibly Marketed Outside US 2003,21 CFR 349,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ca4d2c43-632d-447d-89bb-4809a3c13f41,,
POLYSORBATE 20,9005-64-5,https://drugs.ncats.io/drug/7T1F30V5YH,6,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""9005%2064%205"")%20AND%20(root_names_name:""%5EPOLYSORBATE%2020$"")",EXACT NAME,US Previously Marketed ,21 CFR 310.527(a) hair loss prevention polysorbate 20,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec310-527.xml,Possibly Marketed Outside US 1978,60-Second Fluoride Mint by Patterson Dental Supply Inc,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ad3685e0-c6f0-49dd-b638-eec7ec7be795,,
POLYSORBATE 80,9005-65-6,https://drugs.ncats.io/drug/6OZP39ZG8H,3,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""9005%2065%206"")%20AND%20(root_names_name:""%5EPOLYSORBATE%2080$"")",EXACT NAME,US Approved OTC ,21 CFR 349.12(d)(4) ophthalmic:demulcents polysorbate 80,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec349-12.xml,US Previously Marketed 1949,Olothorb by Merck Sharp & Dohme,DeHaen 1940-1975 NMEs,Dry eye syndrome,Approved
POLYSTYRENE SULFONATE,28210-41-5,https://drugs.ncats.io/drug/ZSL2FB6GXN,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""28210%2041%205"")",ONLY CAS,US Approved Rx 1998,ANDA040029,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=040029,Possibly Marketed Outside US 1953,NDA022556,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4e8248ad-f213-401c-9c0a-1e32e7341345,,
POLYTHIAZIDE,346-18-9,https://drugs.ncats.io/drug/36780APV5N,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""346%2018%209"")",ONLY CAS,US Previously Marketed 1980,MINIZIDE by PFIZER,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017986,US Previously Marketed 1961,RENESE by PFIZER,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=012845,Edema; Hypertension,Approved; Approved
POLYURETHANE,9009-54-5,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""9009%2054%205"")",ONLY CAS,,,,,,,,
POLYVINYL ALCOHOL,9002-89-5,https://drugs.ncats.io/drug/532B59J990,11,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""9002%2089%205"")%20AND%20(root_names_name:""%5EPOLYVINYL%20ALCOHOL$"")",EXACT NAME,US Approved OTC ,21 CFR 349.12(e) ophthalmic:demulcents polyvinyl alcohol,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec349-12.xml,Possibly Marketed Outside US 1984,Hemocyte F by US Pharmaceutical Corporation,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=30138a3b-2759-48ee-afac-70eb294292f7,,
POMALIDOMIDE,19171-19-8,https://drugs.ncats.io/drug/D2UX06XLB5,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""19171%2019%208"")",ONLY CAS,US Approved Rx 2013,NDA204026,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204026,US Approved Rx 2013,NDA204026,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204026,Multiple myeloma,Approved
PONATINIB,943319-70-8,https://drugs.ncats.io/drug/4340891KFS,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""943319%2070%208"")",ONLY CAS,US Approved Rx 2012,NDA203469,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203469,US Approved Rx 2012,NDA203469,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203469,Headache; Philadelphia chromosome positive acute lymphoblastic leukemia; Chronic myeloid leukemia,Discontinued; Approved; Approved
PONAZURIL,69004-04-2,https://drugs.ncats.io/drug/JPW84AS66U,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""69004%2004%202"")",ONLY CAS,Possibly Marketed Outside US ,Canada:PONAZURIL,https://tripod.nih.gov/npc/#Download,Possibly Marketed Outside US 2015,NADA141188,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f26dfd14-238b-48f6-90ba-b44524973602,Coccidiosis; Equine protozoal myeloencephalitis,Basic research; Approved
PORACTANT ALFA,129069-19-8,https://drugs.ncats.io/drug/KE3U2023NP,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""129069%2019%208"")",ONLY CAS,US Approved Rx 1999,BLA020744,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020744,US Approved Rx 1999,BLA020744,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020744,,
PORFIMER SODIUM,87806-31-3,https://drugs.ncats.io/drug/Y3834SIK5F,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""87806%2031%203"")",ONLY CAS,US Approved Rx 2003,NDA021525,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021525,US Approved Rx 1995,NDA020451,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020451,Microinvasive endobronchial nonsmall cell lung cancer; Esophageal cancer; Barrett’s esophagus; Completely or partially obstructing endobronchial nonsmall cell lung cancer,Approved; Approved; Approved; Approved
POSACONAZOLE,171228-49-2,https://drugs.ncats.io/drug/6TK1G07BHZ,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""171228%2049%202"")",ONLY CAS,US Approved Rx 2020,ANDA208773,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208773,US Approved Rx 2006,NDA022003,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022003,Aspergillus infections; Candida infections; Oropharyngeal candidiasis,Approved; Approved; Approved
POTASSIUM,7440-09-7,https://drugs.ncats.io/drug/RWP5GA015D,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""7440%2009%207"")",ONLY CAS,Possibly Marketed Outside US ,V & M Vitamin and Mineral Supplement by Garden State Nutritionals [Canada],https://www.drugbank.ca/drugs/DB14500,Possibly Marketed Outside US 2012,21 CFR 352,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=86f0e36e-e824-483a-9a53-3b20cf109844,,
POTASSIUM PERMANGANATE,7722-64-7,https://drugs.ncats.io/drug/00OT1QX5U4,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""7722%2064%207"")",ONLY CAS,US Previously Marketed 1921,Potassium Permanganate U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,US Previously Marketed 1921,Potassium Permanganate U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,,
POVIDONE,9003-39-8,https://drugs.ncats.io/drug/FZ989GH94E,13,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""9003%2039%208"")%20AND%20(root_names_name:""%5EPOVIDONE$"")",EXACT NAME,US Approved OTC ,21 CFR 349.12(f) ophthalmic:demulcents povidone,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec349-12.xml,US Previously Marketed 1961,SALPIX POVIDONE by ORTHO,https://www.govinfo.gov/content/pkg/FR-1971-06-18/pdf/FR-1971-06-18.pdf#page=1,,
POVIDONE-IODINE,25655-41-8,https://drugs.ncats.io/drug/85H0HZU99M,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""25655%2041%208"")",ONLY CAS,US Approved OTC ,21 CFR 333.210(d) antifungal povidone-iodine,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec333-210.xml,US Previously Marketed 1921,Iodine U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,antiseptic,Approved
PRALATREXATE,146464-95-1,https://drugs.ncats.io/drug/A8Q8I19Q20,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""146464%2095%201"")",ONLY CAS,US Approved Rx 2009,NDA022468,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022468,US Approved Rx 2009,NDA022468,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022468,Peripheral T-cell lymphoma (relapsed or refractory),Approved
PRALIDOXIME,6735-59-7,https://drugs.ncats.io/drug/P7MU9UTP52,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""6735%2059%207"")",ONLY CAS,US Approved Rx 1964,NDA014134,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=014134,US Approved Rx 1964,NDA014134,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=014134,Organophosphate poisoning,Approved
PRAMIPEXOLE,104632-26-0,https://drugs.ncats.io/drug/83619PEU5T,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""104632%2026%200"")",ONLY CAS,US Approved Rx 2021,ANDA212797,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212797,US Previously Marketed 1997,MIRAPEX by BOEHRINGER INGELHEIM,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020667,Idiopathic Parkinson's disease; Restless legs syndrome,Approved; Approved
PRAMLINTIDE,151126-32-8,https://drugs.ncats.io/drug/D3FM8FA78T,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""151126%2032%208"")",ONLY CAS,US Approved Rx 2005,NDA021332,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021332,US Approved Rx 2005,NDA021332,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021332,Type 1 diabetes,Approved
PRAMOCAINE,140-65-8,https://drugs.ncats.io/drug/068X84E056,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""140%2065%208"")",ONLY CAS,US Approved OTC ,21 CFR 346.10(g) anorectal:local anesthetic pramoxine hydrochloride,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec346-10.xml,US Previously Marketed 1953,Tronothane by Abbott,OB NME Appendix 1950-1985,Dermatoses,Approved
PRASTERONE,53-43-0,https://drugs.ncats.io/drug/459AG36T1B,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""53%2043%200"")",ONLY CAS,US Approved Rx 2016,NDA208470,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208470,Possibly Marketed Outside US 2014,"Prasterone by Health Science Funding, LLC",https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d509cc4f-d92f-4216-a117-16b467a29126,Dyspareunia,Approved
PRASUGREL,150322-43-3,https://drugs.ncats.io/drug/34K66TBT99,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""150322%2043%203"")",ONLY CAS,US Approved Rx 2009,NDA022307,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22307,US Approved Rx 2009,NDA022307,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22307,Cardiovascular diseases,Approved
PRAVASTATIN,81093-37-0,https://drugs.ncats.io/drug/KXO2KT9N0G,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""81093%2037%200"")",ONLY CAS,US Approved Rx 2006,ANDA076341,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=076341,US Previously Marketed 1991,PRAVACHOL by BRISTOL MYERS SQUIBB,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019898,Coronary heart disease; Dysbetalipoproteinemia; Mixed dyslipidemia; Hypercholesterolemia,Approved; Approved; Approved; Approved
PRAZIQUANTEL,55268-74-1,https://drugs.ncats.io/drug/6490C9U457,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""55268%2074%201"")",ONLY CAS,US Approved Rx 1982,NDA018714,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018714,Possibly Marketed Outside US 1981,NADA111607,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=641f1874-ad52-40fd-9c63-2ca537a6e147,Schistosoma mekongi infection; Schistosoma hematobium infection; Schistosoma japonicum infection; Clonorchis sinensis/Opisthorchis viverrini,Approved; Approved; Approved; Approved
PRAZOSIN,19216-56-9,https://drugs.ncats.io/drug/XM03YJ541D,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""19216%2056%209"")",ONLY CAS,US Approved Rx 2021,ANDA214608,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214608,US Approved Rx 1976,NDA017442,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017442,Prostatic hyperplasia; Post-traumatic headache; Hypertension,Phase IV; Phase IV; Approved
PREDNICARBATE,73771-04-7,https://drugs.ncats.io/drug/V901LV1K7D,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""73771%2004%207"")",ONLY CAS,US Approved Rx 2007,ANDA077236,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=077236,US Previously Marketed 1991,DERMATOP by VALEANT PHARMS NORTH,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019568,Dermatoses,Approved
PREDNISOLONE,50-24-8,https://drugs.ncats.io/drug/9PHQ9Y1OLM,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""50%2024%208"")",ONLY CAS,US Approved Rx 2022,ANDA216715,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216715,US Previously Marketed 1955,Meticortelone by Schering,DeHaen 1940-1975 NMEs,Iritis; Herpes zoster keratitis; Superficial punctate keratitis; Allergic conjunctivitis; Acne rosacea; Inflammation and pain; Anaphylaxis; Brain edema; Acute asthma attack; Pulmonary edema; Rheumatoid arthritis; Primary or secondary adrenocortical insufficiency; Rheumatic diseases; Allergic states; Mycosis fungoides; Acute leukemia; Multiple sclerosis; Uveitis; Hematologic disorders; Symptomatic sarcoidosis,Approved; Approved; Approved; Approved; Approved; Approved; Approved; Approved; Approved; Approved; Approved; Approved; Approved; Approved; Approved; Approved; Approved; Approved; Approved; Approved
PREDNISONE,53-03-2,https://drugs.ncats.io/drug/VB0R961HZT,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""53%2003%202"")",ONLY CAS,US Approved Rx 1976,ANDA085162,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=085162,US Previously Marketed 1955,METICORTEN by SCHERING,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=009766,Atopic dermatitis; Severe erythema multiforme (Stevens-Johnson syndrome); Crohn's disease; Congenital adrenal hyperplasia; Aggressive lymphoma; Diamond-Blackfan anemia,Approved; Approved; Approved; Approved; Approved; Approved
PREGABALIN,148553-50-8,https://drugs.ncats.io/drug/55JG375S6M,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""148553%2050%208"")",ONLY CAS,US Approved Rx 2019,ANDA207623,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207623,US Approved Rx 2004,NDA021723,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021723,Partial onset seizures; Fibromyalgia; Postherpetic neuralgia; Diabetic peripheral neuropathy,Approved; Approved; Approved; Approved
PREGNENOLONE,145-13-1,https://drugs.ncats.io/drug/73R90F7MQ8,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""145%2013%201"")",ONLY CAS,US Previously Marketed 1950,Natolone by National (MerrellNational),DeHaen 1940-1975 NMEs,US Previously Marketed 1950,Natolone by National (MerrellNational),DeHaen 1940-1975 NMEs,Schizophrenia; Spatial memory disorder; Autism; Obsessive-compulsive disorder; Schizophrenia; Major depressive disorder; Marijuana dependence; Bipolar disorder,Preclinical; Preclinical; Phase II; Phase II; Phase IV; Phase IV; Phase II; Phase IV
PRILOCAINE,721-50-6,https://drugs.ncats.io/drug/046O35D44R,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""721%2050%206"")",ONLY CAS,US Approved Rx 2003,ANDA076453,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=076453,US Approved Rx 1965,NDA021383,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021383,,
PRIMAQUINE,90-34-6,https://drugs.ncats.io/drug/MVR3634GX1,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""90%2034%206"")",ONLY CAS,US Approved Rx 2014,ANDA204476,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204476,US Approved Rx 1952,NDA008316,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=008316,Plasmodium vivax malaria; Plasmodium vivax malaria,Approved; Approved
PRIMIDONE,125-33-7,https://drugs.ncats.io/drug/13AFD7670Q,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""125%2033%207"")",ONLY CAS,US Approved Rx 2008,ANDA040866,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=040866,US Approved Rx 1954,NDA009170,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=009170,Focal epileptic seizures; Psychomotor epileptic seizures; Grand mal epileptic seizures,Approved; Approved; Approved
PROBENECID,57-66-9,https://drugs.ncats.io/drug/PO572Z7917,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""57%2066%209"")",ONLY CAS,US Approved Rx 2008,ANDA040618,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=040618,US Previously Marketed 1951,BENEMID by MERCK,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=007898,Gouty arthritis; Gout,Approved; Approved
PROCAINAMIDE,51-06-9,https://drugs.ncats.io/drug/L39WTC366D,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""51%2006%209"")",ONLY CAS,US Approved Rx 1986,ANDA089069,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=089069,US Previously Marketed 1950,PRONESTYL by APOTHECON,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=007335,Ventricular tachycardia,Approved
PROCAINE,59-46-1,https://drugs.ncats.io/drug/4Z8Y51M438,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""59%2046%201"")",ONLY CAS,US Previously Marketed 1954,TETRACYN by PFIZER,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=060285,US Previously Marketed 1905,Novocaine,https://books.google.com/books?id=HEMfAQAAIAAJ&lpg=PA588&ots=mRz14jeh0L&dq=alypin%20discovery%201905&pg=PA588#v=onepage&q=alypin%20discovery%201905&f=false,Pain,Approved
PROCARBAZINE,671-16-9,https://drugs.ncats.io/drug/35S93Y190K,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""671%2016%209"")",ONLY CAS,US Approved Rx 1969,NDA016785,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016785,US Approved Rx 1969,NDA016785,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016785,Hodgkin's lymphoma; Glioblastoma multiforme; Anaplastic astrocytoma,Approved; Approved; Approved
PROCHLORPERAZINE,58-38-8,https://drugs.ncats.io/drug/YHP6YLT61T,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""58%2038%208"")",ONLY CAS,US Approved Rx 2023,ANDA217478,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217478,US Previously Marketed 1956,COMPAZINE by GLAXOSMITHKLINE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=010571,Dengue fever; Nausea; Vomiting; Generalized non-psychotic anxiety; Schizophrenia,Preclinical; Approved; Approved; Approved; Approved
PROCYCLIDINE,77-37-2,https://drugs.ncats.io/drug/C6QE1Q1TKR,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""77%2037%202"")",ONLY CAS,US Previously Marketed 1955,KEMADRIN by MONARCH PHARMS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=009818,US Previously Marketed 1955,KEMADRIN by MONARCH PHARMS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=009818,Postencephalitic parkinsonism; Idiopathic Parkinson's disease; Arteriosclerotic parkinsonism,Approved; Approved; Approved
PROFLAVINE,92-62-6,https://drugs.ncats.io/drug/CY3RNB3K4T,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""92%2062%206"")",ONLY CAS,US Previously Marketed 1919,Proflavine,https://books.google.com/books?id=Mp0hAQAAMAAJ&lpg=PA1443&ots=_xoaFHPs4k&dq=proflavine%20first%20marketed&pg=PA1443#v=onepage&q=proflavine%20first%20marketed&f=false,US Previously Marketed 1919,Proflavine,https://books.google.com/books?id=Mp0hAQAAMAAJ&lpg=PA1443&ots=_xoaFHPs4k&dq=proflavine%20first%20marketed&pg=PA1443#v=onepage&q=proflavine%20first%20marketed&f=false,Head and neck cancer; Colon polyps; Genital herpes; Gram-positive bacterial infections; Barrett’s esophagus; Cervical cancer,Not Provided; Phase I; Phase II; Approved; Phase II; Phase I
PROGESTERONE,57-83-0,https://drugs.ncats.io/drug/4G7DS2Q64Y,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""57%2083%200"")",ONLY CAS,US Approved Rx 1998,NDA020843,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020843,US Previously Marketed 1934,Proluton,https://archive.org/details/newnonofficialre39coun,Amenorrhea; Abnormal uterine bleeding,Approved; Approved
PROGUANIL,500-92-5,https://drugs.ncats.io/drug/S61K3P7B2V,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""500%2092%205"")",ONLY CAS,US Approved Rx 2011,ANDA091211,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=091211,US Previously Marketed 1947,Chloroguanide by Squibb,DeHaen 1940-1975 NMEs,Plasmodium falciparum malaria; Plasmodium falciparum malaria,Approved; Approved
PROLINE,4305-67-3,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""4305%2067%203"")",ONLY CAS,,,,,,,,
PROMETHAZINE,60-87-7,https://drugs.ncats.io/drug/FF28EJQ494,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""60%2087%207"")",ONLY CAS,US Approved Rx 1982,ANDA087953,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=087953,US Previously Marketed 1951,PHENERGAN by DELCOR ASSET CORP,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=007935,Perennial allergic rhinitis; Seasonal allergic rhinitis; Nausea and vomiting; Allergic conjunctivitis; Motion sickness,Approved; Approved; Approved; Approved; Approved
PROPAFENONE,54063-53-5,https://drugs.ncats.io/drug/68IQX3T69U,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""54063%2053%205"")",ONLY CAS,US Approved Rx 2019,ANDA210339,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210339,US Previously Marketed 1989,RYTHMOL by GLAXOSMITHKLINE LLC,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019151,Atrial fibrillation; Ventricular arrhythmia,Approved; Approved
PROPANE,74-98-6,https://drugs.ncats.io/drug/T75W9911L6,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""74%2098%206"")",ONLY CAS,Possibly Marketed Outside US 2011,21 CFR 333A,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5846f414-8329-4034-b99f-92721bdb3d14,Possibly Marketed Outside US 1974,M,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=21668731-8b8a-404f-80ab-962a0a9d5f63,,
PROPANTHELINE,298-50-0,https://drugs.ncats.io/drug/1306V2B0Q8,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""298%2050%200"")",ONLY CAS,US Previously Marketed 1982,PROPANTHELINE BROMIDE by HEATHER,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=085780,US Previously Marketed 1953,PRO-BANTHINE by SHIRE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=008732,Overactive bladder; Urinary calculus; Peptic ulcer,Approved; Phase IV; Approved
PROPIONIC ACID,79-09-4,https://drugs.ncats.io/drug/JHU490RVYR,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""79%2009%204"")",ONLY CAS,US Previously Marketed 1921,sodium propionate,https://catalog.hathitrust.org/Record/100163146,US Previously Marketed 1921,sodium propionate,https://catalog.hathitrust.org/Record/100163146,,
PROPOFOL,2078-54-8,https://drugs.ncats.io/drug/YI7VU623SF,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""2078%2054%208"")",ONLY CAS,US Approved Rx 2018,ANDA205067,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205067,US Approved Rx 1989,NDA019627,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019627,Pain,Approved
PROPOLIS,64-17-5,https://drugs.ncats.io/drug/3K9958V90M,3,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""64%2017%205"")",ONLY CAS,US Approved Rx 2001,NDA021074,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021074,US Previously Marketed 0652,alcohol,https://en.wikipedia.org/wiki/Alcohol_(drug),Bacterial infections,Approved
PROPRANOLOL,525-66-6,https://drugs.ncats.io/drug/9Y8NXQ24VQ,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""525%2066%206"")",ONLY CAS,US Approved Rx 1987,ANDA070690,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=070690,US Previously Marketed 1967,INDERAL by WYETH PHARMS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016418,Angina pectoris; hypertension; Hypertrophic subaortic stenosis; Migraine,Approved; Approved; Approved; Approved
PROPYLENE GLYCOL,57-55-6,https://drugs.ncats.io/drug/6DC9Q167V3,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""57%2055%206"")",ONLY CAS,US Approved OTC ,21 CFR 349.12(d)(5) ophthalmic:demulcents propylene glycol,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec349-12.xml,US Previously Marketed 1961,VOSOL PROPYLENE GLYCOL by WAMPOLE LABS,https://www.govinfo.gov/content/pkg/FR-1972-12-14/pdf/FR-1972-12-14.pdf,Dryness of the eye,Approved
PROPYLHEXEDRINE,101-40-6,https://drugs.ncats.io/drug/LQU92IU8LL,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""101%2040%206"")",ONLY CAS,US Approved OTC ,21 CFR 341.20(b)(9) cough/cold:nasal decongestant propylhexedrine,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec341-20.xml,US Previously Marketed 1949,Benzedrex by Smith Kline & French,DeHaen 1940-1975 NMEs,Nasal congestion,Approved
PROPYLPARABEN,94-13-3,https://drugs.ncats.io/drug/Z8IX2SC1OH,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""94%2013%203"")",ONLY CAS,US Previously Marketed ,21 CFR 310.545(a)(22)(ii) antifungal:diaper rash propylparaben,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec310-545.xml,Possibly Marketed Outside US 1961,NDA012911,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3a27d0ef-83a7-4e1c-9430-46a3326ee8d8,Gram-positive bacterial skin infections; Fungal skin infections; Gram-negative bacterial skin infections; dermatitis,Basic research; Basic research; Basic research; Approved
PROPYLTHIOURACIL,51-52-5,https://drugs.ncats.io/drug/721M9407IY,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""51%2052%205"")",ONLY CAS,US Approved Rx 2023,ANDA208867,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208867,US Approved Rx 1947,NDA006188,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=006188,Hyperthyroidism,Approved
PROTAMINE,9012-00-4,https://drugs.ncats.io/drug/72G3UY6T4N,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""9012%2000%204"")",ONLY CAS,US Approved Rx 1987,ANDA089454,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=089454,US Previously Marketed 1950,PROTAMINE SULFATE by LILLY,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=006460,,
PROTEASE,75847-73-3,https://drugs.ncats.io/drug/69PN84IO1A,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""75847%2073%203"")",ONLY CAS,US Approved Rx 2001,ANDA075727,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=075727,US Approved Rx 1985,NDA018998,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018998,Hypertension; Asymptomatic left ventricular dysfunction; Heart failure,Approved; Approved; Approved
PROTEIN C,60202-16-6,https://drugs.ncats.io/drug/3Z6S89TXPW,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""60202%2016%206"")",ONLY CAS,Possibly Marketed Outside US ,Octaplex by Octapharma Pharmazeutika Produktionsges M B H [Canada],https://www.drugbank.ca/drugs/DB11312,Possibly Marketed Outside US 2007,BLA125234,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=926914a9-78b2-40ea-b37d-2a55c09bf275,,
PROTEIN S,128-44-9,https://drugs.ncats.io/drug/I4807BK602,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""128%2044%209"")",ONLY CAS,US Previously Marketed 1921,Benzosulphinide U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,US Previously Marketed 1921,Benzosulphinide U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,Unknown,
PROTEIN TESTS,50-70-4,https://drugs.ncats.io/drug/506T60A25R,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""50%2070%204"")",ONLY CAS,US Approved Rx 2020,NDA202049,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202049,Possibly Marketed Outside US 1955,Levsin by Alaven Pharmaceutical LLC,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=32388e18-08de-455c-aad4-9c2264435f0f,Constipation; End-Stage Renal Disease; Cystic fibrosis; Asthma; Acute renal failure; Elevated intraocular pressure; Cerebral edema,Basic research; Approved; Approved; Approved; Approved; Approved; Approved
PROTHROMBIN,103658-53-3,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""103658%2053%203"")",ONLY CAS,,,,,,,,
PROTIRELIN,24305-27-9,https://drugs.ncats.io/drug/5Y5F15120W,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""24305%2027%209"")",ONLY CAS,US Previously Marketed 1978,THYREL TRH by FERRING,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018087,US Previously Marketed 1976,THYPINONE by ABBOTT,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017638,Primary hypothyroidism; Thyroid Diseases,Phase II; Approved
PROTRIPTYLINE,438-60-8,https://drugs.ncats.io/drug/4NDU154T12,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""438%2060%208"")",ONLY CAS,US Approved Rx 2012,ANDA202220,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202220,US Previously Marketed 1967,VIVACTIL by TEVA WOMENS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016012,Mental depression,Approved
PROXYMETACAINE,499-67-2,https://drugs.ncats.io/drug/B4OB0JHI1X,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""499%2067%202"")",ONLY CAS,US Approved Rx 1971,ANDA080027,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=080027,US Previously Marketed 1953,OPHTHAINE by APOTHECON,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=008883,Pain,Approved
PRUCALOPRIDE,179474-81-8,https://drugs.ncats.io/drug/0A09IUW5TP,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""179474%2081%208"")",ONLY CAS,US Approved Rx 2018,NDA210166,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210166,US Approved Rx 2018,NDA210166,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210166,"Constipation, chronic",Approved
PSEUDOEPHEDRINE,90-82-4,https://drugs.ncats.io/drug/7CUC9DDI9F,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""90%2082%204"")",ONLY CAS,US Approved OTC ,21 CFR 341.20(a)(3) cough/cold:nasal decongestant pseudoephedrine sulfate,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec341-20.xml,US Previously Marketed 1961,DISOPHROL by SCHERING,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=012394,,
PUERARIA,117060-54-5,https://drugs.ncats.io/drug/M7KVR1LSN0,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""117060%2054%205"")",ONLY CAS,,,,,,,,
PUMICE,1332-09-8,https://drugs.ncats.io/drug/NT5NN5KL16,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1332%2009%208"")",ONLY CAS,US Previously Marketed 1921,Pumice N.F.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,US Previously Marketed 1921,Pumice N.F.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,,
PYGEUM AFRICANUM,85865-74-3,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""85865%2074%203"")",ONLY CAS,,,,,,,,
PYRANTEL,15686-83-6,https://drugs.ncats.io/drug/4QIH0N49E7,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""15686%2083%206"")",ONLY CAS,US Approved OTC ,21 CFR 357.110 anthelmintic pyrantel pamoate,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec357-110.xml,US Previously Marketed 1971,Antiminth by Roerig (Pfizer),OB NME Appendix 1950-1985,Strongyloidiasis; Pinworm infection; Large roundworms infection; Tapeworm infection,Approved; Approved; Approved; Approved
PYRAZINAMIDE,98-96-4,https://drugs.ncats.io/drug/2KNI5N06TI,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""98%2096%204"")",ONLY CAS,US Approved Rx 1971,ANDA080157,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=080157,US Previously Marketed 1955,Pyrazinamide by Merck (Merck Sharp & Dohme),OB NME Appendix 1950-1985,Tuberculosis,Approved
PYRETHRINS,8003-34-7,https://drugs.ncats.io/drug/e4443c7a,3,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""8003%2034%207"")%20AND%20(root_names_name:""%5EPYRETHRINS$"")",EXACT NAME,,,,,,,,
PYRIDOSTIGMINE,155-97-5,https://drugs.ncats.io/drug/19QM69HH21,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""155%2097%205"")",ONLY CAS,US Approved Rx 1955,NDA009830,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=009830,US Approved Rx 1955,NDA009830,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=009830,Myasthenia gravis,Approved
PYRIDOXAL,66-72-8,https://drugs.ncats.io/drug/3THM379K8A,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""66%2072%208"")",ONLY CAS,Possibly Marketed Outside US 2019,21 CFR 347,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8c17ee80-ceac-53e9-e053-2995a90a8193,Possibly Marketed Outside US 2019,21 CFR 347,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8c17ee80-ceac-53e9-e053-2995a90a8193,,
PYRIDOXAL 5 PHOSPHATE,54-47-7,https://drugs.ncats.io/drug/F06SGE49M6,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""54%2047%207"")",ONLY CAS,Possibly Marketed Outside US ,Dexivite by Lifsa Drugs Llc,https://www.drugbank.ca/drugs/DB00114,Possibly Marketed Outside US 2011,EnLyte by Jaymac Pharma,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e83b2dd3-a9a0-40bc-ade4-6cd4db433b06,Tardive dyskinesia; Metabolic syndrome; Type 2 diabetes mellitus,Phase II; Phase II; Phase II
PYRIDOXINE,65-23-6,https://drugs.ncats.io/drug/KV2JZ1BI6Z,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""65%2023%206"")",ONLY CAS,US Approved Rx 2016,NDA209661,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209661,US Previously Marketed 1947,BEROCCA PN by ROCHE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=006071,West syndrome; Pyridoxine deficiency; Pyridoxine-dependent epilepsy,Approved; Approved; Approved
PYRIMETHAMINE,58-14-0,https://drugs.ncats.io/drug/Z3614QOX8W,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""58%2014%200"")",ONLY CAS,US Approved Rx 2021,ANDA211271,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211271,US Approved Rx 1953,NDA008578,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=008578,Toxoplasmosis; Malaria; Acute malaria,Approved; Approved; Approved
PYRITHIONE ZINC,13463-41-7,https://drugs.ncats.io/drug/R953O2RHZ5,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""13463%2041%207"")",ONLY CAS,US Approved OTC ,21 CFR 358.710(a)(2) dandruff:dandruff (wash-off) pyrithione zinc,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec358-710.xml,US Previously Marketed 1961,Head & Shoulders Shampoo by Proctor and Gamble,OB NME Appendix 1950-1985,Seborrhea; Acute myeloid leukemia,Approved; Preclinical
PYROXYLIN,9004-70-0,https://drugs.ncats.io/drug/KYR8BR2X6O,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""9004%2070%200"")",ONLY CAS,US Previously Marketed 1921,Pyroxylin U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,US Previously Marketed 1921,Pyroxylin U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,,
PYRUVIC ACID,127-17-3,https://drugs.ncats.io/drug/8558G7RUTR,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""127%2017%203"")",ONLY CAS,Possibly Marketed Outside US 2020,21 CFR 333A,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0923fbdc-b85a-4113-a07f-715820fffa3f,Possibly Marketed Outside US 1987,21 CFR 349,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=45ac4335-3ecd-4a03-865e-82dd9cd3c715,Coronary Disease; Blood Transfusion,Phase II; Approved
QUAZEPAM,36735-22-5,https://drugs.ncats.io/drug/JF8V0828ZI,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""36735%2022%205"")",ONLY CAS,US Approved Rx 1985,NDA018708,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018708,US Approved Rx 1985,NDA018708,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018708,Insomnia,Approved
QUERCETIN,117-39-5,https://drugs.ncats.io/drug/9IKM0I5T1E,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""117%2039%205"")",ONLY CAS,US Previously Marketed 1953,Quertine by Abbott,DeHaen 1940-1975 NMEs,US Previously Marketed 1953,Quertine by Abbott,DeHaen 1940-1975 NMEs,Thromboembolism; Chronic obstructive pulmonary disease; Acute mountain sickness,Phase III; Phase I; Phase III
QUERCUS ALBA,68917-11-3,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""68917%2011%203"")",ONLY CAS,,,,,,,,
QUERCUS ROBUR,71011-28-4,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""71011%2028%204"")",ONLY CAS,,,,,,,,
QUETIAPINE,111974-69-7,https://drugs.ncats.io/drug/BGL0JSY5SI,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""111974%2069%207"")",ONLY CAS,US Approved Rx 2012,ANDA201109,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201109,US Approved Rx 1997,NDA020639,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020639,Schizophrenia; Bipolar disorder; Major depressive disorder,Approved; Approved; Approved
QUINAPRIL,85441-61-8,https://drugs.ncats.io/drug/RJ84Y44811,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""85441%2061%208"")",ONLY CAS,US Approved Rx 2011,ANDA201356,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201356,US Previously Marketed 1991,ACCUPRIL by PFIZER PHARMS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019885,Hypertension,Approved
QUINIDINE,56-54-2,https://drugs.ncats.io/drug/ITX08688JL,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""56%2054%202"")",ONLY CAS,US Approved Rx 2010,NDA021879,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021879,US Previously Marketed 1921,Quinidine N.F.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,Ventricular arrhythmia; Plasmodium falciparum malaria; Atrial fibrillation,Approved; Approved; Approved
QUININE,72402-53-0,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""72402%2053%200"")",ONLY CAS,,,,,,,,
QUINUPRISTIN,120138-50-3,https://drugs.ncats.io/drug/23OW28RS7P,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""120138%2050%203"")",ONLY CAS,US Approved Rx 1999,NDA050747,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050747,US Approved Rx 1999,NDA050747,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050747,Complicated skin and skin structure infections caused by Staphylococcus aureus or Streptococcus pyogenes,Approved
RABEPRAZOLE,117976-89-3,https://drugs.ncats.io/drug/32828355LL,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""117976%2089%203"")",ONLY CAS,US Approved Rx 2013,ANDA076824,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=076824,US Approved Rx 1999,NDA020973,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020973,Zollinger-Ellison syndrome; Erosive or ulcerative gastroesophageal reflux disease; Duodenal ulcer,Approved; Approved; Approved
RACEPHEDRINE,53214-57-6,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""53214%2057%206"")",ONLY CAS,,,,,,,,
RACEPINEFRINE,329-65-7,https://drugs.ncats.io/drug/GR0L9S3J0F,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""329%2065%207"")",ONLY CAS,US Approved OTC ,21 CFR 341.16(g) cough/cold:bronchodilator racepinephrine hydrochloride,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec341-16.xml,Possibly Marketed Outside US 2000,21 CFR 341,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=dd1b35c7-b23b-4b95-8162-df3d263fe32e,Asthma; Bronchiolitis,Approved; Approved
RADIUM RA-223,15623-45-7,https://drugs.ncats.io/drug/8BR2SOL3L1,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""15623%2045%207"")",ONLY CAS,Possibly Marketed Outside US ,WHO-ATC:V10XX03,https://ginas.ncats.nih.gov/ginas/app/substance/8BR2SOL3L1,,,,,
RALOXIFENE,84449-90-1,https://drugs.ncats.io/drug/YX9162EO3I,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""84449%2090%201"")",ONLY CAS,US Approved Rx 2016,ANDA206384,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206384,US Approved Rx 1997,NDA020815,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020815,Breast cancer in postmenopausal women with osteoporosis; Breast cancer in postmenopausal women at high risk for invasive breast cancer; Osteoporosis in postmenopausal women,Approved; Approved; Approved
RALTEGRAVIR,518048-05-0,https://drugs.ncats.io/drug/22VKV8053U,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""518048%2005%200"")",ONLY CAS,US Approved Rx 2013,NDA205786,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205786,US Approved Rx 2007,NDA022145,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022145,HIV-1 infection,Approved
RAMELTEON,196597-26-9,https://drugs.ncats.io/drug/901AS54I69,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""196597%2026%209"")",ONLY CAS,US Approved Rx 2005,NDA021782,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021782,US Approved Rx 2005,NDA021782,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021782,Insomnia,Approved
RAMIPRIL,87333-19-5,https://drugs.ncats.io/drug/L35JN3I7SJ,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""87333%2019%205"")",ONLY CAS,US Approved Rx 2005,ANDA076549,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=076549,US Approved Rx 1991,NDA019901,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019901,,
RAMUCIRUMAB,947687-13-0,https://drugs.ncats.io/drug/D99YVK4L0X,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""947687%2013%200"")",ONLY CAS,US Approved Rx 2014,BLA125477,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125477,US Approved Rx 2014,BLA125477,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125477,,
RANIBIZUMAB,347396-82-1,https://drugs.ncats.io/drug/ZL1R02VT79,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""347396%2082%201"")",ONLY CAS,US Approved Rx 2006,BLA125156,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125156,US Approved Rx 2006,BLA125156,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125156,,
RANITIDINE,82530-72-1,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""82530%2072%201"")",ONLY CAS,,,,,,,,
RANOLAZINE,95635-55-5,https://drugs.ncats.io/drug/A6IEZ5M406,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""95635%2055%205"")",ONLY CAS,US Approved Rx 2020,ANDA211745,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211745,US Previously Marketed 2006,RANEXA by MENARINI INTL,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021526,Angina,Approved
RANUNCULUS BULBOSUS,90106-07-3,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""90106%2007%203"")",ONLY CAS,,,,,,,,
RAPACURONIUM,465499-11-0,https://drugs.ncats.io/drug/GG1LBM463S,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""465499%2011%200"")",ONLY CAS,US Previously Marketed 1999,RAPLON by ORGANON USA INC,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020984,US Previously Marketed 1999,RAPLON by ORGANON USA INC,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020984,Skeletal muscle relaxation,Withdrawn
RAPHANUS SATIVUS,84775-94-0,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""84775%2094%200"")",ONLY CAS,,,,,,,,
RASAGILINE,136236-51-6,https://drugs.ncats.io/drug/003N66TS6T,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""136236%2051%206"")",ONLY CAS,US Approved Rx 2019,ANDA206153,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206153,US Approved Rx 2006,NDA021641,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021641,Idiopathic Parkinson's disease,Approved
RASBURICASE,134774-45-1,https://drugs.ncats.io/drug/08GY9K1EUO,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""134774%2045%201"")",ONLY CAS,US Approved Rx 2002,BLA103946,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103946,US Approved Rx 2002,BLA103946,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103946,,
RAUWOLFIA SERPENTINA,8063-17-0,https://drugs.ncats.io/drug/H192N84N1G,2,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""8063%2017%200"")%20AND%20(root_names_name:""%5ERAUWOLFIA%20SERPENTINA$"")",EXACT NAME,US Previously Marketed 1982,RAUWOLFIA SERPENTINA by TABLICAPS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=083444,US Previously Marketed 1953,Rauwiloid by Riker,DeHaen 1940-1975 NMEs,,
RAVULIZUMAB,1803171-55-2,https://drugs.ncats.io/drug/C3VX249T6L,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1803171%2055%202"")",ONLY CAS,US Approved Rx 2018,BLA761108,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761108,US Approved Rx 2018,BLA761108,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761108,,
REGADENOSON,313348-27-5,https://drugs.ncats.io/drug/7AXV542LZ4,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""313348%2027%205"")",ONLY CAS,US Approved Rx 2008,NDA022161,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022161,US Approved Rx 2008,NDA022161,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022161,Radionuclide myocardial perfusion imaging,Approved
REGORAFENIB,755037-03-7,https://drugs.ncats.io/drug/24T2A1DOYB,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""755037%2003%207"")",ONLY CAS,US Approved Rx 2012,NDA203085,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203085,US Approved Rx 2012,NDA203085,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203085,Colorectal cancer; Gastrointestinal stromal tumor,Approved; Approved
REMIFENTANIL,132875-61-7,https://drugs.ncats.io/drug/P10582JYYK,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""132875%2061%207"")",ONLY CAS,US Approved Rx 2020,ANDA210594,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210594,US Approved Rx 1996,NDA020630,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020630,Pain,Approved
REPAGLINIDE,135062-02-1,https://drugs.ncats.io/drug/668Z8C33LU,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""135062%2002%201"")",ONLY CAS,US Approved Rx 2013,ANDA201189,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201189,US Previously Marketed 1997,PRANDIN by GEMINI LABS LLC,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020741,Type 2 diabetes mellitus,Approved
RESERPINE,50-55-5,https://drugs.ncats.io/drug/8B1QWR724A,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""50%2055%205"")",ONLY CAS,US Previously Marketed 1982,SANDRIL by LILLY,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=009376,US Previously Marketed 1954,SERPASIL by NOVARTIS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=009434,Hypertension; Agitated psychotic states,Approved; Approved
RESLIZUMAB,241473-69-8,https://drugs.ncats.io/drug/35A26E427H,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""241473%2069%208"")",ONLY CAS,US Approved Rx 2016,BLA761033,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761033,US Approved Rx 2016,BLA761033,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761033,,
RESORCINOL,108-46-3,https://drugs.ncats.io/drug/YUL4LO94HK,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""108%2046%203"")",ONLY CAS,US Approved OTC ,21 CFR 333.310(b) acne resorcinol (when combined with sulfur),https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec333-310.xml,US Previously Marketed 1894,Resorcinol,https://www.google.com/books/edition/The_New_England_Journal_of_Medicine/4641AQAAMAAJ?hl=en&gbpv=1&dq=RESORCINOL%20treatment&pg=PA241&printsec=frontcover&bsq=RESORCINOL%20treatment,Psoriasis; Acne,Approved; Approved
RESORCINOL ACETATE,102-29-4,https://drugs.ncats.io/drug/YL6O37RD1S,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""102%2029%204"")",ONLY CAS,US Approved OTC ,21 CFR 333.310(c) acne resorcinol monoacetate (when combined with sulfur),https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec333-310.xml,US Previously Marketed 1906,Euresol by Knoll & Co,https://www.google.com/books/edition/Journal_of_the_American_Medical_Associat/Xc0-AQAAMAAJ?hl=en&gbpv=1&dq=euresol&pg=PA1194&printsec=frontcover&bsq=euresol,Acne,Approved
RESVERATROL,501-36-0,https://drugs.ncats.io/drug/Q369O8926L,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""501%2036%200"")",ONLY CAS,Possibly Marketed Outside US ,"Co-Balamin by Home Aide Diagnostics, Inc.",https://www.drugbank.ca/drugs/DB02709,Possibly Marketed Outside US 2011,21 CFR 352,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=58fd7b0c-4b4b-4705-b325-49fbfbac889a,Osteoarthritis of knee; Seasonal allergic rhinitis; Type 2 diabetes mellitus,Phase III; Phase III; Phase III
RETAPAMULIN,224452-66-8,https://drugs.ncats.io/drug/4MG6O8991R,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""224452%2066%208"")",ONLY CAS,US Approved Rx 2007,NDA022055,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022055,US Approved Rx 2007,NDA022055,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022055,Impetigo due to Staphylococcus aureus; Impetigo due to Streptococcus pyogenes,Approved; Approved
RETEPLASE,133652-38-7,https://drugs.ncats.io/drug/DQA630RIE9,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""133652%2038%207"")",ONLY CAS,US Approved Rx 1998,BLA103786,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103786,Possibly Marketed Outside US 1996,BLA103786,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e7b63b16-d911-478b-a445-b690a1360b48,,
RETIGABINE,150812-12-7,https://drugs.ncats.io/drug/12G01I6BBU,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""150812%2012%207"")",ONLY CAS,US Previously Marketed 2011,POTIGA by GLAXOSMITHKLINE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022345,US Previously Marketed 2011,POTIGA by GLAXOSMITHKLINE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022345,Partial-onset seizures,Approved
RETINOL,11103-57-4,https://drugs.ncats.io/drug/81G40H8B0T,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""11103%2057%204"")",ONLY CAS,US Approved Rx 2001,NDA021265,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021265,US Previously Marketed 1947,BEROCCA PN by ROCHE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=006071,Vitamin A deficiency; Maternal morbidity; Maternal mortality; Measles; Vitamin A deficiency; Skin aging; Skin photodamage,Phase III; Phase III; Phase III; Approved; Approved; Phase IV; Phase II
REVEFENACIN,864750-70-9,https://drugs.ncats.io/drug/G2AE2VE07O,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""864750%2070%209"")",ONLY CAS,US Approved Rx 2018,NDA210598,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210598,US Approved Rx 2018,NDA210598,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210598,Chronic obstructive pulmonary disease,Approved
RHODIOLA ROSEA,501-94-0,https://drugs.ncats.io/drug/1AK4MU3SNX,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""501%2094%200"")",ONLY CAS,Clinical 2016,NCT02783989: Not Applicable Interventional Completed Cardiovascular Disease,https://clinicaltrials.gov/ct2/show/NCT02783989,,,,,
RIBAVIRIN,36791-04-5,https://drugs.ncats.io/drug/49717AWG6K,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""36791%2004%205"")",ONLY CAS,US Approved Rx 2006,ANDA077743,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=077743,US Approved Rx 1985,NDA018859,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018859,Chronic hepatitis C; Respiratory syncytial virus infection,Approved; Approved
RIBOCICLIB,1211441-98-3,https://drugs.ncats.io/drug/TK8ERE8P56,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1211441%2098%203"")",ONLY CAS,US Approved Rx 2017,NDA209935,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209935,US Approved Rx 2017,NDA209935,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209935,(HER2)-negative advanced or metastatic breast cancer; Breast cancer,Approved; Phase III
RIBOFLAVIN,83-88-5,https://drugs.ncats.io/drug/TLM2976OFR,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""83%2088%205"")",ONLY CAS,US Approved Rx 2001,NDA021265,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021265,US Previously Marketed 1953,M.V.I.-12 ADULT by HOSPIRA,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=008809,Progressive keratoconus; Corneal ectasia,Approved; Approved
RIBOSE,10257-32-6,https://drugs.ncats.io/drug/681HV46001,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""10257%2032%206"")",ONLY CAS,Possibly Marketed Outside US 2011,21 CFR 352,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d5805b6c-30a4-4df4-9ef0-46e1e2868b4e,Possibly Marketed Outside US 2011,21 CFR 352,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d5805b6c-30a4-4df4-9ef0-46e1e2868b4e,Heart failure; Fibromyalgia; Fatigue,Phase II; Phase II; Phase II
RICINOLEIC ACID,141-22-0,https://drugs.ncats.io/drug/I2D0F69854,2,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""141%2022%200"")%20AND%20(root_names_name:""%5ERICINOLEIC%20ACID$"")",EXACT NAME,Possibly Marketed Outside US 2010,21 CFR 347,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d75c073d-04d5-465f-bab8-0db0945e568a,Possibly Marketed Outside US 2009,21 CFR 352,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=92ca04d5-6f41-4f06-bd17-6747199ab018,Inflammation,Basic research
RIFABUTIN,72559-06-9,https://drugs.ncats.io/drug/1W306TDA6S,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""72559%2006%209"")",ONLY CAS,US Approved Rx 2019,NDA213004,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213004,US Approved Rx 1992,NDA050689,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050689,Disseminated Mycobacterium avium complex (MAC) disease,Approved
RIFAMPICIN,13292-46-1,https://drugs.ncats.io/drug/VJT6J7R4TR,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""13292%2046%201"")",ONLY CAS,US Approved Rx 2016,ANDA205039,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205039,US Previously Marketed 1971,RIFADIN by SANOFI AVENTIS US,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050420,Tuberculosis; Asymptomatic meningococcal infection,Approved; Approved
RIFAPENTINE,61379-65-5,https://drugs.ncats.io/drug/XJM390A33U,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""61379%2065%205"")",ONLY CAS,US Approved Rx 1998,NDA021024,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021024,US Approved Rx 1998,NDA021024,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021024,Pulmonary tuberculosis,Approved
RIFAXIMIN,80621-81-4,https://drugs.ncats.io/drug/L36O5T016N,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""80621%2081%204"")",ONLY CAS,US Approved Rx 2004,NDA021361,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021361,US Approved Rx 2004,NDA021361,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021361,Irritable bowel syndrome with diarrhea; Overt hepatic encephalopathy recurrence; Travelers’ diarrhea,Approved; Approved; Approved
RILONACEPT,501081-76-1,https://drugs.ncats.io/drug/8K80YB5GMG,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""501081%2076%201"")",ONLY CAS,US Approved Rx 2008,BLA125249,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125249,US Approved Rx 2008,BLA125249,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125249,,
RILPIVIRINE,500287-72-9,https://drugs.ncats.io/drug/FI96A8X663,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""500287%2072%209"")",ONLY CAS,US Approved Rx 2011,NDA202022,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202022,US Approved Rx 2011,NDA202022,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202022,HIV-1 infection,Approved
RILUZOLE,1744-22-5,https://drugs.ncats.io/drug/7LJ087RS6F,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1744%2022%205"")",ONLY CAS,US Approved Rx 1995,NDA020599,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020599,US Approved Rx 1995,NDA020599,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020599,Amyotrophic lateral sclerosis,Approved
RIMANTADINE,13392-28-4,https://drugs.ncats.io/drug/0T2EF4JQTU,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""13392%2028%204"")",ONLY CAS,US Approved Rx 2002,ANDA076132,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=076132,US Previously Marketed 1993,FLUMADINE by SUN PHARM INDS INC,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019649,Influenza A virus infection; Respiratory tract infections,Approved; Phase II
RIMEXOLONE,49697-38-3,https://drugs.ncats.io/drug/O7M2E4264D,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""49697%2038%203"")",ONLY CAS,US Previously Marketed 1994,VEXOL by HARROW EYE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020474,US Previously Marketed 1994,VEXOL by HARROW EYE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020474,Postoperative inflammation following ocular surgery; Anterior uveitis,Approved; Approved
RIOCIGUAT,625115-55-1,https://drugs.ncats.io/drug/RU3FE2Y4XI,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""625115%2055%201"")",ONLY CAS,US Approved Rx 2022,ANDA211135,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211135,US Approved Rx 2013,NDA204819,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204819,Pulmonary arterial hypertension; Chronic thromboembolic pulmonary hypertension,Approved; Approved
RISEDRONIC ACID,105462-24-6,https://drugs.ncats.io/drug/KM2Z91756Z,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""105462%2024%206"")",ONLY CAS,US Approved Rx 2014,ANDA079215,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=079215,US Approved Rx 1998,NDA020835,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020835,Paget’s disease of bone; Postmenopausal osteoporosis; Glucocorticoid-induced osteoporosis; Increase bone mass in men with osteoporosis,Approved; Approved; Approved; Approved
RISPERIDONE,106266-06-2,https://drugs.ncats.io/drug/L6UH7ZF8HC,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""106266%2006%202"")",ONLY CAS,US Approved Rx 2009,ANDA077719,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=077719,US Approved Rx 1993,NDA020272,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020272,Schizophrenia; Irritability associated with autistic disorder; Acute manic or mixed episodes associated with Bipolar I disorder,Approved; Approved; Approved
RITODRINE,26652-09-5,https://drugs.ncats.io/drug/I0Q6O6740J,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""26652%2009%205"")",ONLY CAS,US Previously Marketed 1991,RITODRINE HYDROCHLORIDE by HOSPIRA,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=071619,US Previously Marketed 1980,Ritodrine by Duphar,OB NME Appendix 1950-1985,Preterm labor,Approved
RITONAVIR,155213-67-5,https://drugs.ncats.io/drug/O3J8G9O825,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""155213%2067%205"")",ONLY CAS,US Approved Rx 2016,ANDA207407,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207407,US Previously Marketed 1996,NORVIR by ABBOTT,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020680,HIV-1 infection,Approved
RITUXIMAB,174722-31-7,https://drugs.ncats.io/drug/4F4X42SYQ6,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""174722%2031%207"")",ONLY CAS,US Approved Rx 2017,BLA761064,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761064,US Approved Rx 1997,BLA103705,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103705,,
RIVAROXABAN,366789-02-8,https://drugs.ncats.io/drug/9NDF7JZ4M3,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""366789%2002%208"")",ONLY CAS,US Approved Rx 2011,NDA202439,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202439,US Approved Rx 2011,NDA202439,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202439,Pulmonary embolism,Approved
RIVASTIGMINE,123441-03-2,https://drugs.ncats.io/drug/PKI06M3IW0,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""123441%2003%202"")",ONLY CAS,US Approved Rx 2012,ANDA091689,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=091689,US Previously Marketed 2000,EXELON by NOVARTIS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020823,Mild to moderate dementia associated with Parkinson’s disease; Alzheimer’s disease; Mild to moderate dementia of the Alzheimer’s type,Approved; Phase IV; Approved
RIZATRIPTAN,144034-80-0,https://drugs.ncats.io/drug/51086HBW8G,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""144034%2080%200"")",ONLY CAS,US Approved Rx 2013,ANDA201914,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201914,US Approved Rx 1998,NDA020864,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020864,Migraine with aura; Migraine with aura,Approved; Approved
ROCURONIUM BROMIDE,119302-91-9,https://drugs.ncats.io/drug/I65MW4OFHZ,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""119302%2091%209"")",ONLY CAS,US Approved Rx 2008,ANDA079195,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=079195,US Previously Marketed 1994,ZEMURON by ORGANON USA INC,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020214,Pain,Approved
ROFECOXIB,162011-90-7,https://drugs.ncats.io/drug/0QTW8Z7MCR,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""162011%2090%207"")",ONLY CAS,US Previously Marketed 1999,VIOXX by MERCK,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021052,US Previously Marketed 1999,VIOXX by MERCK,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021052,Hemophilic Arthropathy; Rheumatoid arthritis; Migraine; Osteoarthritis; Acute pain; Primary dysmenorrhea,Phase II; Withdrawn; Withdrawn; Withdrawn; Withdrawn; Withdrawn
ROFLUMILAST,162401-32-3,https://drugs.ncats.io/drug/0P6C6ZOP5U,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""162401%2032%203"")",ONLY CAS,US Approved Rx 2020,ANDA208247,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208247,US Approved Rx 2011,NDA022522,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022522,Chronic obstructive pulmonary disease,Approved
ROLAPITANT,552292-08-7,https://drugs.ncats.io/drug/NLE429IZUC,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""552292%2008%207"")",ONLY CAS,US Approved Rx 2015,NDA206500,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206500,US Approved Rx 2015,NDA206500,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206500,Delayed nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy,Approved
ROMIDEPSIN,128517-07-7,https://drugs.ncats.io/drug/CX3T89XQBK,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""128517%2007%207"")",ONLY CAS,US Approved Rx 2021,ANDA206254,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206254,US Approved Rx 2009,NDA022393,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022393,,
ROMIPLOSTIM,267639-76-9,https://drugs.ncats.io/drug/GN5XU2DXKV,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""267639%2076%209"")",ONLY CAS,US Approved Rx 2008,BLA125268,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125268,US Approved Rx 2008,BLA125268,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125268,,
ROPINIROLE,91374-21-9,https://drugs.ncats.io/drug/030PYR8953,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""91374%2021%209"")",ONLY CAS,US Approved Rx 2012,ANDA091395,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=091395,US Previously Marketed 1997,REQUIP by GLAXOSMITHKLINE LLC,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020658,Restless legs syndrome; Sexual dysfunction; Parkinson's disease,Approved; Phase IV; Approved
ROPIVACAINE,84057-95-4,https://drugs.ncats.io/drug/7IO5LYA57N,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""84057%2095%204"")",ONLY CAS,US Approved Rx 2014,ANDA078601,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=078601,US Approved Rx 1996,NDA020533,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020533,Pain,Approved
ROSANILINE,632-99-5,https://drugs.ncats.io/drug/8UUC89LHB2,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""632%2099%205"")",ONLY CAS,US Previously Marketed ,21 CFR 310.545(a)(22)(ii) antifungal:diaper rash basic fuchsin,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec310-545.xml,Possibly Marketed Outside US 1972,21 CFR 333A,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3aa69d68-7a22-4a55-9682-ecc14540984a,Skin infections; Unknown,Approved
ROSA CANINA,84696-47-9,https://drugs.ncats.io/drug/10d6be56,2,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""84696%2047%209"")%20AND%20(root_names_name:""%5EROSA%20CANINA"")",APPROXIMATE NAME,,,,,,,,
ROSE BENGAL,4159-77-7,https://drugs.ncats.io/drug/BIU7Q7W2SH,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""4159%2077%207"")",ONLY CAS,Clinical 2015,NCT02322086: Phase 2 Interventional Completed Psoriasis,https://clinicaltrials.gov/ct2/show/NCT02322086,,,,Unknown,
ROSIGLITAZONE,122320-73-4,https://drugs.ncats.io/drug/05V02F2KDG,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""122320%2073%204"")",ONLY CAS,US Previously Marketed 2007,ROSIGLITAZONE by WATSON LABS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=078023,US Previously Marketed 1999,AVANDIA by WOODWARD,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021071,Type 2 diabetes mellitus,Approved
ROSMARINUS OFFICINALIS,3650-09-7,https://drugs.ncats.io/drug/LI791SXT24,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""3650%2009%207"")",ONLY CAS,,,,,,,Ultraviolet-induced erythema,Not Provided
ROSUVASTATIN,287714-41-4,https://drugs.ncats.io/drug/413KH5ZJ73,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""287714%2041%204"")",ONLY CAS,US Approved Rx 2016,ANDA079169,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=079169,US Approved Rx 2003,NDA021366,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021366,Dyslipidemia; Hypertriglyceridemia; Dysbetalipoproteinemia; Hypercholesterolemia; Atherosclerosis,Approved; Approved; Approved; Approved; Approved
ROTIGOTINE,99755-59-6,https://drugs.ncats.io/drug/87T4T8BO2E,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""99755%2059%206"")",ONLY CAS,US Approved Rx 2007,NDA021829,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021829,US Approved Rx 2007,NDA021829,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021829,Restless legs syndrome; Parkinson's disease,Approved; Approved
ROYAL JELLY,8031-67-2,https://drugs.ncats.io/drug/L497I37F0C,2,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""8031%2067%202"")%20AND%20(root_names_name:""%5EROYAL%20JELLY$"")",EXACT NAME,Possibly Marketed Outside US ,Yellow Toner by Iruri Nature Handmade Soap & Cosmetic Inc,https://www.drugbank.ca/drugs/DB14250,Possibly Marketed Outside US 2017,Yellow Toner by Iruri Nature Handmade Soap & Cosmetic Inc,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=551513bc-e3dc-618c-e054-00144ff88e88,,
RUCAPARIB,283173-50-2,https://drugs.ncats.io/drug/8237F3U7EH,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""283173%2050%202"")",ONLY CAS,US Approved Rx 2016,NDA209115,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209115,US Approved Rx 2016,NDA209115,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209115,Castrate-resistant prostate cancer; Breast cancer; Ovarian cancer; Melanoma,Phase III; Phase II; Approved; Phase II
RUFINAMIDE,106308-44-5,https://drugs.ncats.io/drug/WFW942PR79,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""106308%2044%205"")",ONLY CAS,US Approved Rx 2016,ANDA204988,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204988,US Approved Rx 2008,NDA021911,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021911,Lennox-Gastaut syndrome,Approved
RURIOCTOCOG ALFA PEGOL,1417412-83-9,https://drugs.ncats.io/drug/5X3GF74R79,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1417412%2083%209"")",ONLY CAS,Possibly Marketed Outside US 2021,NCT04690322: Phase 4 Interventional Recruiting Hemophilia A,https://clinicaltrials.gov/ct2/show/NCT04690322,,,,,
RUTOSIDE,153-18-4,https://drugs.ncats.io/drug/5G06TVY3R7,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""153%2018%204"")",ONLY CAS,US Previously Marketed 1921,rutin,https://catalog.hathitrust.org/Record/100163146,US Previously Marketed 1921,rutin,https://catalog.hathitrust.org/Record/100163146,Osteoarthritis; Open-angle glaucoma; Postmastectomy lymphoedema of the arm,Approved; Phase II; Approved
RUXOLITINIB,941678-49-5,https://drugs.ncats.io/drug/82S8X8XX8H,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""941678%2049%205"")",ONLY CAS,US Approved Rx 2011,NDA202192,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202192,US Approved Rx 2011,NDA202192,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202192,Primary myelofibrosis; Polycythemia vera,Approved; Approved
SACCHARIN,128-44-9,https://drugs.ncats.io/drug/I4807BK602,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""128%2044%209"")",ONLY CAS,US Previously Marketed 1921,Benzosulphinide U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,US Previously Marketed 1921,Benzosulphinide U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,Unknown,
SACCHAROMYCES CEREVISIAE,554-62-1,https://drugs.ncats.io/drug/GIN46U9Q2Q,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""554%2062%201"")",ONLY CAS,Possibly Marketed Outside US ,"P1P AC Repair Ampoule by Phytos Co., Ltd.",https://www.drugbank.ca/drugs/DB14119,Possibly Marketed Outside US 2002,M020,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4bfbfac7-6738-4996-a152-95dfbd759154,Metabolic syndrome; Acne vulgaris; Hyperpigmentation; Skin Care,Phase II; Phase II; Basic research; Approved
SACROSIDASE,85897-35-4,https://drugs.ncats.io/drug/8A7F670F2Y,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""85897%2035%204"")",ONLY CAS,US Approved Rx 1998,BLA020772,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020772,US Approved Rx 1998,BLA020772,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020772,,
SACUBITRIL,149709-62-6,https://drugs.ncats.io/drug/17ERJ0MKGI,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""149709%2062%206"")",ONLY CAS,US Approved Rx 2015,NDA207620,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207620,US Approved Rx 2015,NDA207620,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207620,Chronic heart failure,Approved
SAFINAMIDE,133865-89-1,https://drugs.ncats.io/drug/90ENL74SIG,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""133865%2089%201"")",ONLY CAS,US Approved Rx 2017,NDA207145,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207145,US Approved Rx 2017,NDA207145,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207145,Parkinson's disease,Approved
SALBUTAMOL,18559-94-9,https://drugs.ncats.io/drug/QF8SVZ843E,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""18559%2094%209"")",ONLY CAS,US Approved Rx 2013,ANDA078171,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=078171,US Approved Rx 1999,NDA020837,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020837,Asthma; Chronic obstructive pulmonary disease,Approved; Approved
SALCAPROZIC ACID,183990-46-7,https://drugs.ncats.io/drug/X88E147FCU,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""183990%2046%207"")",ONLY CAS,Possibly Marketed Outside US 2017,NDA213051,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=27f15fac-7d98-4114-a2ec-92494a91da98,Possibly Marketed Outside US 2017,NDA213051,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=27f15fac-7d98-4114-a2ec-92494a91da98,,
SALCATONIN,9007-12-9,https://drugs.ncats.io/drug/DF35I47HCM,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""9007%2012%209"")",ONLY CAS,Possibly Marketed Outside US 2020,NCT04445857: Phase 4 Interventional Completed Analgesia,https://clinicaltrials.gov/ct2/show/NCT04445857,,,,,
SALICYLAMIDE,65-45-2,https://drugs.ncats.io/drug/EM8BM710ZC,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""65%2045%202"")",ONLY CAS,US Previously Marketed 1943,Salicylamide by Various Mfrs.,DeHaen 1940-1975 NMEs,US Previously Marketed 1943,Salicylamide by Various Mfrs.,DeHaen 1940-1975 NMEs,Arthritis; Common cold,Approved; Approved
SALICYLANILIDE,87-17-2,https://drugs.ncats.io/drug/LHP8NEY345,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""87%2017%202"")",ONLY CAS,US Previously Marketed 1946,Salicylanilide by Various Mfrs.,DeHaen 1940-1975 NMEs,US Previously Marketed 1946,Salicylanilide by Various Mfrs.,DeHaen 1940-1975 NMEs,Tinea capitis,Approved
SALICYLIC ACID,69-72-7,https://drugs.ncats.io/drug/O414PZ4LPZ,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""69%2072%207"")",ONLY CAS,US Approved OTC ,21 CFR 358.110(b) wart remover:collodoin-like vehicle salicylic acid,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec358-110.xml,US Previously Marketed 1860,sodium salicylate,https://catalog.hathitrust.org/Record/100782317,Psoriasis; Ichthyosis vulgaris; Keratosis palmaris; Bruises; Arthritis; Strains and sprains; Simple backache,Approved; Approved; Approved; Approved; Approved; Approved; Approved
SALMETEROL,89365-50-4,https://drugs.ncats.io/drug/2I4BC502BT,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""89365%2050%204"")",ONLY CAS,US Approved Rx 2020,ANDA203433,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203433,US Previously Marketed 1994,SEREVENT by GLAXOSMITHKLINE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020236,Asthma; Exercise-induced bronchospasm; Chronic obstructive pulmonary disease,Approved; Approved; Approved
SALSALATE,552-94-3,https://drugs.ncats.io/drug/V9MO595C9I,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""552%2094%203"")",ONLY CAS,US Previously Marketed ,21 CFR 310.545(a)(23)(i) internal analgesic salsalate,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec310-545.xml,Possibly Marketed Outside US 1995,"Salsalate by Caraco Pharmaceutical Laboratories, Ltd.",https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=90813662-c27e-4541-86a5-70b435533b69,Rheumatoid arthritis; Osteoarthritis; Type 2 diabetes mellitus,Approved; Approved; Phase III
SALVIA OFFICINALIS,8022-56-8,https://drugs.ncats.io/drug/7214ba40,3,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""8022%2056%208"")%20AND%20(root_names_name:""%5ESALVIA%20OFFICINALIS$"")",EXACT NAME,,,,,,,,
SALVIA SCLAREA,84775-83-7,https://drugs.ncats.io/drug/U3HSK5JC0Q,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""84775%2083%207"")",ONLY CAS,Possibly Marketed Outside US 2022,21 CFR 355,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=dc1c793b-b636-f13a-e053-2995a90ace61,Possibly Marketed Outside US 2007,21 CFR 352,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c9096881-929d-4b70-9d60-a40528b74e44,,
SAMARIUM (153SM) LEXIDRONAM,122575-21-7,https://drugs.ncats.io/drug/745X144DZY,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""122575%2021%207"")",ONLY CAS,US Previously Marketed 1997,QUADRAMET by LANTHEUS MEDICAL,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020570,US Previously Marketed 1997,QUADRAMET by LANTHEUS MEDICAL,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020570,Pain relief,Approved
SAMARIUM (153 SM) LEXIDRONAM,122575-21-7,https://drugs.ncats.io/drug/745X144DZY,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""122575%2021%207"")",ONLY CAS,US Previously Marketed 1997,QUADRAMET by LANTHEUS MEDICAL,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020570,US Previously Marketed 1997,QUADRAMET by LANTHEUS MEDICAL,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020570,Pain relief,Approved
SAPROPTERIN,62989-33-7,https://drugs.ncats.io/drug/EGX657432I,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""62989%2033%207"")",ONLY CAS,US Approved Rx 2022,ANDA215420,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215420,US Approved Rx 2007,NDA022181,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022181,Phenylketonuria,Approved
SAQUINAVIR,127779-20-8,https://drugs.ncats.io/drug/L3JE09KZ2F,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""127779%2020%208"")",ONLY CAS,US Previously Marketed 2004,INVIRASE by HOFFMANN-LA ROCHE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021785,US Previously Marketed 1995,Invirase,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=20628,HIV infection,Approved
SARECYCLINE,1035654-66-0,https://drugs.ncats.io/drug/94O110CX2E,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1035654%2066%200"")",ONLY CAS,US Approved Rx 2018,NDA209521,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209521,US Approved Rx 2018,NDA209521,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209521,Inflammatory lesions of non-nodular moderate to severe acne vulgaris,Approved
SARGRAMOSTIM,83869-56-1,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""83869%2056%201"")",ONLY CAS,,,,,,,,
SARILUMAB,1189541-98-7,https://drugs.ncats.io/drug/NU90V55F8I,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1189541%2098%207"")",ONLY CAS,US Approved Rx 2017,BLA761037,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761037,US Approved Rx 2017,BLA761037,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761037,,
SAXAGLIPTIN,361442-04-8,https://drugs.ncats.io/drug/8I7IO46IVQ,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""361442%2004%208"")",ONLY CAS,US Approved Rx 2023,ANDA205972,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205972,US Previously Marketed 2009,Onglyza,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22350,Type 2 diabetes mellitus,Approved
SCARLET RED,85-83-6,https://drugs.ncats.io/drug/I35E9QU96C,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""85%2083%206"")",ONLY CAS,Possibly Marketed Outside US ,Canada:SCARLET RED,https://tripod.nih.gov/npc/#Download,Possibly Marketed Outside US 1962,RED-KOTE Veterinary Scarlet-Red Oil by H. W. Naylor Company Inc.,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=eed276d1-4aea-c7ed-95b7-a03f29a763c0,Lacerations; Slow healing ulcers; Abrasions; Burn,Basic research; Basic research; Basic research; Basic research
SCHISANDRA CHINENSIS,7432-28-2,https://drugs.ncats.io/drug/G01BQC0879,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""7432%2028%202"")",ONLY CAS,,,,,,,Alzheimer’s disease; Drug-induced liver injury; Allergic asthma; Breast cancer,Preclinical; Preclinical; Preclinical; Basic research
SCOPOLAMINE,51-34-3,https://drugs.ncats.io/drug/DL48G20X8X,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""51%2034%203"")",ONLY CAS,US Approved Rx 2020,ANDA212342,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212342,US Previously Marketed 1899,Hyoscine,https://en.wikipedia.org/wiki/Hyoscine,Postoperative nausea and vomiting; Depression; Motion sickness,Approved; Phase IV; Approved
SCROPHULARIA NODOSA,90106-65-3,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""90106%2065%203"")",ONLY CAS,,,,,,,,
SEA SALT,7647-14-5,https://drugs.ncats.io/drug/451W47IQ8X,5,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""7647%2014%205"")",ONLY CAS,US Approved OTC ,21 CFR 349.16 ophthalmic:hypertonic agent sodium chloride,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec349-16.xml,US Previously Marketed 1921,Sodium Chloride U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,,
SEBELIPASE ALFA,1276027-63-4,https://drugs.ncats.io/drug/K4YTU42T8G,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1276027%2063%204"")",ONLY CAS,US Approved Rx 2015,BLA125561,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125561,US Approved Rx 2015,BLA125561,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125561,,
SECBUTABARBITAL,125-40-6,https://drugs.ncats.io/drug/P0078O25A9,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""125%2040%206"")",ONLY CAS,US Previously Marketed 1973,SODIUM BUTABARBITAL by IVAX SUB TEVA PHARMS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=083484,US Previously Marketed 1939,BUTISOL SODIUM by MYLAN SPECIALITY LP,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=000793,Sleeplessness,Approved
SECNIDAZOLE,3366-95-8,https://drugs.ncats.io/drug/R3459K699K,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""3366%2095%208"")",ONLY CAS,US Approved Rx 2017,NDA209363,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209363,US Approved Rx 2017,NDA209363,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209363,Giardiasis; Bacterial vaginosis,Approved; Approved
SECOBARBITAL,76-73-3,https://drugs.ncats.io/drug/1P7H87IN75,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""76%2073%203"")",ONLY CAS,US Previously Marketed 1982,SECOBARBITAL SODIUM by VITARINE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=086273,US Previously Marketed 1929,secobarbital,https://archive.org/details/newnonofficialre39coun,Insomnia; Preoperative sedation,Approved; Approved
SECRETIN,1393-25-5,https://drugs.ncats.io/drug/88C55N56UU,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1393%2025%205"")",ONLY CAS,US Previously Marketed 1981,SECRETIN-FERRING by FERRING,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018290,US Previously Marketed 1981,SECRETIN-FERRING by FERRING,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018290,Exocrine pancreatic insufficiency; Gastrinoma,Approved; Approved
SECUKINUMAB,1229022-83-6,https://drugs.ncats.io/drug/DLG4EML025,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1229022%2083%206"")",ONLY CAS,US Approved Rx 2023,BLA761349,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761349,US Approved Rx 2015,BLA125504,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125504,,
SELEGILINE,14611-51-9,https://drugs.ncats.io/drug/2K1V7GP655,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""14611%2051%209"")",ONLY CAS,US Approved Rx 1997,ANDA074871,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=074871,US Previously Marketed 1989,SELEGILINE HYDROCHLORIDE by SOMERSET,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019334,Bipolar depression; Cognitive disorders; Cocaine-related disorders; Parkinson's disease; Major depressive disorder,Approved; Phase II; Phase III; Approved; Approved
SELENIC ACID,7783-08-6,https://drugs.ncats.io/drug/HV0Y51NC4J,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""7783%2008%206"")",ONLY CAS,Possibly Marketed Outside US ,"Corvita by Trigen Laboratories, LLC",https://www.drugbank.ca/drugs/DB11068,Possibly Marketed Outside US 2011,"Corvita by Trigen Laboratories, LLC",https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c920c091-1eef-49e1-a697-eb5bf6aae145,Liver cirrhosis; Alzheimer’s disease,Not Provided; Basic research
SELENIOUS ACID,7783-00-8,https://drugs.ncats.io/drug/F6A27P4Q4R,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""7783%2000%208"")",ONLY CAS,US Approved Rx 2020,NDA209376,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209376,Possibly Marketed Outside US 1964,NADA030315,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=74620a2d-a633-4af7-9a29-9da71623e450,,
SELENIUM,7782-49-2,https://drugs.ncats.io/drug/H6241UJ22B,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""7782%2049%202"")",ONLY CAS,Possibly Marketed Outside US ,V & M Vitamin and Mineral Supplement by Garden State Nutritionals [Canada],https://www.drugbank.ca/drugs/DB11135,Possibly Marketed Outside US 1996,"Strovite Forte Caplet by Everett Laboratories, Inc.",https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=add96910-9404-48aa-bb3c-945e321a11ab,,
SELENOMETHIONINE,1464-42-2,https://drugs.ncats.io/drug/J9V40V4PKZ,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1464%2042%202"")",ONLY CAS,,,,,,,Lung cancer; Colorectal cancer,Phase II; Phase II
SELENOMETHIONINE (75SE),1187-56-0,https://drugs.ncats.io/drug/P6708E7555,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1187%2056%200"")",ONLY CAS,US Previously Marketed 1976,SELENOMETHIONINE SE 75 by GE HEALTHCARE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017257,US Previously Marketed 1973,SETHOTOPE by BRACCO,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017047,Investigate methionine metabolism,Approved
SELEXIPAG,475086-01-2,https://drugs.ncats.io/drug/5EXC0E384L,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""475086%2001%202"")",ONLY CAS,US Approved Rx 2021,NDA214275,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214275,US Approved Rx 2015,NDA207947,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207947,Pulmonary arterial hypertension,Approved
SEMAGLUTIDE,910463-68-2,https://drugs.ncats.io/drug/53AXN4NNHX,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""910463%2068%202"")",ONLY CAS,US Approved Rx 2020,NDA213182,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213182,US Approved Rx 2017,NDA209637,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209637,Type 2 diabetes mellitus,Approved
SENNA,517-43-1,https://drugs.ncats.io/drug/9VK7V8762D,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""517%2043%201"")",ONLY CAS,Possibly Marketed Outside US ,part334,https://www.drugbank.ca/drugs/DB11365,Possibly Marketed Outside US 1998,21 CFR 334,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c3277678-c1c5-4722-afcc-994f6b6253f6,,
SENNOSIDES A&B,8013-11-4,https://drugs.ncats.io/drug/51e4a495,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""8013%2011%204"")",ONLY CAS,,,,,,,,
SEPIA OFFICINALIS,8049-97-6,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""8049%2097%206"")",ONLY CAS,,,,,,,,
SERINE,56-45-1,https://drugs.ncats.io/drug/452VLY9402,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""56%2045%201"")",ONLY CAS,Possibly Marketed Outside US ,Clinimix by Baxter Laboratories [Canada],https://www.drugbank.ca/drugs/DB00133,Possibly Marketed Outside US 1971,NDA016822,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=aa89dad1-bf4f-4f7e-ad1b-2431bdf36a2d,Hereditary sensory and autonomic neuropathy type 1; Amyotrophic lateral sclerosis; Alzheimer’s disease; Burns,Phase II; Phase II; Phase II; Approved
SERMORELIN,86168-78-7,https://drugs.ncats.io/drug/89243S03TE,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""86168%2078%207"")",ONLY CAS,US Previously Marketed 1997,GEREF by EMD SERONO INC,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020443,US Previously Marketed 1990,GEREF by EMD SERONO,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019863,growth hormone deficiency,Approved
SEROTONIN,50-67-9,https://drugs.ncats.io/drug/333DO1RDJY,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""50%2067%209"")",ONLY CAS,Possibly Marketed Outside US 2021,"NCT04597190: Phase 4 Interventional Active, not recruiting PTSD",https://clinicaltrials.gov/ct2/show/NCT04597190,,,,,
SERTACONAZOLE,99592-32-2,https://drugs.ncats.io/drug/72W71I16EG,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""99592%2032%202"")",ONLY CAS,US Approved Rx 2003,NDA021385,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021385,US Approved Rx 2003,NDA021385,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021385,Interdigital tinea pedis,Approved
SERTRALINE,79617-96-2,https://drugs.ncats.io/drug/QUC7NX6WMB,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""79617%2096%202"")",ONLY CAS,US Approved Rx 2014,ANDA202825,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202825,US Approved Rx 1991,NDA019839,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019839,Phobic disorders; Major depressive disorder; Post-traumatic stress disorder; Premenstrual dysphoric disorder; Panic disorder; Obsessive-compulsive disorder,Approved; Approved; Approved; Approved; Approved; Approved
SEVELAMER,52757-95-6,https://drugs.ncats.io/drug/941N5DUU5C,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""52757%2095%206"")",ONLY CAS,US Approved Rx 2018,ANDA210464,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210464,US Previously Marketed 1998,RENAGEL by GENZYME,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020926,,
SEVOFLURANE,28523-86-6,https://drugs.ncats.io/drug/38LVP0K73A,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""28523%2086%206"")",ONLY CAS,US Approved Rx 2007,ANDA078650,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=078650,US Approved Rx 1995,NDA020478,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020478,Pain,Approved
SHARK CARTILAGE,305838-77-1,https://drugs.ncats.io/drug/D2YCN1I522,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""305838%2077%201"")",ONLY CAS,Possibly Marketed Outside US 2010,21 CFR 348,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f9ef2e9e-8b09-4797-8a14-03cca5bd1059,Possibly Marketed Outside US 2010,21 CFR 348,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f9ef2e9e-8b09-4797-8a14-03cca5bd1059,,
SIAM BENZOIN,119-53-9,https://drugs.ncats.io/drug/L7J6A1NE81,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""119%2053%209"")",ONLY CAS,US Previously Marketed 1921,Benzoin U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,US Previously Marketed 1921,Benzoin U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,Unknown,
SIBUTRAMINE,106650-56-0,https://drugs.ncats.io/drug/WV5EC51866,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""106650%2056%200"")",ONLY CAS,US Previously Marketed 1997,MERIDIA by ABBOTT,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020632,US Previously Marketed 1997,MERIDIA by ABBOTT,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020632,Obesity,Withdrawn
SILDENAFIL,139755-83-2,https://drugs.ncats.io/drug/3M7OB98Y7H,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""139755%2083%202"")",ONLY CAS,US Approved Rx 2013,ANDA078380,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=078380,US Approved Rx 1998,NDA020895,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020895,Erectile dysfunction; Pulmonary arterial hypertension,Approved; Approved
SILICONE OIL,7440-21-3,https://drugs.ncats.io/drug/Z4152N8IUI,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""7440%2021%203"")",ONLY CAS,Possibly Marketed Outside US ,"Calcium Complex High Grade by New Spirit Naturals, Inc. [Canada]",https://www.drugbank.ca/drugs/DB12982,Possibly Marketed Outside US 1996,M005,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2096e241-3ed3-49cd-88c4-71db1fd2934a,Scarring,Approved
SILICON DIOXIDE,7631-86-9,https://drugs.ncats.io/drug/ETJ7Z6XBU4,5,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""7631%2086%209"")%20AND%20(root_names_name:""%5ESILICON%20DIOXIDE$"")",EXACT NAME,US Approved OTC ,21 CFR 332.10 antiflatulent simethicone,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec332-10.xml,US Previously Marketed 1952,Mylicon by Stuart,OB NME Appendix 1950-1985,Pain; Gastrointestinal disorders; Heartburn,Approved; Approved; Approved
SILODOSIN,160970-54-7,https://drugs.ncats.io/drug/CUZ39LUY82,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""160970%2054%207"")",ONLY CAS,US Approved Rx 2018,ANDA210687,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210687,US Approved Rx 2008,NDA022206,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022206,Benign prostatic hyperplasia,Approved
SILTUXIMAB,541502-14-1,https://drugs.ncats.io/drug/T4H8FMA7IM,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""541502%2014%201"")",ONLY CAS,US Approved Rx 2014,BLA125496,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125496,Possibly Marketed Outside US 2014,BLA125496,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=451f535b-8b6b-4ecf-9f19-d921b72eea39,,
SILVER,7440-22-4,https://drugs.ncats.io/drug/3M4G523W1G,2,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""7440%2022%204"")%20AND%20(root_names_name:""%5ESILVER$"")",EXACT NAME,Possibly Marketed Outside US ,Argentyn 23Professionele Eer Professionele Eerste Hulp Zilver Gel by Natural Immunogenics Corp.,https://www.drugbank.ca/drugs/DB12965,Possibly Marketed Outside US 2008,Acne Care Swab Step 1 Clean by Swabplus Inc.,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4e82ba38-c094-42c1-8b5a-10805034bbab,,
SILYBUM MARIANUM,65666-07-1,https://drugs.ncats.io/drug/U946SH95EE,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""65666%2007%201"")",ONLY CAS,Possibly Marketed Outside US ,Milk Thistle Plus Turmeric by Puresource Inc. [Canada],https://www.drugbank.ca/drugs/DB14375,Possibly Marketed Outside US 2010,21 CFR 352,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6d5756fa-02cc-4caf-938d-f3c14f5cbd34,,
SIMEPREVIR,923604-59-5,https://drugs.ncats.io/drug/9WS5RD66HZ,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""923604%2059%205"")",ONLY CAS,US Previously Marketed 2013,OLYSIO by JANSSEN PRODS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205123,US Previously Marketed 2013,OLYSIO by JANSSEN PRODS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205123,Chronic hepatitis C,Approved
SIMETICONE,8050-81-5,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""8050%2081%205"")",ONLY CAS,,,,,,,,
SIMOCTOCOG ALFA,1219013-68-9,https://drugs.ncats.io/drug/U50VWW6XH6,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1219013%2068%209"")",ONLY CAS,Possibly Marketed Outside US ,Nuwiq by Octapharma Pharmazeutika Produktionsges M B H [Canada],https://www.drugbank.ca/drugs/DB09108,Possibly Marketed Outside US 2015,BLA125555,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d6cb51f8-3acd-412c-93ec-41a8017dff3e,,
SIMVASTATIN,79902-63-9,https://drugs.ncats.io/drug/AGG2FN16EV,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""79902%2063%209"")",ONLY CAS,US Approved Rx 2007,ANDA078103,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=078103,US Approved Rx 1991,NDA019766,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019766,Coronary heart disease mortality and cardiovascular events; Hyperlipidemia; Homozygous and heterozygous familial hypercholesterolemia; Unknown,Approved; Approved; Approved
SINCALIDE,25126-32-3,https://drugs.ncats.io/drug/M03GIQ7Z6P,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""25126%2032%203"")",ONLY CAS,US Approved Rx 1976,NDA017697,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017697,US Approved Rx 1976,NDA017697,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017697,Pancreas disorders; Gallbladder disease,Approved; Approved
SINECATECHINS,188265-33-0,https://drugs.ncats.io/drug/T432289GYZ,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""188265%2033%200"")",ONLY CAS,US Approved Rx 2006,NDA021902,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021902,Possibly Marketed Outside US 1992,21 CFR 358A,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=94fc4999-0186-4d3d-91ad-962423ccfb74,,
SIPULEUCEL-T,917381-47-6,https://drugs.ncats.io/drug/8Q622VDR18,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""917381%2047%206"")",ONLY CAS,Possibly Marketed Outside US ,WHO-ATC:L03AX17,https://ginas.ncats.nih.gov/ginas/app/substance/8Q622VDR18,Possibly Marketed Outside US 2010,BLA125197,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8309b497-5d4e-4408-ac0c-2452c11c8a35,,
SIROLIMUS,53123-88-9,https://drugs.ncats.io/drug/W36ZG6FT64,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""53123%2088%209"")",ONLY CAS,US Approved Rx 2020,ANDA208691,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208691,Possibly Marketed Outside US 1999,NDA021083,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3275b824-3f82-4151-2ab2-0036a9ba0acc,Lymphangioleiomyomatosis,Approved
SITAGLIPTIN,486460-32-6,https://drugs.ncats.io/drug/QFP0P1DV7Z,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""486460%2032%206"")",ONLY CAS,US Approved Rx 2007,NDA022044,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022044,US Approved Rx 2006,NDA021995,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21995,Type 2 diabetes mellitus,Approved
SKIN LOTION,69-72-7,https://drugs.ncats.io/drug/O414PZ4LPZ,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""69%2072%207"")",ONLY CAS,US Approved OTC ,21 CFR 358.110(b) wart remover:collodoin-like vehicle salicylic acid,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec358-110.xml,US Previously Marketed 1860,sodium salicylate,https://catalog.hathitrust.org/Record/100782317,Psoriasis; Ichthyosis vulgaris; Keratosis palmaris; Bruises; Arthritis; Strains and sprains; Simple backache,Approved; Approved; Approved; Approved; Approved; Approved; Approved
SODIUM,7440-23-5,https://drugs.ncats.io/drug/9NEZ333N27,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""7440%2023%205"")",ONLY CAS,US Previously Marketed 1921,Sodium Indigotindisulphonate U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,US Previously Marketed 1921,Sodium Indigotindisulphonate U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,,
SODIUM AMIDOTRIZOATE,737-31-5,https://drugs.ncats.io/drug/V5403H8VG7,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""737%2031%205"")",ONLY CAS,US Approved Rx 2022,ANDA214201,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214201,US Previously Marketed 1954,HYPAQUE by GE HEALTHCARE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=009561,Urinary system disease; Gastrointestinal disorders,Approved; Approved
SODIUM OXYBATE,502-85-2,https://drugs.ncats.io/drug/7G33012534,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""502%2085%202"")",ONLY CAS,US Approved Rx 2023,NDA214755,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214755,US Approved Rx 2002,NDA021196,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021196,Narcolepsy,Approved
SOFOSBUVIR,1190307-88-0,https://drugs.ncats.io/drug/WJ6CA3ZU8B,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1190307%2088%200"")",ONLY CAS,US Approved Rx 2016,NDA208341,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208341,US Approved Rx 2013,NDA204671,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204671,Chronic hepatitis C,Approved
SOFT LENS SOLUTIONS,67-63-0,https://drugs.ncats.io/drug/ND2M416302,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""67%2063%200"")",ONLY CAS,US Approved OTC ,21 CFR 344.12 otic:ear drying aid isopropyl alcohol,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec344-12.xml,US Previously Marketed 1921,Rubbing Alcohol,https://books.google.com/books?id=1n4gAQAAMAAJ&newbks=1&newbks_redir=0&dq=alcohol%20rubbing%20usp&pg=PA85#v=onepage&q=alcohol%20rubbing%20usp&f=false,,
SOFT SOAP,3380-34-5,https://drugs.ncats.io/drug/4NM5039Y5X,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""3380%2034%205"")",ONLY CAS,US Previously Marketed 1997,COLGATE TOTAL by COLGATE PALMOLIVE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020231,US Previously Marketed 1969,P-300 Antibacterial by Colgate-Palmolive,OB NME Appendix 1950-1993,Bacterial infections,Approved
SOLIFENACIN,242478-37-1,https://drugs.ncats.io/drug/A8910SQJ1U,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""242478%2037%201"")",ONLY CAS,US Approved Rx 2024,ANDA204374,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204374,US Approved Rx 2004,NDA021518,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021518,"Overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency",Approved
SOMATROPIN,1338578-34-9,https://drugs.ncats.io/drug/8FOJ430U94,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1338578%2034%209"")",ONLY CAS,US Approved Rx 2020,BLA761156,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761156,US Approved Rx 2020,BLA761156,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761156,,
SONIDEGIB,956697-53-3,https://drugs.ncats.io/drug/0RLU3VTK5M,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""956697%2053%203"")",ONLY CAS,US Approved Rx 2015,NDA205266,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205266,US Approved Rx 2015,NDA205266,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205266,Basal cell carcinoma,Approved
SORAFENIB,284461-73-0,https://drugs.ncats.io/drug/9ZOQ3TZI87,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""284461%2073%200"")",ONLY CAS,US Approved Rx 2022,ANDA216073,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216073,US Approved Rx 2005,NDA021923,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021923,Hepatocellular carcinoma; Renal cell carcinoma; Differentiated thyroid carcinoma,Approved; Approved; Approved
SORBIC ACID,110-44-1,https://drugs.ncats.io/drug/X045WJ989B,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""110%2044%201"")",ONLY CAS,Possibly Marketed Outside US 1966,NDA012750,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e9bae0d9-c2d9-49bd-92d4-a90281f35540,Possibly Marketed Outside US 1952,NDA008697,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9ce19944-dd88-4a7b-84ca-b07f4ec23bad,Acne,Approved
SORBINICATE,6184-06-1,https://drugs.ncats.io/drug/38Y76163XT,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""6184%2006%201"")",ONLY CAS,Clinical ,INN:sorbinicate,https://tripod.nih.gov/npc/#Download,,,,,
SORBITAN,12441-09-7,https://drugs.ncats.io/drug/6O92ICV9RU,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""12441%2009%207"")",ONLY CAS,Possibly Marketed Outside US 2012,"TL-Select DHA by Trigen Laboratories, Inc.",https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c0e91f52-a38e-4f8a-acd3-d229e4eaf299,Possibly Marketed Outside US 1986,NDA019600,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ae951dc4-9031-43bf-943c-cb2366951f23,,
SORBITAN OLEATE,1338-43-8,https://drugs.ncats.io/drug/06XEA2VD56,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1338%2043%208"")",ONLY CAS,Possibly Marketed Outside US 2009,21 CFR 333C,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fb58c46f-d405-4b45-b947-39f177624df5,Possibly Marketed Outside US 1972,ANDA061621,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e142a363-a8b8-40b9-ae9d-28777367e718,,
SORBITOL,50-70-4,https://drugs.ncats.io/drug/506T60A25R,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""50%2070%204"")",ONLY CAS,US Approved Rx 2020,NDA202049,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202049,Possibly Marketed Outside US 1955,Levsin by Alaven Pharmaceutical LLC,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=32388e18-08de-455c-aad4-9c2264435f0f,Constipation; End-Stage Renal Disease; Cystic fibrosis; Asthma; Acute renal failure; Elevated intraocular pressure; Cerebral edema,Basic research; Approved; Approved; Approved; Approved; Approved; Approved
SOTALOL,3930-20-9,https://drugs.ncats.io/drug/A6D97U294I,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""3930%2020%209"")",ONLY CAS,US Approved Rx 2001,ANDA075500,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=075500,US Approved Rx 1992,NDA019865,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019865,Atrial fibrillation; Atrial flutter; Ventricular arrhythmia,Approved; Approved; Approved
SOYA LECITHIN,8030-76-0,https://drugs.ncats.io/drug/1DI56QDM62,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""8030%2076%200"")",ONLY CAS,Possibly Marketed Outside US ,IQQU Acne Serum by Iqqu Usa Co.,https://www.drugbank.ca/drugs/DB14161,Possibly Marketed Outside US 1996,ANDA091226,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d0a0feb6-84f0-4693-a11f-eb4f7ae0a87d,hypertension,Preclinical
SPARFLOXACIN,110871-86-8,https://drugs.ncats.io/drug/Q90AGA787L,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""110871%2086%208"")",ONLY CAS,US Previously Marketed 1996,ZAGAM by MYLAN,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020677,US Previously Marketed 1996,ZAGAM by MYLAN,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020677,Chronic bronchitis; Community-acquired pneumonia,Approved; Approved
SPECTINOMYCIN,1695-77-8,https://drugs.ncats.io/drug/93AKI1U6QF,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1695%2077%208"")",ONLY CAS,US Previously Marketed 1971,Trobicin by Upjohn,OB NME Appendix 1950-1993,US Previously Marketed 1971,Trobicin by Upjohn,OB NME Appendix 1950-1993,Acute gonorrheal urethritis; Acute gonorrheal urethritis; Acute gonorrheal urethritis,Approved; Approved; Approved
SPIGELIA ANTHELMIA,84961-60-4,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""84961%2060%204"")",ONLY CAS,,,,,,,,
SPINOSAD,168316-95-8,https://drugs.ncats.io/drug/XPA88EAP6V,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""168316%2095%208"")",ONLY CAS,US Approved Rx 2011,NDA022408,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022408,US Approved Rx 2011,NDA022408,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022408,Pediculosis,Approved
SPIRONOLACTONE,52-01-7,https://drugs.ncats.io/drug/27O7W4T232,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""52%2001%207"")",ONLY CAS,US Approved Rx 2016,ANDA203512,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203512,US Approved Rx 1960,NDA012151,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=012151,Essential hypertension; Discrete aldosterone-producing adrenal adenomas; Congestive heart failure,Approved; Approved; Approved
SPIRULINA,112-80-1,https://drugs.ncats.io/drug/2UMI9U37CP,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""112%2080%201"")",ONLY CAS,US Previously Marketed 1921,Oleic Acid U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,US Previously Marketed 1921,Oleic Acid U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,Obesity; Colorectal cancer; Type 2 diabetes mellitus; Atherosclerosis; Unknown,Phase I; Phase II; Phase I; Phase I
SQUALANE,111-01-3,https://drugs.ncats.io/drug/GW89575KF9,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""111%2001%203"")",ONLY CAS,Possibly Marketed Outside US ,"WELLAGE Deep Layer Silky Facial Oil by Hugel Pharma Co.,Ltd.",https://www.drugbank.ca/drugs/DB11420,Possibly Marketed Outside US 1990,M017,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=789a6669-3320-4558-8d6f-ab255db50d8d,Sunburn,Approved
SQUALENE,111-02-4,https://drugs.ncats.io/drug/7QWM220FJH,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""111%2002%204"")",ONLY CAS,Possibly Marketed Outside US 2015,BLA125510,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=05be1932-bb7a-4e3a-9200-4ccdc5565edc,Possibly Marketed Outside US 2002,21 CFR 352,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=172ce1b6-4f93-4f2e-95f7-7315a5f2b6fd,Hypercholesterolemia; Obesity; Cancer; Hypertension,Phase I; Preclinical; Preclinical; Preclinical
SQUARIC ACID DIBUTYL ESTER,2892-62-8,https://drugs.ncats.io/drug/4RTO57VG65,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""2892%2062%208"")",ONLY CAS,US Previously Marketed 2019,squaric acid dibutyl ester,https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-216/subpart-B/section-216.23,US Previously Marketed 2019,squaric acid dibutyl ester,https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-216/subpart-B/section-216.23,,
STANOZOLOL,302-96-5,https://drugs.ncats.io/drug/4R1VB9P8V3,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""302%2096%205"")",ONLY CAS,US Previously Marketed 1962,WINSTROL by LUNDBECK INC,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=012885,US Previously Marketed 1962,WINSTROL by LUNDBECK INC,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=012885,Angioedema,Approved
STARCH,9005-25-8,https://drugs.ncats.io/drug/O8232NY3SJ,11,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""9005%2025%208"")%20AND%20(root_names_name:""%5ESTARCH"")",APPROXIMATE NAME,US Approved OTC ,21 CFR 346.14(a)(9) anorectal:protectant topical starch,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec346-14.xml,Possibly Marketed Outside US 1955,Levsin by Alaven Pharmaceutical LLC,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=32388e18-08de-455c-aad4-9c2264435f0f,,
STAVUDINE,3056-17-5,https://drugs.ncats.io/drug/BO9LE4QFZF,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""3056%2017%205"")",ONLY CAS,US Previously Marketed 2007,LAMIVUDINE; STAVUDINE by MATRIX LABS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022085,US Previously Marketed 1994,ZERIT by BRISTOL,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020412,HIV-1 infection,Approved
STEARIC ACID,57-11-4,https://drugs.ncats.io/drug/4ELV7Z65AP,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""57%2011%204"")",ONLY CAS,US Previously Marketed 1921,Stearic Acid U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,US Previously Marketed 1921,Stearic Acid U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,Sunburn; Skin Diseases; Type 2 diabetes mellitus; Diabetic foot; Dyslipidemia,Approved; Approved; Phase I; Phase I; Phase I
STEARIN,555-43-1,https://drugs.ncats.io/drug/P6OCJ2551R,2,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""555%2043%201"")",ONLY CAS,Possibly Marketed Outside US 2013,MIF900014,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=75cda3a3-50dd-4eaa-85cb-92fa7bf38e72,Possibly Marketed Outside US 1993,ANDA074091,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=82e65393-25b7-4114-9c71-5840ee8bad84,,
STELLARIA MEDIA,90131-34-3,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""90131%2034%203"")",ONLY CAS,,,,,,,,
STERCULIA GUM,9000-36-6,https://drugs.ncats.io/drug/73W9IQY50Q,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""9000%2036%206"")",ONLY CAS,US Approved Allergenic Extract 1965,BLA103753,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=721936bc-3d1f-4be5-bb4a-9c87898aff37,US Approved Allergenic Extract 1965,BLA103753,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=721936bc-3d1f-4be5-bb4a-9c87898aff37,,
STEVIA REBAUDIANA,58543-16-1,https://drugs.ncats.io/drug/B3FUD0528F,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""58543%2016%201"")",ONLY CAS,Possibly Marketed Outside US 2018,21 CFR 334,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0effa2f8-b1ee-4963-a2aa-20832703fc4e,Possibly Marketed Outside US 2015,21 CFR 341,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6d82469b-d51c-4824-9830-6c1874ad4fe4,,
STEVIOSIDE,57817-89-7,https://drugs.ncats.io/drug/0YON5MXJ9P,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""57817%2089%207"")",ONLY CAS,Possibly Marketed Outside US 2016,21 CFR 352,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2fd24cc7-5007-1117-e054-00144ff88e88,Possibly Marketed Outside US 2013,21 CFR 355,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d6adca01-eb68-46e3-b988-654baf046a6e,Cancer; Hypertension; Dental caries,Basic research; Phase I; Phase II
STIGMASTEROL,83-48-7,https://drugs.ncats.io/drug/99WUK5D0Y8,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""83%2048%207"")",ONLY CAS,Clinical ,Br J Nutr. Nov 2008;100(5):937-41.: Not Applicable Human clinical trial Completed  Hypercholesterolemia/metabolism,https://dx.doi.org/10.1017/s0007114508966113,,,,Unknown,
STOMACH,34552-83-5,https://drugs.ncats.io/drug/77TI35393C,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""34552%2083%205"")",ONLY CAS,US Approved Rx 2021,ANDA215579,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215579,US Previously Marketed 1976,IMODIUM by J AND J CONSUMER INC,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017690,Diarrhea,Approved
STREPTOKINASE,9002-01-1,https://drugs.ncats.io/drug/8X1OXL3SNU,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""9002%2001%201"")",ONLY CAS,Possibly Marketed Outside US ,Canada:STREPTOKINASE,https://tripod.nih.gov/npc/#Download,,,,,
STREPTOMYCIN,57-92-1,https://drugs.ncats.io/drug/Y45QSO73OB,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""57%2092%201"")",ONLY CAS,US Approved Rx 1998,ANDA064210,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=064210,US Previously Marketed 1946,STREPTOMYCIN SULFATE by PFIZER,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=060076,Tularemia; Chancroid; Tuberculosis; Plague,Approved; Approved; Approved; Approved
STREPTONIAZID,4480-58-4,https://drugs.ncats.io/drug/IAB9JFQ8U2,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""4480%2058%204"")",ONLY CAS,Clinical ,INN:streptoniazid,https://tripod.nih.gov/npc/#Download,,,,,
STREPTOZOCIN,18883-66-4,https://drugs.ncats.io/drug/5W494URQ81,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""18883%2066%204"")",ONLY CAS,US Approved Rx 1982,NDA050577,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050577,US Approved Rx 1982,NDA050577,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050577,Malignant neoplasms of pancreas (metastatic islet cell carcinoma),Approved
STRONTIUM,7440-24-6,https://drugs.ncats.io/drug/YZS2RPE8LE,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""7440%2024%206"")",ONLY CAS,Possibly Marketed Outside US 2012,21 CFR 352,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=86f0e36e-e824-483a-9a53-3b20cf109844,Possibly Marketed Outside US 2012,21 CFR 352,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=86f0e36e-e824-483a-9a53-3b20cf109844,,
SUCCIMER,304-55-2,https://drugs.ncats.io/drug/DX1U2629QE,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""304%2055%202"")",ONLY CAS,US Approved Rx 1991,NDA019998,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019998,Possibly Marketed Outside US 1982,NDA214993,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ddd90c4a-5792-49c9-837f-710d1a604742,Lead poisoning in children,Approved
SUCCINIC ACID,110-15-6,https://drugs.ncats.io/drug/AB6MNQ6J6L,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""110%2015%206"")",ONLY CAS,US Previously Marketed 1921,sodium succinate,https://catalog.hathitrust.org/Record/100163146,US Previously Marketed 1921,sodium succinate,https://catalog.hathitrust.org/Record/100163146,Hypertension; Gastrointestinal infections; Overactive bladder,Approved; Not Provided; Approved
SUCRALFATE,54182-58-0,https://drugs.ncats.io/drug/XX73205DH5,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""54182%2058%200"")",ONLY CAS,US Approved Rx 2022,ANDA215576,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215576,US Approved Rx 1981,NDA018333,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018333,Ulcer,Approved
SUCRALOSE,56038-13-2,https://drugs.ncats.io/drug/96K6UQ3ZD4,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""56038%2013%202"")",ONLY CAS,Possibly Marketed Outside US 2008,21 CFR 334,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d96986dd-eab8-4025-9987-77deb208972e,Possibly Marketed Outside US 2006,Antiseptic Rinse by Meijer,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f6c5d4cd-6d6f-4efa-b455-3a9f3b2aab34,Glucose Metabolism Disorders; Diarrhea; Gingivitis,Approved; Approved; Approved
SUCROSE,57-50-1,https://drugs.ncats.io/drug/C151H8M554,3,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""57%2050%201"")%20AND%20(root_names_name:""%5ESUCROSE$"")",EXACT NAME,US Previously Marketed 1921,Sugar U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,US Previously Marketed 1921,Sugar U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,Pain,Natural Metabolite
SUFENTANIL,56030-54-7,https://drugs.ncats.io/drug/AFE2YW0IIZ,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""56030%2054%207"")",ONLY CAS,US Approved Rx 2018,NDA209128,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209128,US Approved Rx 1984,NDA019050,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019050,Pain,Approved
SUGAMMADEX,343306-71-8,https://drugs.ncats.io/drug/361LPM2T56,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""343306%2071%208"")",ONLY CAS,US Approved Rx 2015,NDA022225,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022225,US Approved Rx 2015,NDA022225,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022225,Neuromuscular blockade,Approved
SULBACTAM,68373-14-8,https://drugs.ncats.io/drug/S4TF6I2330,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""68373%2014%208"")",ONLY CAS,US Approved Rx 2023,NDA216974,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216974,US Approved Rx 1986,NDA050608,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050608,Staphylococcus aureus (beta-lactamase and non-beta-lactamase producing); Staphylococcus epidermidis (beta-lactamase and non-beta-lactamase producing); Moraxella (Branhamella) catarrhalis (beta-lactamase and non-beta-lactamase producing); Bacterial infections; Peptostreptococcus species; Hemophilus influenzae  (beta-lactamase and non-beta-lactamase producing),Approved; Approved; Approved; Approved; Approved; Approved
SULCONAZOLE,61318-90-9,https://drugs.ncats.io/drug/5D9HAA5Q5S,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""61318%2090%209"")",ONLY CAS,US Approved Rx 1985,NDA018738,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018738,US Approved Rx 1985,NDA018738,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018738,Tinea Corporis; Tinea cruris; Athlete’s foot,Approved; Approved; Approved
SULFABENZAMIDE,127-71-9,https://drugs.ncats.io/drug/G58F8OPL4I,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""127%2071%209"")",ONLY CAS,US Previously Marketed 1985,TRIPLE SULFA by PHARMADERM,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=088462,US Previously Marketed 1945,SULTRIN by ORTHO MCNEIL PHARM,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=005794,Vaginitis caused by Gardnerella vaginalis,Approved
SULFACETAMIDE,144-80-9,https://drugs.ncats.io/drug/4965G3J0F5,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""144%2080%209"")",ONLY CAS,US Approved Rx 1994,ANDA040066,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=040066,US Previously Marketed 1941,Sulamyd by Schering,DeHaen 1940-1975 NMEs,Eye infections; Acne vulgaris,Approved; Approved
SULFADIAZINE,68-35-9,https://drugs.ncats.io/drug/0N7609K889,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""68%2035%209"")",ONLY CAS,US Approved Rx 1994,ANDA040091,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=040091,US Previously Marketed 1941,Sulfadiazine Sodium by DeHaen 1940-1975 NMEs,*!,Toxoplasmosis encephalitis; Urinary tract infections; Malaria,Approved; Approved; Approved
SULFADOXINE,2447-57-6,https://drugs.ncats.io/drug/88463U4SM5,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""2447%2057%206"")",ONLY CAS,US Previously Marketed 1981,FANSIDAR by ROCHE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018557,US Previously Marketed 1981,FANSIDAR by ROCHE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018557,Plasmodium falciparum malaria,Approved
SULFAFURAZOLE,127-69-5,https://drugs.ncats.io/drug/740T4C525W,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""127%2069%205"")",ONLY CAS,US Previously Marketed 1949,Gantrisin by Hoffmann-La Roche,DeHaen 1940-1975 NMEs,US Previously Marketed 1948,GANTRISIN by ROCHE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=006525,Acute otitis media,Approved
SULFAMETHIZOLE,144-82-1,https://drugs.ncats.io/drug/25W8454H16,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""144%2082%201"")",ONLY CAS,US Previously Marketed 1961,THIOSULFIL SULFAMETHIZOLE by AYER5T,https://patents.google.com/patent/US20170253372A1/en,US Previously Marketed 1953,THIOSULFIL by WYETH AYERST,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=008565,Urinary tract infections,Approved
SULFAMETHOXAZOLE,723-46-6,https://drugs.ncats.io/drug/JE42381TNV,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""723%2046%206"")",ONLY CAS,US Approved Rx 2019,ANDA212231,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212231,US Previously Marketed 1961,GANTANOL by ROCHE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=012715,Shigellosis; Pneumocystis jiroveci pneumonia; Urinary tract infections; Travelers’ diarrhea; Acute exacerbations of chronic bronchitis in adults; Acute otitis media,Approved; Approved; Approved; Approved; Approved; Approved
SULFANILAMIDE,63-74-1,https://drugs.ncats.io/drug/21240MF57M,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""63%2074%201"")",ONLY CAS,US Previously Marketed 1965,AVC by MYLAN SPECIALITY LP,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=006530,US Previously Marketed 1936,sulfanilamide,https://archive.org/details/newnonofficialre39coun,Vulvovaginal candidiasis,Approved
SULFAPYRIDINE,144-83-2,https://drugs.ncats.io/drug/Y5V2N1KE8U,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""144%2083%202"")",ONLY CAS,US Previously Marketed 1938,M&B 693 by May & Baker,https://books.google.com/books?id=AqzmCwAAQBAJ&lpg=PA9&ots=WuZEH-OpEK&dq=sulfapyridine%20introduced%20to%20the%20US&pg=PA9#v=onepage&q=sulfapyridine%20introduced%20to%20the%20US&f=false,US Previously Marketed 1938,M&B 693 by May & Baker,https://books.google.com/books?id=AqzmCwAAQBAJ&lpg=PA9&ots=WuZEH-OpEK&dq=sulfapyridine%20introduced%20to%20the%20US&pg=PA9#v=onepage&q=sulfapyridine%20introduced%20to%20the%20US&f=false,Dermatitis herpetiformis,Approved
SULFASALAZINE,599-79-1,https://drugs.ncats.io/drug/3XC8GUZ6CB,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""599%2079%201"")",ONLY CAS,US Approved Rx 1977,ANDA085828,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=085828,US Approved Rx 1950,NDA007073,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=007073,Rheumatoid arthritis; Ulcerative colitis,Approved; Approved
SULFATHIAZOLE,72-14-0,https://drugs.ncats.io/drug/Y7FKS2XWQH,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""72%2014%200"")",ONLY CAS,US Previously Marketed 1985,TRIPLE SULFA by FOUGERA,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=088463,US Previously Marketed 1940,Sulfathiazole by Winthrop,https://books.google.com/books?id=pm9KAQAAIAAJ&lpg=PA470&ots=aA7IeOI1kb&dq=cyverine%20suspended&pg=PA470#v=onepage&q=cyverine%20suspended&f=false,Vaginal infections,Approved
SULFINPYRAZONE,57-96-5,https://drugs.ncats.io/drug/V6OFU47K3W,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""57%2096%205"")",ONLY CAS,US Previously Marketed 1959,ANTURANE by NOVARTIS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=011556,US Previously Marketed 1959,ANTURANE by NOVARTIS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=011556,Gouty arthritis,Approved
SULFOGAIACOL,7134-11-4,https://drugs.ncats.io/drug/6L00O0WHZR,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""7134%2011%204"")",ONLY CAS,Clinical ,INN:sulfogaiacol [INN],https://ginas.ncats.nih.gov/ginas/app/substance/6L00O0WHZR,,,,Common cold; Asthma; Respiratory infections,Not Provided; Not Provided; Not Provided
SULFUR,7704-34-9,https://drugs.ncats.io/drug/70FD1KFU70,4,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""7704%2034%209"")%20AND%20(root_names_name:""%5ESULFUR$"")",EXACT NAME,US Approved OTC ,21 CFR 358.710(a)(7) dandruff:dandruff sulfur,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec358-710.xml,US Previously Marketed 1921,Washed Sulphur U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,Scalp itching and flaking,Approved
SULFURIC ACID,7664-93-9,https://drugs.ncats.io/drug/O40UQP6WCF,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""7664%2093%209"")",ONLY CAS,US Approved Rx 2023,ANDA215469,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215469,US Previously Marketed 1921,Potassium Sulphate N.F.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,Bowel Cleanser,Approved
SULFUR HEXAFLUORIDE,2551-62-4,https://drugs.ncats.io/drug/WS7LR3I1D6,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""2551%2062%204"")",ONLY CAS,US Approved Rx 2014,NDA203684,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203684,US Approved Rx 2014,NDA203684,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203684,Vesicoureteral reflux; Heart Disease; Focal liver lesions,Approved; Approved; Approved
SULINDAC,38194-50-2,https://drugs.ncats.io/drug/184SNS8VUH,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""38194%2050%202"")",ONLY CAS,US Approved Rx 1991,ANDA072050,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=072050,US Previously Marketed 1978,CLINORIL by MERCK,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017911,Ankylosing spondylitis; Osteoarthritis; Rheumatoid arthritis,Approved; Approved; Approved
SULPHAN BLUE,68238-36-8,https://drugs.ncats.io/drug/39N9K8S2A4,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""68238%2036%208"")",ONLY CAS,US Approved Rx 2021,ANDA213130,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213130,US Previously Marketed 1981,LYMPHAZURIN by COVIDIEN,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018310,Lymphatic vessel delineation,Approved
SUMATRIPTAN,103628-46-2,https://drugs.ncats.io/drug/8R78F6L9VO,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""103628%2046%202"")",ONLY CAS,US Approved Rx 2009,ANDA079123,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=079123,US Approved Rx 1992,NDA020080,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020080,Cluster headache; Migraine without aura; Migraine with aura,Approved; Approved; Approved
SUNITINIB,557795-19-4,https://drugs.ncats.io/drug/V99T50803M,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""557795%2019%204"")",ONLY CAS,US Approved Rx 2023,ANDA218012,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218012,US Approved Rx 2006,NDA021968,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021968,Gastrointestinal stromal tumor; Advanced renal cell carcinoma; Pancreatic neuroendocrine tumors,Approved; Approved; Approved
SUPROFEN,40828-46-4,https://drugs.ncats.io/drug/988GU2F9PE,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""40828%2046%204"")",ONLY CAS,US Previously Marketed 1985,Suprol by Ortho,OB NME Appendix 1950-1993,US Previously Marketed 1985,Suprol by Ortho,OB NME Appendix 1950-1993,Intraoperative miosis,Approved
SUSOCTOCOG ALFA,1339940-90-7,https://drugs.ncats.io/drug/6892UQT2GK,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1339940%2090%207"")",ONLY CAS,Possibly Marketed Outside US ,EU/1/15/1035/003,https://www.drugbank.ca/drugs/DB11606,Possibly Marketed Outside US 2014,BLA125512,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a69ccbb3-7648-4978-8c6d-7ca6b95a9b01,,
SUVOREXANT,1030377-33-3,https://drugs.ncats.io/drug/081L192FO9,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1030377%2033%203"")",ONLY CAS,US Approved Rx 2014,NDA204569,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204569,US Approved Rx 2014,NDA204569,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204569,Sleep-onset insomnia,Approved
SUXAMETHONIUM,306-40-1,https://drugs.ncats.io/drug/J2R869A8YF,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""306%2040%201"")",ONLY CAS,US Approved Rx 2021,NDA215143,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215143,US Approved Rx 1952,NDA008453,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=008453,Skeletal muscle relaxation,Approved
SYNTHETIC SPONGE,1332-37-2,https://drugs.ncats.io/drug/1K09F3G675,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1332%2037%202"")",ONLY CAS,US Approved OTC ,21 CFR 347.10(c) skin protectant calamine,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec347-10.xml,US Previously Marketed 1921,Saccharated Ferric Oxide N.F.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,Iron deficiency anemia; Radioactive cesium and/or radioactive or non-radioactive thallium internal contamination; Pain; Unknown; Chronic kidney disease; Unknown; Unknown; Unknown; Dental diseases; Parenteral Nutrition; Iron deficiency,Approved; Approved; Approved; Approved; Basic research; Approved; Approved
SYSTEMIC ANALGESICS,2016-63-9,https://drugs.ncats.io/drug/ZTY15D026H,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""2016%2063%209"")",ONLY CAS,Possibly Marketed Outside US ,WHO-ATC:R03DA08,https://ginas.ncats.nih.gov/ginas/app/substance/ZTY15D026H,,,,,
TACRINE,321-64-2,https://drugs.ncats.io/drug/4VX7YNB537,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""321%2064%202"")",ONLY CAS,US Previously Marketed 1993,COGNEX by SHIONOGI INC,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020070,US Previously Marketed 1993,COGNEX by SHIONOGI INC,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020070,Alzheimer’s disease,Approved
TACROLIMUS,104987-11-3,https://drugs.ncats.io/drug/Y5L2157C4J,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""104987%2011%203"")",ONLY CAS,US Approved Rx 1994,NDA050708,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050708,US Approved Rx 1994,NDA050708,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050708,Organ rejection; Atopic dermatitis,Approved; Phase III
TADALAFIL,171596-29-5,https://drugs.ncats.io/drug/742SXX0ICT,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""171596%2029%205"")",ONLY CAS,US Approved Rx 2019,ANDA206285,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206285,US Approved Rx 2003,NDA021368,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021368,Benign prostatic hyperplasia; Erectile dysfunction,Approved; Approved
TAFENOQUINE,106635-80-7,https://drugs.ncats.io/drug/262P8GS9L9,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""106635%2080%207"")",ONLY CAS,,,,,,,Malaria,Approved
TAFLUPROST,209860-87-7,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""209860%2087%207"")",ONLY CAS,,,,,,,,
TAGRAXOFUSP,2055491-00-2,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""2055491%2000%202"")",ONLY CAS,,,,,,,,
TALAZOPARIB,1207456-01-6,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1207456%2001%206"")",ONLY CAS,,,,,,,,
TALC,308076-02-0,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""308076%2002%200"")",ONLY CAS,,,,,,,,
TALIGLUCERASE ALFA,37228-64-1,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""37228%2064%201"")",ONLY CAS,,,,,,,,
TALIMOGENE LAHERPAREPVEC,1187560-31-1,https://drugs.ncats.io/drug/07730V90L6,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1187560%2031%201"")%20AND%20(root_names_name:""%5ETALIMOGENE%20LAHERPAREPVEC"")",APPROXIMATE NAME,Possibly Marketed Outside US ,WHO-ATC:L01XX51,https://ginas.ncats.nih.gov/ginas/app/substance/07730V90L6,Possibly Marketed Outside US 2015,BLA125518,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=64ffb680-ea8c-42fc-9649-9e8c0eb77ddb,,
TAMOXIFEN,10540-29-1,https://drugs.ncats.io/drug/094ZI81Y45,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""10540%2029%201"")",ONLY CAS,US Approved Rx 2005,NDA021807,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021807,US Previously Marketed 1977,NOLVADEX by ASTRAZENECA,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017970,Reduction in breast cancer incidence; Breast cancer; Ductal carcinoma in situ,Approved; Approved; Approved
TAMSULOSIN,106133-20-4,https://drugs.ncats.io/drug/G3P28OML5I,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""106133%2020%204"")",ONLY CAS,US Approved Rx 2013,ANDA202433,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202433,US Approved Rx 1997,NDA020579,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020579,Benign prostatic hyperplasia,Approved
TANNIC ACID,1401-55-4,https://drugs.ncats.io/drug/28F9E0DJY6,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1401%2055%204"")",ONLY CAS,US Previously Marketed 1921,Tannic Acid U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,US Previously Marketed 1921,Tannic Acid U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,Alzheimer’s disease; Pain; Addisonian anemia,Preclinical; Not Provided; Approved
TAPENTADOL,175591-23-8,https://drugs.ncats.io/drug/H8A007M585,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""175591%2023%208"")",ONLY CAS,US Approved Rx 2008,NDA022304,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022304,US Approved Rx 2008,NDA022304,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022304,Pain,Approved
TARTARIC ACID,526-83-0,https://drugs.ncats.io/drug/W4888I119H,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""526%2083%200"")",ONLY CAS,US Approved OTC ,21 CFR 331.11(m) antacid:tartrate-containing tartrate (acid or salt),https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec331-11.xml,US Previously Marketed 1921,Tartaric Acid U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,skin cleasing,Approved
TARTRAZINE,12225-21-7,https://drugs.ncats.io/drug/JQ6BLH9FR7,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""12225%2021%207"")",ONLY CAS,Possibly Marketed Outside US 2023,NDA216956,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=65171e4a-d136-4abc-b08c-c40c1b486ff6,Possibly Marketed Outside US 2018,21 CFR 331,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3495102f-55d2-4a94-8d55-f46f49e00c27,,
TASIMELTEON,609799-22-6,https://drugs.ncats.io/drug/SHS4PU80D9,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""609799%2022%206"")",ONLY CAS,US Approved Rx 2023,ANDA211654,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211654,US Approved Rx 2014,NDA205677,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205677,"Sleep disorders, circadian rhythm",Approved
TAURINE,107-35-7,https://drugs.ncats.io/drug/1EQV5MLY3D,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""107%2035%207"")",ONLY CAS,Possibly Marketed Outside US ,Smofkabiven Electrolyte Free by Fresenius Kabi [Canada],https://www.drugbank.ca/drugs/DB01956,Possibly Marketed Outside US 1984,NDA019018,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1d88fbe0-eb97-4964-8a78-88940064f8f0,Prehypertension; Fatigue; Hepatitis; Congestive heart failure; Psychotic disorder,Phase III; Approved; Approved; Approved; Phase III
TAUROCHOLIC ACID,81-24-3,https://drugs.ncats.io/drug/5E090O0G3Z,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""81%2024%203"")",ONLY CAS,Possibly Marketed Outside US ,Regubil by Laboratoire Riva Inc [Canada],https://www.drugbank.ca/drugs/DB04348,,,,Type 2 diabetes mellitus; Obesity,Phase II; Phase II
TAVABOROLE,174671-46-6,https://drugs.ncats.io/drug/K124A4EUQ3,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""174671%2046%206"")",ONLY CAS,US Approved Rx 2020,ANDA212256,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212256,US Approved Rx 2014,NDA204427,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204427,Onychomycosis,Approved
TAZAROTENE,118292-40-3,https://drugs.ncats.io/drug/81BDR9Y8PS,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""118292%2040%203"")",ONLY CAS,US Approved Rx 2019,NDA211882,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211882,US Approved Rx 1997,NDA020600,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020600,Facial acne vulgaris; Plaque psoriasis; Unknown,Approved; Approved
TAZOBACTAM,89786-04-9,https://drugs.ncats.io/drug/SE10G96M8W,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""89786%2004%209"")",ONLY CAS,US Approved Rx 2010,ANDA065362,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=065362,US Previously Marketed 1993,ZOSYN by WYETH PHARMS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050684,Female pelvic infections; Skin and skin structure infections; Pneumonia; Intra-abdominal infections; Complicated urinary tract infections,Approved; Approved; Approved; Approved; Approved
TEAR TEST,532-27-4,https://drugs.ncats.io/drug/88B5039IQG,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""532%2027%204"")",ONLY CAS,,,,,,,,
TEDIZOLID,856866-72-3,https://drugs.ncats.io/drug/97HLQ82NGL,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""856866%2072%203"")",ONLY CAS,US Approved Rx 2014,NDA205436,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205436,US Approved Rx 2014,NDA205436,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205436,Skin bacterial infections; Staphylococcal skin infections; Skin infections; Unknown,Approved; Approved; Approved
TEDUGLUTIDE,197922-42-2,https://drugs.ncats.io/drug/7M19191IKG,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""197922%2042%202"")",ONLY CAS,US Approved Rx 2012,NDA203441,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203441,US Approved Rx 2012,NDA203441,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203441,Short bowel syndrome,Approved
TEGASEROD,145158-71-0,https://drugs.ncats.io/drug/458VC51857,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""145158%2071%200"")",ONLY CAS,US Previously Marketed 2002,ZELNORM by ALFASIGMA,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021200,US Previously Marketed 2002,ZELNORM by ALFASIGMA,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021200,Constipation,Approved
TELAPREVIR,402957-28-2,https://drugs.ncats.io/drug/655M5O3W0U,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""402957%2028%202"")",ONLY CAS,US Previously Marketed 2011,INCIVEK by VERTEX PHARMS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201917,US Previously Marketed 2011,INCIVEK by VERTEX PHARMS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201917,Chronic hepatitis C,Approved
TELAVANCIN,372151-71-8,https://drugs.ncats.io/drug/XK134822Z0,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""372151%2071%208"")",ONLY CAS,US Approved Rx 2013,NDA022407,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022407,US Approved Rx 2009,NDA022110,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022110,Hospital-acquired and ventilator-associated bacterial pneumonia,Approved
TELBIVUDINE,3424-98-4,https://drugs.ncats.io/drug/2OC4HKD3SF,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""3424%2098%204"")",ONLY CAS,US Previously Marketed 2006,TYZEKA by NOVARTIS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022011,US Previously Marketed 2006,TYZEKA by NOVARTIS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022011,Chronic hepatitis B,Approved
TELITHROMYCIN,191114-48-4,https://drugs.ncats.io/drug/KI8H7H19WL,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""191114%2048%204"")",ONLY CAS,US Previously Marketed 2004,KETEK by SANOFI AVENTIS US,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021144,US Previously Marketed 2004,KETEK by SANOFI AVENTIS US,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021144,Acute bacterial sinusitis; Acute bacterial exacerbation of chronic bronchitis; Community-acquired pneumonia,Approved; Approved; Approved
TELMESTEINE,122946-43-4,https://drugs.ncats.io/drug/124I3FE35T,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""122946%2043%204"")",ONLY CAS,Possibly Marketed Outside US 2009,NCT01093469: Phase 4 Interventional Completed Atopic Dermatitis,https://clinicaltrials.gov/ct2/show/NCT01093469,,,,,
TELMISARTAN,144701-48-4,https://drugs.ncats.io/drug/U5SYW473RQ,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""144701%2048%204"")",ONLY CAS,US Approved Rx 2017,ANDA208605,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208605,US Approved Rx 1998,NDA020850,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020850,Cardiovascular diseases; Hypertension,Approved; Approved
TELOTRISTAT ETIPRATE,1137608-69-5,https://drugs.ncats.io/drug/3T25U84H4U,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1137608%2069%205"")",ONLY CAS,US Approved Rx 2017,NDA208794,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208794,US Approved Rx 2017,NDA208794,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208794,Carcinoid syndrome,Approved
TEMAZEPAM,846-50-4,https://drugs.ncats.io/drug/CHB1QD2QSS,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""846%2050%204"")",ONLY CAS,US Approved Rx 2023,ANDA217875,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217875,US Approved Rx 1981,NDA018163,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018163,Insomnia,Approved
TEMOZOLOMIDE,85622-93-1,https://drugs.ncats.io/drug/YF1K15M17Y,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""85622%2093%201"")",ONLY CAS,US Approved Rx 2014,ANDA201742,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201742,US Previously Marketed 1999,TEMODAR by MERCK SHARP DOHME,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021029,Refractory anaplastic astrocytoma; Glioblastoma multiforme; Cancer,Approved; Approved; Basic research
TEMSIROLIMUS,162635-04-3,https://drugs.ncats.io/drug/624KN6GM2T,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""162635%2004%203"")",ONLY CAS,US Approved Rx 2007,NDA022088,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022088,US Approved Rx 2007,NDA022088,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022088,Advanced renal cell carcinoma,Approved
TENECTEPLASE,191588-94-0,https://drugs.ncats.io/drug/WGD229O42W,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""191588%2094%200"")",ONLY CAS,US Approved Rx 2000,BLA103909,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103909,US Approved Rx 2000,BLA103909,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103909,,
TENIPOSIDE,29767-20-2,https://drugs.ncats.io/drug/957E6438QA,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""29767%2020%202"")",ONLY CAS,US Previously Marketed 1992,VUMON by HQ SPECLT PHARMA,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020119,US Previously Marketed 1992,VUMON by HQ SPECLT PHARMA,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020119,Refractory childhood acute lymphoblastic leukemia,Approved
TENOFOVIR ALAFENAMIDE,379270-37-8,https://drugs.ncats.io/drug/EL9943AG5J,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""379270%2037%208"")",ONLY CAS,US Approved Rx 2018,NDA022142,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022142,US Approved Rx 2001,NDA021356,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021356,HBV infections; HIV-1 infection; HIV-1 infection; Hepatitis B,Approved; Approved; Basic research; Phase II
TENOFOVIR DISOPROXIL,201341-05-1,https://drugs.ncats.io/drug/F4YU4LON7I,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""201341%2005%201"")",ONLY CAS,US Approved Rx 2018,NDA022142,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022142,US Approved Rx 2001,NDA021356,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021356,HBV infections; HIV-1 infection; HIV-1 infection; Hepatitis B,Approved; Approved; Basic research; Phase II
TERAZOSIN,63590-64-7,https://drugs.ncats.io/drug/8L5014XET7,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""63590%2064%207"")",ONLY CAS,US Approved Rx 1998,ANDA074823,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=074823,US Previously Marketed 1987,HYTRIN by ABBOTT,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019057,Benign prostatic hyperplasia; Hypertension,Approved; Approved
TERBINAFINE,91161-71-6,https://drugs.ncats.io/drug/G7RIW8S0XP,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""91161%2071%206"")",ONLY CAS,US Approved Rx 2006,NDA021958,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021958,US Previously Marketed 1992,LAMISIL by NOVARTIS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020192,Onychomycosis,Approved
TERBUTALINE,23031-25-6,https://drugs.ncats.io/drug/N8ONU3L3PG,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""23031%2025%206"")",ONLY CAS,US Approved Rx 2009,ANDA078630,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=078630,US Previously Marketed 1974,BRICANYL by SANOFI AVENTIS US,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017466,Asthma,Approved
TERCONAZOLE,67915-31-5,https://drugs.ncats.io/drug/0KJ2VE664U,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""67915%2031%205"")",ONLY CAS,US Approved Rx 2004,NDA021735,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021735,US Previously Marketed 1987,TERAZOL 7 by JANSSEN PHARMS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019579,Vulvovaginal candidiasis; HIV infection,Approved; Phase I
TERFENADINE,50679-08-8,https://drugs.ncats.io/drug/7BA5G9Y06Q,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""50679%2008%208"")",ONLY CAS,US Previously Marketed 1985,Seldane by Dow,OB NME Appendix 1950-1993,US Previously Marketed 1985,Seldane by Dow,OB NME Appendix 1950-1993,,
TERIFLUNOMIDE,163451-81-8,https://drugs.ncats.io/drug/1C058IKG3B,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""163451%2081%208"")",ONLY CAS,US Approved Rx 2020,ANDA209677,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209677,US Approved Rx 1998,NDA020905,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020905,Multiple sclerosis; Active rheumatoid arthritis,Approved; Approved
TERIPARATIDE,52232-67-4,https://drugs.ncats.io/drug/10T9CSU89I,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""52232%2067%204"")",ONLY CAS,US Approved Rx 2023,ANDA211097,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211097,US Previously Marketed 1987,PARATHAR by SANOFI AVENTIS US,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019498,Postmenopausal Osteoporosis,Approved
TERPIN HYDRATE,8006-39-1,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""8006%2039%201"")",ONLY CAS,,,,,,,,
TESAMORELIN,218949-48-5,https://drugs.ncats.io/drug/MQG94M5EEO,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""218949%2048%205"")",ONLY CAS,US Approved Rx 2010,BLA022505,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22505,US Approved Rx 2010,BLA022505,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=22505,HIV-associated lipodystrophy,Approved
TESTOLACTONE,968-93-4,https://drugs.ncats.io/drug/6J9BLA949Q,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""968%2093%204"")",ONLY CAS,US Previously Marketed 1970,TESLAC by BRISTOL MYERS SQUIBB,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016118,US Previously Marketed 1969,TESLAC by BRISTOL MYERS SQUIBB,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016119,Breast cancer,Approved
TESTOSTERONE,58-22-0,https://drugs.ncats.io/drug/3XMK78S47O,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""58%2022%200"")",ONLY CAS,US Approved Rx 2017,ANDA204255,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204255,US Previously Marketed 1937,Oreton-F by Schering,https://archive.org/details/in.ernet.dli.2015.145864,Hypogonadism,Approved
TETRABENAZINE,718635-93-9,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""718635%2093%209"")",ONLY CAS,,,,,,,,
TETRACAINE,94-24-6,https://drugs.ncats.io/drug/0619F35CGV,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""94%2024%206"")",ONLY CAS,US Approved OTC ,21 CFR 346.10(i) anorectal:local anesthetic tetracaine hydrochloride,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec346-10.xml,US Previously Marketed 1932,tetracaine,https://archive.org/details/newnonofficialre39coun,Rapid and short-acting topical ophthalmic anesthetic,Approved
TETRACOSACTIDE,16960-16-0,https://drugs.ncats.io/drug/72YY86EA29,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""16960%2016%200"")",ONLY CAS,US Approved Rx 2012,ANDA202147,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202147,US Approved Rx 1970,NDA016750,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016750,Adrenocortical insufficiency,Approved
TETRACYCLINE,60-54-8,https://drugs.ncats.io/drug/F8VB5M810T,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""60%2054%208"")",ONLY CAS,US Approved OTC ,21 CFR 333.110(f) first aid antibiotic:ointment tetracycline hydrochloride,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec333-110.xml,US Previously Marketed 1953,ACHROMYCIN by LEDERLE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050273,Bacterial infections,Approved
TETRASTARCH,9005-27-0,https://drugs.ncats.io/drug/1GVO236S58,3,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""9005%2027%200"")",ONLY CAS,Possibly Marketed Outside US ,WHO-ATC:B05AA07,https://ginas.ncats.nih.gov/ginas/app/substance/1GVO236S58,Possibly Marketed Outside US 2007,ANDA110013,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=be7729c9-f7cf-483b-bafe-0d42d6b62f06,,
TETRYLAMMONIUM,66-40-0,https://drugs.ncats.io/drug/5AV7G7EIEE,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""66%2040%200"")",ONLY CAS,US Previously Marketed 1947,Etamon Chloride by Parke-Davis,DeHaen 1940-1975 NMEs,US Previously Marketed 1947,Etamon Chloride by Parke-Davis,DeHaen 1940-1975 NMEs,Hypertension; Disease of mental health,Not Provided; Not Provided
TETRYZOLINE,84-22-0,https://drugs.ncats.io/drug/S9U025Y077,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""84%2022%200"")",ONLY CAS,US Approved OTC ,21 CFR 349.18(d) ophthalmic:vasoconstrictor tetrahydrozoline hydrochloride,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec349-18.xml,US Previously Marketed 1954,Tyzine by Pfizer,OB NME Appendix 1950-1985,Nasal congestion,Approved
TEZACAFTOR,1152311-62-0,https://drugs.ncats.io/drug/8RW88Y506K,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1152311%2062%200"")",ONLY CAS,US Approved Rx 2018,NDA210491,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210491,US Approved Rx 2018,NDA210491,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210491,Cystic fibrosis,Approved
THALIDOMIDE,50-35-1,https://drugs.ncats.io/drug/4Z8R6ORS6L,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""50%2035%201"")",ONLY CAS,US Approved Rx 1998,NDA020785,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020785,US Approved Rx 1998,NDA020785,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020785,Erythema nodosum leprosum; Multiple myeloma,Approved; Approved
THEANINE,3081-61-6,https://drugs.ncats.io/drug/8021PR16QO,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""3081%2061%206"")",ONLY CAS,Possibly Marketed Outside US 2013,21 CFR 352,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2ba70ab3-a7ce-4096-ace4-09b78a83c792,Possibly Marketed Outside US 2013,21 CFR 352,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2ba70ab3-a7ce-4096-ace4-09b78a83c792,Schizophrenia; Anxiety; Attention deficit hyperactivity disorder,Phase III; Approved; Phase II
THEOBROMINE,83-67-0,https://drugs.ncats.io/drug/OBD445WZ5P,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""83%2067%200"")",ONLY CAS,US Previously Marketed 1921,Theobromine Sodio-Salicylate U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,US Previously Marketed 1921,Theobromine Sodio-Salicylate U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,Acute bronchitis; Hypertension; Angina pectoris,Phase III; Approved; Approved
THEOPHYLLINE,58-55-9,https://drugs.ncats.io/drug/0I55128JYK,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""58%2055%209"")",ONLY CAS,US Approved Rx 1983,ANDA087943,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=087943,US Previously Marketed 1921,Theophylline U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,Airway obstruction,Approved
THIAMAZOLE,60-56-0,https://drugs.ncats.io/drug/554Z48XN5E,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""60%2056%200"")",ONLY CAS,US Approved Rx 2007,ANDA040734,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=040734,US Previously Marketed 1950,TAPAZOLE by KING PHARMS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=007517,Hyperthyroidism,Approved
THIAMINE,70-16-6,https://drugs.ncats.io/drug/4ABT0J945J,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""70%2016%206"")",ONLY CAS,US Approved Rx 2012,ANDA091623,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=091623,US Previously Marketed 1947,BEROCCA PN by ROCHE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=006071,Thiamine deficiency,Approved
THIETHYLPERAZINE,1420-55-9,https://drugs.ncats.io/drug/8ETK1WAF6R,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1420%2055%209"")",ONLY CAS,US Previously Marketed 1963,TORECAN by NOVARTIS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=013247,US Previously Marketed 1961,TORECAN by NOVARTIS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=012753,Vomiting; Nausea,Approved; Approved
THIOCTIC ACID,1077-28-7,https://drugs.ncats.io/drug/73Y7P0K73Y,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1077%2028%207"")",ONLY CAS,Possibly Marketed Outside US ,"Canada:LIPOIC ACID, ALPHA",https://tripod.nih.gov/npc/#Download,Possibly Marketed Outside US 2001,"Strovite OneCaplets by Exeltis USA, Inc.",https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b9b71fa4-89c7-4f5b-8174-950649434ba5,Type 2 diabetes mellitus; Nonalcoholic steatohepatitis; Stress (tako-tsubo) cardiomyopathy; Subchorionic hematoma; Carpal tunnel syndrome; Women infertility,Phase IV; Phase IV; Phase IV; Phase IV; Phase IV; Phase IV
THIOMERSAL,54-64-8,https://drugs.ncats.io/drug/2225PI3MOV,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""54%2064%208"")",ONLY CAS,US Previously Marketed ,21 CFR 310.545(a)(27)(i) antimicrobial:first aid antiseptic thimerosal,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec310-545.xml,Possibly Marketed Outside US 1947,BLA101062,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=600e54ad-af13-462f-8a2d-2c3f7d91a8cd,Influenza virus infections; Diaper rash,Approved; Withdrawn
THIOPENTAL,76-75-5,https://drugs.ncats.io/drug/JI8Z5M7NA3,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""76%2075%205"")",ONLY CAS,US Previously Marketed 1959,PENTOTHAL by ABBOTT,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=011679,US Previously Marketed 1934,thiopental,https://archive.org/details/newnonofficialre39coun,Pain,Approved
THIORIDAZINE,50-52-2,https://drugs.ncats.io/drug/N3D6TG58NI,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""50%2052%202"")",ONLY CAS,US Approved Rx 1983,ANDA088004,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=088004,US Previously Marketed 1962,MELLARIL by NOVARTIS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=011808,Schizophrenia,Approved
THIOTEPA,52-24-4,https://drugs.ncats.io/drug/905Z5W3GKH,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""52%2024%204"")",ONLY CAS,US Approved Rx 2018,ANDA210337,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210337,US Previously Marketed 1959,THIOTEPA by IMMUNEX,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=011683,Superficial papillary carcinoma of the urinary bladder; Breast adenocarcinoma; Adenocarcinoma of the ovary,Approved; Approved; Approved
THONZYLAMINE,91-85-0,https://drugs.ncats.io/drug/R79646H5Z8,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""91%2085%200"")",ONLY CAS,US Approved OTC ,21 CFR 341.12(l) cough/cold:antihistamine thonzylamine hydrochloride,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec341-12.xml,US Previously Marketed 1948,Neohetramine HCl by Nepera (Warner/ Chilcolt),DeHaen 1940-1975 NMEs,Tuberculosis; Runny nose; Nasal congestion; Itching; Sneezing,Preclinical; Approved; Approved; Approved; Approved
THREONINE,72-19-5,https://drugs.ncats.io/drug/2ZD004190S,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""72%2019%205"")",ONLY CAS,US Previously Marketed ,21 CFR 310.545(a)(20) weight control threonine,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec310-545.xml,Possibly Marketed Outside US 1971,NDA016822,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=aa89dad1-bf4f-4f7e-ad1b-2431bdf36a2d,Multiple sclerosis; Spasticity; Amyotrophic lateral sclerosis; Burns,Phase II; Phase II; Phase II; Approved
THROAT LOZENGES,108-95-2,https://drugs.ncats.io/drug/339NCG44TV,2,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""108%2095%202"")",ONLY CAS,US Approved Allergenic Extract 1941,BLA103888,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d756bf9e-2e57-48a4-897a-ec1d96472dec,US Previously Marketed 1921,Phenol U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,Unknown; Sore throat; Onychocryptosis,Approved; Approved
THROMBIN,9002-04-4,https://drugs.ncats.io/drug/6K15ABL77G,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""9002%2004%204"")",ONLY CAS,Possibly Marketed Outside US ,TachoSil by Takeda [Canada],https://www.drugbank.ca/drugs/DB11571,Possibly Marketed Outside US 1998,BLA103980,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b3f69e25-1b87-4507-81fa-582ea084673d,,
THROMBIN ALFA,869858-13-9,https://drugs.ncats.io/drug/SCK81AMR7R,2,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""869858%2013%209"")%20AND%20(root_names_name:""%5ETHROMBIN%20ALFA$"")",EXACT NAME,Possibly Marketed Outside US ,Recothrom by Baxter Laboratories [Canada],https://www.drugbank.ca/drugs/DB11572,Possibly Marketed Outside US 2008,BLA125248,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=54885644-e51e-4263-aadb-366abaeb56a3,,
THYMOL,89-83-8,https://drugs.ncats.io/drug/3J50XA376E,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""89%2083%208"")",ONLY CAS,US Previously Marketed 1921,Thymol U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,US Previously Marketed 1921,Thymol U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,Gingivitis; Cataract,Not Provided; Basic research
THYROTROPIN ALFA,194100-83-9,https://drugs.ncats.io/drug/AVX3D5A4LM,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""194100%2083%209"")",ONLY CAS,US Approved Rx 1998,BLA020898,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020898,US Approved Rx 1998,BLA020898,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020898,,
TIABENDAZOLE,148-79-8,https://drugs.ncats.io/drug/N1Q45E87DT,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""148%2079%208"")",ONLY CAS,US Previously Marketed 1967,MINTEZOL by MERCK SHARP DOHME,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016097,US Previously Marketed 1967,MINTEZOL by MERCK SHARP DOHME,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016097,Strongyloidiasis; Cutaneous larva migrans; Trichinosis; Visceral larva migrans,Approved; Approved; Approved; Approved
TIAGABINE,115103-54-3,https://drugs.ncats.io/drug/Z80I64HMNP,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""115103%2054%203"")",ONLY CAS,US Approved Rx 2011,ANDA077555,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=077555,US Approved Rx 1997,NDA020646,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020646,Partial seizures; Cocaine-related disorders; Anxiety,Approved; Phase II; Phase III
TICAGRELOR,274693-27-5,https://drugs.ncats.io/drug/GLH0314RVC,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""274693%2027%205"")",ONLY CAS,US Approved Rx 2023,ANDA208567,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208567,US Approved Rx 2011,NDA022433,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022433,Myocardial infarction; Acute coronary syndrome,Approved; Approved
TICARCILLIN,34787-01-4,https://drugs.ncats.io/drug/F93UJX4SWT,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""34787%2001%204"")",ONLY CAS,US Previously Marketed 1986,TIMENTIN by GLAXOSMITHKLINE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=062691,US Previously Marketed 1976,TICAR by GLAXOSMITHKLINE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050497,Skin and soft tissue infections; Sepsis; Intra-abdominal infections; Infections of the female pelvis and genital tract; Acute and chronic respiratory tract infections,Approved; Approved; Approved; Approved; Approved
TICLOPIDINE,55142-85-3,https://drugs.ncats.io/drug/OM90ZUW7M1,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""55142%2085%203"")",ONLY CAS,US Approved Rx 1999,ANDA075089,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=075089,US Previously Marketed 1991,TICLID by ROCHE PALO,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019979,Coronary artery disease; Thrombotic stroke,Approved; Approved
TIGECYCLINE,220620-09-7,https://drugs.ncats.io/drug/70JE2N95KR,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""220620%2009%207"")",ONLY CAS,US Approved Rx 2019,ANDA206335,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206335,US Approved Rx 2005,NDA021821,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021821,Complicated skin and skin structure infections; Community-acquired bacterial pneumonia; Complicated intra-abdominal infections,Approved; Approved; Approved
TILACTASE,9031-11-2,https://drugs.ncats.io/drug/37515NWH9U,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""9031%2011%202"")",ONLY CAS,Possibly Marketed Outside US ,Lacteeze Tablets - Extra Strength by Gelda Scientific and Industrial Development Corporation [Canada],https://www.drugbank.ca/drugs/DB13761,,,,,
TILDRAKIZUMAB,1326244-10-3,https://drugs.ncats.io/drug/DEW6X41BEK,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1326244%2010%203"")",ONLY CAS,US Approved Rx 2018,BLA761067,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761067,US Approved Rx 2018,BLA761067,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761067,,
TILUDRONIC ACID,89987-06-4,https://drugs.ncats.io/drug/6PNS59HP4Y,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""89987%2006%204"")",ONLY CAS,US Previously Marketed 1997,SKELID by SANOFI AVENTIS US,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020707,US Previously Marketed 1997,SKELID by SANOFI AVENTIS US,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020707,Paget's disease,Approved
TIMOLOL,26839-75-8,https://drugs.ncats.io/drug/5JKY92S7BR,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""26839%2075%208"")",ONLY CAS,US Approved Rx 2022,ANDA216533,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216533,US Previously Marketed 1978,TIMOPTIC by BAUSCH AND LOMB INC,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018086,Glaucoma; Open-angle glaucoma; Ocular hypertension,Approved; Approved; Approved
TINIDAZOLE,148159-84-6,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""148159%2084%206"")",ONLY CAS,,,,,,,,
TINZAPARIN,9005-49-6,https://drugs.ncats.io/drug/7UQ7X4Y489,12,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""9005%2049%206"")%20AND%20(root_names_name:""%5ETINZAPARIN$"")",EXACT NAME,US Previously Marketed 2000,INNOHEP by LEO PHARMA AS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020484,US Previously Marketed 2000,INNOHEP by LEO PHARMA AS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020484,,
TIOCONAZOLE,65899-73-2,https://drugs.ncats.io/drug/S57Y5X1117,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""65899%2073%202"")",ONLY CAS,US Approved Rx 1997,NDA020676,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020676,US Previously Marketed 1983,TZ-3 by PFIZER,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018682,Vaginal candidiasis,Approved
TIOGUANINE,154-42-7,https://drugs.ncats.io/drug/WIX31ZPX66,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""154%2042%207"")",ONLY CAS,US Previously Marketed 1966,Thioguanine by Burroughs Wellcome,OB NME Appendix 1950-1985,US Previously Marketed 1966,Thioguanine by Burroughs Wellcome,OB NME Appendix 1950-1985,Acute non-lymphocytic leukemia,Approved
TIOPRONIN,1953-02-2,https://drugs.ncats.io/drug/C5W04GO61S,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1953%2002%202"")",ONLY CAS,US Approved Rx 2024,ANDA216990,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216990,US Approved Rx 1988,NDA019569,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019569,Homozygous cystinuria,Approved
TIOTIXENE,3313-26-6,https://drugs.ncats.io/drug/7318FJ13YJ,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""3313%2026%206"")",ONLY CAS,US Approved Rx 2019,ANDA211642,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211642,US Previously Marketed 1967,NAVANE by PFIZER,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016584,Unknown; Schizophrenia,Approved
TIOTROPIUM BROMIDE,136310-93-5,https://drugs.ncats.io/drug/XX112XZP0J,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""136310%2093%205"")",ONLY CAS,US Approved Rx 2023,ANDA211287,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211287,US Approved Rx 2004,NDA021395,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021395,Chronic obstructive pulmonary disease,Approved
TIPIRACIL,183204-74-2,https://drugs.ncats.io/drug/NGO10K751P,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""183204%2074%202"")",ONLY CAS,US Approved Rx 2015,NDA207981,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207981,US Approved Rx 2015,NDA207981,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207981,Metastatic colorectal cancer,Approved
TIPRANAVIR,174484-41-4,https://drugs.ncats.io/drug/ZZT404XD09,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""174484%2041%204"")",ONLY CAS,US Approved Rx 2005,NDA021814,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021814,US Approved Rx 2005,NDA021814,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021814,HIV-1 infection,Approved
TIROFIBAN,144494-65-5,https://drugs.ncats.io/drug/GGX234SI5H,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""144494%2065%205"")",ONLY CAS,US Approved Rx 2023,ANDA216379,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216379,US Approved Rx 1998,NDA020912,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020912,Acute coronary syndrome,Approved
TITANIUM,7440-32-6,https://drugs.ncats.io/drug/D1JT611TNE,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""7440%2032%206"")",ONLY CAS,US Approved Rx 2008,NDA022009,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022009,Possibly Marketed Outside US 1993,21 CFR 352,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=31454764-6b51-4f4e-ba25-b6ab932855e0,Denture stomatitis; Sunburn,Not Provided; Approved
TIZANIDINE,51322-75-9,https://drugs.ncats.io/drug/6AI06C00GW,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""51322%2075%209"")",ONLY CAS,US Approved Rx 2019,ANDA211798,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211798,US Approved Rx 1996,NDA020397,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020397,Spasticity; Unilateral inguinal hernia; Low back pain,Approved; Phase IV; Phase IV
TOBRAMYCIN,32986-56-4,https://drugs.ncats.io/drug/VZ8RRZ51VK,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""32986%2056%204"")",ONLY CAS,US Approved Rx 2019,ANDA211847,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211847,US Previously Marketed 1975,NEBCIN by LILLY,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050477,External infections of the eye; Cystic fibrosis,Approved; Approved
TOCAINIDE,41708-72-9,https://drugs.ncats.io/drug/27DXO59SAN,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""41708%2072%209"")",ONLY CAS,US Previously Marketed 1984,TONOCARD by ASTRAZENECA,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018257,US Previously Marketed 1984,TONOCARD by ASTRAZENECA,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018257,Ventricular arrhythmia,Approved
TOFACITINIB,477600-75-2,https://drugs.ncats.io/drug/87LA6FU830,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""477600%2075%202"")",ONLY CAS,US Approved Rx 2016,NDA208246,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208246,US Approved Rx 2012,NDA203214,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203214,Rheumatoid arthritis,Approved
TOLAZAMIDE,1156-19-0,https://drugs.ncats.io/drug/9LT1BRO48Q,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1156%2019%200"")",ONLY CAS,US Previously Marketed 1988,TOLAZAMIDE by USL PHARMA,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=071355,US Previously Marketed 1966,TOLINASE by PHARMACIA AND UPJOHN,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=015500,Type 2 diabetes mellitus,Approved
TOLAZOLINE,59-98-3,https://drugs.ncats.io/drug/CHH9H12AQ3,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""59%2098%203"")",ONLY CAS,US Previously Marketed 1948,PRISCOLINE by NOVARTIS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=006403,US Previously Marketed 1948,PRISCOLINE by NOVARTIS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=006403,Persistent pulmonary hypertension of the newborn,Approved
TOLBUTAMIDE,64-77-7,https://drugs.ncats.io/drug/982XCM1FOI,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""64%2077%207"")",ONLY CAS,US Previously Marketed 1985,TOLBUTAMIDE by PUREPAC PHARM,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=088950,US Previously Marketed 1957,ORINASE by PHARMACIA AND UPJOHN,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=010670,Type 2 diabetes mellitus,Approved
TOLCAPONE,134308-13-7,https://drugs.ncats.io/drug/CIF6334OLY,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""134308%2013%207"")",ONLY CAS,US Approved Rx 2018,ANDA208937,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208937,US Approved Rx 1998,NDA020697,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020697,Idiopathic Parkinson's disease,Approved
TOLMETIN,26171-23-3,https://drugs.ncats.io/drug/D8K2JPN18B,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""26171%2023%203"")",ONLY CAS,US Approved Rx 1994,ANDA074473,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=074473,US Previously Marketed 1976,TOLECTIN by ORTHO MCNEIL JANSSEN,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017628,Osteoarthritis; Rheumatoid arthritis,Approved; Approved
TOLNAFTATE,2398-96-1,https://drugs.ncats.io/drug/06KB629TKV,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""2398%2096%201"")",ONLY CAS,US Approved OTC ,21 CFR 333.210(e) antifungal tolnaftate,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec333-210.xml,US Previously Marketed 1965,Tinactin by Schering,OB NME Appendix 1950-1985,Tinea corporis; Tinea cruris; Tinea pedis; Tinea manuum; Pityriasis (Tinea) versicolor,Approved; Approved; Approved; Approved; Approved
TOLTERODINE,124937-51-5,https://drugs.ncats.io/drug/WHE7A56U7K,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""124937%2051%205"")",ONLY CAS,US Approved Rx 2000,NDA021228,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021228,US Approved Rx 1998,NDA020771,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020771,Overactive bladder,Approved
TOLU BALSAM,119-53-9,https://drugs.ncats.io/drug/L7J6A1NE81,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""119%2053%209"")",ONLY CAS,US Previously Marketed 1921,Benzoin U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,US Previously Marketed 1921,Benzoin U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,Unknown,
TOLVAPTAN,150683-30-0,https://drugs.ncats.io/drug/21G72T1950,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""150683%2030%200"")",ONLY CAS,US Approved Rx 2018,NDA204441,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204441,US Approved Rx 2009,NDA022275,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022275,Hypervolemic and euvolemic hyponatremia,Approved
TOOTHPASTES,56-40-6,https://drugs.ncats.io/drug/TE7660XO1C,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""56%2040%206"")",ONLY CAS,US Approved OTC ,21 CFR 331.11(f) antacid glycine (aminoacetic acid),https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec331-11.xml,US Previously Marketed 1921,Glycocoll,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,Cystic fibrosis; Brain tumor malignancy; Schizophrenia; Malnutrition,Phase II; Natural Metabolite; Phase III; Approved
TOPICAL ANALGESICS,137-58-6,https://drugs.ncats.io/drug/98PI200987,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""137%2058%206"")",ONLY CAS,US Approved OTC ,21 CFR 346.10(f) anorectal:local anesthetic lidocaine,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec346-10.xml,US Previously Marketed 1948,XYLOCAINE DENTAL by DENTSPLY PHARM,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021380,Ventricular arrhythmia; Pain,Approved; Approved
TOPIRAMATE,97240-79-4,https://drugs.ncats.io/drug/0H73WJJ391,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""97240%2079%204"")",ONLY CAS,US Approved Rx 2009,ANDA077733,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=077733,US Approved Rx 1996,NDA020505,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020505,Migraine; Epilepsy,Approved; Approved
TOPOTECAN,123948-87-8,https://drugs.ncats.io/drug/7M7YKX2N15,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""123948%2087%208"")",ONLY CAS,US Approved Rx 2011,ANDA201191,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201191,US Approved Rx 1996,NDA020671,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020671,Metastatic carcinoma of the ovary; Small cell lung cancer platinum-sensitive disease,Approved; Approved
TORASEMIDE,56211-40-6,https://drugs.ncats.io/drug/W31X2H97FB,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""56211%2040%206"")",ONLY CAS,US Approved Rx 2005,ANDA076894,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=076894,US Previously Marketed 1993,DEMADEX by MYLAN SPECIALITY LP,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020136,Edema associated with congestive heart failure; Hypertension,Approved; Approved
TOREMIFENE,89778-26-7,https://drugs.ncats.io/drug/7NFE54O27T,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""89778%2026%207"")",ONLY CAS,US Approved Rx 2020,ANDA212818,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212818,US Approved Rx 1997,NDA020497,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020497,Metastatic breast cancer,Approved
TOSITUMOMAB IODINE-131,192391-48-3,https://drugs.ncats.io/drug/K1KT5M40JC,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""192391%2048%203"")",ONLY CAS,US Previously Marketed 2003,Bexxar,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125011,US Previously Marketed 2003,Bexxar,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125011,,
TRABECTEDIN,114899-77-3,https://drugs.ncats.io/drug/ID0YZQ2TCP,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""114899%2077%203"")",ONLY CAS,US Approved Rx 2015,NDA207953,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207953,US Approved Rx 2015,NDA207953,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207953,Ovarian cancer; Leiomyosarcoma; Liposarcoma,Approved; Approved; Approved
TRAMADOL,123154-38-1,https://drugs.ncats.io/drug/0NG5TTM63P,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""123154%2038%201"")",ONLY CAS,US Approved Rx 2011,ANDA201384,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201384,US Previously Marketed 1995,ULTRAM by JANSSEN PHARMS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020281,Mild-severe pain; Osteoarthritis; Low back pain,Approved; Phase IV; Phase IV
TRAMETINIB,871700-17-3,https://drugs.ncats.io/drug/33E86K87QN,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""871700%2017%203"")",ONLY CAS,US Approved Rx 2013,NDA204114,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204114,US Approved Rx 2013,NDA204114,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204114,Melanoma,Approved
TRANDOLAPRIL,87679-37-6,https://drugs.ncats.io/drug/1T0N3G9CRC,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""87679%2037%206"")",ONLY CAS,US Approved Rx 2010,ANDA079135,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=079135,US Previously Marketed 1996,TARKA by ABBVIE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020591,Hypertension; Heart failure post myocardial infarction,Approved; Approved
TRANEXAMIC ACID,1197-18-8,https://drugs.ncats.io/drug/6T84R30KC1,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1197%2018%208"")",ONLY CAS,US Approved Rx 2017,ANDA206713,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206713,US Previously Marketed 1986,CYKLOKAPRON by PHARMACIA AND UPJOHN,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019280,Cyclic heavy menstrual bleeding,Approved
TRANILAST,53902-12-8,https://drugs.ncats.io/drug/HVF50SMY6E,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""53902%2012%208"")",ONLY CAS,Possibly Marketed Outside US ,Japan:Tranilast,https://tripod.nih.gov/npc/#Download,,,,Bronchial asthma; Allergic rhinitis; Keloid,Approved; Approved; Approved
TRANYLCYPROMINE,3721-26-4,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""3721%2026%204"")",ONLY CAS,,,,,,,,
TRASTUZUMAB,180288-69-1,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""180288%2069%201"")",ONLY CAS,,,,,,,,
TRASTUZUMAB EMTANSINE,1018448-65-1,https://drugs.ncats.io/drug/SE2KH7T06F,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1018448%2065%201"")%20AND%20(root_names_name:""%5ETRASTUZUMAB%20EMTANSINE"")",APPROXIMATE NAME,US Approved Rx 2013,BLA125427,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125427,US Approved Rx 2013,BLA125427,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125427,Breast cancer,Approved
TRAVOPROST,157283-68-6,https://drugs.ncats.io/drug/WJ68R08KX9,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""157283%2068%206"")",ONLY CAS,US Approved Rx 2023,NDA218010,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218010,US Previously Marketed 2001,TRAVATAN by ALCON PHARMS LTD,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021257,Open-angle glaucoma; Infertility; Labor delay,Approved; Preclinical; Preclinical
TRAZODONE,19794-93-5,https://drugs.ncats.io/drug/YBK48BXK30,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""19794%2093%205"")",ONLY CAS,US Approved Rx 2020,ANDA204852,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204852,US Previously Marketed 1981,DESYREL by PRAGMA,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018207,Alzheimer’s disease; Major depressive disorder; Insomnia,Phase III; Approved; Phase IV
TREPROSTINIL,81846-19-7,https://drugs.ncats.io/drug/RUM6K67ESG,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""81846%2019%207"")",ONLY CAS,US Approved Rx 2009,NDA022387,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022387,US Approved Rx 2002,NDA021272,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=21272,Pulmonary arterial hypertension,Approved
TRETINOIN,302-79-4,https://drugs.ncats.io/drug/5688UTC01R,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""302%2079%204"")",ONLY CAS,US Approved Rx 2019,ANDA211644,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211644,US Previously Marketed 1971,RETIN-A by VALEANT INTL,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016921,,
TRIACETIN,102-76-1,https://drugs.ncats.io/drug/XHX3C3X673,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""102%2076%201"")",ONLY CAS,US Previously Marketed 1957,Fungacetin by Harvey,DeHaen 1940-1975 NMEs,US Previously Marketed 1957,Fungacetin by Harvey,DeHaen 1940-1975 NMEs,Major depressive disorder,Approved
TRIAMCINOLONE,124-94-7,https://drugs.ncats.io/drug/1ZK20VI6TY,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""124%2094%207"")",ONLY CAS,US Previously Marketed 1975,TRIAMCINOLONE by BARR,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=084268,US Previously Marketed 1957,ARISTOCORT by ASTELLAS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=011161,Perennial or seasonal allergic rhinitis; Congenital adrenal hyperplasia; Leukemias and lymphomas; Bullous dermatitis herpetiformi; Uveitis,Approved; Approved; Approved; Approved; Approved
TRIAMCINOLONE ACETONIDE,76-25-5,https://drugs.ncats.io/drug/F446C597KA,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""76%2025%205"")",ONLY CAS,US Approved Rx 2017,ANDA207730,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207730,US Previously Marketed 1958,TRIAMCINOLONE ACETONIDE by MYLAN,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=011601,Perennial allergic rhinitis; Sympathetic ophthalmia; Uveitis; Seasonal allergic rhinitis; Temporal arteritis,Approved; Approved; Approved; Approved; Approved
TRIAMCINOLONE HEXACETONIDE,5611-51-8,https://drugs.ncats.io/drug/I7GT1U99Y9,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""5611%2051%208"")",ONLY CAS,US Approved Rx 2017,ANDA207730,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207730,US Previously Marketed 1958,TRIAMCINOLONE ACETONIDE by MYLAN,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=011601,Perennial allergic rhinitis; Sympathetic ophthalmia; Uveitis; Seasonal allergic rhinitis; Temporal arteritis,Approved; Approved; Approved; Approved; Approved
TRIAMTERENE,396-01-0,https://drugs.ncats.io/drug/WS821Z52LQ,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""396%2001%200"")",ONLY CAS,US Approved Rx 1964,NDA013174,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=013174,US Approved Rx 1964,NDA013174,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=013174,Edema associated with congestive heart failure,Approved
TRIAZOLAM,28911-01-5,https://drugs.ncats.io/drug/1HM943223R,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""28911%2001%205"")",ONLY CAS,US Approved Rx 2020,ANDA214219,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214219,US Approved Rx 1982,NDA017892,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017892,Insomnia,Approved
TRIBULUS TERRESTRIS,90131-68-3,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""90131%2068%203"")",ONLY CAS,,,,,,,,
TRICHLORMETHIAZIDE,133-67-5,https://drugs.ncats.io/drug/Q58C92TUN0,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""133%2067%205"")",ONLY CAS,US Previously Marketed 1977,TRICHLOREX by LANNETT,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=085630,US Previously Marketed 1960,NAQUA by SCHERING,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=012265,Hypertension,Approved
TRICHLOROACETIC ACID,76-03-9,https://drugs.ncats.io/drug/5V2JDO056X,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""76%2003%209"")",ONLY CAS,US Previously Marketed 2022,trichloroacetic acid,https://www.federalregister.gov/documents/2022/01/27/2022-01558/list-of-bulk-drug-substances-for-which-there-is-a-clinical-need-under-section-503b-of-the-federal,Possibly Marketed Outside US 2010,TRI-CHLOR by Gordon Laboratories,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d929f1d6-3234-491c-b084-644c91e61302,Anal high-grade squamous intraepithelial lesions; Melasma,Basic research; Phase III
TRICLOCARBAN,101-20-2,https://drugs.ncats.io/drug/BGG1Y1ED0Y,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""101%2020%202"")",ONLY CAS,US Previously Marketed ,21 CFR 310.545(a)(27)(viii) antimicrobial:personnel hand wash triclocarban,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec310-545.xml,Possibly Marketed Outside US 2009,21 CFR 333,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b3598ec2-9432-4870-bf1b-0f79c301b6ae,Skin bacterial infections,Withdrawn
TRICLOSAN,3380-34-5,https://drugs.ncats.io/drug/4NM5039Y5X,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""3380%2034%205"")",ONLY CAS,US Previously Marketed 1997,COLGATE TOTAL by COLGATE PALMOLIVE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020231,US Previously Marketed 1969,P-300 Antibacterial by Colgate-Palmolive,OB NME Appendix 1950-1993,Bacterial infections,Approved
TRIENTINE,112-24-3,https://drugs.ncats.io/drug/SJ76Y07H5F,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""112%2024%203"")",ONLY CAS,US Approved Rx 2019,ANDA211554,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211554,US Approved Rx 1985,NDA019194,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019194,Wilson's disease; Macular edema,Approved; Phase II
TRIFLUOPERAZINE,117-89-5,https://drugs.ncats.io/drug/214IZI85K3,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""117%2089%205"")",ONLY CAS,US Approved Rx 1981,ANDA085789,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=085789,US Previously Marketed 1959,STELAZINE by GLAXOSMITHKLINE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=011552,Schizophrenia; Non psychotic anxiety,Approved; Approved
TRIFLUPROMAZINE,146-54-3,https://drugs.ncats.io/drug/RO16TQF95Y,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""146%2054%203"")",ONLY CAS,US Previously Marketed 1958,VESPRIN by APOTHECON,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=011325,US Previously Marketed 1957,VESPRIN by BRISTOL MYERS SQUIBB,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=011123,Psychosis,Approved
TRIFLURIDINE,70-00-8,https://drugs.ncats.io/drug/RMW9V5RW38,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""70%2000%208"")",ONLY CAS,US Approved Rx 2015,NDA207981,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207981,US Approved Rx 1980,NDA018299,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018299,Keratoconjunctivitis,Approved
TRIGLYCERIDES,6217-54-5,https://drugs.ncats.io/drug/ZAD9OKH9JC,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""6217%2054%205"")",ONLY CAS,Possibly Marketed Outside US ,Ultra Omega 3 by Liberty Bioscience LLC,https://www.drugbank.ca/drugs/DB03756,Possibly Marketed Outside US 2007,"DHA by Exeltis USA, Inc",https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a0e273e2-0876-4830-a903-282085be7f32,Alzheimer’s disease; Coronary heart disease; Age-related macular degeneration; Pregnancy,Approved; Approved; Phase III; Phase III
TRIHEXYPHENIDYL,144-11-6,https://drugs.ncats.io/drug/6RC5V8B7PO,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""144%2011%206"")",ONLY CAS,US Approved Rx 1974,ANDA084364,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=084364,US Previously Marketed 1949,ARTANE by LEDERLE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=006773,Parkinson's disease; Extrapyramidal disorders caused by central nervous system drugs,Approved; Approved
TRILOSTANE,13647-35-3,https://drugs.ncats.io/drug/L0FPV48Q5R,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""13647%2035%203"")",ONLY CAS,US Previously Marketed 1984,MODRASTANE by BIOENVISION,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018719,US Previously Marketed 1984,MODRASTANE by BIOENVISION,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018719,Post-menopausal breast cancer; Cushing’s disease; Conn’s syndrome; Pituitary-dependent hyperadrenocorticism,Approved; Approved; Approved; Approved
TRIMETHOBENZAMIDE,138-56-7,https://drugs.ncats.io/drug/W2X096QY97,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""138%2056%207"")",ONLY CAS,US Approved Rx 2003,ANDA076546,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=076546,US Previously Marketed 1959,Tigan by Hoffmann-La Roche,OB NME Appendix 1950-1985,Postoperative nausea and vomiting; Nausea associated with gastroenteritis,Approved; Approved
TRIMETHOPRIM,738-70-5,https://drugs.ncats.io/drug/AN164J8Y0X,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""738%2070%205"")",ONLY CAS,US Approved Rx 1973,NDA017377,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017377,US Approved Rx 1973,NDA017377,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017377,Urinary tract infections,Approved
TRIMETREXATE,52128-35-5,https://drugs.ncats.io/drug/UPN4ITI8T4,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""52128%2035%205"")",ONLY CAS,US Previously Marketed 1993,NEUTREXIN by MEDIMMUNE ONCOLOGY,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020326,US Previously Marketed 1993,NEUTREXIN by MEDIMMUNE ONCOLOGY,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020326,Pneumocystis carinii pneumonia; Colorectal cancer; Pancreatic cancer; Refractory acute leukemia,Approved; Phase II; Phase II; Phase II
TRIMIPRAMINE,3564-75-8,https://drugs.ncats.io/drug/9K5931C1H5,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""3564%2075%208"")",ONLY CAS,US Approved Rx 2006,ANDA077361,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=077361,US Previously Marketed 1979,SURMONTIL by ODYSSEY PHARMS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016792,Depression,Approved
TRIOXYSALEN,3902-71-4,https://drugs.ncats.io/drug/Y6UY8OV51T,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""3902%2071%204"")",ONLY CAS,US Previously Marketed 1964,TRISORALEN by VALEANT PHARM INTL,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=012697,US Previously Marketed 1964,TRISORALEN by VALEANT PHARM INTL,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=012697,Vitiligo,Approved
TRIPELENNAMINE,91-81-6,https://drugs.ncats.io/drug/3C5ORO99TY,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""91%2081%206"")",ONLY CAS,US Previously Marketed 1976,TRIPELENNAMINE HYDROCHLORIDE by WATSON LABS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=085188,US Previously Marketed 1948,PBZ by NOVARTIS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=005914,Hives; Rashes; Sneezing,Approved; Approved; Approved
TRIPROLIDINE,486-12-4,https://drugs.ncats.io/drug/2L8T9S52QM,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""486%2012%204"")",ONLY CAS,US Approved OTC ,21 CFR 341.12(m) cough/cold:antihistamine triprolidine hydrochloride,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec341-12.xml,US Previously Marketed 1958,ACTIDIL by GLAXOSMITHKLINE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=011110,Allergy; Common cold,Approved; Approved
TRIPTORELIN,57773-63-4,https://drugs.ncats.io/drug/9081Y98W2V,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""57773%2063%204"")",ONLY CAS,US Approved Rx 2000,NDA020715,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020715,US Approved Rx 2000,NDA020715,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020715,Advanced prostate cancer,Approved
TRITICUM VULGARE,68917-73-7,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""68917%2073%207"")",ONLY CAS,,,,,,,,
TROGLITAZONE,97322-87-7,https://drugs.ncats.io/drug/I66ZZ0ZN0E,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""97322%2087%207"")",ONLY CAS,US Previously Marketed 1997,PRELAY by SANKYO,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020719,US Previously Marketed 1997,PRELAY by SANKYO,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020719,Liposarcoma; Polycystic ovary syndrome; Type 2 diabetes mellitus,Phase II; Phase III; Withdrawn
TROLAMINE,102-71-6,https://drugs.ncats.io/drug/9O3K93S3TK,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""102%2071%206"")",ONLY CAS,US Previously Marketed ,21 CFR 310.545(a)(18)(iv) skin protectant:fever blister/cold sore trolamine,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec310-545.xml,Possibly Marketed Outside US 1952,NDA007936,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6a621a9c-7380-4a9f-ac54-75b48fe8518e,Impacted cerumen; Sunburns,Withdrawn; Approved
TROLEANDOMYCIN,2751-09-9,https://drugs.ncats.io/drug/C4DZ64560D,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""2751%2009%209"")",ONLY CAS,US Previously Marketed 1958,TAO by PFIZER,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050332,US Previously Marketed 1958,TAO by PFIZER,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050332,Upper and lower respiratory tract infections,Approved
TROMETAMOL,77-86-1,https://drugs.ncats.io/drug/023C2WHX2V,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""77%2086%201"")",ONLY CAS,US Previously Marketed 1965,THAM-E by HOSPIRA,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=013025,US Previously Marketed 1965,THAM-E by HOSPIRA,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=013025,Metabolic acidosis,Approved
TROPICAMIDE,1508-75-4,https://drugs.ncats.io/drug/N0A3Z5XTC6,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1508%2075%204"")",ONLY CAS,US Approved Rx 1994,ANDA040067,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=040067,Possibly Marketed Outside US 1959,ANDA084306,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=57165763-29dc-4812-b840-a8a5086416f3,Eye diseases,Approved
TROSPIUM,10405-02-4,https://drugs.ncats.io/drug/1E6682427E,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""10405%2002%204"")",ONLY CAS,US Approved Rx 2010,ANDA091575,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=091575,US Previously Marketed 2004,SANCTURA by ALLERGAN,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021595,Overactive bladder,Approved
TROVAFLOXACIN,147059-72-1,https://drugs.ncats.io/drug/9F388J00UK,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""147059%2072%201"")",ONLY CAS,US Previously Marketed 1997,TROVAN PRESERVATIVE FREE by PFIZER,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020760,US Previously Marketed 1997,TROVAN PRESERVATIVE FREE by PFIZER,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020760,Complicated skin and skin structure infections; Pneumonia; Intra-abdominal infections; Complicated intra-abdominal infections; Skin infections; Pneumonia; Gynecologic infections; Nosocomial pneumonia,Approved; Approved; Approved; Withdrawn; Withdrawn; Withdrawn; Withdrawn; Withdrawn
TRYPAN BLUE,72-57-1,https://drugs.ncats.io/drug/I2ZWO3LS3M,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""72%2057%201"")",ONLY CAS,US Approved Rx 2004,NDA021670,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021670,US Approved Rx 2004,NDA021670,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021670,Glaucoma; Idiopathic epiretinal membranes; Cataract,Not Provided; Not Provided; Approved
TRYPSIN,9002-07-7,https://drugs.ncats.io/drug/GV54A213NN,3,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""9002%2007%207"")%20AND%20(root_names_name:""%5ETRYPSIN$"")",EXACT NAME,US Previously Marketed 1951,Tryptar by Armour,OB NME Appendix 1950-1985,US Previously Marketed 1951,Tryptar by Armour,OB NME Appendix 1950-1985,,
TRYPTOPHAN,73-22-3,https://drugs.ncats.io/drug/8DUH1N11BX,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""73%2022%203"")",ONLY CAS,US Previously Marketed ,21 CFR 310.545(a)(20) weight control tryptophan,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec310-545.xml,Possibly Marketed Outside US 1971,NDA016822,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=aa89dad1-bf4f-4f7e-ad1b-2431bdf36a2d,Anxiety; Depression,Approved; Approved
TUBOCURARINE,57-95-4,https://drugs.ncats.io/drug/W9YXS298BM,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""57%2095%204"")",ONLY CAS,US Previously Marketed 1947,TUBOCURARINE CHLORIDE by HOSPIRA,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=006095,US Previously Marketed 1945,TUBOCURARINE CHLORIDE by BRISTOL MYERS SQUIBB,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=005657,Myasthenia gravis,Approved
TUROCTOCOG ALFA,1192451-26-5,https://drugs.ncats.io/drug/969NZA3X9T,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1192451%2026%205"")",ONLY CAS,Possibly Marketed Outside US ,Zonovate by Novo Nordisk [Canada],https://www.drugbank.ca/drugs/DB09109,,,,,
TURPENTINE OIL,"8006-64-2
9005-90-7",N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""8006%2064%202
9005%2090%207"")",ONLY CAS,,,,,,,,
TYLOSIN,1401-69-0,https://drugs.ncats.io/drug/YEF4JXN031,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1401%2069%200"")",ONLY CAS,Possibly Marketed Outside US ,Canada:TYLOSIN PHOSPHATE,https://tripod.nih.gov/npc/#Download,Possibly Marketed Outside US 2009,Tylosin Phosphate by Biovet Joint Stock Company,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=59e7addc-2891-44da-ac7d-27f36447c463,Calf diphtheria; Bovine respiratory complex,Approved; Approved
TYLOXAPOL,25301-02-4,https://drugs.ncats.io/drug/Y27PUL9H56,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""25301%2002%204"")",ONLY CAS,US Previously Marketed 1961,ALEVAIRE TYLOXAPOL by BREON,https://cdn.loc.gov/service/ll/fedreg/fr038/fr038045/fr038045.pdf,US Previously Marketed 1953,Triton by Winthrop,DeHaen 1940-1975 NMEs,Pulmonary immaturity,Approved
TYROPANOIC ACID,27293-82-9,https://drugs.ncats.io/drug/4F05V145YR,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""27293%2082%209"")",ONLY CAS,US Previously Marketed 1969,BILOPAQUE by GE HEALTHCARE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=013731,US Previously Marketed 1969,BILOPAQUE by GE HEALTHCARE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=013731,Cholelithiasis,Approved
TYROSINE,60-18-4,https://drugs.ncats.io/drug/42HK56048U,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""60%2018%204"")",ONLY CAS,US Previously Marketed 1961,TPN by INTL MINERALS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=008378,US Previously Marketed 1961,TPN by INTL MINERALS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=008378,Negative nitrogen balance,Approved
UBIDECARENONE,303-98-0,https://drugs.ncats.io/drug/EJ27X76M46,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""303%2098%200"")",ONLY CAS,Possibly Marketed Outside US ,Watkins Coq10 by Watkins Incorporated [Canada],https://www.drugbank.ca/drugs/DB09270,Possibly Marketed Outside US 1993,21 CFR 352,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=31454764-6b51-4f4e-ba25-b6ab932855e0,Progressive supranuclear palsy; Atypical parkinsonian syndrome corticobasal degeneration; Parkinson's disease; Coronary artery disease patients under statin therapy,Phase III; Phase III; Phase III; Phase III
ULIPRISTAL ACETATE,126784-99-4,https://drugs.ncats.io/drug/YF7V70N02B,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""126784%2099%204"")",ONLY CAS,US Approved Rx 2010,NDA022474,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022474,US Approved Rx 2010,NDA022474,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022474,Pregnancy,Approved
ULOBETASOL,98651-66-2,https://drugs.ncats.io/drug/9P6159HM7T,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""98651%2066%202"")",ONLY CAS,US Approved Rx 2004,ANDA076994,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=076994,US Previously Marketed 1990,ULTRAVATE by SUN PHARM INDS INC,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019967,Corticosteroid-responsive dermatoses,Approved
UMECLIDINIUM BROMIDE,869113-09-7,https://drugs.ncats.io/drug/7AN603V4JV,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""869113%2009%207"")",ONLY CAS,US Approved Rx 2017,NDA209482,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209482,US Approved Rx 2013,NDA203975,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203975,Chronic obstructive pulmonary disease,Approved
UNDECYLENIC ACID,112-38-9,https://drugs.ncats.io/drug/K3D86KJ24N,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""112%2038%209"")",ONLY CAS,US Approved OTC ,21 CFR 333.210(f) antifungal undecylenic acid,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec333-210.xml,US Previously Marketed 1945,Desenex Sol. by Pennwalt,DeHaen 1940-1975 NMEs,Tinea corporis; Herpes labialis; Itching; Tinea pedis,Approved; Phase III; Approved; Approved
UNITHIOL,4076-02-2,https://drugs.ncats.io/drug/690VN2L7TK,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""4076%2002%202"")",ONLY CAS,Possibly Marketed Outside US ,"DIMAVAL by Petrunkin, V.E.",https://www.ncbi.nlm.nih.gov/pubmed/20664538 | https://www.ncbi.nlm.nih.gov/pubmed/24178900,,,,Mercury poisoning,Approved
UNOPROSTONE ISOPROPYL ESTER,120373-24-2,https://drugs.ncats.io/drug/5M161S5O5P,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""120373%2024%202"")",ONLY CAS,US Previously Marketed 2000,RESCULA by SUCAMPO PHARMA LLC,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021214,US Previously Marketed 2000,RESCULA by SUCAMPO PHARMA LLC,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021214,Ocular hypertension; Open-angle glaucoma,Approved; Approved
UREA,57-13-6,https://drugs.ncats.io/drug/8W8T17847W,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""57%2013%206"")",ONLY CAS,US Previously Marketed 1921,urea,https://catalog.hathitrust.org/Record/100163146,US Previously Marketed 1921,urea,https://catalog.hathitrust.org/Record/100163146,Ichthyosis; Keratosis; Eczema,Approved; Approved; Approved
URIDINE TRIACETATE,4105-38-8,https://drugs.ncats.io/drug/2WP61F175M,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""4105%2038%208"")",ONLY CAS,US Approved Rx 2015,NDA208169,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208169,US Approved Rx 2015,NDA208169,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208169,"Toxicity Due to Chemotherapy (fluorouracil); Toxicity Due to Chemotherapy (capecitabine); Orotic aciduria, hereditary; Overdose of capecitabine or fluorouracil; Hereditary orotic aciduria",Approved; Approved; Approved; Approved; Approved
URIDINE TRIPHOSPHATE,63-39-8,https://drugs.ncats.io/drug/UT0S826Z60,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""63%2039%208"")",ONLY CAS,Possibly Marketed Outside US 2023,BLA125734,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=24610d9f-0c5a-4f55-93b3-d456300bfd5d,Possibly Marketed Outside US 2023,BLA125734,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=24610d9f-0c5a-4f55-93b3-d456300bfd5d,,
UROFOLLITROPIN,97048-13-0,https://drugs.ncats.io/drug/W9BB98U6HP,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""97048%2013%200"")",ONLY CAS,US Approved Rx 2002,BLA021484,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021484,US Previously Marketed 1986,METRODIN by SERONO,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019415,,
UROKINASE,9039-53-6,https://drugs.ncats.io/drug/83G67E21XI,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""9039%2053%206"")",ONLY CAS,US Previously Marketed 1978,KINLYTIC by MICROBIX BIOSYSTEMS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021846,US Previously Marketed 1978,KINLYTIC by MICROBIX BIOSYSTEMS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021846,,
URSODEOXYCHOLIC ACID,128-13-2,https://drugs.ncats.io/drug/724L30Y2QR,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""128%2013%202"")",ONLY CAS,US Approved Rx 2019,ANDA212452,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212452,US Approved Rx 1987,NDA019594,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019594,Primary biliary cirrhosis,Approved
URTICA DIOICA,84012-40-8,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""84012%2040%208"")",ONLY CAS,,,,,,,,
USTEKINUMAB,815610-63-0,https://drugs.ncats.io/drug/FU77B4U5Z0,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""815610%2063%200"")",ONLY CAS,US Approved Rx 2009,BLA125261,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125261,US Approved Rx 2009,BLA125261,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125261,,
VABORBACTAM,1360457-46-0,https://drugs.ncats.io/drug/1C75676F8V,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1360457%2046%200"")",ONLY CAS,US Approved Rx 2017,NDA209776,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209776,US Approved Rx 2017,NDA209776,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209776,Urinary tract infections; Pneumonia,Approved; Phase III
VACCINE- BACILLUS CALMETTE-GUERIN,76-60-8,https://drugs.ncats.io/drug/8YGN0Y942M,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""76%2060%208"")",ONLY CAS,,,,,,,,
VACCINE- TETANUS,410527-75-2,https://drugs.ncats.io/drug/0UHG2WF4HP,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""410527%2075%202"")",ONLY CAS,Clinical ,USAN:MAVEROPEPIMUT-S COMPONENT A16L [USAN],https://ginas.ncats.nih.gov/ginas/app/substance/0UHG2WF4HP,,,,,
VALACICLOVIR,124832-26-4,https://drugs.ncats.io/drug/MZ1IW7Q79D,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""124832%2026%204"")",ONLY CAS,US Approved Rx 2019,ANDA210774,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210774,US Approved Rx 1982,NDA018604,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018604,Cold sores; Genital herpes; Herpes zoster infections; Herpes simplex infection; Herpes zoster infections,Approved; Approved; Approved; Approved; Approved
VALBENAZINE,1025504-45-3,https://drugs.ncats.io/drug/54K37P50KH,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1025504%2045%203"")",ONLY CAS,US Approved Rx 2017,NDA209241,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209241,US Approved Rx 2017,NDA209241,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209241,Neurological disorders; tardive dyskinesia,Phase I; Approved
VALDECOXIB,181695-72-7,https://drugs.ncats.io/drug/2919279Q3W,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""181695%2072%207"")",ONLY CAS,US Previously Marketed 2001,BEXTRA by GD SEARLE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021341,US Previously Marketed 2001,BEXTRA by GD SEARLE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021341,"Pain, postoperative; Primary dysmenorrhea; Rheumatoid arthritis; Osteoarthritis",Approved; Withdrawn; Withdrawn; Withdrawn
VALERIANA OFFICINALIS,81397-67-3,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""81397%2067%203"")",ONLY CAS,,,,,,,,
VALGANCICLOVIR,175865-60-8,https://drugs.ncats.io/drug/GCU97FKN3R,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""175865%2060%208"")",ONLY CAS,US Approved Rx 2003,ANDA076222,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=076222,US Previously Marketed 1989,CYTOVENE by CHEPLAPHARM,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019661,"Unknown; Cytomegalovirus retinitis; Cytomegalovirus infectious disease in kidney, heart, and kidney-pancreas transplantation; Cytomegalovirus retinitis; Acute herpetic keratitis",Approved; Approved; Approved; Approved
VALINE,72-18-4,https://drugs.ncats.io/drug/HG18B9YRS7,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""72%2018%204"")",ONLY CAS,US Previously Marketed ,21 CFR 310.545(a)(20) weight control valine,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec310-545.xml,Possibly Marketed Outside US 1971,NDA016822,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=aa89dad1-bf4f-4f7e-ad1b-2431bdf36a2d,Central fatigue; Burns,Natural Metabolite; Approved
VALPROATE SEMISODIUM,76584-70-8,https://drugs.ncats.io/drug/644VL95AO6,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""76584%2070%208"")",ONLY CAS,US Approved Rx 2020,ANDA213181,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213181,US Previously Marketed 1964,Virac by Ruson,OB NME Appendix 1950-1985,"Migraine; Bipolar disorder, manic episodes; Epilepsy",Approved; Approved; Approved
VALPROIC ACID,99-66-1,https://drugs.ncats.io/drug/614OI1Z5WI,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""99%2066%201"")",ONLY CAS,US Approved Rx 2020,ANDA213181,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213181,US Previously Marketed 1964,Virac by Ruson,OB NME Appendix 1950-1985,"Migraine; Bipolar disorder, manic episodes; Epilepsy",Approved; Approved; Approved
VALRUBICIN,56124-62-0,https://drugs.ncats.io/drug/2C6NUM6878,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""56124%2062%200"")",ONLY CAS,US Approved Rx 2019,ANDA206430,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206430,Possibly Marketed Outside US 1981,ANDA206430,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8739ae02-e4c5-0fa2-e053-2a91aa0a1b74,Bladder cancer,Approved
VALSARTAN,137862-53-4,https://drugs.ncats.io/drug/80M03YXJ7I,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""137862%2053%204"")",ONLY CAS,US Approved Rx 1998,NDA020818,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020818,US Previously Marketed 1996,DIOVAN by NOVARTIS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020665,Chronic heart failure with reduced ejection fraction; Unknown; Heart failure; Myocardial infarction; Hypertension,Approved; Approved; Approved; Approved
VANADIUM,7440-62-2,https://drugs.ncats.io/drug/00J9J9XKDE,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""7440%2062%202"")",ONLY CAS,Possibly Marketed Outside US ,Multi-actin by Ahmed's Sunforce International Products Inc. [Canada],https://www.drugbank.ca/drugs/DB13971,Possibly Marketed Outside US 1961,ADELGADINA by ProMex LLC,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d5aa95d0-8001-40ef-beea-e98449649a81,Unknown,
VANCOMYCIN,1404-90-6,https://drugs.ncats.io/drug/6Q205EH1VU,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1404%2090%206"")",ONLY CAS,US Approved Rx 2016,ANDA091532,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=091532,US Previously Marketed 1958,Vancocin by Lilly,DeHaen 1940-1975 NMEs,Severe infections caused by susceptible strains of methicillin-resistant staphylococci; Bacterial endocarditis,Approved; Approved
VANDETANIB,443913-73-3,https://drugs.ncats.io/drug/YO460OQ37K,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""443913%2073%203"")",ONLY CAS,US Approved Rx 2011,NDA022405,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022405,US Approved Rx 2011,NDA022405,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022405,Thyroid cancer,Approved
VANILLIN,121-33-5,https://drugs.ncats.io/drug/CHI530446X,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""121%2033%205"")",ONLY CAS,US Previously Marketed 1921,Vanillin U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,US Previously Marketed 1921,Vanillin U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,Parkinson's disease; Premature newborns; Toxoplasmosis; Alzheimer’s disease,Preclinical; Phase I; Preclinical; Preclinical
VARDENAFIL,224785-90-4,https://drugs.ncats.io/drug/UCE6F4125H,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""224785%2090%204"")",ONLY CAS,US Approved Rx 2012,ANDA091347,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=091347,Possibly Marketed Outside US 2003,NDA021400,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a01def95-c0ef-43b9-bd9e-5565b2385ad3,Erectile dysfunction,Approved
VARENICLINE,249296-44-4,https://drugs.ncats.io/drug/W6HS99O8ZO,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""249296%2044%204"")",ONLY CAS,US Approved Rx 2023,ANDA201962,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201962,US Previously Marketed 2006,CHANTIX by PF PRISM CV,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021928,Nicotine dependence,Approved
VASOPRESSIN,150683-30-0,https://drugs.ncats.io/drug/21G72T1950,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""150683%2030%200"")",ONLY CAS,US Approved Rx 2018,NDA204441,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204441,US Approved Rx 2009,NDA022275,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022275,Hypervolemic and euvolemic hyponatremia,Approved
VECURONIUM BROMIDE,50700-72-6,https://drugs.ncats.io/drug/7E4PHP5N1D,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""50700%2072%206"")",ONLY CAS,US Approved Rx 2010,ANDA090243,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=090243,US Previously Marketed 1981,Isoptin by Knoll,OB NME Appendix 1950-1985,Postoperative complications,Approved
VEDOLIZUMAB,943609-66-3,https://drugs.ncats.io/drug/9RV78Q2002,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""943609%2066%203"")",ONLY CAS,US Approved Rx 2014,BLA125476,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125476,US Approved Rx 2014,BLA125476,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125476,,
VEGETABLE LAXATIVE,517-43-1,https://drugs.ncats.io/drug/9VK7V8762D,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""517%2043%201"")",ONLY CAS,Possibly Marketed Outside US ,part334,https://www.drugbank.ca/drugs/DB11365,Possibly Marketed Outside US 1998,21 CFR 334,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c3277678-c1c5-4722-afcc-994f6b6253f6,,
VEGETABLE OIL,7440-43-9,https://drugs.ncats.io/drug/00BH33GNGH,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""7440%2043%209"")",ONLY CAS,Possibly Marketed Outside US ,Canada:CADMIUM METALLICUM,https://tripod.nih.gov/npc/#Download,Possibly Marketed Outside US 2018,"EBV/CFS Plus by Deseret Biologicals, Inc.",https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1c744874-554e-4039-b72c-24bb59e5021f,Unknown,
VELAGLUCERASE ALFA,884604-91-5,https://drugs.ncats.io/drug/23HYE36B0I,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""884604%2091%205"")",ONLY CAS,US Approved Rx 2010,BLA022575,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022575,US Approved Rx 2010,BLA022575,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022575,,
VELPATASVIR,1377049-84-7,https://drugs.ncats.io/drug/KCU0C7RS7Z,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1377049%2084%207"")",ONLY CAS,US Approved Rx 2021,NDA214187,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214187,US Approved Rx 2016,NDA208341,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208341,Hepatitis C,Approved
VEMURAFENIB,918504-65-1,https://drugs.ncats.io/drug/207SMY3FQT,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""918504%2065%201"")",ONLY CAS,US Approved Rx 2011,NDA202429,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202429,US Approved Rx 2011,NDA202429,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202429,Advanced melanoma,Approved
VENETOCLAX,1257044-40-8,https://drugs.ncats.io/drug/N54AIC43PW,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1257044%2040%208"")",ONLY CAS,US Approved Rx 2016,NDA208573,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208573,US Approved Rx 2016,NDA208573,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208573,Refractory myeloma; Acute myeloid leukemia; Chronic lymphocytic leukemia,Phase III; Phase III; Approved
VENLAFAXINE,93413-69-5,https://drugs.ncats.io/drug/GRZ5RCB1QG,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""93413%2069%205"")",ONLY CAS,US Approved Rx 2018,ANDA206250,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206250,US Previously Marketed 1993,EFFEXOR by WYETH PHARMS INC,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020151,Major depressive disorder; Social anxiety disorder,Approved; Approved
VERAPAMIL,52-53-9,https://drugs.ncats.io/drug/CJ0O37KU29,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""52%2053%209"")",ONLY CAS,US Approved Rx 1987,ANDA070738,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=070738,US Previously Marketed 1978,Depakene by Abbott,OB NME Appendix 1950-1985,Essential hypertension; Arrhythmia; Angina,Approved; Approved; Approved
VERBENA OFFICINALIS,977000-41-1,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""977000%2041%201"")",ONLY CAS,,,,,,,,
VERTEPORFIN,129497-78-5,https://drugs.ncats.io/drug/0X9PA28K43,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""129497%2078%205"")",ONLY CAS,US Approved Rx 2000,NDA021119,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021119,US Approved Rx 2000,NDA021119,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021119,Subfoveal choroidal neovascularization,Approved
VESTRONIDASE ALFA,1638194-78-1,https://drugs.ncats.io/drug/7XZ4062R17,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1638194%2078%201"")",ONLY CAS,US Approved Rx 2017,BLA761047,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761047,US Approved Rx 2017,BLA761047,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761047,,
VIDARABINE,5536-17-4,https://drugs.ncats.io/drug/3XQD2MEW34,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""5536%2017%204"")",ONLY CAS,US Approved Rx 2005,ANDA077133,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=077133,US Previously Marketed 1976,VIRA-A by PARKEDALE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050486,Keratoconjunctivitis; Epithelial keratitis; Herpes simplex infection; Paroxysmal supraventricular tachycardia,Approved; Approved; Phase III; Approved
VIGABATRIN,68506-86-5,https://drugs.ncats.io/drug/GR120KRT6K,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""68506%2086%205"")",ONLY CAS,US Approved Rx 2022,ANDA214961,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214961,US Approved Rx 2009,NDA020427,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020427,Epilepsy,Approved
VILANTEROL,503068-34-6,https://drugs.ncats.io/drug/028LZY775B,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""503068%2034%206"")",ONLY CAS,US Approved Rx 2017,NDA209482,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209482,US Approved Rx 2013,NDA204275,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204275,Chronic obstructive pulmonary disease,Approved
VILAZODONE,163521-12-8,https://drugs.ncats.io/drug/S239O2OOV3,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""163521%2012%208"")",ONLY CAS,US Approved Rx 2023,ANDA208228,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208228,US Approved Rx 2011,NDA022567,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022567,Major depressive disorder,Approved
VINBLASTINE,865-21-4,https://drugs.ncats.io/drug/5V9KLZ54CY,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""865%2021%204"")",ONLY CAS,US Approved Rx 1987,ANDA089515,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=089515,US Previously Marketed 1961,VELBAN by LILLY,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=012665,Non-Hodgkin's lymphoma; Hodgkin's lymphoma; Kaposi’s sarcoma; Carcinoma of the testis; Letterer-Siwe disease (histiocytosis X); Mycosis fungoides,Approved; Approved; Approved; Approved; Approved; Approved
VINCRISTINE,57-22-7,https://drugs.ncats.io/drug/5J49Q6B70F,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""57%2022%207"")",ONLY CAS,US Approved Rx 1988,ANDA071484,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=071484,US Previously Marketed 1963,ONCOVIN by LILLY,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=014103,Philadelphia chromosome-negative (Ph-) acute lymphoblastic leukemia (ALL) in second or greater relapse,Approved
VINORELBINE,71486-22-1,https://drugs.ncats.io/drug/Q6C979R91Y,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""71486%2022%201"")",ONLY CAS,US Approved Rx 2012,ANDA091106,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=091106,US Previously Marketed 1994,NAVELBINE by PIERRE FABRE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020388,Breast cancer; Non-small cell lung cancer,Approved; Approved
VINPOCETINE,42971-09-5,https://drugs.ncats.io/drug/543512OBTC,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""42971%2009%205"")",ONLY CAS,Possibly Marketed Outside US ,Japan:Vinpocetine,https://tripod.nih.gov/npc/#Download,,,,Vascular dementia; Acute ischemic stroke; Epilepsy,Approved; Phase III; Phase II
VISMODEGIB,879085-55-9,https://drugs.ncats.io/drug/25X868M3DS,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""879085%2055%209"")",ONLY CAS,US Approved Rx 2012,NDA203388,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203388,US Approved Rx 2012,NDA203388,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203388,Basal cell carcinoma,Approved
VITAMIN B COMPLEX,123-31-9,https://drugs.ncats.io/drug/XV74C1N1AE,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""123%2031%209"")",ONLY CAS,US Approved Rx 2002,NDA021112,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021112,Possibly Marketed Outside US 1984,"NU-DERM SUNFADER  Skin Lightener with Sunscreen (SPF 15) PABA FREE by OMP, INC.",https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c67b0629-5529-412d-99ee-186df4ecad5a,Melasma of the face,Approved
VITAMIN E,1406-18-4,https://drugs.ncats.io/drug/ec554f7b,2,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1406%2018%204"")%20AND%20(root_names_name:""%5EVITAMIN%20E$"")",EXACT NAME,,,,,,,,
VITAMIN F,7771-44-0,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""7771%2044%200"")",ONLY CAS,,,,,,,,
VITAMIN K,12001-79-5,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""12001%2079%205"")",ONLY CAS,,,,,,,,
VITIS VINIFERA,184362-10-5,https://drugs.ncats.io/drug/C3JJ5TC7LJ,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""184362%2010%205"")",ONLY CAS,,,,,,,,
VORAPAXAR,618385-01-6,https://drugs.ncats.io/drug/ZCE93644N2,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""618385%2001%206"")",ONLY CAS,US Approved Rx 2014,NDA204886,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204886,US Approved Rx 2014,NDA204886,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204886,Peripheral arterial disease; Myocardial infarction,Approved; Approved
VORETIGENE NEPARVOVEC,1646819-03-5,https://drugs.ncats.io/drug/2SPI046IKD,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1646819%2003%205"")",ONLY CAS,Possibly Marketed Outside US 2017,BLA125610,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=08313a24-e7ce-457a-bb3f-161bc45517ee,Possibly Marketed Outside US 2017,BLA125610,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=08313a24-e7ce-457a-bb3f-161bc45517ee,,
VORHYALURONIDASE ALFA,757971-58-7,https://drugs.ncats.io/drug/743QUY4VD8,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""757971%2058%207"")",ONLY CAS,US Approved Rx 2020,BLA761145,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761145,US Approved Rx 2005,BLA021859,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021859,,
VORICONAZOLE,188416-29-7,https://drugs.ncats.io/drug/USG4B1CD29,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""188416%2029%207"")",ONLY CAS,US Approved Rx 2016,ANDA206747,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206747,US Approved Rx 2002,NDA021267,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021267,Esophageal candidiasis; Fusarium spp.; Scedosporium apiospermum infection; Invasive aspergillosis,Approved; Approved; Approved; Approved
VORINOSTAT,149647-78-9,https://drugs.ncats.io/drug/58IFB293JI,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""149647%2078%209"")",ONLY CAS,US Approved Rx 2006,NDA021991,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021991,US Approved Rx 2006,NDA021991,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021991,Cutaneous T-cell lymphoma,Approved
VORTIOXETINE,508233-74-7,https://drugs.ncats.io/drug/3O2K1S3WQV,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""508233%2074%207"")",ONLY CAS,US Approved Rx 2013,NDA204447,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204447,US Approved Rx 2013,NDA204447,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204447,Major depressive disorder,Approved
VOXILAPREVIR,1535212-07-7,https://drugs.ncats.io/drug/0570F37359,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""1535212%2007%207"")",ONLY CAS,US Approved Rx 2017,NDA209195,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209195,US Approved Rx 2017,NDA209195,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209195,Chronic hepatitis C,Approved
WARFARIN,81-81-2,https://drugs.ncats.io/drug/5Q7ZVV76EI,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""81%2081%202"")",ONLY CAS,US Approved Rx 2006,ANDA040616,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=040616,US Previously Marketed 1954,COUMADIN by BRISTOL MYERS SQUIBB,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=009218,Myocardial infarction; Venous thrombosis; Thromboembolic complications associated with atrial fibrillation,Approved; Approved; Approved
WATER,7732-18-5,https://drugs.ncats.io/drug/059QF0KO0R,12,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""7732%2018%205"")%20AND%20(root_names_name:""%5EWATER$"")",EXACT NAME,US Approved OTC ,"21 CFR 349.2 ophthalmic:eyewash water, purified",https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec349-20.xml,US Previously Marketed 1921,Water U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,Plane warts; Genital warts; Nail grooves; Molluscum contagiosum; Hyperkalemia,Phase II; Phase II; Approved; Phase III; Approved
WATER FOR IRRIGATION,7647-14-5,https://drugs.ncats.io/drug/451W47IQ8X,5,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""7647%2014%205"")",ONLY CAS,US Approved OTC ,21 CFR 349.16 ophthalmic:hypertonic agent sodium chloride,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec349-16.xml,US Previously Marketed 1921,Sodium Chloride U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,,
WITHANIA SOMNIFERA,30655-48-2,https://drugs.ncats.io/drug/XY366XV8JT,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""30655%2048%202"")",ONLY CAS,Possibly Marketed Outside US 2022,M016,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=27be84c1-0227-41ca-beb6-3855eff77e41,Possibly Marketed Outside US 2022,M016,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=27be84c1-0227-41ca-beb6-3855eff77e41,,
WOOL ALCOHOLS,8027-33-6,https://drugs.ncats.io/drug/884C3FA9HE,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""8027%2033%206"")",ONLY CAS,US Approved Allergenic Extract 1994,BLA103738,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2f082b68-dc74-418a-9e6f-b3c285b41d44,Possibly Marketed Outside US 1957,21 CFR 334,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6601b210-3d9f-49da-a6a1-27691596b29c,,
WOUND HEALING AGENTS,121-54-0,https://drugs.ncats.io/drug/PH41D05744,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""121%2054%200"")",ONLY CAS,US Previously Marketed 1942,Phemerol Chloride by Parke-Davis,DeHaen 1940-1975 NMEs,US Previously Marketed 1942,Phemerol Chloride by Parke-Davis,DeHaen 1940-1975 NMEs,Head and neck cancer; Methicillin-resistant Staphylococcus aureus; Skin infections; Bacterial Infections,Preclinical; Basic research; Basic research; Approved
XANTHAN GUM,11138-66-2,https://drugs.ncats.io/drug/TTV12P4NEE,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""11138%2066%202"")",ONLY CAS,US Previously Marketed ,21 CFR 310.545(a)(20) weight control xanthan gum,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec310-545.xml,Possibly Marketed Outside US 1984,Liquid Polibar Plus by E-Z-EM Canada Inc,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5b78c1b9-3013-4add-b439-663c419054b3,,
XANTINOL NICOTINATE,437-74-1,https://drugs.ncats.io/drug/8G60H12X2D,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""437%2074%201"")",ONLY CAS,Possibly Marketed Outside US ,WHO-ATC:C04AD02,https://ginas.ncats.nih.gov/ginas/app/substance/8G60H12X2D,,,,Cerebrovascular disorders; Peripheral vascular disease,Approved; Approved
XANTOFYL,127-40-2,https://drugs.ncats.io/drug/X72A60C9MT,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""127%2040%202"")",ONLY CAS,Possibly Marketed Outside US ,"Strovite One Caplets by Exeltis Usa, Inc.",https://www.drugbank.ca/drugs/DB00137,Possibly Marketed Outside US 2001,"Strovite OneCaplets by Exeltis USA, Inc.",https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b9b71fa4-89c7-4f5b-8174-950649434ba5,Age-related macular degeneration; Subclinical atherosclerosis; Alzheimer’s disease,Approved; Phase III; Phase II
XYLANASE,9025-57-4,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""9025%2057%204"")",ONLY CAS,,,,,,,,
XYLITOL,87-99-0,https://drugs.ncats.io/drug/VCQ006KQ1E,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""87%2099%200"")",ONLY CAS,Possibly Marketed Outside US ,"L'ECLAT Blanc Toothpaste by Toaon Co., Ltd.",https://www.drugbank.ca/drugs/DB11195,Possibly Marketed Outside US 1978,60-Second Fluoride Pina Colada by Patterson Dental Supply Inc,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ad3685e0-c6f0-49dd-b638-eec7ec7be795,Acute otitis media; Osteoporosis; Dental caries; Diabetes mellitus,Approved; Preclinical; Approved; Approved
XYLOMETAZOLINE,526-36-3,https://drugs.ncats.io/drug/WPY40FTH8K,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""526%2036%203"")",ONLY CAS,US Approved OTC ,21 CFR 341.20(b)(10) cough/cold:nasal decongestant xylometazoline hydrochloride,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec341-20.xml,US Previously Marketed 1959,Otrivin by Ciba Geigy,OB NME Appendix 1950-1985,Rhinitis; Allergic rhinitis; Common cold,Approved; Approved; Approved
XYLOSE,10257-31-5,N/A,0,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""10257%2031%205"")",ONLY CAS,,,,,,,,
YOHIMBINE,146-48-5,https://drugs.ncats.io/drug/2Y49VWD90Q,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""146%2048%205"")",ONLY CAS,US Previously Marketed ,21 CFR 310.528(a) aphrodisiac yohimbinum,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec310-528.xml,Possibly Marketed Outside US 2015,NADA140866,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=479a43d4-8b9f-4bc3-a6b8-a7418fdb4626,Erectile dysfunction,Approved
ZAFIRLUKAST,107753-78-6,https://drugs.ncats.io/drug/XZ629S5L50,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""107753%2078%206"")",ONLY CAS,US Approved Rx 2023,ANDA213163,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213163,US Approved Rx 1996,NDA020547,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020547,Asthma,Approved
ZALCITABINE,7481-89-2,https://drugs.ncats.io/drug/6L3XT8CB3I,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""7481%2089%202"")",ONLY CAS,US Previously Marketed 1992,HIVID by ROCHE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020199,US Previously Marketed 1992,HIVID by ROCHE,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020199,HIV infection,Approved
ZALEPLON,151319-34-5,https://drugs.ncats.io/drug/S62U433RMH,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""151319%2034%205"")",ONLY CAS,US Approved Rx 2008,ANDA077505,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=077505,US Approved Rx 1999,NDA020859,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020859,Insomnia,Approved
ZANAMIVIR,139110-80-8,https://drugs.ncats.io/drug/L6O3XI777I,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""139110%2080%208"")",ONLY CAS,US Approved Rx 1999,NDA021036,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021036,US Approved Rx 1999,NDA021036,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021036,Influenza virus infections,Approved
ZEAXANTHIN,144-68-3,https://drugs.ncats.io/drug/CV0IB81ORO,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""144%2068%203"")",ONLY CAS,Possibly Marketed Outside US ,"Ocuvel by Adler-Stern Pharmaceuticals, LLC",https://www.drugbank.ca/drugs/DB11176,Possibly Marketed Outside US 2014,"Ocuvel by Adler-Stern Pharmaceuticals, LLC",https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=888dde46-a454-41cf-9a7a-31fca36e9202,Vision disorders; Cataract; Age-related memory impairment,Approved; Phase III; Phase III
ZICONOTIDE,107452-89-1,https://drugs.ncats.io/drug/7I64C51O16,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""107452%2089%201"")",ONLY CAS,US Approved Rx 2004,NDA021060,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021060,US Approved Rx 2004,NDA021060,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021060,severe chronic pain,Approved
ZIDOVUDINE,30516-87-1,https://drugs.ncats.io/drug/4B9XT59T7S,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""30516%2087%201"")",ONLY CAS,US Approved Rx 2008,ANDA077981,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=077981,US Approved Rx 1987,NDA019655,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019655,HIV-1 infection,Approved
ZILEUTON,111406-87-2,https://drugs.ncats.io/drug/V1L22WVE2S,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""111406%2087%202"")",ONLY CAS,US Approved Rx 2020,ANDA211390,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211390,Possibly Marketed Outside US 1996,NDA020471,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=aee65202-fddb-497f-9f11-17cc727cb157,Asthma,Approved
ZINC,7440-66-6,https://drugs.ncats.io/drug/J41CSQ7QDS,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""7440%2066%206"")",ONLY CAS,US Approved OTC ,21 CFR 333.110(a) first aid antibiotic:ointment bacitracin,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec333-110.xml,US Previously Marketed 1921,Zinc U.S.P.,https://www.gutenberg.org/files/41778/41778-h/41778-h.htm,Skin diseases; Infection; Superficial infections of the external eye and its adnexa caused by susceptible bacteria,Approved; Approved; Approved
ZIPRASIDONE,146939-27-7,https://drugs.ncats.io/drug/6UKA5VEJ6X,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""146939%2027%207"")",ONLY CAS,US Approved Rx 2012,ANDA077565,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=077565,US Approved Rx 2001,NDA020825,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020825,Schizophrenia; Bipolar disorder,Approved; Approved
ZIRCONIUM,7440-67-7,https://drugs.ncats.io/drug/C6V6S92N3C,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""7440%2067%207"")",ONLY CAS,US Previously Marketed ,21 CFR 310.502(a) certain drugs zirconium,https://www.gpo.gov/fdsys/pkg/CFR-2018-title21-vol5/xml/CFR-2018-title21-vol5-sec310-502.xml,,,,,
ZIRCONIUM CYCLOSILICATE,17141-74-1,https://drugs.ncats.io/drug/D652ZWF066,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""17141%2074%201"")",ONLY CAS,US Approved Rx 2018,NDA207078,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207078,US Approved Rx 2018,NDA207078,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207078,,
ZOLEDRONIC ACID,118072-93-8,https://drugs.ncats.io/drug/70HZ18PH24,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""118072%2093%208"")",ONLY CAS,US Approved Rx 2013,ANDA091363,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=091363,US Previously Marketed 2001,ZOMETA by NOVARTIS,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021223,Postmenopausal osteoporosis; Hypercalcemia; Prostate cancer with bone metastasis; Renal osteodystrophy; Disuse osteoporosis,Approved; Approved; Approved; Approved; Approved
ZOLMITRIPTAN,139264-17-8,https://drugs.ncats.io/drug/2FS66TH3YW,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""139264%2017%208"")",ONLY CAS,US Approved Rx 2016,ANDA205074,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205074,US Previously Marketed 1997,ZOMIG by IPR,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020768,Migraine with aura; Migraine without aura,Approved; Approved
ZOLPIDEM,82626-48-0,https://drugs.ncats.io/drug/7K383OQI23,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""82626%2048%200"")",ONLY CAS,US Approved Rx 2016,ANDA201509,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201509,US Approved Rx 1992,NDA019908,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019908,Insomnia,Approved
ZONISAMIDE,68291-97-4,https://drugs.ncats.io/drug/459384H98V,1,"https://drugs.ncats.io/substances?q=(root_codes_CAS:""68291%2097%204"")",ONLY CAS,US Approved Rx 2006,ANDA077634,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=077634,US Approved Rx 2000,NDA020789,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020789,Epilepsy,Approved
